data_2jzb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jzb _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.569 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 38.4 p90 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.18 121.72 13.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.241 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.67 -26.56 60.96 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.645 2.23 . . . . 0.0 111.469 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 18.9 tt -69.59 -31.99 50.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.494 ' CD2' HG12 ' A' ' 282' ' ' VAL . 34.2 mt -75.15 -45.16 42.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.4 -0.812 . . . . 0.0 109.39 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.569 HD21 ' CZ2' ' A' ' 321' ' ' TRP . 0.3 OUTLIER -64.01 -37.35 87.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.453 ' CD ' ' OD2' ' A' ' 259' ' ' ASP . 5.2 ttp180 -59.6 141.86 88.1 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.241 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.2 Cg_endo -68.87 133.6 27.65 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.651 2.234 . . . . 0.0 111.691 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.46 ' CA ' HD13 ' A' ' 260' ' ' LEU . 1.0 OUTLIER -44.9 -25.36 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 256' ' ' PRO . 91.1 m-20 -69.58 -30.56 68.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.212 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 48.8 t0 -66.7 -22.55 66.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.46 HD13 ' CA ' ' A' ' 257' ' ' VAL . 38.5 mt -43.62 131.44 5.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -55.93 -24.79 40.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' A' ' 306' ' ' VAL . 5.6 mp -62.35 163.59 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.3 p -62.87 161.09 13.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.4 t -54.76 -26.1 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -51.93 -44.11 63.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.436 ' CB ' ' OE1' ' A' ' 302' ' ' GLU . 8.7 t -58.79 -50.61 73.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -70.49 -33.56 71.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.42 -38.22 71.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 299' ' ' SER . 24.8 m -60.62 -64.6 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.7 -46.64 81.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 76.9 tttt -52.98 -34.01 54.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 269' ' ' CYS . . . -53.76 -23.59 12.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 96.9 mt-10 -89.05 22.59 2.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 71.89 36.48 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.516 ' CG2' ' HB3' ' A' ' 280' ' ' ASP . 70.6 mt -112.16 127.38 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.592 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.9 p80 -116.68 -30.28 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.588 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.592 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.8 m-30 -106.57 127.8 53.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 80.5 mt -48.26 -30.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.566 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -46.5 -48.64 16.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 275' ' ' ILE . 40.0 t0 -53.39 -32.96 51.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.198 . . . . 0.0 108.899 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -56.82 -46.95 81.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.386 -0.821 . . . . 0.0 109.111 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 17.1 m -69.01 -23.22 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.513 ' N ' HG22 ' A' ' 282' ' ' VAL . 95.5 mt-30 -66.2 -36.98 84.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.948 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -104.4 143.06 33.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.417 ' OG1' ' HG3' ' A' ' 288' ' ' GLU . 43.9 p -80.0 151.83 29.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.411 ' OE2' ' OG ' ' A' ' 313' ' ' SER . 8.9 mt-10 -54.45 -39.46 67.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 291' ' ' LYS . 55.8 t -52.98 -55.27 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.417 ' HG3' ' OG1' ' A' ' 285' ' ' THR . 95.6 mt-10 -53.15 -30.58 37.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 292' ' ' THR . 8.4 mp -79.64 -42.42 24.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.499 ' CD2' ' CD1' ' A' ' 300' ' ' LEU . 3.7 mt -65.04 -12.75 54.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 287' ' ' VAL . 45.7 mmtm -89.14 12.34 16.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.531 ' CG2' ' HG ' ' A' ' 295' ' ' LEU . 7.5 t -124.83 138.74 31.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.595 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.54 ' CB ' ' CA ' ' B' ' 479' ' ' GLY . 49.7 Cg_endo -70.82 -27.05 21.89 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.789 2.326 . . . . 0.0 111.78 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.432 ' N ' HD11 ' B' ' 464' ' ' ILE . 26.2 m120 -48.32 -24.4 1.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.531 ' HG ' ' CG2' ' A' ' 292' ' ' THR . 20.3 mt -87.6 143.13 27.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.358 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 299' ' ' SER . . . -110.47 160.38 13.36 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.92 -42.27 72.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -1.156 . . . . 0.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -67.38 -37.84 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.364 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 269' ' ' CYS . 81.1 p -59.18 -39.4 82.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.337 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.499 ' CD1' ' CD2' ' A' ' 290' ' ' LEU . 0.6 OUTLIER -57.99 -42.65 85.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.378 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 49.8 m -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.436 ' OE1' ' CB ' ' A' ' 266' ' ' SER . 96.1 mt-10 -56.59 -42.8 79.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 80.7 mt -57.91 -48.26 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -54.74 -41.57 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -58.29 -51.42 69.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' A' ' 262' ' ' LEU . 1.6 t -68.72 -37.19 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 313' ' ' SER . 20.0 tp -62.03 -26.43 68.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.315 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.23 -29.99 66.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.5 t -74.11 -13.37 60.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.2 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.463 ' O ' HD21 ' A' ' 314' ' ' LEU . 51.2 mtt-85 61.17 13.51 4.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 109.307 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -88.98 -24.56 31.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.52 ' CD1' HG12 ' A' ' 306' ' ' VAL . 1.6 pt? -139.32 153.25 47.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -1.139 . . . . 0.0 109.562 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.3 OUTLIER 71.45 32.62 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.5 mm? -89.27 14.12 11.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.268 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.5 44.88 92.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.509 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 8.0 mtm -94.21 168.75 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.442 ' C ' HD23 ' A' ' 318' ' ' LEU . 53.6 mtt180 -134.05 121.61 21.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 317' ' ' ARG . 5.2 mt -113.4 138.11 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.383 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.58 -32.17 67.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.159 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.3 m-20 -135.05 -64.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 108.988 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.569 ' CZ2' HD21 ' A' ' 254' ' ' LEU . 1.2 t-105 164.73 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.371 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.5 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -68.09 107.91 1.63 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.595 2.197 . . . . 0.0 111.967 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' ' 249' ' ' PHE . 50.2 Cg_endo -70.51 163.07 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.667 2.245 . . . . 0.0 111.689 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.18 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' SER . . . . . 0.41 ' CB ' ' N ' ' A' ' 249' ' ' PHE . 3.8 t -58.73 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.429 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 30.3 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.444 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 26.8 m120 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.437 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 3.1 tttp -67.77 136.52 92.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.512 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.437 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.31 136.53 31.75 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.69 2.26 . . . . 0.0 111.724 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -71.13 159.51 34.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.38 -33.77 63.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.73 -48.32 77.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.424 HD11 ' HA ' ' B' ' 456' ' ' LEU . 16.3 tp -70.1 -38.4 75.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -73.06 -31.44 64.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -84.83 7.73 19.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' B' ' 456' ' ' LEU . 30.1 tp -72.28 133.83 45.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.86 140.83 40.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.16 2.96 68.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.464 HG21 HD12 ' B' ' 481' ' ' LEU . 58.8 t -130.82 137.15 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -1.187 . . . . 0.0 109.421 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 39.6 p30 -103.75 173.55 6.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.561 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 74.8 mtt85 -58.31 -40.52 82.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.63 -49.53 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.509 ' CG ' ' OD1' ' B' ' 441' ' ' ASP . 45.8 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.544 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.29 89.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 17.3 m-30 -66.18 -47.99 72.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.403 ' O ' HD11 ' B' ' 470' ' ' ILE . 61.6 mttt -58.88 -46.38 87.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.585 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.505 ' CD1' ' HB ' ' B' ' 453' ' ' VAL . 3.1 tm? -64.12 -41.17 97.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.36 -30.68 71.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -56.79 -18.52 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.401 ' NH1' ' CB ' ' B' ' 469' ' ' ASP . 14.3 mtp85 -90.65 31.6 1.04 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.82 -18.88 6.84 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' B' ' 448' ' ' LEU . 96.3 t -63.51 139.87 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.878 -1.366 . . . . 0.0 109.382 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.511 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -135.01 -36.01 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 109.701 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.428 ' HA ' ' HB1' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -111.04 148.63 32.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.521 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 30.0 tp -46.17 -40.14 10.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.167 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -56.75 -49.65 74.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.848 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.455 ' HB3' HG11 ' B' ' 453' ' ' VAL . 37.4 t0 -54.8 -38.78 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.108 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 2.9 tm? -60.04 -41.49 92.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 485' ' ' ALA . . . -63.15 -34.14 76.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 0.0 109.393 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.93 -30.77 71.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.474 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -67.53 151.85 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 109.565 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.84 165.82 12.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 28.9 mt -53.28 -35.75 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -1.209 . . . . 0.0 109.4 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.02 -31.27 67.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.525 HD12 ' CB ' ' B' ' 478' ' ' ALA . 23.4 mt -75.44 -29.05 59.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -23.75 62.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . 0.401 ' CB ' ' NH1' ' B' ' 451' ' ' ARG . 86.3 m-20 -50.1 -33.97 20.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.403 HD11 ' O ' ' B' ' 447' ' ' LYS . 65.6 mt -100.89 127.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.25 -33.09 74.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.04 -31.56 40.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.492 HD21 ' CD2' ' B' ' 444' ' ' LEU . 50.5 mt -101.11 140.49 35.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 474' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 478' ' ' ALA . 24.4 m -104.11 161.85 13.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.389 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -57.91 -37.62 74.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -73.88 -46.06 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.455 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 39.2 tttp -68.74 -37.02 79.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.525 ' CB ' HD12 ' B' ' 467' ' ' LEU . . . -64.08 -44.68 91.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.54 ' CA ' ' CB ' ' A' ' 293' ' ' PRO . . . -63.87 -43.1 98.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.82 -33.97 70.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -1.125 . . . . 0.0 109.406 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.464 HD12 HG21 ' B' ' 440' ' ' VAL . 31.0 mt -74.39 -35.16 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 478' ' ' ALA . 78.6 mt -64.03 -53.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.537 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.505 ' HE3' ' N ' ' A' ' 292' ' ' THR . 52.6 mmm -60.74 -42.48 97.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 109.426 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.445 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -58.29 -47.36 83.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 460' ' ' ALA . . . -66.0 -47.68 73.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.536 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 40.2 ttm180 -60.8 -42.62 97.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.48 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 95.9 m-20 -58.85 -39.25 80.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.521 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 66.1 mt -62.27 -40.35 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.82 -52.06 16.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.679 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . 0.481 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 67.2 m95 -64.44 -38.48 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.9 m-85 -99.19 13.1 34.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.569 ' CG ' ' HG3' ' A' ' 323' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.4 126.56 84.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.46 -32.21 50.01 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.794 2.329 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.456 ' O ' HD13 ' A' ' 278' ' ' ILE . 2.9 tt -66.27 -23.55 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 282' ' ' VAL . 5.3 tp -74.28 -44.12 54.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.459 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.537 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 2.2 mm? -73.63 -20.36 60.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.555 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.434 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -63.87 149.87 92.41 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.0 Cg_endo -69.86 136.31 32.41 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.604 2.202 . . . . 0.0 111.934 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.79 -31.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.885 . . . . 0.0 109.424 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 267' ' ' ALA . 97.6 m-20 -62.35 -30.95 71.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 256' ' ' PRO . 53.8 m-20 -73.03 -14.09 61.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 278' ' ' ILE . 59.4 mt -54.13 150.73 7.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.12 -21.52 65.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 5.3 mp -64.64 166.08 9.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -79.88 165.27 22.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.9 t -47.0 -32.85 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -52.78 -50.21 64.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 22.2 t -59.53 -51.11 71.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.415 ' HB3' ' OD1' ' A' ' 258' ' ' ASP . . . -62.67 -37.34 86.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.315 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -56.64 -36.89 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.339 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 272' ' ' ALA . 60.0 m -55.41 -64.98 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.407 HD12 HD13 ' A' ' 281' ' ' LEU . 65.2 mt -62.41 -47.69 82.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 23.2 tttt -53.02 -36.88 61.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -52.79 -30.0 30.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 90.9 mt-10 -94.01 23.99 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.377 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.07 41.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 90.3 mt -122.82 107.66 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.519 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.463 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 64.0 m-70 -109.71 -6.75 15.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.35 129.24 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.507 HD11 ' CD2' ' A' ' 260' ' ' LEU . 80.9 mt -54.72 -30.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.577 ' HA3' ' CZ2' ' A' ' 321' ' ' TRP . . . -46.02 -46.78 14.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.492 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 79.4 m-20 -53.48 -30.9 43.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.038 -1.272 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 278' ' ' ILE . 31.4 tp -59.26 -49.9 76.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 109.136 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 30.2 m -67.51 -30.55 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 108.967 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.497 ' N ' HG23 ' A' ' 282' ' ' VAL . 63.6 tt0 -59.44 -32.83 70.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 108.949 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -109.84 143.84 39.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.447 ' O ' HD21 ' A' ' 289' ' ' LEU . 9.0 m -63.7 137.96 58.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.49 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.412 ' OE1' ' CD2' ' A' ' 307' ' ' LEU . 80.4 tt0 -50.58 -33.51 22.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.387 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.498 ' HA ' ' CD1' ' A' ' 290' ' ' LEU . 55.2 t -54.86 -54.34 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -51.15 -30.72 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.24 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.522 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 3.3 mm? -79.15 -43.67 23.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.257 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.5 ' HA ' ' CD1' ' A' ' 295' ' ' LEU . 5.4 mt -56.85 -18.73 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.495 ' O ' ' HE3' ' B' ' 483' ' ' MET . 69.5 mttt -81.44 -21.94 38.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.357 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 9.8 m -59.49 128.52 86.12 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.634 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.52 ' HD3' ' CG ' ' B' ' 483' ' ' MET . 50.8 Cg_endo -71.16 -14.84 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.804 2.336 . . . . 0.0 112.001 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.449 ' N ' HD11 ' B' ' 464' ' ' ILE . 53.2 m-80 -78.47 3.65 15.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 72.1 mt -81.33 149.55 28.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.517 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . 0.449 ' N ' ' OG ' ' A' ' 299' ' ' SER . . . -108.63 140.92 15.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -52.81 -47.13 67.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -1.188 . . . . 0.0 109.455 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.99 -25.31 59.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 296' ' ' GLY . 82.5 p -73.13 -36.8 66.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 296' ' ' GLY . 29.7 mt -54.31 -39.24 66.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -54.26 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.423 ' CD ' ' HA ' ' A' ' 262' ' ' LEU . 67.7 tt0 -53.82 -39.97 65.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 109.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.465 ' O ' HD13 ' A' ' 307' ' ' LEU . 84.5 mt -57.63 -45.85 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 108.917 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.11 -33.93 74.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 108.964 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.42 -41.58 97.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 109.248 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.543 ' CG1' ' CD2' ' A' ' 312' ' ' LEU . 1.7 t -68.25 -45.65 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 303' ' ' ILE . 8.2 mp -56.43 -26.77 54.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.11 70.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.0 t -65.51 -17.39 64.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.433 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 11.7 ttp180 65.93 9.07 5.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.368 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -94.95 -0.3 63.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.543 ' CD2' ' CG1' ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.29 163.09 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -1.215 . . . . 0.0 109.44 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.47 54.96 9.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.641 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.433 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 76.7 mt -91.81 9.39 32.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.36 38.22 96.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 314' ' ' LEU . 5.6 ptt? -113.3 157.44 21.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.428 ' C ' HD12 ' A' ' 318' ' ' LEU . 77.6 mtt85 -130.23 137.72 50.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 2.8 mp -123.47 140.89 52.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 108.951 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.5 m-20 -122.45 -81.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.577 ' CZ2' ' HA3' ' A' ' 279' ' ' GLY . 1.5 t-105 165.24 -65.98 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.539 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 50.7 Cg_endo -69.47 107.77 1.88 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.563 2.175 . . . . 0.0 111.95 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.569 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.1 Cg_endo -71.91 163.91 37.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.622 2.214 . . . . 0.0 111.6 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.6 25.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.969 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 p -70.54 -38.97 74.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.46 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.523 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 34.3 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 24.3 m120 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.234 0.54 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 20.0 tttm -53.03 136.89 47.48 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.459 ' HD2' ' HG3' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.09 136.76 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.641 2.227 . . . . 0.0 111.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.1 153.23 41.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.513 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -47.06 -38.6 11.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -62.29 -40.73 97.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.5 tm? -66.66 -29.87 69.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . . . . . . . . . 25.2 tp -85.69 -28.52 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.85 -5.81 43.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.524 ' CD1' HD12 ' B' ' 456' ' ' LEU . 35.4 tp -65.82 134.81 53.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -78.26 141.19 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.3 8.34 64.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.44 HG21 HD22 ' B' ' 481' ' ' LEU . 46.6 t -128.19 132.22 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.164 . . . . 0.0 109.471 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -97.89 166.0 11.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.7 -43.14 72.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.401 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.1 m-20 -66.15 -50.15 64.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 mt -55.74 -43.43 76.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.85 78.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.6 m-30 -64.59 -45.12 88.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -45.17 93.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.447 ' CD1' ' C ' ' B' ' 448' ' ' LEU . 1.4 tm? -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -67.14 -28.89 68.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.24 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -93.24 32.06 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.392 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.43 -18.61 6.65 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.491 HG12 ' N ' ' B' ' 459' ' ' LEU . 84.3 t -60.9 139.48 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.9 -1.353 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.433 ' N ' HG13 ' B' ' 453' ' ' VAL . 10.9 m -135.05 -35.88 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.769 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.59 159.39 20.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.896 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.524 HD12 ' CD1' ' B' ' 437' ' ' LEU . 0.3 OUTLIER -48.56 -41.37 30.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.288 -0.883 . . . . 0.0 109.027 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -55.59 -42.28 74.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 0.0 108.766 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.483 ' CB ' HG12 ' B' ' 453' ' ' VAL . 89.5 m-20 -59.86 -43.55 94.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 108.893 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.491 ' N ' HG12 ' B' ' 453' ' ' VAL . 5.8 tt -54.31 -49.15 70.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 0.0 109.172 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.99 71.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.98 -25.71 67.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.357 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.474 ' CG ' HG22 ' B' ' 453' ' ' VAL . 98.5 mm-40 -70.48 152.23 44.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' B' ' 467' ' ' LEU . . . -116.12 162.84 12.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 57.2 mt -49.68 -36.67 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.5 -37.06 79.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.06 -25.12 66.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.523 ' CD2' ' CB ' ' B' ' 478' ' ' ALA . 6.6 mp -91.42 -27.72 18.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 0.0 109.484 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.85 -23.2 66.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.458 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.13 -32.85 68.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 73.5 mt -99.84 128.72 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.67 -32.37 74.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -55.38 -28.8 51.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . . . . . . . . . 60.7 mt -103.68 137.19 42.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.504 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.06 165.8 10.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.68 -39.23 80.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.45 -45.39 31.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.463 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 48.0 tttm -60.75 -46.47 90.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' B' ' 467' ' ' LEU . . . -62.98 -53.22 57.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.506 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -58.38 -48.0 86.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.0 62.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -1.116 . . . . 0.0 109.388 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.44 HD22 HG21 ' B' ' 440' ' ' VAL . 96.5 mt -61.9 -43.67 98.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.5 mt -53.44 -56.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.52 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 50.1 mtp -52.93 -46.17 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.57 -52.93 63.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' B' ' 456' ' ' LEU . . . -61.75 -48.84 78.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.507 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 34.4 ttt180 -56.16 -45.28 79.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.83 -34.06 72.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.514 HD12 ' CD1' ' B' ' 456' ' ' LEU . 79.7 mt -68.31 -39.4 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.519 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.8 -50.59 16.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . 0.507 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 36.3 m95 -58.7 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.18 10.91 31.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.56 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.476 ' HB3' HG21 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -52.71 141.22 36.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.183 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.461 ' HA ' HD21 ' A' ' 254' ' ' LEU . 43.1 Cg_endo -65.0 -23.04 61.86 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.652 2.234 . . . . 0.0 111.903 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.526 ' CG2' HD12 ' A' ' 253' ' ' LEU . 13.2 tt -64.77 -32.09 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.122 -0.986 . . . . 0.0 108.707 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.526 HD12 ' CG2' ' A' ' 252' ' ' ILE . 5.3 mp -74.34 -30.96 62.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.194 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.567 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.5 mm? -69.13 -40.0 78.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.452 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.446 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -61.72 147.58 88.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.446 ' HD2' ' HG2' ' A' ' 255' ' ' ARG . 48.3 Cg_endo -70.24 138.73 36.97 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.683 2.256 . . . . 0.0 111.701 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.509 ' CA ' HD12 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -43.5 -36.05 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.807 . . . . 0.0 109.461 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.49 -31.33 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 256' ' ' PRO . 70.6 m-20 -75.45 -11.0 59.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.537 ' CD2' HD12 ' A' ' 278' ' ' ILE . 61.0 mt -47.47 143.54 3.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -59.94 -18.17 43.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.523 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 6.3 mp -67.86 167.1 14.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.9 p -69.53 160.23 31.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.0 t -50.5 -39.25 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -53.66 -48.96 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.9 m -57.78 -50.56 72.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 257' ' ' VAL . . . -65.77 -35.87 81.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.299 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -58.51 -36.68 74.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 272' ' ' ALA . 79.2 m -55.76 -65.03 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.03 -46.68 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 24.6 tttt -53.46 -37.74 62.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -53.37 -24.81 13.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 73.7 mm-40 -89.35 23.71 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 71.93 38.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 20.0 mm -112.29 121.53 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.449 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.436 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.3 p80 -113.13 -33.2 6.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.436 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.2 m-85 -109.8 131.28 55.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.591 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.537 HD12 ' CD2' ' A' ' 260' ' ' LEU . 76.6 mt -48.88 -30.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.179 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.534 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -47.62 -45.35 23.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.456 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 57.3 m-20 -53.68 -35.02 60.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 109.078 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 35.5 tp -56.28 -48.3 76.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 109.258 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 22.6 m -71.94 -35.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.013 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.496 ' N ' HG23 ' A' ' 282' ' ' VAL . 58.8 tt0 -51.54 -34.9 38.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.338 -0.851 . . . . 0.0 108.89 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -112.36 143.62 43.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.391 -0.818 . . . . 0.0 109.095 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 m -59.93 138.77 57.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.617 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -61.96 -28.53 69.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.93 -53.13 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.42 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 71.1 mm-40 -51.66 -35.86 44.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.522 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 3.3 mm? -76.65 -36.27 57.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.066 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.525 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 2.0 tm? -56.43 -29.17 61.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.521 ' CB ' ' CE ' ' B' ' 483' ' ' MET . 9.1 mttt -81.68 -18.84 43.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.467 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 11.3 m -58.82 129.12 85.09 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.531 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 51.6 Cg_endo -70.46 -10.4 27.92 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.812 2.342 . . . . 0.0 111.83 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.522 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 32.6 m120 -79.66 4.09 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 66.1 mt -84.0 146.99 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -111.66 141.6 16.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -48.74 -50.87 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.51 -33.97 71.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 303' ' ' ILE . 37.4 m -61.98 -40.79 96.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 296' ' ' GLY . 46.1 mt -52.97 -42.86 65.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.7 m -54.72 -50.83 67.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.516 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 98.3 mt-10 -58.73 -39.23 80.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.51 ' CG2' HD12 ' A' ' 307' ' ' LEU . 23.9 mm -58.07 -47.32 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -60.56 -38.16 83.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.05 -46.4 89.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.359 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 312' ' ' LEU . 2.0 t -70.19 -44.86 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 313' ' ' SER . 6.6 mp -62.78 -27.2 69.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.498 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.98 -33.26 70.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 66.2 p -77.49 -5.04 48.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 109.548 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 8.9 mtt85 63.73 10.49 5.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.219 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 253' ' ' LEU . . . -73.07 -22.23 79.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.507 ' CD2' HG13 ' A' ' 306' ' ' VAL . 0.3 OUTLIER -146.64 163.1 36.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.379 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.7 OUTLIER 65.9 28.8 10.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 93.4 mt -66.34 -14.41 62.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.24 11.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.513 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 4.6 ptt? -111.47 162.22 15.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.114 . . . . 0.0 109.448 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -130.76 133.49 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 4.6 mp -118.3 145.29 45.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.79 -34.04 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 37.8 t-20 -125.94 -71.26 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.299 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.567 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.7 OUTLIER 167.43 -68.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.0 Cg_endo -69.7 107.88 1.94 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.504 2.136 . . . . 0.0 111.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.56 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 51.0 Cg_endo -72.1 158.12 52.86 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.529 2.153 . . . . 0.0 111.573 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.6 -15.69 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.378 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.1 m -68.55 -44.34 74.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.472 HD11 ' CB ' ' A' ' 322' ' ' PRO . 24.5 pt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.3 m120 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.425 ' CG ' ' HD2' ' B' ' 430' ' ' PRO . 9.8 tttt -51.21 139.92 24.07 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.468 ' CD ' ' CE1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.07 142.45 46.6 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.65 2.233 . . . . 0.0 111.933 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -73.55 150.35 41.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.34 -36.71 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -65.26 -46.36 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' B' ' 445' ' ' ALA . 3.4 tm? -67.87 -37.82 82.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.478 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.7 OUTLIER -69.16 -31.08 69.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.515 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -89.02 9.88 23.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.489 HD23 ' CG2' ' B' ' 440' ' ' VAL . 43.0 tp -72.43 133.56 44.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.87 142.1 40.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.77 6.57 67.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' B' ' 481' ' ' LEU . 57.4 t -127.62 131.38 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -83.75 149.04 26.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.497 ' NH1' ' CG ' ' B' ' 442' ' ' ARG . 9.4 mtt85 -50.02 -45.81 52.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.09 -39.46 82.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' B' ' 473' ' ' LEU . 15.8 tp -58.88 -37.77 77.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' B' ' 434' ' ' LEU . . . -60.7 -42.01 96.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.468 ' CE1' ' CD ' ' B' ' 430' ' ' PRO . 77.8 m-85 -64.69 -44.24 90.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.518 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 13.7 ttmm -58.63 -48.55 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' B' ' 448' ' ' LEU . 3.4 tm? -65.17 -41.24 94.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.835 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -57.25 -26.84 61.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.68 -20.53 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.948 . . . . 0.0 109.472 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.432 ' HD2' HD11 ' B' ' 470' ' ' ILE . 48.6 mtp85 -89.75 26.59 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.942 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.88 7.13 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 57.6 t -62.32 135.82 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.306 . . . . 0.0 109.326 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 69.0 m -135.01 -36.96 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.63 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.44 ' HA ' ' HB1' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -103.72 146.56 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 36.4 tp -47.69 -42.81 25.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . 0.446 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 26.2 mm-40 -55.86 -46.53 78.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.041 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.78 -41.58 74.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 108.913 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 3.3 tm? -57.4 -43.92 84.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.111 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.37 76.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.326 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -30.13 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.41 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.2 mm-40 -75.12 140.76 43.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -100.03 163.53 19.29 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 81.3 mt -47.52 -33.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.07 -36.28 79.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.41 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 86.8 m-20 -68.66 -30.61 69.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.503 HD23 ' CB ' ' B' ' 478' ' ' ALA . 6.9 mp -82.73 -30.05 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.328 -0.858 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.09 58.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.09 -30.5 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.518 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 63.9 mt -104.92 123.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.74 -31.7 71.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.37 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.13 -32.69 36.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.546 ' CD2' ' N ' ' B' ' 473' ' ' LEU . 2.7 mm? -103.13 138.78 39.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.224 -1.162 . . . . 0.0 109.54 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 28.7 m -104.04 161.87 13.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.877 . . . . 0.0 109.333 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -57.45 -38.08 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.81 -45.95 26.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.51 ' HE2' ' CD2' ' B' ' 444' ' ' LEU . 19.0 tttt -66.14 -47.19 74.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.503 ' CB ' HD23 ' B' ' 467' ' ' LEU . . . -59.24 -46.74 87.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.512 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.18 -49.88 68.77 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.35 54.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -1.185 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' B' ' 440' ' ' VAL . 26.4 mt -56.62 -37.6 70.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 50.4 mt -63.33 -51.08 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.414 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.521 ' CE ' ' CB ' ' A' ' 291' ' ' LYS . 23.6 mtp -52.61 -48.41 66.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -55.71 -55.74 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.408 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.438 ' HA ' HD22 ' B' ' 456' ' ' LEU . . . -59.46 -47.98 83.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -62.8 -40.98 99.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.0 m-20 -58.24 -44.93 88.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.583 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 57.2 mt -61.6 -37.56 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . 0.446 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.2 OUTLIER -76.12 -52.02 10.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -61.33 -31.59 71.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 13.1 m-30 -71.0 -33.69 70.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 253' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.95 150.37 29.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.575 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.56 -25.28 55.16 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.749 2.299 . . . . 0.0 111.643 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 15.1 tt -68.6 -27.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 109.179 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 249' ' ' PHE . 26.8 mt -74.11 -45.24 50.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.576 HD21 ' CZ2' ' A' ' 321' ' ' TRP . 0.5 OUTLIER -63.88 -34.65 78.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.456 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -55.91 141.74 66.23 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.156 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.0 Cg_endo -69.03 133.95 28.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.695 2.263 . . . . 0.0 111.742 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 267' ' ' ALA . 0.1 OUTLIER -43.41 -34.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.475 ' HB2' ' NZ ' ' A' ' 271' ' ' LYS . 55.3 t0 -59.44 -30.97 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 m-20 -73.75 -17.12 61.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.504 ' CD2' HD13 ' A' ' 278' ' ' ILE . 51.5 mt -43.5 144.95 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -63.92 -22.06 66.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.529 ' CB ' ' OG ' ' A' ' 266' ' ' SER . 5.2 mp -65.56 166.84 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.2 p -66.71 166.59 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.557 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.6 t -57.35 -36.47 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 109.639 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.14 -48.65 70.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 262' ' ' LEU . 95.2 p -57.94 -51.04 71.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 257' ' ' VAL . . . -62.62 -42.41 99.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -56.58 -37.44 70.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 85.4 m -50.37 -60.48 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.32 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.464 HD11 ' CD1' ' A' ' 281' ' ' LEU . 74.0 mt -57.51 -45.06 85.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.376 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.475 ' NZ ' ' HB2' ' A' ' 258' ' ' ASP . 82.3 mttt -52.92 -29.91 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.359 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.14 -34.32 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 45.1 mt-10 -90.53 26.13 2.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.21 40.91 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.515 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 22.7 mm -108.14 124.24 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.432 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.575 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -115.83 -37.27 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.37 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.575 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -106.32 133.04 51.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.504 HD13 ' CD2' ' A' ' 260' ' ' LEU . 88.7 mt -46.72 -30.36 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.552 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -46.34 -48.64 15.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.515 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 94.0 m-20 -53.24 -31.27 42.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.004 -1.292 . . . . 0.0 108.727 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 270' ' ' LEU . 44.9 tp -55.72 -51.9 65.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 34.5 m -64.39 -28.26 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 108.832 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.523 ' N ' HG21 ' A' ' 282' ' ' VAL . 62.3 tt0 -59.75 -34.89 73.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.848 . . . . 0.0 108.903 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.446 ' HG2' ' NH1' ' A' ' 284' ' ' ARG . 18.6 mtt-85 -107.07 144.29 33.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.256 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.8 m -68.43 143.4 55.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 0.0 109.559 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -55.62 -30.25 60.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.62 -51.61 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -51.91 -33.97 39.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.388 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.2 mm? -74.68 -30.52 61.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.77 -30.91 70.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.524 ' O ' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.73 -12.7 58.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.168 -0.958 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 294' ' ' ASN . 23.8 m -79.38 117.67 68.33 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.648 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.534 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 48.4 Cg_endo -69.86 -20.43 34.39 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.784 2.322 . . . . 0.0 111.866 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.502 ' N ' HD12 ' B' ' 464' ' ' ILE . 53.0 m-80 -48.85 -31.41 7.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 289' ' ' LEU . 0.5 OUTLIER -105.02 144.63 31.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -85.83 169.23 42.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -64.92 -40.9 95.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -1.145 . . . . 0.0 109.479 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -59.78 -40.12 87.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 303' ' ' ILE . 24.6 m -57.57 -41.55 81.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.48 ' CD1' ' C ' ' A' ' 300' ' ' LEU . 2.2 tm? -54.83 -37.04 65.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 27.5 m -55.75 -59.42 4.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.219 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 305' ' ' ASP . 75.2 tt0 -54.92 -44.47 74.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 67.8 mt -57.48 -52.38 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 108.856 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -53.28 -36.41 61.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.312 -0.867 . . . . 0.0 108.675 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 302' ' ' GLU . 62.5 t0 -57.46 -48.14 79.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 108.913 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 312' ' ' LEU . 11.6 t -66.17 -34.81 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.939 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 313' ' ' SER . 21.4 mt -64.23 -26.66 68.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.42 -29.99 66.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.117 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 79.8 p -79.14 -7.94 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.45 ' HB3' HD12 ' A' ' 314' ' ' LEU . 73.6 mtt85 61.76 13.15 5.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -73.03 -36.15 57.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.523 HD23 ' CG1' ' A' ' 306' ' ' VAL . 2.1 pt? -135.05 159.37 41.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 109.688 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.468 ' HB2' HD21 ' A' ' 307' ' ' LEU . 0.2 OUTLIER 61.31 63.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.892 . . . . 0.0 109.677 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.2 mm? -96.32 12.38 31.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.65 92.28 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.462 ' CE ' ' CE1' ' A' ' 249' ' ' PHE . 10.9 ptt? -114.36 150.63 34.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -109.12 133.34 53.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.75 138.48 42.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.898 . . . . 0.0 109.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.69 -47.21 82.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.017 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 36.2 t-20 -126.64 -59.04 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 108.976 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.576 ' CZ2' HD21 ' A' ' 254' ' ' LEU . 1.5 t-105 163.4 -65.52 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.283 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.533 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.4 Cg_endo -69.03 107.67 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.624 2.216 . . . . 0.0 111.923 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 51.0 Cg_endo -71.31 161.0 47.14 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.591 2.194 . . . . 0.0 111.45 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.2 -15.37 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.8 t -69.57 -46.42 66.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.499 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 22.2 pt . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 109.504 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' B' ' 449' ' ' ALA . 31.1 m120 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.322 0.582 . . . . 0.0 109.463 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.439 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 33.3 tttt -64.52 136.84 96.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.3 Cg_endo -70.7 139.69 37.52 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.607 2.205 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -66.03 156.03 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -54.77 -36.99 65.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -62.63 -48.74 78.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.0 tm? -65.83 -35.52 80.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.422 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -85.34 6.29 27.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.533 ' CD2' ' CD1' ' B' ' 456' ' ' LEU . 37.9 tp -75.42 131.55 40.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.28 145.2 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.906 . . . . 0.0 109.507 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.19 7.5 67.68 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' B' ' 437' ' ' LEU . 59.6 t -124.43 129.5 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.414 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -85.13 147.39 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.06 -43.62 51.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.528 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 90.6 m-20 -70.3 -41.06 73.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.456 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 10.5 tp -58.49 -46.11 87.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.468 ' CB ' HD13 ' B' ' 434' ' ' LEU . . . -59.26 -39.34 82.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 15.9 m-30 -60.29 -43.79 95.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.01 -44.88 95.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' B' ' 448' ' ' LEU . 2.4 tm? -67.31 -38.08 84.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.39 -28.25 68.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -55.33 -18.92 7.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.415 ' NH2' HG12 ' B' ' 470' ' ' ILE . 33.6 mtt-85 -91.39 30.38 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.85 -18.9 6.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.482 HG12 ' N ' ' B' ' 459' ' ' LEU . 46.4 t -61.63 136.07 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.893 -1.357 . . . . 0.0 109.326 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 9.4 m -135.17 -37.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.49 147.76 26.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' B' ' 437' ' ' LEU . 16.3 tp -47.2 -41.81 18.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.056 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.85 -47.27 77.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.864 . . . . 0.0 109.028 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.41 ' CB ' HG13 ' B' ' 453' ' ' VAL . 74.8 m-20 -55.14 -44.72 75.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.482 ' N ' HG12 ' B' ' 453' ' ' VAL . 6.9 tt -53.11 -49.91 65.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' B' ' 486' ' ' ARG . . . -54.54 -39.36 67.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.65 -34.69 67.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.439 ' O ' HD13 ' B' ' 482' ' ' ILE . 99.6 mm-40 -63.65 151.77 40.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.25 154.12 16.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 60.3 mt -45.09 -40.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -1.177 . . . . 0.0 109.228 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.36 -43.06 92.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.296 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 469' ' ' ASP . 78.1 m-20 -63.41 -23.79 67.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' B' ' 478' ' ' ALA . 6.8 mp -93.09 -19.23 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.22 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.535 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' B' ' 470' ' ' ILE . 18.6 p30 -79.29 3.7 17.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.453 HG13 ' OD1' ' B' ' 469' ' ' ASP . 36.4 mt -105.53 126.63 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.965 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.45 133.33 52.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.11 -30.16 10.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.456 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 64.8 mt -88.21 128.72 35.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -1.16 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 474' ' ' THR . . . . . 0.466 HG23 ' N ' ' B' ' 475' ' ' ASP . 51.9 m -104.01 162.15 13.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.466 ' N ' HG23 ' B' ' 474' ' ' THR . 86.7 m-20 -58.97 -36.76 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -76.95 -43.32 35.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.46 ' O ' HD13 ' B' ' 481' ' ' LEU . 76.6 tttt -61.58 -47.58 84.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 482' ' ' ILE . . . -63.66 -40.84 97.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.46 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.73 -38.08 95.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.27 77.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -1.216 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.474 HD11 ' N ' ' B' ' 481' ' ' LEU . 8.6 mp -68.81 -27.05 65.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.474 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 52.3 mt -77.08 -56.5 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.524 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 60.2 mtp -52.81 -38.3 61.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.83 14.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 109.317 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.466 ' HB3' ' HG ' ' B' ' 456' ' ' LEU . . . -61.35 -45.96 92.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.514 ' HD2' ' CG2' ' B' ' 482' ' ' ILE . 42.2 mtp180 -57.42 -45.67 84.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 91.3 m-20 -57.96 -37.13 73.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 63.6 mt -68.88 -36.99 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.52 -50.37 15.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.397 -0.814 . . . . 0.0 109.561 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.47 -43.51 90.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.917 . . . . 0.0 109.601 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 98.7 m-85 -95.46 12.41 29.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 323' ' ' PRO . 34.0 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.62 151.14 32.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.23 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.04 -24.13 60.27 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.455 2.103 . . . . 0.0 111.72 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.524 ' CG2' HD13 ' A' ' 253' ' ' LEU . 15.9 tt -58.94 -32.42 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.554 ' CD2' ' CE ' ' A' ' 316' ' ' MET . 5.3 mp -74.26 -35.39 63.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.942 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.58 HD11 ' CZ2' ' A' ' 321' ' ' TRP . 2.6 mm? -72.2 -20.07 61.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.779 . . . . 0.0 109.189 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -78.08 144.33 67.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 49.5 Cg_endo -69.61 139.16 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.809 2.34 . . . . 0.0 111.907 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.495 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.34 -34.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.294 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.454 ' OD1' ' HB1' ' A' ' 267' ' ' ALA . 93.4 m-20 -61.78 -30.79 71.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.3 m-20 -76.95 -9.74 58.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.407 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.534 ' CD2' ' CD1' ' A' ' 278' ' ' ILE . 74.3 mt -57.32 144.91 34.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.92 -18.93 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 306' ' ' VAL . 6.7 mp -64.49 169.69 4.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.5 p -75.45 164.25 26.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 109.629 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.65 -27.48 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -59.82 -41.91 92.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.15 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.448 ' OG ' HD22 ' A' ' 262' ' ' LEU . 26.4 t -60.66 -50.42 73.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.454 ' HB1' ' OD1' ' A' ' 258' ' ' ASP . . . -66.11 -36.56 83.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.942 . . . . 0.0 109.296 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.74 -40.1 82.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 73.3 m -52.08 -65.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.517 ' CD2' HD12 ' A' ' 281' ' ' LEU . 6.6 mp -65.24 -42.36 93.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.283 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.574 ' HE2' ' CE1' ' A' ' 276' ' ' HIS . 50.3 tttm -52.79 -40.11 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.26 -26.69 12.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 90.5 mt-10 -91.85 20.63 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 37.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 77.7 mt -124.01 107.88 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.574 ' CE1' ' HE2' ' A' ' 271' ' ' LYS . 61.5 m-70 -107.37 -4.85 18.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.1 m-85 -112.94 133.55 54.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.42 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 260' ' ' LEU . 50.7 mt -62.1 -30.99 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.191 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.575 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -48.62 -45.82 30.3 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 92.0 m-20 -53.61 -36.54 62.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -1.114 . . . . 0.0 109.153 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.517 HD12 ' CD2' ' A' ' 270' ' ' LEU . 4.3 tt -53.15 -49.12 67.24 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.948 . . . . 0.0 108.953 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 13.4 m -67.46 -22.97 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.114 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.498 ' N ' HG23 ' A' ' 282' ' ' VAL . 61.5 tt0 -65.82 -33.33 75.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.002 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -105.29 143.51 33.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.044 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 m -59.99 138.04 57.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 85.2 tt0 -55.64 -29.53 59.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.32 -50.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -51.72 -37.54 51.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.4 mm? -69.72 -37.66 76.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 300' ' ' LEU . 37.3 tp -64.4 -26.27 68.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.307 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.452 ' O ' ' HE3' ' B' ' 483' ' ' MET . 35.8 mttm -93.01 25.9 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.448 ' HB ' HD11 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -114.21 134.84 22.16 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.163 -0.96 . . . . 0.0 109.487 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.536 ' HD3' ' CG ' ' B' ' 483' ' ' MET . 52.3 Cg_endo -71.92 -24.33 21.08 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.839 2.36 . . . . 0.0 112.018 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.519 ' N ' HD11 ' B' ' 464' ' ' ILE . 75.7 m-80 -57.79 -28.69 64.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 5.0 mp -94.54 125.4 39.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.9 171.5 32.96 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' B' ' 461' ' ' GLU . 24.8 mttm -51.89 -36.71 49.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -75.01 -38.57 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.592 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.4 m -57.61 -49.06 77.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.521 HD22 ' CD1' ' A' ' 290' ' ' LEU . 23.9 tp -52.81 -42.87 65.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 56.9 m -52.45 -53.51 44.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.439 ' HB3' HD23 ' A' ' 262' ' ' LEU . 96.8 mt-10 -54.07 -39.69 66.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -0.944 . . . . 0.0 109.069 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 303' ' ' ILE . 76.5 mt -58.47 -43.22 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.117 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -60.73 -41.51 95.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.264 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -58.28 -47.13 84.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.935 . . . . 0.0 109.225 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.489 ' CG1' HD22 ' A' ' 312' ' ' LEU . 2.2 t -73.28 -37.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 313' ' ' SER . 0.1 OUTLIER -60.95 -26.41 67.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' A' ' 310' ' ' ARG . . . -58.22 -32.06 67.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -60.55 -13.99 17.28 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 109.843 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.478 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 75.0 mtm-85 63.67 9.83 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.462 ' O ' HD13 ' A' ' 253' ' ' LEU . . . -113.08 -7.65 21.09 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.516 ' CD1' HD23 ' A' ' 281' ' ' LEU . 7.9 tp -127.04 130.68 50.43 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.188 -1.183 . . . . 0.0 109.335 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 307' ' ' LEU . 12.8 t 68.84 56.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.764 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.2 mt -105.66 21.57 17.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.149 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.97 39.82 94.65 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.554 ' CE ' ' CD2' ' A' ' 253' ' ' LEU . 3.1 mtm -86.79 170.08 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -143.28 126.24 16.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 4.0 mp -124.3 134.0 53.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 109.708 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.9 -39.89 95.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.912 . . . . 0.0 108.988 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 78.4 m-20 -119.1 -75.3 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.58 ' CZ2' HD11 ' A' ' 254' ' ' LEU . 1.1 t-105 168.73 -58.3 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.496 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.0 Cg_endo -68.49 107.49 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.654 2.236 . . . . 0.0 112.001 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.563 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 50.0 Cg_endo -71.26 165.08 33.56 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.609 2.206 . . . . 0.0 111.592 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.07 -23.35 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.0 t -77.09 -38.36 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.529 ' CD1' HD13 ' A' ' 254' ' ' LEU . 20.0 tt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.6 m120 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.06 128.91 50.05 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 109.554 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.523 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.1 Cg_endo -70.71 136.53 30.69 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.593 2.195 . . . . 0.0 111.728 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.514 ' CB ' HG23 ' B' ' 455' ' ' THR . . . -64.15 153.05 38.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -55.09 -36.91 66.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.69 -44.91 92.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.352 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 3.4 tm? -69.97 -37.12 75.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.3 tm? -70.21 -33.17 71.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.588 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -90.17 8.3 33.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.646 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' B' ' 488' ' ' ILE . 25.5 tp -73.6 136.25 43.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -77.2 145.05 37.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.89 -6.06 73.02 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.78 135.68 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -1.214 . . . . 0.0 109.468 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -91.04 152.84 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -49.85 -38.66 36.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.63 -40.68 80.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.863 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.444 HD11 ' NZ ' ' B' ' 477' ' ' LYS . 20.1 mt -64.61 -34.65 78.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.394 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.88 76.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.523 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.1 m-85 -62.91 -44.05 97.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.526 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 7.1 ttmm -55.03 -37.84 67.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.435 HD13 HD12 ' B' ' 459' ' ' LEU . 85.2 mt -69.16 -39.92 78.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -59.24 -33.05 70.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.58 -35.75 6.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.506 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 9.5 mtp85 -90.12 21.47 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.502 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.72 7.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' B' ' 458' ' ' ASP . 4.9 t -81.8 112.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.915 -1.344 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.5 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 3.8 p -128.04 -42.17 1.57 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.514 HG23 ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -74.22 144.83 44.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.483 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.505 ' CD1' HD11 ' B' ' 437' ' ' LEU . 36.8 tp -48.87 -45.44 41.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.87 -45.87 78.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.216 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.527 ' CB ' HG12 ' B' ' 453' ' ' VAL . 89.5 m-20 -56.55 -40.3 74.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.275 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.437 ' HA ' HG13 ' B' ' 453' ' ' VAL . 20.5 tp -60.1 -43.59 95.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.46 -33.1 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.282 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' A' ' 297' ' ' LYS . 72.5 mm-40 -68.09 -31.05 70.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.43 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.526 ' CG ' HG21 ' B' ' 453' ' ' VAL . 99.3 mm-40 -78.0 136.86 38.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.51 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -98.13 160.1 20.71 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 65.0 mt -44.04 -39.67 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.432 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.98 -36.53 81.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 85.7 m-20 -70.51 -28.59 65.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.302 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' B' ' 478' ' ' ALA . 7.4 mp -82.0 -28.27 32.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.65 65.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -56.99 -31.02 64.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.526 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 59.6 mt -103.22 118.28 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.72 -31.01 57.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.83 -32.4 48.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' B' ' 473' ' ' LEU . 2.8 mm? -107.58 138.03 44.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 24.4 m -104.04 165.08 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.09 -38.46 79.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -75.79 -46.12 32.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.51 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 20.8 tttt -63.2 -48.01 80.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.519 ' HB3' ' CD2' ' B' ' 467' ' ' LEU . . . -60.22 -36.44 77.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.502 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.76 -44.13 97.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.26 86.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.51 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.2 mp -69.17 -34.11 74.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 62.4 mt -69.49 -56.48 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.536 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 40.9 mmm -54.53 -38.79 66.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.465 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -62.14 -54.16 45.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -63.82 -42.41 97.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -57.53 -44.09 84.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -64.44 -36.62 84.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.466 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.567 ' CD1' ' CD1' ' B' ' 437' ' ' LEU . 65.9 mt -66.72 -37.15 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 4.8 m -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -66.61 -33.33 75.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -98.19 10.53 40.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.578 ' CG ' ' HG3' ' A' ' 323' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.29 133.58 93.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.55 -26.18 54.57 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.782 2.321 . . . . 0.0 111.467 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.516 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 14.5 tt -66.65 -25.57 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.225 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.497 HD21 ' CG1' ' A' ' 282' ' ' VAL . 44.7 mt -74.23 -45.41 48.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 109.573 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.574 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.2 mm? -66.85 -26.84 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.547 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.16 143.66 96.14 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.147 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 259' ' ' ASP . 48.4 Cg_endo -69.07 132.77 25.16 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.63 2.22 . . . . 0.0 111.757 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 267' ' ' ALA . 0.1 OUTLIER -43.68 -32.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.31 -31.07 71.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.354 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' PRO . 33.0 m-20 -70.52 -14.46 62.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 257' ' ' VAL . 53.3 mt -48.16 138.0 10.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.33 -15.06 59.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 302' ' ' GLU . 6.9 mp -69.8 173.15 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.8 p -66.86 162.15 22.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.422 HG11 ' ND2' ' A' ' 268' ' ' ASN . 21.2 t -60.79 -23.92 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.01 -44.28 97.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.274 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -48.78 80.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -67.23 -39.55 86.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.422 ' ND2' HG11 ' A' ' 264' ' ' VAL . 91.7 m-20 -56.8 -37.22 70.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.447 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 25.2 m -53.33 -64.77 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.479 ' CD2' HD13 ' A' ' 289' ' ' LEU . 78.8 mt -60.37 -45.13 94.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 64.9 tttm -52.86 -35.76 58.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -54.06 -20.42 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 96.4 mt-10 -94.8 23.84 5.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.468 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.56 37.32 1.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.496 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.6 mt -115.54 128.19 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.609 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -116.34 -27.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.609 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.4 m-85 -110.55 137.07 48.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 90.8 mt -55.47 -29.78 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.89 -46.7 14.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 78.0 m-20 -53.58 -31.3 46.2 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.041 -1.27 . . . . 0.0 108.688 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 278' ' ' ILE . 43.4 tp -57.07 -50.75 71.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.498 -0.751 . . . . 0.0 109.13 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 35.9 m -64.7 -29.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 108.912 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.506 ' N ' HG22 ' A' ' 282' ' ' VAL . 58.9 tt0 -59.45 -35.86 74.85 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.316 -0.865 . . . . 0.0 108.723 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -98.95 150.03 22.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.46 -0.775 . . . . 0.0 109.084 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 25.5 m -79.5 142.42 35.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.464 ' CD ' ' CD1' ' A' ' 307' ' ' LEU . 82.8 tt0 -55.63 -27.6 50.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' A' ' 291' ' ' LYS . 47.8 t -52.74 -55.5 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.12 -30.69 70.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.158 -0.964 . . . . 0.0 108.645 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' A' ' 303' ' ' ILE . 20.1 tp -61.95 -37.33 84.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.509 -0.744 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.01 -23.33 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.533 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 48.5 mttm -81.62 -17.11 49.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.405 ' O ' HD13 ' A' ' 295' ' ' LEU . 2.1 m -73.46 117.29 59.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.549 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.512 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 50.9 Cg_endo -71.07 -20.5 28.65 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.68 2.253 . . . . 0.0 111.865 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.514 ' N ' HD12 ' B' ' 464' ' ' ILE . 33.9 m120 -52.89 -20.43 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 2.4 mp -101.98 132.59 47.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -76.68 157.64 47.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.506 ' CE ' ' HA ' ' B' ' 461' ' ' GLU . 23.6 mttm -49.66 -39.33 35.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -1.169 . . . . 0.0 109.396 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -71.46 -38.61 71.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.2 m -61.88 -47.4 85.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.522 HD23 ' CB ' ' A' ' 295' ' ' LEU . 77.7 mt -53.01 -42.82 66.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.255 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 44.4 m -52.99 -51.73 60.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.496 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 94.0 mt-10 -55.78 -39.76 71.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.317 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.521 ' CG2' HD22 ' A' ' 289' ' ' LEU . 33.5 mm -58.03 -48.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.901 . . . . 0.0 109.236 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -56.69 -41.45 77.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -58.58 -45.88 88.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.275 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.587 ' CG1' ' CD1' ' A' ' 312' ' ' LEU . 2.2 t -62.0 -38.28 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.103 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 313' ' ' SER . 20.5 mt -54.63 -25.44 26.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.416 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.41 -39.18 75.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.416 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -20.71 2.83 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.404 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 310' ' ' ARG . 21.0 tpt180 64.9 10.23 6.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -106.8 -0.92 36.61 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.587 ' CD1' ' CG1' ' A' ' 306' ' ' VAL . 0.5 OUTLIER -138.45 148.55 44.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -1.169 . . . . 0.0 109.565 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.526 ' CB ' HD23 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 51.21 64.5 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.589 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.45 9.24 43.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.97 31.0 64.84 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.528 ' HE2' ' CG1' ' A' ' 282' ' ' VAL . 12.7 ptt? -114.08 150.22 34.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.411 ' C ' HD11 ' A' ' 318' ' ' LEU . 72.0 mtt85 -124.63 143.17 50.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.4 mp -118.83 140.57 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.75 -40.23 79.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 108.939 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 38.7 t-20 -122.08 -71.46 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.574 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 1.4 t-105 167.59 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.617 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.2 Cg_endo -67.8 107.89 1.57 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 112.069 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.578 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 54.3 Cg_endo -73.49 164.86 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.721 2.281 . . . . 0.0 111.684 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.09 66.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 44.6 m -76.46 -38.58 55.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.877 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.471 ' CG2' ' O ' ' A' ' 323' ' ' PRO . 19.2 tt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 28.4 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.637 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.416 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 0.7 OUTLIER -55.75 132.38 72.42 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.969 . . . . 0.0 109.376 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.444 ' HB3' ' CD2' ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.01 141.05 43.21 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.62 2.214 . . . . 0.0 111.715 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.536 ' CB ' HG22 ' B' ' 455' ' ' THR . . . -75.3 156.38 35.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.2 m-20 -47.24 -38.56 12.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . 0.443 ' C ' ' HB2' ' B' ' 456' ' ' LEU . 51.3 m-20 -60.49 -48.47 81.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.533 ' CD1' HD13 ' B' ' 459' ' ' LEU . 25.5 tp -68.18 -37.89 81.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 0.0 109.556 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.471 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.6 OUTLIER -76.85 -28.86 55.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.428 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' B' ' 432' ' ' ASP . 36.8 t-20 -90.32 10.27 25.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.523 ' CD1' HD11 ' B' ' 488' ' ' ILE . 41.9 tp -78.31 129.88 35.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.19 146.1 35.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.33 7.97 72.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.486 ' CG2' HD21 ' B' ' 481' ' ' LEU . 77.7 t -124.6 129.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 109.458 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -83.34 147.25 28.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -50.01 -40.81 45.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.455 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.9 m-20 -72.44 -40.55 66.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.439 ' CD2' ' HE3' ' B' ' 477' ' ' LYS . 23.1 tp -59.72 -42.28 92.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.72 80.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.38 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 11.7 m-30 -65.35 -41.58 93.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.46 -51.21 69.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' B' ' 453' ' ' VAL . 3.9 tt -62.23 -43.14 99.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -58.24 -31.31 67.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.75 -17.17 33.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.363 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -89.32 33.26 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 0.0 109.423 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.54 -18.97 7.66 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.512 ' CB ' HD22 ' B' ' 448' ' ' LEU . 61.4 t -64.17 135.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.281 . . . . 0.0 109.34 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' B' ' 431' ' ' ALA . 0.8 OUTLIER -131.82 -33.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.536 HG22 ' CB ' ' B' ' 431' ' ' ALA . 0.6 OUTLIER -115.1 142.14 47.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.0 109.733 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' B' ' 485' ' ' ALA . 2.0 tm? -45.42 -39.47 7.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 108.867 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.0 -48.2 76.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.205 -0.934 . . . . 0.0 108.653 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -54.26 -42.77 70.33 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.334 -0.853 . . . . 0.0 108.72 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' B' ' 434' ' ' LEU . 5.1 tt -53.7 -48.91 69.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 109.018 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.515 ' HB1' ' N ' ' B' ' 486' ' ' ARG . . . -56.03 -35.62 67.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . 0.506 ' HA ' ' CE ' ' A' ' 297' ' ' LYS . 96.7 mt-10 -67.21 -28.34 68.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -63.78 164.87 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.26 154.07 16.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 294' ' ' ASN . 45.9 mt -52.33 -34.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.15 -34.28 74.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.52 -31.92 63.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.526 ' HB2' ' CB ' ' B' ' 478' ' ' ALA . 34.6 mt -74.94 -34.86 62.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.333 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.92 -21.52 11.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.545 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -50.19 -36.97 32.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.2 125.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -62.24 -35.61 79.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.446 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -33.14 22.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' B' ' 478' ' ' ALA . 10.9 tp -99.17 141.7 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 474' ' ' THR . . . . . 0.483 HG21 ' N ' ' B' ' 475' ' ' ASP . 89.0 m -104.15 164.79 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.483 ' N ' HG21 ' B' ' 474' ' ' THR . 92.3 m-20 -56.5 -40.11 74.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -75.4 -46.25 34.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.439 ' HE3' ' CD2' ' B' ' 444' ' ' LEU . 37.7 tttp -60.41 -38.28 83.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 109.275 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.526 ' CB ' ' HB2' ' B' ' 467' ' ' LEU . . . -68.75 -50.66 48.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' B' ' 464' ' ' ILE . . . -62.58 -48.59 80.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.97 61.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -1.121 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.486 HD21 ' CG2' ' B' ' 440' ' ' VAL . 64.1 mt -62.41 -40.92 98.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.265 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 50.0 mt -55.01 -55.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.23 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 31.8 mtp -53.14 -45.3 68.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.26 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.9 -45.09 90.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.164 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -63.13 -52.27 63.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.255 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.515 ' N ' ' HB1' ' B' ' 460' ' ' ALA . 89.2 mtt180 -59.46 -39.57 84.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 93.6 m-20 -57.31 -41.59 80.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.523 HD11 ' CD1' ' B' ' 437' ' ' LEU . 83.3 mt -59.65 -36.61 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.43 -51.62 9.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.772 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -63.84 -45.92 87.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.0 m-85 -76.08 -29.5 57.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.892 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.574 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 44.4 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.4 124.93 57.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.305 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.07 -22.68 61.76 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.623 2.215 . . . . 0.0 111.665 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.519 ' CD1' HD23 ' A' ' 312' ' ' LEU . 12.7 tt -71.8 -31.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 108.833 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.523 ' CD2' HG12 ' A' ' 282' ' ' VAL . 31.8 mt -74.85 -45.03 45.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 109.345 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.632 ' CD2' ' CZ2' ' A' ' 321' ' ' TRP . 0.7 OUTLIER -65.48 -35.54 81.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 278' ' ' ILE . 6.4 mtt85 -55.82 141.52 65.95 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.004 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 48.1 Cg_endo -68.93 132.16 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.623 2.216 . . . . 0.0 111.935 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.84 -28.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.485 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 95.5 m-20 -65.54 -30.68 71.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 260' ' ' LEU . 72.4 m-20 -74.96 -8.58 56.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 257' ' ' VAL . 0.7 OUTLIER -42.85 129.48 4.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -15.47 50.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 302' ' ' GLU . 40.3 mt -70.18 -162.13 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 7.1 p -81.01 155.9 26.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.419 HG11 ' ND2' ' A' ' 268' ' ' ASN . 22.8 t -57.67 -24.07 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' B' ' 465' ' ' ASP . 55.6 ttt85 -57.81 -43.36 85.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.7 m -58.82 -46.83 86.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.371 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -68.96 -39.5 79.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.419 ' ND2' HG11 ' A' ' 264' ' ' VAL . 86.7 m-20 -60.28 -32.17 70.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 272' ' ' ALA . 81.4 m -66.9 -64.9 0.76 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.453 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 281' ' ' LEU . 69.0 mt -54.84 -47.82 73.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.502 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 20.5 ttpt -52.94 -39.52 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.449 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -52.4 -23.68 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 95.3 mt-10 -94.11 23.07 5.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.42 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 68.5 33.26 4.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -0.929 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 75.8 mt -120.26 108.2 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.502 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 91.2 m-70 -104.59 -11.09 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.824 . . . . 0.0 109.581 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.98 133.37 54.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 49.8 mt -62.03 -30.9 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.554 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -52.27 -41.25 54.11 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.493 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 92.1 m-20 -53.45 -36.36 61.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -1.181 . . . . 0.0 109.119 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.519 ' CD2' HD13 ' A' ' 312' ' ' LEU . 3.1 tp -59.19 -46.49 88.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.297 -0.877 . . . . 0.0 109.229 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 15.4 m -68.37 -23.29 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.505 ' N ' HG21 ' A' ' 282' ' ' VAL . 60.9 tt0 -68.26 -33.09 73.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.826 . . . . 0.0 108.813 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -105.74 143.4 33.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.02 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 25.8 m -60.0 137.6 58.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.092 -1.005 . . . . 0.0 109.394 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.98 -30.5 71.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 50.0 t -53.1 -50.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.331 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -51.8 -39.39 58.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.4 mm? -72.8 -39.65 66.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.291 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.8 tm? -57.61 -33.21 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.228 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.465 ' C ' ' CE ' ' B' ' 483' ' ' MET . 32.5 mttm -88.45 17.64 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 289' ' ' LEU . 2.9 m -103.75 135.99 19.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.524 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 50.3 Cg_endo -70.81 -24.82 24.45 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.671 2.247 . . . . 0.0 111.802 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.502 ' N ' HD12 ' B' ' 464' ' ' ILE . 32.1 m120 -57.1 -21.01 28.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.57 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 13.3 mt -81.8 149.89 28.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -112.93 147.6 18.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.08 -44.88 71.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.409 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 302' ' ' GLU . 40.1 mttp -66.52 -41.58 88.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.4 m -64.39 -32.77 74.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.456 HD11 HD22 ' A' ' 290' ' ' LEU . 32.5 tp -53.36 -42.2 66.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.426 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.8 m -54.8 -43.41 72.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.494 ' HB3' ' CD1' ' A' ' 262' ' ' LEU . 39.5 mp0 -67.15 -37.86 84.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.24 -47.16 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.44 -36.54 84.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.47 -45.2 89.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.564 ' CG1' ' CD2' ' A' ' 312' ' ' LEU . 20.6 t -68.71 -43.33 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.475 HD12 ' OG ' ' A' ' 313' ' ' SER . 16.6 tp -54.73 -29.68 54.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.606 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.62 73.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 83.0 p -79.22 -1.11 34.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.467 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.519 ' HA ' ' CD2' ' A' ' 314' ' ' LEU . 65.8 mtm180 56.88 16.99 3.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.012 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -72.55 -38.94 57.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.564 ' CD2' ' CG1' ' A' ' 306' ' ' VAL . 1.3 pp -149.5 160.99 43.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -1.219 . . . . 0.0 109.978 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.5 OUTLIER 76.72 29.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.795 . . . . 0.0 109.538 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' A' ' 310' ' ' ARG . 72.9 mt -85.8 14.91 5.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 54.69 41.69 75.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.508 ' CG ' ' HB2' ' A' ' 314' ' ' LEU . 5.0 mtm -86.2 176.95 7.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -1.094 . . . . 0.0 109.49 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -140.98 125.77 18.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.405 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 4.0 mp -126.55 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.85 -38.49 88.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.239 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.9 m-20 -125.31 -69.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.632 ' CZ2' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER 166.08 -66.41 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.451 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.533 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.87 107.75 1.76 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.652 2.235 . . . . 0.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 51.5 Cg_endo -71.71 162.45 42.04 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.625 2.217 . . . . 0.0 111.505 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.55 -17.26 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 36.4 m -66.12 -42.62 88.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.48 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 326' ' ' ILE . 18.1 mt . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 27.0 m120 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -86.46 124.56 69.55 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.56 140.93 40.76 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.664 2.242 . . . . 0.0 111.686 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -80.88 160.15 24.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.3 m-20 -53.46 -37.47 62.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.305 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 18.3 m-20 -61.39 -49.99 74.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.387 -0.82 . . . . 0.0 109.512 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.459 HD13 ' CD1' ' B' ' 448' ' ' LEU . 17.8 tp -63.45 -35.79 81.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.577 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' B' ' 442' ' ' ARG . 22.2 tp -83.51 -23.08 32.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' B' ' 432' ' ' ASP . 35.3 t-20 -88.24 7.34 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.575 ' CD1' ' CD1' ' B' ' 488' ' ' ILE . 28.6 tp -78.43 129.93 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.501 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.82 137.28 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.06 9.32 70.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.43 HG11 HD22 ' B' ' 444' ' ' LEU . 41.8 t -123.67 131.12 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.137 . . . . 0.0 109.475 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -102.46 161.82 13.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.524 ' HA ' ' CD1' ' B' ' 435' ' ' LEU . 61.7 mtt180 -50.19 -45.59 53.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.481 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.459 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 93.4 m-20 -61.08 -47.44 86.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.435 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.553 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 27.9 tp -55.67 -43.11 76.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.334 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' B' ' 434' ' ' LEU . . . -59.02 -43.07 91.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.23 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 17.3 m-85 -57.68 -44.75 86.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.26 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -58.24 -45.06 88.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.459 ' CD1' HD13 ' B' ' 434' ' ' LEU . 79.1 mt -61.34 -44.03 97.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.16 -36.19 77.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.42 33.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 16.0 mtp-105 -90.32 23.57 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.68 6.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.501 HG23 ' NE2' ' B' ' 462' ' ' GLN . 21.3 t -80.53 109.75 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.34 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 31.1 m -124.91 -34.45 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 140.89 33.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.628 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.0 tm? -48.56 -40.78 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.72 -38.77 91.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -0.922 . . . . 0.0 108.899 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.496 ' CB ' HG11 ' B' ' 453' ' ' VAL . 92.5 m-20 -61.58 -40.12 93.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -63.29 -39.03 93.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.518 ' HB1' ' N ' ' B' ' 486' ' ' ARG . . . -63.48 -32.63 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.295 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -72.61 -30.33 64.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.501 ' NE2' HG23 ' B' ' 453' ' ' VAL . 97.8 mm-40 -61.65 156.91 18.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' B' ' 482' ' ' ILE . . . -117.25 155.97 15.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 52.2 mt -49.68 -38.33 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -1.131 . . . . 0.0 109.501 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 265' ' ' ARG . 89.2 m-20 -65.22 -37.51 87.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.425 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 89.6 m-20 -71.11 -31.07 67.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.525 ' CD1' ' HB1' ' B' ' 478' ' ' ALA . 22.0 mt -76.81 -29.85 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.61 63.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -52.67 -32.35 41.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.456 HD12 HG23 ' B' ' 470' ' ' ILE . 68.9 mt -104.73 128.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -63.77 -33.94 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -51.12 -28.63 18.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.553 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 55.1 mt -105.86 137.6 43.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 474' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' B' ' 478' ' ' ALA . 29.8 m -103.97 162.0 13.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.395 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -58.3 -37.51 75.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -76.97 -45.94 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 70.7 tttt -65.83 -46.4 78.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.525 ' HB1' ' CD1' ' B' ' 467' ' ' LEU . . . -60.02 -44.64 94.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 109.535 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.473 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.27 -52.34 50.21 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -50.98 -33.74 26.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -1.169 . . . . 0.0 109.617 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -75.33 -37.36 60.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 92.8 mt -60.54 -55.63 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.507 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 41.2 mmm -59.68 -47.64 84.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.42 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.46 -53.15 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.445 ' CB ' HD22 ' B' ' 456' ' ' LEU . . . -60.83 -48.62 80.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.518 ' N ' ' HB1' ' B' ' 460' ' ' ALA . 44.9 ttp85 -56.98 -43.75 82.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.7 m-20 -57.92 -39.06 77.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.616 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.575 ' CD1' ' CD1' ' B' ' 437' ' ' LEU . 76.9 mt -63.68 -36.9 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.51 -52.07 59.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.56 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -61.17 -38.75 87.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 17.2 m-85 -64.03 -31.33 72.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.492 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 323' ' ' PRO . 79.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.78 155.22 2.04 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.273 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 254' ' ' LEU . 41.0 Cg_endo -64.5 -26.31 62.47 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.47 2.114 . . . . 0.0 111.425 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' HD12 ' A' ' 253' ' ' LEU . 13.2 tt -53.38 -34.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.537 ' CD2' HG12 ' A' ' 282' ' ' VAL . 5.3 mp -74.45 -39.21 62.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.463 -0.773 . . . . 0.0 109.01 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.58 HD11 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -71.32 -23.14 61.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.459 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 278' ' ' ILE . 0.2 OUTLIER -73.0 141.19 81.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.466 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 259' ' ' ASP . 51.5 Cg_endo -70.66 136.37 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.728 2.285 . . . . 0.0 111.736 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.16 -26.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.368 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 271' ' ' LYS . 88.3 m-20 -67.61 -30.77 70.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 256' ' ' PRO . 49.9 m-20 -74.71 -9.8 58.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.449 ' CD2' HD12 ' A' ' 278' ' ' ILE . 49.5 mt -58.44 135.75 57.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 0.0 109.359 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.44 -21.22 66.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.571 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.59 168.35 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.2 p -70.5 166.74 19.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.41 HG11 ' OD1' ' A' ' 268' ' ' ASN . 19.0 t -63.89 -23.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -55.4 -45.09 76.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.9 p -69.16 -45.89 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -63.82 -42.4 97.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.41 ' OD1' HG11 ' A' ' 264' ' ' VAL . 95.2 m-20 -54.13 -38.36 65.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.3 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 295' ' ' LEU . 61.0 m -51.29 -62.14 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.473 HD23 ' CD1' ' A' ' 281' ' ' LEU . 63.8 mt -56.47 -46.28 80.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 16.3 mttt -53.25 -33.23 52.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.73 -33.7 49.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 86.1 mt-10 -92.01 25.84 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 68.23 45.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 91.2 mt -115.61 124.91 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.571 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.5 p80 -114.09 -39.93 3.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.571 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -103.14 134.73 46.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 252' ' ' ILE . 78.1 mt -46.66 -30.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.067 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.574 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -46.89 -49.41 17.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.512 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 87.5 m-20 -53.43 -32.19 48.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 108.988 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.473 ' CD1' HD23 ' A' ' 270' ' ' LEU . 53.9 tp -53.99 -51.29 64.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.332 -0.855 . . . . 0.0 109.07 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 17.7 m -68.17 -33.46 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.18 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.467 ' N ' HG23 ' A' ' 282' ' ' VAL . 61.9 tt0 -53.06 -32.43 46.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.294 -0.879 . . . . 0.0 108.819 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -107.74 150.61 26.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 72.2 p -81.6 157.07 24.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.945 . . . . 0.0 109.616 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.471 ' OE2' ' CB ' ' A' ' 313' ' ' SER . 7.2 mt-10 -63.52 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.918 . . . . 0.0 109.442 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.5 t -52.79 -50.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -55.14 -37.57 67.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 65.8 mt -72.62 -40.75 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.242 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.9 tm? -57.31 -32.69 66.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.865 . . . . 0.0 109.21 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.521 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 66.9 mttm -82.26 -13.27 57.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.82 . . . . 0.0 109.474 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.1 m -86.94 112.6 48.5 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HB2' ' CD1' ' B' ' 482' ' ' ILE . 51.3 Cg_endo -70.86 -13.16 31.71 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.767 2.311 . . . . 0.0 111.845 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.509 ' N ' HD13 ' B' ' 464' ' ' ILE . 30.6 m120 -48.93 -41.08 32.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 269' ' ' CYS . 0.4 OUTLIER -83.74 143.17 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -80.34 165.2 48.27 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -64.48 -41.51 96.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.568 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -63.94 -39.0 93.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 303' ' ' ILE . 19.6 m -59.73 -41.67 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.427 ' HG ' ' CE ' ' A' ' 304' ' ' LYS . 24.2 tp -53.06 -37.93 62.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.9 m -60.85 -45.83 92.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.14 -46.09 88.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 307' ' ' LEU . 30.6 mm -58.76 -51.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.427 ' CE ' ' HG ' ' A' ' 300' ' ' LEU . 22.5 mttm -53.13 -39.06 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.15 -48.3 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.461 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 12.0 t -73.71 -40.84 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.53 HD22 ' CB ' ' A' ' 313' ' ' SER . 8.4 mp -66.02 -26.71 67.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 304' ' ' LYS . . . -58.78 -29.57 66.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 8.2 t -75.2 -0.16 18.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 309' ' ' SER . 40.5 mtm-85 70.31 3.89 4.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 253' ' ' LEU . . . -69.32 -27.82 73.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -140.81 152.89 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 109.261 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.53 ' CB ' HD22 ' A' ' 307' ' ' LEU . 16.5 m 63.67 66.85 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.46 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 314' ' ' LEU . 4.7 mp -103.06 9.99 38.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.61 73.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.538 ' HE1' ' CG1' ' A' ' 282' ' ' VAL . 15.4 ptt? -113.04 147.38 37.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -126.53 141.66 51.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.292 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.561 HD21 ' CZ ' ' A' ' 249' ' ' PHE . 3.7 mp -116.9 141.78 47.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.02 -34.4 77.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.983 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 85.6 m-20 -117.41 -81.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.58 ' CZ2' HD11 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 165.89 -62.23 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.8 Cg_endo -68.33 108.09 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.66 2.24 . . . . 0.0 111.989 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.576 ' HB3' ' CD1' ' A' ' 249' ' ' PHE . 53.9 Cg_endo -76.34 161.91 34.29 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.421 2.08 . . . . 0.0 111.414 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.64 -13.92 17.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.1 p -70.35 -35.52 73.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.764 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 322' ' ' PRO . 21.2 pt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.771 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' B' ' 449' ' ' ALA . 26.8 m120 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 130.17 92.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 144.01 48.72 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.792 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -75.65 146.34 40.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -47.99 -32.9 7.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 109.455 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.53 -48.01 68.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.489 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.5 tm? -67.91 -36.96 81.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -72.89 -31.95 65.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.86 11.32 20.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.516 ' CD1' HD12 ' B' ' 456' ' ' LEU . 50.2 tp -74.05 133.64 42.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -76.6 145.47 38.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.74 75.1 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 95.3 t -123.54 135.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -1.214 . . . . 0.0 109.489 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 442' ' ' ARG . 58.2 t0 -85.27 146.38 27.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 95.8 mtt180 -49.92 -43.79 49.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -68.65 -37.74 79.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.293 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 15.2 tp -63.66 -35.57 80.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.37 97.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.953 . . . . 0.0 109.419 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 71.8 m-85 -65.88 -48.46 71.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 31.4 ttmt -57.94 -42.86 85.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.536 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 10.0 tt -69.73 -37.3 76.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.27 -27.6 67.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.496 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.06 -16.9 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.416 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 12.1 mtp85 -90.46 28.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.81 6.8 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 19.2 t -65.33 133.24 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.303 . . . . 0.0 109.427 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 60.4 m -135.08 -35.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.57 152.1 24.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.003 . . . . 0.0 109.847 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' B' ' 437' ' ' LEU . 0.3 OUTLIER -51.78 -42.77 62.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.332 -0.855 . . . . 0.0 109.363 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.83 -42.2 75.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.137 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 84.3 m-20 -61.4 -41.2 96.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.342 -0.849 . . . . 0.0 109.217 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.536 ' CD2' ' CD1' ' B' ' 448' ' ' LEU . 3.4 tm? -60.97 -38.92 87.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.16 -35.72 81.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.82 -35.34 80.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 3.5 mm100 -65.53 144.88 56.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.47 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' B' ' 482' ' ' ILE . . . -102.92 159.72 17.26 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 294' ' ' ASN . 80.3 mt -46.07 -35.14 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.238 . . . . 0.0 109.204 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -63.47 -37.45 87.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.919 . . . . 0.0 109.021 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.4 m-20 -68.51 -31.55 70.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.16 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.434 ' CB ' ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -80.84 -32.86 34.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.396 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.48 -33.07 67.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 109.392 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -46.83 -28.67 1.64 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.401 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.514 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 62.1 mt -105.79 121.53 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -55.93 -32.65 63.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.94 -28.82 49.57 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 65.0 mt -103.5 135.77 44.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -1.132 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.95 161.91 13.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.354 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.426 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 82.5 m-20 -58.29 -37.39 74.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.13 -46.03 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.509 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 25.2 tttp -62.86 -44.22 96.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.46 ' O ' HG13 ' B' ' 482' ' ' ILE . . . -63.85 -44.34 93.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.23 -35.85 91.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.16 76.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -1.144 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -69.51 -36.56 76.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 109.642 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 293' ' ' PRO . 30.9 mt -68.84 -56.35 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.518 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.521 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 61.2 mtp -52.62 -39.08 61.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.446 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.35 -49.23 44.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' B' ' 456' ' ' LEU . . . -63.98 -46.41 84.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 45.9 ttm-85 -57.6 -45.05 85.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.34 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.0 m-20 -57.9 -40.0 79.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.446 HG13 ' O ' ' B' ' 484' ' ' ALA . 84.8 mt -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.73 -49.23 49.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -65.99 -32.22 73.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 13.8 m-85 -79.22 -34.27 42.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.568 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.53 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 10.4 p90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.456 ' O ' HD22 ' A' ' 254' ' ' LEU . 0.9 OUTLIER -57.86 136.95 83.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 109.272 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.492 ' HA ' HD22 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.05 -30.93 56.03 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.597 2.198 . . . . 0.0 111.55 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.527 ' CD1' HD22 ' A' ' 312' ' ' LEU . 18.2 tt -63.11 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.527 HD22 ' CG1' ' A' ' 282' ' ' VAL . 31.4 mt -74.31 -42.57 59.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.195 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -59.94 -34.99 73.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.813 . . . . 0.0 109.14 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -66.12 146.47 99.02 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.3 Cg_endo -70.22 140.01 39.94 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.714 2.276 . . . . 0.0 111.89 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -44.12 -36.92 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.362 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -58.13 -30.98 66.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 256' ' ' PRO . 21.9 m-20 -72.38 -11.41 60.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.527 ' CD2' HD11 ' A' ' 278' ' ' ILE . 36.8 mt -55.35 150.64 11.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -23.23 67.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.437 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.522 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 5.6 mp -62.85 166.74 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -75.53 162.66 28.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 t -48.85 -39.67 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -51.18 -50.22 59.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.522 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 17.7 t -58.71 -51.02 71.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.96 -37.06 85.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.491 ' HA ' ' CE ' ' A' ' 271' ' ' LYS . 94.7 m-20 -58.54 -36.47 73.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.322 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -53.64 54.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.304 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 281' ' ' LEU . 6.6 mp -61.28 -47.87 83.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.491 ' CE ' ' HA ' ' A' ' 268' ' ' ASN . 54.8 mtmt -52.8 -38.14 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.23 20.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 86.3 mt-10 -92.95 25.29 3.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.453 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.05 45.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 83.2 mt -120.85 119.58 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.457 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.7 p80 -110.17 -40.05 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.557 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.457 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.6 m-30 -105.47 136.13 45.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 260' ' ' LEU . 93.5 mt -46.7 -29.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.98 -45.13 14.29 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 89.3 m-20 -53.52 -33.83 55.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.293 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 278' ' ' ILE . 38.7 tp -57.35 -49.48 76.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 13.2 m -63.44 -23.34 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 108.73 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.509 ' N ' HG21 ' A' ' 282' ' ' VAL . 63.1 tt0 -67.45 -34.95 78.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -98.73 158.57 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 154.26 23.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.074 -1.016 . . . . 0.0 109.773 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 313' ' ' SER . 9.0 mt-10 -61.68 -36.33 80.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.524 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 42.1 t -52.64 -49.36 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -51.95 -32.55 33.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.083 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 36.8 mt -69.25 -41.18 77.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.147 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.39 -25.31 66.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.342 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.524 ' HE3' ' CG1' ' A' ' 287' ' ' VAL . 54.8 mttt -86.32 -12.87 48.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.484 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.486 ' CG2' ' CD1' ' A' ' 295' ' ' LEU . 53.0 m -81.85 112.3 33.69 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.522 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.528 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 52.6 Cg_endo -71.06 -14.25 31.88 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.821 2.347 . . . . 0.0 111.916 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.51 ' ND2' HD11 ' B' ' 464' ' ' ILE . 31.9 m120 -61.98 -25.47 67.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.491 HD22 ' CD1' ' A' ' 303' ' ' ILE . 4.7 mp -88.02 142.35 27.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -91.39 169.28 32.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.55 -41.07 80.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.145 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -70.14 -43.07 71.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.6 m -59.2 -49.45 77.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.39 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 296' ' ' GLY . 83.5 mt -55.37 -42.37 73.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.3 m -55.41 -52.62 62.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.873 . . . . 0.0 109.451 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.424 ' CB ' HD22 ' A' ' 262' ' ' LEU . 89.2 mt-10 -54.82 -39.4 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.491 ' CD1' HD22 ' A' ' 295' ' ' LEU . 78.6 mt -58.15 -51.54 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.33 -42.51 73.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.36 -44.08 79.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.463 HG11 HD23 ' A' ' 312' ' ' LEU . 1.9 t -65.93 -39.58 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.178 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 313' ' ' SER . 20.1 mt -54.63 -26.16 31.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.37 68.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.7 t -66.06 -15.53 63.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 314' ' ' LEU . 92.8 mtt180 59.32 14.17 3.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.442 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -105.27 1.99 40.33 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 252' ' ' ILE . 0.6 OUTLIER -149.94 142.58 24.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -1.19 . . . . 0.0 109.641 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.1 OUTLIER 67.22 38.87 3.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.577 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 310' ' ' ARG . 28.1 mt -88.97 18.2 5.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.31 36.29 91.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.521 ' HE2' ' CD1' ' A' ' 253' ' ' LEU . 6.4 mtm -87.21 167.33 14.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -143.15 131.29 21.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.6 mp -130.0 139.26 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.927 . . . . 0.0 109.621 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.32 -43.97 88.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 108.88 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 69.1 m-20 -122.06 -69.42 0.83 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.041 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.507 ' N ' ' HD2' ' A' ' 322' ' ' PRO . 2.6 t-105 168.42 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.354 -0.841 . . . . 0.0 109.405 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.3 Cg_endo -68.52 107.79 1.69 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.545 2.163 . . . . 0.0 111.898 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.517 ' O ' ' CG2' ' A' ' 326' ' ' ILE . 51.4 Cg_endo -71.47 152.91 60.69 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.611 2.207 . . . . 0.0 111.711 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.76 6.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 42.9 m -68.18 -32.64 73.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 323' ' ' PRO . 18.7 tt . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.315 -0.865 . . . . 0.0 109.564 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 449' ' ' ALA . 22.4 m120 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 2.0 tttt -54.07 129.87 58.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.513 ' HG3' ' CD1' ' B' ' 446' ' ' PHE . 48.6 Cg_endo -69.98 140.85 42.85 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.677 2.251 . . . . 0.0 111.774 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.04 152.57 42.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.888 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -50.1 -39.42 42.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.4 -44.48 92.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 2.9 tm? -64.18 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.25 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.49 ' CD1' ' HG2' ' B' ' 442' ' ' ARG . 24.7 tp -79.88 -30.29 40.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -78.43 -0.77 30.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' B' ' 488' ' ' ILE . 28.8 tp -72.34 134.58 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.513 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -73.6 141.26 46.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.93 8.55 66.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.52 126.42 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.452 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.26 161.46 13.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' B' ' 435' ' ' LEU . 87.9 mtt-85 -55.01 -46.63 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.17 -45.6 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' B' ' 477' ' ' LYS . 12.9 tp -60.85 -41.83 96.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' B' ' 434' ' ' LEU . . . -59.15 -40.66 86.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.513 ' CD1' ' HG3' ' B' ' 430' ' ' PRO . 17.3 m-85 -63.83 -46.65 84.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.502 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 5.9 ttmm -57.66 -46.36 84.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.455 ' CD1' HD12 ' B' ' 459' ' ' LEU . 8.7 tt -68.24 -36.51 79.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.586 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.81 -26.79 67.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -49.14 -22.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.695 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -88.66 25.01 1.83 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.63 7.15 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 44.7 t -62.87 132.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.942 -1.328 . . . . 0.0 109.326 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 87.5 m -135.11 -38.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 109.666 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 150.56 21.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.738 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.551 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 27.1 tp -48.41 -42.15 31.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.255 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -55.94 -48.36 75.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.102 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.413 ' C ' HG13 ' B' ' 453' ' ' VAL . 82.6 m-20 -54.89 -40.99 70.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.065 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.471 HD11 ' CD2' ' B' ' 434' ' ' LEU . 4.6 tt -57.21 -47.05 82.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.65 70.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.08 -34.87 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.46 ' HG3' HG22 ' B' ' 453' ' ' VAL . 6.2 mm100 -67.44 156.01 37.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.463 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -117.57 155.08 16.32 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.51 HD11 ' ND2' ' A' ' 294' ' ' ASN . 30.0 mt -47.6 -42.63 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -1.176 . . . . 0.0 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -58.34 -42.43 86.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.14 -30.04 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.514 ' CD1' ' CB ' ' B' ' 478' ' ' ALA . 24.0 mt -77.98 -26.48 48.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.26 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.32 69.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.873 . . . . 0.0 109.301 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -53.74 -32.28 51.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.502 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 61.0 mt -100.43 122.84 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.88 -26.84 67.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . 0.46 ' HA3' ' CD ' ' B' ' 447' ' ' LYS . . . -59.7 -26.5 62.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.73 134.66 51.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -1.163 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.02 161.93 13.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.403 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.419 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 79.9 m-20 -57.68 -38.05 74.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -76.79 -46.08 26.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 43.7 tttt -64.93 -42.06 95.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' B' ' 467' ' ' LEU . . . -63.85 -42.15 97.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.1 -42.92 99.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.07 85.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -66.88 -39.89 87.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.528 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 28.9 mt -64.69 -56.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.523 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 48.3 mtp -52.67 -40.35 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.83 -56.45 15.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' B' ' 456' ' ' LEU . . . -62.05 -44.42 96.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.714 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 290' ' ' LEU . 50.2 ttt180 -60.28 -45.97 91.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 84.5 m-20 -59.2 -41.13 87.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.551 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 71.0 mt -64.54 -37.14 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.07 -50.56 32.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.55 -39.69 77.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.5 m-85 -96.77 16.32 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.482 ' HB3' ' CB ' ' A' ' 325' ' ' SER . 43.5 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.347 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -65.93 135.51 95.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.68 -25.44 54.16 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.763 2.309 . . . . 0.0 111.79 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.434 HD11 HD23 ' A' ' 312' ' ' LEU . 19.7 tt -79.54 -21.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.494 ' CD1' HG12 ' A' ' 282' ' ' VAL . 5.6 tp -74.08 -37.91 64.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.295 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.531 HD13 ' CH2' ' A' ' 321' ' ' TRP . 3.8 mm? -82.99 -27.74 30.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.519 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 0.0 OUTLIER -63.75 144.19 97.95 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.542 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 51.1 Cg_endo -71.0 149.55 59.18 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.728 2.285 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.22 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.803 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 259' ' ' ASP . 9.3 p-10 -58.52 -31.0 67.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.6 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.519 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 68.6 m-20 -74.1 -13.45 60.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 46.1 mt -51.17 144.13 9.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -68.71 -16.26 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.479 ' CD2' ' HB3' ' A' ' 302' ' ' GLU . 28.6 mt -59.72 -174.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 22.2 p -87.27 159.09 18.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.429 HG11 ' OD1' ' A' ' 268' ' ' ASN . 13.5 t -56.35 -30.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -56.05 -46.43 78.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 87.4 p -66.39 -45.27 80.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.4 90.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.429 ' OD1' HG11 ' A' ' 264' ' ' VAL . 93.3 m-20 -58.11 -33.21 68.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.378 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 92.8 m -59.25 -64.3 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.938 . . . . 0.0 109.41 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 281' ' ' LEU . 63.6 mt -60.79 -48.2 82.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.329 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.501 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 73.1 tttt -54.47 -38.71 66.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -55.45 -24.63 31.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 94.5 mt-10 -92.22 21.12 5.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 34.34 1.44 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 109.604 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 85.3 mt -120.73 107.63 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.12 -0.988 . . . . 0.0 109.458 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.501 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 58.6 m-70 -108.05 -3.99 18.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.618 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.6 m-85 -113.98 131.05 56.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 255' ' ' ARG . 73.8 mt -59.47 -30.43 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -46.32 -47.06 16.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.51 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 80.4 m-20 -53.5 -33.66 55.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.249 . . . . 0.0 108.997 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.509 ' CD1' HD13 ' A' ' 270' ' ' LEU . 35.0 tp -56.29 -49.28 74.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.134 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 22.3 m -66.39 -24.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 108.884 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.507 ' N ' HG21 ' A' ' 282' ' ' VAL . 63.5 tt0 -65.05 -35.68 81.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 108.969 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -98.36 141.22 31.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.331 -0.856 . . . . 0.0 109.191 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 8.1 m -71.38 140.77 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.531 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.469 ' O ' HD22 ' A' ' 290' ' ' LEU . 48.4 tp10 -49.98 -29.75 9.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.59 -51.3 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.163 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.433 ' O ' ' OG1' ' A' ' 292' ' ' THR . 96.1 mt-10 -53.36 -34.06 56.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 109.117 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 39.9 mt -63.88 -41.91 97.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.331 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.68 -31.4 72.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.527 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 78.0 mttt -85.22 -10.64 56.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.492 HG22 ' CD1' ' A' ' 295' ' ' LEU . 28.8 m -83.87 113.03 44.92 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 49.1 Cg_endo -70.66 -18.79 32.5 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.753 2.302 . . . . 0.0 111.851 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.432 ' N ' HD12 ' B' ' 464' ' ' ILE . 71.2 m-80 -56.95 -27.16 60.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 4.1 mp -92.7 136.48 33.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.23 179.46 40.75 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -62.26 -38.98 91.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -1.125 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.89 -43.49 88.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 25.0 m -59.42 -49.86 76.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.491 HD12 ' CD1' ' A' ' 290' ' ' LEU . 23.4 tp -52.88 -44.52 66.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 48.1 m -56.1 -44.42 79.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.414 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 95.5 mt-10 -60.5 -43.29 97.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 83.9 mt -57.95 -46.97 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -58.77 -39.99 82.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.63 -50.64 73.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 312' ' ' LEU . 1.8 t -67.18 -40.17 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 313' ' ' SER . 18.5 tp -55.26 -27.46 46.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.94 69.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.135 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.7 t -74.02 -14.64 61.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.868 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.427 ' HB3' HD11 ' A' ' 314' ' ' LEU . 66.5 mtt-85 63.59 11.5 5.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.418 ' HA3' HG21 ' A' ' 252' ' ' ILE . . . -78.35 -29.57 52.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.527 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.6 pt? -139.74 153.55 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -1.215 . . . . 0.0 109.61 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.7 OUTLIER 72.21 43.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.486 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.4 mm? -86.73 14.52 6.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.54 36.75 68.5 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.46 ' HE3' ' HB ' ' A' ' 282' ' ' VAL . 3.4 mtm -90.6 167.81 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.12 . . . . 0.0 109.517 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -142.7 126.02 16.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.85 . . . . 0.0 109.295 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.524 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.7 mp -138.99 131.91 29.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.68 -52.81 63.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 321' ' ' TRP . 13.5 t-20 -130.32 36.95 3.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.581 ' N ' ' HD3' ' A' ' 322' ' ' PRO . 16.9 t90 44.28 57.13 13.84 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 321' ' ' TRP . 54.7 Cg_endo -99.9 71.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.333 2.688 . . . . 0.0 112.242 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CG ' ' CD1' ' A' ' 326' ' ' ILE . 48.6 Cg_endo -70.18 132.81 23.41 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.288 1.992 . . . . 0.0 111.727 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.0 69.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' SER . . . . . 0.482 ' CB ' ' HB3' ' A' ' 249' ' ' PHE . 19.1 m -62.69 -46.1 89.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.541 ' CD1' ' CG ' ' A' ' 323' ' ' PRO . 63.0 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 17.9 m120 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -82.62 127.03 71.99 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 109.531 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.429 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.7 Cg_endo -70.69 136.28 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.662 2.241 . . . . 0.0 111.716 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' HA ' ' B' ' 455' ' ' THR . . . -63.82 158.58 21.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.95 -31.56 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.551 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.38 -44.18 79.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.4 tm? -70.0 -38.91 76.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -66.6 -33.92 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.296 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.84 11.76 23.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.513 ' CD1' HD11 ' B' ' 456' ' ' LEU . 47.0 tp -77.93 133.02 38.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.63 145.26 50.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.45 -7.31 82.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' B' ' 444' ' ' LEU . 73.2 t -111.68 122.47 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -80.59 158.61 25.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -52.18 -54.34 32.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.348 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -66.67 -35.2 79.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 108.937 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.522 HD12 ' CG1' ' B' ' 440' ' ' VAL . 3.4 tm? -58.95 -42.93 91.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.429 -0.795 . . . . 0.0 109.1 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' B' ' 434' ' ' LEU . . . -58.87 -48.19 82.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 109.025 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -53.38 -41.35 65.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -60.05 -38.04 81.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.849 . . . . 0.0 109.211 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.46 HD21 ' CD1' ' B' ' 473' ' ' LEU . 65.1 mt -64.99 -37.87 89.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.11 -36.79 6.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.52 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.2 mtp-105 -91.14 23.25 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.585 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.69 -18.88 6.67 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.494 ' CG2' ' HG3' ' B' ' 462' ' ' GLN . 5.7 t -78.14 111.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.895 -1.356 . . . . 0.0 109.325 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 12.0 m -126.84 -40.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.712 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.511 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -77.93 140.86 39.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.734 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.54 ' CD2' ' CB ' ' B' ' 485' ' ' ALA . 0.2 OUTLIER -46.79 -43.78 18.61 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 108.963 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.43 -40.5 82.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.427 ' C ' HG13 ' B' ' 453' ' ' VAL . 92.1 m-20 -59.03 -40.79 86.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.442 HD12 HD13 ' B' ' 448' ' ' LEU . 16.9 tp -64.4 -37.84 88.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 109.446 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.14 77.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.07 -28.0 61.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.494 ' HG3' ' CG2' ' B' ' 453' ' ' VAL . 95.0 mm-40 -68.64 148.4 50.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -104.43 154.92 17.51 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 22.2 mt -45.3 -36.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.242 . . . . 0.0 109.406 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.28 -39.03 93.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.484 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -67.32 -28.47 68.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.498 ' HB2' ' CB ' ' B' ' 478' ' ' ALA . 7.3 mp -79.6 -25.18 41.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.96 -22.55 66.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.367 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -53.37 -32.47 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.412 HG13 ' HD2' ' B' ' 451' ' ' ARG . 76.9 mt -101.1 124.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -54.52 -42.88 71.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.1 -27.45 30.85 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.466 ' CD2' HD22 ' B' ' 444' ' ' LEU . 32.9 mt -95.87 125.94 40.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 164.1 11.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.13 -38.45 76.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -75.21 -45.9 37.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 45.2 tttt -60.77 -44.89 96.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.379 -0.825 . . . . 0.0 109.426 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' B' ' 467' ' ' LEU . . . -63.38 -41.19 98.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -62.08 -46.91 93.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.55 74.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -1.124 . . . . 0.0 109.618 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 6.8 mp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.657 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.528 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 50.9 mt -58.07 -56.24 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.66 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 52.3 mtp -52.93 -38.54 62.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 109.536 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.16 -47.75 64.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -64.81 -44.14 90.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.462 ' NH2' ' CZ2' ' B' ' 490' ' ' TRP . 51.5 ttt85 -58.86 -46.06 88.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 88.4 m-20 -59.62 -41.18 89.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.486 ' O ' ' CA ' ' B' ' 492' ' ' GLY . 79.5 mt -63.84 -37.01 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.84 -49.78 17.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.693 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . 0.462 ' CZ2' ' NH2' ' B' ' 486' ' ' ARG . 77.7 m95 -68.63 -40.89 80.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 97.9 m-85 -95.88 4.01 53.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.578 ' CG ' ' HG3' ' A' ' 323' ' ' PRO . 41.2 t80 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.426 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.5 OUTLIER -53.93 116.58 10.51 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.236 -0.915 . . . . 0.0 109.242 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 255' ' ' ARG . 42.7 Cg_endo -65.03 -24.47 59.94 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.669 2.246 . . . . 0.0 111.671 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.464 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.2 tt -68.02 -30.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 108.928 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 249' ' ' PHE . 34.5 mt -74.73 -45.35 44.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.438 HD22 HD13 ' A' ' 326' ' ' ILE . 1.6 mt -62.75 -25.52 68.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 251' ' ' PRO . 0.6 OUTLIER -58.0 140.7 82.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 108.889 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.4 Cg_endo -69.06 129.72 18.87 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.587 2.191 . . . . 0.0 111.977 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.76 -29.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.351 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.431 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 96.8 m-20 -64.44 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.249 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 256' ' ' PRO . 56.4 t0 -70.0 -17.4 63.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 257' ' ' VAL . 6.0 mp -43.78 129.14 5.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.417 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.34 -22.4 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.481 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.442 ' HG ' ' OE1' ' A' ' 302' ' ' GLU . 5.5 mp -61.01 172.82 0.9 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.0 p -66.05 168.15 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.99 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.603 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -41.09 97.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.213 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.2 m -59.97 -49.7 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -67.55 -40.55 84.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -57.17 -36.94 71.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.37 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.443 ' HB3' HD22 ' A' ' 295' ' ' LEU . 74.3 m -54.17 -65.04 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.4 -45.13 88.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.514 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 34.3 tttt -53.03 -37.75 61.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.53 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.55 19.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 93.8 mt-10 -91.41 21.61 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 70.82 34.3 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.7 mt -120.42 107.87 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.514 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 76.5 m-70 -105.14 -12.19 16.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.65 135.35 50.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.502 ' CG2' HD23 ' A' ' 312' ' ' LEU . 34.1 mt -62.9 -29.85 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.84 -43.1 11.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.522 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 77.0 m-20 -53.9 -36.41 62.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.261 . . . . 0.0 108.818 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.516 ' CD1' ' HG ' ' A' ' 289' ' ' LEU . 33.1 tp -55.79 -47.94 76.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.82 . . . . 0.0 109.096 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 20.4 m -69.47 -25.53 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.52 ' N ' HG21 ' A' ' 282' ' ' VAL . 62.6 tt0 -63.49 -31.52 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 108.899 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -113.12 151.21 31.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.46 -0.775 . . . . 0.0 109.152 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 26.7 m -63.78 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.46 ' OE1' ' CD1' ' A' ' 307' ' ' LEU . 86.4 tt0 -56.06 -33.11 64.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.453 HG13 ' HE2' ' A' ' 291' ' ' LYS . 47.5 t -52.78 -50.68 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.905 . . . . 0.0 109.356 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -51.8 -32.7 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.046 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.521 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 3.4 mm? -73.97 -46.48 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.803 . . . . 0.0 109.173 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 300' ' ' LEU . 7.8 mt -55.69 -20.07 13.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.271 -0.893 . . . . 0.0 109.067 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.471 ' O ' ' HE2' ' B' ' 483' ' ' MET . 54.4 mttm -81.71 -29.85 32.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.177 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.3 m -59.87 125.66 81.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.521 ' HG3' ' CA ' ' B' ' 479' ' ' GLY . 50.4 Cg_endo -71.09 -19.84 29.41 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.676 2.251 . . . . 0.0 111.807 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.457 ' N ' HD12 ' B' ' 464' ' ' ILE . 77.2 m-20 -64.45 -26.87 68.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 5.8 mt -67.21 144.82 55.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -101.25 146.92 17.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -54.03 -40.39 67.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -76.51 -29.96 56.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 71.2 p -64.36 -45.39 87.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.505 ' CD1' HD21 ' A' ' 290' ' ' LEU . 53.6 tp -52.91 -45.19 67.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.1 m -51.66 -54.48 27.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.442 ' OE1' ' HG ' ' A' ' 262' ' ' LEU . 94.0 mt-10 -54.74 -46.25 74.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.27 -41.78 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.157 -0.964 . . . . 0.0 109.169 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -57.36 -40.18 77.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.159 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.11 -46.49 87.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.227 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.05 -35.15 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.205 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.519 ' CD2' ' OG ' ' A' ' 313' ' ' SER . 3.3 tt -62.37 -26.5 68.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.507 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.36 -35.31 71.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.389 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 1.7 t -61.94 -14.38 34.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 309' ' ' SER . 31.6 mtt180 72.91 1.42 4.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CD2' ' A' ' 253' ' ' LEU . . . -71.49 -22.14 78.64 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 313' ' ' SER . 0.8 OUTLIER -132.09 156.44 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 109.487 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 2.3 p 84.56 -141.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.732 -0.605 . . . . 0.0 109.793 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.534 ' N ' ' OG ' ' A' ' 313' ' ' SER . 3.9 mm? 67.66 14.48 9.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 314' ' ' LEU . . . 42.22 45.04 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.524 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 29.5 mtm -61.67 169.01 2.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.327 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.425 ' C ' HD12 ' A' ' 318' ' ' LEU . 79.9 mtt180 -136.88 130.99 32.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.576 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 5.1 mp -136.29 127.69 28.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 318' ' ' LEU . 96.1 mt-10 -43.91 -46.66 8.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.88 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 34.1 t30 -131.3 -56.35 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.241 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.519 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 1.6 t-105 164.8 -61.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.519 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 47.5 Cg_endo -67.51 107.75 1.48 Allowed 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.71 2.273 . . . . 0.0 111.98 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.578 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.0 Cg_endo -74.19 163.91 35.45 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.492 2.128 . . . . 0.0 111.579 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.78 -16.53 11.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 0.0 109.615 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.2 t -65.14 -46.71 79.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.438 HD13 HD22 ' A' ' 254' ' ' LEU . 28.5 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 16.1 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.454 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 2.3 tttm -83.66 136.57 42.07 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.285 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.457 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.2 Cg_endo -69.7 131.73 21.94 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 111.84 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -66.7 148.13 52.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.55 -33.78 15.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.69 -46.61 75.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 22.4 tp -69.86 -38.38 76.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.4 tm? -72.78 -30.3 64.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -91.22 8.68 34.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' B' ' 456' ' ' LEU . 37.4 tp -72.94 138.75 46.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.69 138.01 36.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.29 5.37 63.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.486 ' CG2' HD23 ' B' ' 437' ' ' LEU . 59.6 t -122.92 132.66 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -1.16 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -86.85 150.32 24.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -49.83 -45.45 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.575 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.4 m-20 -64.75 -46.07 83.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 109.231 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.489 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 13.1 tp -53.9 -43.32 69.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.58 90.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.7 m-30 -56.84 -44.4 82.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 109.103 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' B' ' 470' ' ' ILE . 20.3 mttm -60.83 -40.39 92.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.25 -47.02 87.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.376 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -60.94 -34.51 74.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.481 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -48.13 -35.4 11.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.434 ' HD2' HG13 ' B' ' 470' ' ' ILE . 47.2 mtp180 -91.11 22.93 3.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.79 -18.74 7.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 21.4 t -78.12 108.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.899 -1.354 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.482 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 95.3 m -119.84 -42.56 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.758 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 140.8 44.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' B' ' 437' ' ' LEU . 27.0 tp -49.97 -41.61 47.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.293 -0.88 . . . . 0.0 109.036 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . 0.451 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 31.7 mm-40 -57.32 -46.22 83.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 108.953 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.428 ' C ' HG11 ' B' ' 453' ' ' VAL . 70.6 m-20 -58.24 -38.73 77.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.101 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -62.35 -42.85 99.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.18 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.439 ' HB1' ' HB1' ' B' ' 485' ' ' ALA . . . -60.42 -35.79 76.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.47 -30.81 71.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.412 ' CG ' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -67.38 156.29 36.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.12 161.46 13.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.504 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 68.1 mt -52.75 -35.65 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -1.184 . . . . 0.0 109.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.12 -33.81 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.17 -31.47 65.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' B' ' 478' ' ' ALA . 20.1 mt -77.15 -33.89 56.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.81 55.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.98 -39.09 93.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' B' ' 447' ' ' LYS . 88.1 mt -82.54 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.47 152.65 29.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.576 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.52 -33.49 4.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.489 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 66.9 mt -85.99 126.6 34.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 35.4 m -103.64 161.98 13.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.488 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 87.8 m-20 -59.55 -36.03 75.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -76.03 -46.04 31.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -65.1 -47.58 76.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.529 ' CB ' HD11 ' B' ' 467' ' ' LEU . . . -57.83 -44.51 86.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.521 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -59.31 -47.67 89.7 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.29 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.48 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.457 HD23 HG21 ' B' ' 440' ' ' VAL . 28.0 mt -61.64 -36.47 80.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.9 mt -62.52 -53.64 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.515 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 33.9 mtp -54.24 -48.92 70.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -52.67 -56.16 17.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.499 ' CB ' ' HG ' ' B' ' 456' ' ' LEU . . . -60.19 -49.35 77.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 109.572 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.457 ' NE ' ' CG2' ' B' ' 482' ' ' ILE . 90.3 mtt180 -59.63 -42.05 91.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.492 ' O ' ' CD1' ' B' ' 491' ' ' PHE . 99.5 m-20 -58.36 -42.75 87.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' B' ' 456' ' ' LEU . 38.3 mt -64.34 -38.32 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.0 OUTLIER -75.96 -51.92 11.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -63.22 -28.01 69.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 109.42 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' B' ' 487' ' ' ASN . 3.6 m-30 -72.23 -34.36 68.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.558 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 14.3 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.47 126.74 56.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.382 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.25 -27.49 56.03 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.674 2.25 . . . . 0.0 111.601 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 8.3 tt -69.07 -28.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.505 HD12 ' CE ' ' A' ' 316' ' ' MET . 26.2 mt -74.54 -43.42 55.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.421 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.412 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.7 mt -64.18 -32.31 73.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 278' ' ' ILE . 5.7 ttp180 -55.82 135.89 72.46 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.6 Cg_endo -68.58 129.79 19.57 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.641 2.227 . . . . 0.0 111.842 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.526 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.3 OUTLIER -44.69 -25.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.35 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 256' ' ' PRO . 97.8 m-20 -67.18 -30.88 70.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 256' ' ' PRO . 37.0 m-20 -75.36 -9.72 58.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 4.5 mp -43.77 127.18 4.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 262' ' ' LEU . 97.0 mt-10 -62.63 -27.84 69.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.514 ' CD1' ' HG2' ' A' ' 302' ' ' GLU . 18.8 mt -54.41 -170.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.457 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -80.41 159.72 25.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.459 HG13 ' ND2' ' A' ' 268' ' ' ASN . 19.5 t -53.43 -30.58 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -52.37 -45.53 65.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.4 m -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.87 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 257' ' ' VAL . . . -65.84 -37.92 87.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.459 ' ND2' HG13 ' A' ' 264' ' ' VAL . 95.4 m-20 -59.79 -34.29 72.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -58.29 -64.0 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.45 -45.4 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -52.9 -40.38 63.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.11 -25.05 66.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 73.4 mm-40 -88.51 17.42 5.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 70.63 33.32 2.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.0 mt -108.59 127.05 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.5 p80 -112.23 -35.02 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.57 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.503 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.1 m-30 -110.07 128.8 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 281' ' ' LEU . 76.6 mt -46.45 -29.92 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.579 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -45.82 -47.15 13.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.414 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 54.0 m-20 -53.36 -30.87 41.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.235 . . . . 0.0 108.798 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 278' ' ' ILE . 41.8 tp -59.74 -49.71 76.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.468 -0.77 . . . . 0.0 109.273 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 27.3 m -65.71 -29.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.152 -0.967 . . . . 0.0 108.866 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.501 ' N ' HG21 ' A' ' 282' ' ' VAL . 60.6 tt0 -60.9 -33.99 73.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.371 -0.831 . . . . 0.0 108.961 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 56.1 mtt180 -100.12 143.33 30.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.299 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.3 m -69.03 143.53 54.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -54.29 -28.3 41.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.333 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 43.1 t -52.83 -50.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.304 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.454 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.2 mt-10 -52.19 -33.29 40.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 281' ' ' LEU . 60.8 mt -70.88 -30.61 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.64 -31.69 67.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.529 ' O ' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.8 -14.3 56.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.02 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.45 ' O ' HD21 ' A' ' 295' ' ' LEU . 77.0 m -81.76 115.88 59.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.538 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 52.5 Cg_endo -70.62 -16.91 33.96 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.698 2.265 . . . . 0.0 111.773 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.559 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 27.0 m120 -47.21 -33.13 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 292' ' ' THR . 0.4 OUTLIER -107.26 137.12 45.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.441 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -81.58 172.06 53.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -57.75 -41.97 83.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.408 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -63.46 -35.97 82.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.932 . . . . 0.0 109.298 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 28.2 m -58.3 -37.42 75.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 28.7 tp -53.97 -33.54 57.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 109.292 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.3 m -60.93 -57.46 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.514 ' HG2' ' CD1' ' A' ' 262' ' ' LEU . 42.8 tt0 -53.57 -46.12 70.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 108.996 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 56.2 mt -57.74 -50.73 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -56.11 -38.73 71.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 108.761 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 302' ' ' GLU . 64.4 m-20 -53.85 -45.66 71.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.525 ' CG1' ' CD2' ' A' ' 312' ' ' LEU . 4.5 t -66.86 -40.81 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 108.865 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.509 ' CD2' ' HB2' ' A' ' 313' ' ' SER . 21.3 mt -53.83 -25.65 20.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.441 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.9 63.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 108.983 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 p -71.4 -9.09 57.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.203 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 53.01 19.35 1.34 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -107.96 0.22 33.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.525 ' CD2' ' CG1' ' A' ' 306' ' ' VAL . 0.6 OUTLIER -147.23 145.87 29.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -1.231 . . . . 0.0 109.644 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.509 ' HB2' ' CD2' ' A' ' 307' ' ' LEU . 0.5 OUTLIER 58.13 46.69 15.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.398 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 312' ' ' LEU . 3.8 mm? -90.46 23.95 2.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.2 39.3 95.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.505 ' CE ' HD12 ' A' ' 253' ' ' LEU . 1.3 mtm -93.63 170.95 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.108 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -136.15 117.05 14.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 4.5 mt -112.47 139.81 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.354 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.88 -35.37 79.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.256 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 24.7 m120 -140.46 -47.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 109.157 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.579 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.52 -62.83 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.522 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -67.87 107.04 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.549 2.166 . . . . 0.0 111.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.483 ' O ' ' CG2' ' A' ' 326' ' ' ILE . 50.6 Cg_endo -69.65 165.18 31.71 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.665 2.243 . . . . 0.0 111.85 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.93 -15.72 56.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 97.0 p -85.82 -26.27 25.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.211 -0.93 . . . . 0.0 109.454 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.483 ' CG2' ' O ' ' A' ' 323' ' ' PRO . 16.3 tt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 25.6 m120 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 4.5 tttm -53.98 131.94 58.61 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.459 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.9 Cg_endo -70.3 144.42 51.09 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.627 2.218 . . . . 0.0 111.833 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' B' ' 454' ' ' CYS . . . -79.45 161.06 26.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.453 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' B' ' 436' ' ' ASN . 85.9 m-20 -52.09 -37.55 54.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . 0.474 ' CB ' ' HB3' ' B' ' 456' ' ' LEU . 16.7 m-20 -61.08 -50.12 74.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' B' ' 459' ' ' LEU . 23.2 tp -68.91 -38.07 79.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.703 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.1 tm? -77.04 -29.6 55.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.563 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' B' ' 432' ' ' ASP . 78.9 m-20 -93.77 10.87 31.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.457 ' CD1' HD12 ' B' ' 488' ' ' ILE . 29.1 tp -75.53 133.22 41.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.57 143.29 48.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.6 -4.76 82.35 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.573 ' CG2' ' CD2' ' B' ' 481' ' ' LEU . 49.6 t -126.56 135.77 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -1.182 . . . . 0.0 109.419 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . 0.467 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 49.6 p30 -103.41 175.08 5.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.437 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 64.4 mtm180 -61.61 -38.19 86.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.18 -41.06 99.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.467 ' CG ' ' OD1' ' B' ' 441' ' ' ASP . 21.9 mt -72.23 -39.74 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.407 ' O ' ' HB1' ' B' ' 449' ' ' ALA . . . -61.21 -35.82 78.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.873 . . . . 0.0 109.439 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.437 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 15.2 m-30 -73.08 -46.07 53.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.505 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.502 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 17.5 ttmt -61.65 -44.14 97.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.492 ' CD1' ' CB ' ' B' ' 453' ' ' VAL . 2.9 tm? -65.62 -45.45 83.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -55.93 -31.36 62.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.564 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' B' ' 447' ' ' LYS . . . -53.39 -20.55 4.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.4 mtp-105 -89.62 32.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.88 -18.72 7.17 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.492 ' CB ' ' CD1' ' B' ' 448' ' ' LEU . 48.0 t -61.71 137.1 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.815 -1.403 . . . . 0.0 109.318 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' B' ' 431' ' ' ALA . 1.0 OUTLIER -133.17 -34.63 1.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.783 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.438 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.4 OUTLIER -116.93 144.0 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 109.972 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' B' ' 485' ' ' ALA . 1.4 tm? -45.47 -39.43 7.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 108.889 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -55.68 -49.43 72.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.882 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -55.13 -41.66 72.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.855 . . . . 0.0 108.946 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.521 ' CD1' HD11 ' B' ' 434' ' ' LEU . 4.0 tt -55.86 -48.46 75.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.317 -0.864 . . . . 0.0 109.278 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' B' ' 485' ' ' ALA . . . -57.38 -33.09 67.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.313 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.365 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.75 160.94 28.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -116.94 152.87 17.67 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.559 ' CD1' ' ND2' ' A' ' 294' ' ' ASN . 57.8 mt -44.93 -42.49 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -1.172 . . . . 0.0 109.343 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.05 -39.78 83.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.343 -0.848 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.79 -29.06 66.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.523 HD13 ' CB ' ' B' ' 478' ' ' ALA . 20.8 mt -78.4 -28.25 46.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.6 -25.57 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.05 -31.28 18.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.502 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 60.0 mt -103.79 121.83 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.569 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.37 -32.55 72.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.78 -26.48 25.59 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.401 ' CD1' HD21 ' B' ' 448' ' ' LEU . 64.0 mt -108.82 139.26 43.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -1.122 . . . . 0.0 109.523 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 24.7 m -103.7 164.66 11.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -60.49 -37.15 80.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.415 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -75.47 -46.02 35.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 64.4 tttm -63.92 -40.5 96.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.445 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' B' ' 467' ' ' LEU . . . -64.91 -39.83 94.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -63.16 -42.36 99.46 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.09 85.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.573 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.573 ' CD2' ' CG2' ' B' ' 440' ' ' VAL . 29.2 mt -67.16 -38.63 85.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 26.3 mt -65.4 -56.02 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 57.4 mtp -52.36 -36.77 54.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.386 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.451 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.66 -44.53 64.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -62.86 -52.02 64.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.421 ' N ' ' HB2' ' B' ' 460' ' ' ALA . 68.2 mtt180 -58.08 -41.74 84.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.387 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.2 m-20 -57.46 -35.88 70.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.227 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' B' ' 437' ' ' LEU . 88.1 mt -70.88 -36.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.254 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 11.3 t -74.63 -51.69 13.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.755 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -61.73 -30.7 70.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 19.5 m-30 -82.95 -34.27 26.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.072 -1.017 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.553 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.415 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -55.17 142.81 56.89 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.601 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.48 ' HB2' ' NH2' ' A' ' 255' ' ' ARG . 43.5 Cg_endo -65.46 -22.97 58.54 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.807 2.338 . . . . 0.0 111.654 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.523 HG23 ' CA ' ' A' ' 311' ' ' GLY . 10.3 tt -70.01 -28.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.88 . . . . 0.0 108.927 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.535 ' CD1' ' HA2' ' A' ' 279' ' ' GLY . 0.8 OUTLIER -69.23 -38.5 78.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 277' ' ' TYR . 3.8 mm? -86.04 -24.0 26.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.365 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.515 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 4.8 ttm-85 -64.03 145.02 98.15 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.454 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 48.8 Cg_endo -70.01 136.72 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.728 2.285 . . . . 0.0 111.837 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 270' ' ' LEU . 0.1 OUTLIER -45.74 -33.38 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.0 109.522 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.51 -30.83 71.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.515 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 25.5 m-20 -68.24 -9.61 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.426 ' CD2' HD12 ' A' ' 278' ' ' ILE . 51.2 mt -66.18 139.38 58.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 262' ' ' LEU . 74.8 mm-40 -69.38 -20.23 63.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.497 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.59 ' CD2' ' CG ' ' A' ' 302' ' ' GLU . 26.2 mt -52.46 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 p -80.69 160.15 25.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.21 -27.64 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -51.97 -48.0 64.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.0 m -58.97 -50.97 72.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.339 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.32 -33.27 75.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -61.38 -37.73 84.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.38 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.8 m -53.24 -64.55 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 275' ' ' ILE . 57.7 mt -66.51 -45.24 80.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 21.4 tptm -53.19 -40.06 64.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.12 -21.42 65.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 96.6 mt-10 -94.14 23.36 5.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.61 17.62 7.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 56.2 mt -104.81 122.98 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.456 ' ND1' ' HD2' ' A' ' 271' ' ' LYS . 92.2 m-70 -113.09 -12.87 13.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 254' ' ' LEU . 4.5 m-85 -112.84 141.4 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 281' ' ' LEU . 74.3 mt -65.1 -28.97 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.444 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.541 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.26 -47.5 10.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.506 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 67.8 m-20 -53.35 -32.96 51.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.99 -1.3 . . . . 0.0 108.893 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 278' ' ' ILE . 26.7 tp -55.65 -50.73 69.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.183 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 28.2 m -66.77 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 108.787 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.519 ' N ' HG22 ' A' ' 282' ' ' VAL . 62.6 tt0 -54.92 -35.42 64.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 0.0 108.668 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -107.58 144.07 35.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.076 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 45.6 p -76.23 157.15 32.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.419 ' C ' HD11 ' A' ' 290' ' ' LEU . 10.0 mt-10 -56.16 -38.63 71.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.297 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.434 ' HA ' ' CD1' ' A' ' 290' ' ' LEU . 41.2 t -52.88 -52.78 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.283 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.55 -32.3 58.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 289' ' ' LEU . 7.6 mp -80.42 -33.08 37.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 300' ' ' LEU . 4.9 mt -69.66 -17.12 63.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.958 . . . . 0.0 109.353 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.449 ' O ' ' HE1' ' B' ' 483' ' ' MET . 33.8 mmtt -86.48 10.95 13.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 0.0 109.482 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 292' ' ' THR . 7.3 t -125.82 142.72 43.0 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.525 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 51.9 Cg_endo -71.35 -20.71 27.43 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.796 2.33 . . . . 0.0 111.941 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.508 ' N ' HD12 ' B' ' 464' ' ' ILE . 21.8 m120 -43.3 -44.14 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.634 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.401 HD22 ' CG2' ' A' ' 292' ' ' THR . 0.2 OUTLIER -107.64 137.07 46.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.499 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -91.73 -179.16 42.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.35 -44.19 95.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -1.204 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -60.85 -42.57 98.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.4 m -54.9 -46.32 74.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.31 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.487 ' CD2' HD23 ' A' ' 290' ' ' LEU . 2.3 tm? -52.68 -45.11 66.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.241 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 23.9 m -50.84 -51.54 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.091 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.59 ' CG ' ' CD2' ' A' ' 262' ' ' LEU . 38.6 tp10 -54.19 -42.33 69.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.403 HD11 HG23 ' A' ' 303' ' ' ILE . 23.7 mm -57.95 -41.15 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -0.867 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . 0.485 ' HE3' ' CD1' ' A' ' 300' ' ' LEU . 82.9 mttt -59.43 -40.53 87.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.327 -0.858 . . . . 0.0 108.872 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.18 -46.97 87.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 312' ' ' LEU . 6.0 t -70.14 -37.4 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.109 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 313' ' ' SER . 19.9 tp -61.38 -27.3 68.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.34 76.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -79.21 -0.22 31.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 309' ' ' SER . 64.4 mtt180 63.24 11.04 5.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.182 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.523 ' CA ' HG23 ' A' ' 252' ' ' ILE . . . -64.75 -51.1 54.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 312' ' ' LEU . 0.5 OUTLIER -144.41 168.53 19.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -1.156 . . . . 0.0 109.566 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.3 OUTLIER 72.4 32.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.3 mm? -75.85 -4.9 43.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.51 41.24 96.34 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -111.54 157.96 19.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -1.139 . . . . 0.0 109.638 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -115.19 133.45 56.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 109.223 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.18 140.76 40.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -58.28 -38.51 77.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 40.7 t-20 -132.96 -73.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.404 -0.81 . . . . 0.0 109.001 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.553 ' N ' ' CD ' ' A' ' 322' ' ' PRO . 1.5 t90 175.78 -45.07 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -97.73 74.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 123.473 2.782 . . . . 0.0 112.601 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.21 165.15 29.56 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.499 2.132 . . . . 0.0 111.615 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -44.82 -26.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.5 m -67.97 -61.01 2.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.651 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.511 ' CD1' HD21 ' A' ' 253' ' ' LEU . 9.5 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 18.4 m120 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' B' ' 454' ' ' CYS . 0.0 OUTLIER -78.71 136.08 59.37 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.546 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.58 133.24 23.63 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.674 2.25 . . . . 0.0 111.772 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -66.08 153.83 41.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.17 -35.34 59.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.53 -47.75 74.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.87 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.514 ' CD1' HD23 ' B' ' 448' ' ' LEU . 21.4 tp -66.35 -38.31 87.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 109.45 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -70.57 -32.46 69.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.403 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -88.65 7.31 34.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.499 HD22 ' CG2' ' B' ' 440' ' ' VAL . 40.3 tp -72.3 134.83 45.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -80.74 141.77 34.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.51 68.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.499 ' CG2' HD22 ' B' ' 437' ' ' LEU . 87.6 t -122.84 126.98 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 109.399 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.52 154.3 23.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -50.26 -48.87 54.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.552 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.2 m-20 -61.91 -44.48 96.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.551 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 15.3 tp -55.65 -44.45 77.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.395 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.75 87.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.552 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 13.0 m-30 -58.98 -43.06 91.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.357 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.67 -40.71 93.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.521 HD21 ' CD2' ' B' ' 459' ' ' LEU . 19.7 tp -60.99 -47.28 87.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.93 -31.5 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.97 -33.81 57.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.443 ' HD3' HG13 ' B' ' 470' ' ' ILE . 33.5 mtm105 -90.32 22.06 3.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.432 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.87 6.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.488 ' HB ' ' CD1' ' B' ' 448' ' ' LEU . 3.0 t -76.87 111.49 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.915 -1.344 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' B' ' 429' ' ' LYS . 29.5 m -121.51 -35.44 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 142.63 27.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.502 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 35.3 tp -48.71 -42.06 33.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.173 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.94 -45.79 78.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.142 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.417 ' C ' HG12 ' B' ' 453' ' ' VAL . 93.6 m-20 -57.77 -41.69 82.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.887 . . . . 0.0 109.078 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.521 ' CD2' HD21 ' B' ' 448' ' ' LEU . 3.4 tm? -59.23 -41.4 88.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 109.278 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' B' ' 486' ' ' ARG . . . -62.09 -37.15 83.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.83 -25.86 67.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.441 ' HG3' HG23 ' B' ' 453' ' ' VAL . 88.1 mm-40 -78.36 138.92 38.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.433 ' HA2' HD11 ' B' ' 482' ' ' ILE . . . -97.85 165.38 22.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 68.1 mt -48.04 -36.29 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.425 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -65.55 -38.65 90.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.256 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.73 -31.69 72.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -78.14 -26.84 48.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.6 66.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -52.85 -33.12 48.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.443 HG13 ' HD3' ' B' ' 451' ' ' ARG . 68.8 mt -104.67 128.58 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.08 -33.47 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -55.35 -27.33 46.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.551 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 35.1 mt -102.62 134.32 46.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.9 m -104.2 161.93 13.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.95 -36.35 76.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -76.94 -46.02 25.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 38.9 tttp -66.33 -40.2 89.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.518 ' HB1' ' CD2' ' B' ' 467' ' ' LEU . . . -65.3 -42.47 93.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.0 -45.11 96.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.14 90.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -1.186 . . . . 0.0 109.659 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -65.83 -39.93 91.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 88.7 mt -61.88 -56.14 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.522 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 67.1 mmm -54.06 -43.23 70.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.44 62.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.2 90.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.377 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' B' ' 460' ' ' ALA . 63.1 mtp180 -59.48 -43.82 93.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 94.2 m-20 -58.28 -43.44 87.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.502 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 68.7 mt -60.25 -37.47 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.0 m -78.8 -51.98 8.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -59.71 -45.95 90.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 51.6 m-85 -76.2 -39.68 54.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.606 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.574 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 91.8 m-85 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.12 154.84 76.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.433 ' HA ' HD13 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.43 -24.72 56.63 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.672 2.248 . . . . 0.0 111.698 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 18.2 tt -64.9 -30.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.934 . . . . 0.0 108.525 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.545 HD21 ' CH2' ' A' ' 321' ' ' TRP . 2.0 tp -72.8 -27.27 61.88 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.531 HD21 ' CZ2' ' A' ' 321' ' ' TRP . 1.9 mt -90.93 -24.57 20.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.4 mtt85 -55.95 149.54 33.35 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 257' ' ' VAL . 50.1 Cg_endo -70.18 130.34 18.66 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.604 2.203 . . . . 0.0 111.665 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.66 -26.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.2 t0 -63.21 -31.0 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.427 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' PRO . 83.1 m-20 -72.76 -12.47 61.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.674 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -46.22 137.44 6.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.52 -16.08 63.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 302' ' ' GLU . 4.6 mp -64.16 170.45 3.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.7 p -71.58 164.07 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.402 HG11 ' ND2' ' A' ' 268' ' ' ASN . 11.5 t -51.31 -31.12 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -57.32 -45.05 84.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.038 . . . . 0.0 109.299 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.7 t -59.94 -50.06 75.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.592 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -64.59 -44.25 91.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.364 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.402 ' ND2' HG11 ' A' ' 264' ' ' VAL . 86.6 m-20 -53.54 -32.63 51.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.427 ' SG ' HD23 ' A' ' 295' ' ' LEU . 28.5 t -63.49 -57.22 10.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 270' ' ' LEU . 3.6 mm? -66.4 -48.15 70.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 42.7 mttt -55.61 -37.53 68.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.93 -28.79 53.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -88.92 23.52 2.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . 68.36 40.47 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 83.5 mt -116.34 125.63 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.596 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.1 p80 -115.89 -29.72 6.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.596 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.5 m-85 -111.36 131.68 54.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.531 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 260' ' ' LEU . 78.5 mt -46.97 -32.15 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.268 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.57 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -46.08 -47.88 14.93 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.492 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.1 m-20 -53.49 -34.29 57.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.901 -1.352 . . . . 0.0 108.878 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 278' ' ' ILE . 40.0 tp -52.97 -50.86 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.417 -0.802 . . . . 0.0 109.022 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 35.5 m -65.98 -30.05 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 108.772 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 282' ' ' VAL . 49.6 tt0 -54.32 -37.6 65.02 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.4 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 58.6 mtt-85 -105.8 141.38 37.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.476 -0.765 . . . . 0.0 109.066 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -65.22 141.69 58.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -53.99 -23.93 14.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.73 -51.02 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 109.103 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.5 mt-10 -51.9 -37.28 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.133 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.66 -45.11 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.117 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 300' ' ' LEU . 6.1 mt -60.65 -29.11 69.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.516 ' O ' ' CE ' ' B' ' 483' ' ' MET . 62.8 mttm -82.02 -20.93 37.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 116.33 60.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.374 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 50.5 Cg_endo -70.6 -9.16 25.23 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.715 2.277 . . . . 0.0 111.821 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' B' ' 464' ' ' ILE . 30.5 m120 -60.77 -37.38 81.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.427 HD23 ' SG ' ' A' ' 269' ' ' CYS . 1.3 pp -100.18 137.5 38.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -0.955 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -86.71 168.71 39.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -64.7 -36.74 85.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.7 -42.16 83.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 303' ' ' ILE . 85.1 p -63.07 -34.09 76.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.471 HD22 ' CD2' ' A' ' 290' ' ' LEU . 22.2 tp -56.76 -33.41 66.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.1 m -61.49 -52.12 65.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.456 ' HB3' HD22 ' A' ' 262' ' ' LEU . 80.9 tt0 -62.91 -46.3 88.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.335 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.492 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 62.7 mt -57.74 -46.99 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 108.844 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.51 -40.54 65.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.07 -44.66 87.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.822 . . . . 0.0 108.811 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.519 ' CG1' HD21 ' A' ' 312' ' ' LEU . 6.3 t -63.91 -34.98 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.287 -0.883 . . . . 0.0 108.925 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 303' ' ' ILE . 8.4 mp -60.17 -25.99 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 109.238 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.65 68.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -60.97 -14.62 24.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.41 ' HG2' HD12 ' A' ' 314' ' ' LEU . 24.2 ttm180 70.03 4.81 4.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.11 16.25 35.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 5.3 mp -146.58 138.63 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.629 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.524 ' N ' HG11 ' A' ' 282' ' ' VAL . 0.6 OUTLIER 47.13 59.41 4.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.537 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 312' ' ' LEU . 3.7 mm? -91.12 9.88 29.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.04 87.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.503 ' CE ' HG12 ' A' ' 282' ' ' VAL . 7.1 ptt? -114.58 153.51 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -1.2 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -125.08 125.95 44.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 2.5 mp -103.26 138.66 39.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.83 -35.23 76.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.158 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 39.8 t30 -125.82 -69.29 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.57 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 1.2 t-105 165.63 -62.89 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.528 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.1 Cg_endo -67.99 108.26 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.546 2.164 . . . . 0.0 112.021 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 53.5 Cg_endo -75.16 164.39 33.15 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.608 2.205 . . . . 0.0 111.506 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.9 -10.86 31.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 48.2 m -73.32 -43.78 60.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.673 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.506 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 25.1 pt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' B' ' 449' ' ' ALA . 26.5 m120 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.454 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -53.34 128.62 50.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 109.409 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 49.9 Cg_endo -69.88 141.55 45.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.676 2.251 . . . . 0.0 111.902 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -73.51 148.06 43.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.481 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -46.9 -37.28 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.5 -42.82 93.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.3 tm? -67.24 -30.93 70.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' B' ' 442' ' ' ARG . 21.7 tp -81.33 -29.63 34.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 109.566 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -74.87 -3.8 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.634 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.448 HD11 HD11 ' B' ' 456' ' ' LEU . 37.2 tp -68.26 134.53 50.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.73 142.19 42.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.77 8.39 67.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.52 128.49 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.39 158.66 15.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' B' ' 435' ' ' LEU . 90.6 mtt-85 -50.22 -48.55 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.33 -51.08 69.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.563 ' CD2' ' CE ' ' B' ' 477' ' ' LYS . 20.7 tp -55.08 -40.6 70.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.73 91.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -60.69 -48.16 83.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.3 -45.84 83.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' B' ' 459' ' ' LEU . 0.7 OUTLIER -65.21 -42.85 93.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.35 -27.91 69.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.16 -20.04 3.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -92.23 30.07 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.64 7.5 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 3.4 t -60.76 135.99 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 0.0 109.386 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.439 ' SG ' ' OD2' ' B' ' 458' ' ' ASP . 31.1 p -135.24 -35.89 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 109.881 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.6 159.79 17.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 109.877 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.496 ' CD1' HD11 ' B' ' 488' ' ' ILE . 0.3 OUTLIER -52.25 -43.71 64.5 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.277 -0.89 . . . . 0.0 109.238 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.74 -44.03 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 108.951 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.458 ' CB ' HG11 ' B' ' 453' ' ' VAL . 82.0 m-20 -56.81 -43.34 80.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.288 -0.883 . . . . 0.0 108.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.51 ' CD1' ' HG ' ' B' ' 448' ' ' LEU . 24.6 tp -56.89 -45.18 82.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.23 72.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.384 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -65.94 -32.28 73.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.4 ' CD ' ' CG2' ' B' ' 453' ' ' VAL . 2.3 mp0 -62.15 157.6 18.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -123.28 153.91 17.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.481 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 45.3 mt -50.85 -38.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 109.296 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -70.17 -32.22 70.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.497 ' CD1' ' CB ' ' B' ' 478' ' ' ALA . 22.6 mt -77.19 -29.2 54.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.08 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.59 -33.68 66.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.451 HD13 HG22 ' B' ' 470' ' ' ILE . 76.3 mt -103.03 129.2 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -62.1 -29.92 70.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.04 -32.75 50.02 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.561 ' CD1' ' CD1' ' B' ' 444' ' ' LEU . 2.9 mm? -106.13 133.22 51.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.426 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 474' ' ' THR . . . . . 0.45 ' O ' ' HB1' ' B' ' 478' ' ' ALA . 28.3 m -103.62 161.87 13.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.436 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 84.0 m-20 -58.71 -36.95 75.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -76.31 -45.53 31.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.568 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.563 ' CE ' ' CD2' ' B' ' 444' ' ' LEU . 25.3 tttp -67.35 -41.24 85.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.497 ' CB ' ' CD1' ' B' ' 467' ' ' LEU . . . -63.7 -45.18 91.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 109.587 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.65 -42.09 99.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.95 91.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.459 HD11 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -65.3 -47.15 77.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 35.7 mt -55.19 -56.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.516 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 55.8 mtp -52.91 -41.93 64.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.444 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.34 -43.89 96.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.697 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -65.5 -49.69 68.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.493 ' NH1' ' HA ' ' A' ' 293' ' ' PRO . 95.3 mtt180 -57.79 -46.1 85.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 87.6 m-20 -57.91 -38.45 75.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.554 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.496 HD11 ' CD1' ' B' ' 456' ' ' LEU . 76.4 mt -70.94 -36.79 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 13.5 t -77.71 -51.51 10.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.787 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -63.54 -45.72 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 99.6 m-85 -93.94 13.9 21.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.573 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 14.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.507 ' CB ' HD11 ' A' ' 253' ' ' LEU . 25.0 m-20 -54.07 124.58 45.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.105 -0.997 . . . . 0.0 109.31 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.75 -25.61 60.93 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.664 2.242 . . . . 0.0 111.624 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.523 ' CG2' HD12 ' A' ' 253' ' ' LEU . 14.5 tt -63.5 -33.72 63.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 108.622 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 311' ' ' GLY . 5.5 mp -74.86 -41.37 59.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.407 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.575 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.7 mt -72.08 -30.48 65.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.776 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -56.43 138.35 75.46 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 108.849 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 259' ' ' ASP . 46.3 Cg_endo -68.23 130.57 21.58 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.64 2.227 . . . . 0.0 111.757 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.442 ' CG2' ' HE3' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -44.55 -26.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 t0 -68.46 -30.77 69.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.255 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 256' ' ' PRO . 35.2 m-20 -69.87 -16.57 63.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.48 ' CD2' HD13 ' A' ' 278' ' ' ILE . 37.7 mt -56.07 138.26 49.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.2 tt0 -66.02 -16.22 63.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.513 ' CD1' ' HB3' ' A' ' 302' ' ' GLU . 33.4 mt -53.5 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.0 p -88.27 157.56 18.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.68 -37.1 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 265' ' ' ARG . 17.7 tpt85 -57.17 -46.5 82.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.455 ' OG ' ' OE1' ' A' ' 302' ' ' GLU . 20.1 m -57.97 -47.55 82.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -68.93 -39.71 79.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.375 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -56.66 -34.9 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.445 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 69.0 m -57.11 -64.37 0.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.64 -48.09 78.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 32.3 mttt -54.75 -37.63 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.04 27.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -89.95 25.83 2.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.397 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . 67.17 42.7 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 88.8 mt -115.72 124.6 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.45 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.478 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.3 p80 -110.99 -41.53 4.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.484 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.478 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 8.4 m-30 -105.22 135.02 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.19 -0.944 . . . . 0.0 109.427 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.48 HD13 ' CD2' ' A' ' 260' ' ' LEU . 86.7 mt -46.95 -30.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.545 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -46.98 -46.34 19.83 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.519 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 83.1 m-20 -53.45 -34.54 58.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -1.167 . . . . 0.0 108.884 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 278' ' ' ILE . 35.1 tp -54.96 -49.88 70.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 108.987 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 312' ' ' LEU . 14.3 m -65.26 -23.13 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 0.0 108.84 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 282' ' ' VAL . 63.9 tt0 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.02 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -96.39 159.9 14.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.345 -0.847 . . . . 0.0 109.227 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' THR . . . . . 0.444 ' O ' HD23 ' A' ' 289' ' ' LEU . 36.0 m -81.39 139.09 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 77.9 tt0 -58.56 -32.21 68.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . 0.484 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 45.7 t -52.72 -50.37 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.878 . . . . 0.0 109.359 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 292' ' ' THR . 97.5 mt-10 -55.2 -33.34 62.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.344 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 3.8 mm? -64.93 -43.44 92.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.07 -23.97 66.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 483' ' ' MET . 37.7 mttt -90.45 -8.54 50.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.515 ' HB ' ' CD1' ' A' ' 295' ' ' LEU . 2.1 m -86.99 113.73 54.92 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 49.6 Cg_endo -70.48 -22.25 29.04 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.661 2.24 . . . . 0.0 111.923 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.525 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 31.1 m120 -50.47 -22.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.116 -0.99 . . . . 0.0 109.345 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.515 ' CD1' ' HB ' ' A' ' 292' ' ' THR . 4.9 mp -90.79 138.75 31.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.408 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.98 167.78 36.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -55.02 -45.83 75.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -69.39 -37.84 77.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.9 m -58.58 -51.48 69.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.481 ' CD2' HD23 ' A' ' 295' ' ' LEU . 78.3 mt -53.83 -46.41 71.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.475 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 32.2 m -51.77 -51.09 58.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.978 . . . . 0.0 109.29 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 262' ' ' LEU . 80.4 mt-10 -53.89 -38.47 64.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.967 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.454 ' O ' HD11 ' A' ' 307' ' ' LEU . 74.1 mt -59.34 -48.04 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.104 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -56.57 -36.54 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.28 -47.82 82.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.125 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.47 HG12 HD22 ' A' ' 312' ' ' LEU . 2.0 t -66.23 -38.06 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.032 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 313' ' ' SER . 4.7 mp -54.4 -26.71 32.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.221 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.17 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.444 -0.785 . . . . 0.0 109.503 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 2.0 t -61.63 -31.85 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.467 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 309' ' ' SER . 29.5 mtm180 82.74 -24.72 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.536 -0.727 . . . . 0.0 110.38 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' A' ' 253' ' ' LEU . . . -60.04 -21.18 55.59 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 0.4 OUTLIER -125.36 159.95 30.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.46 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.522 ' CB ' ' HG ' ' A' ' 307' ' ' LEU . 4.6 t 77.0 -144.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 314' ' ' LEU . 4.0 mm? 63.59 13.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 45.73 51.58 10.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.522 ' CE ' HD21 ' A' ' 253' ' ' LEU . 26.2 mtm -68.1 173.42 4.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -1.174 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.447 ' O ' HD22 ' A' ' 318' ' ' LEU . 50.4 mtt-85 -132.54 120.59 22.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.447 HD22 ' O ' ' A' ' 317' ' ' ARG . 5.2 mt -122.43 141.71 51.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.29 -37.57 87.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 80.4 m-20 -143.28 -47.92 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.371 -0.831 . . . . 0.0 108.926 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.575 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 164.05 -68.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.481 -0.762 . . . . 0.0 109.236 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.5 Cg_endo -69.77 110.93 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.58 2.187 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 50.5 Cg_endo -70.72 155.07 63.5 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.665 2.244 . . . . 0.0 111.654 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.97 -22.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.4 m -62.06 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 19.5 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' B' ' 454' ' ' CYS . 8.3 tttt -94.27 137.82 22.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.498 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.8 Cg_endo -70.49 132.57 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.703 2.268 . . . . 0.0 111.69 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' B' ' 455' ' ' THR . . . -63.77 151.22 42.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.38 -37.71 57.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.46 -44.77 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' B' ' 445' ' ' ALA . 3.3 tm? -69.96 -36.24 75.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.4 OUTLIER -69.54 -31.97 70.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -89.32 9.26 26.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.518 ' CD2' ' CD1' ' B' ' 456' ' ' LEU . 35.0 tp -80.13 132.28 35.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.497 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -77.23 144.74 38.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.67 4.63 65.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.24 126.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.395 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -84.54 151.87 24.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -50.06 -47.07 53.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.498 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 91.7 m-20 -64.99 -45.47 85.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.508 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 14.2 tp -57.27 -44.35 83.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' B' ' 434' ' ' LEU . . . -59.01 -41.72 88.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.91 . . . . 0.0 109.23 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.498 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.3 m-30 -58.62 -44.6 90.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -58.76 -40.78 84.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.867 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' B' ' 459' ' ' LEU . 93.3 mt -61.84 -38.94 90.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -64.6 -32.7 74.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.9 -37.56 14.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.987 . . . . 0.0 109.408 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.475 ' CZ ' ' CB ' ' B' ' 469' ' ' ASP . 84.0 mtt-85 -89.66 23.0 2.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.576 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.65 -18.79 6.74 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.517 HG13 ' CB ' ' B' ' 458' ' ' ASP . 46.7 t -76.79 108.52 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.305 . . . . 0.0 109.407 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 19.9 m -127.03 -38.85 1.98 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.686 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.476 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -78.39 144.32 36.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.529 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.518 ' CD1' ' CD2' ' B' ' 437' ' ' LEU . 25.8 tp -47.04 -42.72 18.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . 0.413 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 50.2 tp10 -55.95 -45.98 78.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.096 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.517 ' CB ' HG13 ' B' ' 453' ' ' VAL . 91.5 m-20 -56.66 -43.48 80.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.076 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' B' ' 448' ' ' LEU . 4.1 tt -55.52 -45.56 77.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.98 77.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 109.392 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.94 -28.09 68.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.439 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.6 mm-40 -75.45 140.01 42.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' B' ' 482' ' ' ILE . . . -98.45 166.06 21.71 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.539 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 20.5 mt -49.83 -34.02 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -1.125 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.18 -40.5 82.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.439 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 90.5 m-20 -63.29 -31.86 73.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.52 ' HB2' ' CB ' ' B' ' 478' ' ' ALA . 7.1 mp -82.59 -27.79 31.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.65 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -66.4 -21.1 66.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.541 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . 0.475 ' CB ' ' CZ ' ' B' ' 451' ' ' ARG . 82.1 m-20 -52.08 -31.91 32.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 64.1 mt -100.38 129.41 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.04 -36.06 72.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -55.8 -30.81 57.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 81.8 mt -98.91 131.37 45.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 45.7 m -104.13 162.01 13.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 109.378 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -57.12 -38.4 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -74.4 -45.97 43.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.464 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.507 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 34.4 tttp -61.58 -46.35 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' B' ' 467' ' ' LEU . . . -60.28 -45.05 94.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -57.55 -47.72 86.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.1 mp -67.18 -44.51 79.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 36.3 mt -60.99 -55.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.577 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 57.7 mtp -52.38 -36.53 54.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.332 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.458 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.29 -51.74 34.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.52 65.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.544 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 49.2 ttm-85 -50.56 -46.87 57.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 97.5 m-20 -58.01 -43.25 86.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.512 HD11 ' CD2' ' B' ' 456' ' ' LEU . 81.3 mt -61.56 -37.32 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . 0.413 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 62.9 m -77.84 -50.29 12.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . 0.544 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 20.7 m95 -60.13 -43.23 95.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 56.6 m-85 -83.38 -27.21 29.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.549 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 41.0 p90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -65.33 134.42 95.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.14 -29.32 56.14 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.752 2.301 . . . . 0.0 111.661 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 18.6 tt -61.34 -29.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 108.929 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.524 HD11 ' CE ' ' A' ' 316' ' ' MET . 19.0 mt -74.33 -43.02 58.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.523 ' CD1' HD13 ' A' ' 326' ' ' ILE . 4.3 mm? -61.55 -28.55 69.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 278' ' ' ILE . 1.8 mtt180 -75.13 140.86 73.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.525 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.6 Cg_endo -70.88 141.6 41.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.717 2.278 . . . . 0.0 111.921 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.428 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.63 -37.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.1 -30.89 69.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.956 . . . . 0.0 109.366 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' PRO . 34.2 m-20 -75.33 -11.53 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 262' ' ' LEU . 74.1 mt -53.82 152.84 5.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -64.37 -23.98 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.496 ' HG ' ' CG ' ' A' ' 302' ' ' GLU . 3.7 mp -57.46 167.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 4.0 p -81.33 165.01 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.464 ' CG1' ' ND2' ' A' ' 268' ' ' ASN . 42.3 t -49.14 -41.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.485 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.422 ' O ' ' SG ' ' A' ' 269' ' ' CYS . 70.6 ttt180 -49.82 -45.01 49.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.367 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 14.9 m -70.41 -46.56 63.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.73 -46.88 88.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.464 ' ND2' ' CG1' ' A' ' 264' ' ' VAL . 85.6 m-20 -56.33 -34.74 66.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.367 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 266' ' ' SER . 87.9 m -50.52 -65.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.422 HD23 HD11 ' A' ' 281' ' ' LEU . 6.6 mp -62.94 -44.93 94.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.241 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.5 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 17.0 ttpp -52.95 -40.93 64.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.89 -21.95 3.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 273' ' ' GLU . 70.1 tt0 -94.82 20.75 8.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.895 . . . . 0.0 109.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.11 35.33 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 89.0 mt -123.08 107.53 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.5 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 81.5 m-70 -107.29 -11.66 15.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.445 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 4.8 m-85 -111.54 134.23 53.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 61.5 mt -60.14 -30.73 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.266 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 321' ' ' TRP . . . -51.05 -42.5 48.28 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 93.0 m-20 -53.54 -35.18 60.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -1.174 . . . . 0.0 109.047 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.422 HD11 HD23 ' A' ' 270' ' ' LEU . 28.3 tp -58.05 -47.84 81.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 21.1 m -70.05 -24.26 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.163 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.498 ' N ' HG23 ' A' ' 282' ' ' VAL . 63.7 tt0 -65.81 -32.65 74.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.196 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.64 145.02 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -62.17 138.36 58.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.418 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 80.6 tt0 -62.85 -27.4 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.2 t -52.92 -51.76 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.4 -34.88 67.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 51.3 mt -74.97 -38.18 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.94 -30.25 70.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.493 ' C ' ' CE ' ' B' ' 483' ' ' MET . 10.0 mmtt -87.78 17.6 4.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.35 -0.844 . . . . 0.0 109.52 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.413 ' C ' ' SD ' ' B' ' 483' ' ' MET . 0.7 OUTLIER -109.81 136.72 20.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.524 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 50.0 Cg_endo -70.12 -23.25 29.37 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.819 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.51 ' N ' HD11 ' B' ' 464' ' ' ILE . 22.3 m120 -56.2 -24.68 43.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 14.6 mt -81.45 138.02 35.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -95.21 145.37 17.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' B' ' 461' ' ' GLU . 24.3 mttm -55.29 -42.62 73.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -1.106 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -67.49 -39.42 85.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 303' ' ' ILE . 22.0 m -64.04 -36.71 84.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 300' ' ' LEU . 3.4 tm? -53.1 -42.59 66.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.0 m -60.64 -51.91 67.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.496 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.7 tp10 -57.91 -45.69 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 82.9 mt -57.79 -47.29 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.065 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.02 -39.34 63.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 108.916 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.65 -42.98 99.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.507 ' CG1' HD21 ' A' ' 312' ' ' LEU . 32.0 t -69.22 -34.8 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.845 . . . . 0.0 108.995 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.514 HD22 ' CB ' ' A' ' 313' ' ' SER . 25.2 mt -63.62 -26.68 68.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.397 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.44 -36.26 73.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 109.151 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 16.3 t -67.68 -16.87 64.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 314' ' ' LEU . 56.5 mtt180 64.46 10.81 6.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.184 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 252' ' ' ILE . . . -78.77 -24.25 62.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.7 pt? -137.36 147.03 45.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.514 ' CB ' HD22 ' A' ' 307' ' ' LEU . 1.7 t 77.21 39.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 310' ' ' ARG . 12.3 mt -89.9 15.26 10.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.916 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.25 97.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.524 ' CE ' HD11 ' A' ' 253' ' ' LEU . 4.5 mtm -90.33 163.19 14.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -143.14 123.09 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.504 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 1.4 mp -131.31 140.73 49.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -45.74 -36.49 5.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 108.482 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 43.6 t30 -129.42 -72.2 0.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.595 ' CE2' ' HA3' ' A' ' 279' ' ' GLY . 16.2 t90 160.77 -57.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.589 -0.695 . . . . 0.0 109.547 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.3 Cg_endo -66.97 107.81 1.38 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.132 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -73.44 165.2 33.1 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.686 2.258 . . . . 0.0 111.657 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -43.84 -26.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.582 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' SER . . . . . 0.532 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 22.8 m -61.71 -58.4 8.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.579 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 254' ' ' LEU . 35.1 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -87.68 123.62 68.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.455 ' HD2' ' HD2' ' B' ' 429' ' ' LYS . 50.4 Cg_endo -70.46 134.68 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.671 2.247 . . . . 0.0 111.845 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' B' ' 454' ' ' CYS . . . -70.88 166.6 20.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.498 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.19 -38.54 73.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.306 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 75.1 m-20 -61.74 -49.91 74.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.185 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.5 tm? -64.98 -38.67 91.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -73.36 -33.94 65.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -85.67 8.54 19.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.39 131.07 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.98 143.04 49.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 6.58 70.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' B' ' 481' ' ' LEU . 54.4 t -138.36 128.97 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -1.169 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' B' ' 444' ' ' LEU . 32.5 p30 -98.84 -177.21 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.647 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 97.6 mtt180 -62.14 -43.74 98.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.78 -55.92 19.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 13.9 tp -56.55 -40.84 75.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 441' ' ' ASP . . . -59.88 -36.77 77.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.387 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 15.1 m-30 -66.72 -43.36 84.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.447 ' O ' HD13 ' B' ' 470' ' ' ILE . 43.5 mttt -61.7 -42.0 98.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.525 ' CG ' HD21 ' B' ' 459' ' ' LEU . 2.7 tm? -62.85 -44.49 95.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -62.03 -26.82 68.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.633 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.11 -17.18 9.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 7.1 mtp85 -92.25 27.97 2.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.68 7.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.491 HG12 ' N ' ' B' ' 459' ' ' LEU . 47.8 t -63.73 140.3 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.927 -1.337 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' B' ' 431' ' ' ALA . 27.1 m -135.09 -36.21 0.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.51 151.48 24.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.535 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.1 tm? -52.03 -38.32 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.2 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' B' ' 457' ' ' GLU . 43.8 mm-40 -58.12 -47.65 82.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 108.839 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -55.93 -44.66 78.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.857 . . . . 0.0 109.054 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.525 HD21 ' CG ' ' B' ' 448' ' ' LEU . 2.8 tm? -55.5 -42.72 74.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.074 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . 0.405 ' O ' ' HE3' ' A' ' 297' ' ' LYS . . . -60.01 -36.06 76.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.202 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' B' ' 461' ' ' GLU . 77.1 tt0 -68.78 -13.13 62.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.439 ' CG ' HG21 ' B' ' 453' ' ' VAL . 96.3 mm-40 -74.65 147.6 41.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -106.17 158.21 15.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 24.0 mt -52.29 -34.12 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.143 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.95 -37.08 78.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.09 -32.09 69.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' B' ' 478' ' ' ALA . 23.4 mt -74.86 -30.01 61.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.57 63.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -52.77 -31.44 38.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.447 HD13 ' O ' ' B' ' 447' ' ' LYS . 64.4 mt -102.24 128.93 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -64.44 -35.67 81.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.47 -28.52 36.68 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.526 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 81.4 mt -102.41 134.48 45.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 474' ' ' THR . . . . . 0.496 HG21 ' N ' ' B' ' 475' ' ' ASP . 51.4 m -103.85 162.08 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.496 ' N ' HG21 ' B' ' 474' ' ' THR . 84.8 m-20 -56.69 -38.63 72.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.94 -46.0 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.511 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 43.4 tttp -66.66 -46.74 74.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.273 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' B' ' 467' ' ' LEU . . . -58.08 -45.18 87.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.513 ' CA ' ' CB ' ' A' ' 293' ' ' PRO . . . -59.58 -45.54 95.45 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.37 68.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -70.05 -30.58 67.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.432 HG13 ' O ' ' B' ' 478' ' ' ALA . 46.0 mt -69.83 -54.95 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 44.0 mmm -57.6 -44.31 85.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.344 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.447 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -61.38 -56.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.358 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' B' ' 459' ' ' LEU . . . -61.18 -46.74 89.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.48 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 77.1 ttt180 -55.18 -47.46 75.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.6 m-20 -57.76 -41.37 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.447 HG13 ' O ' ' B' ' 484' ' ' ALA . 75.7 mt -56.02 -37.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.74 -51.91 8.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . 0.48 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 63.1 m95 -62.53 -47.15 85.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.7 m-85 -74.74 -33.03 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.524 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . 1.1 m-20 -65.95 141.52 97.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.61 -22.78 57.7 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 7.3 tt -67.57 -26.52 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.297 -0.877 . . . . 0.0 109.169 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.578 ' CD2' ' CG1' ' A' ' 282' ' ' VAL . 2.2 mt -73.96 -45.36 50.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.602 ' CD2' ' CH2' ' A' ' 321' ' ' TRP . 3.1 mm? -68.73 -30.74 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.48 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.24 139.44 91.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.49 134.85 27.36 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.695 2.264 . . . . 0.0 111.782 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.426 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.4 -32.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.95 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.229 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.1 m-20 -75.71 -12.99 60.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.842 . . . . 0.0 109.411 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.518 ' CD2' HD12 ' A' ' 278' ' ' ILE . 85.2 mt -55.71 136.86 50.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.1 tt0 -63.96 -16.84 62.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 302' ' ' GLU . 6.4 mp -62.56 165.85 5.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.3 p -71.97 169.11 16.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.5 t -51.42 -31.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -50.64 -46.91 58.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 20.7 t -60.26 -50.62 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.41 -42.99 99.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.3 m -52.45 -58.38 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.509 HD12 ' CD1' ' A' ' 281' ' ' LEU . 3.1 mm? -73.74 -39.41 64.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.552 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 12.7 tptm -57.77 -42.14 83.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.36 -21.45 65.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 63.6 tt0 -89.35 21.67 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.43 17.29 8.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.499 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 72.9 mt -107.31 125.41 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.552 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 95.3 m-70 -113.43 -25.67 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 109.352 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 96.0 m-85 -105.19 141.43 36.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.518 HD12 ' CD2' ' A' ' 260' ' ' LEU . 76.0 mt -63.58 -31.39 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.273 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 253' ' ' LEU . . . -50.72 -45.68 48.24 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.499 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 79.3 m-20 -53.78 -37.38 63.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -1.207 . . . . 0.0 109.215 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.509 ' CD1' HD12 ' A' ' 270' ' ' LEU . 34.9 tp -52.53 -48.57 65.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.271 -0.893 . . . . 0.0 108.866 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.578 ' CG1' ' CD2' ' A' ' 253' ' ' LEU . 3.8 m -66.77 -23.89 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 108.821 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.543 ' N ' HG21 ' A' ' 282' ' ' VAL . 63.6 tt0 -62.45 -35.92 80.8 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.464 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 72.3 mtt180 -105.97 141.92 36.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.2 m -63.68 137.89 58.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.963 . . . . 0.0 109.543 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 47.0 tp10 -53.7 -29.22 38.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 37.1 t -52.79 -48.25 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 108.999 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 96.3 mt-10 -51.93 -35.66 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.905 . . . . 0.0 109.008 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 3.8 mm? -65.48 -44.16 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 108.907 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.473 ' HB3' ' NH2' ' B' ' 486' ' ' ARG . 3.4 mm? -63.56 -17.59 62.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 108.958 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.53 ' O ' ' CE ' ' B' ' 483' ' ' MET . 21.6 mttt -93.3 26.51 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.748 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.419 ' CG2' ' OD1' ' A' ' 294' ' ' ASN . 86.7 m -138.02 122.28 11.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 50.3 Cg_endo -71.17 -20.24 28.63 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.686 2.257 . . . . 0.0 111.893 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.536 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 33.5 m120 -50.26 -22.32 1.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 3.8 mp -95.54 122.03 37.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -82.87 156.51 34.56 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -48.86 -39.51 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.563 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 19.4 m -64.52 -52.02 59.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 290' ' ' LEU . 34.7 tp -53.18 -39.13 63.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.7 m -58.8 -49.73 76.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.533 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 74.2 mt-10 -59.75 -40.67 88.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 83.9 mt -57.83 -52.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.284 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -54.54 -38.99 67.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.158 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.83 -42.08 83.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.46 HG12 HD22 ' A' ' 312' ' ' LEU . 2.3 t -72.39 -42.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.542 ' CD2' ' CB ' ' A' ' 313' ' ' SER . 24.4 mt -54.54 -26.91 34.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.92 74.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.4 p -68.47 -20.31 64.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.0 109.408 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.44 ' HG2' HD13 ' A' ' 314' ' ' LEU . 32.4 ttm180 67.59 7.39 5.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -78.31 -22.47 67.75 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.7 pt? -137.08 155.94 49.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.604 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.542 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 1.3 t 75.47 51.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.0 mm? -93.14 21.25 6.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 47.04 46.16 20.15 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.467 ' HG3' HG23 ' A' ' 282' ' ' VAL . 11.0 ptt? -121.91 139.83 53.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -1.185 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.47 ' O ' HD13 ' A' ' 318' ' ' LEU . 55.9 mtt180 -100.14 137.43 38.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 321' ' ' TRP . 2.4 mm? -122.28 111.37 16.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.901 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -77.07 -30.49 55.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.945 . . . . 0.0 108.753 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 321' ' ' TRP . 21.2 t-20 -165.29 26.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.053 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.602 ' CH2' ' CD2' ' A' ' 254' ' ' LEU . 0.4 OUTLIER -43.37 104.25 0.36 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.5 71.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.727 2.951 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 50.2 Cg_endo -70.05 155.83 64.04 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.54 2.16 . . . . 0.0 111.816 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.76 -27.97 67.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.291 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.2 m -59.1 -40.08 84.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.524 ' HB ' ' CD1' ' A' ' 254' ' ' LEU . 20.5 tt . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' B' ' 449' ' ' ALA . 23.7 m120 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.98 131.84 30.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.5 Cg_endo -70.3 136.37 31.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.907 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' B' ' 454' ' ' CYS . . . -66.84 160.55 25.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -53.15 -33.87 54.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -65.04 -49.61 69.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.624 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' B' ' 430' ' ' PRO . 17.2 tp -65.05 -38.44 90.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.5 OUTLIER -73.61 -33.22 64.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -86.87 9.84 17.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.458 HD11 HD12 ' B' ' 456' ' ' LEU . 44.8 tp -77.24 133.29 38.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -77.45 142.26 39.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.1 2.8 65.99 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.435 ' CG2' HD21 ' B' ' 481' ' ' LEU . 93.8 t -131.06 129.56 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.13 -1.218 . . . . 0.0 109.497 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.86 155.22 18.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -50.04 -40.62 45.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -66.9 -45.45 77.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.466 HD11 ' HE2' ' B' ' 477' ' ' LYS . 45.5 mt -60.39 -42.09 95.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' B' ' 449' ' ' ALA . . . -58.82 -45.97 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.355 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 11.2 m-30 -58.51 -43.41 89.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.463 ' O ' HD11 ' B' ' 470' ' ' ILE . 45.6 mttp -60.59 -52.5 64.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 7.1 tt -65.55 -42.03 92.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' B' ' 445' ' ' ALA . . . -55.99 -27.0 50.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.977 . . . . 0.0 109.487 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.36 -24.0 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.417 ' NH1' ' CG1' ' B' ' 470' ' ' ILE . 41.9 mtt-85 -88.8 26.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.63 6.93 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.497 HG13 ' N ' ' B' ' 459' ' ' LEU . 73.2 t -60.71 130.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.33 . . . . 0.0 109.472 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' B' ' 431' ' ' ALA . 57.0 m -135.06 -36.59 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.743 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.12 153.08 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.783 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.515 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 42.5 tp -49.48 -40.42 37.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.325 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.71 -49.93 71.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 108.994 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.434 ' HB2' HG11 ' B' ' 453' ' ' VAL . 81.0 m-20 -55.52 -40.55 71.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 108.971 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.558 ' CD2' ' CD1' ' B' ' 448' ' ' LEU . 3.4 tm? -55.62 -42.98 75.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.73 -25.69 66.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.262 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.13 -21.19 63.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -79.98 153.81 28.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.454 ' HA2' HD13 ' B' ' 482' ' ' ILE . . . -117.3 152.35 17.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.536 ' CD1' ' ND2' ' A' ' 294' ' ' ASN . 33.6 mt -44.46 -36.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -63.95 -35.59 81.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.473 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 87.2 m-20 -77.35 -31.55 54.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' B' ' 478' ' ' ALA . 23.1 mt -73.48 -35.52 65.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.91 69.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.51 -33.2 72.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.463 HD11 ' O ' ' B' ' 447' ' ' LYS . 80.5 mt -85.24 131.39 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.436 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.95 150.4 46.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.19 -29.39 12.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.434 HD22 ' HD3' ' B' ' 477' ' ' LYS . 64.6 mt -99.72 136.49 39.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -1.16 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.03 162.07 13.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -57.3 -38.11 73.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.65 -45.94 56.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.466 ' HE2' HD11 ' B' ' 444' ' ' LEU . 14.5 tttp -62.58 -45.68 91.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' B' ' 467' ' ' LEU . . . -58.7 -42.49 88.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -61.7 -46.3 94.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.83 78.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.517 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.0 mp -66.38 -35.36 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.594 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 293' ' ' PRO . 59.6 mt -70.32 -56.33 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.579 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 39.9 mtp -52.92 -37.8 61.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.34 69.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' B' ' 459' ' ' LEU . . . -64.81 -49.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.515 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 66.3 ttt-85 -53.85 -47.06 71.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.97 -45.84 86.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.515 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 46.2 mt -59.1 -39.51 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 91.2 m -75.3 -49.13 20.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . 0.515 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 15.0 m95 -59.39 -41.3 89.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 9.19 43.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.463 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.627 ' CD1' ' CB ' ' A' ' 323' ' ' PRO . 2.5 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -61.67 139.55 95.27 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' A' ' 254' ' ' LEU . 42.0 Cg_endo -64.56 -34.05 53.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.505 2.137 . . . . 0.0 111.473 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.532 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 8.7 tt -53.71 -34.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.581 HD23 ' CH2' ' A' ' 321' ' ' TRP . 0.6 OUTLIER -74.57 -21.67 59.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.571 HD12 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -89.58 -24.8 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.263 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.464 ' O ' HD11 ' A' ' 278' ' ' ILE . 4.5 mtm180 -66.23 147.5 98.85 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.8 Cg_endo -70.69 140.88 40.15 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.698 2.265 . . . . 0.0 111.715 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.465 ' O ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.54 -34.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 109.365 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.84 -30.92 71.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 256' ' ' PRO . 30.2 m-20 -76.0 -14.96 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 257' ' ' VAL . 48.7 mt -44.75 149.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.56 -19.17 65.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.512 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 6.1 mp -64.07 169.32 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 9.2 p -78.22 159.88 28.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.2 t -47.25 -37.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.486 ' NH2' ' OD2' ' B' ' 465' ' ' ASP . 52.0 ttt85 -53.37 -46.85 69.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.512 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 19.4 m -63.58 -51.05 67.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.943 . . . . 0.0 109.387 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.07 78.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -59.7 -33.31 71.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.914 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.407 ' O ' ' HB1' ' A' ' 272' ' ' ALA . 56.5 m -62.29 -63.82 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.292 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.0 mt -58.64 -47.66 83.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.501 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 19.0 tttt -52.69 -32.11 40.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 269' ' ' CYS . . . -60.97 -17.46 51.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.328 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 58.5 tt0 -95.6 21.33 8.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.05 23.3 3.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 97.0 mt -112.34 107.66 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.501 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 50.5 m-70 -107.1 -9.2 16.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.5 m-85 -114.55 131.96 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 74.7 mt -54.16 -36.5 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 109.119 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.591 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -46.38 -47.53 16.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.501 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 89.2 m-20 -53.27 -34.41 57.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 108.704 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 278' ' ' ILE . 31.2 tp -53.78 -50.48 65.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.146 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 34.8 m -67.09 -29.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.533 ' N ' HG22 ' A' ' 282' ' ' VAL . 93.9 mt-30 -57.2 -34.34 68.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -96.99 159.55 14.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.416 -0.802 . . . . 0.0 109.017 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 m -83.35 140.15 32.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 88.3 tt0 -52.7 -31.18 36.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.325 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.89 -51.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.039 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 69.9 mm-40 -51.93 -37.0 51.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.087 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 62.2 mt -60.75 -47.24 87.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.515 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.8 tm? -59.81 -33.53 71.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.283 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.508 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 45.8 mttt -83.06 -17.84 41.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.402 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -77.08 113.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.528 ' HB2' ' CD1' ' B' ' 482' ' ' ILE . 50.8 Cg_endo -71.0 -23.29 25.31 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.766 2.311 . . . . 0.0 112.165 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.508 ' N ' HD13 ' B' ' 464' ' ' ILE . 70.8 m-80 -50.93 -21.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.699 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 3.2 mp -101.31 122.69 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -73.8 156.64 50.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -49.09 -38.63 25.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.293 -1.122 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -67.2 -42.68 83.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.355 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 59.5 p -58.43 -47.14 84.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.431 HD22 HD23 ' A' ' 290' ' ' LEU . 22.9 tp -52.94 -44.19 66.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.294 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 52.2 m -52.5 -52.31 55.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.209 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.46 ' CB ' HD22 ' A' ' 262' ' ' LEU . 84.7 mt-10 -53.61 -42.24 67.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.57 -39.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.183 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -62.16 -36.11 80.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.39 -51.24 61.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 312' ' ' LEU . 3.2 t -72.29 -37.52 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.251 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 15.5 tp -60.25 -26.27 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.441 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.08 -30.7 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 109.434 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.7 OUTLIER -68.95 -7.35 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.86 . . . . 0.0 109.555 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 92.9 mtt-85 61.76 12.52 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . 0.422 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -93.21 -2.94 65.66 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.526 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 0.0 OUTLIER -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -1.197 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.509 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 46.36 67.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.486 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.6 mt -101.64 11.86 38.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.63 73.83 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.53 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 13.5 ptt? -107.7 150.83 26.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -1.216 . . . . 0.0 109.54 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -125.57 145.85 49.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -124.04 140.95 52.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.68 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.1 -32.2 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 85.8 m-20 -122.35 -78.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.167 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.591 ' CH2' ' HA3' ' A' ' 279' ' ' GLY . 0.8 OUTLIER 168.76 -58.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.76 107.8 1.74 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.647 2.231 . . . . 0.0 111.889 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.627 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 52.8 Cg_endo -73.16 165.12 33.55 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.554 2.169 . . . . 0.0 111.688 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.89 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.9 m -76.82 -38.68 53.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 323' ' ' PRO . 18.5 tt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 20.0 m120 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -61.85 130.13 92.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.575 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.9 138.74 34.82 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.703 2.269 . . . . 0.0 111.728 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -73.71 157.52 36.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -56.89 -33.54 66.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 436' ' ' ASN . 56.0 m-20 -69.61 -37.3 76.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.32 -33.24 71.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 109.34 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' B' ' 442' ' ' ARG . 33.1 tp -86.43 -30.59 21.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 433' ' ' ASP . 24.3 p-10 -80.0 5.84 12.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.834 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.444 HD21 HD13 ' B' ' 456' ' ' LEU . 25.5 tp -77.87 133.81 38.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.9 139.22 50.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.2 63.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.432 HG22 HD23 ' B' ' 437' ' ' LEU . 48.8 t -129.5 130.88 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -1.157 . . . . 0.0 109.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -101.35 158.42 16.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.505 ' HA ' ' CD1' ' B' ' 435' ' ' LEU . 76.8 mtt-85 -50.12 -52.45 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.17 -48.38 81.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.51 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 12.3 tp -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.34 87.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -56.23 -44.45 79.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -60.1 -44.74 94.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' B' ' 459' ' ' LEU . 2.6 tm? -73.29 -39.35 65.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.8 -28.31 69.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.35 -16.89 10.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -92.3 30.13 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.562 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.71 -18.86 6.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 49.1 t -63.82 138.25 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.336 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 72.6 m -135.14 -34.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.866 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.421 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -115.97 159.31 21.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.498 ' CD2' HD11 ' B' ' 488' ' ' ILE . 33.8 tp -50.67 -40.11 52.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.338 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . 0.406 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 48.0 tp10 -55.88 -48.62 75.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.185 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.422 ' HB2' HG13 ' B' ' 453' ' ' VAL . 86.7 m-20 -57.3 -40.81 78.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' B' ' 448' ' ' LEU . 17.0 tp -59.49 -45.31 92.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.35 -38.99 78.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -76.26 146.52 38.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' B' ' 482' ' ' ILE . . . -106.28 154.41 16.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.514 ' CG2' ' HA ' ' B' ' 475' ' ' ASP . 59.7 mt -44.03 -36.59 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . 0.486 ' OD2' ' NH2' ' A' ' 265' ' ' ARG . 48.0 t0 -63.2 -41.04 99.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -66.68 -25.08 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' B' ' 478' ' ' ALA . 7.2 mp -85.52 -24.46 27.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.81 -23.9 63.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -52.06 -32.16 33.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.84 124.73 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.507 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.46 -35.38 80.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.405 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.54 -31.62 52.35 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.51 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 60.0 mt -101.79 135.58 43.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 39.1 m -103.73 163.87 12.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.514 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 90.7 m-20 -56.88 -39.42 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -71.86 -45.88 59.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.504 ' HD3' ' CD2' ' B' ' 473' ' ' LEU . 40.3 tttm -61.07 -46.74 89.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.453 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' B' ' 467' ' ' LEU . . . -58.9 -41.93 88.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.357 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' B' ' 464' ' ' ILE . . . -59.2 -45.77 94.83 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.61 -35.96 73.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . . . . . . . . . 25.3 mt -68.96 -44.11 73.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.523 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 293' ' ' PRO . 30.4 mt -59.5 -55.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.508 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 43.9 mtp -52.76 -44.47 66.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 0.0 109.374 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.6 -49.78 76.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.46 ' HB1' ' HG ' ' B' ' 456' ' ' LEU . . . -68.25 -47.75 66.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' A' ' 291' ' ' LYS . 39.5 ttm180 -55.1 -45.65 75.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.487 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 74.6 m-20 -61.02 -41.24 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' B' ' 456' ' ' LEU . 63.2 mt -67.42 -38.74 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . 0.406 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 47.4 m -67.44 -49.56 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -68.0 -39.51 83.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 16.9 m-30 -83.31 -13.12 55.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.568 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 16.4 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -54.64 135.67 63.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.22 -31.72 53.16 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.604 2.203 . . . . 0.0 111.672 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 8.2 tt -63.18 -28.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 108.756 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.567 ' CD1' ' CE ' ' A' ' 316' ' ' MET . 37.9 mt -74.6 -44.16 52.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.98 -34.78 78.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.67 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 278' ' ' ILE . 4.3 ttp180 -56.04 141.11 68.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.0 109.068 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.7 Cg_endo -68.72 130.96 21.65 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 267' ' ' ALA . 0.3 OUTLIER -43.51 -35.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.89 . . . . 0.0 109.396 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.98 -30.93 70.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.321 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.3 m-20 -76.81 -14.9 59.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.87 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 257' ' ' VAL . 68.3 mt -44.79 140.88 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' LEU . 98.0 mt-10 -64.83 -26.58 68.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 261' ' ' GLU . 29.7 mt -52.84 -173.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 13.0 p -84.84 159.39 20.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.41 HG13 ' OD1' ' A' ' 268' ' ' ASN . 8.7 t -55.16 -34.66 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.357 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -53.71 -46.45 70.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.7 p -64.42 -45.04 89.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -67.47 -39.33 85.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.41 ' OD1' HG13 ' A' ' 264' ' ' VAL . 89.3 m-20 -58.52 -32.2 68.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.451 ' SG ' ' CD1' ' A' ' 295' ' ' LEU . 21.4 t -57.6 -64.99 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.76 -47.71 79.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -0.845 . . . . 0.0 109.454 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.491 ' HG3' ' CE1' ' A' ' 276' ' ' HIS . 36.1 ttpt -55.08 -37.17 66.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.441 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.75 -21.15 6.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 94.7 mt-10 -95.65 21.17 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.86 28.04 4.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.518 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.9 mt -117.09 111.48 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.491 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 96.1 m-70 -104.4 -10.13 17.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.578 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.86 143.45 33.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 92.0 mt -72.29 -31.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.524 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -47.22 -48.33 20.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.7 m-20 -53.79 -35.32 61.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -1.138 . . . . 0.0 108.757 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -52.78 -47.16 67.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 283' ' ' GLN . 6.5 m -68.25 -23.81 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.54 ' N ' HG22 ' A' ' 282' ' ' VAL . 63.6 tt0 -62.23 -35.69 79.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -100.99 141.18 34.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 74.0 p -76.2 147.11 38.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.82 -34.1 26.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 0.0 109.339 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.76 -51.26 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.281 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.14 -37.84 62.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.9 mm? -68.37 -40.77 81.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.516 HD12 ' CD2' ' A' ' 300' ' ' LEU . 34.8 tp -62.3 -25.45 67.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 109.331 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.467 ' O ' ' HE3' ' B' ' 483' ' ' MET . 22.2 mttt -88.66 17.25 5.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -116.84 136.99 23.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' B' ' 483' ' ' MET . 52.6 Cg_endo -71.72 -30.64 14.23 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.691 2.26 . . . . 0.0 111.85 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.51 ' N ' HD12 ' B' ' 464' ' ' ILE . 33.4 m120 -52.53 -20.8 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 5.3 mp -104.74 124.48 49.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.605 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.79 173.86 35.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -51.37 -44.66 62.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -70.33 -36.77 74.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.9 t -54.93 -52.27 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 290' ' ' LEU . 22.5 tp -52.91 -39.49 62.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.8 m -59.11 -50.17 75.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.236 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.459 ' OE2' HD21 ' A' ' 262' ' ' LEU . 54.0 tt0 -53.73 -44.92 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.089 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.65 -40.43 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 108.783 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.66 -40.08 90.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.343 -0.848 . . . . 0.0 108.742 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.09 -46.18 85.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.367 -0.833 . . . . 0.0 108.827 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.9 t -69.95 -35.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 108.819 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 313' ' ' SER . 17.1 tp -63.5 -26.78 68.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.371 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.77 -28.92 64.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.209 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.2 p -69.31 -12.14 61.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.404 ' C ' HD21 ' A' ' 314' ' ' LEU . 69.8 mtt180 57.36 15.78 2.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.37 -15.47 13.91 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.496 ' CD1' ' CG2' ' A' ' 278' ' ' ILE . 9.0 tp -137.5 136.15 37.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -1.182 . . . . 0.0 109.155 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.3 OUTLIER 73.37 41.93 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.8 mm? -92.22 13.17 19.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.68 36.88 83.86 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.567 ' CE ' ' CD1' ' A' ' 253' ' ' LEU . 7.5 mtm -84.28 170.3 13.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -141.0 129.56 22.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.7 mp -133.05 136.32 45.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.48 -39.89 64.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.038 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 69.5 m-20 -129.75 -65.13 0.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.537 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.0 t-105 167.31 -65.92 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.69 107.99 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.679 2.253 . . . . 0.0 112.169 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.8 Cg_endo -72.86 161.21 44.29 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.622 2.214 . . . . 0.0 111.53 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.84 -18.84 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.601 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' SER . . . . . 0.457 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 16.3 m -64.29 -49.26 72.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 26.9 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.956 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.9 m120 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -62.02 121.83 68.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . 0.429 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 49.5 Cg_endo -70.05 131.21 20.36 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.641 2.227 . . . . 0.0 111.741 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' B' ' 455' ' ' THR . . . -66.37 153.86 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' B' ' 436' ' ' ASN . 92.0 m-20 -54.32 -29.57 48.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 456' ' ' LEU . 91.2 m-20 -67.05 -50.1 62.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 27.3 tp -67.78 -42.02 82.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -71.35 -26.88 63.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.38 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 432' ' ' ASP . 40.8 t30 -96.65 7.92 45.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.628 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' B' ' 438' ' ' GLU . 1.6 tm? -78.09 120.39 22.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' B' ' 437' ' ' LEU . 23.6 pt-20 -60.57 140.89 57.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 96.31 -3.64 64.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.558 ' CG2' ' CD2' ' B' ' 481' ' ' LEU . 47.0 t -120.67 129.98 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.123 -1.222 . . . . 0.0 109.487 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -87.05 154.42 20.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -49.98 -45.18 51.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.33 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . 0.565 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 94.3 m-20 -67.83 -46.56 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' B' ' 473' ' ' LEU . 14.1 tp -53.67 -40.83 66.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.114 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.4 91.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 108.978 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 12.7 m-30 -58.55 -40.18 82.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.102 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -62.21 -42.43 99.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -45.01 95.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.87 -40.33 84.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.9 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.55 -33.25 3.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 26.2 mtp85 -91.24 22.32 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.6 7.17 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' B' ' 458' ' ' ASP . 5.8 t -83.15 110.0 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.914 -1.344 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 14.9 m -127.51 -35.76 2.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.94 . . . . 0.0 109.587 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -79.62 140.69 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.554 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 23.5 tp -45.64 -43.64 12.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.191 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . 0.403 ' HA ' ' SG ' ' B' ' 489' ' ' CYS . 13.3 mt-10 -60.1 -46.32 90.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.177 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.495 ' CB ' HG13 ' B' ' 453' ' ' VAL . 88.4 m-20 -54.94 -38.01 67.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.133 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.403 ' HA ' HG11 ' B' ' 453' ' ' VAL . 33.3 tp -63.79 -42.9 97.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.226 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.36 -37.69 75.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.46 -30.55 71.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.466 ' CG ' HG22 ' B' ' 453' ' ' VAL . 97.8 mm-40 -73.52 148.72 42.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -107.71 154.11 16.66 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.517 ' CG2' ' HA ' ' B' ' 475' ' ' ASP . 96.5 mt -44.98 -36.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.144 -1.21 . . . . 0.0 109.27 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -36.88 82.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.245 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.2 m-20 -71.41 -28.71 64.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' B' ' 478' ' ' ALA . 7.1 mp -82.84 -30.68 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.963 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.39 -24.69 60.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -51.35 -33.15 28.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.892 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.443 ' HB ' HD21 ' B' ' 473' ' ' LEU . 64.4 mt -102.24 127.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -59.73 -31.01 69.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.2 -25.67 60.37 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' B' ' 444' ' ' LEU . 3.5 mm? -103.38 129.19 50.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -1.106 . . . . 0.0 109.562 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 23.4 m -103.61 162.02 13.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.517 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 83.6 m-20 -55.88 -39.14 71.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.1 -45.85 25.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -62.37 -46.62 87.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 482' ' ' ILE . . . -65.53 -45.91 81.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -63.59 -52.12 48.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.48 -42.22 61.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.215 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.558 ' CD2' ' CG2' ' B' ' 440' ' ' VAL . 6.4 mp -67.28 -42.3 84.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.36 -0.837 . . . . 0.0 109.442 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.52 ' CG2' ' NE ' ' B' ' 486' ' ' ARG . 45.3 mt -56.41 -56.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.526 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 43.4 mmm -53.29 -44.88 68.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -57.26 -60.77 3.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.193 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' B' ' 456' ' ' LEU . . . -55.7 -43.3 76.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.196 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.52 ' NE ' ' CG2' ' B' ' 482' ' ' ILE . 94.8 mtt180 -59.55 -41.96 91.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.831 . . . . 0.0 109.19 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.569 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 98.1 m-20 -57.84 -41.31 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.291 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.554 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 24.3 mt -68.55 -38.55 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.309 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' B' ' 457' ' ' GLU . 66.4 m -70.27 -51.62 29.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -61.37 -38.19 86.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 19.2 m-30 -76.29 -36.86 58.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.0 109.406 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' PHE . . . . . 0.556 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 42.0 p90 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 254' ' ' LEU . 0.5 OUTLIER -69.67 137.53 88.11 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.239 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 255' ' ' ARG . 43.2 Cg_endo -65.31 -26.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.705 2.27 . . . . 0.0 111.673 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 250' ' ' ASP . 6.0 tt -71.22 -28.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 108.709 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' LEU . . . . . 0.588 HD22 ' CZ3' ' A' ' 321' ' ' TRP . 3.1 tp -74.35 -27.18 60.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.562 ' HG ' ' CH2' ' A' ' 321' ' ' TRP . 4.0 mp -101.67 -20.98 14.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 251' ' ' PRO . 16.2 mtt180 -55.09 147.59 33.69 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.019 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.6 Cg_endo -69.56 132.46 23.7 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.687 2.258 . . . . 0.0 111.954 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' VAL . . . . . 0.445 HG21 ' HG3' ' A' ' 271' ' ' LYS . 0.2 OUTLIER -44.62 -30.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.275 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -64.25 -30.69 71.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 12.9 m-20 -69.57 -16.99 63.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 46.1 mt -57.43 144.73 35.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 82.2 tt0 -65.23 -14.4 60.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.504 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.496 HD23 ' CB ' ' A' ' 302' ' ' GLU . 8.0 mp -60.24 173.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.574 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.7 p -74.73 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 268' ' ' ASN . 18.5 t -62.56 -31.76 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' ARG . . . . . 0.53 ' HD3' ' N ' ' A' ' 265' ' ' ARG . 6.8 mmt85 -60.08 -44.95 94.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.136 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' SER . . . . . 0.45 ' OG ' HD22 ' A' ' 262' ' ' LEU . 7.8 t -57.83 -51.01 71.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.214 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -66.56 -34.21 77.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.912 . . . . 0.0 109.106 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 264' ' ' VAL . 93.3 m-20 -61.61 -38.88 89.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 265' ' ' ARG . 39.8 m -49.86 -60.12 3.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' A' ' 281' ' ' LEU . 45.3 mt -63.52 -48.33 77.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.301 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 52.5 mtmt -53.27 -39.69 64.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.81 -24.74 6.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.334 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -93.47 24.72 3.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . 66.23 29.85 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' ILE . . . . . 0.519 HG22 ' CB ' ' A' ' 280' ' ' ASP . 54.7 mt -124.22 108.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 256' ' ' PRO . 89.5 m-70 -100.85 -6.83 24.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.14 140.83 37.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 281' ' ' LEU . 56.6 mt -72.61 -30.19 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.529 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' GLY . . . . . 0.551 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -45.5 -48.37 11.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ASP . . . . . 0.519 ' CB ' HG22 ' A' ' 275' ' ' ILE . 82.5 m-20 -53.0 -33.73 53.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.922 -1.34 . . . . 0.0 108.527 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 270' ' ' LEU . 26.9 tp -52.98 -52.7 57.42 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 25.3 m -62.47 -27.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' GLN . . . . . 0.531 ' N ' HG21 ' A' ' 282' ' ' VAL . 53.0 tt0 -58.21 -37.95 75.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 86.0 mtt-85 -98.07 140.92 31.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.799 . . . . 0.0 108.975 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.0 m -63.64 141.17 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 109.712 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 49.0 tp10 -53.33 -27.27 22.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.3 t -52.8 -51.81 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 93.6 mt-10 -51.87 -33.66 37.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.083 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 40.5 mt -64.94 -46.76 80.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.88 -29.76 70.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' LYS . . . . . 0.529 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 23.4 mttm -84.96 -20.65 30.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 295' ' ' LEU . 15.7 m -82.12 116.42 63.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.63 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 52.1 Cg_endo -71.16 -24.35 23.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.626 2.217 . . . . 0.0 111.843 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.5 ' N ' HD13 ' B' ' 464' ' ' ILE . 34.4 m120 -46.94 -23.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 3.0 mp -96.02 138.87 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.84 163.29 33.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -50.79 -45.28 59.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -1.189 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -65.73 -42.12 91.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.8 t -56.1 -55.13 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 109.277 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 295' ' ' LEU . 49.9 mt -54.42 -47.02 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.4 m -50.37 -53.0 32.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.234 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' GLU . . . . . 0.496 ' CB ' HD23 ' A' ' 262' ' ' LEU . 60.9 mm-40 -53.75 -38.44 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 300' ' ' LEU . 93.5 mt -57.79 -46.04 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -60.38 -39.76 88.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.06 -49.92 70.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.851 . . . . 0.0 109.347 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' VAL . . . . . 0.487 ' CG1' HD21 ' A' ' 312' ' ' LEU . 2.2 t -63.55 -41.09 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 109.203 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' LEU . . . . . 0.52 HD11 ' CB ' ' A' ' 313' ' ' SER . 24.1 tp -53.91 -26.62 26.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.86 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.313 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 20.9 t -68.98 -7.72 37.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' ARG . . . . . 0.51 ' HA ' ' CD2' ' A' ' 314' ' ' LEU . 66.2 mtt180 65.64 8.98 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.365 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -72.26 -31.24 63.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' LEU . . . . . 0.487 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -148.16 173.12 13.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 109.51 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' SER . . . . . 0.52 ' CB ' HD11 ' A' ' 307' ' ' LEU . 2.8 m 61.77 30.66 18.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.897 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' LEU . . . . . 0.51 ' CD2' ' HA ' ' A' ' 310' ' ' ARG . 68.4 mt -79.41 -5.46 54.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.515 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.86 38.82 65.36 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' MET . . . . . 0.506 ' HE1' ' CD1' ' A' ' 253' ' ' LEU . 4.2 ptt? -107.42 162.11 14.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -1.216 . . . . 0.0 109.361 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ARG . . . . . 0.418 ' C ' HD11 ' A' ' 318' ' ' LEU . 44.5 mtm180 -128.2 134.37 49.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -116.51 143.12 45.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.78 -33.71 70.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.261 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -135.02 -68.23 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' TRP . . . . . 0.588 ' CZ3' HD22 ' A' ' 253' ' ' LEU . 0.7 OUTLIER 176.98 -64.96 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.376 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 49.9 Cg_endo -68.67 107.5 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 112.041 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.7 Cg_endo -72.54 164.79 34.56 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.571 2.181 . . . . 0.0 111.579 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.92 -19.03 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.279 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.0 m -65.77 -47.85 73.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' ILE . . . . . 0.52 ' CD1' HD22 ' A' ' 254' ' ' LEU . 19.4 mt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 428' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 29.5 m120 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -51.19 136.25 29.72 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.9 140.97 39.5 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.711 2.274 . . . . 0.0 111.652 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 431' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' B' ' 455' ' ' THR . . . -73.92 165.56 24.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 109.662 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 432' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' B' ' 432' ' ' ASP . 25.4 p-10 -61.68 -34.12 75.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 433' ' ' ASP . . . . . 0.582 ' CB ' ' CB ' ' B' ' 456' ' ' LEU . 5.2 m-20 -63.4 -49.21 74.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.072 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 434' ' ' LEU . . . . . 0.498 ' CD1' ' HB1' ' B' ' 445' ' ' ALA . 3.4 tm? -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 435' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.72 -35.55 67.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -88.57 4.68 46.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 437' ' ' LEU . . . . . 0.413 HD23 HG23 ' B' ' 440' ' ' VAL . 31.8 tp -71.98 132.76 44.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -76.78 141.59 40.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.2 9.39 62.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 440' ' ' VAL . . . . . 0.413 HG23 HD23 ' B' ' 437' ' ' LEU . 47.9 t -125.89 131.52 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -1.129 . . . . 0.0 109.422 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -97.64 160.66 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 442' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 93.7 mtt180 -52.08 -41.35 62.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.964 . . . . 0.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.03 -42.29 85.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.449 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 444' ' ' LEU . . . . . 0.427 HD13 ' NZ ' ' B' ' 477' ' ' LYS . 53.6 mt -64.98 -42.56 94.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 445' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.18 -41.46 88.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 446' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 10.3 m-30 -64.14 -40.5 96.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 447' ' ' LYS . . . . . 0.458 ' HB3' HD12 ' B' ' 470' ' ' ILE . 66.5 mttm -61.68 -41.23 97.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 448' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' B' ' 473' ' ' LEU . 80.9 mt -64.86 -39.22 93.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 449' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -67.06 -37.46 84.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.97 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 451' ' ' ARG . . . . . 0.493 ' NH1' ' O ' ' B' ' 466' ' ' ASP . 35.3 mtm105 -89.7 23.34 2.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.74 6.77 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 453' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 8.9 t -81.84 107.24 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.355 . . . . 0.0 109.314 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 454' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 60.4 m -123.74 -44.38 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 0.0 109.697 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 455' ' ' THR . . . . . 0.521 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -71.97 140.84 49.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 456' ' ' LEU . . . . . 0.582 ' CB ' ' CB ' ' B' ' 433' ' ' ASP . 2.6 tm? -51.76 -37.91 53.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.14 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -63.07 -40.83 98.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.743 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 458' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 68.7 m-20 -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.089 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 459' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 3.5 tm? -59.65 -41.84 91.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.37 74.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.394 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.68 -25.76 62.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 462' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 98.3 mm-40 -67.79 163.11 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.66 156.86 15.98 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 464' ' ' ILE . . . . . 0.522 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 58.6 mt -51.94 -34.95 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -1.182 . . . . 0.0 109.495 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -68.48 -35.95 78.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 466' ' ' ASP . . . . . 0.493 ' O ' ' NH1' ' B' ' 451' ' ' ARG . 87.3 m-20 -72.34 -31.52 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 467' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' B' ' 478' ' ' ALA . 21.7 mt -74.41 -25.34 59.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -24.27 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -48.06 -33.58 8.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 470' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' B' ' 447' ' ' LYS . 61.3 mt -103.36 128.1 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.37 -31.82 72.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -56.81 -30.92 60.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 473' ' ' LEU . . . . . 0.424 HD13 ' CD2' ' B' ' 448' ' ' LEU . 73.8 mt -101.53 131.03 47.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -1.185 . . . . 0.0 109.579 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.84 163.35 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 475' ' ' ASP . . . . . 0.466 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 88.3 m-20 -57.87 -38.19 75.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -73.81 -46.04 47.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 477' ' ' LYS . . . . . 0.453 ' O ' HD13 ' B' ' 481' ' ' LEU . 15.7 tttp -64.78 -42.44 95.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 478' ' ' ALA . . . . . 0.518 ' CB ' HD12 ' B' ' 467' ' ' LEU . . . -61.55 -46.03 91.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 479' ' ' GLY . . . . . 0.437 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.33 -45.98 92.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.91 84.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -1.116 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 481' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.4 mp -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 482' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 47.9 mt -66.89 -54.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 483' ' ' MET . . . . . 0.529 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 49.1 mtp -52.22 -37.41 55.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.395 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 484' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.49 -57.13 5.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.167 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 485' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' B' ' 456' ' ' LEU . . . -62.87 -52.09 64.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 486' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' B' ' 482' ' ' ILE . 21.6 ttm180 -46.27 -48.77 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.203 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 487' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.2 m-20 -58.95 -41.5 87.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 488' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 492' ' ' GLY . 80.2 mt -58.93 -37.61 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 41.7 t -70.58 -49.12 51.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.606 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.41 -41.77 72.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 491' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 46.1 m-85 -79.78 -36.06 37.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 492' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.569 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 38.4 p90 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.18 121.72 13.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.241 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.67 -26.56 60.96 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.645 2.23 . . . . 0.0 111.469 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 18.9 tt -69.59 -31.99 50.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.494 ' CD2' HG12 ' A' ' 282' ' ' VAL . 34.2 mt -75.15 -45.16 42.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.4 -0.812 . . . . 0.0 109.39 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.569 HD21 ' CZ2' ' A' ' 321' ' ' TRP . 0.3 OUTLIER -64.01 -37.35 87.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.453 ' CD ' ' OD2' ' A' ' 259' ' ' ASP . 5.2 ttp180 -59.6 141.86 88.1 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.241 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.2 Cg_endo -68.87 133.6 27.65 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.651 2.234 . . . . 0.0 111.691 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.46 ' CA ' HD13 ' A' ' 260' ' ' LEU . 1.0 OUTLIER -44.9 -25.36 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 256' ' ' PRO . 91.1 m-20 -69.58 -30.56 68.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.212 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 48.8 t0 -66.7 -22.55 66.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.46 HD13 ' CA ' ' A' ' 257' ' ' VAL . 38.5 mt -43.62 131.44 5.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -55.93 -24.79 40.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' A' ' 306' ' ' VAL . 5.6 mp -62.35 163.59 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.3 p -62.87 161.09 13.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 20.4 t -54.76 -26.1 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -51.93 -44.11 63.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.436 ' CB ' ' OE1' ' A' ' 302' ' ' GLU . 8.7 t -58.79 -50.61 73.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.446 ' HB3' ' O ' ' A' ' 257' ' ' VAL . . . -70.49 -33.56 71.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -56.42 -38.22 71.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 299' ' ' SER . 24.8 m -60.62 -64.6 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 63.7 mt -64.7 -46.64 81.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 76.9 tttt -52.98 -34.01 54.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.4 ' HB3' ' O ' ' A' ' 269' ' ' CYS . . . -53.76 -23.59 12.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.442 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 96.9 mt-10 -89.05 22.59 2.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.442 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 71.89 36.48 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.516 ' CG2' ' HB3' ' A' ' 280' ' ' ASP . 70.6 mt -112.16 127.38 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.592 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.9 p80 -116.68 -30.28 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.588 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.592 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.8 m-30 -106.57 127.8 53.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.528 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 80.5 mt -48.26 -30.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.566 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -46.5 -48.64 16.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.516 ' HB3' ' CG2' ' A' ' 275' ' ' ILE . 40.0 t0 -53.39 -32.96 51.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.198 . . . . 0.0 108.899 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.498 ' CD1' ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -56.82 -46.95 81.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.386 -0.821 . . . . 0.0 109.111 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.52 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 17.1 m -69.01 -23.22 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.513 ' N ' HG22 ' A' ' 282' ' ' VAL . 95.5 mt-30 -66.2 -36.98 84.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.948 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -104.4 143.06 33.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.417 ' OG1' ' HG3' ' A' ' 288' ' ' GLU . 43.9 p -80.0 151.83 29.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.411 ' OE2' ' OG ' ' A' ' 313' ' ' SER . 8.9 mt-10 -54.45 -39.46 67.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.462 ' O ' ' HG2' ' A' ' 291' ' ' LYS . 55.8 t -52.98 -55.27 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.417 ' HG3' ' OG1' ' A' ' 285' ' ' THR . 95.6 mt-10 -53.15 -30.58 37.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.466 ' O ' HG23 ' A' ' 292' ' ' THR . 8.4 mp -79.64 -42.42 24.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.499 ' CD2' ' CD1' ' A' ' 300' ' ' LEU . 3.7 mt -65.04 -12.75 54.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 287' ' ' VAL . 45.7 mmtm -89.14 12.34 16.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.531 ' CG2' ' HG ' ' A' ' 295' ' ' LEU . 7.5 t -124.83 138.74 31.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.595 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.54 ' CB ' ' CA ' ' B' ' 479' ' ' GLY . 49.7 Cg_endo -70.82 -27.05 21.89 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.789 2.326 . . . . 0.0 111.78 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.432 ' N ' HD11 ' B' ' 464' ' ' ILE . 26.2 m120 -48.32 -24.4 1.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.531 ' HG ' ' CG2' ' A' ' 292' ' ' THR . 20.3 mt -87.6 143.13 27.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.358 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . 0.459 ' O ' ' OG ' ' A' ' 299' ' ' SER . . . -110.47 160.38 13.36 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.92 -42.27 72.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -1.156 . . . . 0.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -67.38 -37.84 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.364 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 269' ' ' CYS . 81.1 p -59.18 -39.4 82.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.337 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.499 ' CD1' ' CD2' ' A' ' 290' ' ' LEU . 0.6 OUTLIER -57.99 -42.65 85.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.378 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 49.8 m -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.436 ' OE1' ' CB ' ' A' ' 266' ' ' SER . 96.1 mt-10 -56.59 -42.8 79.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 80.7 mt -57.91 -48.26 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -54.74 -41.57 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -58.29 -51.42 69.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' A' ' 262' ' ' LEU . 1.6 t -68.72 -37.19 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.428 HD13 ' HB3' ' A' ' 313' ' ' SER . 20.0 tp -62.03 -26.43 68.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.315 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.23 -29.99 66.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.5 t -74.11 -13.37 60.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.2 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.463 ' O ' HD21 ' A' ' 314' ' ' LEU . 51.2 mtt-85 61.17 13.51 4.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 109.307 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -88.98 -24.56 31.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.52 ' CD1' HG12 ' A' ' 306' ' ' VAL . 1.6 pt? -139.32 153.25 47.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -1.139 . . . . 0.0 109.562 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.458 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.3 OUTLIER 71.45 32.62 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.509 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.5 mm? -89.27 14.12 11.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.268 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.5 44.88 92.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.509 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 8.0 mtm -94.21 168.75 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.442 ' C ' HD23 ' A' ' 318' ' ' LEU . 53.6 mtt180 -134.05 121.61 21.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.442 HD23 ' C ' ' A' ' 317' ' ' ARG . 5.2 mt -113.4 138.11 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.383 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.58 -32.17 67.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.159 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.491 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.3 m-20 -135.05 -64.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 108.988 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.569 ' CZ2' HD21 ' A' ' 254' ' ' LEU . 1.2 t-105 164.73 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.371 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.5 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -68.09 107.91 1.63 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.595 2.197 . . . . 0.0 111.967 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.446 ' HG2' ' HB3' ' A' ' 249' ' ' PHE . 50.2 Cg_endo -70.51 163.07 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.667 2.245 . . . . 0.0 111.689 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.18 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' SER . . . . . 0.41 ' CB ' ' N ' ' A' ' 249' ' ' PHE . 3.8 t -58.73 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.443 ' O ' ' O ' ' A' ' 327' ' ' ALA . 30.3 mt -56.36 -36.48 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 326' ' ' ILE . . . 44.47 -166.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.47 -38.45 69.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.444 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.494 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -56.92 -34.73 68.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -1.16 . . . . 0.0 109.538 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.444 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 26.8 m120 57.99 44.4 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.395 -179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.437 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 3.1 tttp -67.77 136.52 92.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.512 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.437 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.31 136.53 31.75 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.69 2.26 . . . . 0.0 111.724 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -71.13 159.51 34.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.38 -33.77 63.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.73 -48.32 77.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.424 HD11 ' HA ' ' B' ' 456' ' ' LEU . 16.3 tp -70.1 -38.4 75.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.489 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -73.06 -31.44 64.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -84.83 7.73 19.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.455 ' HB2' HD12 ' B' ' 456' ' ' LEU . 30.1 tp -72.28 133.83 45.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.86 140.83 40.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.16 2.96 68.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.464 HG21 HD12 ' B' ' 481' ' ' LEU . 58.8 t -130.82 137.15 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -1.187 . . . . 0.0 109.421 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 39.6 p30 -103.75 173.55 6.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.561 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 74.8 mtt85 -58.31 -40.52 82.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.63 -49.53 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.509 ' CG ' ' OD1' ' B' ' 441' ' ' ASP . 45.8 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.544 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.29 89.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.561 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 17.3 m-30 -66.18 -47.99 72.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.403 ' O ' HD11 ' B' ' 470' ' ' ILE . 61.6 mttt -58.88 -46.38 87.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.585 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.505 ' CD1' ' HB ' ' B' ' 453' ' ' VAL . 3.1 tm? -64.12 -41.17 97.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.36 -30.68 71.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -56.79 -18.52 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.401 ' NH1' ' CB ' ' B' ' 469' ' ' ASP . 14.3 mtp85 -90.65 31.6 1.04 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.82 -18.88 6.84 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.505 ' HB ' ' CD1' ' B' ' 448' ' ' LEU . 96.3 t -63.51 139.87 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.878 -1.366 . . . . 0.0 109.382 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.511 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -135.01 -36.01 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 109.701 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.428 ' HA ' ' HB1' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -111.04 148.63 32.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.521 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 30.0 tp -46.17 -40.14 10.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.167 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -56.75 -49.65 74.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.848 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.455 ' HB3' HG11 ' B' ' 453' ' ' VAL . 37.4 t0 -54.8 -38.78 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.108 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 2.9 tm? -60.04 -41.49 92.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 485' ' ' ALA . . . -63.15 -34.14 76.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 0.0 109.393 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.93 -30.77 71.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.474 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -67.53 151.85 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 109.565 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.84 165.82 12.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.507 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 28.9 mt -53.28 -35.75 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -1.209 . . . . 0.0 109.4 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.02 -31.27 67.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.525 HD12 ' CB ' ' B' ' 478' ' ' ALA . 23.4 mt -75.44 -29.05 59.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -23.75 62.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . 0.401 ' CB ' ' NH1' ' B' ' 451' ' ' ARG . 86.3 m-20 -50.1 -33.97 20.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.403 HD11 ' O ' ' B' ' 447' ' ' LYS . 65.6 mt -100.89 127.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.25 -33.09 74.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.04 -31.56 40.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.492 HD21 ' CD2' ' B' ' 444' ' ' LEU . 50.5 mt -101.11 140.49 35.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 474' ' ' THR . . . . . 0.4 ' O ' ' HB3' ' B' ' 478' ' ' ALA . 24.4 m -104.11 161.85 13.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.389 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 81.3 m-20 -57.91 -37.62 74.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -73.88 -46.06 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.455 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 39.2 tttp -68.74 -37.02 79.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.525 ' CB ' HD12 ' B' ' 467' ' ' LEU . . . -64.08 -44.68 91.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.54 ' CA ' ' CB ' ' A' ' 293' ' ' PRO . . . -63.87 -43.1 98.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.82 -33.97 70.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -1.125 . . . . 0.0 109.406 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.464 HD12 HG21 ' B' ' 440' ' ' VAL . 31.0 mt -74.39 -35.16 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 478' ' ' ALA . 78.6 mt -64.03 -53.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.537 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.505 ' HE3' ' N ' ' A' ' 292' ' ' THR . 52.6 mmm -60.74 -42.48 97.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 109.426 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.445 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -58.29 -47.36 83.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' B' ' 460' ' ' ALA . . . -66.0 -47.68 73.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.536 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.481 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 40.2 ttm180 -60.8 -42.62 97.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.48 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 95.9 m-20 -58.85 -39.25 80.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.521 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 66.1 mt -62.27 -40.35 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.82 -52.06 16.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.679 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . 0.481 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 67.2 m95 -64.44 -38.48 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.455 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.9 m-85 -99.19 13.1 34.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.8 -29.76 75.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.41 -36.18 71.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.133 . . . . 0.0 109.428 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -93.31 138.71 31.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.442 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.569 ' CG ' ' HG3' ' A' ' 323' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.4 126.56 84.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.46 -32.21 50.01 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.794 2.329 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.456 ' O ' HD13 ' A' ' 278' ' ' ILE . 2.9 tt -66.27 -23.55 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.464 HD13 HG13 ' A' ' 282' ' ' VAL . 5.3 tp -74.28 -44.12 54.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.459 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.537 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 2.2 mm? -73.63 -20.36 60.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.555 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.434 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -63.87 149.87 92.41 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.0 Cg_endo -69.86 136.31 32.41 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.604 2.202 . . . . 0.0 111.934 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.411 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.79 -31.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.885 . . . . 0.0 109.424 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 267' ' ' ALA . 97.6 m-20 -62.35 -30.95 71.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 256' ' ' PRO . 53.8 m-20 -73.03 -14.09 61.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.507 ' CD2' HD11 ' A' ' 278' ' ' ILE . 59.4 mt -54.13 150.73 7.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.12 -21.52 65.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.524 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 5.3 mp -64.64 166.08 9.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -79.88 165.27 22.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.9 t -47.0 -32.85 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.457 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -52.78 -50.21 64.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.524 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 22.2 t -59.53 -51.11 71.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.415 ' HB3' ' OD1' ' A' ' 258' ' ' ASP . . . -62.67 -37.34 86.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.315 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -56.64 -36.89 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.339 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 272' ' ' ALA . 60.0 m -55.41 -64.98 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.407 HD12 HD13 ' A' ' 281' ' ' LEU . 65.2 mt -62.41 -47.69 82.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 23.2 tttt -53.02 -36.88 61.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -52.79 -30.0 30.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.461 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 90.9 mt-10 -94.01 23.99 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.377 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.461 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.07 41.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 90.3 mt -122.82 107.66 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.519 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.463 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 64.0 m-70 -109.71 -6.75 15.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.35 129.24 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.507 HD11 ' CD2' ' A' ' 260' ' ' LEU . 80.9 mt -54.72 -30.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.577 ' HA3' ' CZ2' ' A' ' 321' ' ' TRP . . . -46.02 -46.78 14.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.492 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 79.4 m-20 -53.48 -30.9 43.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.038 -1.272 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.459 ' HB3' ' O ' ' A' ' 278' ' ' ILE . 31.4 tp -59.26 -49.9 76.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 109.136 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 30.2 m -67.51 -30.55 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 108.967 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.497 ' N ' HG23 ' A' ' 282' ' ' VAL . 63.6 tt0 -59.44 -32.83 70.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 108.949 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -109.84 143.84 39.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.447 ' O ' HD21 ' A' ' 289' ' ' LEU . 9.0 m -63.7 137.96 58.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.49 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.412 ' OE1' ' CD2' ' A' ' 307' ' ' LEU . 80.4 tt0 -50.58 -33.51 22.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.387 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.498 ' HA ' ' CD1' ' A' ' 290' ' ' LEU . 55.2 t -54.86 -54.34 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -51.15 -30.72 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.24 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.522 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 3.3 mm? -79.15 -43.67 23.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.257 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.5 ' HA ' ' CD1' ' A' ' 295' ' ' LEU . 5.4 mt -56.85 -18.73 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.495 ' O ' ' HE3' ' B' ' 483' ' ' MET . 69.5 mttt -81.44 -21.94 38.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.357 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.46 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 9.8 m -59.49 128.52 86.12 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.634 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.52 ' HD3' ' CG ' ' B' ' 483' ' ' MET . 50.8 Cg_endo -71.16 -14.84 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.804 2.336 . . . . 0.0 112.001 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.449 ' N ' HD11 ' B' ' 464' ' ' ILE . 53.2 m-80 -78.47 3.65 15.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 72.1 mt -81.33 149.55 28.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.517 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . 0.449 ' N ' ' OG ' ' A' ' 299' ' ' SER . . . -108.63 140.92 15.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -52.81 -47.13 67.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -1.188 . . . . 0.0 109.455 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.99 -25.31 59.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.449 ' OG ' ' N ' ' A' ' 296' ' ' GLY . 82.5 p -73.13 -36.8 66.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 296' ' ' GLY . 29.7 mt -54.31 -39.24 66.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -54.26 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.423 ' CD ' ' HA ' ' A' ' 262' ' ' LEU . 67.7 tt0 -53.82 -39.97 65.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 109.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.465 ' O ' HD13 ' A' ' 307' ' ' LEU . 84.5 mt -57.63 -45.85 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 108.917 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.11 -33.93 74.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 108.964 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.42 -41.58 97.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 109.248 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.543 ' CG1' ' CD2' ' A' ' 312' ' ' LEU . 1.7 t -68.25 -45.65 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 303' ' ' ILE . 8.2 mp -56.43 -26.77 54.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.11 70.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.0 t -65.51 -17.39 64.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.433 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 11.7 ttp180 65.93 9.07 5.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.368 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -94.95 -0.3 63.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.543 ' CD2' ' CG1' ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.29 163.09 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -1.215 . . . . 0.0 109.44 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 48.47 54.96 9.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.641 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.433 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 76.7 mt -91.81 9.39 32.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.36 38.22 96.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.413 ' HG2' ' HB2' ' A' ' 314' ' ' LEU . 5.6 ptt? -113.3 157.44 21.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.428 ' C ' HD12 ' A' ' 318' ' ' LEU . 77.6 mtt85 -130.23 137.72 50.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.566 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 2.8 mp -123.47 140.89 52.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 108.951 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.5 m-20 -122.45 -81.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.577 ' CZ2' ' HA3' ' A' ' 279' ' ' GLY . 1.5 t-105 165.24 -65.98 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.539 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 50.7 Cg_endo -69.47 107.77 1.88 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.563 2.175 . . . . 0.0 111.95 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.569 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.1 Cg_endo -71.91 163.91 37.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.622 2.214 . . . . 0.0 111.6 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.6 25.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.969 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 62.1 p -70.54 -38.97 74.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.46 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.523 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 34.3 mt -53.32 -33.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.52 75.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -36.23 70.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.475 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.476 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -56.02 -38.0 69.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -1.167 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 24.3 m120 -85.53 -3.01 58.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 20.0 tttm -53.03 136.89 47.48 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.459 ' HD2' ' HG3' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.09 136.76 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.641 2.227 . . . . 0.0 111.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.1 153.23 41.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.513 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -47.06 -38.6 11.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -62.29 -40.73 97.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.5 tm? -66.66 -29.87 69.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . . . . . . . . . 25.2 tp -85.69 -28.52 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.85 -5.81 43.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.524 ' CD1' HD12 ' B' ' 456' ' ' LEU . 35.4 tp -65.82 134.81 53.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -78.26 141.19 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.3 8.34 64.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.44 HG21 HD22 ' B' ' 481' ' ' LEU . 46.6 t -128.19 132.22 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.164 . . . . 0.0 109.471 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 83.7 m-20 -97.89 166.0 11.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 92.7 mtt180 -54.7 -43.14 72.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.401 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.1 m-20 -66.15 -50.15 64.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . . . . . . . . . 29.7 mt -55.74 -43.43 76.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.09 -37.85 78.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.482 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.401 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.6 m-30 -64.59 -45.12 88.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -62.86 -45.17 93.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 0.0 109.438 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.447 ' CD1' ' C ' ' B' ' 448' ' ' LEU . 1.4 tm? -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.471 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -67.14 -28.89 68.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.24 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -93.24 32.06 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.392 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.43 -18.61 6.65 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.491 HG12 ' N ' ' B' ' 459' ' ' LEU . 84.3 t -60.9 139.48 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.9 -1.353 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.433 ' N ' HG13 ' B' ' 453' ' ' VAL . 10.9 m -135.05 -35.88 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.769 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.59 159.39 20.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.896 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.524 HD12 ' CD1' ' B' ' 437' ' ' LEU . 0.3 OUTLIER -48.56 -41.37 30.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.288 -0.883 . . . . 0.0 109.027 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -55.59 -42.28 74.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 0.0 108.766 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.483 ' CB ' HG12 ' B' ' 453' ' ' VAL . 89.5 m-20 -59.86 -43.55 94.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 108.893 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.491 ' N ' HG12 ' B' ' 453' ' ' VAL . 5.8 tt -54.31 -49.15 70.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 0.0 109.172 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.99 71.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.98 -25.71 67.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.357 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.474 ' CG ' HG22 ' B' ' 453' ' ' VAL . 98.5 mm-40 -70.48 152.23 44.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' B' ' 467' ' ' LEU . . . -116.12 162.84 12.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.509 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 57.2 mt -49.68 -36.67 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.5 -37.06 79.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.06 -25.12 66.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.523 ' CD2' ' CB ' ' B' ' 478' ' ' ALA . 6.6 mp -91.42 -27.72 18.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 0.0 109.484 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.85 -23.2 66.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.458 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.13 -32.85 68.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 73.5 mt -99.84 128.72 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.588 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.67 -32.37 74.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -55.38 -28.8 51.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . . . . . . . . . 60.7 mt -103.68 137.19 42.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.504 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.06 165.8 10.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -58.68 -39.23 80.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.45 -45.39 31.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.463 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.413 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 48.0 tttm -60.75 -46.47 90.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.523 ' CB ' ' CD2' ' B' ' 467' ' ' LEU . . . -62.98 -53.22 57.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.506 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -58.38 -48.0 86.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.0 62.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -1.116 . . . . 0.0 109.388 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.44 HD22 HG21 ' B' ' 440' ' ' VAL . 96.5 mt -61.9 -43.67 98.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.478 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.5 mt -53.44 -56.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.52 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 50.1 mtp -52.93 -46.17 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.57 -52.93 63.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.487 ' HB2' ' CD2' ' B' ' 456' ' ' LEU . . . -61.75 -48.84 78.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.507 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 34.4 ttt180 -56.16 -45.28 79.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.83 -34.06 72.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.514 HD12 ' CD1' ' B' ' 456' ' ' LEU . 79.7 mt -68.31 -39.4 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.519 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.8 -50.59 16.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . 0.507 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 36.3 m95 -58.7 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.18 10.91 31.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.25 -31.83 78.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.6 -37.27 85.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.491 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -55.36 143.61 28.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.469 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.56 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.476 ' HB3' HG21 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -52.71 141.22 36.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.183 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.461 ' HA ' HD21 ' A' ' 254' ' ' LEU . 43.1 Cg_endo -65.0 -23.04 61.86 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.652 2.234 . . . . 0.0 111.903 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.526 ' CG2' HD12 ' A' ' 253' ' ' LEU . 13.2 tt -64.77 -32.09 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.122 -0.986 . . . . 0.0 108.707 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.526 HD12 ' CG2' ' A' ' 252' ' ' ILE . 5.3 mp -74.34 -30.96 62.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.194 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.567 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.5 mm? -69.13 -40.0 78.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.452 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.446 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -61.72 147.58 88.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.446 ' HD2' ' HG2' ' A' ' 255' ' ' ARG . 48.3 Cg_endo -70.24 138.73 36.97 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.683 2.256 . . . . 0.0 111.701 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.509 ' CA ' HD12 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -43.5 -36.05 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.807 . . . . 0.0 109.461 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.49 -31.33 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 256' ' ' PRO . 70.6 m-20 -75.45 -11.0 59.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.537 ' CD2' HD12 ' A' ' 278' ' ' ILE . 61.0 mt -47.47 143.54 3.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -59.94 -18.17 43.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.523 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 6.3 mp -67.86 167.1 14.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.9 p -69.53 160.23 31.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.0 t -50.5 -39.25 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -53.66 -48.96 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.523 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.9 m -57.78 -50.56 72.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 257' ' ' VAL . . . -65.77 -35.87 81.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.299 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -58.51 -36.68 74.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.436 ' O ' ' HB2' ' A' ' 272' ' ' ALA . 79.2 m -55.76 -65.03 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 75.2 mt -58.03 -46.68 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 24.6 tttt -53.46 -37.74 62.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -53.37 -24.81 13.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.399 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.447 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 73.7 mm-40 -89.35 23.71 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.447 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 71.93 38.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.456 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 20.0 mm -112.29 121.53 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.449 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.436 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.3 p80 -113.13 -33.2 6.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.436 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.2 m-85 -109.8 131.28 55.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.591 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.537 HD12 ' CD2' ' A' ' 260' ' ' LEU . 76.6 mt -48.88 -30.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.179 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.534 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -47.62 -45.35 23.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.456 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 57.3 m-20 -53.68 -35.02 60.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 109.078 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . . . . . . . . . 35.5 tp -56.28 -48.3 76.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 109.258 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 22.6 m -71.94 -35.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.013 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.496 ' N ' HG23 ' A' ' 282' ' ' VAL . 58.8 tt0 -51.54 -34.9 38.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.338 -0.851 . . . . 0.0 108.89 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -112.36 143.62 43.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.391 -0.818 . . . . 0.0 109.095 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 m -59.93 138.77 57.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.617 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -61.96 -28.53 69.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.93 -53.13 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.42 ' OE1' ' HA ' ' A' ' 288' ' ' GLU . 71.1 mm-40 -51.66 -35.86 44.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.522 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 3.3 mm? -76.65 -36.27 57.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.066 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 290' ' ' LEU . 2.0 tm? -56.43 -29.17 61.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.521 ' CB ' ' CE ' ' B' ' 483' ' ' MET . 9.1 mttt -81.68 -18.84 43.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.467 ' O ' ' HG ' ' A' ' 295' ' ' LEU . 11.3 m -58.82 129.12 85.09 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.531 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 51.6 Cg_endo -70.46 -10.4 27.92 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.812 2.342 . . . . 0.0 111.83 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.522 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 32.6 m120 -79.66 4.09 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 66.1 mt -84.0 146.99 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . 0.461 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -111.66 141.6 16.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -48.74 -50.87 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.51 -33.97 71.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.456 ' O ' HG12 ' A' ' 303' ' ' ILE . 37.4 m -61.98 -40.79 96.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 296' ' ' GLY . 46.1 mt -52.97 -42.86 65.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.7 m -54.72 -50.83 67.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.516 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 98.3 mt-10 -58.73 -39.23 80.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.51 ' CG2' HD12 ' A' ' 307' ' ' LEU . 23.9 mm -58.07 -47.32 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -60.56 -38.16 83.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.05 -46.4 89.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.359 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.507 HG13 ' CD2' ' A' ' 312' ' ' LEU . 2.0 t -70.19 -44.86 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 313' ' ' SER . 6.6 mp -62.78 -27.2 69.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.498 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.98 -33.26 70.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 66.2 p -77.49 -5.04 48.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 109.548 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.521 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 8.9 mtt85 63.73 10.49 5.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.219 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.444 ' O ' HD12 ' A' ' 253' ' ' LEU . . . -73.07 -22.23 79.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.507 ' CD2' HG13 ' A' ' 306' ' ' VAL . 0.3 OUTLIER -146.64 163.1 36.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.379 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.7 OUTLIER 65.9 28.8 10.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 93.4 mt -66.34 -14.41 62.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.24 11.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.513 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 4.6 ptt? -111.47 162.22 15.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.114 . . . . 0.0 109.448 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 87.3 mtt-85 -130.76 133.49 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.502 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 4.6 mp -118.3 145.29 45.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.79 -34.04 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 37.8 t-20 -125.94 -71.26 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.299 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.567 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.7 OUTLIER 167.43 -68.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.0 Cg_endo -69.7 107.88 1.94 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.504 2.136 . . . . 0.0 111.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.56 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 51.0 Cg_endo -72.1 158.12 52.86 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.529 2.153 . . . . 0.0 111.573 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.6 -15.69 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.378 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.1 m -68.55 -44.34 74.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.472 HD11 ' CB ' ' A' ' 322' ' ' PRO . 24.5 pt -86.01 -5.97 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.56 72.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 329' ' ' GLU . 58.6 t0 -56.24 -35.86 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.445 ' HB3' ' O ' ' A' ' 328' ' ' ASP . 83.8 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.44 -35.44 74.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 109.491 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.474 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.3 m120 -80.25 1.3 29.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.425 ' CG ' ' HD2' ' B' ' 430' ' ' PRO . 9.8 tttt -51.21 139.92 24.07 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.468 ' CD ' ' CE1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.07 142.45 46.6 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.65 2.233 . . . . 0.0 111.933 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -73.55 150.35 41.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.34 -36.71 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -65.26 -46.36 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' B' ' 445' ' ' ALA . 3.4 tm? -67.87 -37.82 82.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.478 ' O ' ' CD1' ' B' ' 435' ' ' LEU . 0.7 OUTLIER -69.16 -31.08 69.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.515 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -89.02 9.88 23.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.489 HD23 ' CG2' ' B' ' 440' ' ' VAL . 43.0 tp -72.43 133.56 44.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.87 142.1 40.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.77 6.57 67.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.495 HG23 ' CD2' ' B' ' 481' ' ' LEU . 57.4 t -127.62 131.38 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -83.75 149.04 26.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.497 ' HG3' ' NH1' ' B' ' 442' ' ' ARG . 9.4 mtt85 -50.02 -45.81 52.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.09 -39.46 82.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.522 ' CD1' HD13 ' B' ' 473' ' ' LEU . 15.8 tp -58.88 -37.77 77.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' B' ' 434' ' ' LEU . . . -60.7 -42.01 96.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.468 ' CE1' ' CD ' ' B' ' 430' ' ' PRO . 77.8 m-85 -64.69 -44.24 90.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.518 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 13.7 ttmm -58.63 -48.55 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' B' ' 448' ' ' LEU . 3.4 tm? -65.17 -41.24 94.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.835 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -57.25 -26.84 61.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.68 -20.53 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.948 . . . . 0.0 109.472 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.432 ' HD2' HD11 ' B' ' 470' ' ' ILE . 48.6 mtp85 -89.75 26.59 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.942 . . . . 0.0 109.564 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.88 7.13 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 57.6 t -62.32 135.82 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.306 . . . . 0.0 109.326 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 69.0 m -135.01 -36.96 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.63 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.44 ' HA ' ' HB1' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -103.72 146.56 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 36.4 tp -47.69 -42.81 25.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . 0.446 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 26.2 mm-40 -55.86 -46.53 78.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.041 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.78 -41.58 74.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 108.913 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.496 ' C ' ' CD1' ' B' ' 459' ' ' LEU . 3.3 tm? -57.4 -43.92 84.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.111 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.94 -36.37 76.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.326 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -30.13 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.41 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.2 mm-40 -75.12 140.76 43.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -100.03 163.53 19.29 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.531 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 81.3 mt -47.52 -33.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.07 -36.28 79.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.41 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 86.8 m-20 -68.66 -30.61 69.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.503 ' CD2' ' HB1' ' B' ' 478' ' ' ALA . 6.9 mp -82.73 -30.05 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.328 -0.858 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.09 58.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.09 -30.5 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.518 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 63.9 mt -104.92 123.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.74 -31.7 71.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.37 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.13 -32.69 36.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.546 ' N ' ' CD2' ' B' ' 473' ' ' LEU . 2.7 mm? -103.13 138.78 39.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.224 -1.162 . . . . 0.0 109.54 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 28.7 m -104.04 161.87 13.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.877 . . . . 0.0 109.333 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -57.45 -38.08 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.385 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.81 -45.95 26.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.51 ' HE2' ' CD2' ' B' ' 444' ' ' LEU . 19.0 tttt -66.14 -47.19 74.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.503 ' HB1' ' CD2' ' B' ' 467' ' ' LEU . . . -59.24 -46.74 87.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.512 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.18 -49.88 68.77 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.35 54.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -1.185 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.495 ' CD2' HG23 ' B' ' 440' ' ' VAL . 26.4 mt -56.62 -37.6 70.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 50.4 mt -63.33 -51.08 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.414 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.521 ' CE ' ' CB ' ' A' ' 291' ' ' LYS . 23.6 mtp -52.61 -48.41 66.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -55.71 -55.74 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.408 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.438 ' HA ' HD22 ' B' ' 456' ' ' LEU . . . -59.46 -47.98 83.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 75.1 mtt180 -62.8 -40.98 99.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.0 m-20 -58.24 -44.93 88.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.583 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 57.2 mt -61.6 -37.56 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . 0.446 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.2 OUTLIER -76.12 -52.02 10.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.902 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -61.33 -31.59 71.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 13.1 m-30 -71.0 -33.69 70.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -57.92 -35.93 78.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -57.45 -37.42 72.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -1.151 . . . . 0.0 109.536 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -102.8 136.64 42.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.509 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 253' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -55.95 150.37 29.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.575 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.56 -25.28 55.16 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.749 2.299 . . . . 0.0 111.643 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.467 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 15.1 tt -68.6 -27.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 109.179 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 249' ' ' PHE . 26.8 mt -74.11 -45.24 50.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.576 HD21 ' CZ2' ' A' ' 321' ' ' TRP . 0.5 OUTLIER -63.88 -34.65 78.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.456 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -55.91 141.74 66.23 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.156 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.0 Cg_endo -69.03 133.95 28.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.695 2.263 . . . . 0.0 111.742 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.456 ' O ' ' HB1' ' A' ' 267' ' ' ALA . 0.1 OUTLIER -43.41 -34.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.475 ' HB2' ' NZ ' ' A' ' 271' ' ' LYS . 55.3 t0 -59.44 -30.97 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 m-20 -73.75 -17.12 61.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.504 ' CD2' HD13 ' A' ' 278' ' ' ILE . 51.5 mt -43.5 144.95 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -63.92 -22.06 66.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.529 ' CB ' ' OG ' ' A' ' 266' ' ' SER . 5.2 mp -65.56 166.84 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.2 p -66.71 166.59 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.557 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 6.6 t -57.35 -36.47 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 109.639 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.14 -48.65 70.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 262' ' ' LEU . 95.2 p -57.94 -51.04 71.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.456 ' HB1' ' O ' ' A' ' 257' ' ' VAL . . . -62.62 -42.41 99.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -56.58 -37.44 70.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 85.4 m -50.37 -60.48 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.32 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.464 HD11 ' CD1' ' A' ' 281' ' ' LEU . 74.0 mt -57.51 -45.06 85.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.376 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.475 ' NZ ' ' HB2' ' A' ' 258' ' ' ASP . 82.3 mttt -52.92 -29.91 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.359 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.14 -34.32 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 45.1 mt-10 -90.53 26.13 2.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.407 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.21 40.91 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.515 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 22.7 mm -108.14 124.24 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.432 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.575 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -115.83 -37.27 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.37 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.575 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -106.32 133.04 51.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.504 HD13 ' CD2' ' A' ' 260' ' ' LEU . 88.7 mt -46.72 -30.36 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.552 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -46.34 -48.64 15.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.515 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 94.0 m-20 -53.24 -31.27 42.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.004 -1.292 . . . . 0.0 108.727 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.464 ' CD1' HD11 ' A' ' 270' ' ' LEU . 44.9 tp -55.72 -51.9 65.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 34.5 m -64.39 -28.26 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 108.832 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.523 ' N ' HG21 ' A' ' 282' ' ' VAL . 62.3 tt0 -59.75 -34.89 73.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.848 . . . . 0.0 108.903 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.446 ' HG2' ' NH1' ' A' ' 284' ' ' ARG . 18.6 mtt-85 -107.07 144.29 33.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.256 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.8 m -68.43 143.4 55.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 0.0 109.559 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 50.4 tp10 -55.62 -30.25 60.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.62 -51.61 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -51.91 -33.97 39.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.388 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.489 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.2 mm? -74.68 -30.52 61.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.77 -30.91 70.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.524 ' O ' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.73 -12.7 58.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.168 -0.958 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.403 HG22 ' HB2' ' A' ' 294' ' ' ASN . 23.8 m -79.38 117.67 68.33 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.648 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.534 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 48.4 Cg_endo -69.86 -20.43 34.39 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.784 2.322 . . . . 0.0 111.866 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.502 ' N ' HD12 ' B' ' 464' ' ' ILE . 53.0 m-80 -48.85 -31.41 7.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.402 HD21 ' O ' ' A' ' 289' ' ' LEU . 0.5 OUTLIER -105.02 144.63 31.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -85.83 169.23 42.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 44.7 mttt -64.92 -40.9 95.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -1.145 . . . . 0.0 109.479 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -59.78 -40.12 87.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.434 ' O ' HG13 ' A' ' 303' ' ' ILE . 24.6 m -57.57 -41.55 81.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.48 ' CD1' ' C ' ' A' ' 300' ' ' LEU . 2.2 tm? -54.83 -37.04 65.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 27.5 m -55.75 -59.42 4.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.219 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 305' ' ' ASP . 75.2 tt0 -54.92 -44.47 74.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.459 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 67.8 mt -57.48 -52.38 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 108.856 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -53.28 -36.41 61.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.312 -0.867 . . . . 0.0 108.675 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.421 ' HB3' ' O ' ' A' ' 302' ' ' GLU . 62.5 t0 -57.46 -48.14 79.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 108.913 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.523 ' CG1' HD23 ' A' ' 312' ' ' LEU . 11.6 t -66.17 -34.81 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.939 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 313' ' ' SER . 21.4 mt -64.23 -26.66 68.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.42 -29.99 66.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.117 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 79.8 p -79.14 -7.94 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.45 ' HB3' HD12 ' A' ' 314' ' ' LEU . 73.6 mtt85 61.76 13.15 5.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.467 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -73.03 -36.15 57.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.523 HD23 ' CG1' ' A' ' 306' ' ' VAL . 2.1 pt? -135.05 159.37 41.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 109.688 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.468 ' HB2' HD21 ' A' ' 307' ' ' LEU . 0.2 OUTLIER 61.31 63.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.892 . . . . 0.0 109.677 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.2 mm? -96.32 12.38 31.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.65 92.28 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.462 ' CE ' ' CE1' ' A' ' 249' ' ' PHE . 10.9 ptt? -114.36 150.63 34.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -109.12 133.34 53.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 6.1 mt -106.75 138.48 42.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.898 . . . . 0.0 109.349 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.69 -47.21 82.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.017 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 36.2 t-20 -126.64 -59.04 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 108.976 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.576 ' CZ2' HD21 ' A' ' 254' ' ' LEU . 1.5 t-105 163.4 -65.52 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.283 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.533 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.4 Cg_endo -69.03 107.67 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.624 2.216 . . . . 0.0 111.923 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.499 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 51.0 Cg_endo -71.31 161.0 47.14 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.591 2.194 . . . . 0.0 111.45 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.2 -15.37 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.8 t -69.57 -46.42 66.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.499 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 22.2 pt -92.4 4.45 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.77 147.48 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.559 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.64 0.27 43.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 0.0 109.649 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.492 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -57.19 -35.69 69.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -1.121 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.436 ' O ' ' HB3' ' B' ' 449' ' ' ALA . 31.1 m120 57.38 44.68 21.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.463 179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.439 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 33.3 tttt -64.52 136.84 96.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.439 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.3 Cg_endo -70.7 139.69 37.52 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.607 2.205 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -66.03 156.03 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -54.77 -36.99 65.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -62.63 -48.74 78.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.0 tm? -65.83 -35.52 80.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.422 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -85.34 6.29 27.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.533 ' CD2' ' CD1' ' B' ' 456' ' ' LEU . 37.9 tp -75.42 131.55 40.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.28 145.2 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.906 . . . . 0.0 109.507 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.19 7.5 67.68 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.447 HG21 ' CD2' ' B' ' 437' ' ' LEU . 59.6 t -124.43 129.5 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.414 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -85.13 147.39 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.06 -43.62 51.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.528 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 90.6 m-20 -70.3 -41.06 73.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.456 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 10.5 tp -58.49 -46.11 87.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.468 ' CB ' HD13 ' B' ' 434' ' ' LEU . . . -59.26 -39.34 82.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.528 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 15.9 m-30 -60.29 -43.79 95.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.01 -44.88 95.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' B' ' 448' ' ' LEU . 2.4 tm? -67.31 -38.08 84.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.39 -28.25 68.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -55.33 -18.92 7.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.415 ' NH2' HG12 ' B' ' 470' ' ' ILE . 33.6 mtt-85 -91.39 30.38 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.85 -18.9 6.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.482 HG12 ' N ' ' B' ' 459' ' ' LEU . 46.4 t -61.63 136.07 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.893 -1.357 . . . . 0.0 109.326 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 9.4 m -135.17 -37.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.49 147.76 26.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.533 ' CD1' ' CD2' ' B' ' 437' ' ' LEU . 16.3 tp -47.2 -41.81 18.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.056 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.85 -47.27 77.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.864 . . . . 0.0 109.028 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.41 ' CB ' HG13 ' B' ' 453' ' ' VAL . 74.8 m-20 -55.14 -44.72 75.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.482 ' N ' HG12 ' B' ' 453' ' ' VAL . 6.9 tt -53.11 -49.91 65.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.463 ' HB3' ' HG3' ' B' ' 486' ' ' ARG . . . -54.54 -39.36 67.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.65 -34.69 67.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.439 ' O ' HD13 ' B' ' 482' ' ' ILE . 99.6 mm-40 -63.65 151.77 40.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.25 154.12 16.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.531 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 60.3 mt -45.09 -40.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -1.177 . . . . 0.0 109.228 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.36 -43.06 92.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.296 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 469' ' ' ASP . 78.1 m-20 -63.41 -23.79 67.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.426 ' HB3' ' HB2' ' B' ' 478' ' ' ALA . 6.8 mp -93.09 -19.23 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.22 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.535 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . 0.453 ' OD1' HG13 ' B' ' 470' ' ' ILE . 18.6 p30 -79.29 3.7 17.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.453 HG13 ' OD1' ' B' ' 469' ' ' ASP . 36.4 mt -105.53 126.63 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.965 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.45 133.33 52.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.11 -30.16 10.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.456 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 64.8 mt -88.21 128.72 35.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -1.16 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 474' ' ' THR . . . . . 0.466 HG23 ' N ' ' B' ' 475' ' ' ASP . 51.9 m -104.01 162.15 13.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.466 ' N ' HG23 ' B' ' 474' ' ' THR . 86.7 m-20 -58.97 -36.76 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -76.95 -43.32 35.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.46 ' O ' HD13 ' B' ' 481' ' ' LEU . 76.6 tttt -61.58 -47.58 84.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 482' ' ' ILE . . . -63.66 -40.84 97.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.46 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.73 -38.08 95.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.27 77.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -1.216 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.474 HD11 ' N ' ' B' ' 481' ' ' LEU . 8.6 mp -68.81 -27.05 65.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.474 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.534 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 52.3 mt -77.08 -56.5 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.524 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 60.2 mtp -52.81 -38.3 61.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.83 14.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 109.317 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.466 ' HB3' ' HG ' ' B' ' 456' ' ' LEU . . . -61.35 -45.96 92.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.514 ' HD2' ' CG2' ' B' ' 482' ' ' ILE . 42.2 mtp180 -57.42 -45.67 84.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 91.3 m-20 -57.96 -37.13 73.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.514 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 63.6 mt -68.88 -36.99 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.52 -50.37 15.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.397 -0.814 . . . . 0.0 109.561 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.47 -43.51 90.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.917 . . . . 0.0 109.601 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 98.7 m-85 -95.46 12.41 29.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . -71.56 135.41 23.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -51.54 -38.97 56.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -1.19 . . . . 0.0 109.436 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.78 -34.21 72.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.528 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.563 ' CE1' ' HB3' ' A' ' 323' ' ' PRO . 34.0 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -56.62 151.14 32.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.23 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.485 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.04 -24.13 60.27 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.455 2.103 . . . . 0.0 111.72 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.524 ' CG2' HD13 ' A' ' 253' ' ' LEU . 15.9 tt -58.94 -32.42 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.554 ' CD2' ' CE ' ' A' ' 316' ' ' MET . 5.3 mp -74.26 -35.39 63.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.942 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.58 HD11 ' CZ2' ' A' ' 321' ' ' TRP . 2.6 mm? -72.2 -20.07 61.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.779 . . . . 0.0 109.189 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -78.08 144.33 67.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 49.5 Cg_endo -69.61 139.16 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.809 2.34 . . . . 0.0 111.907 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.495 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.34 -34.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.294 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.454 ' OD1' ' HB1' ' A' ' 267' ' ' ALA . 93.4 m-20 -61.78 -30.79 71.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.3 m-20 -76.95 -9.74 58.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.407 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.534 ' CD2' ' CD1' ' A' ' 278' ' ' ILE . 74.3 mt -57.32 144.91 34.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.92 -18.93 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.456 HD11 HG22 ' A' ' 306' ' ' VAL . 6.7 mp -64.49 169.69 4.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.5 p -75.45 164.25 26.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 109.629 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.65 -27.48 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -59.82 -41.91 92.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.15 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.448 ' OG ' HD22 ' A' ' 262' ' ' LEU . 26.4 t -60.66 -50.42 73.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.454 ' HB1' ' OD1' ' A' ' 258' ' ' ASP . . . -66.11 -36.56 83.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.942 . . . . 0.0 109.296 179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -58.74 -40.1 82.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 73.3 m -52.08 -65.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.517 ' CD2' HD12 ' A' ' 281' ' ' LEU . 6.6 mp -65.24 -42.36 93.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.283 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.574 ' HE2' ' CE1' ' A' ' 276' ' ' HIS . 50.3 tttm -52.79 -40.11 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.26 -26.69 12.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.454 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 90.5 mt-10 -91.85 20.63 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.454 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 37.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.523 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 77.7 mt -124.01 107.88 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.574 ' CE1' ' HE2' ' A' ' 271' ' ' LYS . 61.5 m-70 -107.37 -4.85 18.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.466 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.1 m-85 -112.94 133.55 54.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.42 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.534 ' CD1' ' CD2' ' A' ' 260' ' ' LEU . 50.7 mt -62.1 -30.99 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.191 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.575 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -48.62 -45.82 30.3 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.523 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 92.0 m-20 -53.61 -36.54 62.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -1.114 . . . . 0.0 109.153 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.517 HD12 ' CD2' ' A' ' 270' ' ' LEU . 4.3 tt -53.15 -49.12 67.24 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.948 . . . . 0.0 108.953 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 13.4 m -67.46 -22.97 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.114 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.498 ' N ' HG23 ' A' ' 282' ' ' VAL . 61.5 tt0 -65.82 -33.33 75.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.002 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -105.29 143.51 33.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.044 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 m -59.99 138.04 57.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.415 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 85.2 tt0 -55.64 -29.53 59.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.32 -50.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -51.72 -37.54 51.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.466 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.4 mm? -69.72 -37.66 76.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.521 ' CD1' HD22 ' A' ' 300' ' ' LEU . 37.3 tp -64.4 -26.27 68.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.307 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.452 ' O ' ' HE3' ' B' ' 483' ' ' MET . 35.8 mttm -93.01 25.9 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.448 ' HB ' HD11 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -114.21 134.84 22.16 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.163 -0.96 . . . . 0.0 109.487 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.536 ' HD3' ' CG ' ' B' ' 483' ' ' MET . 52.3 Cg_endo -71.92 -24.33 21.08 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.839 2.36 . . . . 0.0 112.018 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.519 ' N ' HD11 ' B' ' 464' ' ' ILE . 75.7 m-80 -57.79 -28.69 64.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 5.0 mp -94.54 125.4 39.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.9 171.5 32.96 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.45 ' HE3' ' OE2' ' B' ' 461' ' ' GLU . 24.8 mttm -51.89 -36.71 49.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -75.01 -38.57 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.592 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.4 m -57.61 -49.06 77.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.521 HD22 ' CD1' ' A' ' 290' ' ' LEU . 23.9 tp -52.81 -42.87 65.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 56.9 m -52.45 -53.51 44.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.439 ' HB3' HD23 ' A' ' 262' ' ' LEU . 96.8 mt-10 -54.07 -39.69 66.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -0.944 . . . . 0.0 109.069 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.459 HD13 HG23 ' A' ' 303' ' ' ILE . 76.5 mt -58.47 -43.22 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.117 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -60.73 -41.51 95.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.264 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -58.28 -47.13 84.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.935 . . . . 0.0 109.225 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.489 ' CG1' HD22 ' A' ' 312' ' ' LEU . 2.2 t -73.28 -37.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 313' ' ' SER . 0.1 OUTLIER -60.95 -26.41 67.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.473 ' O ' ' HG3' ' A' ' 310' ' ' ARG . . . -58.22 -32.06 67.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -60.55 -13.99 17.28 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 109.843 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.478 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 75.0 mtm-85 63.67 9.83 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.462 ' O ' HD13 ' A' ' 253' ' ' LEU . . . -113.08 -7.65 21.09 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.516 ' CD1' HD23 ' A' ' 281' ' ' LEU . 7.9 tp -127.04 130.68 50.43 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.188 -1.183 . . . . 0.0 109.335 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.523 ' HB3' ' CD1' ' A' ' 307' ' ' LEU . 12.8 t 68.84 56.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.764 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.478 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.2 mt -105.66 21.57 17.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.149 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.97 39.82 94.65 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.554 ' CE ' ' CD2' ' A' ' 253' ' ' LEU . 3.1 mtm -86.79 170.08 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 40.6 mtt85 -143.28 126.24 16.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.558 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 4.0 mp -124.3 134.0 53.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 109.708 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.9 -39.89 95.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.912 . . . . 0.0 108.988 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 78.4 m-20 -119.1 -75.3 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.58 ' CZ2' HD11 ' A' ' 254' ' ' LEU . 1.1 t-105 168.73 -58.3 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.496 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.0 Cg_endo -68.49 107.49 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.654 2.236 . . . . 0.0 112.001 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.563 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 50.0 Cg_endo -71.26 165.08 33.56 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.609 2.206 . . . . 0.0 111.592 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.07 -23.35 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.0 t -77.09 -38.36 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.529 ' CD1' HD13 ' A' ' 254' ' ' LEU . 20.0 tt -58.67 -21.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.506 ' N ' HG22 ' A' ' 326' ' ' ILE . . . -70.48 -28.4 64.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.544 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -54.56 -36.33 64.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.488 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -54.15 -36.22 63.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -1.131 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.6 m120 58.05 44.69 19.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.06 128.91 50.05 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 109.554 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.523 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.1 Cg_endo -70.71 136.53 30.69 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.593 2.195 . . . . 0.0 111.728 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.514 ' CB ' HG23 ' B' ' 455' ' ' THR . . . -64.15 153.05 38.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -55.09 -36.91 66.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.69 -44.91 92.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.352 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.5 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 3.4 tm? -69.97 -37.12 75.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.514 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.3 tm? -70.21 -33.17 71.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.588 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -90.17 8.3 33.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.646 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.567 ' CD1' ' CD1' ' B' ' 488' ' ' ILE . 25.5 tp -73.6 136.25 43.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -77.2 145.05 37.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.89 -6.06 73.02 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 61.7 t -121.78 135.68 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -1.214 . . . . 0.0 109.468 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -91.04 152.84 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -49.85 -38.66 36.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.63 -40.68 80.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.863 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.444 HD11 ' NZ ' ' B' ' 477' ' ' LYS . 20.1 mt -64.61 -34.65 78.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.394 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.88 76.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.523 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.1 m-85 -62.91 -44.05 97.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.526 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 7.1 ttmm -55.03 -37.84 67.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.435 HD13 HD12 ' B' ' 459' ' ' LEU . 85.2 mt -69.16 -39.92 78.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -59.24 -33.05 70.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.58 -35.75 6.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.506 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 9.5 mtp85 -90.12 21.47 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.502 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.72 7.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' B' ' 458' ' ' ASP . 4.9 t -81.8 112.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.915 -1.344 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.5 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 3.8 p -128.04 -42.17 1.57 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.514 HG23 ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -74.22 144.83 44.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.483 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.505 ' CD1' HD11 ' B' ' 437' ' ' LEU . 36.8 tp -48.87 -45.44 41.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.87 -45.87 78.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.216 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.527 ' CB ' HG12 ' B' ' 453' ' ' VAL . 89.5 m-20 -56.55 -40.3 74.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.275 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.437 ' HA ' HG13 ' B' ' 453' ' ' VAL . 20.5 tp -60.1 -43.59 95.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.46 -33.1 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.282 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . 0.45 ' OE2' ' HE3' ' A' ' 297' ' ' LYS . 72.5 mm-40 -68.09 -31.05 70.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.43 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.526 ' CG ' HG21 ' B' ' 453' ' ' VAL . 99.3 mm-40 -78.0 136.86 38.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.51 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -98.13 160.1 20.71 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.532 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 65.0 mt -44.04 -39.67 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.432 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.98 -36.53 81.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 85.7 m-20 -70.51 -28.59 65.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.302 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.519 ' CD2' ' HB3' ' B' ' 478' ' ' ALA . 7.4 mp -82.0 -28.27 32.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.65 65.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -56.99 -31.02 64.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.526 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 59.6 mt -103.22 118.28 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.72 -31.01 57.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.83 -32.4 48.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' B' ' 473' ' ' LEU . 2.8 mm? -107.58 138.03 44.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 24.4 m -104.04 165.08 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.09 -38.46 79.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -75.79 -46.12 32.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.51 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 20.8 tttt -63.2 -48.01 80.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.519 ' HB3' ' CD2' ' B' ' 467' ' ' LEU . . . -60.22 -36.44 77.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.502 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.76 -44.13 97.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.26 86.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.51 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.2 mp -69.17 -34.11 74.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.459 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 62.4 mt -69.49 -56.48 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.536 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 40.9 mmm -54.53 -38.79 66.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.465 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -62.14 -54.16 45.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -63.82 -42.41 97.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -57.53 -44.09 84.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -64.44 -36.62 84.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.466 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.567 ' CD1' ' CD1' ' B' ' 437' ' ' LEU . 65.9 mt -66.72 -37.15 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 4.8 m -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -66.61 -33.33 75.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -98.19 10.53 40.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -61.31 -25.64 65.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -54.78 -36.55 65.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -1.128 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' B' ' 495' ' ' ALA . 75.8 mm-40 -90.66 147.76 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.578 ' CG ' ' HG3' ' A' ' 323' ' ' PRO . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -67.29 133.58 93.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.55 -26.18 54.57 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.782 2.321 . . . . 0.0 111.467 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.516 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 14.5 tt -66.65 -25.57 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.225 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.497 HD21 ' CG1' ' A' ' 282' ' ' VAL . 44.7 mt -74.23 -45.41 48.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 109.573 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.574 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.2 mm? -66.85 -26.84 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.547 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.16 143.66 96.14 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.147 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 259' ' ' ASP . 48.4 Cg_endo -69.07 132.77 25.16 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.63 2.22 . . . . 0.0 111.757 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.458 ' O ' ' HB2' ' A' ' 267' ' ' ALA . 0.1 OUTLIER -43.68 -32.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.31 -31.07 71.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.354 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' PRO . 33.0 m-20 -70.52 -14.46 62.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.453 HD13 HG12 ' A' ' 257' ' ' VAL . 53.3 mt -48.16 138.0 10.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.33 -15.06 59.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.496 ' CD2' ' HB3' ' A' ' 302' ' ' GLU . 6.9 mp -69.8 173.15 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.8 p -66.86 162.15 22.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.422 HG11 ' ND2' ' A' ' 268' ' ' ASN . 21.2 t -60.79 -23.92 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.01 -44.28 97.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.274 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -48.78 80.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -67.23 -39.55 86.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.422 ' ND2' HG11 ' A' ' 264' ' ' VAL . 91.7 m-20 -56.8 -37.22 70.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.447 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 25.2 m -53.33 -64.77 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.479 ' CD2' HD13 ' A' ' 289' ' ' LEU . 78.8 mt -60.37 -45.13 94.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.465 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 64.9 tttm -52.86 -35.76 58.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -54.06 -20.42 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 96.4 mt-10 -94.8 23.84 5.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.468 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.56 37.32 1.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.496 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.6 mt -115.54 128.19 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.609 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -116.34 -27.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.609 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.4 m-85 -110.55 137.07 48.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.516 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 90.8 mt -55.47 -29.78 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.543 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.89 -46.7 14.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.496 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 78.0 m-20 -53.58 -31.3 46.2 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.041 -1.27 . . . . 0.0 108.688 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 278' ' ' ILE . 43.4 tp -57.07 -50.75 71.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.498 -0.751 . . . . 0.0 109.13 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 35.9 m -64.7 -29.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 108.912 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.506 ' N ' HG22 ' A' ' 282' ' ' VAL . 58.9 tt0 -59.45 -35.86 74.85 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.316 -0.865 . . . . 0.0 108.723 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -98.95 150.03 22.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.46 -0.775 . . . . 0.0 109.084 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 25.5 m -79.5 142.42 35.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.464 ' CD ' ' CD1' ' A' ' 307' ' ' LEU . 82.8 tt0 -55.63 -27.6 50.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.467 ' O ' ' HG3' ' A' ' 291' ' ' LYS . 47.8 t -52.74 -55.5 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.12 -30.69 70.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.158 -0.964 . . . . 0.0 108.645 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.521 HD22 ' CG2' ' A' ' 303' ' ' ILE . 20.1 tp -61.95 -37.33 84.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.509 -0.744 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.01 -23.33 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.533 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 48.5 mttm -81.62 -17.11 49.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.405 ' O ' HD13 ' A' ' 295' ' ' LEU . 2.1 m -73.46 117.29 59.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.549 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.512 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 50.9 Cg_endo -71.07 -20.5 28.65 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.68 2.253 . . . . 0.0 111.865 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.514 ' N ' HD12 ' B' ' 464' ' ' ILE . 33.9 m120 -52.89 -20.43 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.572 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 2.4 mp -101.98 132.59 47.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -76.68 157.64 47.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.506 ' CE ' ' HA ' ' B' ' 461' ' ' GLU . 23.6 mttm -49.66 -39.33 35.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -1.169 . . . . 0.0 109.396 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -71.46 -38.61 71.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.2 m -61.88 -47.4 85.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.522 HD23 ' CB ' ' A' ' 295' ' ' LEU . 77.7 mt -53.01 -42.82 66.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.255 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 44.4 m -52.99 -51.73 60.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.496 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 94.0 mt-10 -55.78 -39.76 71.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.317 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.521 ' CG2' HD22 ' A' ' 289' ' ' LEU . 33.5 mm -58.03 -48.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.901 . . . . 0.0 109.236 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -56.69 -41.45 77.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -58.58 -45.88 88.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.275 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.587 ' CG1' ' CD1' ' A' ' 312' ' ' LEU . 2.2 t -62.0 -38.28 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.103 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.526 HD23 ' CB ' ' A' ' 313' ' ' SER . 20.5 mt -54.63 -25.44 26.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.416 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.41 -39.18 75.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.416 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -20.71 2.83 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.404 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 310' ' ' ARG . 21.0 tpt180 64.9 10.23 6.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -106.8 -0.92 36.61 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.587 ' CD1' ' CG1' ' A' ' 306' ' ' VAL . 0.5 OUTLIER -138.45 148.55 44.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -1.169 . . . . 0.0 109.565 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.526 ' CB ' HD23 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 51.21 64.5 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.589 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.45 9.24 43.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.97 31.0 64.84 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.528 ' HE2' ' CG1' ' A' ' 282' ' ' VAL . 12.7 ptt? -114.08 150.22 34.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.411 ' C ' HD11 ' A' ' 318' ' ' LEU . 72.0 mtt85 -124.63 143.17 50.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.562 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.4 mp -118.83 140.57 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.75 -40.23 79.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 108.939 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.461 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 38.7 t-20 -122.08 -71.46 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.574 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 1.4 t-105 167.59 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.617 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.2 Cg_endo -67.8 107.89 1.57 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 112.069 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.578 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 54.3 Cg_endo -73.49 164.86 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.721 2.281 . . . . 0.0 111.684 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.09 66.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 44.6 m -76.46 -38.58 55.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.877 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.472 HG21 ' N ' ' A' ' 327' ' ' ALA . 19.2 tt -58.49 -20.66 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.472 ' N ' HG21 ' A' ' 326' ' ' ILE . . . -64.14 145.92 55.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.465 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 329' ' ' GLU . 91.2 m-20 -57.9 -38.84 76.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.471 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 328' ' ' ASP . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.85 -35.97 73.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -1.14 . . . . 0.0 109.474 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 28.4 m120 -87.31 8.93 22.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.416 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 0.7 OUTLIER -55.75 132.38 72.42 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.969 . . . . 0.0 109.376 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.444 ' HB3' ' CD2' ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.01 141.05 43.21 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.62 2.214 . . . . 0.0 111.715 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.536 ' CB ' HG22 ' B' ' 455' ' ' THR . . . -75.3 156.38 35.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . 0.479 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.2 m-20 -47.24 -38.56 12.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . 0.443 ' C ' ' HB2' ' B' ' 456' ' ' LEU . 51.3 m-20 -60.49 -48.47 81.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.533 ' CD1' HD13 ' B' ' 459' ' ' LEU . 25.5 tp -68.18 -37.89 81.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 0.0 109.556 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.471 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.6 OUTLIER -76.85 -28.86 55.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.428 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . 0.479 ' N ' ' O ' ' B' ' 432' ' ' ASP . 36.8 t-20 -90.32 10.27 25.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.523 ' CD1' HD11 ' B' ' 488' ' ' ILE . 41.9 tp -78.31 129.88 35.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.19 146.1 35.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.33 7.97 72.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.486 ' CG2' HD21 ' B' ' 481' ' ' LEU . 77.7 t -124.6 129.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 109.458 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -83.34 147.25 28.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -50.01 -40.81 45.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.455 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.9 m-20 -72.44 -40.55 66.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.439 ' CD2' ' HE3' ' B' ' 477' ' ' LYS . 23.1 tp -59.72 -42.28 92.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.72 80.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.38 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.455 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 11.7 m-30 -65.35 -41.58 93.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.46 -51.21 69.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' B' ' 453' ' ' VAL . 3.9 tt -62.23 -43.14 99.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -58.24 -31.31 67.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.75 -17.17 33.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.363 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -89.32 33.26 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 0.0 109.423 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.54 -18.97 7.66 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.512 ' CB ' HD22 ' B' ' 448' ' ' LEU . 61.4 t -64.17 135.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.281 . . . . 0.0 109.34 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' B' ' 431' ' ' ALA . 0.8 OUTLIER -131.82 -33.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.536 HG22 ' CB ' ' B' ' 431' ' ' ALA . 0.6 OUTLIER -115.1 142.14 47.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.0 109.733 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' B' ' 485' ' ' ALA . 2.0 tm? -45.42 -39.47 7.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 108.867 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.0 -48.2 76.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.205 -0.934 . . . . 0.0 108.653 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -54.26 -42.77 70.33 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.334 -0.853 . . . . 0.0 108.72 179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.533 HD13 ' CD1' ' B' ' 434' ' ' LEU . 5.1 tt -53.7 -48.91 69.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 109.018 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.515 ' HB1' ' N ' ' B' ' 486' ' ' ARG . . . -56.03 -35.62 67.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . 0.506 ' HA ' ' CE ' ' A' ' 297' ' ' LYS . 96.7 mt-10 -67.21 -28.34 68.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -63.78 164.87 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.26 154.07 16.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.514 HD12 ' N ' ' A' ' 294' ' ' ASN . 45.9 mt -52.33 -34.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.15 -34.28 74.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.52 -31.92 63.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.526 ' HB2' ' CB ' ' B' ' 478' ' ' ALA . 34.6 mt -74.94 -34.86 62.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.333 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.92 -21.52 11.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.545 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -50.19 -36.97 32.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.2 125.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -62.24 -35.61 79.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.446 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -33.14 22.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.46 HD21 ' HA ' ' B' ' 478' ' ' ALA . 10.9 tp -99.17 141.7 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 474' ' ' THR . . . . . 0.483 HG21 ' N ' ' B' ' 475' ' ' ASP . 89.0 m -104.15 164.79 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.483 ' N ' HG21 ' B' ' 474' ' ' THR . 92.3 m-20 -56.5 -40.11 74.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -75.4 -46.25 34.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.439 ' HE3' ' CD2' ' B' ' 444' ' ' LEU . 37.7 tttp -60.41 -38.28 83.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 109.275 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.526 ' CB ' ' HB2' ' B' ' 467' ' ' LEU . . . -68.75 -50.66 48.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.46 ' HA3' HD13 ' B' ' 464' ' ' ILE . . . -62.58 -48.59 80.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.97 61.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -1.121 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.486 HD21 ' CG2' ' B' ' 440' ' ' VAL . 64.1 mt -62.41 -40.92 98.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.265 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 50.0 mt -55.01 -55.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.23 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 31.8 mtp -53.14 -45.3 68.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.26 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.9 -45.09 90.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.164 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -63.13 -52.27 63.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.255 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.515 ' N ' ' HB1' ' B' ' 460' ' ' ALA . 89.2 mtt180 -59.46 -39.57 84.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 93.6 m-20 -57.31 -41.59 80.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.523 HD11 ' CD1' ' B' ' 437' ' ' LEU . 83.3 mt -59.65 -36.61 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.43 -51.62 9.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.772 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -63.84 -45.92 87.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.47 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.0 m-85 -76.08 -29.5 57.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -61.53 -27.89 68.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.64 -36.38 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -1.115 . . . . 0.0 109.497 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.27 -32.29 69.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.511 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.457 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.574 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 44.4 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.4 124.93 57.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.305 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.07 -22.68 61.76 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.623 2.215 . . . . 0.0 111.665 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.519 ' CD1' HD23 ' A' ' 312' ' ' LEU . 12.7 tt -71.8 -31.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 108.833 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.523 ' CD2' HG12 ' A' ' 282' ' ' VAL . 31.8 mt -74.85 -45.03 45.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 109.345 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.632 ' CD2' ' CZ2' ' A' ' 321' ' ' TRP . 0.7 OUTLIER -65.48 -35.54 81.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.423 ' O ' HG13 ' A' ' 278' ' ' ILE . 6.4 mtt85 -55.82 141.52 65.95 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.004 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 48.1 Cg_endo -68.93 132.16 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.623 2.216 . . . . 0.0 111.935 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.84 -28.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.485 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 95.5 m-20 -65.54 -30.68 71.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.441 ' O ' ' C ' ' A' ' 260' ' ' LEU . 72.4 m-20 -74.96 -8.58 56.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 257' ' ' VAL . 0.7 OUTLIER -42.85 129.48 4.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -15.47 50.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 302' ' ' GLU . 40.3 mt -70.18 -162.13 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 7.1 p -81.01 155.9 26.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.419 HG11 ' ND2' ' A' ' 268' ' ' ASN . 22.8 t -57.67 -24.07 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' B' ' 465' ' ' ASP . 55.6 ttt85 -57.81 -43.36 85.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.7 m -58.82 -46.83 86.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.371 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.485 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -68.96 -39.5 79.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.419 ' ND2' HG11 ' A' ' 264' ' ' VAL . 86.7 m-20 -60.28 -32.17 70.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' A' ' 272' ' ' ALA . 81.4 m -66.9 -64.9 0.76 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.453 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.438 HD11 HD12 ' A' ' 281' ' ' LEU . 69.0 mt -54.84 -47.82 73.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.502 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 20.5 ttpt -52.94 -39.52 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.449 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.448 ' HB2' ' O ' ' A' ' 269' ' ' CYS . . . -52.4 -23.68 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.406 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 95.3 mt-10 -94.11 23.07 5.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.42 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.406 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 68.5 33.26 4.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -0.929 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 75.8 mt -120.26 108.2 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.502 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 91.2 m-70 -104.59 -11.09 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.824 . . . . 0.0 109.581 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.98 133.37 54.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.487 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 49.8 mt -62.03 -30.9 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.554 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -52.27 -41.25 54.11 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.493 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 92.1 m-20 -53.45 -36.36 61.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -1.181 . . . . 0.0 109.119 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.519 ' CD2' HD13 ' A' ' 312' ' ' LEU . 3.1 tp -59.19 -46.49 88.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.297 -0.877 . . . . 0.0 109.229 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 15.4 m -68.37 -23.29 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.505 ' N ' HG21 ' A' ' 282' ' ' VAL . 60.9 tt0 -68.26 -33.09 73.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.826 . . . . 0.0 108.813 179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -105.74 143.4 33.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.02 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 25.8 m -60.0 137.6 58.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.092 -1.005 . . . . 0.0 109.394 -179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.98 -30.5 71.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 50.0 t -53.1 -50.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.331 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -51.8 -39.39 58.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.491 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.4 mm? -72.8 -39.65 66.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.291 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.512 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.8 tm? -57.61 -33.21 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.228 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.465 ' C ' ' CE ' ' B' ' 483' ' ' MET . 32.5 mttm -88.45 17.64 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.436 ' OG1' ' HA ' ' A' ' 289' ' ' LEU . 2.9 m -103.75 135.99 19.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.524 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 50.3 Cg_endo -70.81 -24.82 24.45 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.671 2.247 . . . . 0.0 111.802 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.502 ' N ' HD12 ' B' ' 464' ' ' ILE . 32.1 m120 -57.1 -21.01 28.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.57 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 13.3 mt -81.8 149.89 28.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -112.93 147.6 18.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.08 -44.88 71.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.409 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 302' ' ' GLU . 40.1 mttp -66.52 -41.58 88.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.4 m -64.39 -32.77 74.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.456 HD11 HD22 ' A' ' 290' ' ' LEU . 32.5 tp -53.36 -42.2 66.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.426 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.8 m -54.8 -43.41 72.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.494 ' HB3' ' CD1' ' A' ' 262' ' ' LEU . 39.5 mp0 -67.15 -37.86 84.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 77.2 mt -58.24 -47.16 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.448 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.44 -36.54 84.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.47 -45.2 89.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.564 ' CG1' ' CD2' ' A' ' 312' ' ' LEU . 20.6 t -68.71 -43.33 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.475 HD12 ' OG ' ' A' ' 313' ' ' SER . 16.6 tp -54.73 -29.68 54.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.606 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.62 73.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 83.0 p -79.22 -1.11 34.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.467 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.519 ' HA ' ' CD2' ' A' ' 314' ' ' LEU . 65.8 mtm180 56.88 16.99 3.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.012 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -72.55 -38.94 57.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.564 ' CD2' ' CG1' ' A' ' 306' ' ' VAL . 1.3 pp -149.5 160.99 43.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -1.219 . . . . 0.0 109.978 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.5 OUTLIER 76.72 29.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.795 . . . . 0.0 109.538 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.519 ' CD2' ' HA ' ' A' ' 310' ' ' ARG . 72.9 mt -85.8 14.91 5.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 54.69 41.69 75.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.508 ' CG ' ' HB2' ' A' ' 314' ' ' LEU . 5.0 mtm -86.2 176.95 7.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -1.094 . . . . 0.0 109.49 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 92.8 mtt180 -140.98 125.77 18.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.405 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.543 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 4.0 mp -126.55 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.85 -38.49 88.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.239 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.9 m-20 -125.31 -69.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.632 ' CZ2' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER 166.08 -66.41 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.451 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.533 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.87 107.75 1.76 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.652 2.235 . . . . 0.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 51.5 Cg_endo -71.71 162.45 42.04 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.625 2.217 . . . . 0.0 111.505 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.55 -17.26 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 36.4 m -66.12 -42.62 88.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.48 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.473 HG22 HD12 ' A' ' 326' ' ' ILE . 18.1 mt -58.23 -31.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.89 75.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.968 . . . . 0.0 109.393 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -55.45 -37.36 67.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.372 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.427 ' HG2' ' OXT' ' A' ' 329' ' ' GLU . 84.3 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 88.8 m-20 -54.28 -36.98 64.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' B' ' 427' ' ' ASP . 27.0 m120 59.71 51.24 6.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.434 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -86.46 124.56 69.55 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.56 140.93 40.76 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.664 2.242 . . . . 0.0 111.686 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -80.88 160.15 24.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.476 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.3 m-20 -53.46 -37.47 62.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.305 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . 0.531 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 18.3 m-20 -61.39 -49.99 74.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.387 -0.82 . . . . 0.0 109.512 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.459 HD13 ' CD1' ' B' ' 448' ' ' LEU . 17.8 tp -63.45 -35.79 81.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.577 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' B' ' 442' ' ' ARG . 22.2 tp -83.51 -23.08 32.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' B' ' 432' ' ' ASP . 35.3 t-20 -88.24 7.34 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.575 ' CD1' ' CD1' ' B' ' 488' ' ' ILE . 28.6 tp -78.43 129.93 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.501 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.82 137.28 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.06 9.32 70.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.43 HG11 HD22 ' B' ' 444' ' ' LEU . 41.8 t -123.67 131.12 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.137 . . . . 0.0 109.475 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -102.46 161.82 13.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.524 ' HA ' ' CD1' ' B' ' 435' ' ' LEU . 61.7 mtt180 -50.19 -45.59 53.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.481 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.459 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 93.4 m-20 -61.08 -47.44 86.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.435 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.553 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 27.9 tp -55.67 -43.11 76.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.334 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.42 ' HB3' HD21 ' B' ' 434' ' ' LEU . . . -59.02 -43.07 91.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.23 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.459 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 17.3 m-85 -57.68 -44.75 86.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.26 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -58.24 -45.06 88.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.459 ' CD1' HD13 ' B' ' 434' ' ' LEU . 79.1 mt -61.34 -44.03 97.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.16 -36.19 77.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.42 33.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.527 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 16.0 mtp-105 -90.32 23.57 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.68 6.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.501 HG23 ' NE2' ' B' ' 462' ' ' GLN . 21.3 t -80.53 109.75 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.34 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.448 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 31.1 m -124.91 -34.45 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.09 140.89 33.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.628 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.0 tm? -48.56 -40.78 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.72 -38.77 91.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -0.922 . . . . 0.0 108.899 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.496 ' CB ' HG11 ' B' ' 453' ' ' VAL . 92.5 m-20 -61.58 -40.12 93.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.486 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -63.29 -39.03 93.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.518 ' HB1' ' N ' ' B' ' 486' ' ' ARG . . . -63.48 -32.63 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.295 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -72.61 -30.33 64.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.501 ' NE2' HG23 ' B' ' 453' ' ' VAL . 97.8 mm-40 -61.65 156.91 18.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.445 ' HA2' HD13 ' B' ' 482' ' ' ILE . . . -117.25 155.97 15.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 52.2 mt -49.68 -38.33 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -1.131 . . . . 0.0 109.501 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 265' ' ' ARG . 89.2 m-20 -65.22 -37.51 87.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.425 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 89.6 m-20 -71.11 -31.07 67.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.525 ' CD1' ' HB1' ' B' ' 478' ' ' ALA . 22.0 mt -76.81 -29.85 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.61 63.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -52.67 -32.35 41.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.456 HD12 HG23 ' B' ' 470' ' ' ILE . 68.9 mt -104.73 128.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -63.77 -33.94 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -51.12 -28.63 18.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.553 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 55.1 mt -105.86 137.6 43.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 474' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' B' ' 478' ' ' ALA . 29.8 m -103.97 162.0 13.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.395 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -58.3 -37.51 75.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.494 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -76.97 -45.94 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.465 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 70.7 tttt -65.83 -46.4 78.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.525 ' HB1' ' CD1' ' B' ' 467' ' ' LEU . . . -60.02 -44.64 94.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 109.535 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.473 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.27 -52.34 50.21 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -50.98 -33.74 26.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -1.169 . . . . 0.0 109.617 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -75.33 -37.36 60.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 92.8 mt -60.54 -55.63 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.507 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 41.2 mmm -59.68 -47.64 84.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.42 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.46 -53.15 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.445 ' CB ' HD22 ' B' ' 456' ' ' LEU . . . -60.83 -48.62 80.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.518 ' N ' ' HB1' ' B' ' 460' ' ' ALA . 44.9 ttp85 -56.98 -43.75 82.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.7 m-20 -57.92 -39.06 77.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.616 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.575 ' CD1' ' CD1' ' B' ' 437' ' ' LEU . 76.9 mt -63.68 -36.9 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.51 -52.07 59.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.56 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -61.17 -38.75 87.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 17.2 m-85 -64.03 -31.33 72.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.492 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.86 -30.06 72.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -53.15 -37.86 62.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -1.138 . . . . 0.0 109.466 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.27 -33.05 72.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.531 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.525 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 323' ' ' PRO . 79.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -50.78 155.22 2.04 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.273 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.456 ' HA ' HD23 ' A' ' 254' ' ' LEU . 41.0 Cg_endo -64.5 -26.31 62.47 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.47 2.114 . . . . 0.0 111.425 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' HD12 ' A' ' 253' ' ' LEU . 13.2 tt -53.38 -34.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.537 ' CD2' HG12 ' A' ' 282' ' ' VAL . 5.3 mp -74.45 -39.21 62.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.463 -0.773 . . . . 0.0 109.01 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.58 HD11 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -71.32 -23.14 61.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.459 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.417 ' O ' HG13 ' A' ' 278' ' ' ILE . 0.2 OUTLIER -73.0 141.19 81.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.466 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 259' ' ' ASP . 51.5 Cg_endo -70.66 136.37 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.728 2.285 . . . . 0.0 111.736 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.16 -26.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.368 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.441 ' OD1' ' NZ ' ' A' ' 271' ' ' LYS . 88.3 m-20 -67.61 -30.77 70.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 256' ' ' PRO . 49.9 m-20 -74.71 -9.8 58.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.449 ' CD2' HD12 ' A' ' 278' ' ' ILE . 49.5 mt -58.44 135.75 57.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 0.0 109.359 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.44 -21.22 66.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.571 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.4 mp -62.59 168.35 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.2 p -70.5 166.74 19.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.41 HG11 ' OD1' ' A' ' 268' ' ' ASN . 19.0 t -63.89 -23.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -55.4 -45.09 76.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.9 p -69.16 -45.89 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -63.82 -42.4 97.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.41 ' OD1' HG11 ' A' ' 264' ' ' VAL . 95.2 m-20 -54.13 -38.36 65.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.3 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 295' ' ' LEU . 61.0 m -51.29 -62.14 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.473 HD23 ' CD1' ' A' ' 281' ' ' LEU . 63.8 mt -56.47 -46.28 80.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 16.3 mttt -53.25 -33.23 52.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.73 -33.7 49.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 86.1 mt-10 -92.01 25.84 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.404 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 68.23 45.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.512 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 91.2 mt -115.61 124.91 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.571 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.5 p80 -114.09 -39.93 3.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.571 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -103.14 134.73 46.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.45 HD11 ' O ' ' A' ' 252' ' ' ILE . 78.1 mt -46.66 -30.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.067 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.574 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -46.89 -49.41 17.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.512 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 87.5 m-20 -53.43 -32.19 48.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 108.988 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.473 ' CD1' HD23 ' A' ' 270' ' ' LEU . 53.9 tp -53.99 -51.29 64.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.332 -0.855 . . . . 0.0 109.07 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 17.7 m -68.17 -33.46 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.18 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.467 ' N ' HG23 ' A' ' 282' ' ' VAL . 61.9 tt0 -53.06 -32.43 46.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.294 -0.879 . . . . 0.0 108.819 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -107.74 150.61 26.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 72.2 p -81.6 157.07 24.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.945 . . . . 0.0 109.616 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.471 ' OE2' ' CB ' ' A' ' 313' ' ' SER . 7.2 mt-10 -63.52 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.918 . . . . 0.0 109.442 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.5 t -52.79 -50.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -55.14 -37.57 67.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 65.8 mt -72.62 -40.75 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.242 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.518 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.9 tm? -57.31 -32.69 66.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.865 . . . . 0.0 109.21 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.521 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 66.9 mttm -82.26 -13.27 57.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.82 . . . . 0.0 109.474 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.1 m -86.94 112.6 48.5 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HB2' ' CD1' ' B' ' 482' ' ' ILE . 51.3 Cg_endo -70.86 -13.16 31.71 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.767 2.311 . . . . 0.0 111.845 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.509 ' N ' HD13 ' B' ' 464' ' ' ILE . 30.6 m120 -48.93 -41.08 32.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.46 ' HB3' ' HB3' ' A' ' 269' ' ' CYS . 0.4 OUTLIER -83.74 143.17 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -80.34 165.2 48.27 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -64.48 -41.51 96.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.568 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -63.94 -39.0 93.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 303' ' ' ILE . 19.6 m -59.73 -41.67 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.427 ' HG ' ' CE ' ' A' ' 304' ' ' LYS . 24.2 tp -53.06 -37.93 62.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.9 m -60.85 -45.83 92.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.14 -46.09 88.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.488 HG23 ' CD2' ' A' ' 307' ' ' LEU . 30.6 mm -58.76 -51.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.427 ' CE ' ' HG ' ' A' ' 300' ' ' LEU . 22.5 mttm -53.13 -39.06 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.15 -48.3 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.461 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 12.0 t -73.71 -40.84 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.53 HD22 ' CB ' ' A' ' 313' ' ' SER . 8.4 mp -66.02 -26.71 67.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 304' ' ' LYS . . . -58.78 -29.57 66.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 8.2 t -75.2 -0.16 18.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 309' ' ' SER . 40.5 mtm-85 70.31 3.89 4.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.445 ' O ' HD12 ' A' ' 253' ' ' LEU . . . -69.32 -27.82 73.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.469 ' HG ' HD12 ' A' ' 252' ' ' ILE . 0.0 OUTLIER -140.81 152.89 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 109.261 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.53 ' CB ' HD22 ' A' ' 307' ' ' LEU . 16.5 m 63.67 66.85 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.46 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 314' ' ' LEU . 4.7 mp -103.06 9.99 38.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.61 73.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.538 ' HE1' ' CG1' ' A' ' 282' ' ' VAL . 15.4 ptt? -113.04 147.38 37.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 76.3 mtm180 -126.53 141.66 51.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.292 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.561 HD21 ' CZ ' ' A' ' 249' ' ' PHE . 3.7 mp -116.9 141.78 47.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.02 -34.4 77.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.983 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 85.6 m-20 -117.41 -81.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.58 ' CZ2' HD11 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 165.89 -62.23 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.8 Cg_endo -68.33 108.09 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.66 2.24 . . . . 0.0 111.989 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.576 ' HB3' ' CD1' ' A' ' 249' ' ' PHE . 53.9 Cg_endo -76.34 161.91 34.29 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.421 2.08 . . . . 0.0 111.414 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.64 -13.92 17.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.1 p -70.35 -35.52 73.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.764 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.463 HD11 ' HB3' ' A' ' 322' ' ' PRO . 21.2 pt -94.0 -3.75 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.8 74.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.16 -38.14 76.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.489 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -57.5 -36.35 71.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -1.134 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' B' ' 449' ' ' ALA . 26.8 m120 56.2 40.04 30.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 130.17 92.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 144.01 48.72 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.792 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.463 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -75.65 146.34 40.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -47.99 -32.9 7.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 109.455 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.53 -48.01 68.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.489 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.5 tm? -67.91 -36.96 81.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -72.89 -31.95 65.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.86 11.32 20.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.516 ' CD1' HD12 ' B' ' 456' ' ' LEU . 50.2 tp -74.05 133.64 42.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -76.6 145.47 38.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.74 75.1 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 95.3 t -123.54 135.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -1.214 . . . . 0.0 109.489 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 442' ' ' ARG . 58.2 t0 -85.27 146.38 27.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.447 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 95.8 mtt180 -49.92 -43.79 49.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -68.65 -37.74 79.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.293 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 15.2 tp -63.66 -35.57 80.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -63.81 -41.37 97.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.953 . . . . 0.0 109.419 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 71.8 m-85 -65.88 -48.46 71.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.514 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 31.4 ttmt -57.94 -42.86 85.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.536 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 10.0 tt -69.73 -37.3 76.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.27 -27.6 67.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.496 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.06 -16.9 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.416 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 12.1 mtp85 -90.46 28.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.81 6.8 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 19.2 t -65.33 133.24 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.303 . . . . 0.0 109.427 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 60.4 m -135.08 -35.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -106.57 152.1 24.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.003 . . . . 0.0 109.847 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.516 HD12 ' CD1' ' B' ' 437' ' ' LEU . 0.3 OUTLIER -51.78 -42.77 62.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.332 -0.855 . . . . 0.0 109.363 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.83 -42.2 75.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.137 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 84.3 m-20 -61.4 -41.2 96.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.342 -0.849 . . . . 0.0 109.217 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.536 ' CD2' ' CD1' ' B' ' 448' ' ' LEU . 3.4 tm? -60.97 -38.92 87.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.16 -35.72 81.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.82 -35.34 80.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 3.5 mm100 -65.53 144.88 56.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.47 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.458 ' HA2' HD13 ' B' ' 482' ' ' ILE . . . -102.92 159.72 17.26 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.509 HD13 ' N ' ' A' ' 294' ' ' ASN . 80.3 mt -46.07 -35.14 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.238 . . . . 0.0 109.204 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -63.47 -37.45 87.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.919 . . . . 0.0 109.021 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.4 m-20 -68.51 -31.55 70.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.16 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.434 ' CB ' ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -80.84 -32.86 34.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.396 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.48 -33.07 67.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 109.392 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -46.83 -28.67 1.64 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.401 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.514 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 62.1 mt -105.79 121.53 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -55.93 -32.65 63.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.94 -28.82 49.57 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 65.0 mt -103.5 135.77 44.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -1.132 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.95 161.91 13.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.354 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.426 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 82.5 m-20 -58.29 -37.39 74.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.13 -46.03 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.509 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 25.2 tttp -62.86 -44.22 96.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.46 ' O ' HG13 ' B' ' 482' ' ' ILE . . . -63.85 -44.34 93.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.23 -35.85 91.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.16 76.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -1.144 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.509 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -69.51 -36.56 76.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 109.642 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.539 ' CD1' ' HB2' ' A' ' 293' ' ' PRO . 30.9 mt -68.84 -56.35 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.518 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.521 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 61.2 mtp -52.62 -39.08 61.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.446 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.35 -49.23 44.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.471 ' HB2' ' CD2' ' B' ' 456' ' ' LEU . . . -63.98 -46.41 84.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 45.9 ttm-85 -57.6 -45.05 85.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.34 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.0 m-20 -57.9 -40.0 79.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.446 HG13 ' O ' ' B' ' 484' ' ' ALA . 84.8 mt -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.73 -49.23 49.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 58.4 m95 -65.99 -32.22 73.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.514 ' HB3' ' N ' ' B' ' 495' ' ' ALA . 13.8 m-85 -79.22 -34.27 42.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.568 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 54.87 -135.37 46.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -51.0 -40.45 58.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -1.167 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.34 -36.63 66.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . 0.514 ' N ' ' HB3' ' B' ' 491' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.558 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.53 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 10.4 p90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.456 ' O ' HD22 ' A' ' 254' ' ' LEU . 0.9 OUTLIER -57.86 136.95 83.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 109.272 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.492 ' HA ' HD22 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.05 -30.93 56.03 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.597 2.198 . . . . 0.0 111.55 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.527 ' CD1' HD22 ' A' ' 312' ' ' LEU . 18.2 tt -63.11 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.527 HD22 ' CG1' ' A' ' 282' ' ' VAL . 31.4 mt -74.31 -42.57 59.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.195 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 251' ' ' PRO . 0.5 OUTLIER -59.94 -34.99 73.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.813 . . . . 0.0 109.14 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -66.12 146.47 99.02 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.3 Cg_endo -70.22 140.01 39.94 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.714 2.276 . . . . 0.0 111.89 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.421 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -44.12 -36.92 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.362 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -58.13 -30.98 66.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 256' ' ' PRO . 21.9 m-20 -72.38 -11.41 60.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.527 ' CD2' HD11 ' A' ' 278' ' ' ILE . 36.8 mt -55.35 150.64 11.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -23.23 67.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.437 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.522 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 5.6 mp -62.85 166.74 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -75.53 162.66 28.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 11.8 t -48.85 -39.67 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -51.18 -50.22 59.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.522 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 17.7 t -58.71 -51.02 71.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.96 -37.06 85.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.491 ' HA ' ' CE ' ' A' ' 271' ' ' LYS . 94.7 m-20 -58.54 -36.47 73.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.322 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -53.64 54.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.304 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.415 HD22 HD11 ' A' ' 281' ' ' LEU . 6.6 mp -61.28 -47.87 83.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.491 ' CE ' ' HA ' ' A' ' 268' ' ' ASN . 54.8 mtmt -52.8 -38.14 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.23 20.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.409 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 86.3 mt-10 -92.95 25.29 3.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.453 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.409 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.05 45.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 83.2 mt -120.85 119.58 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.457 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.7 p80 -110.17 -40.05 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.557 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.457 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.6 m-30 -105.47 136.13 45.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.527 HD11 ' CD2' ' A' ' 260' ' ' LEU . 93.5 mt -46.7 -29.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.98 -45.13 14.29 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 89.3 m-20 -53.52 -33.83 55.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.293 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 278' ' ' ILE . 38.7 tp -57.35 -49.48 76.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 13.2 m -63.44 -23.34 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 108.73 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.509 ' N ' HG21 ' A' ' 282' ' ' VAL . 63.1 tt0 -67.45 -34.95 78.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -98.73 158.57 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 154.26 23.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.074 -1.016 . . . . 0.0 109.773 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.466 ' OE2' ' O ' ' A' ' 313' ' ' SER . 9.0 mt-10 -61.68 -36.33 80.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.524 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 42.1 t -52.64 -49.36 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -51.95 -32.55 33.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.083 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 36.8 mt -69.25 -41.18 77.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.147 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.519 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.39 -25.31 66.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.342 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.524 ' HE3' ' CG1' ' A' ' 287' ' ' VAL . 54.8 mttt -86.32 -12.87 48.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.484 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.486 ' CG2' ' CD1' ' A' ' 295' ' ' LEU . 53.0 m -81.85 112.3 33.69 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.522 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.528 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 52.6 Cg_endo -71.06 -14.25 31.88 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.821 2.347 . . . . 0.0 111.916 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.51 ' ND2' HD11 ' B' ' 464' ' ' ILE . 31.9 m120 -61.98 -25.47 67.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.491 HD22 ' CD1' ' A' ' 303' ' ' ILE . 4.7 mp -88.02 142.35 27.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -91.39 169.28 32.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.55 -41.07 80.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.145 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -70.14 -43.07 71.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.6 m -59.2 -49.45 77.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.39 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 296' ' ' GLY . 83.5 mt -55.37 -42.37 73.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.3 m -55.41 -52.62 62.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.873 . . . . 0.0 109.451 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.424 ' CB ' HD22 ' A' ' 262' ' ' LEU . 89.2 mt-10 -54.82 -39.4 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.491 ' CD1' HD22 ' A' ' 295' ' ' LEU . 78.6 mt -58.15 -51.54 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.33 -42.51 73.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.36 -44.08 79.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.463 HG11 HD23 ' A' ' 312' ' ' LEU . 1.9 t -65.93 -39.58 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.178 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.541 ' CD2' ' CB ' ' A' ' 313' ' ' SER . 20.1 mt -54.63 -26.16 31.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.37 68.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.7 t -66.06 -15.53 63.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.506 ' O ' ' CD1' ' A' ' 314' ' ' LEU . 92.8 mtt180 59.32 14.17 3.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.442 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -105.27 1.99 40.33 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 252' ' ' ILE . 0.6 OUTLIER -149.94 142.58 24.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -1.19 . . . . 0.0 109.641 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.1 OUTLIER 67.22 38.87 3.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.577 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.506 ' CD1' ' O ' ' A' ' 310' ' ' ARG . 28.1 mt -88.97 18.2 5.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.31 36.29 91.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.521 ' HE2' ' CD1' ' A' ' 253' ' ' LEU . 6.4 mtm -87.21 167.33 14.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 36.1 mtp180 -143.15 131.29 21.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.489 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.6 mp -130.0 139.26 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.927 . . . . 0.0 109.621 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.32 -43.97 88.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 108.88 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.459 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 69.1 m-20 -122.06 -69.42 0.83 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.041 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.507 ' N ' ' HD2' ' A' ' 322' ' ' PRO . 2.6 t-105 168.42 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.354 -0.841 . . . . 0.0 109.405 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.3 Cg_endo -68.52 107.79 1.69 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.545 2.163 . . . . 0.0 111.898 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.517 ' O ' ' CG2' ' A' ' 326' ' ' ILE . 51.4 Cg_endo -71.47 152.91 60.69 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.611 2.207 . . . . 0.0 111.711 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.76 6.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 42.9 m -68.18 -32.64 73.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.517 ' CG2' ' O ' ' A' ' 323' ' ' PRO . 18.7 tt -61.11 -25.29 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.315 -0.865 . . . . 0.0 109.564 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.469 ' N ' HG23 ' A' ' 326' ' ' ILE . . . -59.24 144.05 47.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.543 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -60.05 -37.57 80.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.04 -35.0 72.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -1.15 . . . . 0.0 109.449 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.431 ' O ' ' HB3' ' B' ' 449' ' ' ALA . 22.4 m120 -85.54 5.65 30.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 2.0 tttt -54.07 129.87 58.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.513 ' HG3' ' CD1' ' B' ' 446' ' ' PHE . 48.6 Cg_endo -69.98 140.85 42.85 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.677 2.251 . . . . 0.0 111.774 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.04 152.57 42.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.888 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -50.1 -39.42 42.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.4 -44.48 92.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.496 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 2.9 tm? -64.18 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.25 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.49 ' CD1' ' HG2' ' B' ' 442' ' ' ARG . 24.7 tp -79.88 -30.29 40.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -78.43 -0.77 30.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.463 ' CD1' HD13 ' B' ' 488' ' ' ILE . 28.8 tp -72.34 134.58 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.513 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -73.6 141.26 46.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.93 8.55 66.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 47.4 t -129.52 126.42 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.452 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.26 161.46 13.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.49 ' HG2' ' CD1' ' B' ' 435' ' ' LEU . 87.9 mtt-85 -55.01 -46.63 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.17 -45.6 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.504 ' CD2' ' HE2' ' B' ' 477' ' ' LYS . 12.9 tp -60.85 -41.83 96.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.422 ' CB ' HD13 ' B' ' 434' ' ' LEU . . . -59.15 -40.66 86.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.513 ' CD1' ' HG3' ' B' ' 430' ' ' PRO . 17.3 m-85 -63.83 -46.65 84.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.502 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 5.9 ttmm -57.66 -46.36 84.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.455 ' CD1' HD12 ' B' ' 459' ' ' LEU . 8.7 tt -68.24 -36.51 79.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.586 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.81 -26.79 67.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -49.14 -22.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.695 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -88.66 25.01 1.83 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.63 7.15 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 44.7 t -62.87 132.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.942 -1.328 . . . . 0.0 109.326 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 87.5 m -135.11 -38.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 109.666 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 150.56 21.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.738 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.551 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 27.1 tp -48.41 -42.15 31.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.255 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -55.94 -48.36 75.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.102 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.413 ' C ' HG13 ' B' ' 453' ' ' VAL . 82.6 m-20 -54.89 -40.99 70.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.065 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.471 HD11 ' CD2' ' B' ' 434' ' ' LEU . 4.6 tt -57.21 -47.05 82.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.65 70.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.08 -34.87 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.46 ' HG3' HG22 ' B' ' 453' ' ' VAL . 6.2 mm100 -67.44 156.01 37.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.463 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -117.57 155.08 16.32 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.51 HD11 ' ND2' ' A' ' 294' ' ' ASN . 30.0 mt -47.6 -42.63 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -1.176 . . . . 0.0 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -58.34 -42.43 86.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.14 -30.04 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.514 ' CD1' ' CB ' ' B' ' 478' ' ' ALA . 24.0 mt -77.98 -26.48 48.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.26 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.32 69.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.873 . . . . 0.0 109.301 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -53.74 -32.28 51.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.502 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 61.0 mt -100.43 122.84 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.88 -26.84 67.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . 0.46 ' HA3' ' CD ' ' B' ' 447' ' ' LYS . . . -59.7 -26.5 62.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . . . . . . . . . 38.7 mt -109.73 134.66 51.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -1.163 . . . . 0.0 109.573 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.02 161.93 13.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.403 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.419 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 79.9 m-20 -57.68 -38.05 74.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -76.79 -46.08 26.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.525 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 43.7 tttt -64.93 -42.06 95.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.514 ' CB ' ' CD1' ' B' ' 467' ' ' LEU . . . -63.85 -42.15 97.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.1 -42.92 99.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.07 85.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -66.88 -39.89 87.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.528 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 28.9 mt -64.69 -56.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.523 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 48.3 mtp -52.67 -40.35 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.83 -56.45 15.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.461 ' HB1' ' HG ' ' B' ' 456' ' ' LEU . . . -62.05 -44.42 96.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.714 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 290' ' ' LEU . 50.2 ttt180 -60.28 -45.97 91.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 84.5 m-20 -59.2 -41.13 87.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.551 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 71.0 mt -64.54 -37.14 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.07 -50.56 32.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.55 -39.69 77.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.5 m-85 -96.77 16.32 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -59.43 -33.76 77.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.17 -36.85 76.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -1.141 . . . . 0.0 109.388 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . 0.432 ' O ' ' HB1' ' B' ' 495' ' ' ALA . 98.0 mt-10 -62.17 -32.37 72.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.449 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . 0.432 ' HB1' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.482 ' HB3' ' CB ' ' A' ' 325' ' ' SER . 43.5 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.347 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -65.93 135.51 95.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.68 -25.44 54.16 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.763 2.309 . . . . 0.0 111.79 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.434 HD11 HD23 ' A' ' 312' ' ' LEU . 19.7 tt -79.54 -21.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.494 ' CD1' HG12 ' A' ' 282' ' ' VAL . 5.6 tp -74.08 -37.91 64.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.295 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.531 HD13 ' CH2' ' A' ' 321' ' ' TRP . 3.8 mm? -82.99 -27.74 30.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.519 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 0.0 OUTLIER -63.75 144.19 97.95 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.542 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 51.1 Cg_endo -71.0 149.55 59.18 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.728 2.285 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -53.53 -39.22 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.803 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 259' ' ' ASP . 9.3 p-10 -58.52 -31.0 67.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.6 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.519 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 68.6 m-20 -74.1 -13.45 60.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . . . . . . . . . 46.1 mt -51.17 144.13 9.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -68.71 -16.26 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.479 ' CD2' ' HB3' ' A' ' 302' ' ' GLU . 28.6 mt -59.72 -174.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 22.2 p -87.27 159.09 18.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.429 HG11 ' OD1' ' A' ' 268' ' ' ASN . 13.5 t -56.35 -30.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -56.05 -46.43 78.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 87.4 p -66.39 -45.27 80.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.4 90.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.429 ' OD1' HG11 ' A' ' 264' ' ' VAL . 93.3 m-20 -58.11 -33.21 68.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.378 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 92.8 m -59.25 -64.3 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.938 . . . . 0.0 109.41 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.509 HD13 ' CD1' ' A' ' 281' ' ' LEU . 63.6 mt -60.79 -48.2 82.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.329 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.501 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 73.1 tttt -54.47 -38.71 66.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -55.45 -24.63 31.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.465 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 94.5 mt-10 -92.22 21.12 5.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 34.34 1.44 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 109.604 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.51 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 85.3 mt -120.73 107.63 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.12 -0.988 . . . . 0.0 109.458 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.501 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 58.6 m-70 -108.05 -3.99 18.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.618 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.6 m-85 -113.98 131.05 56.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 255' ' ' ARG . 73.8 mt -59.47 -30.43 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.536 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -46.32 -47.06 16.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.51 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 80.4 m-20 -53.5 -33.66 55.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.249 . . . . 0.0 108.997 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.509 ' CD1' HD13 ' A' ' 270' ' ' LEU . 35.0 tp -56.29 -49.28 74.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.134 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.536 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 22.3 m -66.39 -24.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 108.884 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.507 ' N ' HG21 ' A' ' 282' ' ' VAL . 63.5 tt0 -65.05 -35.68 81.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 108.969 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -98.36 141.22 31.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.331 -0.856 . . . . 0.0 109.191 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 8.1 m -71.38 140.77 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.531 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.469 ' O ' HD22 ' A' ' 290' ' ' LEU . 48.4 tp10 -49.98 -29.75 9.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.59 -51.3 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.163 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.433 ' O ' ' OG1' ' A' ' 292' ' ' THR . 96.1 mt-10 -53.36 -34.06 56.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 109.117 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.456 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 39.9 mt -63.88 -41.91 97.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.331 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.514 HD23 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.68 -31.4 72.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.527 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 78.0 mttt -85.22 -10.64 56.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.492 HG22 ' CD1' ' A' ' 295' ' ' LEU . 28.8 m -83.87 113.03 44.92 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 49.1 Cg_endo -70.66 -18.79 32.5 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.753 2.302 . . . . 0.0 111.851 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.432 ' N ' HD12 ' B' ' 464' ' ' ILE . 71.2 m-80 -56.95 -27.16 60.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.511 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 4.1 mp -92.7 136.48 33.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.23 179.46 40.75 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -62.26 -38.98 91.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -1.125 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.89 -43.49 88.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 25.0 m -59.42 -49.86 76.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.491 HD12 ' CD1' ' A' ' 290' ' ' LEU . 23.4 tp -52.88 -44.52 66.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 48.1 m -56.1 -44.42 79.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.414 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.479 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 95.5 mt-10 -60.5 -43.29 97.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 83.9 mt -57.95 -46.97 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -58.77 -39.99 82.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.63 -50.64 73.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.527 ' CG1' HD21 ' A' ' 312' ' ' LEU . 1.8 t -67.18 -40.17 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.455 HD12 ' HB3' ' A' ' 313' ' ' SER . 18.5 tp -55.26 -27.46 46.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.94 69.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.135 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.7 t -74.02 -14.64 61.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.868 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.427 ' HB3' HD11 ' A' ' 314' ' ' LEU . 66.5 mtt-85 63.59 11.5 5.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.418 ' HA3' HG21 ' A' ' 252' ' ' ILE . . . -78.35 -29.57 52.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.527 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.6 pt? -139.74 153.55 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -1.215 . . . . 0.0 109.61 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.465 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.7 OUTLIER 72.21 43.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.486 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.4 mm? -86.73 14.52 6.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.54 36.75 68.5 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.46 ' HE3' ' HB ' ' A' ' 282' ' ' VAL . 3.4 mtm -90.6 167.81 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.12 . . . . 0.0 109.517 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -142.7 126.02 16.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.85 . . . . 0.0 109.295 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.524 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.7 mp -138.99 131.91 29.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.68 -52.81 63.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 321' ' ' TRP . 13.5 t-20 -130.32 36.95 3.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.581 ' N ' ' HD3' ' A' ' 322' ' ' PRO . 16.9 t90 44.28 57.13 13.84 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 321' ' ' TRP . 54.7 Cg_endo -99.9 71.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.333 2.688 . . . . 0.0 112.242 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CG ' ' CD1' ' A' ' 326' ' ' ILE . 48.6 Cg_endo -70.18 132.81 23.41 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.288 1.992 . . . . 0.0 111.727 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.0 69.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' SER . . . . . 0.482 ' CB ' ' HB3' ' A' ' 249' ' ' PHE . 19.1 m -62.69 -46.1 89.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.541 ' CD1' ' CG ' ' A' ' 323' ' ' PRO . 63.0 mt -63.09 -28.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.69 147.98 51.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.95 -39.24 74.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.512 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . 0.416 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 84.2 m-20 -52.2 -38.8 58.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.416 ' HB2' ' O ' ' B' ' 427' ' ' ASP . 17.9 m120 59.08 50.7 7.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.414 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -82.62 127.03 71.99 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 109.531 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.429 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.7 Cg_endo -70.69 136.28 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.662 2.241 . . . . 0.0 111.716 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' HA ' ' B' ' 455' ' ' THR . . . -63.82 158.58 21.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.95 -31.56 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.551 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.38 -44.18 79.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.499 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.4 tm? -70.0 -38.91 76.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.497 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -66.6 -33.92 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.296 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.84 11.76 23.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.513 ' CD1' HD11 ' B' ' 456' ' ' LEU . 47.0 tp -77.93 133.02 38.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.63 145.26 50.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.45 -7.31 82.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.522 ' CG1' HD12 ' B' ' 444' ' ' LEU . 73.2 t -111.68 122.47 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -80.59 158.61 25.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -52.18 -54.34 32.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.348 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -66.67 -35.2 79.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 108.937 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.522 HD12 ' CG1' ' B' ' 440' ' ' VAL . 3.4 tm? -58.95 -42.93 91.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.429 -0.795 . . . . 0.0 109.1 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.487 ' HB2' ' CD1' ' B' ' 434' ' ' LEU . . . -58.87 -48.19 82.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 109.025 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -53.38 -41.35 65.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 19.2 mttt -60.05 -38.04 81.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.849 . . . . 0.0 109.211 179.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.46 HD21 ' CD1' ' B' ' 473' ' ' LEU . 65.1 mt -64.99 -37.87 89.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.11 -36.79 6.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.52 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.2 mtp-105 -91.14 23.25 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.585 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.69 -18.88 6.67 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.494 ' CG2' ' HG3' ' B' ' 462' ' ' GLN . 5.7 t -78.14 111.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.895 -1.356 . . . . 0.0 109.325 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.474 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 12.0 m -126.84 -40.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.712 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.511 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -77.93 140.86 39.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.734 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.54 ' CD2' ' CB ' ' B' ' 485' ' ' ALA . 0.2 OUTLIER -46.79 -43.78 18.61 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 108.963 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.43 -40.5 82.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.427 ' C ' HG13 ' B' ' 453' ' ' VAL . 92.1 m-20 -59.03 -40.79 86.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.442 HD12 HD13 ' B' ' 448' ' ' LEU . 16.9 tp -64.4 -37.84 88.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 109.446 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.14 77.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.07 -28.0 61.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.494 ' HG3' ' CG2' ' B' ' 453' ' ' VAL . 95.0 mm-40 -68.64 148.4 50.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.468 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -104.43 154.92 17.51 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.53 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 22.2 mt -45.3 -36.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.242 . . . . 0.0 109.406 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.28 -39.03 93.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.484 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -67.32 -28.47 68.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.498 ' HB2' ' CB ' ' B' ' 478' ' ' ALA . 7.3 mp -79.6 -25.18 41.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.96 -22.55 66.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.367 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -53.37 -32.47 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.412 HG13 ' HD2' ' B' ' 451' ' ' ARG . 76.9 mt -101.1 124.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -54.52 -42.88 71.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.1 -27.45 30.85 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.466 ' CD2' HD22 ' B' ' 444' ' ' LEU . 32.9 mt -95.87 125.94 40.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 164.1 11.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.13 -38.45 76.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -75.21 -45.9 37.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.49 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 45.2 tttt -60.77 -44.89 96.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.379 -0.825 . . . . 0.0 109.426 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.498 ' CB ' ' HB2' ' B' ' 467' ' ' LEU . . . -63.38 -41.19 98.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.45 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -62.08 -46.91 93.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.55 74.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -1.124 . . . . 0.0 109.618 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.49 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 6.8 mp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.657 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.528 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 50.9 mt -58.07 -56.24 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.66 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 52.3 mtp -52.93 -38.54 62.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 109.536 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.16 -47.75 64.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -64.81 -44.14 90.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.462 ' NH2' ' CZ2' ' B' ' 490' ' ' TRP . 51.5 ttt85 -58.86 -46.06 88.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 88.4 m-20 -59.62 -41.18 89.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.486 ' O ' ' CA ' ' B' ' 492' ' ' GLY . 79.5 mt -63.84 -37.01 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.84 -49.78 17.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.693 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . 0.462 ' CZ2' ' NH2' ' B' ' 486' ' ' ARG . 77.7 m95 -68.63 -40.89 80.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.463 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 97.9 m-85 -95.88 4.01 53.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . -63.02 -27.08 69.83 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -55.21 -36.66 66.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -1.14 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.96 143.33 38.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.489 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.578 ' CG ' ' HG3' ' A' ' 323' ' ' PRO . 41.2 t80 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.426 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.5 OUTLIER -53.93 116.58 10.51 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.236 -0.915 . . . . 0.0 109.242 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.454 ' O ' ' HD3' ' A' ' 255' ' ' ARG . 42.7 Cg_endo -65.03 -24.47 59.94 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.669 2.246 . . . . 0.0 111.671 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.464 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.2 tt -68.02 -30.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 108.928 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.576 HD12 ' CE2' ' A' ' 249' ' ' PHE . 34.5 mt -74.73 -45.35 44.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.438 HD22 HD13 ' A' ' 326' ' ' ILE . 1.6 mt -62.75 -25.52 68.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.454 ' HD3' ' O ' ' A' ' 251' ' ' PRO . 0.6 OUTLIER -58.0 140.7 82.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 108.889 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.4 Cg_endo -69.06 129.72 18.87 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.587 2.191 . . . . 0.0 111.977 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.463 ' O ' ' HB2' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.76 -29.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.351 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.431 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 96.8 m-20 -64.44 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.249 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 256' ' ' PRO . 56.4 t0 -70.0 -17.4 63.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.463 ' HB2' ' O ' ' A' ' 257' ' ' VAL . 6.0 mp -43.78 129.14 5.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.417 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.34 -22.4 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.481 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.442 ' HG ' ' OE1' ' A' ' 302' ' ' GLU . 5.5 mp -61.01 172.82 0.9 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.0 p -66.05 168.15 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 30.4 t -61.99 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.603 -179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -41.09 97.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.213 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.2 m -59.97 -49.7 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.431 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -67.55 -40.55 84.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -57.17 -36.94 71.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.37 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.443 ' HB3' HD22 ' A' ' 295' ' ' LEU . 74.3 m -54.17 -65.04 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.4 -45.13 88.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.406 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.514 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 34.3 tttt -53.03 -37.75 61.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.53 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.55 19.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.415 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 93.8 mt-10 -91.41 21.61 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.415 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 70.82 34.3 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.7 mt -120.42 107.87 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.514 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 76.5 m-70 -105.14 -12.19 16.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.65 135.35 50.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.502 ' CG2' HD23 ' A' ' 312' ' ' LEU . 34.1 mt -62.9 -29.85 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.533 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.84 -43.1 11.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.522 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 77.0 m-20 -53.9 -36.41 62.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.261 . . . . 0.0 108.818 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.516 ' CD1' ' HG ' ' A' ' 289' ' ' LEU . 33.1 tp -55.79 -47.94 76.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.82 . . . . 0.0 109.096 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 20.4 m -69.47 -25.53 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.52 ' N ' HG21 ' A' ' 282' ' ' VAL . 62.6 tt0 -63.49 -31.52 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 108.899 179.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -113.12 151.21 31.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.46 -0.775 . . . . 0.0 109.152 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 26.7 m -63.78 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.46 ' OE1' ' CD1' ' A' ' 307' ' ' LEU . 86.4 tt0 -56.06 -33.11 64.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.453 HG13 ' HE2' ' A' ' 291' ' ' LYS . 47.5 t -52.78 -50.68 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.905 . . . . 0.0 109.356 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -51.8 -32.7 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.046 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.521 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 3.4 mm? -73.97 -46.48 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.803 . . . . 0.0 109.173 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.505 HD21 ' CD1' ' A' ' 300' ' ' LEU . 7.8 mt -55.69 -20.07 13.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.271 -0.893 . . . . 0.0 109.067 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.471 ' O ' ' HE2' ' B' ' 483' ' ' MET . 54.4 mttm -81.71 -29.85 32.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.177 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 40.3 m -59.87 125.66 81.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.521 ' HG3' ' CA ' ' B' ' 479' ' ' GLY . 50.4 Cg_endo -71.09 -19.84 29.41 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.676 2.251 . . . . 0.0 111.807 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.457 ' N ' HD12 ' B' ' 464' ' ' ILE . 77.2 m-20 -64.45 -26.87 68.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 5.8 mt -67.21 144.82 55.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -101.25 146.92 17.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -54.03 -40.39 67.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -76.51 -29.96 56.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 71.2 p -64.36 -45.39 87.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.505 ' CD1' HD21 ' A' ' 290' ' ' LEU . 53.6 tp -52.91 -45.19 67.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.1 m -51.66 -54.48 27.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.442 ' OE1' ' HG ' ' A' ' 262' ' ' LEU . 94.0 mt-10 -54.74 -46.25 74.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.27 -41.78 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.157 -0.964 . . . . 0.0 109.169 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -57.36 -40.18 77.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.159 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.11 -46.49 87.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.227 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 2.3 t -73.05 -35.15 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.205 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.519 ' CD2' ' OG ' ' A' ' 313' ' ' SER . 3.3 tt -62.37 -26.5 68.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.507 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.36 -35.31 71.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.389 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 1.7 t -61.94 -14.38 34.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 309' ' ' SER . 31.6 mtt180 72.91 1.42 4.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CD2' ' A' ' 253' ' ' LEU . . . -71.49 -22.14 78.64 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.561 ' O ' ' CB ' ' A' ' 313' ' ' SER . 0.8 OUTLIER -132.09 156.44 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 109.487 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.561 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 2.3 p 84.56 -141.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.732 -0.605 . . . . 0.0 109.793 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.534 ' N ' ' OG ' ' A' ' 313' ' ' SER . 3.9 mm? 67.66 14.48 9.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 314' ' ' LEU . . . 42.22 45.04 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.524 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 29.5 mtm -61.67 169.01 2.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.327 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.425 ' C ' HD12 ' A' ' 318' ' ' LEU . 79.9 mtt180 -136.88 130.99 32.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.576 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.435 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 5.1 mp -136.29 127.69 28.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 318' ' ' LEU . 96.1 mt-10 -43.91 -46.66 8.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.88 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 34.1 t30 -131.3 -56.35 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.241 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.519 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 1.6 t-105 164.8 -61.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.519 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 47.5 Cg_endo -67.51 107.75 1.48 Allowed 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.71 2.273 . . . . 0.0 111.98 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.578 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.0 Cg_endo -74.19 163.91 35.45 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.492 2.128 . . . . 0.0 111.579 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.78 -16.53 11.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 0.0 109.615 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.2 t -65.14 -46.71 79.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.438 HD13 HD22 ' A' ' 254' ' ' LEU . 28.5 mt -56.39 -38.29 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.7 78.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.18 -37.56 69.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.467 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.94 -32.62 73.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -1.145 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 16.1 m120 -89.47 19.0 4.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.454 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 2.3 tttm -83.66 136.57 42.07 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.285 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.457 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.2 Cg_endo -69.7 131.73 21.94 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 111.84 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -66.7 148.13 52.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.55 -33.78 15.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.69 -46.61 75.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.482 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 22.4 tp -69.86 -38.38 76.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.513 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.4 tm? -72.78 -30.3 64.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -91.22 8.68 34.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.538 ' CD2' ' CD1' ' B' ' 456' ' ' LEU . 37.4 tp -72.94 138.75 46.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.69 138.01 36.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.29 5.37 63.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.486 ' CG2' HD23 ' B' ' 437' ' ' LEU . 59.6 t -122.92 132.66 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -1.16 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -86.85 150.32 24.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -49.83 -45.45 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.575 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.4 m-20 -64.75 -46.07 83.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 109.231 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.489 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 13.1 tp -53.9 -43.32 69.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.58 90.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.575 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.7 m-30 -56.84 -44.4 82.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 109.103 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.446 ' HB3' ' CG2' ' B' ' 470' ' ' ILE . 20.3 mttm -60.83 -40.39 92.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . . . . . . . . . 89.0 mt -60.25 -47.02 87.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.376 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -60.94 -34.51 74.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.481 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -48.13 -35.4 11.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.434 ' HD2' HG13 ' B' ' 470' ' ' ILE . 47.2 mtp180 -91.11 22.93 3.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.79 -18.74 7.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 21.4 t -78.12 108.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.899 -1.354 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.482 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 95.3 m -119.84 -42.56 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.758 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.91 140.8 44.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' B' ' 437' ' ' LEU . 27.0 tp -49.97 -41.61 47.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.293 -0.88 . . . . 0.0 109.036 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . 0.451 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 31.7 mm-40 -57.32 -46.22 83.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 108.953 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.428 ' C ' HG11 ' B' ' 453' ' ' VAL . 70.6 m-20 -58.24 -38.73 77.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.101 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -62.35 -42.85 99.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.18 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.439 ' HB1' ' HB1' ' B' ' 485' ' ' ALA . . . -60.42 -35.79 76.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.47 -30.81 71.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.412 ' CG ' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -67.38 156.29 36.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.12 161.46 13.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.504 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 68.1 mt -52.75 -35.65 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -1.184 . . . . 0.0 109.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.12 -33.81 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.17 -31.47 65.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.529 HD11 ' CB ' ' B' ' 478' ' ' ALA . 20.1 mt -77.15 -33.89 56.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.81 55.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.98 -39.09 93.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.446 ' CG2' ' HB3' ' B' ' 447' ' ' LYS . 88.1 mt -82.54 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.47 152.65 29.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.576 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.52 -33.49 4.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.489 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 66.9 mt -85.99 126.6 34.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 35.4 m -103.64 161.98 13.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.488 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 87.8 m-20 -59.55 -36.03 75.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -76.03 -46.04 31.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . . . . . . . . . 34.4 tttp -65.1 -47.58 76.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.529 ' CB ' HD11 ' B' ' 467' ' ' LEU . . . -57.83 -44.51 86.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.521 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -59.31 -47.67 89.7 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.29 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.48 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.457 HD23 HG21 ' B' ' 440' ' ' VAL . 28.0 mt -61.64 -36.47 80.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.46 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.9 mt -62.52 -53.64 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.515 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 33.9 mtp -54.24 -48.92 70.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -52.67 -56.16 17.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.499 ' CB ' ' HG ' ' B' ' 456' ' ' LEU . . . -60.19 -49.35 77.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 109.572 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.457 ' NE ' ' CG2' ' B' ' 482' ' ' ILE . 90.3 mtt180 -59.63 -42.05 91.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.492 ' O ' ' CD1' ' B' ' 491' ' ' PHE . 99.5 m-20 -58.36 -42.75 87.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.516 HD12 ' CD2' ' B' ' 456' ' ' LEU . 38.3 mt -64.34 -38.32 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . 0.451 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.0 OUTLIER -75.96 -51.92 11.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -63.22 -28.01 69.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 109.42 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' B' ' 487' ' ' ASN . 3.6 m-30 -72.23 -34.36 68.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -53.82 -34.58 51.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -56.29 -40.05 73.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -1.157 . . . . 0.0 109.569 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.37 -32.51 72.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.549 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.558 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 14.3 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.47 126.74 56.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.382 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -65.25 -27.49 56.03 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.674 2.25 . . . . 0.0 111.601 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.52 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 8.3 tt -69.07 -28.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.505 HD12 ' CE ' ' A' ' 316' ' ' MET . 26.2 mt -74.54 -43.42 55.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.421 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.412 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.7 mt -64.18 -32.31 73.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.462 ' O ' HG13 ' A' ' 278' ' ' ILE . 5.7 ttp180 -55.82 135.89 72.46 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.6 Cg_endo -68.58 129.79 19.57 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.641 2.227 . . . . 0.0 111.842 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.526 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.3 OUTLIER -44.69 -25.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.35 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 256' ' ' PRO . 97.8 m-20 -67.18 -30.88 70.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 256' ' ' PRO . 37.0 m-20 -75.36 -9.72 58.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 4.5 mp -43.77 127.18 4.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 262' ' ' LEU . 97.0 mt-10 -62.63 -27.84 69.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.514 ' CD1' ' HG2' ' A' ' 302' ' ' GLU . 18.8 mt -54.41 -170.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.457 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -80.41 159.72 25.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.459 HG13 ' ND2' ' A' ' 268' ' ' ASN . 19.5 t -53.43 -30.58 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -52.37 -45.53 65.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.4 m -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.87 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 257' ' ' VAL . . . -65.84 -37.92 87.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.459 ' ND2' HG13 ' A' ' 264' ' ' VAL . 95.4 m-20 -59.79 -34.29 72.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -58.29 -64.0 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.45 -45.4 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -52.9 -40.38 63.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.11 -25.05 66.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.417 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 73.4 mm-40 -88.51 17.42 5.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 70.63 33.32 2.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.0 mt -108.59 127.05 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.5 p80 -112.23 -35.02 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.57 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.503 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.1 m-30 -110.07 128.8 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.475 ' O ' ' N ' ' A' ' 281' ' ' LEU . 76.6 mt -46.45 -29.92 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.579 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -45.82 -47.15 13.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.414 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 54.0 m-20 -53.36 -30.87 41.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.235 . . . . 0.0 108.798 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.475 ' N ' ' O ' ' A' ' 278' ' ' ILE . 41.8 tp -59.74 -49.71 76.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.468 -0.77 . . . . 0.0 109.273 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 27.3 m -65.71 -29.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.152 -0.967 . . . . 0.0 108.866 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.501 ' N ' HG21 ' A' ' 282' ' ' VAL . 60.6 tt0 -60.9 -33.99 73.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.371 -0.831 . . . . 0.0 108.961 179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 56.1 mtt180 -100.12 143.33 30.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.299 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.3 m -69.03 143.53 54.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -54.29 -28.3 41.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.333 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 43.1 t -52.83 -50.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.304 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.454 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.2 mt-10 -52.19 -33.29 40.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.46 HD13 HD11 ' A' ' 281' ' ' LEU . 60.8 mt -70.88 -30.61 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.64 -31.69 67.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.529 ' O ' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.8 -14.3 56.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.02 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.45 ' O ' HD21 ' A' ' 295' ' ' LEU . 77.0 m -81.76 115.88 59.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.538 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 52.5 Cg_endo -70.62 -16.91 33.96 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.698 2.265 . . . . 0.0 111.773 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.559 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 27.0 m120 -47.21 -33.13 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.45 HD21 ' O ' ' A' ' 292' ' ' THR . 0.4 OUTLIER -107.26 137.12 45.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.441 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -81.58 172.06 53.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -57.75 -41.97 83.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.408 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -63.46 -35.97 82.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.932 . . . . 0.0 109.298 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 28.2 m -58.3 -37.42 75.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 28.7 tp -53.97 -33.54 57.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 109.292 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.3 m -60.93 -57.46 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.514 ' HG2' ' CD1' ' A' ' 262' ' ' LEU . 42.8 tt0 -53.57 -46.12 70.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 108.996 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.463 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 56.2 mt -57.74 -50.73 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -56.11 -38.73 71.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 108.761 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . 0.419 ' HB2' ' O ' ' A' ' 302' ' ' GLU . 64.4 m-20 -53.85 -45.66 71.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.525 ' CG1' ' CD2' ' A' ' 312' ' ' LEU . 4.5 t -66.86 -40.81 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 108.865 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.509 ' CD2' ' HB2' ' A' ' 313' ' ' SER . 21.3 mt -53.83 -25.65 20.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.441 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.9 63.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 108.983 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 p -71.4 -9.09 57.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.203 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . . . . . . . . . 55.6 mtm180 53.01 19.35 1.34 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -107.96 0.22 33.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.525 ' CD2' ' CG1' ' A' ' 306' ' ' VAL . 0.6 OUTLIER -147.23 145.87 29.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -1.231 . . . . 0.0 109.644 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.509 ' HB2' ' CD2' ' A' ' 307' ' ' LEU . 0.5 OUTLIER 58.13 46.69 15.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.398 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.493 ' CD2' ' N ' ' A' ' 312' ' ' LEU . 3.8 mm? -90.46 23.95 2.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.2 39.3 95.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.505 ' CE ' HD12 ' A' ' 253' ' ' LEU . 1.3 mtm -93.63 170.95 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.108 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 67.4 mtm-85 -136.15 117.05 14.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 4.5 mt -112.47 139.81 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.354 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.88 -35.37 79.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.256 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 24.7 m120 -140.46 -47.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 109.157 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.579 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.52 -62.83 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.522 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -67.87 107.04 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.549 2.166 . . . . 0.0 111.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.483 ' O ' ' CG2' ' A' ' 326' ' ' ILE . 50.6 Cg_endo -69.65 165.18 31.71 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.665 2.243 . . . . 0.0 111.85 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.93 -15.72 56.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 97.0 p -85.82 -26.27 25.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.211 -0.93 . . . . 0.0 109.454 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.483 ' CG2' ' O ' ' A' ' 323' ' ' PRO . 16.3 tt -57.22 -23.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.37 140.61 55.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -59.79 -37.98 80.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.437 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -57.08 -39.95 75.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.468 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 25.6 m120 -83.95 8.04 16.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.426 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 4.5 tttm -53.98 131.94 58.61 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.459 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.432 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.9 Cg_endo -70.3 144.42 51.09 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.627 2.218 . . . . 0.0 111.833 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.451 ' N ' ' O ' ' B' ' 454' ' ' CYS . . . -79.45 161.06 26.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.453 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . 0.469 ' O ' ' N ' ' B' ' 436' ' ' ASN . 85.9 m-20 -52.09 -37.55 54.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . 0.474 ' CB ' ' HB3' ' B' ' 456' ' ' LEU . 16.7 m-20 -61.08 -50.12 74.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.521 HD11 ' CD1' ' B' ' 459' ' ' LEU . 23.2 tp -68.91 -38.07 79.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.703 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 1.1 tm? -77.04 -29.6 55.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.563 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' B' ' 432' ' ' ASP . 78.9 m-20 -93.77 10.87 31.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.457 ' CD1' HD12 ' B' ' 488' ' ' ILE . 29.1 tp -75.53 133.22 41.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.57 143.29 48.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.6 -4.76 82.35 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.573 ' CG2' ' CD2' ' B' ' 481' ' ' LEU . 49.6 t -126.56 135.77 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -1.182 . . . . 0.0 109.419 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . 0.467 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 49.6 p30 -103.41 175.08 5.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.437 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 64.4 mtm180 -61.61 -38.19 86.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.18 -41.06 99.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.467 ' CG ' ' OD1' ' B' ' 441' ' ' ASP . 21.9 mt -72.23 -39.74 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.407 ' O ' ' HB1' ' B' ' 449' ' ' ALA . . . -61.21 -35.82 78.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.873 . . . . 0.0 109.439 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.437 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 15.2 m-30 -73.08 -46.07 53.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.505 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.502 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 17.5 ttmt -61.65 -44.14 97.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.492 ' CD1' ' CB ' ' B' ' 453' ' ' VAL . 2.9 tm? -65.62 -45.45 83.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.468 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -55.93 -31.36 62.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.564 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . 0.456 ' HB2' ' O ' ' B' ' 447' ' ' LYS . . . -53.39 -20.55 4.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.483 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.4 mtp-105 -89.62 32.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.88 -18.72 7.17 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.492 ' CB ' ' CD1' ' B' ' 448' ' ' LEU . 48.0 t -61.71 137.1 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.815 -1.403 . . . . 0.0 109.318 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' B' ' 431' ' ' ALA . 1.0 OUTLIER -133.17 -34.63 1.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.783 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.438 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.4 OUTLIER -116.93 144.0 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 109.972 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.532 HD21 ' CB ' ' B' ' 485' ' ' ALA . 1.4 tm? -45.47 -39.43 7.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 108.889 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -55.68 -49.43 72.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.882 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -55.13 -41.66 72.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.855 . . . . 0.0 108.946 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.521 ' CD1' HD11 ' B' ' 434' ' ' LEU . 4.0 tt -55.86 -48.46 75.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.317 -0.864 . . . . 0.0 109.278 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.435 ' CB ' ' HB2' ' B' ' 485' ' ' ALA . . . -57.38 -33.09 67.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.313 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.365 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.75 160.94 28.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.436 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -116.94 152.87 17.67 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.559 ' CD1' ' ND2' ' A' ' 294' ' ' ASN . 57.8 mt -44.93 -42.49 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -1.172 . . . . 0.0 109.343 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.05 -39.78 83.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.343 -0.848 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.79 -29.06 66.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.523 HD13 ' CB ' ' B' ' 478' ' ' ALA . 20.8 mt -78.4 -28.25 46.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.6 -25.57 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.05 -31.28 18.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.502 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 60.0 mt -103.79 121.83 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.569 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.37 -32.55 72.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.78 -26.48 25.59 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.401 ' CD1' HD21 ' B' ' 448' ' ' LEU . 64.0 mt -108.82 139.26 43.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -1.122 . . . . 0.0 109.523 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 24.7 m -103.7 164.66 11.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 81.6 m-20 -60.49 -37.15 80.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.415 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -75.47 -46.02 35.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 64.4 tttm -63.92 -40.5 96.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.445 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.523 ' CB ' HD13 ' B' ' 467' ' ' LEU . . . -64.91 -39.83 94.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -63.16 -42.36 99.46 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.09 85.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.573 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.573 ' CD2' ' CG2' ' B' ' 440' ' ' VAL . 29.2 mt -67.16 -38.63 85.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 26.3 mt -65.4 -56.02 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.529 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 57.4 mtp -52.36 -36.77 54.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.386 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.451 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.66 -44.53 64.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.532 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -62.86 -52.02 64.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.421 ' N ' ' HB2' ' B' ' 460' ' ' ALA . 68.2 mtt180 -58.08 -41.74 84.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.387 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.2 m-20 -57.46 -35.88 70.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.227 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.457 HD12 ' CD1' ' B' ' 437' ' ' LEU . 88.1 mt -70.88 -36.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.254 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 11.3 t -74.63 -51.69 13.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.755 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -61.73 -30.7 70.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 19.5 m-30 -82.95 -34.27 26.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.072 -1.017 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 55.58 -124.45 33.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -45.38 -47.67 13.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.253 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . 0.4 ' O ' ' HB3' ' B' ' 491' ' ' PHE . 81.3 tt0 -66.63 141.44 57.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 109.395 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.396 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 23.4 t80 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.553 . . . . 0.0 109.511 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.415 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -55.17 142.81 56.89 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.601 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.48 ' HB2' ' NH2' ' A' ' 255' ' ' ARG . 43.5 Cg_endo -65.46 -22.97 58.54 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.807 2.338 . . . . 0.0 111.654 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.523 HG23 ' CA ' ' A' ' 311' ' ' GLY . 10.3 tt -70.01 -28.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.88 . . . . 0.0 108.927 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.535 ' CD1' ' HA2' ' A' ' 279' ' ' GLY . 0.8 OUTLIER -69.23 -38.5 78.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.57 ' O ' ' CD2' ' A' ' 277' ' ' TYR . 3.8 mm? -86.04 -24.0 26.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.365 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.515 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 4.8 ttm-85 -64.03 145.02 98.15 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.454 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 48.8 Cg_endo -70.01 136.72 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.728 2.285 . . . . 0.0 111.837 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.445 HG12 ' CD1' ' A' ' 270' ' ' LEU . 0.1 OUTLIER -45.74 -33.38 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.0 109.522 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.1 m-20 -62.51 -30.83 71.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.515 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 25.5 m-20 -68.24 -9.61 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.426 ' CD2' HD12 ' A' ' 278' ' ' ILE . 51.2 mt -66.18 139.38 58.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 262' ' ' LEU . 74.8 mm-40 -69.38 -20.23 63.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.497 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.59 ' CD2' ' CG ' ' A' ' 302' ' ' GLU . 26.2 mt -52.46 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 p -80.69 160.15 25.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 21.2 t -55.21 -27.64 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -51.97 -48.0 64.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.0 m -58.97 -50.97 72.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.339 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.32 -33.27 75.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.422 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -61.38 -37.73 84.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.38 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.8 m -53.24 -64.55 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.448 ' HB3' ' HB ' ' A' ' 275' ' ' ILE . 57.7 mt -66.51 -45.24 80.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.463 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 21.4 tptm -53.19 -40.06 64.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.12 -21.42 65.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.42 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 96.6 mt-10 -94.14 23.36 5.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.42 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.61 17.62 7.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.506 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 56.2 mt -104.81 122.98 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.456 ' ND1' ' HD2' ' A' ' 271' ' ' LYS . 92.2 m-70 -113.09 -12.87 13.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 254' ' ' LEU . 4.5 m-85 -112.84 141.4 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.459 ' O ' ' N ' ' A' ' 281' ' ' LEU . 74.3 mt -65.1 -28.97 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.444 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.541 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -45.26 -47.5 10.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.506 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 67.8 m-20 -53.35 -32.96 51.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.99 -1.3 . . . . 0.0 108.893 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 278' ' ' ILE . 26.7 tp -55.65 -50.73 69.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.183 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.541 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 28.2 m -66.77 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 108.787 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.519 ' N ' HG22 ' A' ' 282' ' ' VAL . 62.6 tt0 -54.92 -35.42 64.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 0.0 108.668 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -107.58 144.07 35.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.076 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 45.6 p -76.23 157.15 32.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.419 ' C ' HD11 ' A' ' 290' ' ' LEU . 10.0 mt-10 -56.16 -38.63 71.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.297 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.434 ' HA ' ' CD1' ' A' ' 290' ' ' LEU . 41.2 t -52.88 -52.78 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.283 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.55 -32.3 58.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.48 ' CD1' ' N ' ' A' ' 289' ' ' LEU . 7.6 mp -80.42 -33.08 37.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.487 HD23 ' CD2' ' A' ' 300' ' ' LEU . 4.9 mt -69.66 -17.12 63.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.958 . . . . 0.0 109.353 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.449 ' O ' ' HE1' ' B' ' 483' ' ' MET . 33.8 mmtt -86.48 10.95 13.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 0.0 109.482 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.473 HG21 ' O ' ' A' ' 292' ' ' THR . 7.3 t -125.82 142.72 43.0 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.525 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 51.9 Cg_endo -71.35 -20.71 27.43 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.796 2.33 . . . . 0.0 111.941 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.508 ' N ' HD12 ' B' ' 464' ' ' ILE . 21.8 m120 -43.3 -44.14 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.634 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.401 HD22 ' CG2' ' A' ' 292' ' ' THR . 0.2 OUTLIER -107.64 137.07 46.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.499 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -91.73 -179.16 42.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.35 -44.19 95.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -1.204 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -60.85 -42.57 98.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.4 m -54.9 -46.32 74.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.31 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.487 ' CD2' HD23 ' A' ' 290' ' ' LEU . 2.3 tm? -52.68 -45.11 66.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.241 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 23.9 m -50.84 -51.54 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.091 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.59 ' CG ' ' CD2' ' A' ' 262' ' ' LEU . 38.6 tp10 -54.19 -42.33 69.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.403 HD11 HG23 ' A' ' 303' ' ' ILE . 23.7 mm -57.95 -41.15 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -0.867 . . . . 0.0 108.892 179.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . 0.485 ' HE3' ' CD1' ' A' ' 300' ' ' LEU . 82.9 mttt -59.43 -40.53 87.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.327 -0.858 . . . . 0.0 108.872 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.18 -46.97 87.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.426 HG13 ' CD1' ' A' ' 312' ' ' LEU . 6.0 t -70.14 -37.4 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.109 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.456 HD23 ' O ' ' A' ' 313' ' ' SER . 19.9 tp -61.38 -27.3 68.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.34 76.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -79.21 -0.22 31.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 309' ' ' SER . 64.4 mtt180 63.24 11.04 5.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.182 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.523 ' CA ' HG23 ' A' ' 252' ' ' ILE . . . -64.75 -51.1 54.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 312' ' ' LEU . 0.5 OUTLIER -144.41 168.53 19.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -1.156 . . . . 0.0 109.566 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.466 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.3 OUTLIER 72.4 32.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.503 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.3 mm? -75.85 -4.9 43.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.51 41.24 96.34 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -111.54 157.96 19.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -1.139 . . . . 0.0 109.638 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -115.19 133.45 56.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 109.223 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.18 140.76 40.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -58.28 -38.51 77.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 40.7 t-20 -132.96 -73.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.404 -0.81 . . . . 0.0 109.001 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.553 ' N ' ' CD ' ' A' ' 322' ' ' PRO . 1.5 t90 175.78 -45.07 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.553 ' CD ' ' N ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -97.73 74.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 123.473 2.782 . . . . 0.0 112.601 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.21 165.15 29.56 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.499 2.132 . . . . 0.0 111.615 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -44.82 -26.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.5 m -67.97 -61.01 2.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.651 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.511 ' CD1' HD21 ' A' ' 253' ' ' LEU . 9.5 mt -52.35 -30.27 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -74.39 145.26 43.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.591 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.68 -37.8 88.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . 0.42 ' HG2' ' OXT' ' A' ' 329' ' ' GLU . 84.7 tt0 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 86.4 m-20 -53.05 -37.77 61.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.171 . . . . 0.0 109.479 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 18.4 m120 60.41 46.43 9.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.362 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.45 ' O ' ' SG ' ' B' ' 454' ' ' CYS . 0.0 OUTLIER -78.71 136.08 59.37 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.546 -179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -70.58 133.24 23.63 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.674 2.25 . . . . 0.0 111.772 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -66.08 153.83 41.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.17 -35.34 59.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.53 -47.75 74.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.87 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.514 ' CD1' HD23 ' B' ' 448' ' ' LEU . 21.4 tp -66.35 -38.31 87.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 109.45 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -70.57 -32.46 69.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.403 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -88.65 7.31 34.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.499 HD22 ' CG2' ' B' ' 440' ' ' VAL . 40.3 tp -72.3 134.83 45.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -80.74 141.77 34.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.51 68.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.499 ' CG2' HD22 ' B' ' 437' ' ' LEU . 87.6 t -122.84 126.98 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 109.399 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.52 154.3 23.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 68.6 mtp85 -50.26 -48.87 54.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.519 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.552 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.2 m-20 -61.91 -44.48 96.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.551 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 15.3 tp -55.65 -44.45 77.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.395 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.75 87.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.552 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 13.0 m-30 -58.98 -43.06 91.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.357 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.67 -40.71 93.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.521 HD21 ' CD2' ' B' ' 459' ' ' LEU . 19.7 tp -60.99 -47.28 87.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.93 -31.5 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.97 -33.81 57.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.443 ' HD3' HG13 ' B' ' 470' ' ' ILE . 33.5 mtm105 -90.32 22.06 3.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.432 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.87 6.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.488 ' HB ' ' CD1' ' B' ' 448' ' ' LEU . 3.0 t -76.87 111.49 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.915 -1.344 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.45 ' SG ' ' O ' ' B' ' 429' ' ' LYS . 29.5 m -121.51 -35.44 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.5 142.63 27.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.502 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 35.3 tp -48.71 -42.06 33.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.173 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.94 -45.79 78.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.142 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.417 ' C ' HG12 ' B' ' 453' ' ' VAL . 93.6 m-20 -57.77 -41.69 82.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.887 . . . . 0.0 109.078 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.521 ' CD2' HD21 ' B' ' 448' ' ' LEU . 3.4 tm? -59.23 -41.4 88.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 109.278 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.409 ' HB2' ' HG2' ' B' ' 486' ' ' ARG . . . -62.09 -37.15 83.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.83 -25.86 67.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.441 ' HG3' HG23 ' B' ' 453' ' ' VAL . 88.1 mm-40 -78.36 138.92 38.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.433 ' HA2' HD11 ' B' ' 482' ' ' ILE . . . -97.85 165.38 22.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.525 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 68.1 mt -48.04 -36.29 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.425 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -65.55 -38.65 90.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.256 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.73 -31.69 72.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.518 ' CD2' ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -78.14 -26.84 48.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.6 66.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -52.85 -33.12 48.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.443 HG13 ' HD3' ' B' ' 451' ' ' ARG . 68.8 mt -104.67 128.58 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.08 -33.47 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -55.35 -27.33 46.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.551 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 35.1 mt -102.62 134.32 46.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.9 m -104.2 161.93 13.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.95 -36.35 76.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -76.94 -46.02 25.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.462 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 38.9 tttp -66.33 -40.2 89.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.518 ' HB1' ' CD2' ' B' ' 467' ' ' LEU . . . -65.3 -42.47 93.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.509 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.0 -45.11 96.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.14 90.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -1.186 . . . . 0.0 109.659 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.462 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -65.83 -39.93 91.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.469 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 88.7 mt -61.88 -56.14 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.522 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 67.1 mmm -54.06 -43.23 70.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.44 62.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.2 90.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.377 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.409 ' HG2' ' HB2' ' B' ' 460' ' ' ALA . 63.1 mtp180 -59.48 -43.82 93.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 94.2 m-20 -58.28 -43.44 87.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.502 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 68.7 mt -60.25 -37.47 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.0 m -78.8 -51.98 8.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -59.71 -45.95 90.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 51.6 m-85 -76.2 -39.68 54.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.606 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 495' ' ' ALA . . . 72.41 36.1 59.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -56.56 -35.09 67.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -1.168 . . . . 0.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.35 -33.58 73.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' B' ' 492' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.497 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.574 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 91.8 m-85 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.12 154.84 76.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.433 ' HA ' HD13 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.43 -24.72 56.63 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.672 2.248 . . . . 0.0 111.698 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.497 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 18.2 tt -64.9 -30.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.934 . . . . 0.0 108.525 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.545 HD21 ' CH2' ' A' ' 321' ' ' TRP . 2.0 tp -72.8 -27.27 61.88 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.531 HD21 ' CZ2' ' A' ' 321' ' ' TRP . 1.9 mt -90.93 -24.57 20.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.4 mtt85 -55.95 149.54 33.35 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 257' ' ' VAL . 50.1 Cg_endo -70.18 130.34 18.66 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.604 2.203 . . . . 0.0 111.665 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.53 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.66 -26.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.407 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.2 t0 -63.21 -31.0 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.427 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' PRO . 83.1 m-20 -72.76 -12.47 61.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.674 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -46.22 137.44 6.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.52 -16.08 63.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 302' ' ' GLU . 4.6 mp -64.16 170.45 3.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.7 p -71.58 164.07 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.402 HG11 ' ND2' ' A' ' 268' ' ' ASN . 11.5 t -51.31 -31.12 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -57.32 -45.05 84.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.038 . . . . 0.0 109.299 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 18.7 t -59.94 -50.06 75.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.592 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.417 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -64.59 -44.25 91.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.364 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.402 ' ND2' HG11 ' A' ' 264' ' ' VAL . 86.6 m-20 -53.54 -32.63 51.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.427 ' SG ' HD23 ' A' ' 295' ' ' LEU . 28.5 t -63.49 -57.22 10.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.463 ' N ' ' CD2' ' A' ' 270' ' ' LEU . 3.6 mm? -66.4 -48.15 70.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 42.7 mttt -55.61 -37.53 68.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.93 -28.79 53.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 67.8 mm-40 -88.92 23.52 2.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . 68.36 40.47 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.492 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 83.5 mt -116.34 125.63 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.596 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.1 p80 -115.89 -29.72 6.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.596 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.5 m-85 -111.36 131.68 54.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.531 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' A' ' 260' ' ' LEU . 78.5 mt -46.97 -32.15 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.268 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.57 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -46.08 -47.88 14.93 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.492 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.1 m-20 -53.49 -34.29 57.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.901 -1.352 . . . . 0.0 108.878 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.417 ' N ' ' O ' ' A' ' 278' ' ' ILE . 40.0 tp -52.97 -50.86 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.417 -0.802 . . . . 0.0 109.022 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.544 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 35.5 m -65.98 -30.05 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 108.772 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 282' ' ' VAL . 49.6 tt0 -54.32 -37.6 65.02 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.4 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 58.6 mtt-85 -105.8 141.38 37.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.476 -0.765 . . . . 0.0 109.066 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -65.22 141.69 58.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -53.99 -23.93 14.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 50.2 t -52.73 -51.02 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 109.103 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.4 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.5 mt-10 -51.9 -37.28 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.133 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . . . . . . . . . 61.5 mt -61.66 -45.11 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.117 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 300' ' ' LEU . 6.1 mt -60.65 -29.11 69.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.516 ' O ' ' CE ' ' B' ' 483' ' ' MET . 62.8 mttm -82.02 -20.93 37.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 116.33 60.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.374 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.529 ' HB3' ' CG2' ' B' ' 482' ' ' ILE . 50.5 Cg_endo -70.6 -9.16 25.23 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.715 2.277 . . . . 0.0 111.821 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' B' ' 464' ' ' ILE . 30.5 m120 -60.77 -37.38 81.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.427 HD23 ' SG ' ' A' ' 269' ' ' CYS . 1.3 pp -100.18 137.5 38.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -0.955 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -86.71 168.71 39.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -64.7 -36.74 85.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.7 -42.16 83.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 303' ' ' ILE . 85.1 p -63.07 -34.09 76.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.471 HD22 ' CD2' ' A' ' 290' ' ' LEU . 22.2 tp -56.76 -33.41 66.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.1 m -61.49 -52.12 65.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.456 ' HB3' HD22 ' A' ' 262' ' ' LEU . 80.9 tt0 -62.91 -46.3 88.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.335 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.492 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 62.7 mt -57.74 -46.99 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 108.844 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.51 -40.54 65.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.07 -44.66 87.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.822 . . . . 0.0 108.811 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.519 ' CG1' HD21 ' A' ' 312' ' ' LEU . 6.3 t -63.91 -34.98 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.287 -0.883 . . . . 0.0 108.925 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 303' ' ' ILE . 8.4 mp -60.17 -25.99 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 109.238 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.65 68.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -60.97 -14.62 24.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.41 ' HG2' HD12 ' A' ' 314' ' ' LEU . 24.2 ttm180 70.03 4.81 4.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.11 16.25 35.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.524 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 5.3 mp -146.58 138.63 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.629 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.524 ' N ' HG11 ' A' ' 282' ' ' VAL . 0.6 OUTLIER 47.13 59.41 4.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.537 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.524 ' CD2' ' N ' ' A' ' 312' ' ' LEU . 3.7 mm? -91.12 9.88 29.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.04 87.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.503 ' CE ' HG12 ' A' ' 282' ' ' VAL . 7.1 ptt? -114.58 153.51 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -1.2 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -125.08 125.95 44.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 2.5 mp -103.26 138.66 39.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.83 -35.23 76.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.158 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 39.8 t30 -125.82 -69.29 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.57 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 1.2 t-105 165.63 -62.89 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.528 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.1 Cg_endo -67.99 108.26 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.546 2.164 . . . . 0.0 112.021 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.574 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 53.5 Cg_endo -75.16 164.39 33.15 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.608 2.205 . . . . 0.0 111.506 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.9 -10.86 31.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 48.2 m -73.32 -43.78 60.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.673 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.506 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 25.1 pt -90.91 -6.83 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.65 139.78 58.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -59.25 -37.23 77.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.505 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -62.22 -31.46 72.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.136 . . . . 0.0 109.463 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.417 ' O ' ' HB3' ' B' ' 449' ' ' ALA . 26.5 m120 -90.13 3.67 52.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.605 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.454 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -53.34 128.62 50.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 109.409 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.454 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 49.9 Cg_endo -69.88 141.55 45.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.676 2.251 . . . . 0.0 111.902 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -73.51 148.06 43.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.481 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -46.9 -37.28 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.5 -42.82 93.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.494 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.3 tm? -67.24 -30.93 70.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.481 ' CD1' ' HA ' ' B' ' 442' ' ' ARG . 21.7 tp -81.33 -29.63 34.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 109.566 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -74.87 -3.8 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.634 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.448 HD11 HD11 ' B' ' 456' ' ' LEU . 37.2 tp -68.26 134.53 50.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.73 142.19 42.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.77 8.39 67.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 43.8 t -127.52 128.49 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.39 158.66 15.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.481 ' HA ' ' CD1' ' B' ' 435' ' ' LEU . 90.6 mtt-85 -50.22 -48.55 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.33 -51.08 69.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.563 ' CD2' ' CE ' ' B' ' 477' ' ' LYS . 20.7 tp -55.08 -40.6 70.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.73 91.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -60.69 -48.16 83.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.3 -45.84 83.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.51 ' HG ' ' CD1' ' B' ' 459' ' ' LEU . 0.7 OUTLIER -65.21 -42.85 93.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.464 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.35 -27.91 69.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.16 -20.04 3.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -92.23 30.07 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.64 7.5 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.464 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 3.4 t -60.76 135.99 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 0.0 109.386 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.439 ' SG ' ' OD2' ' B' ' 458' ' ' ASP . 31.1 p -135.24 -35.89 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 109.881 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.6 159.79 17.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 109.877 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.496 ' CD1' HD11 ' B' ' 488' ' ' ILE . 0.3 OUTLIER -52.25 -43.71 64.5 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.277 -0.89 . . . . 0.0 109.238 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.74 -44.03 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 108.951 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.458 ' CB ' HG11 ' B' ' 453' ' ' VAL . 82.0 m-20 -56.81 -43.34 80.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.288 -0.883 . . . . 0.0 108.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.51 ' CD1' ' HG ' ' B' ' 448' ' ' LEU . 24.6 tp -56.89 -45.18 82.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.23 72.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.384 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -65.94 -32.28 73.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.4 ' CD ' ' CG2' ' B' ' 453' ' ' VAL . 2.3 mp0 -62.15 157.6 18.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.466 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -123.28 153.91 17.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.481 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 45.3 mt -50.85 -38.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 109.296 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -70.17 -32.22 70.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.497 ' CD1' ' CB ' ' B' ' 478' ' ' ALA . 22.6 mt -77.19 -29.2 54.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.08 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.59 -33.68 66.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.451 HD13 HG22 ' B' ' 470' ' ' ILE . 76.3 mt -103.03 129.2 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -62.1 -29.92 70.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.04 -32.75 50.02 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.561 ' CD1' ' CD1' ' B' ' 444' ' ' LEU . 2.9 mm? -106.13 133.22 51.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.426 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 474' ' ' THR . . . . . 0.45 ' O ' ' HB1' ' B' ' 478' ' ' ALA . 28.3 m -103.62 161.87 13.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.436 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 84.0 m-20 -58.71 -36.95 75.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -76.31 -45.53 31.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.568 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.563 ' CE ' ' CD2' ' B' ' 444' ' ' LEU . 25.3 tttp -67.35 -41.24 85.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.497 ' CB ' ' CD1' ' B' ' 467' ' ' LEU . . . -63.7 -45.18 91.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 109.587 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.458 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.65 -42.09 99.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.95 91.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.459 HD11 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -65.3 -47.15 77.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.529 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 35.7 mt -55.19 -56.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.516 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 55.8 mtp -52.91 -41.93 64.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.444 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.34 -43.89 96.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.697 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.492 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -65.5 -49.69 68.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.493 ' NH1' ' HA ' ' A' ' 293' ' ' PRO . 95.3 mtt180 -57.79 -46.1 85.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 87.6 m-20 -57.91 -38.45 75.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.554 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.496 HD11 ' CD1' ' B' ' 456' ' ' LEU . 76.4 mt -70.94 -36.79 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . 0.403 ' O ' ' CB ' ' B' ' 495' ' ' ALA . 13.5 t -77.71 -51.51 10.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.787 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -63.54 -45.72 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 99.6 m-85 -93.94 13.9 21.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.61 131.43 10.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -46.93 -40.45 14.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -1.102 . . . . 0.0 109.444 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.08 -35.04 70.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.524 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . 0.403 ' CB ' ' O ' ' B' ' 489' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.573 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 14.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.507 ' CB ' HD11 ' A' ' 253' ' ' LEU . 25.0 m-20 -54.07 124.58 45.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.105 -0.997 . . . . 0.0 109.31 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -64.75 -25.61 60.93 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.664 2.242 . . . . 0.0 111.624 -179.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.523 ' CG2' HD12 ' A' ' 253' ' ' LEU . 14.5 tt -63.5 -33.72 63.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 108.622 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.529 ' CD1' ' O ' ' A' ' 311' ' ' GLY . 5.5 mp -74.86 -41.37 59.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.407 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.575 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.7 mt -72.08 -30.48 65.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.776 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.8 ttp-105 -56.43 138.35 75.46 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 108.849 179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 259' ' ' ASP . 46.3 Cg_endo -68.23 130.57 21.58 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.64 2.227 . . . . 0.0 111.757 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.442 ' CG2' ' HE3' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -44.55 -26.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 t0 -68.46 -30.77 69.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.255 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 256' ' ' PRO . 35.2 m-20 -69.87 -16.57 63.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.48 ' CD2' HD13 ' A' ' 278' ' ' ILE . 37.7 mt -56.07 138.26 49.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.423 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.2 tt0 -66.02 -16.22 63.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.513 ' CD1' ' HB3' ' A' ' 302' ' ' GLU . 33.4 mt -53.5 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.0 p -88.27 157.56 18.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 7.0 t -50.68 -37.1 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 265' ' ' ARG . 17.7 tpt85 -57.17 -46.5 82.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.455 ' OG ' ' OE1' ' A' ' 302' ' ' GLU . 20.1 m -57.97 -47.55 82.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.33 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -68.93 -39.71 79.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.375 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -56.66 -34.9 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.337 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.445 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 69.0 m -57.11 -64.37 0.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 57.4 mt -56.64 -48.09 78.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 32.3 mttt -54.75 -37.63 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.04 27.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 90.4 mt-10 -89.95 25.83 2.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.397 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . 67.17 42.7 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.519 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 88.8 mt -115.72 124.6 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.45 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.478 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.3 p80 -110.99 -41.53 4.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.484 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.478 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 8.4 m-30 -105.22 135.02 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.19 -0.944 . . . . 0.0 109.427 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.48 HD13 ' CD2' ' A' ' 260' ' ' LEU . 86.7 mt -46.95 -30.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.545 ' HA3' ' CZ3' ' A' ' 321' ' ' TRP . . . -46.98 -46.34 19.83 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.519 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 83.1 m-20 -53.45 -34.54 58.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -1.167 . . . . 0.0 108.884 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.401 ' N ' ' O ' ' A' ' 278' ' ' ILE . 35.1 tp -54.96 -49.88 70.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 108.987 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.534 ' CG1' ' HA ' ' A' ' 312' ' ' LEU . 14.3 m -65.26 -23.13 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 0.0 108.84 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.514 ' N ' HG22 ' A' ' 282' ' ' VAL . 63.9 tt0 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.02 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -96.39 159.9 14.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.345 -0.847 . . . . 0.0 109.227 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' THR . . . . . 0.444 ' O ' HD23 ' A' ' 289' ' ' LEU . 36.0 m -81.39 139.09 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 77.9 tt0 -58.56 -32.21 68.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . 0.484 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 45.7 t -52.72 -50.37 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.878 . . . . 0.0 109.359 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 292' ' ' THR . 97.5 mt-10 -55.2 -33.34 62.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.344 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 3.8 mm? -64.93 -43.44 92.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.516 HD21 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.07 -23.97 66.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.522 ' O ' ' CE ' ' B' ' 483' ' ' MET . 37.7 mttt -90.45 -8.54 50.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.515 ' HB ' ' CD1' ' A' ' 295' ' ' LEU . 2.1 m -86.99 113.73 54.92 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 49.6 Cg_endo -70.48 -22.25 29.04 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.661 2.24 . . . . 0.0 111.923 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.525 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 31.1 m120 -50.47 -22.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.116 -0.99 . . . . 0.0 109.345 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.515 ' CD1' ' HB ' ' A' ' 292' ' ' THR . 4.9 mp -90.79 138.75 31.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.408 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.98 167.78 36.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -55.02 -45.83 75.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -69.39 -37.84 77.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.9 m -58.58 -51.48 69.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.481 ' CD2' HD23 ' A' ' 295' ' ' LEU . 78.3 mt -53.83 -46.41 71.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.475 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 32.2 m -51.77 -51.09 58.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.978 . . . . 0.0 109.29 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.513 ' HB3' ' CD1' ' A' ' 262' ' ' LEU . 80.4 mt-10 -53.89 -38.47 64.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.967 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.454 ' O ' HD11 ' A' ' 307' ' ' LEU . 74.1 mt -59.34 -48.04 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.104 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -56.57 -36.54 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.28 -47.82 82.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.125 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.47 HG12 HD22 ' A' ' 312' ' ' LEU . 2.0 t -66.23 -38.06 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.032 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.522 ' HG ' ' CB ' ' A' ' 313' ' ' SER . 4.7 mp -54.4 -26.71 32.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.221 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.17 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.444 -0.785 . . . . 0.0 109.503 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 2.0 t -61.63 -31.85 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.467 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 309' ' ' SER . 29.5 mtm180 82.74 -24.72 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.536 -0.727 . . . . 0.0 110.38 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.529 ' O ' ' CD1' ' A' ' 253' ' ' LEU . . . -60.04 -21.18 55.59 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.534 ' HA ' ' CG1' ' A' ' 282' ' ' VAL . 0.4 OUTLIER -125.36 159.95 30.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.46 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.522 ' CB ' ' HG ' ' A' ' 307' ' ' LEU . 4.6 t 77.0 -144.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.518 HD23 ' N ' ' A' ' 314' ' ' LEU . 4.0 mm? 63.59 13.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 45.73 51.58 10.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.522 ' CE ' HD21 ' A' ' 253' ' ' LEU . 26.2 mtm -68.1 173.42 4.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -1.174 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.447 ' O ' HD22 ' A' ' 318' ' ' LEU . 50.4 mtt-85 -132.54 120.59 22.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.447 HD22 ' O ' ' A' ' 317' ' ' ARG . 5.2 mt -122.43 141.71 51.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.29 -37.57 87.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 80.4 m-20 -143.28 -47.92 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.371 -0.831 . . . . 0.0 108.926 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.575 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 164.05 -68.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.481 -0.762 . . . . 0.0 109.236 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.5 Cg_endo -69.77 110.93 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.58 2.187 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.502 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 50.5 Cg_endo -70.72 155.07 63.5 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.665 2.244 . . . . 0.0 111.654 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.97 -22.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.4 m -62.06 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 323' ' ' PRO . 19.5 mt -54.47 -42.15 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.74 70.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -52.12 -39.23 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.49 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -55.06 -38.45 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -1.177 . . . . 0.0 109.513 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 21.8 m120 58.06 45.27 18.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.415 ' O ' ' HB3' ' B' ' 454' ' ' CYS . 8.3 tttt -94.27 137.82 22.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.498 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.8 Cg_endo -70.49 132.57 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.703 2.268 . . . . 0.0 111.69 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.476 ' CB ' ' HA ' ' B' ' 455' ' ' THR . . . -63.77 151.22 42.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.38 -37.71 57.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.46 -44.77 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' B' ' 445' ' ' ALA . 3.3 tm? -69.96 -36.24 75.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.477 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.4 OUTLIER -69.54 -31.97 70.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -89.32 9.26 26.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.518 ' CD2' ' CD1' ' B' ' 456' ' ' LEU . 35.0 tp -80.13 132.28 35.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.497 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -77.23 144.74 38.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.67 4.63 65.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . . . . . . . . . 97.9 t -126.24 126.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.395 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -84.54 151.87 24.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -50.06 -47.07 53.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.498 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 91.7 m-20 -64.99 -45.47 85.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.508 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 14.2 tp -57.27 -44.35 83.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.526 ' CB ' HD12 ' B' ' 434' ' ' LEU . . . -59.01 -41.72 88.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.91 . . . . 0.0 109.23 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.498 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.3 m-30 -58.62 -44.6 90.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 24.5 mttt -58.76 -40.78 84.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.867 . . . . 0.0 109.307 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' B' ' 459' ' ' LEU . 93.3 mt -61.84 -38.94 90.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -64.6 -32.7 74.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.9 -37.56 14.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.987 . . . . 0.0 109.408 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.475 ' CZ ' ' CB ' ' B' ' 469' ' ' ASP . 84.0 mtt-85 -89.66 23.0 2.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.576 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.65 -18.79 6.74 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.517 HG13 ' CB ' ' B' ' 458' ' ' ASP . 46.7 t -76.79 108.52 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.305 . . . . 0.0 109.407 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 19.9 m -127.03 -38.85 1.98 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.686 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.476 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -78.39 144.32 36.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.529 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.518 ' CD1' ' CD2' ' B' ' 437' ' ' LEU . 25.8 tp -47.04 -42.72 18.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . 0.413 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 50.2 tp10 -55.95 -45.98 78.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.096 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.517 ' CB ' HG13 ' B' ' 453' ' ' VAL . 91.5 m-20 -56.66 -43.48 80.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.076 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' B' ' 448' ' ' LEU . 4.1 tt -55.52 -45.56 77.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.98 77.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 109.392 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.94 -28.09 68.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.439 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.6 mm-40 -75.45 140.01 42.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.464 ' HA2' HD11 ' B' ' 482' ' ' ILE . . . -98.45 166.06 21.71 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.539 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 20.5 mt -49.83 -34.02 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -1.125 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.18 -40.5 82.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.439 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 90.5 m-20 -63.29 -31.86 73.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.52 ' HB2' ' CB ' ' B' ' 478' ' ' ALA . 7.1 mp -82.59 -27.79 31.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.65 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -66.4 -21.1 66.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.541 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . 0.475 ' CB ' ' CZ ' ' B' ' 451' ' ' ARG . 82.1 m-20 -52.08 -31.91 32.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 64.1 mt -100.38 129.41 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.04 -36.06 72.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -55.8 -30.81 57.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.508 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 81.8 mt -98.91 131.37 45.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 45.7 m -104.13 162.01 13.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 109.378 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 82.3 m-20 -57.12 -38.4 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -74.4 -45.97 43.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.464 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.507 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 34.4 tttp -61.58 -46.35 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' B' ' 467' ' ' LEU . . . -60.28 -45.05 94.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.44 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -57.55 -47.72 86.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.507 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.1 mp -67.18 -44.51 79.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 36.3 mt -60.99 -55.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.577 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.522 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 57.7 mtp -52.38 -36.53 54.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.332 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.458 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.29 -51.74 34.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.52 65.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.544 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 49.2 ttm-85 -50.56 -46.87 57.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.417 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 97.5 m-20 -58.01 -43.25 86.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.512 HD11 ' CD2' ' B' ' 456' ' ' LEU . 81.3 mt -61.56 -37.32 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . 0.413 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 62.9 m -77.84 -50.29 12.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . 0.544 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 20.7 m95 -60.13 -43.23 95.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.417 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 56.6 m-85 -83.38 -27.21 29.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 64.13 -126.12 33.28 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -106.21 92.55 4.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -1.095 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.14 143.37 10.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.505 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.549 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 41.0 p90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.401 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.6 OUTLIER -65.33 134.42 95.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.14 -29.32 56.14 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.752 2.301 . . . . 0.0 111.661 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.522 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 18.6 tt -61.34 -29.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 108.929 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.524 HD11 ' CE ' ' A' ' 316' ' ' MET . 19.0 mt -74.33 -43.02 58.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.523 ' CD1' HD13 ' A' ' 326' ' ' ILE . 4.3 mm? -61.55 -28.55 69.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.457 ' O ' HG13 ' A' ' 278' ' ' ILE . 1.8 mtt180 -75.13 140.86 73.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.525 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.468 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.6 Cg_endo -70.88 141.6 41.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.717 2.278 . . . . 0.0 111.921 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.428 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.63 -37.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.1 -30.89 69.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.956 . . . . 0.0 109.366 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' PRO . 34.2 m-20 -75.33 -11.53 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.487 ' HB3' ' CD1' ' A' ' 262' ' ' LEU . 74.1 mt -53.82 152.84 5.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -64.37 -23.98 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.496 ' HG ' ' CG ' ' A' ' 302' ' ' GLU . 3.7 mp -57.46 167.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 4.0 p -81.33 165.01 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.464 ' CG1' ' ND2' ' A' ' 268' ' ' ASN . 42.3 t -49.14 -41.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.485 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.422 ' O ' ' SG ' ' A' ' 269' ' ' CYS . 70.6 ttt180 -49.82 -45.01 49.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.367 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.467 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 14.9 m -70.41 -46.56 63.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.73 -46.88 88.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.464 ' ND2' ' CG1' ' A' ' 264' ' ' VAL . 85.6 m-20 -56.33 -34.74 66.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.367 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.445 ' HB2' ' O ' ' A' ' 266' ' ' SER . 87.9 m -50.52 -65.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.422 HD23 HD11 ' A' ' 281' ' ' LEU . 6.6 mp -62.94 -44.93 94.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.241 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.5 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 17.0 ttpp -52.95 -40.93 64.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.89 -21.95 3.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 273' ' ' GLU . 70.1 tt0 -94.82 20.75 8.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.895 . . . . 0.0 109.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.11 35.33 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.517 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 89.0 mt -123.08 107.53 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.5 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 81.5 m-70 -107.29 -11.66 15.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.445 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 4.8 m-85 -111.54 134.23 53.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.522 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 61.5 mt -60.14 -30.73 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.266 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.595 ' HA3' ' CE2' ' A' ' 321' ' ' TRP . . . -51.05 -42.5 48.28 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.517 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 93.0 m-20 -53.54 -35.18 60.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -1.174 . . . . 0.0 109.047 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.422 HD11 HD23 ' A' ' 270' ' ' LEU . 28.3 tp -58.05 -47.84 81.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 21.1 m -70.05 -24.26 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.163 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.498 ' N ' HG23 ' A' ' 282' ' ' VAL . 63.7 tt0 -65.81 -32.65 74.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.196 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.64 145.02 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -62.17 138.36 58.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.418 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 80.6 tt0 -62.85 -27.4 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.2 t -52.92 -51.76 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.4 -34.88 67.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.454 ' O ' ' CD1' ' A' ' 295' ' ' LEU . 51.3 mt -74.97 -38.18 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 32.9 tp -60.94 -30.25 70.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.344 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.493 ' C ' ' CE ' ' B' ' 483' ' ' MET . 10.0 mmtt -87.78 17.6 4.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.35 -0.844 . . . . 0.0 109.52 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.413 ' C ' ' SD ' ' B' ' 483' ' ' MET . 0.7 OUTLIER -109.81 136.72 20.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.524 ' HB2' ' CG1' ' B' ' 464' ' ' ILE . 50.0 Cg_endo -70.12 -23.25 29.37 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.819 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.51 ' N ' HD11 ' B' ' 464' ' ' ILE . 22.3 m120 -56.2 -24.68 43.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 14.6 mt -81.45 138.02 35.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -95.21 145.37 17.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' B' ' 461' ' ' GLU . 24.3 mttm -55.29 -42.62 73.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -1.106 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -67.49 -39.42 85.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' SER . . . . . 0.455 ' O ' HG13 ' A' ' 303' ' ' ILE . 22.0 m -64.04 -36.71 84.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 300' ' ' LEU . 3.4 tm? -53.1 -42.59 66.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.0 m -60.64 -51.91 67.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.496 ' CG ' ' HG ' ' A' ' 262' ' ' LEU . 39.7 tp10 -57.91 -45.69 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 82.9 mt -57.79 -47.29 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.065 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.02 -39.34 63.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 108.916 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.65 -42.98 99.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.507 ' CG1' HD21 ' A' ' 312' ' ' LEU . 32.0 t -69.22 -34.8 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.845 . . . . 0.0 108.995 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.514 HD22 ' CB ' ' A' ' 313' ' ' SER . 25.2 mt -63.62 -26.68 68.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.397 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.44 -36.26 73.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 109.151 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.435 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 16.3 t -67.68 -16.87 64.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD1' ' A' ' 314' ' ' LEU . 56.5 mtt180 64.46 10.81 6.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.184 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.443 ' O ' HG21 ' A' ' 252' ' ' ILE . . . -78.77 -24.25 62.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.514 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.7 pt? -137.36 147.03 45.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.514 ' CB ' HD22 ' A' ' 307' ' ' LEU . 1.7 t 77.21 39.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 310' ' ' ARG . 12.3 mt -89.9 15.26 10.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.916 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.25 97.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.524 ' CE ' HD11 ' A' ' 253' ' ' LEU . 4.5 mtm -90.33 163.19 14.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -143.14 123.09 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.504 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.544 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 1.4 mp -131.31 140.73 49.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -45.74 -36.49 5.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 108.482 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.508 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 43.6 t30 -129.42 -72.2 0.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.595 ' CE2' ' HA3' ' A' ' 279' ' ' GLY . 16.2 t90 160.77 -57.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.589 -0.695 . . . . 0.0 109.547 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.3 Cg_endo -66.97 107.81 1.38 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.132 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -73.44 165.2 33.1 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.686 2.258 . . . . 0.0 111.657 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -43.84 -26.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.582 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' SER . . . . . 0.532 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 22.8 m -61.71 -58.4 8.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.579 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 254' ' ' LEU . 35.1 mt -53.85 -38.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.02 144.55 49.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -56.65 -37.85 71.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.464 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . 0.419 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 89.1 m-20 -55.3 -35.98 65.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' B' ' 427' ' ' ASP . 26.5 m120 60.41 43.84 12.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.455 ' HD2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -87.68 123.62 68.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.455 ' HD2' ' HD2' ' B' ' 429' ' ' LYS . 50.4 Cg_endo -70.46 134.68 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.671 2.247 . . . . 0.0 111.845 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.438 ' N ' ' O ' ' B' ' 454' ' ' CYS . . . -70.88 166.6 20.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.498 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.19 -38.54 73.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.306 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . 0.535 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 75.1 m-20 -61.74 -49.91 74.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.185 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' B' ' 434' ' ' LEU . 3.5 tm? -64.98 -38.67 91.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -73.36 -33.94 65.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -85.67 8.54 19.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . . . . . . . . . 36.1 tp -72.39 131.07 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.98 143.04 49.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 6.58 70.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.496 HG21 ' CD2' ' B' ' 481' ' ' LEU . 54.4 t -138.36 128.97 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -1.169 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' B' ' 444' ' ' LEU . 32.5 p30 -98.84 -177.21 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.647 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.433 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 97.6 mtt180 -62.14 -43.74 98.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.78 -55.92 19.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.526 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 13.9 tp -56.55 -40.84 75.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.449 ' HB2' ' O ' ' B' ' 441' ' ' ASP . . . -59.88 -36.77 77.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.387 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 15.1 m-30 -66.72 -43.36 84.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.447 ' O ' HD13 ' B' ' 470' ' ' ILE . 43.5 mttt -61.7 -42.0 98.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.525 ' CG ' HD21 ' B' ' 459' ' ' LEU . 2.7 tm? -62.85 -44.49 95.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -62.03 -26.82 68.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.633 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.11 -17.18 9.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.434 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 7.1 mtp85 -92.25 27.97 2.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.68 7.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.491 HG12 ' N ' ' B' ' 459' ' ' LEU . 47.8 t -63.73 140.3 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.927 -1.337 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' B' ' 431' ' ' ALA . 27.1 m -135.09 -36.21 0.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.51 151.48 24.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.535 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.1 tm? -52.03 -38.32 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.2 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . 0.434 ' HA ' ' OE1' ' B' ' 457' ' ' GLU . 43.8 mm-40 -58.12 -47.65 82.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 108.839 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -55.93 -44.66 78.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.857 . . . . 0.0 109.054 179.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.525 HD21 ' CG ' ' B' ' 448' ' ' LEU . 2.8 tm? -55.5 -42.72 74.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.074 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . 0.405 ' O ' ' HE3' ' A' ' 297' ' ' LYS . . . -60.01 -36.06 76.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.202 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' B' ' 461' ' ' GLU . 77.1 tt0 -68.78 -13.13 62.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.439 ' CG ' HG21 ' B' ' 453' ' ' VAL . 96.3 mm-40 -74.65 147.6 41.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.423 ' HA2' HD12 ' B' ' 482' ' ' ILE . . . -106.17 158.21 15.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.524 ' CG1' ' HB2' ' A' ' 293' ' ' PRO . 24.0 mt -52.29 -34.12 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.143 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.95 -37.08 78.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.09 -32.09 69.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.526 ' CD1' ' HB2' ' B' ' 478' ' ' ALA . 23.4 mt -74.86 -30.01 61.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.57 63.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -52.77 -31.44 38.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.447 HD13 ' O ' ' B' ' 447' ' ' LYS . 64.4 mt -102.24 128.93 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -64.44 -35.67 81.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.47 -28.52 36.68 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.526 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 81.4 mt -102.41 134.48 45.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 474' ' ' THR . . . . . 0.496 HG21 ' N ' ' B' ' 475' ' ' ASP . 51.4 m -103.85 162.08 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.496 ' N ' HG21 ' B' ' 474' ' ' THR . 84.8 m-20 -56.69 -38.63 72.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.94 -46.0 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.511 ' O ' ' CD1' ' B' ' 481' ' ' LEU . 43.4 tttp -66.66 -46.74 74.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.273 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.526 ' HB2' ' CD1' ' B' ' 467' ' ' LEU . . . -58.08 -45.18 87.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.513 ' CA ' ' CB ' ' A' ' 293' ' ' PRO . . . -59.58 -45.54 95.45 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.37 68.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.511 ' CD1' ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -70.05 -30.58 67.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.432 HG13 ' O ' ' B' ' 478' ' ' ALA . 46.0 mt -69.83 -54.95 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 44.0 mmm -57.6 -44.31 85.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.344 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.447 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -61.38 -56.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.358 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.485 ' CB ' HD12 ' B' ' 459' ' ' LEU . . . -61.18 -46.74 89.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.48 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 77.1 ttt180 -55.18 -47.46 75.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.6 m-20 -57.76 -41.37 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.447 HG13 ' O ' ' B' ' 484' ' ' ALA . 75.7 mt -56.02 -37.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.74 -51.91 8.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . 0.48 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 63.1 m95 -62.53 -47.15 85.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.464 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.7 m-85 -74.74 -33.03 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.13 77.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -1.163 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.61 143.91 28.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.459 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.524 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . 1.1 m-20 -65.95 141.52 97.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.61 -22.78 57.7 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 7.3 tt -67.57 -26.52 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.297 -0.877 . . . . 0.0 109.169 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.578 ' CD2' ' CG1' ' A' ' 282' ' ' VAL . 2.2 mt -73.96 -45.36 50.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.602 ' CD2' ' CH2' ' A' ' 321' ' ' TRP . 3.1 mm? -68.73 -30.74 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.48 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.24 139.44 91.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.473 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.49 134.85 27.36 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.695 2.264 . . . . 0.0 111.782 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.426 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.4 -32.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.95 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.229 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.1 m-20 -75.71 -12.99 60.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.842 . . . . 0.0 109.411 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.518 ' CD2' HD12 ' A' ' 278' ' ' ILE . 85.2 mt -55.71 136.86 50.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.447 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.1 tt0 -63.96 -16.84 62.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 302' ' ' GLU . 6.4 mp -62.56 165.85 5.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.3 p -71.97 169.11 16.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.5 t -51.42 -31.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -50.64 -46.91 58.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.418 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 20.7 t -60.26 -50.62 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -62.41 -42.99 99.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.3 m -52.45 -58.38 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.509 HD12 ' CD1' ' A' ' 281' ' ' LEU . 3.1 mm? -73.74 -39.41 64.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.552 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 12.7 tptm -57.77 -42.14 83.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.36 -21.45 65.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.413 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 63.6 tt0 -89.35 21.67 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.413 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.43 17.29 8.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.499 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 72.9 mt -107.31 125.41 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.552 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 95.3 m-70 -113.43 -25.67 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 109.352 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 96.0 m-85 -105.19 141.43 36.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.518 HD12 ' CD2' ' A' ' 260' ' ' LEU . 76.0 mt -63.58 -31.39 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.273 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 253' ' ' LEU . . . -50.72 -45.68 48.24 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.499 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 79.3 m-20 -53.78 -37.38 63.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -1.207 . . . . 0.0 109.215 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.509 ' CD1' HD12 ' A' ' 270' ' ' LEU . 34.9 tp -52.53 -48.57 65.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.271 -0.893 . . . . 0.0 108.866 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.578 ' CG1' ' CD2' ' A' ' 253' ' ' LEU . 3.8 m -66.77 -23.89 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 108.821 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.543 ' N ' HG21 ' A' ' 282' ' ' VAL . 63.6 tt0 -62.45 -35.92 80.8 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.464 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 72.3 mtt180 -105.97 141.92 36.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.2 m -63.68 137.89 58.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.963 . . . . 0.0 109.543 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 47.0 tp10 -53.7 -29.22 38.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 37.1 t -52.79 -48.25 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 108.999 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.464 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 96.3 mt-10 -51.93 -35.66 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.905 . . . . 0.0 109.008 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 3.8 mm? -65.48 -44.16 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 108.907 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.473 ' HB3' ' NH2' ' B' ' 486' ' ' ARG . 3.4 mm? -63.56 -17.59 62.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 108.958 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.53 ' O ' ' CE ' ' B' ' 483' ' ' MET . 21.6 mttt -93.3 26.51 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.748 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.419 ' CG2' ' OD1' ' A' ' 294' ' ' ASN . 86.7 m -138.02 122.28 11.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 50.3 Cg_endo -71.17 -20.24 28.63 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.686 2.257 . . . . 0.0 111.893 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.536 ' ND2' ' CD1' ' B' ' 464' ' ' ILE . 33.5 m120 -50.26 -22.32 1.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 3.8 mp -95.54 122.03 37.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -82.87 156.51 34.56 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -48.86 -39.51 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.563 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 19.4 m -64.52 -52.02 59.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.422 HD23 HD13 ' A' ' 290' ' ' LEU . 34.7 tp -53.18 -39.13 63.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.7 m -58.8 -49.73 76.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.533 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.517 ' HB3' ' CD2' ' A' ' 262' ' ' LEU . 74.2 mt-10 -59.75 -40.67 88.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 83.9 mt -57.83 -52.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.284 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -54.54 -38.99 67.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.158 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.83 -42.08 83.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.46 HG12 HD22 ' A' ' 312' ' ' LEU . 2.3 t -72.39 -42.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.542 ' CD2' ' CB ' ' A' ' 313' ' ' SER . 24.4 mt -54.54 -26.91 34.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.92 74.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.4 p -68.47 -20.31 64.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.0 109.408 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.44 ' HG2' HD13 ' A' ' 314' ' ' LEU . 32.4 ttm180 67.59 7.39 5.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -78.31 -22.47 67.75 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.497 ' O ' ' CB ' ' A' ' 313' ' ' SER . 1.7 pt? -137.08 155.94 49.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.604 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.542 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 1.3 t 75.47 51.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.0 mm? -93.14 21.25 6.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 47.04 46.16 20.15 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.467 ' HG3' HG23 ' A' ' 282' ' ' VAL . 11.0 ptt? -121.91 139.83 53.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -1.185 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.47 ' O ' HD13 ' A' ' 318' ' ' LEU . 55.9 mtt180 -100.14 137.43 38.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.574 ' HG ' ' CD2' ' A' ' 321' ' ' TRP . 2.4 mm? -122.28 111.37 16.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.901 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -77.07 -30.49 55.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.945 . . . . 0.0 108.753 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 321' ' ' TRP . 21.2 t-20 -165.29 26.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.053 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.602 ' CH2' ' CD2' ' A' ' 254' ' ' LEU . 0.4 OUTLIER -43.37 104.25 0.36 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.5 71.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.727 2.951 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.545 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 50.2 Cg_endo -70.05 155.83 64.04 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.54 2.16 . . . . 0.0 111.816 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.76 -27.97 67.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.291 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.2 m -59.1 -40.08 84.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.524 ' HB ' ' CD1' ' A' ' 254' ' ' LEU . 20.5 tt -63.6 -22.78 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.474 ' N ' HG23 ' A' ' 326' ' ' ILE . . . -70.24 143.72 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.384 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -54.81 -37.15 65.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.525 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.488 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . 0.428 ' O ' ' SG ' ' B' ' 454' ' ' CYS . 94.9 m-20 -61.28 -34.23 74.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 109.443 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' B' ' 449' ' ' ALA . 23.7 m120 -59.15 -25.25 63.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.98 131.84 30.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.5 Cg_endo -70.3 136.37 31.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.907 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.487 ' N ' ' O ' ' B' ' 454' ' ' CYS . . . -66.84 160.55 25.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -53.15 -33.87 54.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -65.04 -49.61 69.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.624 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' B' ' 430' ' ' PRO . 17.2 tp -65.05 -38.44 90.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.44 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.5 OUTLIER -73.61 -33.22 64.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -86.87 9.84 17.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.458 HD11 HD12 ' B' ' 456' ' ' LEU . 44.8 tp -77.24 133.29 38.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -77.45 142.26 39.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.1 2.8 65.99 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.435 ' CG2' HD21 ' B' ' 481' ' ' LEU . 93.8 t -131.06 129.56 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.13 -1.218 . . . . 0.0 109.497 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -90.86 155.22 18.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 58.8 mtm180 -50.04 -40.62 45.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -66.9 -45.45 77.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.466 HD11 ' HE2' ' B' ' 477' ' ' LYS . 45.5 mt -60.39 -42.09 95.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' B' ' 449' ' ' ALA . . . -58.82 -45.97 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.355 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.464 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 11.2 m-30 -58.51 -43.41 89.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.463 ' O ' HD11 ' B' ' 470' ' ' ILE . 45.6 mttp -60.59 -52.5 64.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 7.1 tt -65.55 -42.03 92.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' B' ' 445' ' ' ALA . . . -55.99 -27.0 50.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.977 . . . . 0.0 109.487 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.36 -24.0 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.417 ' NH1' ' CG1' ' B' ' 470' ' ' ILE . 41.9 mtt-85 -88.8 26.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.63 6.93 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.497 HG13 ' N ' ' B' ' 459' ' ' LEU . 73.2 t -60.71 130.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.33 . . . . 0.0 109.472 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.487 ' O ' ' N ' ' B' ' 431' ' ' ALA . 57.0 m -135.06 -36.59 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.743 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.12 153.08 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.783 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.515 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 42.5 tp -49.48 -40.42 37.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.325 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.71 -49.93 71.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 108.994 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.434 ' HB2' HG11 ' B' ' 453' ' ' VAL . 81.0 m-20 -55.52 -40.55 71.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 108.971 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.558 ' CD2' ' CD1' ' B' ' 448' ' ' LEU . 3.4 tm? -55.62 -42.98 75.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.73 -25.69 66.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.262 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.13 -21.19 63.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -79.98 153.81 28.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.454 ' HA2' HD13 ' B' ' 482' ' ' ILE . . . -117.3 152.35 17.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.536 ' CD1' ' ND2' ' A' ' 294' ' ' ASN . 33.6 mt -44.46 -36.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -63.95 -35.59 81.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.473 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 87.2 m-20 -77.35 -31.55 54.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.513 HD13 ' CB ' ' B' ' 478' ' ' ALA . 23.1 mt -73.48 -35.52 65.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.91 69.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.51 -33.2 72.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.463 HD11 ' O ' ' B' ' 447' ' ' LYS . 80.5 mt -85.24 131.39 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.436 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.95 150.4 46.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.19 -29.39 12.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.434 HD22 ' HD3' ' B' ' 477' ' ' LYS . 64.6 mt -99.72 136.49 39.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -1.16 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.03 162.07 13.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -57.3 -38.11 73.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.65 -45.94 56.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.466 ' HE2' HD11 ' B' ' 444' ' ' LEU . 14.5 tttp -62.58 -45.68 91.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.513 ' CB ' HD13 ' B' ' 467' ' ' LEU . . . -58.7 -42.49 88.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -61.7 -46.3 94.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.83 78.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.517 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.459 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.0 mp -66.38 -35.36 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.594 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.525 ' CD1' ' HB2' ' A' ' 293' ' ' PRO . 59.6 mt -70.32 -56.33 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.579 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.53 ' CE ' ' O ' ' A' ' 291' ' ' LYS . 39.9 mtp -52.92 -37.8 61.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.34 69.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.419 ' CB ' HD13 ' B' ' 459' ' ' LEU . . . -64.81 -49.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.515 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 66.3 ttt-85 -53.85 -47.06 71.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.97 -45.84 86.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.515 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 46.2 mt -59.1 -39.51 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 91.2 m -75.3 -49.13 20.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . 0.515 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 15.0 m95 -59.39 -41.3 89.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 9.19 43.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.463 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -71.53 131.1 18.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.4 -39.35 75.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -1.152 . . . . 0.0 109.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -34.4 71.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.529 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.516 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.627 ' CD1' ' CB ' ' A' ' 323' ' ' PRO . 2.5 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -61.67 139.55 95.27 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.438 ' HA ' HD22 ' A' ' 254' ' ' LEU . 42.0 Cg_endo -64.56 -34.05 53.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.505 2.137 . . . . 0.0 111.473 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.532 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 8.7 tt -53.71 -34.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.581 HD23 ' CH2' ' A' ' 321' ' ' TRP . 0.6 OUTLIER -74.57 -21.67 59.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.083 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.571 HD12 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -89.58 -24.8 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.263 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.464 ' O ' HD11 ' A' ' 278' ' ' ILE . 4.5 mtm180 -66.23 147.5 98.85 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.504 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.8 Cg_endo -70.69 140.88 40.15 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.698 2.265 . . . . 0.0 111.715 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.465 ' O ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.54 -34.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 109.365 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.84 -30.92 71.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.504 ' N ' ' O ' ' A' ' 256' ' ' PRO . 30.2 m-20 -76.0 -14.96 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 257' ' ' VAL . 48.7 mt -44.75 149.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.56 -19.17 65.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.512 ' HB3' ' CB ' ' A' ' 266' ' ' SER . 6.1 mp -64.07 169.32 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 9.2 p -78.22 159.88 28.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . . . . . . . . . 3.2 t -47.25 -37.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.486 ' NH2' ' OD2' ' B' ' 465' ' ' ASP . 52.0 ttt85 -53.37 -46.85 69.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.512 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 19.4 m -63.58 -51.05 67.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.943 . . . . 0.0 109.387 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.07 78.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -59.7 -33.31 71.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.914 . . . . 0.0 109.27 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.407 ' O ' ' HB1' ' A' ' 272' ' ' ALA . 56.5 m -62.29 -63.82 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.292 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.0 mt -58.64 -47.66 83.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.501 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 19.0 tttt -52.69 -32.11 40.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 269' ' ' CYS . . . -60.97 -17.46 51.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.328 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.445 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 58.5 tt0 -95.6 21.33 8.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.445 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 72.05 23.3 3.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.501 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 97.0 mt -112.34 107.66 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.501 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 50.5 m-70 -107.1 -9.2 16.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.5 m-85 -114.55 131.96 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.532 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 74.7 mt -54.16 -36.5 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 109.119 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.591 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -46.38 -47.53 16.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.501 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 89.2 m-20 -53.27 -34.41 57.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 108.704 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.417 ' HB3' ' O ' ' A' ' 278' ' ' ILE . 31.2 tp -53.78 -50.48 65.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.146 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 34.8 m -67.09 -29.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.533 ' N ' HG22 ' A' ' 282' ' ' VAL . 93.9 mt-30 -57.2 -34.34 68.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -96.99 159.55 14.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.416 -0.802 . . . . 0.0 109.017 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 m -83.35 140.15 32.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 88.3 tt0 -52.7 -31.18 36.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.325 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.89 -51.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.039 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.447 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 69.9 mm-40 -51.93 -37.0 51.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.087 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 62.2 mt -60.75 -47.24 87.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.515 ' O ' ' CD1' ' A' ' 290' ' ' LEU . 1.8 tm? -59.81 -33.53 71.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.283 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.508 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 45.8 mttt -83.06 -17.84 41.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.402 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -77.08 113.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.528 ' HB2' ' CD1' ' B' ' 482' ' ' ILE . 50.8 Cg_endo -71.0 -23.29 25.31 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.766 2.311 . . . . 0.0 112.165 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.508 ' N ' HD13 ' B' ' 464' ' ' ILE . 70.8 m-80 -50.93 -21.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.699 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.568 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 3.2 mp -101.31 122.69 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -73.8 156.64 50.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -49.09 -38.63 25.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.293 -1.122 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -67.2 -42.68 83.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.355 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 59.5 p -58.43 -47.14 84.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.431 HD22 HD23 ' A' ' 290' ' ' LEU . 22.9 tp -52.94 -44.19 66.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.294 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 52.2 m -52.5 -52.31 55.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.209 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.46 ' CB ' HD22 ' A' ' 262' ' ' LEU . 84.7 mt-10 -53.61 -42.24 67.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.57 -39.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.183 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -62.16 -36.11 80.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.39 -51.24 61.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.483 ' O ' ' CD1' ' A' ' 312' ' ' LEU . 3.2 t -72.29 -37.52 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.251 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 15.5 tp -60.25 -26.27 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.441 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.08 -30.7 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 109.434 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.446 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.7 OUTLIER -68.95 -7.35 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.86 . . . . 0.0 109.555 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 92.9 mtt-85 61.76 12.52 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . 0.422 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -93.21 -2.94 65.66 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.526 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 0.0 OUTLIER -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -1.197 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.509 ' N ' HG13 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 46.36 67.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.486 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.6 mt -101.64 11.86 38.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.63 73.83 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.53 ' HE3' ' CG1' ' A' ' 282' ' ' VAL . 13.5 ptt? -107.7 150.83 26.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -1.216 . . . . 0.0 109.54 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 61.7 mtp180 -125.57 145.85 49.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -124.04 140.95 52.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.68 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.1 -32.2 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 85.8 m-20 -122.35 -78.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.167 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.591 ' CH2' ' HA3' ' A' ' 279' ' ' GLY . 0.8 OUTLIER 168.76 -58.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.76 107.8 1.74 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.647 2.231 . . . . 0.0 111.889 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.627 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 52.8 Cg_endo -73.16 165.12 33.55 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.554 2.169 . . . . 0.0 111.688 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.89 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.9 m -76.82 -38.68 53.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.477 ' CG2' ' O ' ' A' ' 323' ' ' PRO . 18.5 tt -60.68 -18.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . 0.424 ' N ' HG22 ' A' ' 326' ' ' ILE . . . -73.0 147.35 45.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.85 -38.47 78.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.414 -179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.46 -33.61 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -1.09 . . . . 0.0 109.478 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 20.0 m120 56.78 43.68 24.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.357 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -61.85 130.13 92.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.575 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.9 138.74 34.82 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.703 2.269 . . . . 0.0 111.728 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -73.71 157.52 36.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -56.89 -33.54 66.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 436' ' ' ASN . 56.0 m-20 -69.61 -37.3 76.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.32 -33.24 71.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 109.34 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.505 ' CD1' ' HA ' ' B' ' 442' ' ' ARG . 33.1 tp -86.43 -30.59 21.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 433' ' ' ASP . 24.3 p-10 -80.0 5.84 12.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.834 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.444 HD21 HD13 ' B' ' 456' ' ' LEU . 25.5 tp -77.87 133.81 38.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.9 139.22 50.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.2 63.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.432 HG22 HD23 ' B' ' 437' ' ' LEU . 48.8 t -129.5 130.88 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -1.157 . . . . 0.0 109.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -101.35 158.42 16.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.505 ' HA ' ' CD1' ' B' ' 435' ' ' LEU . 76.8 mtt-85 -50.12 -52.45 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.17 -48.38 81.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.51 ' CD1' ' CD2' ' B' ' 473' ' ' LEU . 12.3 tp -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.34 87.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -56.23 -44.45 79.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -60.1 -44.74 94.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.5 ' HG ' ' CD1' ' B' ' 459' ' ' LEU . 2.6 tm? -73.29 -39.35 65.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.457 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.8 -28.31 69.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.35 -16.89 10.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -92.3 30.13 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.562 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.71 -18.86 6.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 49.1 t -63.82 138.25 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.336 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 72.6 m -135.14 -34.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.866 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.421 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -115.97 159.31 21.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.498 ' CD2' HD11 ' B' ' 488' ' ' ILE . 33.8 tp -50.67 -40.11 52.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.338 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . 0.406 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 48.0 tp10 -55.88 -48.62 75.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.185 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.422 ' HB2' HG13 ' B' ' 453' ' ' VAL . 86.7 m-20 -57.3 -40.81 78.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.5 ' CD1' ' HG ' ' B' ' 448' ' ' LEU . 17.0 tp -59.49 -45.31 92.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.35 -38.99 78.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 97.8 mm-40 -76.26 146.52 38.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.441 ' HA2' HD11 ' B' ' 482' ' ' ILE . . . -106.28 154.41 16.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.514 ' CG2' ' HA ' ' B' ' 475' ' ' ASP . 59.7 mt -44.03 -36.59 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . 0.486 ' OD2' ' NH2' ' A' ' 265' ' ' ARG . 48.0 t0 -63.2 -41.04 99.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -66.68 -25.08 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.521 ' CB ' ' HB3' ' B' ' 478' ' ' ALA . 7.2 mp -85.52 -24.46 27.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.81 -23.9 63.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -52.06 -32.16 33.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 67.3 mt -97.84 124.73 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.507 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.46 -35.38 80.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.405 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.54 -31.62 52.35 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.51 ' CD2' ' CD1' ' B' ' 444' ' ' LEU . 60.0 mt -101.79 135.58 43.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 39.1 m -103.73 163.87 12.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.514 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 90.7 m-20 -56.88 -39.42 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -71.86 -45.88 59.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.504 ' HD3' ' CD2' ' B' ' 473' ' ' LEU . 40.3 tttm -61.07 -46.74 89.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.453 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.521 ' HB3' ' CB ' ' B' ' 467' ' ' LEU . . . -58.9 -41.93 88.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.357 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.469 ' HA3' HD11 ' B' ' 464' ' ' ILE . . . -59.2 -45.77 94.83 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.61 -35.96 73.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . . . . . . . . . 25.3 mt -68.96 -44.11 73.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.523 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.528 ' CD1' ' HB2' ' A' ' 293' ' ' PRO . 30.4 mt -59.5 -55.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.508 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 43.9 mtp -52.76 -44.47 66.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 0.0 109.374 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.6 -49.78 76.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.46 ' HB1' ' HG ' ' B' ' 456' ' ' LEU . . . -68.25 -47.75 66.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' A' ' 291' ' ' LYS . 39.5 ttm180 -55.1 -45.65 75.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.487 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 74.6 m-20 -61.02 -41.24 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.498 HD11 ' CD2' ' B' ' 456' ' ' LEU . 63.2 mt -67.42 -38.74 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . 0.406 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 47.4 m -67.44 -49.56 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -68.0 -39.51 83.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.487 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 16.9 m-30 -83.31 -13.12 55.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . -57.76 -36.1 77.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.23 -38.28 73.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' B' ' 491' ' ' PHE . 84.0 tt0 -108.02 140.62 40.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.533 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.568 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 16.4 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -54.64 135.67 63.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.348 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -65.22 -31.72 53.16 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.604 2.203 . . . . 0.0 111.672 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.52 ' O ' ' CD1' ' A' ' 278' ' ' ILE . 8.2 tt -63.18 -28.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 108.756 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.567 ' CD1' ' CE ' ' A' ' 316' ' ' MET . 37.9 mt -74.6 -44.16 52.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 1.8 mt -65.98 -34.78 78.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.67 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.459 ' O ' HG13 ' A' ' 278' ' ' ILE . 4.3 ttp180 -56.04 141.11 68.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.0 109.068 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.7 Cg_endo -68.72 130.96 21.65 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 267' ' ' ALA . 0.3 OUTLIER -43.51 -35.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.89 . . . . 0.0 109.396 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.98 -30.93 70.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.321 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.3 m-20 -76.81 -14.9 59.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.87 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 257' ' ' VAL . 68.3 mt -44.79 140.88 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' LEU . 98.0 mt-10 -64.83 -26.58 68.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.463 ' O ' ' O ' ' A' ' 261' ' ' GLU . 29.7 mt -52.84 -173.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 13.0 p -84.84 159.39 20.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.41 HG13 ' OD1' ' A' ' 268' ' ' ASN . 8.7 t -55.16 -34.66 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.357 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -53.71 -46.45 70.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.7 p -64.42 -45.04 89.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -67.47 -39.33 85.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.41 ' OD1' HG13 ' A' ' 264' ' ' VAL . 89.3 m-20 -58.52 -32.2 68.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.451 ' SG ' ' CD1' ' A' ' 295' ' ' LEU . 21.4 t -57.6 -64.99 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.76 -47.71 79.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -0.845 . . . . 0.0 109.454 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.491 ' HG3' ' CE1' ' A' ' 276' ' ' HIS . 36.1 ttpt -55.08 -37.17 66.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.441 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.75 -21.15 6.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . 0.426 ' O ' ' CB ' ' A' ' 274' ' ' ALA . 94.7 mt-10 -95.65 21.17 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . 0.426 ' CB ' ' O ' ' A' ' 273' ' ' GLU . . . 69.86 28.04 4.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.518 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.9 mt -117.09 111.48 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.491 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 96.1 m-70 -104.4 -10.13 17.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.578 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.86 143.45 33.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.52 ' CD1' ' O ' ' A' ' 252' ' ' ILE . 92.0 mt -72.29 -31.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.524 ' O ' ' CG2' ' A' ' 282' ' ' VAL . . . -47.22 -48.33 20.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.518 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.7 m-20 -53.79 -35.32 61.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -1.138 . . . . 0.0 108.757 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -52.78 -47.16 67.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.54 HG22 ' N ' ' A' ' 283' ' ' GLN . 6.5 m -68.25 -23.81 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.54 ' N ' HG22 ' A' ' 282' ' ' VAL . 63.6 tt0 -62.23 -35.69 79.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 64.9 mtt-85 -100.99 141.18 34.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 74.0 p -76.2 147.11 38.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -50.82 -34.1 26.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 0.0 109.339 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.76 -51.26 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.281 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.14 -37.84 62.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.542 ' N ' ' CD2' ' A' ' 289' ' ' LEU . 3.9 mm? -68.37 -40.77 81.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.516 HD12 ' CD2' ' A' ' 300' ' ' LEU . 34.8 tp -62.3 -25.45 67.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 109.331 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.467 ' O ' ' HE3' ' B' ' 483' ' ' MET . 22.2 mttt -88.66 17.25 5.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.447 ' HB ' HD12 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -116.84 136.99 23.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.526 ' HD3' ' CG ' ' B' ' 483' ' ' MET . 52.6 Cg_endo -71.72 -30.64 14.23 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.691 2.26 . . . . 0.0 111.85 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.51 ' N ' HD12 ' B' ' 464' ' ' ILE . 33.4 m120 -52.53 -20.8 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.535 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 5.3 mp -104.74 124.48 49.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.605 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.79 173.86 35.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -51.37 -44.66 62.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -70.33 -36.77 74.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.9 t -54.93 -52.27 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.516 ' CD2' HD12 ' A' ' 290' ' ' LEU . 22.5 tp -52.91 -39.49 62.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.8 m -59.11 -50.17 75.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.236 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.459 ' OE2' HD21 ' A' ' 262' ' ' LEU . 54.0 tt0 -53.73 -44.92 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.089 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 63.6 mt -57.65 -40.43 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 108.783 179.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.66 -40.08 90.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.343 -0.848 . . . . 0.0 108.742 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.09 -46.18 85.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.367 -0.833 . . . . 0.0 108.827 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . . . . . . . . . 16.9 t -69.95 -35.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 108.819 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.467 HD11 ' O ' ' A' ' 313' ' ' SER . 17.1 tp -63.5 -26.78 68.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.371 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.77 -28.92 64.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.209 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.2 p -69.31 -12.14 61.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.404 ' C ' HD21 ' A' ' 314' ' ' LEU . 69.8 mtt180 57.36 15.78 2.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.37 -15.47 13.91 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.496 ' CD1' ' CG2' ' A' ' 278' ' ' ILE . 9.0 tp -137.5 136.15 37.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -1.182 . . . . 0.0 109.155 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.469 ' CB ' ' O ' ' A' ' 312' ' ' LEU . 0.3 OUTLIER 73.37 41.93 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' A' ' 314' ' ' LEU . 3.8 mm? -92.22 13.17 19.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.68 36.88 83.86 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.567 ' CE ' ' CD1' ' A' ' 253' ' ' LEU . 7.5 mtm -84.28 170.3 13.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 45.4 mtm105 -141.0 129.56 22.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.539 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.7 mp -133.05 136.32 45.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.48 -39.89 64.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.038 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 69.5 m-20 -129.75 -65.13 0.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.537 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.0 t-105 167.31 -65.92 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.69 107.99 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.679 2.253 . . . . 0.0 112.169 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.8 Cg_endo -72.86 161.21 44.29 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.622 2.214 . . . . 0.0 111.53 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.84 -18.84 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.601 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' SER . . . . . 0.457 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 16.3 m -64.29 -49.26 72.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . . . . . . . . . 26.9 mt -51.07 -36.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -71.05 148.46 47.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.63 -38.9 82.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.481 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.5 -34.14 74.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.9 m120 -89.48 19.97 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -62.02 121.83 68.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . 0.429 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 49.5 Cg_endo -70.05 131.21 20.36 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.641 2.227 . . . . 0.0 111.741 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.42 ' HB2' ' HA ' ' B' ' 455' ' ' THR . . . -66.37 153.86 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' B' ' 436' ' ' ASN . 92.0 m-20 -54.32 -29.57 48.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' B' ' 456' ' ' LEU . 91.2 m-20 -67.05 -50.1 62.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 27.3 tp -67.78 -42.02 82.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -71.35 -26.88 63.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.38 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 432' ' ' ASP . 40.8 t30 -96.65 7.92 45.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.628 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' B' ' 438' ' ' GLU . 1.6 tm? -78.09 120.39 22.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' B' ' 437' ' ' LEU . 23.6 pt-20 -60.57 140.89 57.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 96.31 -3.64 64.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.558 ' CG2' ' CD2' ' B' ' 481' ' ' LEU . 47.0 t -120.67 129.98 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.123 -1.222 . . . . 0.0 109.487 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -87.05 154.42 20.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 72.8 mtt180 -49.98 -45.18 51.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.33 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . 0.565 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 94.3 m-20 -67.83 -46.56 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' B' ' 473' ' ' LEU . 14.1 tp -53.67 -40.83 66.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.114 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.4 91.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 108.978 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.565 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 12.7 m-30 -58.55 -40.18 82.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.102 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -62.21 -42.43 99.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . . . . . . . . . 88.4 mt -62.02 -45.01 95.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.87 -40.33 84.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.9 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.55 -33.25 3.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 26.2 mtp85 -91.24 22.32 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.6 7.17 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' B' ' 458' ' ' ASP . 5.8 t -83.15 110.0 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.914 -1.344 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 14.9 m -127.51 -35.76 2.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.94 . . . . 0.0 109.587 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.42 ' HA ' ' HB2' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -79.62 140.69 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.554 ' CD2' ' CD1' ' B' ' 488' ' ' ILE . 23.5 tp -45.64 -43.64 12.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.191 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . 0.403 ' HA ' ' SG ' ' B' ' 489' ' ' CYS . 13.3 mt-10 -60.1 -46.32 90.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.177 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.495 ' CB ' HG13 ' B' ' 453' ' ' VAL . 88.4 m-20 -54.94 -38.01 67.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.133 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.403 ' HA ' HG11 ' B' ' 453' ' ' VAL . 33.3 tp -63.79 -42.9 97.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.226 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.36 -37.69 75.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 179.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.46 -30.55 71.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.466 ' CG ' HG22 ' B' ' 453' ' ' VAL . 97.8 mm-40 -73.52 148.72 42.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -107.71 154.11 16.66 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.517 ' CG2' ' HA ' ' B' ' 475' ' ' ASP . 96.5 mt -44.98 -36.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.144 -1.21 . . . . 0.0 109.27 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -36.88 82.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.245 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.2 m-20 -71.41 -28.71 64.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.41 ' CD2' ' CB ' ' B' ' 478' ' ' ALA . 7.1 mp -82.84 -30.68 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.963 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.39 -24.69 60.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -51.35 -33.15 28.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.892 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.443 ' HB ' HD21 ' B' ' 473' ' ' LEU . 64.4 mt -102.24 127.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -59.73 -31.01 69.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -59.2 -25.67 60.37 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.522 ' CD1' ' CD1' ' B' ' 444' ' ' LEU . 3.5 mm? -103.38 129.19 50.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -1.106 . . . . 0.0 109.562 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 23.4 m -103.61 162.02 13.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.517 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 83.6 m-20 -55.88 -39.14 71.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.1 -45.85 25.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -62.37 -46.62 87.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.453 ' O ' HG13 ' B' ' 482' ' ' ILE . . . -65.53 -45.91 81.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -63.59 -52.12 48.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.48 -42.22 61.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.215 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.558 ' CD2' ' CG2' ' B' ' 440' ' ' VAL . 6.4 mp -67.28 -42.3 84.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.36 -0.837 . . . . 0.0 109.442 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.52 ' CG2' ' NE ' ' B' ' 486' ' ' ARG . 45.3 mt -56.41 -56.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.526 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 43.4 mmm -53.29 -44.88 68.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -57.26 -60.77 3.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.193 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.472 ' HB1' ' CD1' ' B' ' 456' ' ' LEU . . . -55.7 -43.3 76.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.196 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.52 ' NE ' ' CG2' ' B' ' 482' ' ' ILE . 94.8 mtt180 -59.55 -41.96 91.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.831 . . . . 0.0 109.19 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.569 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 98.1 m-20 -57.84 -41.31 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.291 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.554 ' CD1' ' CD2' ' B' ' 456' ' ' LEU . 24.3 mt -68.55 -38.55 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.309 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . 0.403 ' SG ' ' HA ' ' B' ' 457' ' ' GLU . 66.4 m -70.27 -51.62 29.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -61.37 -38.19 86.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.569 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 19.2 m-30 -76.29 -36.86 58.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.0 109.406 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 495' ' ' ALA . . . 53.46 -127.67 37.3 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -53.39 -42.12 66.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.352 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . 0.428 ' O ' ' HB3' ' B' ' 495' ' ' ALA . 95.6 mt-10 -54.94 -34.13 62.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' B' ' 491' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.535 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' PHE . . . . . 0.556 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 42.0 p90 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 254' ' ' LEU . 0.5 OUTLIER -69.67 137.53 88.11 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.239 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 255' ' ' ARG . 43.2 Cg_endo -65.31 -26.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.705 2.27 . . . . 0.0 111.673 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ILE . . . . . 0.419 HG23 ' HB3' ' A' ' 250' ' ' ASP . 6.0 tt -71.22 -28.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 108.709 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' LEU . . . . . 0.588 HD22 ' CZ3' ' A' ' 321' ' ' TRP . 3.1 tp -74.35 -27.18 60.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.562 ' HG ' ' CH2' ' A' ' 321' ' ' TRP . 4.0 mp -101.67 -20.98 14.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 251' ' ' PRO . 16.2 mtt180 -55.09 147.59 33.69 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.019 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.6 Cg_endo -69.56 132.46 23.7 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.687 2.258 . . . . 0.0 111.954 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' VAL . . . . . 0.445 HG21 ' HG3' ' A' ' 271' ' ' LYS . 0.2 OUTLIER -44.62 -30.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.275 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -64.25 -30.69 71.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 12.9 m-20 -69.57 -16.99 63.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 46.1 mt -57.43 144.73 35.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 82.2 tt0 -65.23 -14.4 60.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.504 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.496 HD23 ' CB ' ' A' ' 302' ' ' GLU . 8.0 mp -60.24 173.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.574 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.7 p -74.73 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' VAL . . . . . 0.414 ' O ' ' CG ' ' A' ' 268' ' ' ASN . 18.5 t -62.56 -31.76 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ARG . . . . . 0.53 ' HD3' ' N ' ' A' ' 265' ' ' ARG . 6.8 mmt85 -60.08 -44.95 94.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.136 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' SER . . . . . 0.45 ' OG ' HD22 ' A' ' 262' ' ' LEU . 7.8 t -57.83 -51.01 71.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.214 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -66.56 -34.21 77.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.912 . . . . 0.0 109.106 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ASN . . . . . 0.414 ' CG ' ' O ' ' A' ' 264' ' ' VAL . 93.3 m-20 -61.61 -38.88 89.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 265' ' ' ARG . 39.8 m -49.86 -60.12 3.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' LEU . . . . . 0.515 HD13 ' CD1' ' A' ' 281' ' ' LEU . 45.3 mt -63.52 -48.33 77.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.301 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 52.5 mtmt -53.27 -39.69 64.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.81 -24.74 6.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.334 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' GLU . . . . . . . . . . . . . 54.0 tt0 -93.47 24.72 3.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ALA . . . . . . . . . . . . . . . 66.23 29.85 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ILE . . . . . 0.519 HG22 ' CB ' ' A' ' 280' ' ' ASP . 54.7 mt -124.22 108.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 256' ' ' PRO . 89.5 m-70 -100.85 -6.83 24.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.14 140.83 37.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.48 ' O ' ' N ' ' A' ' 281' ' ' LEU . 56.6 mt -72.61 -30.19 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.529 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' GLY . . . . . 0.551 ' HA3' ' CH2' ' A' ' 321' ' ' TRP . . . -45.5 -48.37 11.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ASP . . . . . 0.519 ' CB ' HG22 ' A' ' 275' ' ' ILE . 82.5 m-20 -53.0 -33.73 53.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.922 -1.34 . . . . 0.0 108.527 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' LEU . . . . . 0.515 ' CD1' HD13 ' A' ' 270' ' ' LEU . 26.9 tp -52.98 -52.7 57.42 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' VAL . . . . . 0.533 ' CG2' ' O ' ' A' ' 279' ' ' GLY . 25.3 m -62.47 -27.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' GLN . . . . . 0.531 ' N ' HG21 ' A' ' 282' ' ' VAL . 53.0 tt0 -58.21 -37.95 75.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 86.0 mtt-85 -98.07 140.92 31.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.799 . . . . 0.0 108.975 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.0 m -63.64 141.17 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 109.712 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' GLU . . . . . 0.461 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 49.0 tp10 -53.33 -27.27 22.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.3 t -52.8 -51.81 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 93.6 mt-10 -51.87 -33.66 37.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.083 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 286' ' ' GLU . 40.5 mt -64.94 -46.76 80.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 3.9 mt -61.88 -29.76 70.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.446 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' LYS . . . . . 0.529 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 23.4 mttm -84.96 -20.65 30.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' THR . . . . . 0.464 ' O ' HD12 ' A' ' 295' ' ' LEU . 15.7 m -82.12 116.42 63.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.63 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 464' ' ' ILE . 52.1 Cg_endo -71.16 -24.35 23.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.626 2.217 . . . . 0.0 111.843 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.5 ' N ' HD13 ' B' ' 464' ' ' ILE . 34.4 m120 -46.94 -23.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 295' ' ' LEU . 3.0 mp -96.02 138.87 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.84 163.29 33.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -50.79 -45.28 59.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -1.189 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -65.73 -42.12 91.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.8 t -56.1 -55.13 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 109.277 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' LEU . . . . . 0.464 HD22 ' HB2' ' A' ' 295' ' ' LEU . 49.9 mt -54.42 -47.02 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.4 m -50.37 -53.0 32.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.234 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' GLU . . . . . 0.496 ' CB ' HD23 ' A' ' 262' ' ' LEU . 60.9 mm-40 -53.75 -38.44 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 300' ' ' LEU . 93.5 mt -57.79 -46.04 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -60.38 -39.76 88.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.06 -49.92 70.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.851 . . . . 0.0 109.347 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' VAL . . . . . 0.487 ' CG1' HD21 ' A' ' 312' ' ' LEU . 2.2 t -63.55 -41.09 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 109.203 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' LEU . . . . . 0.52 HD11 ' CB ' ' A' ' 313' ' ' SER . 24.1 tp -53.91 -26.62 26.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.86 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.313 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 20.9 t -68.98 -7.72 37.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' ARG . . . . . 0.51 ' HA ' ' CD2' ' A' ' 314' ' ' LEU . 66.2 mtt180 65.64 8.98 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.365 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -72.26 -31.24 63.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' LEU . . . . . 0.487 HD21 ' CG1' ' A' ' 306' ' ' VAL . 1.0 OUTLIER -148.16 173.12 13.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 109.51 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' SER . . . . . 0.52 ' CB ' HD11 ' A' ' 307' ' ' LEU . 2.8 m 61.77 30.66 18.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.897 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' LEU . . . . . 0.51 ' CD2' ' HA ' ' A' ' 310' ' ' ARG . 68.4 mt -79.41 -5.46 54.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.515 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.86 38.82 65.36 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' MET . . . . . 0.506 ' HE1' ' CD1' ' A' ' 253' ' ' LEU . 4.2 ptt? -107.42 162.11 14.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -1.216 . . . . 0.0 109.361 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ARG . . . . . 0.418 ' C ' HD11 ' A' ' 318' ' ' LEU . 44.5 mtm180 -128.2 134.37 49.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' LEU . . . . . 0.552 ' CD1' ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -116.51 143.12 45.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.78 -33.71 70.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.261 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -135.02 -68.23 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' TRP . . . . . 0.588 ' CZ3' HD22 ' A' ' 253' ' ' LEU . 0.7 OUTLIER 176.98 -64.96 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.376 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 49.9 Cg_endo -68.67 107.5 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 112.041 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.7 Cg_endo -72.54 164.79 34.56 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.571 2.181 . . . . 0.0 111.579 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.92 -19.03 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.279 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 61.0 m -65.77 -47.85 73.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' ILE . . . . . 0.52 ' CD1' HD22 ' A' ' 254' ' ' LEU . 19.4 mt -53.15 -33.98 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -59.86 147.47 38.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -0.98 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -61.58 -38.38 87.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.453 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 426' ' ' GLY . . . . . 0.461 ' O ' ' HG2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.44 -31.46 70.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -1.119 . . . . 0.0 109.421 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 428' ' ' ASN . . . . . 0.487 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 29.5 m120 -123.94 37.97 4.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 429' ' ' LYS . . . . . 0.461 ' HG2' ' O ' ' B' ' 426' ' ' GLY . 1.7 ptmt -51.19 136.25 29.72 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.587 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -70.9 140.97 39.5 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.711 2.274 . . . . 0.0 111.652 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 431' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' B' ' 455' ' ' THR . . . -73.92 165.56 24.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 109.662 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 432' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' B' ' 432' ' ' ASP . 25.4 p-10 -61.68 -34.12 75.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 433' ' ' ASP . . . . . 0.582 ' CB ' ' CB ' ' B' ' 456' ' ' LEU . 5.2 m-20 -63.4 -49.21 74.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.072 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 434' ' ' LEU . . . . . 0.498 ' CD1' ' HB1' ' B' ' 445' ' ' ALA . 3.4 tm? -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 435' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.72 -35.55 67.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -88.57 4.68 46.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 437' ' ' LEU . . . . . 0.413 HD23 HG23 ' B' ' 440' ' ' VAL . 31.8 tp -71.98 132.76 44.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -76.78 141.59 40.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.2 9.39 62.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 440' ' ' VAL . . . . . 0.413 HG23 HD23 ' B' ' 437' ' ' LEU . 47.9 t -125.89 131.52 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -1.129 . . . . 0.0 109.422 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -97.64 160.66 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 442' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 93.7 mtt180 -52.08 -41.35 62.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.964 . . . . 0.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.03 -42.29 85.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.449 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 444' ' ' LEU . . . . . 0.427 HD13 ' NZ ' ' B' ' 477' ' ' LYS . 53.6 mt -64.98 -42.56 94.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 445' ' ' ALA . . . . . 0.498 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.18 -41.46 88.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 446' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 10.3 m-30 -64.14 -40.5 96.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 447' ' ' LYS . . . . . 0.458 ' HB3' HD12 ' B' ' 470' ' ' ILE . 66.5 mttm -61.68 -41.23 97.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 448' ' ' LEU . . . . . 0.424 ' CD2' HD13 ' B' ' 473' ' ' LEU . 80.9 mt -64.86 -39.22 93.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 449' ' ' ALA . . . . . 0.487 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -67.06 -37.46 84.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.97 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 451' ' ' ARG . . . . . 0.493 ' NH1' ' O ' ' B' ' 466' ' ' ASP . 35.3 mtm105 -89.7 23.34 2.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.74 6.77 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 453' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 8.9 t -81.84 107.24 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.355 . . . . 0.0 109.314 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 454' ' ' CYS . . . . . 0.453 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 60.4 m -123.74 -44.38 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 0.0 109.697 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 455' ' ' THR . . . . . 0.521 ' HA ' ' CB ' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -71.97 140.84 49.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 456' ' ' LEU . . . . . 0.582 ' CB ' ' CB ' ' B' ' 433' ' ' ASP . 2.6 tm? -51.76 -37.91 53.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.14 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -63.07 -40.83 98.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.743 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 458' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 68.7 m-20 -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.089 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 459' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' B' ' 459' ' ' LEU . 3.5 tm? -59.65 -41.84 91.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.37 74.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.394 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.68 -25.76 62.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 462' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 98.3 mm-40 -67.79 163.11 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.66 156.86 15.98 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 464' ' ' ILE . . . . . 0.522 ' CD1' ' HG2' ' A' ' 293' ' ' PRO . 58.6 mt -51.94 -34.95 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -1.182 . . . . 0.0 109.495 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -68.48 -35.95 78.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 466' ' ' ASP . . . . . 0.493 ' O ' ' NH1' ' B' ' 451' ' ' ARG . 87.3 m-20 -72.34 -31.52 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 467' ' ' LEU . . . . . 0.518 HD12 ' CB ' ' B' ' 478' ' ' ALA . 21.7 mt -74.41 -25.34 59.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -24.27 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -48.06 -33.58 8.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 470' ' ' ILE . . . . . 0.458 HD12 ' HB3' ' B' ' 447' ' ' LYS . 61.3 mt -103.36 128.1 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.37 -31.82 72.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -56.81 -30.92 60.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 473' ' ' LEU . . . . . 0.424 HD13 ' CD2' ' B' ' 448' ' ' LEU . 73.8 mt -101.53 131.03 47.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -1.185 . . . . 0.0 109.579 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.84 163.35 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 475' ' ' ASP . . . . . 0.466 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 88.3 m-20 -57.87 -38.19 75.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -73.81 -46.04 47.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 477' ' ' LYS . . . . . 0.453 ' O ' HD13 ' B' ' 481' ' ' LEU . 15.7 tttp -64.78 -42.44 95.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 478' ' ' ALA . . . . . 0.518 ' CB ' HD12 ' B' ' 467' ' ' LEU . . . -61.55 -46.03 91.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 479' ' ' GLY . . . . . 0.437 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.33 -45.98 92.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.91 84.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -1.116 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 481' ' ' LEU . . . . . 0.453 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.4 mp -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 482' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 293' ' ' PRO . 47.9 mt -66.89 -54.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 483' ' ' MET . . . . . 0.529 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 49.1 mtp -52.22 -37.41 55.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.395 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 484' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.49 -57.13 5.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.167 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 485' ' ' ALA . . . . . 0.522 ' HB1' ' CD2' ' B' ' 456' ' ' LEU . . . -62.87 -52.09 64.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 486' ' ' ARG . . . . . 0.422 ' N ' ' O ' ' B' ' 482' ' ' ILE . 21.6 ttm180 -46.27 -48.77 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.203 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 487' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.2 m-20 -58.95 -41.5 87.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 488' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 492' ' ' GLY . 80.2 mt -58.93 -37.61 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 41.7 t -70.58 -49.12 51.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.606 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.41 -41.77 72.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 491' ' ' PHE . . . . . 0.466 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 46.1 m-85 -79.78 -36.06 37.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 492' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' B' ' 494' ' ' GLU . . . 66.08 9.51 47.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 63.96 -72.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -1.127 . . . . 0.0 109.607 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 494' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' B' ' 492' ' ' GLY . 89.2 mt-10 -91.28 150.65 21.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 109.441 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 495' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.506 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.569 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 38.4 p90 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.18 121.72 13.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.241 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.67 -26.56 60.96 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.645 2.23 . . . . 0.0 111.469 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.866 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.9 tt -69.59 -31.99 50.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.473 HD11 ' HE2' ' A' ' 316' ' ' MET . 34.2 mt -75.15 -45.16 42.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.4 -0.812 . . . . 0.0 109.39 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.913 HD21 HD11 ' A' ' 326' ' ' ILE . 0.3 OUTLIER -64.01 -37.35 87.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.453 ' CD ' ' OD2' ' A' ' 259' ' ' ASP . 5.2 ttp180 -59.6 141.86 88.1 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.241 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.2 Cg_endo -68.87 133.6 27.65 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.651 2.234 . . . . 0.0 111.691 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.582 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.0 OUTLIER -44.9 -25.36 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 256' ' ' PRO . 91.1 m-20 -69.58 -30.56 68.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.212 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 48.8 t0 -66.7 -22.55 66.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 257' ' ' VAL . 38.5 mt -43.62 131.44 5.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -55.93 -24.79 40.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.724 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.6 mp -62.35 163.59 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.3 p -62.87 161.09 13.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.796 HG12 ' OD1' ' A' ' 268' ' ' ASN . 20.4 t -54.76 -26.1 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -51.93 -44.11 63.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.436 ' CB ' ' OE1' ' A' ' 302' ' ' GLU . 8.7 t -58.79 -50.61 73.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -70.49 -33.56 71.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.796 ' OD1' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -56.42 -38.22 71.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 299' ' ' SER . 24.8 m -60.62 -64.6 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.701 HD13 HD23 ' A' ' 281' ' ' LEU . 63.7 mt -64.7 -46.64 81.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 76.9 tttt -52.98 -34.01 54.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.76 -23.59 12.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.9 mt-10 -89.05 22.59 2.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.89 36.48 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.78 HG23 ' HB3' ' A' ' 280' ' ' ASP . 70.6 mt -112.16 127.38 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.592 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.9 p80 -116.68 -30.28 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.588 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.592 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.8 m-30 -106.57 127.8 53.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.5 mt -48.26 -30.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.972 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.5 -48.64 16.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.78 ' HB3' HG23 ' A' ' 275' ' ' ILE . 40.0 t0 -53.39 -32.96 51.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.198 . . . . 0.0 108.899 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.759 ' C ' HD13 ' A' ' 281' ' ' LEU . 3.4 tm? -56.82 -46.95 81.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.386 -0.821 . . . . 0.0 109.111 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.972 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.1 m -69.01 -23.22 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 95.5 mt-30 -66.2 -36.98 84.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.948 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -104.4 143.06 33.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 288' ' ' GLU . 43.9 p -80.0 151.83 29.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.574 ' OE2' HD22 ' A' ' 307' ' ' LEU . 8.9 mt-10 -54.45 -39.46 67.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.8 t -52.98 -55.27 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 285' ' ' THR . 95.6 mt-10 -53.15 -30.58 37.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 292' ' ' THR . 8.4 mp -79.64 -42.42 24.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.7 mt -65.04 -12.75 54.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.491 ' C ' ' HE2' ' B' ' 483' ' ' MET . 45.7 mmtm -89.14 12.34 16.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.5 t -124.83 138.74 31.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.595 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.7 Cg_endo -70.82 -27.05 21.89 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.789 2.326 . . . . 0.0 111.78 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -48.32 -24.4 1.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 289' ' ' LEU . 20.3 mt -87.6 143.13 27.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.358 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -110.47 160.38 13.36 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.92 -42.27 72.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -1.156 . . . . 0.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -67.38 -37.84 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.364 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 269' ' ' CYS . 81.1 p -59.18 -39.4 82.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.337 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 290' ' ' LEU . 0.6 OUTLIER -57.99 -42.65 85.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.378 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 49.8 m -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.1 mt-10 -56.59 -42.8 79.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 80.7 mt -57.91 -48.26 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -54.74 -41.57 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -58.29 -51.42 69.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.6 t -68.72 -37.19 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.838 HD13 ' HB3' ' A' ' 313' ' ' SER . 20.0 tp -62.03 -26.43 68.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.315 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.23 -29.99 66.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.5 t -74.11 -13.37 60.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.2 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.774 ' HA ' HD11 ' A' ' 314' ' ' LEU . 51.2 mtt-85 61.17 13.51 4.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 109.307 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -88.98 -24.56 31.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.785 ' H ' HD23 ' A' ' 312' ' ' LEU . 1.6 pt? -139.32 153.25 47.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -1.139 . . . . 0.0 109.562 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.838 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 71.45 32.62 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.774 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.5 mm? -89.27 14.12 11.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.268 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.5 44.88 92.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.719 ' HE2' HG11 ' A' ' 282' ' ' VAL . 8.0 mtm -94.21 168.75 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.494 ' C ' HD23 ' A' ' 318' ' ' LEU . 53.6 mtt180 -134.05 121.61 21.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 317' ' ' ARG . 5.2 mt -113.4 138.11 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.383 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.58 -32.17 67.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.159 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 72.3 m-20 -135.05 -64.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 108.988 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.837 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.2 t-105 164.73 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.371 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.565 ' HA ' HD12 ' A' ' 326' ' ' ILE . 48.2 Cg_endo -68.09 107.91 1.63 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.595 2.197 . . . . 0.0 111.967 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.51 163.07 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.667 2.245 . . . . 0.0 111.689 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.18 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.41 ' CB ' ' N ' ' A' ' 249' ' ' PHE . 3.8 t -58.73 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.913 HD11 HD21 ' A' ' 254' ' ' LEU . 30.3 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.455 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 3.1 tttp -67.77 136.52 92.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.512 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.31 136.53 31.75 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.69 2.26 . . . . 0.0 111.724 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -71.13 159.51 34.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.38 -33.77 63.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.73 -48.32 77.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -38.4 75.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.891 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -73.06 -31.44 64.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -84.83 7.73 19.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.774 HD23 HG21 ' B' ' 440' ' ' VAL . 30.1 tp -72.28 133.83 45.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.86 140.83 40.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.16 2.96 68.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.774 HG21 HD23 ' B' ' 437' ' ' LEU . 58.8 t -130.82 137.15 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -1.187 . . . . 0.0 109.421 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 39.6 p30 -103.75 173.55 6.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.565 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 74.8 mtt85 -58.31 -40.52 82.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.63 -49.53 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.64 HD22 HD21 ' B' ' 473' ' ' LEU . 45.8 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.544 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.29 89.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 17.3 m-30 -66.18 -47.99 72.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 470' ' ' ILE . 61.6 mttt -58.88 -46.38 87.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.585 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.865 ' O ' HD13 ' B' ' 448' ' ' LEU . 3.1 tm? -64.12 -41.17 97.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.36 -30.68 71.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -56.79 -18.52 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.401 ' NH1' ' CB ' ' B' ' 469' ' ' ASP . 14.3 mtp85 -90.65 31.6 1.04 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.82 -18.88 6.84 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' B' ' 458' ' ' ASP . 96.3 t -63.51 139.87 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.878 -1.366 . . . . 0.0 109.382 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.511 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -135.01 -36.01 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 109.701 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -111.04 148.63 32.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 1.069 HD21 HD12 ' B' ' 488' ' ' ILE . 30.0 tp -46.17 -40.14 10.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.167 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -56.75 -49.65 74.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.848 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.759 ' HB3' HG13 ' B' ' 453' ' ' VAL . 37.4 t0 -54.8 -38.78 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.108 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.776 HD13 ' C ' ' B' ' 459' ' ' LEU . 2.9 tm? -60.04 -41.49 92.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.14 76.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 0.0 109.393 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.93 -30.77 71.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.474 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -67.53 151.85 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 109.565 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.84 165.82 12.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.884 HD11 ' HG2' ' A' ' 293' ' ' PRO . 28.9 mt -53.28 -35.75 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -1.209 . . . . 0.0 109.4 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.02 -31.27 67.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.999 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -75.44 -29.05 59.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -23.75 62.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 469' ' ' ASP . . . . . 0.401 ' CB ' ' NH1' ' B' ' 451' ' ' ARG . 86.3 m-20 -50.1 -33.97 20.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 447' ' ' LYS . 65.6 mt -100.89 127.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.25 -33.09 74.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.04 -31.56 40.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.64 HD21 HD22 ' B' ' 444' ' ' LEU . 50.5 mt -101.11 140.49 35.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.449 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.11 161.85 13.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.389 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.449 ' N ' HG22 ' B' ' 474' ' ' THR . 81.3 m-20 -57.91 -37.62 74.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -73.88 -46.06 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 39.2 tttp -68.74 -37.02 79.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.999 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.08 -44.68 91.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -63.87 -43.1 98.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.82 -33.97 70.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -1.125 . . . . 0.0 109.406 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 31.0 mt -74.39 -35.16 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 478' ' ' ALA . 78.6 mt -64.03 -53.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.537 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.508 ' HE1' ' O ' ' A' ' 290' ' ' LEU . 52.6 mmm -60.74 -42.48 97.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 109.426 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.44 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -58.29 -47.36 83.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -66.0 -47.68 73.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.536 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.505 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 40.2 ttm180 -60.8 -42.62 97.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.48 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 95.9 m-20 -58.85 -39.25 80.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 1.069 HD12 HD21 ' B' ' 456' ' ' LEU . 66.1 mt -62.27 -40.35 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.82 -52.06 16.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.679 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 490' ' ' TRP . . . . . 0.505 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 67.2 m95 -64.44 -38.48 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.9 m-85 -99.19 13.1 34.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.784 ' N ' ' HG ' ' A' ' 325' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.4 126.56 84.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.46 -32.21 50.01 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.794 2.329 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 278' ' ' ILE . 2.9 tt -66.27 -23.55 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 311' ' ' GLY . 5.3 tp -74.28 -44.12 54.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.459 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 326' ' ' ILE . 2.2 mm? -73.63 -20.36 60.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.555 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -63.87 149.87 92.41 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.0 Cg_endo -69.86 136.31 32.41 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.604 2.202 . . . . 0.0 111.934 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.542 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.79 -31.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.885 . . . . 0.0 109.424 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.35 -30.95 71.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 256' ' ' PRO . 53.8 m-20 -73.03 -14.09 61.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.631 HD21 HD13 ' A' ' 278' ' ' ILE . 59.4 mt -54.13 150.73 7.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.12 -21.52 65.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.811 HD22 ' OG ' ' A' ' 266' ' ' SER . 5.3 mp -64.64 166.08 9.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -79.88 165.27 22.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 264' ' ' VAL . 3.9 t -47.0 -32.85 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.457 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -52.78 -50.21 64.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.811 ' OG ' HD22 ' A' ' 262' ' ' LEU . 22.2 t -59.53 -51.11 71.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.34 86.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.315 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.6 m-20 -56.64 -36.89 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.339 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 60.0 m -55.41 -64.98 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.641 ' CD2' HD12 ' A' ' 289' ' ' LEU . 65.2 mt -62.41 -47.69 82.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 23.2 tttt -53.02 -36.88 61.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.79 -30.0 30.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.9 mt-10 -94.01 23.99 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.377 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.07 41.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 280' ' ' ASP . 90.3 mt -122.82 107.66 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.519 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.472 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 64.0 m-70 -109.71 -6.75 15.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.35 129.24 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.719 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.9 mt -54.72 -30.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.793 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.02 -46.78 14.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.676 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.4 m-20 -53.48 -30.9 43.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.038 -1.272 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 270' ' ' LEU . 31.4 tp -59.26 -49.9 76.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 109.136 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 279' ' ' GLY . 30.2 m -67.51 -30.55 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 108.967 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.44 -32.83 70.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 108.949 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -109.84 143.84 39.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.0 m -63.7 137.96 58.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.412 ' OE1' ' CD2' ' A' ' 307' ' ' LEU . 80.4 tt0 -50.58 -33.51 22.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.387 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 1.046 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.2 t -54.86 -54.34 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -51.15 -30.72 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.24 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.996 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -79.15 -43.67 23.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.257 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 1.046 HD12 ' HA ' ' A' ' 287' ' ' VAL . 5.4 mt -56.85 -18.73 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.645 ' O ' ' HE2' ' B' ' 483' ' ' MET . 69.5 mttt -81.44 -21.94 38.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.357 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 294' ' ' ASN . 9.8 m -59.49 128.52 86.12 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.634 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.675 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.8 Cg_endo -71.16 -14.84 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.804 2.336 . . . . 0.0 112.001 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' B' ' 464' ' ' ILE . 53.2 m-80 -78.47 3.65 15.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.996 HD11 ' O ' ' A' ' 289' ' ' LEU . 72.1 mt -81.33 149.55 28.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.517 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -108.63 140.92 15.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -52.81 -47.13 67.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -1.188 . . . . 0.0 109.455 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.99 -25.31 59.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 296' ' ' GLY . 82.5 p -73.13 -36.8 66.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 295' ' ' LEU . 29.7 mt -54.31 -39.24 66.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -54.26 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 306' ' ' VAL . 67.7 tt0 -53.82 -39.97 65.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 109.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 300' ' ' LEU . 84.5 mt -57.63 -45.85 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 108.917 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.11 -33.93 74.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 108.964 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.42 -41.58 97.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 109.248 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 1.04 HG12 ' CD2' ' A' ' 312' ' ' LEU . 1.7 t -68.25 -45.65 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.441 HD12 HD11 ' A' ' 312' ' ' LEU . 8.2 mp -56.43 -26.77 54.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.11 70.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.0 t -65.51 -17.39 64.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.897 ' O ' HD21 ' A' ' 314' ' ' LEU . 11.7 ttp180 65.93 9.07 5.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.368 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.619 ' O ' HD13 ' A' ' 253' ' ' LEU . . . -94.95 -0.3 63.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.04 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.29 163.09 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -1.215 . . . . 0.0 109.44 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.2 OUTLIER 48.47 54.96 9.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.641 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 310' ' ' ARG . 76.7 mt -91.81 9.39 32.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.36 38.22 96.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.533 ' CE ' HD12 ' A' ' 314' ' ' LEU . 5.6 ptt? -113.3 157.44 21.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.603 ' C ' HD12 ' A' ' 318' ' ' LEU . 77.6 mtt85 -130.23 137.72 50.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.8 mp -123.47 140.89 52.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 108.951 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.5 m-20 -122.45 -81.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.673 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 165.24 -65.98 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 50.7 Cg_endo -69.47 107.77 1.88 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.563 2.175 . . . . 0.0 111.95 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.587 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.1 Cg_endo -71.91 163.91 37.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.622 2.214 . . . . 0.0 111.6 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.6 25.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.969 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.784 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 62.1 p -70.54 -38.97 74.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.46 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 254' ' ' LEU . 34.3 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.827 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 24.3 m120 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.234 0.54 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 20.0 tttm -53.03 136.89 47.48 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.489 ' HD2' ' HG3' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.09 136.76 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.641 2.227 . . . . 0.0 111.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.1 153.23 41.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.513 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -47.06 -38.6 11.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -62.29 -40.73 97.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.996 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.5 tm? -66.66 -29.87 69.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 442' ' ' ARG . 25.2 tp -85.69 -28.52 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.85 -5.81 43.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.908 HD23 HG21 ' B' ' 440' ' ' VAL . 35.4 tp -65.82 134.81 53.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -78.26 141.19 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.3 8.34 64.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.908 HG21 HD23 ' B' ' 437' ' ' LEU . 46.6 t -128.19 132.22 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.164 . . . . 0.0 109.471 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.577 ' H ' HD12 ' B' ' 444' ' ' LEU . 83.7 m-20 -97.89 166.0 11.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.405 ' HG2' HD11 ' B' ' 435' ' ' LEU . 92.7 mtt180 -54.7 -43.14 72.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.411 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.1 m-20 -66.15 -50.15 64.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.577 HD12 ' H ' ' B' ' 441' ' ' ASP . 29.7 mt -55.74 -43.43 76.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.09 -37.85 78.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.6 m-30 -64.59 -45.12 88.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 470' ' ' ILE . 81.5 mttt -62.86 -45.17 93.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 0.0 109.438 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.855 ' O ' HD13 ' B' ' 448' ' ' LEU . 1.4 tm? -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.14 -28.89 68.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.24 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -93.24 32.06 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.392 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.43 -18.61 6.65 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' B' ' 458' ' ' ASP . 84.3 t -60.9 139.48 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.9 -1.353 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 10.9 m -135.05 -35.88 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.769 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.59 159.39 20.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.896 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.771 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -48.56 -41.37 30.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.288 -0.883 . . . . 0.0 109.027 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -55.59 -42.28 74.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 0.0 108.766 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.91 ' CB ' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -59.86 -43.55 94.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 108.893 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.687 HD12 HD21 ' B' ' 434' ' ' LEU . 5.8 tt -54.31 -49.15 70.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 0.0 109.172 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.99 71.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.98 -25.71 67.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.357 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.5 mm-40 -70.48 152.23 44.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' B' ' 467' ' ' LEU . . . -116.12 162.84 12.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.675 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.2 mt -49.68 -36.67 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.5 -37.06 79.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.06 -25.12 66.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.876 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.6 mp -91.42 -27.72 18.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 0.0 109.484 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.85 -23.2 66.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.458 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.13 -32.85 68.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' B' ' 447' ' ' LYS . 73.5 mt -99.84 128.72 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.588 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.67 -32.37 74.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.462 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.38 -28.8 51.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.644 HD13 HD23 ' B' ' 467' ' ' LEU . 60.7 mt -103.68 137.19 42.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.504 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 475' ' ' ASP . 7.0 m -104.06 165.8 10.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.417 ' N ' HG22 ' B' ' 474' ' ' THR . 92.4 m-20 -58.68 -39.23 80.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.45 -45.39 31.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.463 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.51 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 48.0 tttm -60.75 -46.47 90.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.876 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -62.98 -53.22 57.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.516 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -58.38 -48.0 86.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.0 62.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -1.116 . . . . 0.0 109.388 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 96.5 mt -61.9 -43.67 98.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.5 mt -53.44 -56.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.645 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 50.1 mtp -52.93 -46.17 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.57 -52.93 63.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.477 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -61.75 -48.84 78.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 34.4 ttt180 -56.16 -45.28 79.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.83 -34.06 72.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.743 HD12 HD11 ' B' ' 456' ' ' LEU . 79.7 mt -68.31 -39.4 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.519 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.8 -50.59 16.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 490' ' ' TRP . . . . . 0.531 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 36.3 m95 -58.7 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.18 10.91 31.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.83 ' CZ ' HD21 ' A' ' 318' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -52.71 141.22 36.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.183 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.637 ' HA ' HD23 ' A' ' 254' ' ' LEU . 43.1 Cg_endo -65.0 -23.04 61.86 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.652 2.234 . . . . 0.0 111.903 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.923 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -64.77 -32.09 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.122 -0.986 . . . . 0.0 108.707 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.667 HD21 HG11 ' A' ' 282' ' ' VAL . 5.3 mp -74.34 -30.96 62.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.194 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 254' ' ' LEU . 3.5 mm? -69.13 -40.0 78.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.452 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -61.72 147.58 88.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 255' ' ' ARG . 48.3 Cg_endo -70.24 138.73 36.97 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.683 2.256 . . . . 0.0 111.701 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -43.5 -36.05 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.807 . . . . 0.0 109.461 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.49 -31.33 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 256' ' ' PRO . 70.6 m-20 -75.45 -11.0 59.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 257' ' ' VAL . 61.0 mt -47.47 143.54 3.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -59.94 -18.17 43.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.867 HD11 HG21 ' A' ' 306' ' ' VAL . 6.3 mp -67.86 167.1 14.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.9 p -69.53 160.23 31.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.526 HG12 ' OD1' ' A' ' 268' ' ' ASN . 14.0 t -50.5 -39.25 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -53.66 -48.96 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.9 m -57.78 -50.56 72.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.87 81.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.299 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.526 ' OD1' HG12 ' A' ' 264' ' ' VAL . 12.8 m120 -58.51 -36.68 74.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.2 m -55.76 -65.03 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.436 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 281' ' ' LEU . 75.2 mt -58.03 -46.68 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 24.6 tttt -53.46 -37.74 62.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.37 -24.81 13.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.618 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.7 mm-40 -89.35 23.71 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.93 38.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 280' ' ' ASP . 20.0 mm -112.29 121.53 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.449 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 8.3 p80 -113.13 -33.2 6.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.436 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.2 m-85 -109.8 131.28 55.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.591 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 252' ' ' ILE . 76.6 mt -48.88 -30.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.179 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.62 -45.35 23.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.863 ' HB2' HG23 ' A' ' 275' ' ' ILE . 57.3 m-20 -53.68 -35.02 60.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 109.078 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 270' ' ' LEU . 35.5 tp -56.28 -48.3 76.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 109.258 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.6 m -71.94 -35.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.013 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -51.54 -34.9 38.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.338 -0.851 . . . . 0.0 108.89 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -112.36 143.62 43.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.391 -0.818 . . . . 0.0 109.095 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 m -59.93 138.77 57.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.617 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -61.96 -28.53 69.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.93 -53.13 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 288' ' ' GLU . 71.1 mm-40 -51.66 -35.86 44.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.979 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -76.65 -36.27 57.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.066 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 1.008 ' O ' HD13 ' A' ' 290' ' ' LEU . 2.0 tm? -56.43 -29.17 61.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' B' ' 483' ' ' MET . 9.1 mttt -81.68 -18.84 43.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 294' ' ' ASN . 11.3 m -58.82 129.12 85.09 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.6 Cg_endo -70.46 -10.4 27.92 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.812 2.342 . . . . 0.0 111.83 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' B' ' 464' ' ' ILE . 32.6 m120 -79.66 4.09 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.979 HD11 ' O ' ' A' ' 289' ' ' LEU . 66.1 mt -84.0 146.99 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 296' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -111.66 141.6 16.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -48.74 -50.87 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.51 -33.97 71.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 303' ' ' ILE . 37.4 m -61.98 -40.79 96.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 295' ' ' LEU . 46.1 mt -52.97 -42.86 65.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.7 m -54.72 -50.83 67.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 306' ' ' VAL . 98.3 mt-10 -58.73 -39.23 80.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.798 HG22 HD13 ' A' ' 307' ' ' LEU . 23.9 mm -58.07 -47.32 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -60.56 -38.16 83.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.05 -46.4 89.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.359 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.954 ' CG1' HD21 ' A' ' 312' ' ' LEU . 2.0 t -70.19 -44.86 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.798 HD13 HG22 ' A' ' 303' ' ' ILE . 6.6 mp -62.78 -27.2 69.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.498 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.98 -33.26 70.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 66.2 p -77.49 -5.04 48.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 109.548 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.959 ' O ' HD21 ' A' ' 314' ' ' LEU . 8.9 mtt85 63.73 10.49 5.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.219 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -73.07 -22.23 79.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.954 HD21 ' CG1' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -146.64 163.1 36.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.379 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.7 OUTLIER 65.9 28.8 10.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.959 HD21 ' O ' ' A' ' 310' ' ' ARG . 93.4 mt -66.34 -14.41 62.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.24 11.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.673 ' HE3' HG21 ' A' ' 282' ' ' VAL . 4.6 ptt? -111.47 162.22 15.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.114 . . . . 0.0 109.448 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.542 ' C ' HD12 ' A' ' 318' ' ' LEU . 87.3 mtt-85 -130.76 133.49 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 249' ' ' PHE . 4.6 mp -118.3 145.29 45.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.79 -34.04 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 37.8 t-20 -125.94 -71.26 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.299 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.7 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.7 OUTLIER 167.43 -68.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.0 Cg_endo -69.7 107.88 1.94 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.504 2.136 . . . . 0.0 111.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.566 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 51.0 Cg_endo -72.1 158.12 52.86 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.529 2.153 . . . . 0.0 111.573 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.6 -15.69 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.378 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.1 m -68.55 -44.34 74.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 322' ' ' PRO . 24.5 pt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.784 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 21.3 m120 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.43 ' CG ' ' HD2' ' B' ' 430' ' ' PRO . 9.8 tttt -51.21 139.92 24.07 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.07 142.45 46.6 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.65 2.233 . . . . 0.0 111.933 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.55 150.35 41.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.34 -36.71 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -65.26 -46.36 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.774 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -67.87 -37.82 82.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.883 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.7 OUTLIER -69.16 -31.08 69.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.515 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -89.02 9.88 23.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.877 HD22 ' CD1' ' B' ' 456' ' ' LEU . 43.0 tp -72.43 133.56 44.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.87 142.1 40.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.77 6.57 67.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.824 HG21 HD23 ' B' ' 437' ' ' LEU . 57.4 t -127.62 131.38 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -83.75 149.04 26.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.516 ' HG3' ' NH1' ' B' ' 442' ' ' ARG . 9.4 mtt85 -50.02 -45.81 52.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.09 -39.46 82.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' B' ' 473' ' ' LEU . 15.8 tp -58.88 -37.77 77.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -60.7 -42.01 96.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.8 m-85 -64.69 -44.24 90.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.529 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 13.7 ttmm -58.63 -48.55 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.825 ' O ' HD13 ' B' ' 448' ' ' LEU . 3.4 tm? -65.17 -41.24 94.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.835 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -57.25 -26.84 61.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.68 -20.53 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.948 . . . . 0.0 109.472 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -89.75 26.59 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.942 . . . . 0.0 109.564 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.88 7.13 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 57.6 t -62.32 135.82 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.306 . . . . 0.0 109.326 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 69.0 m -135.01 -36.96 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.63 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -103.72 146.56 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 1.014 ' CD2' HD12 ' B' ' 488' ' ' ILE . 36.4 tp -47.69 -42.81 25.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -55.86 -46.53 78.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.041 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.78 -41.58 74.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 108.913 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.762 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.3 tm? -57.4 -43.92 84.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.111 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -59.94 -36.37 76.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.326 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -30.13 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.2 mm-40 -75.12 140.76 43.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -100.03 163.53 19.29 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 294' ' ' ASN . 81.3 mt -47.52 -33.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.07 -36.28 79.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.424 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 86.8 m-20 -68.66 -30.61 69.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.9 mp -82.73 -30.05 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.328 -0.858 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.09 58.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.09 -30.5 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.529 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 63.9 mt -104.92 123.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.74 -31.7 71.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.37 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.456 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -52.13 -32.69 36.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.7 mm? -103.13 138.78 39.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.224 -1.162 . . . . 0.0 109.54 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.461 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.7 m -104.04 161.87 13.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.877 . . . . 0.0 109.333 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.461 ' N ' HG22 ' B' ' 474' ' ' THR . 87.5 m-20 -57.45 -38.08 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.81 -45.95 26.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.584 ' HE2' HD22 ' B' ' 444' ' ' LEU . 19.0 tttt -66.14 -47.19 74.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -59.24 -46.74 87.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.515 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.18 -49.88 68.77 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.35 54.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -1.185 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 440' ' ' VAL . 26.4 mt -56.62 -37.6 70.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 50.4 mt -63.33 -51.08 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.414 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.592 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 23.6 mtp -52.61 -48.41 66.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -55.71 -55.74 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.408 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.623 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -59.46 -47.98 83.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 75.1 mtt180 -62.8 -40.98 99.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.0 m-20 -58.24 -44.93 88.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 1.014 HD12 ' CD2' ' B' ' 456' ' ' LEU . 57.2 mt -61.6 -37.56 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -52.02 10.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -61.33 -31.59 71.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 13.1 m-30 -71.0 -33.69 70.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.592 ' HE2' HD22 ' A' ' 318' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 252' ' ' ILE . 9.9 m-20 -55.95 150.37 29.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.56 -25.28 55.16 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.749 2.299 . . . . 0.0 111.643 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.1 tt -68.6 -27.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 109.179 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 312' ' ' LEU . 26.8 mt -74.11 -45.24 50.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.916 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.5 OUTLIER -63.88 -34.65 78.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.478 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -55.91 141.74 66.23 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.156 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.0 Cg_endo -69.03 133.95 28.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.695 2.263 . . . . 0.0 111.742 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.41 -34.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 271' ' ' LYS . 55.3 t0 -59.44 -30.97 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 m-20 -73.75 -17.12 61.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 257' ' ' VAL . 51.5 mt -43.5 144.95 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -63.92 -22.06 66.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.2 mp -65.56 166.84 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.2 p -66.71 166.59 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.557 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 268' ' ' ASN . 6.6 t -57.35 -36.47 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 109.639 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.14 -48.65 70.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 262' ' ' LEU . 95.2 p -57.94 -51.04 71.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.62 -42.41 99.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.649 HD21 HG12 ' A' ' 264' ' ' VAL . 89.1 m-20 -56.58 -37.44 70.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 85.4 m -50.37 -60.48 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.32 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 281' ' ' LEU . 74.0 mt -57.51 -45.06 85.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.376 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 275' ' ' ILE . 82.3 mttt -52.92 -29.91 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.359 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.14 -34.32 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 45.1 mt-10 -90.53 26.13 2.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.21 40.91 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 22.7 mm -108.14 124.24 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.432 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.575 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -115.83 -37.27 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.37 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.575 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -106.32 133.04 51.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.831 HD12 ' O ' ' A' ' 252' ' ' ILE . 88.7 mt -46.72 -30.36 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.34 -48.64 15.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 94.0 m-20 -53.24 -31.27 42.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.004 -1.292 . . . . 0.0 108.727 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 270' ' ' LEU . 44.9 tp -55.72 -51.9 65.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.5 m -64.39 -28.26 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 108.832 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.75 -34.89 73.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.848 . . . . 0.0 108.903 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.453 ' HG2' ' NH1' ' A' ' 284' ' ' ARG . 18.6 mtt-85 -107.07 144.29 33.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.256 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.8 m -68.43 143.4 55.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 0.0 109.559 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.437 ' HA ' HD23 ' A' ' 289' ' ' LEU . 50.4 tp10 -55.62 -30.25 60.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.62 -51.61 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -51.91 -33.97 39.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.388 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.2 mm? -74.68 -30.52 61.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.77 -30.91 70.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.533 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.73 -12.7 58.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.168 -0.958 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 23.8 m -79.38 117.67 68.33 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.648 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.952 ' HG2' HD11 ' B' ' 464' ' ' ILE . 48.4 Cg_endo -69.86 -20.43 34.39 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.784 2.322 . . . . 0.0 111.866 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.554 ' ND2' HD12 ' B' ' 464' ' ' ILE . 16.6 m120 -48.85 -31.41 7.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.617 HD21 ' O ' ' A' ' 289' ' ' LEU . 0.5 OUTLIER -105.02 144.63 31.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -85.83 169.23 42.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HG2' ' NH2' ' B' ' 486' ' ' ARG . 44.7 mttt -64.92 -40.9 95.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -1.145 . . . . 0.0 109.479 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -59.78 -40.12 87.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 303' ' ' ILE . 24.6 m -57.57 -41.55 81.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.952 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.2 tm? -54.83 -37.04 65.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 27.5 m -55.75 -59.42 4.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.219 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 305' ' ' ASP . 75.2 tt0 -54.92 -44.47 74.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 67.8 mt -57.48 -52.38 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 108.856 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -53.28 -36.41 61.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.312 -0.867 . . . . 0.0 108.675 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 302' ' ' GLU . 62.5 t0 -57.46 -48.14 79.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 108.913 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.634 HG12 HD22 ' A' ' 312' ' ' LEU . 11.6 t -66.17 -34.81 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.939 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 313' ' ' SER . 21.4 mt -64.23 -26.66 68.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.42 -29.99 66.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.117 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 79.8 p -79.14 -7.94 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.658 ' O ' HD11 ' A' ' 314' ' ' LEU . 73.6 mtt85 61.76 13.15 5.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -73.03 -36.15 57.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.82 ' H ' HD23 ' A' ' 312' ' ' LEU . 2.1 pt? -135.05 159.37 41.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 109.688 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.712 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.2 OUTLIER 61.31 63.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.892 . . . . 0.0 109.677 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.788 HD22 ' N ' ' A' ' 314' ' ' LEU . 3.2 mm? -96.32 12.38 31.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.65 92.28 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.462 ' CE ' ' CE1' ' A' ' 249' ' ' PHE . 10.9 ptt? -114.36 150.63 34.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -109.12 133.34 53.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.592 HD22 ' HE2' ' A' ' 249' ' ' PHE . 6.1 mt -106.75 138.48 42.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.898 . . . . 0.0 109.349 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.69 -47.21 82.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.017 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 36.2 t-20 -126.64 -59.04 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 108.976 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.916 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 163.4 -65.52 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.283 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.584 ' HA ' HD11 ' A' ' 326' ' ' ILE . 48.4 Cg_endo -69.03 107.67 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.624 2.216 . . . . 0.0 111.923 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 51.0 Cg_endo -71.31 161.0 47.14 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.591 2.194 . . . . 0.0 111.45 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.2 -15.37 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.8 t -69.57 -46.42 66.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.584 HD11 ' HA ' ' A' ' 322' ' ' PRO . 22.2 pt . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 109.504 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 31.1 m120 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.322 0.582 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.457 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 33.3 tttt -64.52 136.84 96.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.7 139.69 37.52 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.607 2.205 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -66.03 156.03 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -54.77 -36.99 65.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -62.63 -48.74 78.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.77 HD13 ' C ' ' B' ' 434' ' ' LEU . 3.0 tm? -65.83 -35.52 80.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.946 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.422 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -85.34 6.29 27.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 1.042 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.9 tp -75.42 131.55 40.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.28 145.2 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.906 . . . . 0.0 109.507 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.19 7.5 67.68 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.802 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -124.43 129.5 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.414 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -85.13 147.39 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.06 -43.62 51.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.538 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 90.6 m-20 -70.3 -41.06 73.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' B' ' 473' ' ' LEU . 10.5 tp -58.49 -46.11 87.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.707 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.26 -39.34 82.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 15.9 m-30 -60.29 -43.79 95.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.01 -44.88 95.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.944 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.4 tm? -67.31 -38.08 84.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.39 -28.25 68.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -55.33 -18.92 7.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.445 ' NE ' HD11 ' B' ' 470' ' ' ILE . 33.6 mtt-85 -91.39 30.38 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.85 -18.9 6.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.628 HG13 ' CB ' ' B' ' 458' ' ' ASP . 46.4 t -61.63 136.07 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.893 -1.357 . . . . 0.0 109.326 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 9.4 m -135.17 -37.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -102.49 147.76 26.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 1.042 ' CD1' HD22 ' B' ' 437' ' ' LEU . 16.3 tp -47.2 -41.81 18.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.056 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.85 -47.27 77.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.864 . . . . 0.0 109.028 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.628 ' CB ' HG13 ' B' ' 453' ' ' VAL . 74.8 m-20 -55.14 -44.72 75.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 459' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.11 -49.91 65.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.801 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -54.54 -39.36 67.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.65 -34.69 67.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.426 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -63.65 151.77 40.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.25 154.12 16.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' A' ' 293' ' ' PRO . 60.3 mt -45.09 -40.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -1.177 . . . . 0.0 109.228 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.36 -43.06 92.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.296 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 469' ' ' ASP . 78.1 m-20 -63.41 -23.79 67.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.798 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.8 mp -93.09 -19.23 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.22 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.535 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 469' ' ' ASP . . . . . 0.476 ' OD1' HG13 ' B' ' 470' ' ' ILE . 18.6 p30 -79.29 3.7 17.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' B' ' 473' ' ' LEU . 36.4 mt -105.53 126.63 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.965 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.45 133.33 52.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.11 -30.16 10.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.966 ' CD2' HD11 ' B' ' 444' ' ' LEU . 64.8 mt -88.21 128.72 35.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -1.16 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.9 m -104.01 162.15 13.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.492 ' N ' HG22 ' B' ' 474' ' ' THR . 86.7 m-20 -58.97 -36.76 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -76.95 -43.32 35.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.638 ' O ' HD13 ' B' ' 481' ' ' LEU . 76.6 tttt -61.58 -47.58 84.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.798 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.66 -40.84 97.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.482 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.73 -38.08 95.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.27 77.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -1.216 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.638 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.6 mp -68.81 -27.05 65.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.474 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 293' ' ' PRO . 52.3 mt -77.08 -56.5 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 60.2 mtp -52.81 -38.3 61.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.83 14.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 109.317 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' B' ' 460' ' ' ALA . . . -61.35 -45.96 92.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.801 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 42.2 mtp180 -57.42 -45.67 84.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 91.3 m-20 -57.96 -37.13 73.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' B' ' 456' ' ' LEU . 63.6 mt -68.88 -36.99 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.52 -50.37 15.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.397 -0.814 . . . . 0.0 109.561 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.47 -43.51 90.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.917 . . . . 0.0 109.601 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 98.7 m-85 -95.46 12.41 29.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 492' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.92 ' CE2' HD21 ' A' ' 318' ' ' LEU . 34.0 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.436 ' HB2' HG22 ' A' ' 252' ' ' ILE . 4.1 m-20 -56.62 151.14 32.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.04 -24.13 60.27 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.455 2.103 . . . . 0.0 111.72 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.642 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.9 tt -58.94 -32.42 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.892 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.3 mp -74.26 -35.39 63.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.942 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 326' ' ' ILE . 2.6 mm? -72.2 -20.07 61.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.779 . . . . 0.0 109.189 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -78.08 144.33 67.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 49.5 Cg_endo -69.61 139.16 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.809 2.34 . . . . 0.0 111.907 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.34 -34.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.294 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.78 -30.79 71.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.3 m-20 -76.95 -9.74 58.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.407 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.855 HD21 HD13 ' A' ' 278' ' ' ILE . 74.3 mt -57.32 144.91 34.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.92 -18.93 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.68 HD11 HG21 ' A' ' 306' ' ' VAL . 6.7 mp -64.49 169.69 4.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.5 p -75.45 164.25 26.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 109.629 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 264' ' ' VAL . 14.1 t -52.65 -27.48 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -59.82 -41.91 92.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.15 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' HD22 ' A' ' 262' ' ' LEU . 26.4 t -60.66 -50.42 73.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.56 83.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.942 . . . . 0.0 109.296 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -58.74 -40.1 82.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 73.3 m -52.08 -65.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 1.012 HD21 HD12 ' A' ' 281' ' ' LEU . 6.6 mp -65.24 -42.36 93.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.283 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.564 ' HE2' ' CE1' ' A' ' 276' ' ' HIS . 50.3 tttm -52.79 -40.11 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.26 -26.69 12.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.5 mt-10 -91.85 20.63 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 37.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 280' ' ' ASP . 77.7 mt -124.01 107.88 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.564 ' CE1' ' HE2' ' A' ' 271' ' ' LYS . 61.5 m-70 -107.37 -4.85 18.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.1 m-85 -112.94 133.55 54.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.42 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.855 HD13 HD21 ' A' ' 260' ' ' LEU . 50.7 mt -62.1 -30.99 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.191 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.974 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -48.62 -45.82 30.3 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.627 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.0 m-20 -53.61 -36.54 62.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -1.114 . . . . 0.0 109.153 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 312' ' ' LEU . 4.3 tt -53.15 -49.12 67.24 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.948 . . . . 0.0 108.953 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.4 m -67.46 -22.97 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.114 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -65.82 -33.33 75.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.002 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -105.29 143.51 33.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.044 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 m -59.99 138.04 57.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.412 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 85.2 tt0 -55.64 -29.53 59.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.32 -50.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -51.72 -37.54 51.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.695 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.4 mm? -69.72 -37.66 76.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.702 ' CD1' HD22 ' A' ' 300' ' ' LEU . 37.3 tp -64.4 -26.27 68.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.307 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.458 ' O ' ' HE2' ' B' ' 483' ' ' MET . 35.8 mttm -93.01 25.9 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -114.21 134.84 22.16 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.163 -0.96 . . . . 0.0 109.487 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.989 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.3 Cg_endo -71.92 -24.33 21.08 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.839 2.36 . . . . 0.0 112.018 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.415 ' OD1' HD12 ' B' ' 464' ' ' ILE . 75.7 m-80 -57.79 -28.69 64.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.831 ' N ' HD12 ' A' ' 295' ' ' LEU . 5.0 mp -94.54 125.4 39.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.9 171.5 32.96 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HE3' ' OE2' ' B' ' 461' ' ' GLU . 24.8 mttm -51.89 -36.71 49.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -75.01 -38.57 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.592 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.4 m -57.61 -49.06 77.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 290' ' ' LEU . 23.9 tp -52.81 -42.87 65.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 56.9 m -52.45 -53.51 44.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.8 mt-10 -54.07 -39.69 66.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -0.944 . . . . 0.0 109.069 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 295' ' ' LEU . 76.5 mt -58.47 -43.22 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.117 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -60.73 -41.51 95.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.264 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -58.28 -47.13 84.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.935 . . . . 0.0 109.225 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.68 HG21 HD11 ' A' ' 262' ' ' LEU . 2.2 t -73.28 -37.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.565 HD11 ' OG ' ' A' ' 313' ' ' SER . 0.1 OUTLIER -60.95 -26.41 67.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 310' ' ' ARG . . . -58.22 -32.06 67.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -60.55 -13.99 17.28 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 109.843 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.783 ' C ' HD21 ' A' ' 314' ' ' LEU . 75.0 mtm-85 63.67 9.83 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.892 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -113.08 -7.65 21.09 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.079 HD11 HD22 ' A' ' 281' ' ' LEU . 7.9 tp -127.04 130.68 50.43 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.188 -1.183 . . . . 0.0 109.335 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.738 ' H ' HG12 ' A' ' 282' ' ' VAL . 12.8 t 68.84 56.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.764 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.783 HD21 ' C ' ' A' ' 310' ' ' ARG . 11.2 mt -105.66 21.57 17.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.149 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.97 39.82 94.65 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.564 ' CE ' HD21 ' A' ' 253' ' ' LEU . 3.1 mtm -86.79 170.08 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 318' ' ' LEU . 40.6 mtt85 -143.28 126.24 16.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.92 HD21 ' CE2' ' A' ' 249' ' ' PHE . 4.0 mp -124.3 134.0 53.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 109.708 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.9 -39.89 95.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.912 . . . . 0.0 108.988 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 78.4 m-20 -119.1 -75.3 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.682 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 1.1 t-105 168.73 -58.3 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.496 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.0 Cg_endo -68.49 107.49 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.654 2.236 . . . . 0.0 112.001 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 1.036 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.0 Cg_endo -71.26 165.08 33.56 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.609 2.206 . . . . 0.0 111.592 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.07 -23.35 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.0 t -77.09 -38.36 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 1.036 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.0 tt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 85.1 m-20 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.06 128.91 50.05 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 109.554 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.54 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.1 Cg_endo -70.71 136.53 30.69 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.593 2.195 . . . . 0.0 111.728 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -64.15 153.05 38.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -55.09 -36.91 66.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.69 -44.91 92.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.352 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.83 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -69.97 -37.12 75.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.979 ' O ' HD13 ' B' ' 435' ' ' LEU . 1.3 tm? -70.21 -33.17 71.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.588 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -90.17 8.3 33.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.646 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.822 HD22 ' CD1' ' B' ' 456' ' ' LEU . 25.5 tp -73.6 136.25 43.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -77.2 145.05 37.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.89 -6.06 73.02 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.566 HG22 ' CD2' ' B' ' 481' ' ' LEU . 61.7 t -121.78 135.68 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -1.214 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.614 ' H ' HD12 ' B' ' 444' ' ' LEU . 73.1 m-20 -91.04 152.84 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.595 ' HG2' HD11 ' B' ' 435' ' ' LEU . 96.5 mtt180 -49.85 -38.66 36.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.63 -40.68 80.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.863 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.614 HD12 ' H ' ' B' ' 441' ' ' ASP . 20.1 mt -64.61 -34.65 78.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.394 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.88 76.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.54 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.1 m-85 -62.91 -44.05 97.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.639 ' HD2' HD21 ' B' ' 473' ' ' LEU . 7.1 ttmm -55.03 -37.84 67.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 459' ' ' LEU . 85.2 mt -69.16 -39.92 78.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -59.24 -33.05 70.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.58 -35.75 6.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' B' ' 470' ' ' ILE . 9.5 mtp85 -90.12 21.47 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.502 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.72 7.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 1.047 HG21 ' HG3' ' B' ' 462' ' ' GLN . 4.9 t -81.8 112.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.915 -1.344 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 430' ' ' PRO . 3.8 p -128.04 -42.17 1.57 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -74.22 144.83 44.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.483 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.888 HD21 HD12 ' B' ' 488' ' ' ILE . 36.8 tp -48.87 -45.44 41.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.87 -45.87 78.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.216 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.756 ' HB3' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -56.55 -40.3 74.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.275 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 448' ' ' LEU . 20.5 tp -60.1 -43.59 95.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.46 -33.1 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.282 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 461' ' ' GLU . . . . . 0.454 ' OE2' ' HE3' ' A' ' 297' ' ' LYS . 72.5 mm-40 -68.09 -31.05 70.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.43 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 1.047 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.3 mm-40 -78.0 136.86 38.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.51 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -98.13 160.1 20.71 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.989 HD11 ' HG2' ' A' ' 293' ' ' PRO . 65.0 mt -44.04 -39.67 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.432 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.98 -36.53 81.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.446 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 85.7 m-20 -70.51 -28.59 65.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.302 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -82.0 -28.27 32.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.65 65.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -56.99 -31.02 64.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.696 HD11 ' CG ' ' B' ' 451' ' ' ARG . 59.6 mt -103.22 118.28 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.72 -31.01 57.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.54 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -53.83 -32.4 48.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.814 ' N ' HD22 ' B' ' 473' ' ' LEU . 2.8 mm? -107.58 138.03 44.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.495 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.04 165.08 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.495 ' N ' HG22 ' B' ' 474' ' ' THR . 91.5 m-20 -59.09 -38.46 79.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -75.79 -46.12 32.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.572 ' O ' HD13 ' B' ' 481' ' ' LEU . 20.8 tttt -63.2 -48.01 80.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -60.22 -36.44 77.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.76 -44.13 97.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.26 86.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.734 ' HB3' HD21 ' B' ' 459' ' ' LEU . 7.2 mp -69.17 -34.11 74.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 62.4 mt -69.49 -56.48 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.529 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 40.9 mmm -54.53 -38.79 66.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -62.14 -54.16 45.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -63.82 -42.41 97.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -57.53 -44.09 84.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -64.44 -36.62 84.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.466 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.888 HD12 HD21 ' B' ' 456' ' ' LEU . 65.9 mt -66.72 -37.15 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 4.8 m -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -66.61 -33.33 75.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -98.19 10.53 40.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 318' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' A' ' 252' ' ' ILE . 44.7 m-20 -67.29 133.58 93.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.55 -26.18 54.57 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.782 2.321 . . . . 0.0 111.467 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 1.035 HD13 HD22 ' A' ' 312' ' ' LEU . 14.5 tt -66.65 -25.57 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.225 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 312' ' ' LEU . 44.7 mt -74.23 -45.41 48.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 109.573 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.915 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 1.2 mm? -66.85 -26.84 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.547 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.16 143.66 96.14 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.147 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 259' ' ' ASP . 48.4 Cg_endo -69.07 132.77 25.16 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.63 2.22 . . . . 0.0 111.757 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -43.68 -32.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.31 -31.07 71.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.354 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' PRO . 33.0 m-20 -70.52 -14.46 62.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 257' ' ' VAL . 53.3 mt -48.16 138.0 10.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.33 -15.06 59.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 262' ' ' LEU . 6.9 mp -69.8 173.15 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.8 p -66.86 162.15 22.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.638 HG12 ' ND2' ' A' ' 268' ' ' ASN . 21.2 t -60.79 -23.92 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.01 -44.28 97.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.274 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -48.78 80.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.55 86.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.638 ' ND2' HG12 ' A' ' 264' ' ' VAL . 91.7 m-20 -56.8 -37.22 70.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 25.2 m -53.33 -64.77 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.784 HD21 HD11 ' A' ' 289' ' ' LEU . 78.8 mt -60.37 -45.13 94.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 64.9 tttm -52.86 -35.76 58.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.06 -20.42 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.4 mt-10 -94.8 23.84 5.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.468 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.56 37.32 1.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.728 HG23 ' HB2' ' A' ' 280' ' ' ASP . 82.6 mt -115.54 128.19 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.609 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -116.34 -27.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.609 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.4 m-85 -110.55 137.07 48.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 252' ' ' ILE . 90.8 mt -55.47 -29.78 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.89 -46.7 14.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.728 ' HB2' HG23 ' A' ' 275' ' ' ILE . 78.0 m-20 -53.58 -31.3 46.2 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.041 -1.27 . . . . 0.0 108.688 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.714 HD13 HD13 ' A' ' 270' ' ' LEU . 43.4 tp -57.07 -50.75 71.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.498 -0.751 . . . . 0.0 109.13 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.9 m -64.7 -29.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 108.912 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.45 -35.86 74.85 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.316 -0.865 . . . . 0.0 108.723 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -98.95 150.03 22.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.46 -0.775 . . . . 0.0 109.084 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.5 m -79.5 142.42 35.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.464 ' CD ' ' CD1' ' A' ' 307' ' ' LEU . 82.8 tt0 -55.63 -27.6 50.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.499 ' H ' HG22 ' A' ' 285' ' ' THR . 47.8 t -52.74 -55.5 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.12 -30.69 70.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.158 -0.964 . . . . 0.0 108.645 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 270' ' ' LEU . 20.1 tp -61.95 -37.33 84.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.509 -0.744 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.01 -23.33 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.552 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 48.5 mttm -81.62 -17.11 49.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.518 ' HB ' HD13 ' A' ' 295' ' ' LEU . 2.1 m -73.46 117.29 59.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.549 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.946 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.9 Cg_endo -71.07 -20.5 28.65 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.68 2.253 . . . . 0.0 111.865 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.9 m120 -52.89 -20.43 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.869 ' HB2' HD21 ' A' ' 300' ' ' LEU . 2.4 mp -101.98 132.59 47.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -76.68 157.64 47.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' B' ' 461' ' ' GLU . 23.6 mttm -49.66 -39.33 35.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -1.169 . . . . 0.0 109.396 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -71.46 -38.61 71.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.2 m -61.88 -47.4 85.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 295' ' ' LEU . 77.7 mt -53.01 -42.82 66.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.255 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 44.4 m -52.99 -51.73 60.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 306' ' ' VAL . 94.0 mt-10 -55.78 -39.76 71.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.317 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.475 HG21 HD21 ' A' ' 289' ' ' LEU . 33.5 mm -58.03 -48.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.901 . . . . 0.0 109.236 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -56.69 -41.45 77.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -58.58 -45.88 88.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.275 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.719 HG12 ' CD1' ' A' ' 312' ' ' LEU . 2.2 t -62.0 -38.28 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.103 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.5 mt -54.63 -25.44 26.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.416 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.41 -39.18 75.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.416 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -20.71 2.83 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.404 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 310' ' ' ARG . 21.0 tpt180 64.9 10.23 6.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.637 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -106.8 -0.92 36.61 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 252' ' ' ILE . 0.5 OUTLIER -138.45 148.55 44.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -1.169 . . . . 0.0 109.565 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.808 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 51.21 64.5 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.589 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.45 9.24 43.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.97 31.0 64.84 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.486 ' HE1' HD11 ' A' ' 253' ' ' LEU . 12.7 ptt? -114.08 150.22 34.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.583 ' C ' HD12 ' A' ' 318' ' ' LEU . 72.0 mtt85 -124.63 143.17 50.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.847 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.4 mp -118.83 140.57 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.75 -40.23 79.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 108.939 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 38.7 t-20 -122.08 -71.46 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.915 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.4 t-105 167.59 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.617 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.2 Cg_endo -67.8 107.89 1.57 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 112.069 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.996 ' O ' HG22 ' A' ' 326' ' ' ILE . 54.3 Cg_endo -73.49 164.86 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.721 2.281 . . . . 0.0 111.684 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.09 66.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 44.6 m -76.46 -38.58 55.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.877 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.996 HG22 ' O ' ' A' ' 323' ' ' PRO . 19.2 tt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.515 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 28.4 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.401 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 0.7 OUTLIER -55.75 132.38 72.42 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.969 . . . . 0.0 109.376 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.86 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.01 141.05 43.21 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.62 2.214 . . . . 0.0 111.715 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.3 156.38 35.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 432' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.2 m-20 -47.24 -38.56 12.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 433' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 456' ' ' LEU . 51.3 m-20 -60.49 -48.47 81.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.86 HD23 ' HB3' ' B' ' 430' ' ' PRO . 25.5 tp -68.18 -37.89 81.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 0.0 109.556 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.884 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.6 OUTLIER -76.85 -28.86 55.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.428 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 436' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' B' ' 432' ' ' ASP . 36.8 t-20 -90.32 10.27 25.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.835 HD23 HG21 ' B' ' 440' ' ' VAL . 41.9 tp -78.31 129.88 35.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.19 146.1 35.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.33 7.97 72.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.835 HG21 HD23 ' B' ' 437' ' ' LEU . 77.7 t -124.6 129.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 109.458 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -83.34 147.25 28.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -50.01 -40.81 45.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.464 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.9 m-20 -72.44 -40.55 66.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.706 HD11 HD13 ' B' ' 473' ' ' LEU . 23.1 tp -59.72 -42.28 92.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.72 80.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.38 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 11.7 m-30 -65.35 -41.58 93.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.46 -51.21 69.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.798 HD13 HD11 ' B' ' 459' ' ' LEU . 3.9 tt -62.23 -43.14 99.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -58.24 -31.31 67.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.75 -17.17 33.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.363 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -89.32 33.26 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 0.0 109.423 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.54 -18.97 7.66 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' B' ' 458' ' ' ASP . 61.4 t -64.17 135.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.281 . . . . 0.0 109.34 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' B' ' 431' ' ' ALA . 0.8 OUTLIER -131.82 -33.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.624 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.6 OUTLIER -115.1 142.14 47.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.0 109.733 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.806 HD11 ' HA ' ' B' ' 485' ' ' ALA . 2.0 tm? -45.42 -39.47 7.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 108.867 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.0 -48.2 76.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.205 -0.934 . . . . 0.0 108.653 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.574 ' HB3' HG13 ' B' ' 453' ' ' VAL . 28.9 t0 -54.26 -42.77 70.33 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.334 -0.853 . . . . 0.0 108.72 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.798 HD11 HD13 ' B' ' 448' ' ' LEU . 5.1 tt -53.7 -48.91 69.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 109.018 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.897 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -56.03 -35.62 67.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 461' ' ' GLU . . . . . 0.515 ' HA ' ' CE ' ' A' ' 297' ' ' LYS . 96.7 mt-10 -67.21 -28.34 68.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -63.78 164.87 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.26 154.07 16.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.946 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.9 mt -52.33 -34.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.15 -34.28 74.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.52 -31.92 63.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.011 HD12 ' HB1' ' B' ' 478' ' ' ALA . 34.6 mt -74.94 -34.86 62.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.333 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.92 -21.52 11.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.545 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -50.19 -36.97 32.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.2 125.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -62.24 -35.61 79.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.446 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -33.14 22.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.976 HD23 ' HB3' ' B' ' 467' ' ' LEU . 10.9 tp -99.17 141.7 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.554 HG22 ' N ' ' B' ' 475' ' ' ASP . 89.0 m -104.15 164.79 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.554 ' N ' HG22 ' B' ' 474' ' ' THR . 92.3 m-20 -56.5 -40.11 74.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -75.4 -46.25 34.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.469 ' HE3' HD22 ' B' ' 444' ' ' LEU . 37.7 tttp -60.41 -38.28 83.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 109.275 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.011 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -68.75 -50.66 48.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.448 ' HA2' HG12 ' B' ' 464' ' ' ILE . . . -62.58 -48.59 80.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.97 61.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -1.121 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.534 HD22 ' CG2' ' B' ' 440' ' ' VAL . 64.1 mt -62.41 -40.92 98.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.265 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.0 mt -55.01 -55.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.23 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 31.8 mtp -53.14 -45.3 68.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.26 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.9 -45.09 90.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.164 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.806 ' HA ' HD11 ' B' ' 456' ' ' LEU . . . -63.13 -52.27 63.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.255 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.897 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 89.2 mtt180 -59.46 -39.57 84.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 93.6 m-20 -57.31 -41.59 80.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' B' ' 437' ' ' LEU . 83.3 mt -59.65 -36.61 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.43 -51.62 9.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.772 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -63.84 -45.92 87.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.0 m-85 -76.08 -29.5 57.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.892 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.574 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 44.4 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.4 124.93 57.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.305 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.07 -22.68 61.76 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.623 2.215 . . . . 0.0 111.665 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 278' ' ' ILE . 12.7 tt -71.8 -31.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 108.833 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 311' ' ' GLY . 31.8 mt -74.85 -45.03 45.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 109.345 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 1.007 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.7 OUTLIER -65.48 -35.54 81.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 278' ' ' ILE . 6.4 mtt85 -55.82 141.52 65.95 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.004 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 48.1 Cg_endo -68.93 132.16 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.623 2.216 . . . . 0.0 111.935 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.84 -28.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 95.5 m-20 -65.54 -30.68 71.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 256' ' ' PRO . 72.4 m-20 -74.96 -8.58 56.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 257' ' ' VAL . 0.7 OUTLIER -42.85 129.48 4.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -15.47 50.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' A' ' 302' ' ' GLU . 40.3 mt -70.18 -162.13 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 7.1 p -81.01 155.9 26.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.565 HG12 ' ND2' ' A' ' 268' ' ' ASN . 22.8 t -57.67 -24.07 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' B' ' 465' ' ' ASP . 55.6 ttt85 -57.81 -43.36 85.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.7 m -58.82 -46.83 86.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.371 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -68.96 -39.5 79.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.565 ' ND2' HG12 ' A' ' 264' ' ' VAL . 86.7 m-20 -60.28 -32.17 70.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.4 m -66.9 -64.9 0.76 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.0 mt -54.84 -47.82 73.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.507 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 20.5 ttpt -52.94 -39.52 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.449 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.4 -23.68 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 95.3 mt-10 -94.11 23.07 5.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.42 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.5 33.26 4.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -0.929 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.714 HG23 ' HB2' ' A' ' 280' ' ' ASP . 75.8 mt -120.26 108.2 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.507 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 91.2 m-70 -104.59 -11.09 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.824 . . . . 0.0 109.581 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.98 133.37 54.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 252' ' ' ILE . 49.8 mt -62.03 -30.9 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.944 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -52.27 -41.25 54.11 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.714 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.1 m-20 -53.45 -36.36 61.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -1.181 . . . . 0.0 109.119 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.515 ' CD2' HD12 ' A' ' 312' ' ' LEU . 3.1 tp -59.19 -46.49 88.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.297 -0.877 . . . . 0.0 109.229 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 279' ' ' GLY . 15.4 m -68.37 -23.29 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -68.26 -33.09 73.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.826 . . . . 0.0 108.813 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -105.74 143.4 33.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.02 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.8 m -60.0 137.6 58.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.092 -1.005 . . . . 0.0 109.394 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.98 -30.5 71.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.551 ' H ' HG22 ' A' ' 285' ' ' THR . 50.0 t -53.1 -50.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.331 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -51.8 -39.39 58.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -72.8 -39.65 66.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.291 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.996 HD13 ' O ' ' A' ' 290' ' ' LEU . 1.8 tm? -57.61 -33.21 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.228 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' B' ' 483' ' ' MET . 32.5 mttm -88.45 17.64 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 289' ' ' LEU . 2.9 m -103.75 135.99 19.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 1.016 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -70.81 -24.82 24.45 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.671 2.247 . . . . 0.0 111.802 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.46 ' OD1' HD12 ' B' ' 464' ' ' ILE . 77.4 m-20 -57.1 -21.01 28.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.57 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 13.3 mt -81.8 149.89 28.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -112.93 147.6 18.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.08 -44.88 71.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.409 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 302' ' ' GLU . 40.1 mttp -66.52 -41.58 88.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.4 m -64.39 -32.77 74.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 303' ' ' ILE . 32.5 tp -53.36 -42.2 66.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.426 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.8 m -54.8 -43.41 72.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.835 ' HB3' HD13 ' A' ' 262' ' ' LEU . 39.5 mp0 -67.15 -37.86 84.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 300' ' ' LEU . 77.2 mt -58.24 -47.16 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.448 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.44 -36.54 84.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.47 -45.2 89.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 312' ' ' LEU . 20.6 t -68.71 -43.33 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.832 HD13 ' OG ' ' A' ' 313' ' ' SER . 16.6 tp -54.73 -29.68 54.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.606 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.62 73.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 83.0 p -79.22 -1.11 34.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.467 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 1.01 ' HA ' HD21 ' A' ' 314' ' ' LEU . 65.8 mtm180 56.88 16.99 3.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.012 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.669 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.55 -38.94 57.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 306' ' ' VAL . 1.3 pp -149.5 160.99 43.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -1.219 . . . . 0.0 109.978 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.832 ' OG ' HD13 ' A' ' 307' ' ' LEU . 0.5 OUTLIER 76.72 29.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.795 . . . . 0.0 109.538 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 1.01 HD21 ' HA ' ' A' ' 310' ' ' ARG . 72.9 mt -85.8 14.91 5.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 54.69 41.69 75.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.68 ' HE3' ' HB ' ' A' ' 282' ' ' VAL . 5.0 mtm -86.2 176.95 7.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -1.094 . . . . 0.0 109.49 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.73 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.8 mtt180 -140.98 125.77 18.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.821 ' N ' HD12 ' A' ' 318' ' ' LEU . 4.0 mp -126.55 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.85 -38.49 88.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.239 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.9 m-20 -125.31 -69.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 1.007 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 166.08 -66.41 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.451 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.87 107.75 1.76 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.652 2.235 . . . . 0.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 51.5 Cg_endo -71.71 162.45 42.04 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.625 2.217 . . . . 0.0 111.505 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.55 -17.26 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 36.4 m -66.12 -42.62 88.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.48 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.963 HD11 HD21 ' A' ' 254' ' ' LEU . 18.1 mt . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.409 ' C ' ' HB1' ' B' ' 449' ' ' ALA . 83.8 m-20 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -86.46 124.56 69.55 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.523 ' HB3' ' HB1' ' B' ' 445' ' ' ALA . 49.8 Cg_endo -70.56 140.93 40.76 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.664 2.242 . . . . 0.0 111.686 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -80.88 160.15 24.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 432' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.3 m-20 -53.46 -37.47 62.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.305 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 433' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 18.3 m-20 -61.39 -49.99 74.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.387 -0.82 . . . . 0.0 109.512 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.725 HD11 ' CD1' ' B' ' 448' ' ' LEU . 17.8 tp -63.45 -35.79 81.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.577 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' B' ' 442' ' ' ARG . 22.2 tp -83.51 -23.08 32.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 436' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' B' ' 432' ' ' ASP . 35.3 t-20 -88.24 7.34 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.765 HD23 HG21 ' B' ' 440' ' ' VAL . 28.6 tp -78.43 129.93 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.501 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.82 137.28 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.06 9.32 70.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.975 HG13 HD23 ' B' ' 444' ' ' LEU . 41.8 t -123.67 131.12 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.137 . . . . 0.0 109.475 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -102.46 161.82 13.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.755 ' HG2' HD11 ' B' ' 435' ' ' LEU . 61.7 mtt180 -50.19 -45.59 53.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.481 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 93.4 m-20 -61.08 -47.44 86.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.435 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.056 HD11 HD21 ' B' ' 473' ' ' LEU . 27.9 tp -55.67 -43.11 76.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.334 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' B' ' 430' ' ' PRO . . . -59.02 -43.07 91.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.23 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 17.3 m-85 -57.68 -44.75 86.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.26 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -58.24 -45.06 88.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' B' ' 434' ' ' LEU . 79.1 mt -61.34 -44.03 97.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.16 -36.19 77.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.42 33.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.533 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 16.0 mtp-105 -90.32 23.57 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.68 6.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.903 HG21 ' CG ' ' B' ' 462' ' ' GLN . 21.3 t -80.53 109.75 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.34 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 31.1 m -124.91 -34.45 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -82.09 140.89 33.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.628 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.0 tm? -48.56 -40.78 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.72 -38.77 91.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -0.922 . . . . 0.0 108.899 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.562 ' C ' HG13 ' B' ' 453' ' ' VAL . 92.5 m-20 -61.58 -40.12 93.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.85 HD13 ' O ' ' B' ' 459' ' ' LEU . 3.4 tm? -63.29 -39.03 93.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' B' ' 486' ' ' ARG . . . -63.48 -32.63 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.295 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -72.61 -30.33 64.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.903 ' CG ' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -61.65 156.91 18.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.25 155.97 15.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 1.016 HD11 ' HG2' ' A' ' 293' ' ' PRO . 52.2 mt -49.68 -38.33 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -1.131 . . . . 0.0 109.501 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 465' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 265' ' ' ARG . 89.2 m-20 -65.22 -37.51 87.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.44 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 89.6 m-20 -71.11 -31.07 67.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.088 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.0 mt -76.81 -29.85 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.61 63.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -52.67 -32.35 41.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.9 mt -104.73 128.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -63.77 -33.94 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.422 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -51.12 -28.63 18.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.056 HD21 HD11 ' B' ' 444' ' ' LEU . 55.1 mt -105.86 137.6 43.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.456 HG22 ' N ' ' B' ' 475' ' ' ASP . 29.8 m -103.97 162.0 13.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.395 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.456 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.3 -37.51 75.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -76.97 -45.94 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 70.7 tttt -65.83 -46.4 78.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.088 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -60.02 -44.64 94.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 109.535 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -62.27 -52.34 50.21 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -50.98 -33.74 26.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -1.169 . . . . 0.0 109.617 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.63 HD11 HD21 ' B' ' 444' ' ' LEU . 24.7 mt -75.33 -37.36 60.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.522 HD11 ' N ' ' B' ' 464' ' ' ILE . 92.8 mt -60.54 -55.63 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.522 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 41.2 mmm -59.68 -47.64 84.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.46 -53.15 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.45 ' CB ' HD12 ' B' ' 459' ' ' LEU . . . -60.83 -48.62 80.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.475 ' HA ' ' HB1' ' B' ' 460' ' ' ALA . 44.9 ttp85 -56.98 -43.75 82.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.7 m-20 -57.92 -39.06 77.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.616 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' B' ' 437' ' ' LEU . 76.9 mt -63.68 -36.9 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.51 -52.07 59.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.56 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -61.17 -38.75 87.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 17.2 m-85 -64.03 -31.33 72.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.492 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.873 ' CE2' HD21 ' A' ' 318' ' ' LEU . 79.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.482 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.2 OUTLIER -50.78 155.22 2.04 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.273 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.512 ' HA ' HD23 ' A' ' 254' ' ' LEU . 41.0 Cg_endo -64.5 -26.31 62.47 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.47 2.114 . . . . 0.0 111.425 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.788 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -53.38 -34.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 252' ' ' ILE . 5.3 mp -74.45 -39.21 62.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.463 -0.773 . . . . 0.0 109.01 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.702 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -71.32 -23.14 61.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.459 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 278' ' ' ILE . 0.2 OUTLIER -73.0 141.19 81.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.466 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 259' ' ' ASP . 51.5 Cg_endo -70.66 136.37 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.728 2.285 . . . . 0.0 111.736 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.16 -26.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.368 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.443 ' OD1' ' HE2' ' A' ' 271' ' ' LYS . 88.3 m-20 -67.61 -30.77 70.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 256' ' ' PRO . 49.9 m-20 -74.71 -9.8 58.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 49.5 mt -58.44 135.75 57.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 0.0 109.359 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.44 -21.22 66.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.571 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 262' ' ' LEU . 6.4 mp -62.59 168.35 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.2 p -70.5 166.74 19.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.679 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.0 t -63.89 -23.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -55.4 -45.09 76.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.9 p -69.16 -45.89 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -63.82 -42.4 97.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.679 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.2 m-20 -54.13 -38.36 65.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.3 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 295' ' ' LEU . 61.0 m -51.29 -62.14 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.631 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.8 mt -56.47 -46.28 80.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 16.3 mttt -53.25 -33.23 52.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.73 -33.7 49.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.1 mt-10 -92.01 25.84 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.23 45.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 1.025 HG23 ' HB2' ' A' ' 280' ' ' ASP . 91.2 mt -115.61 124.91 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.743 ' O ' HG22 ' A' ' 257' ' ' VAL . 6.5 p80 -114.09 -39.93 3.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.571 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -103.14 134.73 46.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.905 HG21 HD23 ' A' ' 312' ' ' LEU . 78.1 mt -46.66 -30.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.067 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.89 -49.41 17.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 1.025 ' HB2' HG23 ' A' ' 275' ' ' ILE . 87.5 m-20 -53.43 -32.19 48.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 108.988 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 312' ' ' LEU . 53.9 tp -53.99 -51.29 64.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.332 -0.855 . . . . 0.0 109.07 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.7 m -68.17 -33.46 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.18 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -53.06 -32.43 46.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.294 -0.879 . . . . 0.0 108.819 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -107.74 150.61 26.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 72.2 p -81.6 157.07 24.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.945 . . . . 0.0 109.616 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.529 ' OE2' HD23 ' A' ' 307' ' ' LEU . 7.2 mt-10 -63.52 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.918 . . . . 0.0 109.442 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.5 t -52.79 -50.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -55.14 -37.57 67.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.415 HD23 ' OE2' ' A' ' 273' ' ' GLU . 65.8 mt -72.62 -40.75 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.242 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 1.011 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.9 tm? -57.31 -32.69 66.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.865 . . . . 0.0 109.21 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 66.9 mttm -82.26 -13.27 57.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.82 . . . . 0.0 109.474 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.1 m -86.94 112.6 48.5 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 1.043 ' HB2' HD12 ' B' ' 482' ' ' ILE . 51.3 Cg_endo -70.86 -13.16 31.71 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.767 2.311 . . . . 0.0 111.845 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HA ' HD12 ' B' ' 464' ' ' ILE . 30.6 m120 -48.93 -41.08 32.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 269' ' ' CYS . 0.4 OUTLIER -83.74 143.17 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -80.34 165.2 48.27 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -64.48 -41.51 96.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.568 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -63.94 -39.0 93.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 303' ' ' ILE . 19.6 m -59.73 -41.67 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 304' ' ' LYS . 24.2 tp -53.06 -37.93 62.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.9 m -60.85 -45.83 92.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.14 -46.09 88.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.83 HG22 HD22 ' A' ' 307' ' ' LEU . 30.6 mm -58.76 -51.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.434 ' CE ' ' HG ' ' A' ' 300' ' ' LEU . 22.5 mttm -53.13 -39.06 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.15 -48.3 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.461 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.892 HG12 HD11 ' A' ' 312' ' ' LEU . 12.0 t -73.71 -40.84 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.83 HD22 HG22 ' A' ' 303' ' ' ILE . 8.4 mp -66.02 -26.71 67.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -29.57 66.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 8.2 t -75.2 -0.16 18.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.539 ' O ' HD21 ' A' ' 314' ' ' LEU . 40.5 mtm-85 70.31 3.89 4.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -69.32 -27.82 73.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.905 HD23 HG21 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -140.81 152.89 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 109.261 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.525 ' OG ' HD21 ' A' ' 307' ' ' LEU . 16.5 m 63.67 66.85 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.46 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.799 HD13 ' HE2' ' A' ' 316' ' ' MET . 4.7 mp -103.06 9.99 38.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.61 73.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.799 ' HE2' HD13 ' A' ' 314' ' ' LEU . 15.4 ptt? -113.04 147.38 37.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.534 ' C ' HD12 ' A' ' 318' ' ' LEU . 76.3 mtm180 -126.53 141.66 51.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.292 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.873 HD21 ' CE2' ' A' ' 249' ' ' PHE . 3.7 mp -116.9 141.78 47.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.02 -34.4 77.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.983 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 85.6 m-20 -117.41 -81.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 165.89 -62.23 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.545 ' CB ' HD11 ' A' ' 326' ' ' ILE . 48.8 Cg_endo -68.33 108.09 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.66 2.24 . . . . 0.0 111.989 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 249' ' ' PHE . 53.9 Cg_endo -76.34 161.91 34.29 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.421 2.08 . . . . 0.0 111.414 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.64 -13.92 17.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.1 p -70.35 -35.52 73.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.764 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.605 HG21 ' HG ' ' A' ' 254' ' ' LEU . 21.2 pt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.771 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 130.17 92.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 144.01 48.72 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.792 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.65 146.34 40.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -47.99 -32.9 7.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 109.455 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.53 -48.01 68.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.861 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.5 tm? -67.91 -36.96 81.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.93 ' O ' HD13 ' B' ' 435' ' ' LEU . 1.0 OUTLIER -72.89 -31.95 65.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.86 11.32 20.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 1.06 HD13 HD11 ' B' ' 456' ' ' LEU . 50.2 tp -74.05 133.64 42.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -76.6 145.47 38.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.74 75.1 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.732 HG13 HD23 ' B' ' 444' ' ' LEU . 95.3 t -123.54 135.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -1.214 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 442' ' ' ARG . 58.2 t0 -85.27 146.38 27.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.502 ' HG2' HD11 ' B' ' 435' ' ' LEU . 95.8 mtt180 -49.92 -43.79 49.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -68.65 -37.74 79.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.293 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.07 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.2 tp -63.66 -35.57 80.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -63.81 -41.37 97.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.953 . . . . 0.0 109.419 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 71.8 m-85 -65.88 -48.46 71.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.533 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 31.4 ttmt -57.94 -42.86 85.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.829 HD11 ' CD2' ' B' ' 459' ' ' LEU . 10.0 tt -69.73 -37.3 76.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.27 -27.6 67.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.496 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.06 -16.9 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.425 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 12.1 mtp85 -90.46 28.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.81 6.8 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 19.2 t -65.33 133.24 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.303 . . . . 0.0 109.427 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 60.4 m -135.08 -35.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.3 OUTLIER -106.57 152.1 24.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.003 . . . . 0.0 109.847 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 1.06 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -51.78 -42.77 62.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.332 -0.855 . . . . 0.0 109.363 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.83 -42.2 75.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.137 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 84.3 m-20 -61.4 -41.2 96.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.342 -0.849 . . . . 0.0 109.217 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.829 ' CD2' HD11 ' B' ' 448' ' ' LEU . 3.4 tm? -60.97 -38.92 87.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.16 -35.72 81.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.82 -35.34 80.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 3.5 mm100 -65.53 144.88 56.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.47 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -102.92 159.72 17.26 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.889 HD11 ' HG2' ' A' ' 293' ' ' PRO . 80.3 mt -46.07 -35.14 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.238 . . . . 0.0 109.204 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -63.47 -37.45 87.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.919 . . . . 0.0 109.021 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.4 m-20 -68.51 -31.55 70.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.16 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.733 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -80.84 -32.86 34.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.396 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.48 -33.07 67.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 109.392 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -46.83 -28.67 1.64 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.401 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.533 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 62.1 mt -105.79 121.53 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -55.93 -32.65 63.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.454 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.94 -28.82 49.57 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.07 ' CD2' HD11 ' B' ' 444' ' ' LEU . 65.0 mt -103.5 135.77 44.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -1.132 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.95 161.91 13.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.354 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.433 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 82.5 m-20 -58.29 -37.39 74.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.13 -46.03 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.651 ' O ' HD13 ' B' ' 481' ' ' LEU . 25.2 tttp -62.86 -44.22 96.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.733 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.85 -44.34 93.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.23 -35.85 91.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.16 76.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -1.144 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.651 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -69.51 -36.56 76.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 109.642 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.9 mt -68.84 -56.35 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.518 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 61.2 mtp -52.62 -39.08 61.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.35 -49.23 44.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' B' ' 456' ' ' LEU . . . -63.98 -46.41 84.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.422 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 45.9 ttm-85 -57.6 -45.05 85.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.34 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.0 m-20 -57.9 -40.0 79.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.643 HD12 HD11 ' B' ' 456' ' ' LEU . 84.8 mt -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.73 -49.23 49.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 490' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 58.4 m95 -65.99 -32.22 73.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 13.8 m-85 -79.22 -34.27 42.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.568 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.53 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 10.4 p90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.767 ' O ' HD22 ' A' ' 254' ' ' LEU . 0.9 OUTLIER -57.86 136.95 83.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 109.272 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.687 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.05 -30.93 56.03 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.597 2.198 . . . . 0.0 111.55 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.848 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -63.11 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 312' ' ' LEU . 31.4 mt -74.31 -42.57 59.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.195 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.767 HD22 ' O ' ' A' ' 250' ' ' ASP . 0.5 OUTLIER -59.94 -34.99 73.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.813 . . . . 0.0 109.14 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -66.12 146.47 99.02 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.3 Cg_endo -70.22 140.01 39.94 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.714 2.276 . . . . 0.0 111.89 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.556 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.12 -36.92 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.362 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -58.13 -30.98 66.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 256' ' ' PRO . 21.9 m-20 -72.38 -11.41 60.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.556 HD11 HG12 ' A' ' 257' ' ' VAL . 36.8 mt -55.35 150.64 11.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -23.23 67.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.437 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.691 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.6 mp -62.85 166.74 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -75.53 162.66 28.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.657 HG12 ' ND2' ' A' ' 268' ' ' ASN . 11.8 t -48.85 -39.67 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -51.18 -50.22 59.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.666 ' OG ' HD22 ' A' ' 262' ' ' LEU . 17.7 t -58.71 -51.02 71.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.96 -37.06 85.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 264' ' ' VAL . 94.7 m-20 -58.54 -36.47 73.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.322 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -53.64 54.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.304 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.723 HD21 HD13 ' A' ' 281' ' ' LEU . 6.6 mp -61.28 -47.87 83.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' A' ' 268' ' ' ASN . 54.8 mtmt -52.8 -38.14 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.23 20.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.3 mt-10 -92.95 25.29 3.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.453 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.05 45.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.994 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.2 mt -120.85 119.58 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.469 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 7.7 p80 -110.17 -40.05 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.557 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.457 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.6 m-30 -105.47 136.13 45.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 252' ' ' ILE . 93.5 mt -46.7 -29.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.988 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.98 -45.13 14.29 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.994 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.3 m-20 -53.52 -33.83 55.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.293 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 289' ' ' LEU . 38.7 tp -57.35 -49.48 76.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.988 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.2 m -63.44 -23.34 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 108.73 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.1 tt0 -67.45 -34.95 78.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -98.73 158.57 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 154.26 23.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.074 -1.016 . . . . 0.0 109.773 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.666 ' CD ' HD13 ' A' ' 307' ' ' LEU . 9.0 mt-10 -61.68 -36.33 80.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.539 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 42.1 t -52.64 -49.36 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -51.95 -32.55 33.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.083 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 281' ' ' LEU . 36.8 mt -69.25 -41.18 77.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.147 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.39 -25.31 66.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.342 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.546 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 54.8 mttt -86.32 -12.87 48.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.484 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.529 HG22 HD12 ' A' ' 295' ' ' LEU . 53.0 m -81.85 112.3 33.69 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.522 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 1.014 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.6 Cg_endo -71.06 -14.25 31.88 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.821 2.347 . . . . 0.0 111.916 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.67 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.9 m120 -61.98 -25.47 67.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.806 HD23 HD11 ' A' ' 303' ' ' ILE . 4.7 mp -88.02 142.35 27.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 296' ' ' GLY . . . . . 0.465 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -91.39 169.28 32.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.55 -41.07 80.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.145 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -70.14 -43.07 71.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.6 m -59.2 -49.45 77.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.39 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.752 HD21 ' HB2' ' A' ' 295' ' ' LEU . 83.5 mt -55.37 -42.37 73.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.3 m -55.41 -52.62 62.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.873 . . . . 0.0 109.451 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 306' ' ' VAL . 89.2 mt-10 -54.82 -39.4 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.806 HD11 HD23 ' A' ' 295' ' ' LEU . 78.6 mt -58.15 -51.54 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.33 -42.51 73.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.36 -44.08 79.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.986 HG12 HD21 ' A' ' 312' ' ' LEU . 1.9 t -65.93 -39.58 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.178 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.1 mt -54.63 -26.16 31.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.37 68.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.7 t -66.06 -15.53 63.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.784 ' C ' HD21 ' A' ' 314' ' ' LEU . 92.8 mtt180 59.32 14.17 3.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.442 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -105.27 1.99 40.33 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.986 HD21 HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.94 142.58 24.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -1.19 . . . . 0.0 109.641 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.784 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 67.22 38.87 3.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.577 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.784 HD21 ' C ' ' A' ' 310' ' ' ARG . 28.1 mt -88.97 18.2 5.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.31 36.29 91.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.704 ' HE2' HG11 ' A' ' 282' ' ' VAL . 6.4 mtm -87.21 167.33 14.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.571 ' C ' HD12 ' A' ' 318' ' ' LEU . 36.1 mtp180 -143.15 131.29 21.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.6 mp -130.0 139.26 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.927 . . . . 0.0 109.621 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.32 -43.97 88.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 108.88 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 69.1 m-20 -122.06 -69.42 0.83 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.041 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.567 ' HE3' HD22 ' A' ' 318' ' ' LEU . 2.6 t-105 168.42 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.354 -0.841 . . . . 0.0 109.405 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.3 Cg_endo -68.52 107.79 1.69 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.545 2.163 . . . . 0.0 111.898 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 1.016 ' O ' HG22 ' A' ' 326' ' ' ILE . 51.4 Cg_endo -71.47 152.91 60.69 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.611 2.207 . . . . 0.0 111.711 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.76 6.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 42.9 m -68.18 -32.64 73.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 1.016 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.7 tt . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.315 -0.865 . . . . 0.0 109.564 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.641 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 22.4 m120 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.492 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 2.0 tttt -54.07 129.87 58.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.53 ' HG3' ' CD1' ' B' ' 446' ' ' PHE . 48.6 Cg_endo -69.98 140.85 42.85 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.677 2.251 . . . . 0.0 111.774 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.04 152.57 42.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.888 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -50.1 -39.42 42.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.4 -44.48 92.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.766 HD13 ' C ' ' B' ' 434' ' ' LEU . 2.9 tm? -64.18 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.25 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 442' ' ' ARG . 24.7 tp -79.88 -30.29 40.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -78.43 -0.77 30.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.693 HD23 HG21 ' B' ' 440' ' ' VAL . 28.8 tp -72.34 134.58 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.513 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -73.6 141.26 46.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.93 8.55 66.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.693 HG21 HD23 ' B' ' 437' ' ' LEU . 47.4 t -129.52 126.42 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.452 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.26 161.46 13.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.877 ' HG2' HD11 ' B' ' 435' ' ' LEU . 87.9 mtt-85 -55.01 -46.63 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.17 -45.6 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.519 ' CD2' ' HE2' ' B' ' 477' ' ' LYS . 12.9 tp -60.85 -41.83 96.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.635 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.15 -40.66 86.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.53 ' CD1' ' HG3' ' B' ' 430' ' ' PRO . 17.3 m-85 -63.83 -46.65 84.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.513 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 5.9 ttmm -57.66 -46.36 84.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.609 ' O ' HD23 ' B' ' 448' ' ' LEU . 8.7 tt -68.24 -36.51 79.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.586 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -60.81 -26.79 67.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -49.14 -22.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.695 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -88.66 25.01 1.83 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.63 7.15 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.71 HG21 ' HG3' ' B' ' 462' ' ' GLN . 44.7 t -62.87 132.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.942 -1.328 . . . . 0.0 109.326 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 87.5 m -135.11 -38.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 109.666 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 150.56 21.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.738 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 1.037 HD21 HD12 ' B' ' 488' ' ' ILE . 27.1 tp -48.41 -42.15 31.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.255 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -55.94 -48.36 75.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.102 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.6 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.6 m-20 -54.89 -40.99 70.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.065 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' B' ' 481' ' ' LEU . 4.6 tt -57.21 -47.05 82.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.65 70.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.08 -34.87 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.71 ' HG3' HG21 ' B' ' 453' ' ' VAL . 6.2 mm100 -67.44 156.01 37.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.57 155.08 16.32 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.965 HD11 ' HG2' ' A' ' 293' ' ' PRO . 30.0 mt -47.6 -42.63 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -1.176 . . . . 0.0 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -58.34 -42.43 86.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.14 -30.04 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.059 HD12 ' HB1' ' B' ' 478' ' ' ALA . 24.0 mt -77.98 -26.48 48.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.26 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.32 69.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.873 . . . . 0.0 109.301 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -53.74 -32.28 51.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.546 HG22 ' H ' ' B' ' 472' ' ' GLY . 61.0 mt -100.43 122.84 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.88 -26.84 67.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.546 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -59.7 -26.5 62.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.485 ' CD2' HD11 ' B' ' 444' ' ' LEU . 38.7 mt -109.73 134.66 51.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -1.163 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.02 161.93 13.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.403 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.426 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 79.9 m-20 -57.68 -38.05 74.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -76.79 -46.08 26.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.662 ' O ' HD13 ' B' ' 481' ' ' LEU . 43.7 tttt -64.93 -42.06 95.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.85 -42.15 97.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.1 -42.92 99.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.07 85.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -66.88 -39.89 87.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 293' ' ' PRO . 28.9 mt -64.69 -56.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.546 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 48.3 mtp -52.67 -40.35 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.447 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.83 -56.45 15.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -62.05 -44.42 96.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.714 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 290' ' ' LEU . 50.2 ttt180 -60.28 -45.97 91.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 84.5 m-20 -59.2 -41.13 87.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 1.037 HD12 HD21 ' B' ' 456' ' ' LEU . 71.0 mt -64.54 -37.14 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.07 -50.56 32.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.55 -39.69 77.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.5 m-85 -96.77 16.32 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.492 ' HB3' ' CB ' ' A' ' 325' ' ' SER . 43.5 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.347 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -65.93 135.51 95.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.68 -25.44 54.16 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.763 2.309 . . . . 0.0 111.79 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.555 ' O ' HD12 ' A' ' 278' ' ' ILE . 19.7 tt -79.54 -21.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.77 HD21 ' HE1' ' A' ' 321' ' ' TRP . 5.6 tp -74.08 -37.91 64.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.295 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 326' ' ' ILE . 3.8 mm? -82.99 -27.74 30.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.534 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 0.0 OUTLIER -63.75 144.19 97.95 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.542 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 51.1 Cg_endo -71.0 149.55 59.18 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.728 2.285 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.404 HG12 HD11 ' A' ' 260' ' ' LEU . 0.4 OUTLIER -53.53 -39.22 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.803 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 259' ' ' ASP . 9.3 p-10 -58.52 -31.0 67.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.6 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.534 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 68.6 m-20 -74.1 -13.45 60.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 257' ' ' VAL . 46.1 mt -51.17 144.13 9.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -68.71 -16.26 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.762 HD13 ' HB3' ' A' ' 302' ' ' GLU . 28.6 mt -59.72 -174.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' THR . . . . . 0.47 HG23 ' OE2' ' A' ' 302' ' ' GLU . 22.2 p -87.27 159.09 18.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.725 HG12 ' ND2' ' A' ' 268' ' ' ASN . 13.5 t -56.35 -30.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -56.05 -46.43 78.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.401 ' HB3' ' OE1' ' A' ' 302' ' ' GLU . 87.4 p -66.39 -45.27 80.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.4 90.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.725 ' ND2' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -58.11 -33.21 68.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.378 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 92.8 m -59.25 -64.3 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.938 . . . . 0.0 109.41 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.572 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.6 mt -60.79 -48.2 82.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.329 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 73.1 tttt -54.47 -38.71 66.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -55.45 -24.63 31.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.652 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.5 mt-10 -92.22 21.12 5.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 34.34 1.44 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 109.604 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 280' ' ' ASP . 85.3 mt -120.73 107.63 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.12 -0.988 . . . . 0.0 109.458 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 58.6 m-70 -108.05 -3.99 18.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.618 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.6 m-85 -113.98 131.05 56.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 252' ' ' ILE . 73.8 mt -59.47 -30.43 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.929 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.32 -47.06 16.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 275' ' ' ILE . 80.4 m-20 -53.5 -33.66 55.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.249 . . . . 0.0 108.997 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.572 HD13 ' CD1' ' A' ' 270' ' ' LEU . 35.0 tp -56.29 -49.28 74.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.134 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.929 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.3 m -66.39 -24.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 108.884 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -65.05 -35.68 81.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 108.969 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -98.36 141.22 31.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.331 -0.856 . . . . 0.0 109.191 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 8.1 m -71.38 140.77 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.531 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.63 ' CD ' HD12 ' A' ' 289' ' ' LEU . 48.4 tp10 -49.98 -29.75 9.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.59 -51.3 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.163 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.36 -34.06 56.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 109.117 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.63 HD12 ' CD ' ' A' ' 286' ' ' GLU . 39.9 mt -63.88 -41.91 97.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.331 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.68 -31.4 72.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 78.0 mttt -85.22 -10.64 56.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.527 ' HB ' HD13 ' A' ' 295' ' ' LEU . 28.8 m -83.87 113.03 44.92 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.963 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.1 Cg_endo -70.66 -18.79 32.5 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.753 2.302 . . . . 0.0 111.851 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' B' ' 464' ' ' ILE . 71.2 m-80 -56.95 -27.16 60.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 295' ' ' LEU . 4.1 mp -92.7 136.48 33.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.23 179.46 40.75 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -62.26 -38.98 91.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -1.125 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.89 -43.49 88.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 25.0 m -59.42 -49.86 76.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 290' ' ' LEU . 23.4 tp -52.88 -44.52 66.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 48.1 m -56.1 -44.42 79.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.414 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 262' ' ' LEU . 95.5 mt-10 -60.5 -43.29 97.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 295' ' ' LEU . 83.9 mt -57.95 -46.97 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -58.77 -39.99 82.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.63 -50.64 73.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.8 t -67.18 -40.17 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.848 HD13 ' HB3' ' A' ' 313' ' ' SER . 18.5 tp -55.26 -27.46 46.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.94 69.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.135 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.7 t -74.02 -14.64 61.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.868 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.505 ' O ' HD21 ' A' ' 314' ' ' LEU . 66.5 mtt-85 63.59 11.5 5.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.45 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.35 -29.57 52.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 312' ' ' LEU . 1.6 pt? -139.74 153.55 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -1.215 . . . . 0.0 109.61 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.848 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.7 OUTLIER 72.21 43.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.7 HD22 ' N ' ' A' ' 314' ' ' LEU . 3.4 mm? -86.73 14.52 6.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.54 36.75 68.5 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.576 ' HE2' HG11 ' A' ' 282' ' ' VAL . 3.4 mtm -90.6 167.81 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.12 . . . . 0.0 109.517 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.636 ' C ' HD12 ' A' ' 318' ' ' LEU . 95.0 mtt180 -142.7 126.02 16.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.85 . . . . 0.0 109.295 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.7 mp -138.99 131.91 29.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.68 -52.81 63.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 321' ' ' TRP . 13.5 t-20 -130.32 36.95 3.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.77 ' HE1' HD21 ' A' ' 253' ' ' LEU . 16.9 t90 44.28 57.13 13.84 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 321' ' ' TRP . 54.7 Cg_endo -99.9 71.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.333 2.688 . . . . 0.0 112.242 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.853 ' CG ' HD12 ' A' ' 326' ' ' ILE . 48.6 Cg_endo -70.18 132.81 23.41 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.288 1.992 . . . . 0.0 111.727 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.0 69.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 249' ' ' PHE . 19.1 m -62.69 -46.1 89.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 323' ' ' PRO . 63.0 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 73.7 m-20 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -82.62 127.03 71.99 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 109.531 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.7 Cg_endo -70.69 136.28 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.662 2.241 . . . . 0.0 111.716 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.82 158.58 21.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.95 -31.56 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.551 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.38 -44.18 79.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.862 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -70.0 -38.91 76.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -66.6 -33.92 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.296 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.84 11.76 23.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.88 HD13 HD11 ' B' ' 456' ' ' LEU . 47.0 tp -77.93 133.02 38.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.63 145.26 50.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.45 -7.31 82.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 1.084 HG13 HD12 ' B' ' 444' ' ' LEU . 73.2 t -111.68 122.47 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -80.59 158.61 25.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -52.18 -54.34 32.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.348 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -66.67 -35.2 79.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 108.937 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.084 HD12 HG13 ' B' ' 440' ' ' VAL . 3.4 tm? -58.95 -42.93 91.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.429 -0.795 . . . . 0.0 109.1 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.63 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -58.87 -48.19 82.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 109.025 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -53.38 -41.35 65.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.438 ' HB3' HD13 ' B' ' 470' ' ' ILE . 19.2 mttt -60.05 -38.04 81.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.849 . . . . 0.0 109.211 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 459' ' ' LEU . 65.1 mt -64.99 -37.87 89.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.11 -36.79 6.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.534 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.2 mtp-105 -91.14 23.25 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.585 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 452' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.69 -18.88 6.67 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.888 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.7 t -78.14 111.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.895 -1.356 . . . . 0.0 109.325 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' B' ' 430' ' ' PRO . 12.0 m -126.84 -40.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.712 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.722 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -77.93 140.86 39.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.734 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.92 HD11 HD12 ' B' ' 488' ' ' ILE . 0.2 OUTLIER -46.79 -43.78 18.61 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 108.963 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.43 -40.5 82.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.591 ' HB3' HG13 ' B' ' 453' ' ' VAL . 92.1 m-20 -59.03 -40.79 86.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 448' ' ' LEU . 16.9 tp -64.4 -37.84 88.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 109.446 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.14 77.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.07 -28.0 61.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.888 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -68.64 148.4 50.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -104.43 154.92 17.51 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.963 HD11 ' HG2' ' A' ' 293' ' ' PRO . 22.2 mt -45.3 -36.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.242 . . . . 0.0 109.406 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.28 -39.03 93.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.484 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.409 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 79.6 m-20 -67.32 -28.47 68.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.745 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.3 mp -79.6 -25.18 41.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.96 -22.55 66.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.367 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -53.37 -32.47 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' B' ' 447' ' ' LYS . 76.9 mt -101.1 124.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -54.52 -42.88 71.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.1 -27.45 30.85 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.837 HD21 HD21 ' B' ' 444' ' ' LEU . 32.9 mt -95.87 125.94 40.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 164.1 11.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.13 -38.45 76.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -75.21 -45.9 37.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.742 ' O ' HD13 ' B' ' 481' ' ' LEU . 45.2 tttt -60.77 -44.89 96.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.379 -0.825 . . . . 0.0 109.426 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.38 -41.19 98.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -62.08 -46.91 93.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.55 74.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -1.124 . . . . 0.0 109.618 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.877 ' HB3' HD21 ' B' ' 459' ' ' LEU . 6.8 mp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.657 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.962 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.9 mt -58.07 -56.24 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.66 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 52.3 mtp -52.93 -38.54 62.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 109.536 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.16 -47.75 64.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -64.81 -44.14 90.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.462 ' NH2' ' CZ2' ' B' ' 490' ' ' TRP . 51.5 ttt85 -58.86 -46.06 88.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 88.4 m-20 -59.62 -41.18 89.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.92 HD12 HD11 ' B' ' 456' ' ' LEU . 79.5 mt -63.84 -37.01 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.84 -49.78 17.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.693 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 490' ' ' TRP . . . . . 0.462 ' CZ2' ' NH2' ' B' ' 486' ' ' ARG . 77.7 m95 -68.63 -40.89 80.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 97.9 m-85 -95.88 4.01 53.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 492' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.773 ' CE2' HD12 ' A' ' 253' ' ' LEU . 41.2 t80 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.461 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.5 OUTLIER -53.93 116.58 10.51 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.236 -0.915 . . . . 0.0 109.242 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.727 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.7 Cg_endo -65.03 -24.47 59.94 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.669 2.246 . . . . 0.0 111.671 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 312' ' ' LEU . 15.2 tt -68.02 -30.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 108.928 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.881 HD21 ' O ' ' A' ' 311' ' ' GLY . 34.5 mt -74.73 -45.35 44.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.6 mt -62.75 -25.52 68.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 251' ' ' PRO . 0.6 OUTLIER -58.0 140.7 82.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 108.889 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.4 Cg_endo -69.06 129.72 18.87 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.587 2.191 . . . . 0.0 111.977 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.688 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.76 -29.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.351 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.437 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 96.8 m-20 -64.44 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.249 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 256' ' ' PRO . 56.4 t0 -70.0 -17.4 63.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -43.78 129.14 5.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.417 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.34 -22.4 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.481 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 262' ' ' LEU . 5.5 mp -61.01 172.82 0.9 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.0 p -66.05 168.15 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.673 HG12 ' ND2' ' A' ' 268' ' ' ASN . 30.4 t -61.99 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.603 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -41.09 97.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.213 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.2 m -59.97 -49.7 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -67.55 -40.55 84.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.673 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.0 m-20 -57.17 -36.94 71.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 294' ' ' ASN . 74.3 m -54.17 -65.04 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 289' ' ' LEU . 64.5 mt -64.4 -45.13 88.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.406 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.515 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 34.3 tttt -53.03 -37.75 61.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.53 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.55 19.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 93.8 mt-10 -91.41 21.61 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.82 34.3 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.7 mt -120.42 107.87 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.515 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 76.5 m-70 -105.14 -12.19 16.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.65 135.35 50.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 1.034 HG21 HD23 ' A' ' 312' ' ' LEU . 34.1 mt -62.9 -29.85 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.911 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.84 -43.1 11.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 77.0 m-20 -53.9 -36.41 62.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.261 . . . . 0.0 108.818 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 289' ' ' LEU . 33.1 tp -55.79 -47.94 76.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.82 . . . . 0.0 109.096 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 279' ' ' GLY . 20.4 m -69.47 -25.53 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.49 -31.52 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 108.899 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -113.12 151.21 31.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.46 -0.775 . . . . 0.0 109.152 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 287' ' ' VAL . 26.7 m -63.78 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 289' ' ' LEU . 86.4 tt0 -56.06 -33.11 64.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.737 ' HA ' HD12 ' A' ' 290' ' ' LEU . 47.5 t -52.78 -50.68 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.905 . . . . 0.0 109.356 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -51.8 -32.7 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.046 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.694 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.4 mm? -73.97 -46.48 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.803 . . . . 0.0 109.173 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 287' ' ' VAL . 7.8 mt -55.69 -20.07 13.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.271 -0.893 . . . . 0.0 109.067 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.576 ' O ' ' HE2' ' B' ' 483' ' ' MET . 54.4 mttm -81.71 -29.85 32.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.177 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 294' ' ' ASN . 40.3 m -59.87 125.66 81.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.67 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.4 Cg_endo -71.09 -19.84 29.41 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.676 2.251 . . . . 0.0 111.807 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' B' ' 464' ' ' ILE . 77.2 m-20 -64.45 -26.87 68.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 5.8 mt -67.21 144.82 55.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -101.25 146.92 17.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -54.03 -40.39 67.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -76.51 -29.96 56.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 71.2 p -64.36 -45.39 87.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 290' ' ' LEU . 53.6 tp -52.91 -45.19 67.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.1 m -51.66 -54.48 27.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 262' ' ' LEU . 94.0 mt-10 -54.74 -46.25 74.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.27 -41.78 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.157 -0.964 . . . . 0.0 109.169 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -57.36 -40.18 77.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.159 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.11 -46.49 87.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.227 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -73.05 -35.15 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.205 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.958 HD21 ' OG ' ' A' ' 313' ' ' SER . 3.3 tt -62.37 -26.5 68.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.507 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.36 -35.31 71.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.389 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 1.7 t -61.94 -14.38 34.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 309' ' ' SER . 31.6 mtt180 72.91 1.42 4.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.881 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -71.49 -22.14 78.64 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.034 HD23 HG21 ' A' ' 278' ' ' ILE . 0.8 OUTLIER -132.09 156.44 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 109.487 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.958 ' OG ' HD21 ' A' ' 307' ' ' LEU . 2.3 p 84.56 -141.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.732 -0.605 . . . . 0.0 109.793 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.778 HD22 ' OG ' ' A' ' 313' ' ' SER . 3.9 mm? 67.66 14.48 9.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 314' ' ' LEU . . . 42.22 45.04 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.728 ' HE2' HG11 ' A' ' 282' ' ' VAL . 29.5 mtm -61.67 169.01 2.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.327 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.775 ' C ' HD12 ' A' ' 318' ' ' LEU . 79.9 mtt180 -136.88 130.99 32.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.576 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.775 HD12 ' C ' ' A' ' 317' ' ' ARG . 5.1 mp -136.29 127.69 28.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 318' ' ' LEU . 96.1 mt-10 -43.91 -46.66 8.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.88 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 34.1 t30 -131.3 -56.35 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.241 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.635 ' HE3' HD22 ' A' ' 318' ' ' LEU . 1.6 t-105 164.8 -61.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 47.5 Cg_endo -67.51 107.75 1.48 Allowed 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.71 2.273 . . . . 0.0 111.98 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.0 Cg_endo -74.19 163.91 35.45 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.492 2.128 . . . . 0.0 111.579 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.78 -16.53 11.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 0.0 109.615 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.2 t -65.14 -46.71 79.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.506 HD11 HD21 ' A' ' 254' ' ' LEU . 28.5 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 16.1 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 2.3 tttm -83.66 136.57 42.07 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.285 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.478 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.2 Cg_endo -69.7 131.73 21.94 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 111.84 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.7 148.13 52.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.55 -33.78 15.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.69 -46.61 75.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' B' ' 448' ' ' LEU . 22.4 tp -69.86 -38.38 76.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.984 ' O ' HD13 ' B' ' 435' ' ' LEU . 1.4 tm? -72.78 -30.3 64.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -91.22 8.68 34.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 1.004 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.4 tp -72.94 138.75 46.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.69 138.01 36.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.29 5.37 63.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.893 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -122.92 132.66 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -1.16 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -86.85 150.32 24.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -49.83 -45.45 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.586 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.4 m-20 -64.75 -46.07 83.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 109.231 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.1 tp -53.9 -43.32 69.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.58 90.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.7 m-30 -56.84 -44.4 82.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 109.103 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.902 ' HB3' HG21 ' B' ' 470' ' ' ILE . 20.3 mttm -60.83 -40.39 92.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.49 ' CD1' HD11 ' B' ' 434' ' ' LEU . 89.0 mt -60.25 -47.02 87.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.376 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -60.94 -34.51 74.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.481 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -48.13 -35.4 11.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.652 ' HG3' HD11 ' B' ' 470' ' ' ILE . 47.2 mtp180 -91.11 22.93 3.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 452' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.79 -18.74 7.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.73 HG13 ' HB3' ' B' ' 458' ' ' ASP . 21.4 t -78.12 108.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.899 -1.354 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.482 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 95.3 m -119.84 -42.56 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.758 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.619 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -74.91 140.8 44.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 1.004 ' CD1' HD22 ' B' ' 437' ' ' LEU . 27.0 tp -49.97 -41.61 47.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.293 -0.88 . . . . 0.0 109.036 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 457' ' ' GLU . . . . . 0.402 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 31.7 mm-40 -57.32 -46.22 83.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 108.953 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.73 ' HB3' HG13 ' B' ' 453' ' ' VAL . 70.6 m-20 -58.24 -38.73 77.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.101 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.761 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -62.35 -42.85 99.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.18 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -60.42 -35.79 76.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.47 -30.81 71.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.493 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -67.38 156.29 36.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.12 161.46 13.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 294' ' ' ASN . 68.1 mt -52.75 -35.65 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -1.184 . . . . 0.0 109.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.12 -33.81 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.17 -31.47 65.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.033 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.1 mt -77.15 -33.89 56.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.81 55.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.98 -39.09 93.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.902 HG21 ' HB3' ' B' ' 447' ' ' LYS . 88.1 mt -82.54 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.47 152.65 29.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.576 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.52 -33.49 4.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' B' ' 444' ' ' LEU . 66.9 mt -85.99 126.6 34.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 475' ' ' ASP . 35.4 m -103.64 161.98 13.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.493 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 87.8 m-20 -59.55 -36.03 75.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -76.03 -46.04 31.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.448 ' CE ' HD22 ' B' ' 444' ' ' LEU . 34.4 tttp -65.1 -47.58 76.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.033 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -57.83 -44.51 86.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -59.31 -47.67 89.7 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.29 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.48 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.555 HD22 ' CG2' ' B' ' 440' ' ' VAL . 28.0 mt -61.64 -36.47 80.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.9 mt -62.52 -53.64 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.576 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 33.9 mtp -54.24 -48.92 70.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -52.67 -56.16 17.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -60.19 -49.35 77.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 109.572 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.565 ' CG ' ' HB1' ' B' ' 460' ' ' ALA . 90.3 mtt180 -59.63 -42.05 91.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.492 ' O ' ' CD1' ' B' ' 491' ' ' PHE . 99.5 m-20 -58.36 -42.75 87.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.962 HD12 ' CD2' ' B' ' 456' ' ' LEU . 38.3 mt -64.34 -38.32 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 489' ' ' CYS . . . . . 0.402 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.0 OUTLIER -75.96 -51.92 11.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -63.22 -28.01 69.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 109.42 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' B' ' 487' ' ' ASN . 3.6 m-30 -72.23 -34.36 68.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.6 ' N ' ' HG ' ' A' ' 325' ' ' SER . 14.3 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.47 126.74 56.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.382 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.776 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -65.25 -27.49 56.03 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.674 2.25 . . . . 0.0 111.601 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 312' ' ' LEU . 8.3 tt -69.07 -28.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.638 HD13 HG21 ' A' ' 282' ' ' VAL . 26.2 mt -74.54 -43.42 55.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.421 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.776 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.7 mt -64.18 -32.31 73.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 278' ' ' ILE . 5.7 ttp180 -55.82 135.89 72.46 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.6 Cg_endo -68.58 129.79 19.57 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.641 2.227 . . . . 0.0 111.842 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.818 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -44.69 -25.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.35 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 256' ' ' PRO . 97.8 m-20 -67.18 -30.88 70.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 256' ' ' PRO . 37.0 m-20 -75.36 -9.72 58.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 257' ' ' VAL . 4.5 mp -43.77 127.18 4.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 262' ' ' LEU . 97.0 mt-10 -62.63 -27.84 69.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.758 HD13 ' HG2' ' A' ' 302' ' ' GLU . 18.8 mt -54.41 -170.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.457 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -80.41 159.72 25.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.59 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.5 t -53.43 -30.58 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -52.37 -45.53 65.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.4 m -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.87 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.92 87.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.59 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.4 m-20 -59.79 -34.29 72.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -58.29 -64.0 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.45 -45.4 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -52.9 -40.38 63.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.11 -25.05 66.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.4 mm-40 -88.51 17.42 5.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.63 33.32 2.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.769 HG23 ' HB2' ' A' ' 280' ' ' ASP . 79.0 mt -108.59 127.05 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.5 p80 -112.23 -35.02 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.57 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.503 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.1 m-30 -110.07 128.8 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.687 HD11 HD11 ' A' ' 260' ' ' LEU . 76.6 mt -46.45 -29.92 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.836 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.82 -47.15 13.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.769 ' HB2' HG23 ' A' ' 275' ' ' ILE . 54.0 m-20 -53.36 -30.87 41.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.235 . . . . 0.0 108.798 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 289' ' ' LEU . 41.8 tp -59.74 -49.71 76.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.468 -0.77 . . . . 0.0 109.273 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 279' ' ' GLY . 27.3 m -65.71 -29.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.152 -0.967 . . . . 0.0 108.866 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -60.9 -33.99 73.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.371 -0.831 . . . . 0.0 108.961 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 56.1 mtt180 -100.12 143.33 30.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.299 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.3 m -69.03 143.53 54.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -54.29 -28.3 41.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.333 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 43.1 t -52.83 -50.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.304 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.2 mt-10 -52.19 -33.29 40.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 281' ' ' LEU . 60.8 mt -70.88 -30.61 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.64 -31.69 67.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.8 -14.3 56.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.02 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 77.0 m -81.76 115.88 59.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 1.007 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.5 Cg_endo -70.62 -16.91 33.96 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.698 2.265 . . . . 0.0 111.773 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.772 ' ND2' HD12 ' B' ' 464' ' ' ILE . 27.0 m120 -47.21 -33.13 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 295' ' ' LEU . 0.4 OUTLIER -107.26 137.12 45.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.441 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -81.58 172.06 53.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -57.75 -41.97 83.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.408 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -63.46 -35.97 82.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.932 . . . . 0.0 109.298 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 28.2 m -58.3 -37.42 75.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 28.7 tp -53.97 -33.54 57.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 109.292 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.3 m -60.93 -57.46 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.758 ' HG2' HD13 ' A' ' 262' ' ' LEU . 42.8 tt0 -53.57 -46.12 70.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 108.996 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 56.2 mt -57.74 -50.73 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -56.11 -38.73 71.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 108.761 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 302' ' ' GLU . 64.4 m-20 -53.85 -45.66 71.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 1.037 HG12 ' CD2' ' A' ' 312' ' ' LEU . 4.5 t -66.86 -40.81 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 108.865 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 313' ' ' SER . 21.3 mt -53.83 -25.65 20.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.441 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.9 63.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 108.983 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 p -71.4 -9.09 57.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.203 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.685 ' HA ' HD11 ' A' ' 314' ' ' LEU . 55.6 mtm180 53.01 19.35 1.34 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -107.96 0.22 33.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.037 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -147.23 145.87 29.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -1.231 . . . . 0.0 109.644 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.5 OUTLIER 58.13 46.69 15.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.398 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.685 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -90.46 23.95 2.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.2 39.3 95.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.748 ' HE2' HG11 ' A' ' 282' ' ' VAL . 1.3 mtm -93.63 170.95 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.108 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.453 ' C ' HD23 ' A' ' 318' ' ' LEU . 67.4 mtm-85 -136.15 117.05 14.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 317' ' ' ARG . 4.5 mt -112.47 139.81 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.354 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.88 -35.37 79.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.256 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.8 m-20 -140.46 -47.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 109.157 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.604 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.52 -62.83 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -67.87 107.04 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.549 2.166 . . . . 0.0 111.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.6 Cg_endo -69.65 165.18 31.71 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.665 2.243 . . . . 0.0 111.85 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.93 -15.72 56.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 97.0 p -85.82 -26.27 25.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.211 -0.93 . . . . 0.0 109.454 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 323' ' ' PRO . 16.3 tt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.718 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 25.6 m120 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 4.5 tttm -53.98 131.94 58.61 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.459 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.6 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.9 Cg_endo -70.3 144.42 51.09 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.627 2.218 . . . . 0.0 111.833 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -79.45 161.06 26.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.453 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 432' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' B' ' 436' ' ' ASN . 85.9 m-20 -52.09 -37.55 54.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 433' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' B' ' 456' ' ' LEU . 16.7 m-20 -61.08 -50.12 74.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' B' ' 430' ' ' PRO . 23.2 tp -68.91 -38.07 79.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.703 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.971 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.1 tm? -77.04 -29.6 55.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.563 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 436' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 432' ' ' ASP . 78.9 m-20 -93.77 10.87 31.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.487 HD23 HG21 ' B' ' 440' ' ' VAL . 29.1 tp -75.53 133.22 41.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.57 143.29 48.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.6 -4.76 82.35 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.714 ' CG2' HD22 ' B' ' 481' ' ' LEU . 49.6 t -126.56 135.77 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -1.182 . . . . 0.0 109.419 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' HD12 ' B' ' 444' ' ' LEU . 49.6 p30 -103.41 175.08 5.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.534 ' HG2' HD21 ' B' ' 435' ' ' LEU . 64.4 mtm180 -61.61 -38.19 86.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.18 -41.06 99.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.513 HD13 ' HZ1' ' B' ' 477' ' ' LYS . 21.9 mt -72.23 -39.74 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.21 -35.82 78.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.873 . . . . 0.0 109.439 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 15.2 m-30 -73.08 -46.07 53.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.505 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.521 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 17.5 ttmt -61.65 -44.14 97.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.867 HD11 HG21 ' B' ' 453' ' ' VAL . 2.9 tm? -65.62 -45.45 83.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.93 -31.36 62.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.564 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.39 -20.55 4.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.593 ' CG ' HD11 ' B' ' 470' ' ' ILE . 11.4 mtp-105 -89.62 32.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.88 -18.72 7.17 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.867 HG21 HD11 ' B' ' 448' ' ' LEU . 48.0 t -61.71 137.1 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.815 -1.403 . . . . 0.0 109.318 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' B' ' 431' ' ' ALA . 1.0 OUTLIER -133.17 -34.63 1.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.783 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.572 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.4 OUTLIER -116.93 144.0 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 109.972 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.816 HD11 ' HA ' ' B' ' 485' ' ' ALA . 1.4 tm? -45.47 -39.43 7.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 108.889 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 457' ' ' GLU . . . . . 0.422 ' N ' HD13 ' B' ' 456' ' ' LEU . 44.8 mm-40 -55.68 -49.43 72.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.882 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -55.13 -41.66 72.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.855 . . . . 0.0 108.946 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.597 HD13 ' CD1' ' B' ' 434' ' ' LEU . 4.0 tt -55.86 -48.46 75.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.317 -0.864 . . . . 0.0 109.278 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.871 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -57.38 -33.09 67.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.313 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.365 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.75 160.94 28.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -116.94 152.87 17.67 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.938 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.8 mt -44.93 -42.49 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -1.172 . . . . 0.0 109.343 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.05 -39.78 83.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.343 -0.848 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.79 -29.06 66.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.026 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.8 mt -78.4 -28.25 46.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.6 -25.57 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.05 -31.28 18.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.593 HD11 ' CG ' ' B' ' 451' ' ' ARG . 60.0 mt -103.79 121.83 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.569 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.37 -32.55 72.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.78 -26.48 25.59 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.451 ' CD1' HD23 ' B' ' 448' ' ' LEU . 64.0 mt -108.82 139.26 43.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -1.122 . . . . 0.0 109.523 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.493 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.7 m -103.7 164.66 11.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.493 ' N ' HG22 ' B' ' 474' ' ' THR . 81.6 m-20 -60.49 -37.15 80.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.415 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -75.47 -46.02 35.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.513 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 64.4 tttm -63.92 -40.5 96.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.445 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.026 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.91 -39.83 94.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -63.16 -42.36 99.46 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.09 85.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.573 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.714 HD22 ' CG2' ' B' ' 440' ' ' VAL . 29.2 mt -67.16 -38.63 85.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 293' ' ' PRO . 26.3 mt -65.4 -56.02 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.4 mtp -52.36 -36.77 54.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.386 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.66 -44.53 64.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.871 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -62.86 -52.02 64.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.08 -41.74 84.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.387 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.2 m-20 -57.46 -35.88 70.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.227 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.449 HG13 ' O ' ' B' ' 484' ' ' ALA . 88.1 mt -70.88 -36.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.254 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 11.3 t -74.63 -51.69 13.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.755 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -61.73 -30.7 70.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 19.5 m-30 -82.95 -34.27 26.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.072 -1.017 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 253' ' ' LEU . 23.4 t80 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.553 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.427 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -55.17 142.81 56.89 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.601 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.506 ' HB2' ' NH2' ' A' ' 255' ' ' ARG . 43.5 Cg_endo -65.46 -22.97 58.54 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.807 2.338 . . . . 0.0 111.654 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.533 HG21 ' CA ' ' A' ' 311' ' ' GLY . 10.3 tt -70.01 -28.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.88 . . . . 0.0 108.927 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -69.23 -38.5 78.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 253' ' ' LEU . 3.8 mm? -86.04 -24.0 26.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.365 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 4.8 ttm-85 -64.03 145.02 98.15 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.454 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 48.8 Cg_endo -70.01 136.72 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.728 2.285 . . . . 0.0 111.837 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.9 HG11 HD12 ' A' ' 270' ' ' LEU . 0.1 OUTLIER -45.74 -33.38 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.0 109.522 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.473 ' OD1' ' HB1' ' A' ' 267' ' ' ALA . 95.1 m-20 -62.51 -30.83 71.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.524 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 25.5 m-20 -68.24 -9.61 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 278' ' ' ILE . 51.2 mt -66.18 139.38 58.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 262' ' ' LEU . 74.8 mm-40 -69.38 -20.23 63.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.497 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.816 HD22 ' CG ' ' A' ' 302' ' ' GLU . 26.2 mt -52.46 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 p -80.69 160.15 25.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.558 HG12 ' OD1' ' A' ' 268' ' ' ASN . 21.2 t -55.21 -27.64 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -51.97 -48.0 64.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.0 m -58.97 -50.97 72.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.339 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.473 ' HB1' ' OD1' ' A' ' 258' ' ' ASP . . . -65.32 -33.27 75.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.558 ' OD1' HG12 ' A' ' 264' ' ' VAL . 95.5 m-20 -61.38 -37.73 84.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.38 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.8 m -53.24 -64.55 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.9 HD12 HG11 ' A' ' 257' ' ' VAL . 57.7 mt -66.51 -45.24 80.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 21.4 tptm -53.19 -40.06 64.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.12 -21.42 65.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.6 mt-10 -94.14 23.36 5.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.61 17.62 7.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 56.2 mt -104.81 122.98 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.468 ' ND1' ' HD2' ' A' ' 271' ' ' LYS . 92.2 m-70 -113.09 -12.87 13.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 254' ' ' LEU . 4.5 m-85 -112.84 141.4 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 312' ' ' LEU . 74.3 mt -65.1 -28.97 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.444 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.26 -47.5 10.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 67.8 m-20 -53.35 -32.96 51.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.99 -1.3 . . . . 0.0 108.893 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 270' ' ' LEU . 26.7 tp -55.65 -50.73 69.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.183 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 279' ' ' GLY . 28.2 m -66.77 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 108.787 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -54.92 -35.42 64.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 0.0 108.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -107.58 144.07 35.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.076 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 45.6 p -76.23 157.15 32.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 307' ' ' LEU . 10.0 mt-10 -56.16 -38.63 71.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.297 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.927 ' HA ' HD12 ' A' ' 290' ' ' LEU . 41.2 t -52.88 -52.78 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.283 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.55 -32.3 58.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 292' ' ' THR . 7.6 mp -80.42 -33.08 37.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 287' ' ' VAL . 4.9 mt -69.66 -17.12 63.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.958 . . . . 0.0 109.353 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' B' ' 483' ' ' MET . 33.8 mmtt -86.48 10.95 13.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 0.0 109.482 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.87 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.3 t -125.82 142.72 43.0 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.918 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.9 Cg_endo -71.35 -20.71 27.43 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.796 2.33 . . . . 0.0 111.941 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' B' ' 464' ' ' ILE . 87.1 m-20 -43.3 -44.14 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.634 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 292' ' ' THR . 0.2 OUTLIER -107.64 137.07 46.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.499 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -91.73 -179.16 42.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.35 -44.19 95.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -1.204 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -60.85 -42.57 98.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.4 m -54.9 -46.32 74.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.31 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.827 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.3 tm? -52.68 -45.11 66.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.241 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 23.9 m -50.84 -51.54 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.091 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.816 ' CG ' HD22 ' A' ' 262' ' ' LEU . 38.6 tp10 -54.19 -42.33 69.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 23.7 mm -57.95 -41.15 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -0.867 . . . . 0.0 108.892 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LYS . . . . . 0.769 ' HE3' HD12 ' A' ' 300' ' ' LEU . 82.9 mttt -59.43 -40.53 87.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.327 -0.858 . . . . 0.0 108.872 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.18 -46.97 87.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.662 ' CG1' HD11 ' A' ' 312' ' ' LEU . 6.0 t -70.14 -37.4 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.109 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 286' ' ' GLU . 19.9 tp -61.38 -27.3 68.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.34 76.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -79.21 -0.22 31.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.792 ' HA ' HD11 ' A' ' 314' ' ' LEU . 64.4 mtt180 63.24 11.04 5.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.182 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.533 ' CA ' HG21 ' A' ' 252' ' ' ILE . . . -64.75 -51.1 54.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 278' ' ' ILE . 0.5 OUTLIER -144.41 168.53 19.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -1.156 . . . . 0.0 109.566 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.576 ' O ' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 72.4 32.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.3 mm? -75.85 -4.9 43.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.51 41.24 96.34 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -111.54 157.96 19.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -1.139 . . . . 0.0 109.638 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -115.19 133.45 56.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 109.223 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.18 140.76 40.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -58.28 -38.51 77.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 40.7 t-20 -132.96 -73.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.404 -0.81 . . . . 0.0 109.001 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.553 ' N ' ' CD ' ' A' ' 322' ' ' PRO . 1.5 t90 175.78 -45.07 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.583 ' HA ' HD12 ' A' ' 326' ' ' ILE . 52.9 Cg_endo -97.73 74.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 123.473 2.782 . . . . 0.0 112.601 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.21 165.15 29.56 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.499 2.132 . . . . 0.0 111.615 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -44.82 -26.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.5 m -67.97 -61.01 2.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.651 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.842 HD11 HD21 ' A' ' 253' ' ' LEU . 9.5 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 76.9 m-20 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 136.08 59.37 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 51.5 Cg_endo -70.58 133.24 23.63 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.674 2.25 . . . . 0.0 111.772 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.08 153.83 41.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.17 -35.34 59.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.53 -47.75 74.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.87 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.676 ' CD1' HD23 ' B' ' 448' ' ' LEU . 21.4 tp -66.35 -38.31 87.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 109.45 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.774 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -70.57 -32.46 69.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.403 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -88.65 7.31 34.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 440' ' ' VAL . 40.3 tp -72.3 134.83 45.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -80.74 141.77 34.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.51 68.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.865 HG21 HD23 ' B' ' 437' ' ' LEU . 87.6 t -122.84 126.98 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 109.399 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.52 154.3 23.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.432 ' NH1' HD11 ' B' ' 435' ' ' LEU . 68.6 mtp85 -50.26 -48.87 54.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.2 m-20 -61.91 -44.48 96.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.06 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.3 tp -55.65 -44.45 77.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.395 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.75 87.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 13.0 m-30 -58.98 -43.06 91.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.357 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.67 -40.71 93.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.676 HD23 ' CD1' ' B' ' 434' ' ' LEU . 19.7 tp -60.99 -47.28 87.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.93 -31.5 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.97 -33.81 57.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.605 ' HG3' HD11 ' B' ' 470' ' ' ILE . 33.5 mtm105 -90.32 22.06 3.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.432 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.87 6.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' B' ' 458' ' ' ASP . 3.0 t -76.87 111.49 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.915 -1.344 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 29.5 m -121.51 -35.44 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.433 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -87.5 142.63 27.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.996 HD21 HD12 ' B' ' 488' ' ' ILE . 35.3 tp -48.71 -42.06 33.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.173 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.94 -45.79 78.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.142 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.804 ' HB3' HG13 ' B' ' 453' ' ' VAL . 93.6 m-20 -57.77 -41.69 82.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.887 . . . . 0.0 109.078 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.748 HD13 ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -59.23 -41.4 88.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 109.278 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -62.09 -37.15 83.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.83 -25.86 67.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.725 ' HG3' HG21 ' B' ' 453' ' ' VAL . 88.1 mm-40 -78.36 138.92 38.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -97.85 165.38 22.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 293' ' ' PRO . 68.1 mt -48.04 -36.29 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.425 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -65.55 -38.65 90.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.256 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.73 -31.69 72.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.94 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -78.14 -26.84 48.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.6 66.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -52.85 -33.12 48.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.605 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.8 mt -104.67 128.58 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.08 -33.47 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.495 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.35 -27.33 46.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.06 ' CD2' HD11 ' B' ' 444' ' ' LEU . 35.1 mt -102.62 134.32 46.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.9 m -104.2 161.93 13.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.95 -36.35 76.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -76.94 -46.02 25.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.47 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 38.9 tttp -66.33 -40.2 89.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.3 -42.47 93.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.0 -45.11 96.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.14 90.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -1.186 . . . . 0.0 109.659 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -65.83 -39.93 91.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 88.7 mt -61.88 -56.14 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.516 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 67.1 mmm -54.06 -43.23 70.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.44 62.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.2 90.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.377 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.578 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 63.1 mtp180 -59.48 -43.82 93.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 94.2 m-20 -58.28 -43.44 87.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.996 HD12 HD21 ' B' ' 456' ' ' LEU . 68.7 mt -60.25 -37.47 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.0 m -78.8 -51.98 8.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -59.71 -45.95 90.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 51.6 m-85 -76.2 -39.68 54.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.606 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.572 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 91.8 m-85 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.12 154.84 76.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.43 -24.72 56.63 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.672 2.248 . . . . 0.0 111.698 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -64.9 -30.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.934 . . . . 0.0 108.525 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.524 ' CD1' HG11 ' A' ' 282' ' ' VAL . 2.0 tp -72.8 -27.27 61.88 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.899 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.9 mt -90.93 -24.57 20.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.4 mtt85 -55.95 149.54 33.35 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 257' ' ' VAL . 50.1 Cg_endo -70.18 130.34 18.66 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.604 2.203 . . . . 0.0 111.665 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.66 -26.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.479 ' HA ' ' HZ1' ' A' ' 271' ' ' LYS . 55.2 t0 -63.21 -31.0 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.427 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' PRO . 83.1 m-20 -72.76 -12.47 61.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.674 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -46.22 137.44 6.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.52 -16.08 63.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 262' ' ' LEU . 4.6 mp -64.16 170.45 3.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.7 p -71.58 164.07 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 268' ' ' ASN . 11.5 t -51.31 -31.12 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -57.32 -45.05 84.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.038 . . . . 0.0 109.299 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.581 ' OG ' HD22 ' A' ' 262' ' ' LEU . 18.7 t -59.94 -50.06 75.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.592 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.72 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -64.59 -44.25 91.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.364 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.669 HD21 HG12 ' A' ' 264' ' ' VAL . 86.6 m-20 -53.54 -32.63 51.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.74 ' SG ' HD23 ' A' ' 295' ' ' LEU . 28.5 t -63.49 -57.22 10.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.672 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.6 mm? -66.4 -48.15 70.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.72 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 42.7 mttt -55.61 -37.53 68.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.93 -28.79 53.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 67.8 mm-40 -88.92 23.52 2.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.36 40.47 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.92 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.5 mt -116.34 125.63 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.596 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.1 p80 -115.89 -29.72 6.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.596 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.5 m-85 -111.36 131.68 54.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.531 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 252' ' ' ILE . 78.5 mt -46.97 -32.15 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.268 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.884 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.08 -47.88 14.93 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.92 ' HB2' HG23 ' A' ' 275' ' ' ILE . 90.1 m-20 -53.49 -34.29 57.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.901 -1.352 . . . . 0.0 108.878 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 289' ' ' LEU . 40.0 tp -52.97 -50.86 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.417 -0.802 . . . . 0.0 109.022 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.5 m -65.98 -30.05 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 108.772 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 49.6 tt0 -54.32 -37.6 65.02 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.402 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 58.6 mtt-85 -105.8 141.38 37.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.476 -0.765 . . . . 0.0 109.066 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -65.22 141.69 58.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -53.99 -23.93 14.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.781 ' HA ' HD12 ' A' ' 290' ' ' LEU . 50.2 t -52.73 -51.02 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 109.103 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.5 mt-10 -51.9 -37.28 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.133 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 281' ' ' LEU . 61.5 mt -61.66 -45.11 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.117 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 287' ' ' VAL . 6.1 mt -60.65 -29.11 69.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.524 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 62.8 mttm -82.02 -20.93 37.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 116.33 60.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.374 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.983 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.5 Cg_endo -70.6 -9.16 25.23 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.715 2.277 . . . . 0.0 111.821 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.523 ' OD1' HD12 ' B' ' 464' ' ' ILE . 80.0 m-20 -60.77 -37.38 81.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.74 HD23 ' SG ' ' A' ' 269' ' ' CYS . 1.3 pp -100.18 137.5 38.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -0.955 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -86.71 168.71 39.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -64.7 -36.74 85.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.7 -42.16 83.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 303' ' ' ILE . 85.1 p -63.07 -34.09 76.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.2 tp -56.76 -33.41 66.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.1 m -61.49 -52.12 65.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.424 ' CD ' ' HG ' ' A' ' 262' ' ' LEU . 80.9 tt0 -62.91 -46.3 88.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.335 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.492 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 62.7 mt -57.74 -46.99 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 108.844 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.51 -40.54 65.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.07 -44.66 87.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.822 . . . . 0.0 108.811 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.821 ' CG1' HD22 ' A' ' 312' ' ' LEU . 6.3 t -63.91 -34.98 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.287 -0.883 . . . . 0.0 108.925 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 303' ' ' ILE . 8.4 mp -60.17 -25.99 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 109.238 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.65 68.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -60.97 -14.62 24.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.67 ' HA ' HD11 ' A' ' 314' ' ' LEU . 24.2 ttm180 70.03 4.81 4.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.716 ' C ' HD12 ' A' ' 312' ' ' LEU . . . -108.11 16.25 35.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.821 HD22 ' CG1' ' A' ' 306' ' ' VAL . 5.3 mp -146.58 138.63 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.629 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.6 OUTLIER 47.13 59.41 4.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.537 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.679 HD21 ' N ' ' A' ' 312' ' ' LEU . 3.7 mm? -91.12 9.88 29.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.04 87.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.519 ' CE ' HG11 ' A' ' 282' ' ' VAL . 7.1 ptt? -114.58 153.51 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -1.2 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -125.08 125.95 44.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.5 mp -103.26 138.66 39.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.83 -35.23 76.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.158 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 39.8 t30 -125.82 -69.29 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.899 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 1.2 t-105 165.63 -62.89 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.1 Cg_endo -67.99 108.26 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.546 2.164 . . . . 0.0 112.021 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.572 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 53.5 Cg_endo -75.16 164.39 33.15 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.608 2.205 . . . . 0.0 111.506 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.9 -10.86 31.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 48.2 m -73.32 -43.78 60.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.673 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 254' ' ' LEU . 25.1 pt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.594 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 26.5 m120 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -53.34 128.62 50.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 109.409 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 49.9 Cg_endo -69.88 141.55 45.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.676 2.251 . . . . 0.0 111.902 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -73.51 148.06 43.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.481 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 432' ' ' ASP . . . . . 0.519 ' OD1' ' ND2' ' B' ' 436' ' ' ASN . 52.2 t0 -46.9 -37.28 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.5 -42.82 93.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.857 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.3 tm? -67.24 -30.93 70.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 442' ' ' ARG . 21.7 tp -81.33 -29.63 34.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 109.566 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 436' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' B' ' 432' ' ' ASP . 9.1 m120 -74.87 -3.8 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.634 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.793 HD23 HG21 ' B' ' 440' ' ' VAL . 37.2 tp -68.26 134.53 50.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.73 142.19 42.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.77 8.39 67.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.793 HG21 HD23 ' B' ' 437' ' ' LEU . 43.8 t -127.52 128.49 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.39 158.66 15.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.619 ' HG2' HD11 ' B' ' 435' ' ' LEU . 90.6 mtt-85 -50.22 -48.55 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.33 -51.08 69.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.01 HD11 ' CD1' ' B' ' 473' ' ' LEU . 20.7 tp -55.08 -40.6 70.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.14 -42.73 91.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -60.69 -48.16 83.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.3 -45.84 83.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.851 ' O ' HD13 ' B' ' 448' ' ' LEU . 0.7 OUTLIER -65.21 -42.85 93.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -63.35 -27.91 69.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.16 -20.04 3.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -92.23 30.07 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.64 7.5 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.581 HG13 ' CB ' ' B' ' 458' ' ' ASP . 3.4 t -60.76 135.99 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 0.0 109.386 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 31.1 p -135.24 -35.89 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 109.881 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.6 159.79 17.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 109.877 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.957 HD11 HD12 ' B' ' 488' ' ' ILE . 0.3 OUTLIER -52.25 -43.71 64.5 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.277 -0.89 . . . . 0.0 109.238 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.74 -44.03 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 108.951 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.581 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.0 m-20 -56.81 -43.34 80.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.288 -0.883 . . . . 0.0 108.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' B' ' 448' ' ' LEU . 24.6 tp -56.89 -45.18 82.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.23 72.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.384 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -65.94 -32.28 73.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.564 ' OE1' HG22 ' B' ' 453' ' ' VAL . 2.3 mp0 -62.15 157.6 18.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.28 153.91 17.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.3 mt -50.85 -38.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 109.296 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -70.17 -32.22 70.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.041 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.6 mt -77.19 -29.2 54.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.08 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.59 -33.68 66.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.587 HG22 ' H ' ' B' ' 472' ' ' GLY . 76.3 mt -103.03 129.2 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -62.1 -29.92 70.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.587 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.04 -32.75 50.02 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.01 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.9 mm? -106.13 133.22 51.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.426 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.454 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.3 m -103.62 161.87 13.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.454 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.71 -36.95 75.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -76.31 -45.53 31.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.568 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.715 ' CE ' HD22 ' B' ' 444' ' ' LEU . 25.3 tttp -67.35 -41.24 85.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.041 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.7 -45.18 91.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 109.587 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.65 -42.09 99.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.95 91.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.615 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -65.3 -47.15 77.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.934 HD12 ' HB2' ' A' ' 293' ' ' PRO . 35.7 mt -55.19 -56.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 55.8 mtp -52.91 -41.93 64.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.437 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.34 -43.89 96.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.697 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' B' ' 459' ' ' LEU . . . -65.5 -49.69 68.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 293' ' ' PRO . 95.3 mtt180 -57.79 -46.1 85.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 87.6 m-20 -57.91 -38.45 75.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.554 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.957 HD12 HD11 ' B' ' 456' ' ' LEU . 76.4 mt -70.94 -36.79 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 13.5 t -77.71 -51.51 10.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.787 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -63.54 -45.72 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 99.6 m-85 -93.94 13.9 21.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 254' ' ' LEU . 14.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.842 ' HB2' HD13 ' A' ' 253' ' ' LEU . 25.0 m-20 -54.07 124.58 45.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.105 -0.997 . . . . 0.0 109.31 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -64.75 -25.61 60.93 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.664 2.242 . . . . 0.0 111.624 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.701 ' CG2' HD12 ' A' ' 253' ' ' LEU . 14.5 tt -63.5 -33.72 63.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 108.622 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.85 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.5 mp -74.86 -41.37 59.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.407 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.823 HD21 HD11 ' A' ' 326' ' ' ILE . 1.7 mt -72.08 -30.48 65.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.776 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 259' ' ' ASP . 4.8 ttp-105 -56.43 138.35 75.46 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 108.849 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 259' ' ' ASP . 46.3 Cg_endo -68.23 130.57 21.58 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.64 2.227 . . . . 0.0 111.757 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.735 HG23 ' HE3' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -44.55 -26.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 t0 -68.46 -30.77 69.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.255 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 256' ' ' PRO . 35.2 m-20 -69.87 -16.57 63.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 278' ' ' ILE . 37.7 mt -56.07 138.26 49.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.2 tt0 -66.02 -16.22 63.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 302' ' ' GLU . 33.4 mt -53.5 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.0 p -88.27 157.56 18.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.474 HG12 ' OD1' ' A' ' 268' ' ' ASN . 7.0 t -50.68 -37.1 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 265' ' ' ARG . 17.7 tpt85 -57.17 -46.5 82.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.1 m -57.97 -47.55 82.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.33 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -68.93 -39.71 79.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.375 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.474 ' OD1' HG12 ' A' ' 264' ' ' VAL . 12.3 m120 -56.66 -34.9 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 69.0 m -57.11 -64.37 0.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 281' ' ' LEU . 57.4 mt -56.64 -48.09 78.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HE3' HG23 ' A' ' 257' ' ' VAL . 32.3 mttt -54.75 -37.63 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.04 27.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.4 mt-10 -89.95 25.83 2.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.397 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 67.17 42.7 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 1.0 HG23 ' HB2' ' A' ' 280' ' ' ASP . 88.8 mt -115.72 124.6 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.45 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.478 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.3 p80 -110.99 -41.53 4.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.484 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.478 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 8.4 m-30 -105.22 135.02 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.19 -0.944 . . . . 0.0 109.427 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 252' ' ' ILE . 86.7 mt -46.95 -30.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 1.003 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.98 -46.34 19.83 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 1.0 ' HB2' HG23 ' A' ' 275' ' ' ILE . 83.1 m-20 -53.45 -34.54 58.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -1.167 . . . . 0.0 108.884 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 270' ' ' LEU . 35.1 tp -54.96 -49.88 70.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 108.987 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 279' ' ' GLY . 14.3 m -65.26 -23.13 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 0.0 108.84 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.9 tt0 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.02 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -96.39 159.9 14.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.345 -0.847 . . . . 0.0 109.227 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 287' ' ' VAL . 36.0 m -81.39 139.09 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 289' ' ' LEU . 77.9 tt0 -58.56 -32.21 68.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 285' ' ' THR . 45.7 t -52.72 -50.37 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.878 . . . . 0.0 109.359 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 292' ' ' THR . 97.5 mt-10 -55.2 -33.34 62.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.344 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.624 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.8 mm? -64.93 -43.44 92.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm? -66.07 -23.97 66.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 37.7 mttt -90.45 -8.54 50.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' ' CD1' ' A' ' 295' ' ' LEU . 2.1 m -86.99 113.73 54.92 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.6 Cg_endo -70.48 -22.25 29.04 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.661 2.24 . . . . 0.0 111.923 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.802 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.1 m120 -50.47 -22.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.116 -0.99 . . . . 0.0 109.345 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.91 HD23 HD11 ' A' ' 303' ' ' ILE . 4.9 mp -90.79 138.75 31.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.408 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 296' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -87.98 167.78 36.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -55.02 -45.83 75.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -69.39 -37.84 77.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.9 m -58.58 -51.48 69.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 295' ' ' LEU . 78.3 mt -53.83 -46.41 71.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.475 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 32.2 m -51.77 -51.09 58.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.978 . . . . 0.0 109.29 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.638 ' HB3' HD13 ' A' ' 262' ' ' LEU . 80.4 mt-10 -53.89 -38.47 64.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.967 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.91 HD11 HD23 ' A' ' 295' ' ' LEU . 74.1 mt -59.34 -48.04 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.104 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -56.57 -36.54 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.28 -47.82 82.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.125 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 312' ' ' LEU . 2.0 t -66.23 -38.06 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.032 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.55 HD12 HD12 ' A' ' 312' ' ' LEU . 4.7 mp -54.4 -26.71 32.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.221 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.17 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.444 -0.785 . . . . 0.0 109.503 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 2.0 t -61.63 -31.85 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.467 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 309' ' ' SER . 29.5 mtm180 82.74 -24.72 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.536 -0.727 . . . . 0.0 110.38 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.85 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -60.04 -21.18 55.59 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 306' ' ' VAL . 0.4 OUTLIER -125.36 159.95 30.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.46 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.639 ' H ' HG12 ' A' ' 282' ' ' VAL . 4.6 t 77.0 -144.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 314' ' ' LEU . 4.0 mm? 63.59 13.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 45.73 51.58 10.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.724 ' HE2' HG11 ' A' ' 282' ' ' VAL . 26.2 mtm -68.1 173.42 4.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -1.174 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.511 ' O ' HD23 ' A' ' 318' ' ' LEU . 50.4 mtt-85 -132.54 120.59 22.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.516 HD11 ' CG2' ' A' ' 282' ' ' VAL . 5.2 mt -122.43 141.71 51.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.29 -37.57 87.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 80.4 m-20 -143.28 -47.92 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.371 -0.831 . . . . 0.0 108.926 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.567 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.05 -68.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.481 -0.762 . . . . 0.0 109.236 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.5 Cg_endo -69.77 110.93 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.58 2.187 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 50.5 Cg_endo -70.72 155.07 63.5 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.665 2.244 . . . . 0.0 111.654 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.97 -22.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.4 m -62.06 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.823 HD11 HD21 ' A' ' 254' ' ' LEU . 19.5 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' B' ' 454' ' ' CYS . 8.3 tttt -94.27 137.82 22.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.518 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.8 Cg_endo -70.49 132.57 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.703 2.268 . . . . 0.0 111.69 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.77 151.22 42.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.38 -37.71 57.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.46 -44.77 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.767 ' C ' HD13 ' B' ' 434' ' ' LEU . 3.3 tm? -69.96 -36.24 75.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.818 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.4 OUTLIER -69.54 -31.97 70.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -89.32 9.26 26.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.946 HD22 ' CD1' ' B' ' 456' ' ' LEU . 35.0 tp -80.13 132.28 35.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.497 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -77.23 144.74 38.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.67 4.63 65.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.463 HG21 HD23 ' B' ' 437' ' ' LEU . 97.9 t -126.24 126.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.395 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -84.54 151.87 24.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -50.06 -47.07 53.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.508 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 91.7 m-20 -64.99 -45.47 85.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.026 HD11 ' CD2' ' B' ' 473' ' ' LEU . 14.2 tp -57.27 -44.35 83.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.01 -41.72 88.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.91 . . . . 0.0 109.23 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 16.3 m-30 -58.62 -44.6 90.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' B' ' 470' ' ' ILE . 24.5 mttt -58.76 -40.78 84.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.867 . . . . 0.0 109.307 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.8 HD13 HD12 ' B' ' 459' ' ' LEU . 93.3 mt -61.84 -38.94 90.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -64.6 -32.7 74.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.9 -37.56 14.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.987 . . . . 0.0 109.408 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.475 ' CZ ' ' CB ' ' B' ' 469' ' ' ASP . 84.0 mtt-85 -89.66 23.0 2.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.576 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.79 6.74 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.899 HG21 ' CG ' ' B' ' 462' ' ' GLN . 46.7 t -76.79 108.52 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.305 . . . . 0.0 109.407 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 19.9 m -127.03 -38.85 1.98 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.686 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.76 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -78.39 144.32 36.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.529 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.946 ' CD1' HD22 ' B' ' 437' ' ' LEU . 25.8 tp -47.04 -42.72 18.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -55.95 -45.98 78.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.096 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.74 ' HB3' HG13 ' B' ' 453' ' ' VAL . 91.5 m-20 -56.66 -43.48 80.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.076 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.8 HD12 HD13 ' B' ' 448' ' ' LEU . 4.1 tt -55.52 -45.56 77.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.98 77.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 109.392 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.94 -28.09 68.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.899 ' CG ' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -75.45 140.01 42.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -98.45 166.06 21.71 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.962 HD11 ' HG2' ' A' ' 293' ' ' PRO . 20.5 mt -49.83 -34.02 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -1.125 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.18 -40.5 82.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.456 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 90.5 m-20 -63.29 -31.86 73.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.615 ' HB2' ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.59 -27.79 31.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.65 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -66.4 -21.1 66.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.541 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 469' ' ' ASP . . . . . 0.475 ' CB ' ' CZ ' ' B' ' 451' ' ' ARG . 82.1 m-20 -52.08 -31.91 32.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' B' ' 447' ' ' LYS . 64.1 mt -100.38 129.41 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.04 -36.06 72.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.447 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.8 -30.81 57.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.026 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.8 mt -98.91 131.37 45.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.481 HG22 ' N ' ' B' ' 475' ' ' ASP . 45.7 m -104.13 162.01 13.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.481 ' N ' HG22 ' B' ' 474' ' ' THR . 82.3 m-20 -57.12 -38.4 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -74.4 -45.97 43.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.464 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.67 ' O ' HD13 ' B' ' 481' ' ' LEU . 34.4 tttp -61.58 -46.35 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' B' ' 467' ' ' LEU . . . -60.28 -45.05 94.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -57.55 -47.72 86.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.67 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.1 mp -67.18 -44.51 79.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 293' ' ' PRO . 36.3 mt -60.99 -55.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.577 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.7 mtp -52.38 -36.53 54.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.332 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.29 -51.74 34.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.52 65.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.569 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 49.2 ttm-85 -50.56 -46.87 57.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 97.5 m-20 -58.01 -43.25 86.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 456' ' ' LEU . 81.3 mt -61.56 -37.32 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.84 -50.29 12.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 490' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 20.7 m95 -60.13 -43.23 95.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 56.6 m-85 -83.38 -27.21 29.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 249' ' ' PHE . 41.0 p90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 252' ' ' ILE . 0.6 OUTLIER -65.33 134.42 95.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.14 -29.32 56.14 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.752 2.301 . . . . 0.0 111.661 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.6 tt -61.34 -29.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 108.929 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 282' ' ' VAL . 19.0 mt -74.33 -43.02 58.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 254' ' ' LEU . 4.3 mm? -61.55 -28.55 69.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 278' ' ' ILE . 1.8 mtt180 -75.13 140.86 73.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.525 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.88 141.6 41.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.717 2.278 . . . . 0.0 111.921 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.515 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.63 -37.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.1 -30.89 69.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.956 . . . . 0.0 109.366 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' PRO . 34.2 m-20 -75.33 -11.53 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 262' ' ' LEU . 74.1 mt -53.82 152.84 5.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -64.37 -23.98 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 302' ' ' GLU . 3.7 mp -57.46 167.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 4.0 p -81.33 165.01 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.575 HG12 ' ND2' ' A' ' 268' ' ' ASN . 42.3 t -49.14 -41.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.485 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -49.82 -45.01 49.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.367 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 14.9 m -70.41 -46.56 63.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.73 -46.88 88.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.575 ' ND2' HG12 ' A' ' 264' ' ' VAL . 85.6 m-20 -56.33 -34.74 66.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.367 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 266' ' ' SER . 87.9 m -50.52 -65.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 270' ' ' LEU . 6.6 mp -62.94 -44.93 94.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.241 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.51 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 17.0 ttpp -52.95 -40.93 64.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.89 -21.95 3.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 70.1 tt0 -94.82 20.75 8.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.895 . . . . 0.0 109.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.11 35.33 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.779 HG23 ' HB2' ' A' ' 280' ' ' ASP . 89.0 mt -123.08 107.53 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.51 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 81.5 m-70 -107.29 -11.66 15.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.445 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 4.8 m-85 -111.54 134.23 53.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 252' ' ' ILE . 61.5 mt -60.14 -30.73 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.266 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.888 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -51.05 -42.5 48.28 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.779 ' HB2' HG23 ' A' ' 275' ' ' ILE . 93.0 m-20 -53.54 -35.18 60.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -1.174 . . . . 0.0 109.047 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 270' ' ' LEU . 28.3 tp -58.05 -47.84 81.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 279' ' ' GLY . 21.1 m -70.05 -24.26 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.163 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -65.81 -32.65 74.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.196 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.64 145.02 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -62.17 138.36 58.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.433 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 80.6 tt0 -62.85 -27.4 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.2 t -52.92 -51.76 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.4 -34.88 67.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 281' ' ' LEU . 51.3 mt -74.97 -38.18 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 290' ' ' LEU . 32.9 tp -60.94 -30.25 70.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.493 ' C ' ' CE ' ' B' ' 483' ' ' MET . 10.0 mmtt -87.78 17.6 4.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.35 -0.844 . . . . 0.0 109.52 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 293' ' ' PRO . 0.7 OUTLIER -109.81 136.72 20.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.789 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.0 Cg_endo -70.12 -23.25 29.37 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.819 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -56.2 -24.68 43.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.398 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 14.6 mt -81.45 138.02 35.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -95.21 145.37 17.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' B' ' 461' ' ' GLU . 24.3 mttm -55.29 -42.62 73.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -1.106 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -67.49 -39.42 85.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 303' ' ' ILE . 22.0 m -64.04 -36.71 84.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 300' ' ' LEU . 3.4 tm? -53.1 -42.59 66.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.0 m -60.64 -51.91 67.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.768 ' HB3' HD23 ' A' ' 262' ' ' LEU . 39.7 tp10 -57.91 -45.69 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 82.9 mt -57.79 -47.29 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.065 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.02 -39.34 63.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 108.916 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.65 -42.98 99.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.74 HG12 ' CD2' ' A' ' 312' ' ' LEU . 32.0 t -69.22 -34.8 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.845 . . . . 0.0 108.995 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 313' ' ' SER . 25.2 mt -63.62 -26.68 68.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.397 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.44 -36.26 73.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 109.151 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 16.3 t -67.68 -16.87 64.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.875 ' O ' HD11 ' A' ' 314' ' ' LEU . 56.5 mtt180 64.46 10.81 6.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.184 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.77 -24.25 62.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.757 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.7 pt? -137.36 147.03 45.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 307' ' ' LEU . 1.7 t 77.21 39.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.875 HD11 ' O ' ' A' ' 310' ' ' ARG . 12.3 mt -89.9 15.26 10.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.916 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.25 97.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.628 ' HE2' HG11 ' A' ' 282' ' ' VAL . 4.5 mtm -90.33 163.19 14.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.9 mtt180 -143.14 123.09 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 318' ' ' LEU . 1.4 mp -131.31 140.73 49.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -45.74 -36.49 5.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 108.482 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 43.6 t30 -129.42 -72.2 0.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.615 ' CE2' ' HA3' ' A' ' 279' ' ' GLY . 16.2 t90 160.77 -57.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.589 -0.695 . . . . 0.0 109.547 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 326' ' ' ILE . 47.3 Cg_endo -66.97 107.81 1.38 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.132 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -73.44 165.2 33.1 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.686 2.258 . . . . 0.0 111.657 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -43.84 -26.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.582 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.532 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 22.8 m -61.71 -58.4 8.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.579 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 322' ' ' PRO . 35.1 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -87.68 123.62 68.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 429' ' ' LYS . 50.4 Cg_endo -70.46 134.68 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.671 2.247 . . . . 0.0 111.845 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -70.88 166.6 20.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.498 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.19 -38.54 73.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.306 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 433' ' ' ASP . . . . . 0.562 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 75.1 m-20 -61.74 -49.91 74.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.185 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.809 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.5 tm? -64.98 -38.67 91.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.807 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.3 OUTLIER -73.36 -33.94 65.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -85.67 8.54 19.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.525 HD23 HG21 ' B' ' 440' ' ' VAL . 36.1 tp -72.39 131.07 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.98 143.04 49.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 6.58 70.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.877 HG22 HD21 ' B' ' 481' ' ' LEU . 54.4 t -138.36 128.97 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -1.169 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' B' ' 444' ' ' LEU . 32.5 p30 -98.84 -177.21 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.647 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 97.6 mtt180 -62.14 -43.74 98.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.78 -55.92 19.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.003 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.9 tp -56.55 -40.84 75.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.88 -36.77 77.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.387 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 15.1 m-30 -66.72 -43.36 84.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.637 ' HB3' HG21 ' B' ' 470' ' ' ILE . 43.5 mttt -61.7 -42.0 98.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.822 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.7 tm? -62.85 -44.49 95.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -62.03 -26.82 68.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.633 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.11 -17.18 9.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 7.1 mtp85 -92.25 27.97 2.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.68 7.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' B' ' 458' ' ' ASP . 47.8 t -63.73 140.3 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.927 -1.337 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' B' ' 431' ' ' ALA . 27.1 m -135.09 -36.21 0.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -105.51 151.48 24.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.715 HD11 HD12 ' B' ' 488' ' ' ILE . 2.1 tm? -52.03 -38.32 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.2 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 457' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' B' ' 457' ' ' GLU . 43.8 mm-40 -58.12 -47.65 82.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 108.839 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.656 ' HB3' HG13 ' B' ' 453' ' ' VAL . 58.2 m-20 -55.93 -44.66 78.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.857 . . . . 0.0 109.054 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.767 ' C ' HD13 ' B' ' 459' ' ' LEU . 2.8 tm? -55.5 -42.72 74.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.074 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.431 ' O ' ' HE3' ' A' ' 297' ' ' LYS . . . -60.01 -36.06 76.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.202 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 461' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 461' ' ' GLU . 77.1 tt0 -68.78 -13.13 62.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.438 ' HG3' HG21 ' B' ' 453' ' ' VAL . 28.7 mm100 -74.65 147.6 41.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -106.17 158.21 15.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.789 HD11 ' HG2' ' A' ' 293' ' ' PRO . 24.0 mt -52.29 -34.12 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.143 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.95 -37.08 78.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.09 -32.09 69.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.9 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -74.86 -30.01 61.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.57 63.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -52.77 -31.44 38.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' B' ' 447' ' ' LYS . 64.4 mt -102.24 128.93 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -64.44 -35.67 81.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.47 -28.52 36.68 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.003 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.4 mt -102.41 134.48 45.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.491 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.4 m -103.85 162.08 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 474' ' ' THR . 84.8 m-20 -56.69 -38.63 72.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.94 -46.0 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.619 ' CE ' HD22 ' B' ' 444' ' ' LEU . 43.4 tttp -66.66 -46.74 74.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.273 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.9 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.08 -45.18 87.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -59.58 -45.54 95.45 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.37 68.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.877 HD21 HG22 ' B' ' 440' ' ' VAL . 7.7 mp -70.05 -30.58 67.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.559 HD11 ' N ' ' B' ' 464' ' ' ILE . 46.0 mt -69.83 -54.95 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 44.0 mmm -57.6 -44.31 85.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.344 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.448 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -61.38 -56.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.358 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -61.18 -46.74 89.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.504 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 77.1 ttt180 -55.18 -47.46 75.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.6 m-20 -57.76 -41.37 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.715 HD12 HD11 ' B' ' 456' ' ' LEU . 75.7 mt -56.02 -37.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.74 -51.91 8.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 490' ' ' TRP . . . . . 0.504 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 63.1 m95 -62.53 -47.15 85.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.7 m-85 -74.74 -33.03 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . 1.1 m-20 -65.95 141.52 97.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.61 -22.78 57.7 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 7.3 tt -67.57 -26.52 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.297 -0.877 . . . . 0.0 109.169 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 282' ' ' VAL . 2.2 mt -73.96 -45.36 50.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 326' ' ' ILE . 3.1 mm? -68.73 -30.74 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.48 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.24 139.44 91.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.49 134.85 27.36 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.695 2.264 . . . . 0.0 111.782 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.4 -32.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.95 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.229 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.1 m-20 -75.71 -12.99 60.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.842 . . . . 0.0 109.411 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.7 HD21 ' CD1' ' A' ' 278' ' ' ILE . 85.2 mt -55.71 136.86 50.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.1 tt0 -63.96 -16.84 62.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 302' ' ' GLU . 6.4 mp -62.56 165.85 5.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.3 p -71.97 169.11 16.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.438 HG12 ' OD1' ' A' ' 268' ' ' ASN . 3.5 t -51.42 -31.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -50.64 -46.91 58.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 20.7 t -60.26 -50.62 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.9 m-20 -62.41 -42.99 99.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.3 m -52.45 -58.38 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.1 mm? -73.74 -39.41 64.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 12.7 tptm -57.77 -42.14 83.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.36 -21.45 65.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 63.6 tt0 -89.35 21.67 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.43 17.29 8.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 280' ' ' ASP . 72.9 mt -107.31 125.41 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' ' 257' ' ' VAL . 95.3 m-70 -113.43 -25.67 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 109.352 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 96.0 m-85 -105.19 141.43 36.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.7 ' CD1' HD21 ' A' ' 260' ' ' LEU . 76.0 mt -63.58 -31.39 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.273 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.992 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -50.72 -45.68 48.24 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.751 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.3 m-20 -53.78 -37.38 63.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -1.207 . . . . 0.0 109.215 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD13 HD11 ' A' ' 270' ' ' LEU . 34.9 tp -52.53 -48.57 65.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.271 -0.893 . . . . 0.0 108.866 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.992 HG22 ' O ' ' A' ' 279' ' ' GLY . 3.8 m -66.77 -23.89 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 108.821 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.45 -35.92 80.8 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 72.3 mtt180 -105.97 141.92 36.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.2 m -63.68 137.89 58.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.963 . . . . 0.0 109.543 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.606 ' HA ' HD23 ' A' ' 289' ' ' LEU . 47.0 tp10 -53.7 -29.22 38.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 37.1 t -52.79 -48.25 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 108.999 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 96.3 mt-10 -51.93 -35.66 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.905 . . . . 0.0 109.008 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.8 mm? -65.48 -44.16 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 108.907 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -63.56 -17.59 62.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 108.958 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.536 ' O ' ' HE1' ' B' ' 483' ' ' MET . 21.6 mttt -93.3 26.51 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.748 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 294' ' ' ASN . 86.7 m -138.02 122.28 11.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 1.037 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -71.17 -20.24 28.63 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.686 2.257 . . . . 0.0 111.893 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.769 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.5 m120 -50.26 -22.32 1.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 295' ' ' LEU . 3.8 mp -95.54 122.03 37.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -82.87 156.51 34.56 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -48.86 -39.51 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.563 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 19.4 m -64.52 -52.02 59.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 303' ' ' ILE . 34.7 tp -53.18 -39.13 63.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.7 m -58.8 -49.73 76.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.533 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.622 ' HB3' HD23 ' A' ' 262' ' ' LEU . 74.2 mt-10 -59.75 -40.67 88.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 300' ' ' LEU . 83.9 mt -57.83 -52.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.284 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -54.54 -38.99 67.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.158 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.83 -42.08 83.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -72.39 -42.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.778 HD22 ' CB ' ' A' ' 313' ' ' SER . 24.4 mt -54.54 -26.91 34.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.92 74.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.4 p -68.47 -20.31 64.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.0 109.408 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.513 ' O ' HD11 ' A' ' 314' ' ' LEU . 32.4 ttm180 67.59 7.39 5.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -78.31 -22.47 67.75 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.796 ' H ' HD23 ' A' ' 312' ' ' LEU . 1.7 pt? -137.08 155.94 49.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.604 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.778 ' CB ' HD22 ' A' ' 307' ' ' LEU . 1.3 t 75.47 51.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.815 HD22 ' N ' ' A' ' 314' ' ' LEU . 3.0 mm? -93.14 21.25 6.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 47.04 46.16 20.15 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 282' ' ' VAL . 11.0 ptt? -121.91 139.83 53.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -1.185 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.683 ' O ' HD13 ' A' ' 318' ' ' LEU . 55.9 mtt180 -100.14 137.43 38.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 318' ' ' LEU . 2.4 mm? -122.28 111.37 16.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.901 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -77.07 -30.49 55.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.945 . . . . 0.0 108.753 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 321' ' ' TRP . 21.2 t-20 -165.29 26.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.053 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.818 ' CH2' HD22 ' A' ' 254' ' ' LEU . 0.4 OUTLIER -43.37 104.25 0.36 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.5 71.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.727 2.951 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 1.012 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.05 155.83 64.04 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.54 2.16 . . . . 0.0 111.816 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.76 -27.97 67.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.291 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.2 m -59.1 -40.08 84.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.5 tt . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.672 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 86.8 m-20 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.98 131.84 30.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.886 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.3 136.37 31.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.907 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.84 160.55 25.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -53.15 -33.87 54.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -65.04 -49.61 69.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.624 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' B' ' 430' ' ' PRO . 17.2 tp -65.05 -38.44 90.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.5 OUTLIER -73.61 -33.22 64.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -86.87 9.84 17.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.752 HD13 HD13 ' B' ' 456' ' ' LEU . 44.8 tp -77.24 133.29 38.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -77.45 142.26 39.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.1 2.8 65.99 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' B' ' 481' ' ' LEU . 93.8 t -131.06 129.56 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.13 -1.218 . . . . 0.0 109.497 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.607 ' H ' HD12 ' B' ' 444' ' ' LEU . 75.5 m-20 -90.86 155.22 18.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.598 ' HG2' HD11 ' B' ' 435' ' ' LEU . 58.8 mtm180 -50.04 -40.62 45.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -66.9 -45.45 77.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.748 HD22 HD21 ' B' ' 473' ' ' LEU . 45.5 mt -60.39 -42.09 95.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.97 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.355 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 11.2 m-30 -58.51 -43.41 89.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.699 ' HB3' HG21 ' B' ' 470' ' ' ILE . 45.6 mttp -60.59 -52.5 64.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 7.1 tt -65.55 -42.03 92.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.672 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.99 -27.0 50.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.977 . . . . 0.0 109.487 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.36 -24.0 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.417 ' NH1' ' CG1' ' B' ' 470' ' ' ILE . 41.9 mtt-85 -88.8 26.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.63 6.93 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' B' ' 458' ' ' ASP . 73.2 t -60.71 130.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.33 . . . . 0.0 109.472 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' B' ' 431' ' ' ALA . 57.0 m -135.06 -36.59 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.743 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -97.12 153.08 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.783 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.942 HD21 HD12 ' B' ' 488' ' ' ILE . 42.5 tp -49.48 -40.42 37.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.325 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.71 -49.93 71.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 108.994 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.741 ' CB ' HG13 ' B' ' 453' ' ' VAL . 81.0 m-20 -55.52 -40.55 71.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 108.971 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.77 HD13 ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -55.62 -42.98 75.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.73 -25.69 66.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.262 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.13 -21.19 63.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.61 ' CG ' HG21 ' B' ' 453' ' ' VAL . 98.4 mm-40 -79.98 153.81 28.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -117.3 152.35 17.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 293' ' ' PRO . 33.6 mt -44.46 -36.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -63.95 -35.59 81.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.473 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 87.2 m-20 -77.35 -31.55 54.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.01 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.1 mt -73.48 -35.52 65.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.91 69.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.51 -33.2 72.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' B' ' 447' ' ' LYS . 80.5 mt -85.24 131.39 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.436 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.95 150.4 46.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.19 -29.39 12.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.748 HD21 HD22 ' B' ' 444' ' ' LEU . 64.6 mt -99.72 136.49 39.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -1.16 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.03 162.07 13.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -57.3 -38.11 73.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.65 -45.94 56.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.573 ' O ' HD13 ' B' ' 481' ' ' LEU . 14.5 tttp -62.58 -45.68 91.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.01 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.7 -42.49 88.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -61.7 -46.3 94.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.83 78.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.517 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.573 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.0 mp -66.38 -35.36 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.594 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 293' ' ' PRO . 59.6 mt -70.32 -56.33 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.579 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.536 ' HE1' ' O ' ' A' ' 291' ' ' LYS . 39.9 mtp -52.92 -37.8 61.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.34 69.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -64.81 -49.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.541 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 66.3 ttt-85 -53.85 -47.06 71.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.97 -45.84 86.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.942 HD12 HD21 ' B' ' 456' ' ' LEU . 46.2 mt -59.1 -39.51 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 91.2 m -75.3 -49.13 20.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 490' ' ' TRP . . . . . 0.541 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 15.0 m95 -59.39 -41.3 89.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 9.19 43.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.463 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.679 ' HD2' HD22 ' A' ' 253' ' ' LEU . 2.5 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -61.67 139.55 95.27 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.0 Cg_endo -64.56 -34.05 53.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.505 2.137 . . . . 0.0 111.473 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.7 tt -53.71 -34.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.679 HD22 ' HD2' ' A' ' 249' ' ' PHE . 0.6 OUTLIER -74.57 -21.67 59.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.083 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.653 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -89.58 -24.8 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.263 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -66.23 147.5 98.85 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.8 Cg_endo -70.69 140.88 40.15 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.698 2.265 . . . . 0.0 111.715 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.707 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.54 -34.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 109.365 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.84 -30.92 71.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' PRO . 30.2 m-20 -76.0 -14.96 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 257' ' ' VAL . 48.7 mt -44.75 149.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.56 -19.17 65.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 262' ' ' LEU . 6.1 mp -64.07 169.32 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 9.2 p -78.22 159.88 28.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.476 HG12 ' ND2' ' A' ' 268' ' ' ASN . 3.2 t -47.25 -37.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.486 ' NH2' ' OD2' ' B' ' 465' ' ' ASP . 52.0 ttt85 -53.37 -46.85 69.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 19.4 m -63.58 -51.05 67.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.943 . . . . 0.0 109.387 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.07 78.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.476 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.6 m-20 -59.7 -33.31 71.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.914 . . . . 0.0 109.27 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.5 m -62.29 -63.82 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.292 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 295' ' ' LEU . 60.0 mt -58.64 -47.66 83.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 19.0 tttt -52.69 -32.11 40.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.97 -17.46 51.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.328 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 58.5 tt0 -95.6 21.33 8.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.05 23.3 3.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 97.0 mt -112.34 107.66 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.507 ' C ' HG22 ' A' ' 257' ' ' VAL . 50.5 m-70 -107.1 -9.2 16.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.5 m-85 -114.55 131.96 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 252' ' ' ILE . 74.7 mt -54.16 -36.5 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 109.119 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.38 -47.53 16.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.2 m-20 -53.27 -34.41 57.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 108.704 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.498 HD13 HD13 ' A' ' 270' ' ' LEU . 31.2 tp -53.78 -50.48 65.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.146 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.8 m -67.09 -29.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 93.9 mt-30 -57.2 -34.34 68.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -96.99 159.55 14.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.416 -0.802 . . . . 0.0 109.017 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 m -83.35 140.15 32.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 88.3 tt0 -52.7 -31.18 36.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.325 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.89 -51.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.039 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 69.9 mm-40 -51.93 -37.0 51.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.087 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 281' ' ' LEU . 62.2 mt -60.75 -47.24 87.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.995 HD13 ' O ' ' A' ' 290' ' ' LEU . 1.8 tm? -59.81 -33.53 71.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.283 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.527 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 45.8 mttt -83.06 -17.84 41.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.402 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -77.08 113.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 1.026 ' HB2' HD12 ' B' ' 482' ' ' ILE . 50.8 Cg_endo -71.0 -23.29 25.31 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.766 2.311 . . . . 0.0 112.165 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.437 ' HA ' HD12 ' B' ' 464' ' ' ILE . 70.8 m-80 -50.93 -21.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.699 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 270' ' ' LEU . 3.2 mp -101.31 122.69 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -73.8 156.64 50.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -49.09 -38.63 25.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.293 -1.122 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -67.2 -42.68 83.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.355 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 59.5 p -58.43 -47.14 84.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 290' ' ' LEU . 22.9 tp -52.94 -44.19 66.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.294 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 52.2 m -52.5 -52.31 55.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.209 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.485 ' OE1' HD23 ' A' ' 262' ' ' LEU . 84.7 mt-10 -53.61 -42.24 67.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.57 -39.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.183 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -62.16 -36.11 80.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.39 -51.24 61.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 312' ' ' LEU . 3.2 t -72.29 -37.52 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.251 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 15.5 tp -60.25 -26.27 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.441 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.08 -30.7 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 109.434 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.7 OUTLIER -68.95 -7.35 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.86 . . . . 0.0 109.555 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 92.9 mtt-85 61.76 12.52 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -93.21 -2.94 65.66 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 306' ' ' VAL . 0.0 OUTLIER -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -1.197 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.676 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 46.36 67.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.486 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.6 mt -101.64 11.86 38.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.63 73.83 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.709 ' HE3' HG21 ' A' ' 282' ' ' VAL . 13.5 ptt? -107.7 150.83 26.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -1.216 . . . . 0.0 109.54 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.643 ' C ' HD12 ' A' ' 318' ' ' LEU . 61.7 mtp180 -125.57 145.85 49.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.808 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.9 mp -124.04 140.95 52.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.68 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.1 -32.2 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 85.8 m-20 -122.35 -78.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.167 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.653 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 168.76 -58.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.76 107.8 1.74 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.647 2.231 . . . . 0.0 111.889 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 1.017 ' O ' HG22 ' A' ' 326' ' ' ILE . 52.8 Cg_endo -73.16 165.12 33.55 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.554 2.169 . . . . 0.0 111.688 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.89 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.9 m -76.82 -38.68 53.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 1.017 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.5 tt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 20.0 m120 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -61.85 130.13 92.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.575 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.9 138.74 34.82 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.703 2.269 . . . . 0.0 111.728 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.71 157.52 36.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -56.89 -33.54 66.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 433' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 436' ' ' ASN . 56.0 m-20 -69.61 -37.3 76.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.32 -33.24 71.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 109.34 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' B' ' 442' ' ' ARG . 33.1 tp -86.43 -30.59 21.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 436' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 433' ' ' ASP . 24.3 p-10 -80.0 5.84 12.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.834 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.623 HD23 HG21 ' B' ' 440' ' ' VAL . 25.5 tp -77.87 133.81 38.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.9 139.22 50.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.2 63.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.623 HG21 HD23 ' B' ' 437' ' ' LEU . 48.8 t -129.5 130.88 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -1.157 . . . . 0.0 109.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -101.35 158.42 16.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' B' ' 435' ' ' LEU . 76.8 mtt-85 -50.12 -52.45 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.17 -48.38 81.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.067 HD11 ' CD2' ' B' ' 473' ' ' LEU . 12.3 tp -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.34 87.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -56.23 -44.45 79.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.738 ' HB3' HD13 ' B' ' 470' ' ' ILE . 79.2 mttt -60.1 -44.74 94.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.926 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.6 tm? -73.29 -39.35 65.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.8 -28.31 69.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.35 -16.89 10.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -92.3 30.13 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.562 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.71 -18.86 6.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.558 HG13 ' CB ' ' B' ' 458' ' ' ASP . 49.1 t -63.82 138.25 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.336 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 72.6 m -135.14 -34.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.866 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.552 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -115.97 159.31 21.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 485' ' ' ALA . 33.8 tp -50.67 -40.11 52.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.338 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 457' ' ' GLU . . . . . 0.406 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 48.0 tp10 -55.88 -48.62 75.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.185 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.558 ' CB ' HG13 ' B' ' 453' ' ' VAL . 86.7 m-20 -57.3 -40.81 78.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 481' ' ' LEU . 17.0 tp -59.49 -45.31 92.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.35 -38.99 78.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.517 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -76.26 146.52 38.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.28 154.41 16.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 293' ' ' PRO . 59.7 mt -44.03 -36.59 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 465' ' ' ASP . . . . . 0.486 ' OD2' ' NH2' ' A' ' 265' ' ' ARG . 48.0 t0 -63.2 -41.04 99.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -66.68 -25.08 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.749 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -85.52 -24.46 27.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.81 -23.9 63.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -52.06 -32.16 33.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.738 HD13 ' HB3' ' B' ' 447' ' ' LYS . 67.3 mt -97.84 124.73 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.507 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.46 -35.38 80.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.405 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.54 -31.62 52.35 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.067 ' CD2' HD11 ' B' ' 444' ' ' LEU . 60.0 mt -101.79 135.58 43.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.501 HG22 ' N ' ' B' ' 475' ' ' ASP . 39.1 m -103.73 163.87 12.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.52 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 90.7 m-20 -56.88 -39.42 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -71.86 -45.88 59.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.587 ' HD3' HD23 ' B' ' 473' ' ' LEU . 40.3 tttm -61.07 -46.74 89.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.453 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' B' ' 464' ' ' ILE . . . -58.9 -41.93 88.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.357 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.46 ' HA2' ' CG ' ' A' ' 293' ' ' PRO . . . -59.2 -45.77 94.83 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.61 -35.96 73.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' B' ' 459' ' ' LEU . 25.3 mt -68.96 -44.11 73.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.523 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.4 mt -59.5 -55.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 43.9 mtp -52.76 -44.47 66.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 0.0 109.374 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.6 -49.78 76.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -68.25 -47.75 66.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' A' ' 291' ' ' LYS . 39.5 ttm180 -55.1 -45.65 75.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 74.6 m-20 -61.02 -41.24 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.711 HD12 HD21 ' B' ' 456' ' ' LEU . 63.2 mt -67.42 -38.74 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 489' ' ' CYS . . . . . 0.406 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 47.4 m -67.44 -49.56 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -68.0 -39.51 83.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 16.9 m-30 -83.31 -13.12 55.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 492' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.575 ' HD2' HD11 ' A' ' 254' ' ' LEU . 16.4 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 252' ' ' ILE . 15.1 m-20 -54.64 135.67 63.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.348 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.771 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.22 -31.72 53.16 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.604 2.203 . . . . 0.0 111.672 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.672 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.2 tt -63.18 -28.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 108.756 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 312' ' ' LEU . 37.9 mt -74.6 -44.16 52.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.8 mt -65.98 -34.78 78.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.67 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 278' ' ' ILE . 4.3 ttp180 -56.04 141.11 68.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.0 109.068 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.7 Cg_endo -68.72 130.96 21.65 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.3 OUTLIER -43.51 -35.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.89 . . . . 0.0 109.396 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.98 -30.93 70.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.321 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.3 m-20 -76.81 -14.9 59.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.87 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.428 HD11 HG12 ' A' ' 257' ' ' VAL . 68.3 mt -44.79 140.88 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' LEU . 98.0 mt-10 -64.83 -26.58 68.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 306' ' ' VAL . 29.7 mt -52.84 -173.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 13.0 p -84.84 159.39 20.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.67 HG12 ' ND2' ' A' ' 268' ' ' ASN . 8.7 t -55.16 -34.66 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.357 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -53.71 -46.45 70.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.7 p -64.42 -45.04 89.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.33 85.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.67 ' ND2' HG12 ' A' ' 264' ' ' VAL . 89.3 m-20 -58.52 -32.2 68.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' CYS . . . . . 0.644 ' SG ' HD11 ' A' ' 295' ' ' LEU . 21.4 t -57.6 -64.99 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.76 -47.71 79.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -0.845 . . . . 0.0 109.454 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.504 ' HG3' ' CE1' ' A' ' 276' ' ' HIS . 36.1 ttpt -55.08 -37.17 66.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.441 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.75 -21.15 6.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.7 mt-10 -95.65 21.17 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.86 28.04 4.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.9 mt -117.09 111.48 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.504 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 96.1 m-70 -104.4 -10.13 17.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.578 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.86 143.45 33.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' A' ' 312' ' ' LEU . 92.0 mt -72.29 -31.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 1.023 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.22 -48.33 20.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.7 m-20 -53.79 -35.32 61.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -1.138 . . . . 0.0 108.757 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 0.752 HD13 ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -52.78 -47.16 67.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 1.023 HG22 ' O ' ' A' ' 279' ' ' GLY . 6.5 m -68.25 -23.81 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.23 -35.69 79.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HE ' HD11 ' A' ' 275' ' ' ILE . 64.9 mtt-85 -100.99 141.18 34.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 74.0 p -76.2 147.11 38.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 300' ' ' LEU . 85.5 tt0 -50.82 -34.1 26.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 0.0 109.339 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.76 -51.26 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.281 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.14 -37.84 62.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.9 mm? -68.37 -40.77 81.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 1.088 HD13 HD22 ' A' ' 300' ' ' LEU . 34.8 tp -62.3 -25.45 67.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 109.331 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.6 ' O ' ' HE2' ' B' ' 483' ' ' MET . 22.2 mttt -88.66 17.25 5.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -116.84 136.99 23.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 0.883 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.6 Cg_endo -71.72 -30.64 14.23 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.691 2.26 . . . . 0.0 111.85 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.479 ' C ' HD12 ' A' ' 295' ' ' LEU . 76.3 m-20 -52.53 -20.8 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.804 ' N ' HD12 ' A' ' 295' ' ' LEU . 5.3 mp -104.74 124.48 49.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.605 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.79 173.86 35.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -51.37 -44.66 62.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -70.33 -36.77 74.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.9 t -54.93 -52.27 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 1.088 HD22 HD13 ' A' ' 290' ' ' LEU . 22.5 tp -52.91 -39.49 62.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.8 m -59.11 -50.17 75.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.236 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.592 ' HG2' HD13 ' A' ' 262' ' ' LEU . 54.0 tt0 -53.73 -44.92 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.089 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.64 HD11 HD23 ' A' ' 295' ' ' LEU . 63.6 mt -57.65 -40.43 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 108.783 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.66 -40.08 90.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.343 -0.848 . . . . 0.0 108.742 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.09 -46.18 85.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.367 -0.833 . . . . 0.0 108.827 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 312' ' ' LEU . 16.9 t -69.95 -35.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 108.819 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 313' ' ' SER . 17.1 tp -63.5 -26.78 68.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.371 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.77 -28.92 64.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.209 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.2 p -69.31 -12.14 61.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 314' ' ' LEU . 69.8 mtt180 57.36 15.78 2.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.37 -15.47 13.91 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 278' ' ' ILE . 9.0 tp -137.5 136.15 37.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -1.182 . . . . 0.0 109.155 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.3 OUTLIER 73.37 41.93 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -92.22 13.17 19.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.68 36.88 83.86 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.609 ' CE ' HD11 ' A' ' 253' ' ' LEU . 7.5 mtm -84.28 170.3 13.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.791 ' C ' HD12 ' A' ' 318' ' ' LEU . 45.4 mtm105 -141.0 129.56 22.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.819 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.7 mp -133.05 136.32 45.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.48 -39.89 64.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.038 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 69.5 m-20 -129.75 -65.13 0.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.0 t-105 167.31 -65.92 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.523 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.69 107.99 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.679 2.253 . . . . 0.0 112.169 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.8 Cg_endo -72.86 161.21 44.29 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.622 2.214 . . . . 0.0 111.53 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.84 -18.84 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.601 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 16.3 m -64.29 -49.26 72.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 254' ' ' LEU . 26.9 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 74.7 m-20 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -62.02 121.83 68.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 49.5 Cg_endo -70.05 131.21 20.36 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.641 2.227 . . . . 0.0 111.741 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.37 153.86 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 432' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' B' ' 436' ' ' ASN . 92.0 m-20 -54.32 -29.57 48.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 433' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 456' ' ' LEU . 91.2 m-20 -67.05 -50.1 62.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 27.3 tp -67.78 -42.02 82.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.936 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.8 OUTLIER -71.35 -26.88 63.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.38 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 436' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 432' ' ' ASP . 40.8 t30 -96.65 7.92 45.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.628 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.72 HD13 ' N ' ' B' ' 438' ' ' GLU . 1.6 tm? -78.09 120.39 22.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 438' ' ' GLU . . . . . 0.72 ' N ' HD13 ' B' ' 437' ' ' LEU . 23.6 pt-20 -60.57 140.89 57.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 439' ' ' GLY . . . . . 0.437 ' O ' HD11 ' B' ' 481' ' ' LEU . . . 96.31 -3.64 64.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 1.042 HG22 ' CD2' ' B' ' 481' ' ' LEU . 47.0 t -120.67 129.98 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.123 -1.222 . . . . 0.0 109.487 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -87.05 154.42 20.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.529 ' HG2' HD11 ' B' ' 435' ' ' LEU . 72.8 mtt180 -49.98 -45.18 51.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.33 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 443' ' ' ASP . . . . . 0.574 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 94.3 m-20 -67.83 -46.56 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 473' ' ' LEU . 14.1 tp -53.67 -40.83 66.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.114 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.4 91.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 108.978 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 12.7 m-30 -58.55 -40.18 82.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.102 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -62.21 -42.43 99.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 459' ' ' LEU . 88.4 mt -62.02 -45.01 95.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.87 -40.33 84.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.9 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.55 -33.25 3.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 26.2 mtp85 -91.24 22.32 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.6 7.17 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.935 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.8 t -83.15 110.0 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.914 -1.344 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 14.9 m -127.51 -35.76 2.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.94 . . . . 0.0 109.587 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.52 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -79.62 140.69 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.915 ' CD2' HD12 ' B' ' 488' ' ' ILE . 23.5 tp -45.64 -43.64 12.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.191 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 457' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' B' ' 489' ' ' CYS . 13.3 mt-10 -60.1 -46.32 90.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.177 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.702 ' HB3' HG13 ' B' ' 453' ' ' VAL . 88.4 m-20 -54.94 -38.01 67.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.133 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 448' ' ' LEU . 33.3 tp -63.79 -42.9 97.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.226 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 460' ' ' ALA . . . . . 0.641 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -58.36 -37.69 75.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.46 -30.55 71.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.935 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -73.52 148.72 42.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 463' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -107.71 154.11 16.66 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 0.883 HD11 ' HG2' ' A' ' 293' ' ' PRO . 96.5 mt -44.98 -36.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.144 -1.21 . . . . 0.0 109.27 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -36.88 82.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.245 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.2 m-20 -71.41 -28.71 64.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.84 -30.68 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.963 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.39 -24.69 60.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -51.35 -33.15 28.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.892 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' B' ' 473' ' ' LEU . 64.4 mt -102.24 127.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -59.73 -31.01 69.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.531 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -59.2 -25.67 60.37 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 1.025 ' CD1' HD11 ' B' ' 444' ' ' LEU . 3.5 mm? -103.38 129.19 50.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -1.106 . . . . 0.0 109.562 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 474' ' ' THR . . . . . 0.447 HG22 ' N ' ' B' ' 475' ' ' ASP . 23.4 m -103.61 162.02 13.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.526 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 83.6 m-20 -55.88 -39.14 71.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.1 -45.85 25.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.483 ' CE ' HD22 ' B' ' 444' ' ' LEU . 32.8 tttp -62.37 -46.62 87.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.53 -45.91 81.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -63.59 -52.12 48.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.48 -42.22 61.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.215 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 1.042 ' CD2' HG22 ' B' ' 440' ' ' VAL . 6.4 mp -67.28 -42.3 84.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.36 -0.837 . . . . 0.0 109.442 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.55 HD12 HG13 ' B' ' 464' ' ' ILE . 45.3 mt -56.41 -56.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.6 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 43.4 mmm -53.29 -44.88 68.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -57.26 -60.77 3.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.193 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.509 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -55.7 -43.3 76.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.196 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.641 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 94.8 mtt180 -59.55 -41.96 91.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.831 . . . . 0.0 109.19 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 98.1 m-20 -57.84 -41.31 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.291 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.915 HD12 ' CD2' ' B' ' 456' ' ' LEU . 24.3 mt -68.55 -38.55 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.309 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 489' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' B' ' 457' ' ' GLU . 66.4 m -70.27 -51.62 29.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -61.37 -38.19 86.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 19.2 m-30 -76.29 -36.86 58.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.0 109.406 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 249' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 249' ' ' PHE . 42.0 p90 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ASP . . . . . 0.784 ' O ' HD12 ' A' ' 254' ' ' LEU . 0.5 OUTLIER -69.67 137.53 88.11 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.239 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 251' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 255' ' ' ARG . 43.2 Cg_endo -65.31 -26.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.705 2.27 . . . . 0.0 111.673 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ILE . . . . . 0.606 HD13 ' HA3' ' A' ' 311' ' ' GLY . 6.0 tt -71.22 -28.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 108.709 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 253' ' ' LEU . . . . . 0.74 HD11 HG21 ' A' ' 282' ' ' VAL . 3.1 tp -74.35 -27.18 60.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 326' ' ' ILE . 4.0 mp -101.67 -20.98 14.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 251' ' ' PRO . 16.2 mtt180 -55.09 147.59 33.69 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.019 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.6 Cg_endo -69.56 132.46 23.7 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.687 2.258 . . . . 0.0 111.954 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' VAL . . . . . 0.723 HG11 HD12 ' A' ' 270' ' ' LEU . 0.2 OUTLIER -44.62 -30.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.275 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -64.25 -30.69 71.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 12.9 m-20 -69.57 -16.99 63.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 278' ' ' ILE . 46.1 mt -57.43 144.73 35.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 261' ' ' GLU . 82.2 tt0 -65.23 -14.4 60.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.504 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.696 HD21 ' CB ' ' A' ' 302' ' ' GLU . 8.0 mp -60.24 173.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.574 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.7 p -74.73 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' VAL . . . . . 0.755 HG12 HD21 ' A' ' 268' ' ' ASN . 18.5 t -62.56 -31.76 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 265' ' ' ARG . 6.8 mmt85 -60.08 -44.95 94.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.136 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' SER . . . . . 0.433 ' OG ' HD23 ' A' ' 262' ' ' LEU . 7.8 t -57.83 -51.01 71.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.214 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -66.56 -34.21 77.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.912 . . . . 0.0 109.106 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ASN . . . . . 0.755 HD21 HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -61.61 -38.88 89.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.8 m -49.86 -60.12 3.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' LEU . . . . . 0.723 HD12 HG11 ' A' ' 257' ' ' VAL . 45.3 mt -63.52 -48.33 77.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.301 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 271' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 52.5 mtmt -53.27 -39.69 64.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.81 -24.74 6.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.334 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 273' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 54.0 tt0 -93.47 24.72 3.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 274' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 66.23 29.85 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 275' ' ' ILE . . . . . 0.621 HG23 ' OD2' ' A' ' 280' ' ' ASP . 54.7 mt -124.22 108.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 256' ' ' PRO . 89.5 m-70 -100.85 -6.83 24.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.14 140.83 37.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 260' ' ' LEU . 56.6 mt -72.61 -30.19 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.529 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' GLY . . . . . 0.975 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.5 -48.37 11.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ASP . . . . . 0.621 ' OD2' HG23 ' A' ' 275' ' ' ILE . 82.5 m-20 -53.0 -33.73 53.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.922 -1.34 . . . . 0.0 108.527 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 312' ' ' LEU . 26.9 tp -52.98 -52.7 57.42 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 282' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 279' ' ' GLY . 25.3 m -62.47 -27.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 53.0 tt0 -58.21 -37.95 75.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' ARG . . . . . 0.452 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 86.0 mtt-85 -98.07 140.92 31.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.799 . . . . 0.0 108.975 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.0 m -63.64 141.17 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 109.712 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' GLU . . . . . 0.686 ' CD ' HD12 ' A' ' 289' ' ' LEU . 49.0 tp10 -53.33 -27.27 22.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' VAL . . . . . 0.76 ' HA ' HD12 ' A' ' 290' ' ' LEU . 54.3 t -52.8 -51.81 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 93.6 mt-10 -51.87 -33.66 37.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.083 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 281' ' ' LEU . 40.5 mt -64.94 -46.76 80.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.9 mt -61.88 -29.76 70.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.446 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 23.4 mttm -84.96 -20.65 30.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 15.7 m -82.12 116.42 63.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.63 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' PRO . . . . . 1.001 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.1 Cg_endo -71.16 -24.35 23.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.626 2.217 . . . . 0.0 111.843 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.562 ' ND2' HD12 ' B' ' 464' ' ' ILE . 34.4 m120 -46.94 -23.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 300' ' ' LEU . 3.0 mp -96.02 138.87 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.84 163.29 33.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -50.79 -45.28 59.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -1.189 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -65.73 -42.12 91.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.8 t -56.1 -55.13 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 109.277 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 295' ' ' LEU . 49.9 mt -54.42 -47.02 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.4 m -50.37 -53.0 32.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.234 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 306' ' ' VAL . 60.9 mm-40 -53.75 -38.44 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 300' ' ' LEU . 93.5 mt -57.79 -46.04 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -60.38 -39.76 88.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.06 -49.92 70.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.851 . . . . 0.0 109.347 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.2 t -63.55 -41.09 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 109.203 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' LEU . . . . . 0.53 HD13 ' CB ' ' A' ' 313' ' ' SER . 24.1 tp -53.91 -26.62 26.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.86 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.313 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 20.9 t -68.98 -7.72 37.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 310' ' ' ARG . . . . . 0.748 ' CA ' HD21 ' A' ' 314' ' ' LEU . 66.2 mtt180 65.64 8.98 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.365 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 311' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.26 -31.24 63.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -148.16 173.12 13.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 109.51 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 313' ' ' SER . . . . . 0.64 ' N ' HG12 ' A' ' 282' ' ' VAL . 2.8 m 61.77 30.66 18.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.897 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' LEU . . . . . 0.748 HD21 ' CA ' ' A' ' 310' ' ' ARG . 68.4 mt -79.41 -5.46 54.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.515 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.86 38.82 65.36 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' MET . . . . . 0.684 ' HE1' HD12 ' A' ' 314' ' ' LEU . 4.2 ptt? -107.42 162.11 14.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -1.216 . . . . 0.0 109.361 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ARG . . . . . 0.57 ' C ' HD12 ' A' ' 318' ' ' LEU . 44.5 mtm180 -128.2 134.37 49.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -116.51 143.12 45.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.78 -33.71 70.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.261 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -135.02 -68.23 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' TRP . . . . . 0.571 ' CH2' ' HG ' ' A' ' 254' ' ' LEU . 0.7 OUTLIER 176.98 -64.96 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.376 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 322' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 326' ' ' ILE . 49.9 Cg_endo -68.67 107.5 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 112.041 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.7 Cg_endo -72.54 164.79 34.56 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.571 2.181 . . . . 0.0 111.579 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.92 -19.03 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.279 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 249' ' ' PHE . 61.0 m -65.77 -47.85 73.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 254' ' ' LEU . 19.4 mt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 428' ' ' ASN . . . . . 0.838 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 29.5 m120 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -51.19 136.25 29.72 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 430' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.6 Cg_endo -70.9 140.97 39.5 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.711 2.274 . . . . 0.0 111.652 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 431' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.92 165.56 24.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 109.662 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 432' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' B' ' 432' ' ' ASP . 25.4 p-10 -61.68 -34.12 75.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 433' ' ' ASP . . . . . 0.582 ' CB ' ' CB ' ' B' ' 456' ' ' LEU . 5.2 m-20 -63.4 -49.21 74.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.072 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 434' ' ' LEU . . . . . 0.836 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 435' ' ' LEU . . . . . 0.593 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.2 OUTLIER -72.72 -35.55 67.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -88.57 4.68 46.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 437' ' ' LEU . . . . . 0.649 HD23 HG21 ' B' ' 440' ' ' VAL . 31.8 tp -71.98 132.76 44.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -76.78 141.59 40.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.2 9.39 62.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 440' ' ' VAL . . . . . 0.649 HG21 HD23 ' B' ' 437' ' ' LEU . 47.9 t -125.89 131.52 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -1.129 . . . . 0.0 109.422 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 441' ' ' ASP . . . . . 0.645 ' H ' HD12 ' B' ' 444' ' ' LEU . 86.8 m-20 -97.64 160.66 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 442' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 93.7 mtt180 -52.08 -41.35 62.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.964 . . . . 0.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.03 -42.29 85.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.449 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 444' ' ' LEU . . . . . 0.645 HD12 ' H ' ' B' ' 441' ' ' ASP . 53.6 mt -64.98 -42.56 94.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 445' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' B' ' 434' ' ' LEU . . . -59.18 -41.46 88.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 446' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 10.3 m-30 -64.14 -40.5 96.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 447' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' B' ' 470' ' ' ILE . 66.5 mttm -61.68 -41.23 97.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 448' ' ' LEU . . . . . 0.496 HD21 HD11 ' B' ' 473' ' ' LEU . 80.9 mt -64.86 -39.22 93.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 449' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.06 -37.46 84.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.97 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 451' ' ' ARG . . . . . 0.493 ' NH1' ' O ' ' B' ' 466' ' ' ASP . 35.3 mtm105 -89.7 23.34 2.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.74 6.77 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 453' ' ' VAL . . . . . 0.682 HG21 ' HG3' ' B' ' 462' ' ' GLN . 8.9 t -81.84 107.24 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.355 . . . . 0.0 109.314 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 60.4 m -123.74 -44.38 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 0.0 109.697 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 455' ' ' THR . . . . . 0.69 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -71.97 140.84 49.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 456' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' B' ' 485' ' ' ALA . 2.6 tm? -51.76 -37.91 53.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.14 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -63.07 -40.83 98.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.743 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 458' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' B' ' 453' ' ' VAL . 68.7 m-20 -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.089 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 459' ' ' LEU . . . . . 0.763 ' O ' HD13 ' B' ' 459' ' ' LEU . 3.5 tm? -59.65 -41.84 91.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.37 74.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.394 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.68 -25.76 62.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 462' ' ' GLN . . . . . 0.682 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.3 mm-40 -67.79 163.11 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.66 156.86 15.98 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 464' ' ' ILE . . . . . 1.001 HD11 ' HG2' ' A' ' 293' ' ' PRO . 58.6 mt -51.94 -34.95 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -1.182 . . . . 0.0 109.495 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -68.48 -35.95 78.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 466' ' ' ASP . . . . . 0.493 ' O ' ' NH1' ' B' ' 451' ' ' ARG . 87.3 m-20 -72.34 -31.52 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 467' ' ' LEU . . . . . 1.024 HD12 ' HB1' ' B' ' 478' ' ' ALA . 21.7 mt -74.41 -25.34 59.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -24.27 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -48.06 -33.58 8.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 470' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' B' ' 447' ' ' LYS . 61.3 mt -103.36 128.1 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.37 -31.82 72.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 472' ' ' GLY . . . . . 0.484 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -56.81 -30.92 60.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 473' ' ' LEU . . . . . 0.496 HD11 HD21 ' B' ' 448' ' ' LEU . 73.8 mt -101.53 131.03 47.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -1.185 . . . . 0.0 109.579 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.84 163.35 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 475' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 88.3 m-20 -57.87 -38.19 75.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -73.81 -46.04 47.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 477' ' ' LYS . . . . . 0.533 ' O ' HD13 ' B' ' 481' ' ' LEU . 15.7 tttp -64.78 -42.44 95.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 478' ' ' ALA . . . . . 1.024 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -61.55 -46.03 91.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 479' ' ' GLY . . . . . 0.457 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.33 -45.98 92.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.91 84.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -1.116 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 481' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.4 mp -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 482' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 293' ' ' PRO . 47.9 mt -66.89 -54.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 483' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 49.1 mtp -52.22 -37.41 55.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.395 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.49 -57.13 5.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.167 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' B' ' 456' ' ' LEU . . . -62.87 -52.09 64.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 486' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' B' ' 485' ' ' ALA . 21.6 ttm180 -46.27 -48.77 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.203 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 487' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' B' ' 483' ' ' MET . 89.2 m-20 -58.95 -41.5 87.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 488' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 492' ' ' GLY . 80.2 mt -58.93 -37.61 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 41.7 t -70.58 -49.12 51.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.606 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.41 -41.77 72.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 491' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 46.1 m-85 -79.78 -36.06 37.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 492' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.569 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 38.4 p90 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.18 121.72 13.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.241 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.67 -26.56 60.96 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.645 2.23 . . . . 0.0 111.469 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.866 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.9 tt -69.59 -31.99 50.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.473 HD11 ' HE2' ' A' ' 316' ' ' MET . 34.2 mt -75.15 -45.16 42.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.4 -0.812 . . . . 0.0 109.39 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.913 HD21 HD11 ' A' ' 326' ' ' ILE . 0.3 OUTLIER -64.01 -37.35 87.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.453 ' CD ' ' OD2' ' A' ' 259' ' ' ASP . 5.2 ttp180 -59.6 141.86 88.1 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.241 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.2 Cg_endo -68.87 133.6 27.65 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.651 2.234 . . . . 0.0 111.691 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.582 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.0 OUTLIER -44.9 -25.36 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 256' ' ' PRO . 91.1 m-20 -69.58 -30.56 68.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.212 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 48.8 t0 -66.7 -22.55 66.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 257' ' ' VAL . 38.5 mt -43.62 131.44 5.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -55.93 -24.79 40.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.724 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.6 mp -62.35 163.59 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.3 p -62.87 161.09 13.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.796 HG12 ' OD1' ' A' ' 268' ' ' ASN . 20.4 t -54.76 -26.1 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -51.93 -44.11 63.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.436 ' CB ' ' OE1' ' A' ' 302' ' ' GLU . 8.7 t -58.79 -50.61 73.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -70.49 -33.56 71.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.796 ' OD1' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -56.42 -38.22 71.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 299' ' ' SER . 24.8 m -60.62 -64.6 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.701 HD13 HD23 ' A' ' 281' ' ' LEU . 63.7 mt -64.7 -46.64 81.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 76.9 tttt -52.98 -34.01 54.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.76 -23.59 12.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.9 mt-10 -89.05 22.59 2.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.89 36.48 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.78 HG23 ' HB3' ' A' ' 280' ' ' ASP . 70.6 mt -112.16 127.38 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.592 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.9 p80 -116.68 -30.28 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.588 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.592 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.8 m-30 -106.57 127.8 53.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.5 mt -48.26 -30.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.972 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.5 -48.64 16.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.78 ' HB3' HG23 ' A' ' 275' ' ' ILE . 40.0 t0 -53.39 -32.96 51.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.198 . . . . 0.0 108.899 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.759 ' C ' HD13 ' A' ' 281' ' ' LEU . 3.4 tm? -56.82 -46.95 81.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.386 -0.821 . . . . 0.0 109.111 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.972 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.1 m -69.01 -23.22 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 95.5 mt-30 -66.2 -36.98 84.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.948 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -104.4 143.06 33.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 288' ' ' GLU . 43.9 p -80.0 151.83 29.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.574 ' OE2' HD22 ' A' ' 307' ' ' LEU . 8.9 mt-10 -54.45 -39.46 67.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.8 t -52.98 -55.27 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 285' ' ' THR . 95.6 mt-10 -53.15 -30.58 37.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 292' ' ' THR . 8.4 mp -79.64 -42.42 24.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.7 mt -65.04 -12.75 54.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.491 ' C ' ' HE2' ' B' ' 483' ' ' MET . 45.7 mmtm -89.14 12.34 16.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.5 t -124.83 138.74 31.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.595 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.7 Cg_endo -70.82 -27.05 21.89 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.789 2.326 . . . . 0.0 111.78 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -48.32 -24.4 1.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 289' ' ' LEU . 20.3 mt -87.6 143.13 27.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.358 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -110.47 160.38 13.36 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.92 -42.27 72.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -1.156 . . . . 0.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -67.38 -37.84 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.364 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 269' ' ' CYS . 81.1 p -59.18 -39.4 82.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.337 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 290' ' ' LEU . 0.6 OUTLIER -57.99 -42.65 85.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.378 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 49.8 m -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.1 mt-10 -56.59 -42.8 79.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 80.7 mt -57.91 -48.26 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -54.74 -41.57 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -58.29 -51.42 69.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.6 t -68.72 -37.19 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.838 HD13 ' HB3' ' A' ' 313' ' ' SER . 20.0 tp -62.03 -26.43 68.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.315 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.23 -29.99 66.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.5 t -74.11 -13.37 60.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.2 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.774 ' HA ' HD11 ' A' ' 314' ' ' LEU . 51.2 mtt-85 61.17 13.51 4.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 109.307 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -88.98 -24.56 31.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.785 ' H ' HD23 ' A' ' 312' ' ' LEU . 1.6 pt? -139.32 153.25 47.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -1.139 . . . . 0.0 109.562 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.838 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 71.45 32.62 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.774 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.5 mm? -89.27 14.12 11.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.268 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.5 44.88 92.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.719 ' HE2' HG11 ' A' ' 282' ' ' VAL . 8.0 mtm -94.21 168.75 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.494 ' C ' HD23 ' A' ' 318' ' ' LEU . 53.6 mtt180 -134.05 121.61 21.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 317' ' ' ARG . 5.2 mt -113.4 138.11 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.383 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.58 -32.17 67.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.159 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 72.3 m-20 -135.05 -64.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 108.988 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.837 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.2 t-105 164.73 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.371 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.565 ' HA ' HD12 ' A' ' 326' ' ' ILE . 48.2 Cg_endo -68.09 107.91 1.63 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.595 2.197 . . . . 0.0 111.967 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.51 163.07 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.667 2.245 . . . . 0.0 111.689 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.18 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.41 ' CB ' ' N ' ' A' ' 249' ' ' PHE . 3.8 t -58.73 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.913 HD11 HD21 ' A' ' 254' ' ' LEU . 30.3 mt -56.36 -36.48 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 327' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 326' ' ' ILE . . . 44.47 -166.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.47 -38.45 69.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.444 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.494 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -56.92 -34.73 68.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -1.16 . . . . 0.0 109.538 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.99 44.4 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.455 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 3.1 tttp -67.77 136.52 92.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.512 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.31 136.53 31.75 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.69 2.26 . . . . 0.0 111.724 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -71.13 159.51 34.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.38 -33.77 63.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.73 -48.32 77.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -38.4 75.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.891 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -73.06 -31.44 64.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -84.83 7.73 19.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.774 HD23 HG21 ' B' ' 440' ' ' VAL . 30.1 tp -72.28 133.83 45.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.86 140.83 40.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.16 2.96 68.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.774 HG21 HD23 ' B' ' 437' ' ' LEU . 58.8 t -130.82 137.15 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -1.187 . . . . 0.0 109.421 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 39.6 p30 -103.75 173.55 6.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.565 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 74.8 mtt85 -58.31 -40.52 82.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.63 -49.53 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.64 HD22 HD21 ' B' ' 473' ' ' LEU . 45.8 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.544 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.29 89.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 17.3 m-30 -66.18 -47.99 72.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 470' ' ' ILE . 61.6 mttt -58.88 -46.38 87.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.585 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.865 ' O ' HD13 ' B' ' 448' ' ' LEU . 3.1 tm? -64.12 -41.17 97.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.36 -30.68 71.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -56.79 -18.52 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.401 ' NH1' ' CB ' ' B' ' 469' ' ' ASP . 14.3 mtp85 -90.65 31.6 1.04 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.82 -18.88 6.84 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' B' ' 458' ' ' ASP . 96.3 t -63.51 139.87 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.878 -1.366 . . . . 0.0 109.382 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.511 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -135.01 -36.01 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 109.701 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -111.04 148.63 32.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 1.069 HD21 HD12 ' B' ' 488' ' ' ILE . 30.0 tp -46.17 -40.14 10.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.167 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -56.75 -49.65 74.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.848 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.759 ' HB3' HG13 ' B' ' 453' ' ' VAL . 37.4 t0 -54.8 -38.78 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.108 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.776 HD13 ' C ' ' B' ' 459' ' ' LEU . 2.9 tm? -60.04 -41.49 92.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.14 76.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 0.0 109.393 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.93 -30.77 71.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.474 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -67.53 151.85 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 109.565 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.84 165.82 12.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.884 HD11 ' HG2' ' A' ' 293' ' ' PRO . 28.9 mt -53.28 -35.75 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -1.209 . . . . 0.0 109.4 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.02 -31.27 67.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.999 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -75.44 -29.05 59.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -23.75 62.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 469' ' ' ASP . . . . . 0.401 ' CB ' ' NH1' ' B' ' 451' ' ' ARG . 86.3 m-20 -50.1 -33.97 20.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 447' ' ' LYS . 65.6 mt -100.89 127.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.25 -33.09 74.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.04 -31.56 40.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.64 HD21 HD22 ' B' ' 444' ' ' LEU . 50.5 mt -101.11 140.49 35.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.449 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.11 161.85 13.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.389 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.449 ' N ' HG22 ' B' ' 474' ' ' THR . 81.3 m-20 -57.91 -37.62 74.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -73.88 -46.06 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 39.2 tttp -68.74 -37.02 79.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.999 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.08 -44.68 91.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -63.87 -43.1 98.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.82 -33.97 70.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -1.125 . . . . 0.0 109.406 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 31.0 mt -74.39 -35.16 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 478' ' ' ALA . 78.6 mt -64.03 -53.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.537 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.508 ' HE1' ' O ' ' A' ' 290' ' ' LEU . 52.6 mmm -60.74 -42.48 97.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 109.426 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.44 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -58.29 -47.36 83.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -66.0 -47.68 73.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.536 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.505 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 40.2 ttm180 -60.8 -42.62 97.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.48 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 95.9 m-20 -58.85 -39.25 80.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 1.069 HD12 HD21 ' B' ' 456' ' ' LEU . 66.1 mt -62.27 -40.35 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.82 -52.06 16.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.679 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 490' ' ' TRP . . . . . 0.505 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 67.2 m95 -64.44 -38.48 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.9 m-85 -99.19 13.1 34.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.8 -29.76 75.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.41 -36.18 71.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.133 . . . . 0.0 109.428 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -93.31 138.71 31.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.442 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.784 ' N ' ' HG ' ' A' ' 325' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.4 126.56 84.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.46 -32.21 50.01 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.794 2.329 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 278' ' ' ILE . 2.9 tt -66.27 -23.55 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 311' ' ' GLY . 5.3 tp -74.28 -44.12 54.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.459 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 326' ' ' ILE . 2.2 mm? -73.63 -20.36 60.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.555 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -63.87 149.87 92.41 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.0 Cg_endo -69.86 136.31 32.41 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.604 2.202 . . . . 0.0 111.934 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.542 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.79 -31.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.885 . . . . 0.0 109.424 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.35 -30.95 71.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 256' ' ' PRO . 53.8 m-20 -73.03 -14.09 61.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.631 HD21 HD13 ' A' ' 278' ' ' ILE . 59.4 mt -54.13 150.73 7.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.12 -21.52 65.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.811 HD22 ' OG ' ' A' ' 266' ' ' SER . 5.3 mp -64.64 166.08 9.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -79.88 165.27 22.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 264' ' ' VAL . 3.9 t -47.0 -32.85 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.457 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -52.78 -50.21 64.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.811 ' OG ' HD22 ' A' ' 262' ' ' LEU . 22.2 t -59.53 -51.11 71.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.34 86.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.315 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.6 m-20 -56.64 -36.89 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.339 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 60.0 m -55.41 -64.98 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.641 ' CD2' HD12 ' A' ' 289' ' ' LEU . 65.2 mt -62.41 -47.69 82.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 23.2 tttt -53.02 -36.88 61.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.79 -30.0 30.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.9 mt-10 -94.01 23.99 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.377 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.07 41.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 280' ' ' ASP . 90.3 mt -122.82 107.66 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.519 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.472 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 64.0 m-70 -109.71 -6.75 15.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.35 129.24 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.719 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.9 mt -54.72 -30.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.793 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.02 -46.78 14.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.676 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.4 m-20 -53.48 -30.9 43.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.038 -1.272 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 270' ' ' LEU . 31.4 tp -59.26 -49.9 76.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 109.136 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 279' ' ' GLY . 30.2 m -67.51 -30.55 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 108.967 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.44 -32.83 70.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 108.949 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -109.84 143.84 39.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.0 m -63.7 137.96 58.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.412 ' OE1' ' CD2' ' A' ' 307' ' ' LEU . 80.4 tt0 -50.58 -33.51 22.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.387 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 1.046 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.2 t -54.86 -54.34 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -51.15 -30.72 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.24 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.996 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -79.15 -43.67 23.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.257 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 1.046 HD12 ' HA ' ' A' ' 287' ' ' VAL . 5.4 mt -56.85 -18.73 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.645 ' O ' ' HE2' ' B' ' 483' ' ' MET . 69.5 mttt -81.44 -21.94 38.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.357 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 294' ' ' ASN . 9.8 m -59.49 128.52 86.12 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.634 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.675 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.8 Cg_endo -71.16 -14.84 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.804 2.336 . . . . 0.0 112.001 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' B' ' 464' ' ' ILE . 53.2 m-80 -78.47 3.65 15.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.996 HD11 ' O ' ' A' ' 289' ' ' LEU . 72.1 mt -81.33 149.55 28.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.517 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -108.63 140.92 15.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -52.81 -47.13 67.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -1.188 . . . . 0.0 109.455 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.99 -25.31 59.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 296' ' ' GLY . 82.5 p -73.13 -36.8 66.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 295' ' ' LEU . 29.7 mt -54.31 -39.24 66.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -54.26 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 306' ' ' VAL . 67.7 tt0 -53.82 -39.97 65.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 109.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 300' ' ' LEU . 84.5 mt -57.63 -45.85 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 108.917 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.11 -33.93 74.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 108.964 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.42 -41.58 97.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 109.248 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 1.04 HG12 ' CD2' ' A' ' 312' ' ' LEU . 1.7 t -68.25 -45.65 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.441 HD12 HD11 ' A' ' 312' ' ' LEU . 8.2 mp -56.43 -26.77 54.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.11 70.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.0 t -65.51 -17.39 64.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.897 ' O ' HD21 ' A' ' 314' ' ' LEU . 11.7 ttp180 65.93 9.07 5.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.368 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.619 ' O ' HD13 ' A' ' 253' ' ' LEU . . . -94.95 -0.3 63.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.04 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.29 163.09 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -1.215 . . . . 0.0 109.44 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.2 OUTLIER 48.47 54.96 9.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.641 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 310' ' ' ARG . 76.7 mt -91.81 9.39 32.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.36 38.22 96.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.533 ' CE ' HD12 ' A' ' 314' ' ' LEU . 5.6 ptt? -113.3 157.44 21.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.603 ' C ' HD12 ' A' ' 318' ' ' LEU . 77.6 mtt85 -130.23 137.72 50.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.8 mp -123.47 140.89 52.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 108.951 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.5 m-20 -122.45 -81.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.673 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 165.24 -65.98 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 50.7 Cg_endo -69.47 107.77 1.88 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.563 2.175 . . . . 0.0 111.95 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.587 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.1 Cg_endo -71.91 163.91 37.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.622 2.214 . . . . 0.0 111.6 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.6 25.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.969 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.784 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 62.1 p -70.54 -38.97 74.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.46 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 254' ' ' LEU . 34.3 mt -53.32 -33.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.52 75.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -36.23 70.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.475 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.476 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -56.02 -38.0 69.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -1.167 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.827 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 24.3 m120 -85.53 -3.01 58.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 20.0 tttm -53.03 136.89 47.48 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.489 ' HD2' ' HG3' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.09 136.76 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.641 2.227 . . . . 0.0 111.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.1 153.23 41.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.513 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -47.06 -38.6 11.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -62.29 -40.73 97.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.996 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.5 tm? -66.66 -29.87 69.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 442' ' ' ARG . 25.2 tp -85.69 -28.52 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.85 -5.81 43.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.908 HD23 HG21 ' B' ' 440' ' ' VAL . 35.4 tp -65.82 134.81 53.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -78.26 141.19 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.3 8.34 64.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.908 HG21 HD23 ' B' ' 437' ' ' LEU . 46.6 t -128.19 132.22 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.164 . . . . 0.0 109.471 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.577 ' H ' HD12 ' B' ' 444' ' ' LEU . 83.7 m-20 -97.89 166.0 11.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.405 ' HG2' HD11 ' B' ' 435' ' ' LEU . 92.7 mtt180 -54.7 -43.14 72.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.411 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.1 m-20 -66.15 -50.15 64.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.577 HD12 ' H ' ' B' ' 441' ' ' ASP . 29.7 mt -55.74 -43.43 76.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.09 -37.85 78.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.6 m-30 -64.59 -45.12 88.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 470' ' ' ILE . 81.5 mttt -62.86 -45.17 93.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 0.0 109.438 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.855 ' O ' HD13 ' B' ' 448' ' ' LEU . 1.4 tm? -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.14 -28.89 68.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.24 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -93.24 32.06 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.392 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.43 -18.61 6.65 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' B' ' 458' ' ' ASP . 84.3 t -60.9 139.48 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.9 -1.353 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 10.9 m -135.05 -35.88 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.769 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.59 159.39 20.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.896 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.771 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -48.56 -41.37 30.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.288 -0.883 . . . . 0.0 109.027 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -55.59 -42.28 74.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 0.0 108.766 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.91 ' CB ' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -59.86 -43.55 94.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 108.893 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.687 HD12 HD21 ' B' ' 434' ' ' LEU . 5.8 tt -54.31 -49.15 70.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 0.0 109.172 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.99 71.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.98 -25.71 67.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.357 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.5 mm-40 -70.48 152.23 44.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' B' ' 467' ' ' LEU . . . -116.12 162.84 12.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.675 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.2 mt -49.68 -36.67 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.5 -37.06 79.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.06 -25.12 66.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.876 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.6 mp -91.42 -27.72 18.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 0.0 109.484 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.85 -23.2 66.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.458 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.13 -32.85 68.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' B' ' 447' ' ' LYS . 73.5 mt -99.84 128.72 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.588 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.67 -32.37 74.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.462 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.38 -28.8 51.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.644 HD13 HD23 ' B' ' 467' ' ' LEU . 60.7 mt -103.68 137.19 42.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.504 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 475' ' ' ASP . 7.0 m -104.06 165.8 10.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.417 ' N ' HG22 ' B' ' 474' ' ' THR . 92.4 m-20 -58.68 -39.23 80.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.45 -45.39 31.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.463 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.51 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 48.0 tttm -60.75 -46.47 90.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.876 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -62.98 -53.22 57.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.516 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -58.38 -48.0 86.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.0 62.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -1.116 . . . . 0.0 109.388 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 96.5 mt -61.9 -43.67 98.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.5 mt -53.44 -56.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.645 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 50.1 mtp -52.93 -46.17 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.57 -52.93 63.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.477 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -61.75 -48.84 78.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 34.4 ttt180 -56.16 -45.28 79.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.83 -34.06 72.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.743 HD12 HD11 ' B' ' 456' ' ' LEU . 79.7 mt -68.31 -39.4 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.519 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.8 -50.59 16.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 490' ' ' TRP . . . . . 0.531 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 36.3 m95 -58.7 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.18 10.91 31.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.25 -31.83 78.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.6 -37.27 85.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.491 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -55.36 143.61 28.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.469 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.83 ' CZ ' HD21 ' A' ' 318' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -52.71 141.22 36.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.183 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.637 ' HA ' HD23 ' A' ' 254' ' ' LEU . 43.1 Cg_endo -65.0 -23.04 61.86 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.652 2.234 . . . . 0.0 111.903 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.923 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -64.77 -32.09 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.122 -0.986 . . . . 0.0 108.707 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.667 HD21 HG11 ' A' ' 282' ' ' VAL . 5.3 mp -74.34 -30.96 62.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.194 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.701 ' N ' HD22 ' A' ' 254' ' ' LEU . 3.5 mm? -69.13 -40.0 78.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.452 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -61.72 147.58 88.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 255' ' ' ARG . 48.3 Cg_endo -70.24 138.73 36.97 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.683 2.256 . . . . 0.0 111.701 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -43.5 -36.05 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.807 . . . . 0.0 109.461 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.49 -31.33 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 256' ' ' PRO . 70.6 m-20 -75.45 -11.0 59.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 257' ' ' VAL . 61.0 mt -47.47 143.54 3.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -59.94 -18.17 43.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.867 HD11 HG21 ' A' ' 306' ' ' VAL . 6.3 mp -67.86 167.1 14.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.9 p -69.53 160.23 31.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.526 HG12 ' OD1' ' A' ' 268' ' ' ASN . 14.0 t -50.5 -39.25 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -53.66 -48.96 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.9 m -57.78 -50.56 72.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.87 81.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.299 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.526 ' OD1' HG12 ' A' ' 264' ' ' VAL . 12.8 m120 -58.51 -36.68 74.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.2 m -55.76 -65.03 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.436 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 281' ' ' LEU . 75.2 mt -58.03 -46.68 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 24.6 tttt -53.46 -37.74 62.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.37 -24.81 13.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.618 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.7 mm-40 -89.35 23.71 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.93 38.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 280' ' ' ASP . 20.0 mm -112.29 121.53 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.449 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 8.3 p80 -113.13 -33.2 6.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.436 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.2 m-85 -109.8 131.28 55.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.591 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 252' ' ' ILE . 76.6 mt -48.88 -30.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.179 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.62 -45.35 23.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.863 ' HB2' HG23 ' A' ' 275' ' ' ILE . 57.3 m-20 -53.68 -35.02 60.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 109.078 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 270' ' ' LEU . 35.5 tp -56.28 -48.3 76.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 109.258 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.6 m -71.94 -35.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.013 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -51.54 -34.9 38.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.338 -0.851 . . . . 0.0 108.89 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -112.36 143.62 43.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.391 -0.818 . . . . 0.0 109.095 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 m -59.93 138.77 57.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.617 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -61.96 -28.53 69.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.93 -53.13 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 288' ' ' GLU . 71.1 mm-40 -51.66 -35.86 44.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.979 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -76.65 -36.27 57.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.066 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 1.008 ' O ' HD13 ' A' ' 290' ' ' LEU . 2.0 tm? -56.43 -29.17 61.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' B' ' 483' ' ' MET . 9.1 mttt -81.68 -18.84 43.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 294' ' ' ASN . 11.3 m -58.82 129.12 85.09 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.6 Cg_endo -70.46 -10.4 27.92 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.812 2.342 . . . . 0.0 111.83 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' B' ' 464' ' ' ILE . 32.6 m120 -79.66 4.09 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.979 HD11 ' O ' ' A' ' 289' ' ' LEU . 66.1 mt -84.0 146.99 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 296' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -111.66 141.6 16.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -48.74 -50.87 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.51 -33.97 71.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 303' ' ' ILE . 37.4 m -61.98 -40.79 96.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 295' ' ' LEU . 46.1 mt -52.97 -42.86 65.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.7 m -54.72 -50.83 67.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 306' ' ' VAL . 98.3 mt-10 -58.73 -39.23 80.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.798 HG22 HD13 ' A' ' 307' ' ' LEU . 23.9 mm -58.07 -47.32 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -60.56 -38.16 83.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.05 -46.4 89.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.359 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.954 ' CG1' HD21 ' A' ' 312' ' ' LEU . 2.0 t -70.19 -44.86 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.798 HD13 HG22 ' A' ' 303' ' ' ILE . 6.6 mp -62.78 -27.2 69.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.498 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.98 -33.26 70.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 66.2 p -77.49 -5.04 48.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 109.548 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.959 ' O ' HD21 ' A' ' 314' ' ' LEU . 8.9 mtt85 63.73 10.49 5.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.219 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -73.07 -22.23 79.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.954 HD21 ' CG1' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -146.64 163.1 36.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.379 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.7 OUTLIER 65.9 28.8 10.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.959 HD21 ' O ' ' A' ' 310' ' ' ARG . 93.4 mt -66.34 -14.41 62.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.24 11.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.673 ' HE3' HG21 ' A' ' 282' ' ' VAL . 4.6 ptt? -111.47 162.22 15.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.114 . . . . 0.0 109.448 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.542 ' C ' HD12 ' A' ' 318' ' ' LEU . 87.3 mtt-85 -130.76 133.49 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 249' ' ' PHE . 4.6 mp -118.3 145.29 45.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.79 -34.04 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 37.8 t-20 -125.94 -71.26 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.299 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.7 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.7 OUTLIER 167.43 -68.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.0 Cg_endo -69.7 107.88 1.94 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.504 2.136 . . . . 0.0 111.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.566 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 51.0 Cg_endo -72.1 158.12 52.86 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.529 2.153 . . . . 0.0 111.573 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.6 -15.69 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.378 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.1 m -68.55 -44.34 74.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 322' ' ' PRO . 24.5 pt -86.01 -5.97 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.56 72.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 329' ' ' GLU . 58.6 t0 -56.24 -35.86 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 328' ' ' ASP . 83.8 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.44 -35.44 74.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 109.491 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.784 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 21.3 m120 -80.25 1.3 29.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.43 ' CG ' ' HD2' ' B' ' 430' ' ' PRO . 9.8 tttt -51.21 139.92 24.07 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.07 142.45 46.6 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.65 2.233 . . . . 0.0 111.933 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.55 150.35 41.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.34 -36.71 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -65.26 -46.36 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.774 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -67.87 -37.82 82.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.883 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.7 OUTLIER -69.16 -31.08 69.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.515 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -89.02 9.88 23.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.877 HD22 ' CD1' ' B' ' 456' ' ' LEU . 43.0 tp -72.43 133.56 44.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.87 142.1 40.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.77 6.57 67.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.824 HG21 HD23 ' B' ' 437' ' ' LEU . 57.4 t -127.62 131.38 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -83.75 149.04 26.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.516 ' HG3' ' NH1' ' B' ' 442' ' ' ARG . 9.4 mtt85 -50.02 -45.81 52.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.09 -39.46 82.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' B' ' 473' ' ' LEU . 15.8 tp -58.88 -37.77 77.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -60.7 -42.01 96.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.8 m-85 -64.69 -44.24 90.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.529 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 13.7 ttmm -58.63 -48.55 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.825 ' O ' HD13 ' B' ' 448' ' ' LEU . 3.4 tm? -65.17 -41.24 94.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.835 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -57.25 -26.84 61.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.68 -20.53 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.948 . . . . 0.0 109.472 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -89.75 26.59 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.942 . . . . 0.0 109.564 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.88 7.13 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 57.6 t -62.32 135.82 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.306 . . . . 0.0 109.326 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 69.0 m -135.01 -36.96 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.63 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -103.72 146.56 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 1.014 ' CD2' HD12 ' B' ' 488' ' ' ILE . 36.4 tp -47.69 -42.81 25.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -55.86 -46.53 78.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.041 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.78 -41.58 74.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 108.913 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.762 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.3 tm? -57.4 -43.92 84.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.111 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -59.94 -36.37 76.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.326 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -30.13 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.2 mm-40 -75.12 140.76 43.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -100.03 163.53 19.29 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 294' ' ' ASN . 81.3 mt -47.52 -33.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.07 -36.28 79.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.424 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 86.8 m-20 -68.66 -30.61 69.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.9 mp -82.73 -30.05 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.328 -0.858 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.09 58.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.09 -30.5 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.529 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 63.9 mt -104.92 123.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.74 -31.7 71.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.37 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.456 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -52.13 -32.69 36.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.7 mm? -103.13 138.78 39.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.224 -1.162 . . . . 0.0 109.54 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.461 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.7 m -104.04 161.87 13.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.877 . . . . 0.0 109.333 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.461 ' N ' HG22 ' B' ' 474' ' ' THR . 87.5 m-20 -57.45 -38.08 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.81 -45.95 26.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.584 ' HE2' HD22 ' B' ' 444' ' ' LEU . 19.0 tttt -66.14 -47.19 74.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -59.24 -46.74 87.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.515 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.18 -49.88 68.77 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.35 54.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -1.185 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 440' ' ' VAL . 26.4 mt -56.62 -37.6 70.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 50.4 mt -63.33 -51.08 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.414 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.592 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 23.6 mtp -52.61 -48.41 66.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -55.71 -55.74 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.408 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.623 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -59.46 -47.98 83.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 75.1 mtt180 -62.8 -40.98 99.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.0 m-20 -58.24 -44.93 88.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 1.014 HD12 ' CD2' ' B' ' 456' ' ' LEU . 57.2 mt -61.6 -37.56 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -52.02 10.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -61.33 -31.59 71.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 13.1 m-30 -71.0 -33.69 70.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -57.92 -35.93 78.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -57.45 -37.42 72.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -1.151 . . . . 0.0 109.536 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -102.8 136.64 42.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.509 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.592 ' HE2' HD22 ' A' ' 318' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 252' ' ' ILE . 9.9 m-20 -55.95 150.37 29.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.56 -25.28 55.16 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.749 2.299 . . . . 0.0 111.643 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.1 tt -68.6 -27.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 109.179 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 312' ' ' LEU . 26.8 mt -74.11 -45.24 50.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.916 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.5 OUTLIER -63.88 -34.65 78.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.478 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -55.91 141.74 66.23 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.156 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.0 Cg_endo -69.03 133.95 28.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.695 2.263 . . . . 0.0 111.742 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.41 -34.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 271' ' ' LYS . 55.3 t0 -59.44 -30.97 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 m-20 -73.75 -17.12 61.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 257' ' ' VAL . 51.5 mt -43.5 144.95 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -63.92 -22.06 66.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.2 mp -65.56 166.84 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.2 p -66.71 166.59 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.557 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 268' ' ' ASN . 6.6 t -57.35 -36.47 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 109.639 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.14 -48.65 70.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 262' ' ' LEU . 95.2 p -57.94 -51.04 71.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.62 -42.41 99.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.649 HD21 HG12 ' A' ' 264' ' ' VAL . 89.1 m-20 -56.58 -37.44 70.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 85.4 m -50.37 -60.48 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.32 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 281' ' ' LEU . 74.0 mt -57.51 -45.06 85.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.376 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 275' ' ' ILE . 82.3 mttt -52.92 -29.91 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.359 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.14 -34.32 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 45.1 mt-10 -90.53 26.13 2.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.21 40.91 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 22.7 mm -108.14 124.24 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.432 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.575 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -115.83 -37.27 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.37 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.575 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -106.32 133.04 51.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.831 HD12 ' O ' ' A' ' 252' ' ' ILE . 88.7 mt -46.72 -30.36 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.34 -48.64 15.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 94.0 m-20 -53.24 -31.27 42.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.004 -1.292 . . . . 0.0 108.727 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 270' ' ' LEU . 44.9 tp -55.72 -51.9 65.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.5 m -64.39 -28.26 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 108.832 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.75 -34.89 73.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.848 . . . . 0.0 108.903 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.453 ' HG2' ' NH1' ' A' ' 284' ' ' ARG . 18.6 mtt-85 -107.07 144.29 33.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.256 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.8 m -68.43 143.4 55.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 0.0 109.559 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.437 ' HA ' HD23 ' A' ' 289' ' ' LEU . 50.4 tp10 -55.62 -30.25 60.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.62 -51.61 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -51.91 -33.97 39.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.388 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.2 mm? -74.68 -30.52 61.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.77 -30.91 70.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.533 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.73 -12.7 58.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.168 -0.958 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 23.8 m -79.38 117.67 68.33 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.648 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.952 ' HG2' HD11 ' B' ' 464' ' ' ILE . 48.4 Cg_endo -69.86 -20.43 34.39 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.784 2.322 . . . . 0.0 111.866 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.554 ' ND2' HD12 ' B' ' 464' ' ' ILE . 16.6 m120 -48.85 -31.41 7.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.617 HD21 ' O ' ' A' ' 289' ' ' LEU . 0.5 OUTLIER -105.02 144.63 31.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -85.83 169.23 42.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HG2' ' NH2' ' B' ' 486' ' ' ARG . 44.7 mttt -64.92 -40.9 95.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -1.145 . . . . 0.0 109.479 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -59.78 -40.12 87.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 303' ' ' ILE . 24.6 m -57.57 -41.55 81.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.952 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.2 tm? -54.83 -37.04 65.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 27.5 m -55.75 -59.42 4.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.219 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 305' ' ' ASP . 75.2 tt0 -54.92 -44.47 74.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 67.8 mt -57.48 -52.38 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 108.856 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -53.28 -36.41 61.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.312 -0.867 . . . . 0.0 108.675 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 302' ' ' GLU . 62.5 t0 -57.46 -48.14 79.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 108.913 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.634 HG12 HD22 ' A' ' 312' ' ' LEU . 11.6 t -66.17 -34.81 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.939 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 313' ' ' SER . 21.4 mt -64.23 -26.66 68.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.42 -29.99 66.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.117 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 79.8 p -79.14 -7.94 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.658 ' O ' HD11 ' A' ' 314' ' ' LEU . 73.6 mtt85 61.76 13.15 5.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -73.03 -36.15 57.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.82 ' H ' HD23 ' A' ' 312' ' ' LEU . 2.1 pt? -135.05 159.37 41.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 109.688 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.712 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.2 OUTLIER 61.31 63.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.892 . . . . 0.0 109.677 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.788 HD22 ' N ' ' A' ' 314' ' ' LEU . 3.2 mm? -96.32 12.38 31.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.65 92.28 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.462 ' CE ' ' CE1' ' A' ' 249' ' ' PHE . 10.9 ptt? -114.36 150.63 34.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -109.12 133.34 53.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.592 HD22 ' HE2' ' A' ' 249' ' ' PHE . 6.1 mt -106.75 138.48 42.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.898 . . . . 0.0 109.349 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.69 -47.21 82.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.017 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 36.2 t-20 -126.64 -59.04 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 108.976 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.916 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 163.4 -65.52 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.283 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.584 ' HA ' HD11 ' A' ' 326' ' ' ILE . 48.4 Cg_endo -69.03 107.67 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.624 2.216 . . . . 0.0 111.923 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 51.0 Cg_endo -71.31 161.0 47.14 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.591 2.194 . . . . 0.0 111.45 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.2 -15.37 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.8 t -69.57 -46.42 66.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.584 HD11 ' HA ' ' A' ' 322' ' ' PRO . 22.2 pt -92.4 4.45 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.77 147.48 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.559 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.64 0.27 43.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 0.0 109.649 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.492 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -57.19 -35.69 69.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -1.121 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 31.1 m120 57.38 44.68 21.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.463 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.457 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 33.3 tttt -64.52 136.84 96.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.7 139.69 37.52 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.607 2.205 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -66.03 156.03 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -54.77 -36.99 65.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -62.63 -48.74 78.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.77 HD13 ' C ' ' B' ' 434' ' ' LEU . 3.0 tm? -65.83 -35.52 80.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.946 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.422 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -85.34 6.29 27.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 1.042 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.9 tp -75.42 131.55 40.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.28 145.2 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.906 . . . . 0.0 109.507 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.19 7.5 67.68 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.802 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -124.43 129.5 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.414 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -85.13 147.39 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.06 -43.62 51.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.538 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 90.6 m-20 -70.3 -41.06 73.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' B' ' 473' ' ' LEU . 10.5 tp -58.49 -46.11 87.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.707 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.26 -39.34 82.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 15.9 m-30 -60.29 -43.79 95.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.01 -44.88 95.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.944 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.4 tm? -67.31 -38.08 84.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.39 -28.25 68.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -55.33 -18.92 7.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.445 ' NE ' HD11 ' B' ' 470' ' ' ILE . 33.6 mtt-85 -91.39 30.38 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.85 -18.9 6.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.628 HG13 ' CB ' ' B' ' 458' ' ' ASP . 46.4 t -61.63 136.07 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.893 -1.357 . . . . 0.0 109.326 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 9.4 m -135.17 -37.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -102.49 147.76 26.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 1.042 ' CD1' HD22 ' B' ' 437' ' ' LEU . 16.3 tp -47.2 -41.81 18.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.056 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.85 -47.27 77.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.864 . . . . 0.0 109.028 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.628 ' CB ' HG13 ' B' ' 453' ' ' VAL . 74.8 m-20 -55.14 -44.72 75.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 459' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.11 -49.91 65.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.801 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -54.54 -39.36 67.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.65 -34.69 67.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.426 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -63.65 151.77 40.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.25 154.12 16.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' A' ' 293' ' ' PRO . 60.3 mt -45.09 -40.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -1.177 . . . . 0.0 109.228 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.36 -43.06 92.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.296 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 469' ' ' ASP . 78.1 m-20 -63.41 -23.79 67.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.798 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.8 mp -93.09 -19.23 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.22 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.535 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 469' ' ' ASP . . . . . 0.476 ' OD1' HG13 ' B' ' 470' ' ' ILE . 18.6 p30 -79.29 3.7 17.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' B' ' 473' ' ' LEU . 36.4 mt -105.53 126.63 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.965 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.45 133.33 52.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.11 -30.16 10.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.966 ' CD2' HD11 ' B' ' 444' ' ' LEU . 64.8 mt -88.21 128.72 35.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -1.16 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.9 m -104.01 162.15 13.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.492 ' N ' HG22 ' B' ' 474' ' ' THR . 86.7 m-20 -58.97 -36.76 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -76.95 -43.32 35.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.638 ' O ' HD13 ' B' ' 481' ' ' LEU . 76.6 tttt -61.58 -47.58 84.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.798 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.66 -40.84 97.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.482 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.73 -38.08 95.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.27 77.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -1.216 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.638 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.6 mp -68.81 -27.05 65.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.474 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 293' ' ' PRO . 52.3 mt -77.08 -56.5 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 60.2 mtp -52.81 -38.3 61.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.83 14.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 109.317 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' B' ' 460' ' ' ALA . . . -61.35 -45.96 92.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.801 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 42.2 mtp180 -57.42 -45.67 84.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 91.3 m-20 -57.96 -37.13 73.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' B' ' 456' ' ' LEU . 63.6 mt -68.88 -36.99 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.52 -50.37 15.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.397 -0.814 . . . . 0.0 109.561 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.47 -43.51 90.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.917 . . . . 0.0 109.601 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 98.7 m-85 -95.46 12.41 29.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 492' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . -71.56 135.41 23.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -51.54 -38.97 56.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -1.19 . . . . 0.0 109.436 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.78 -34.21 72.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.528 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.92 ' CE2' HD21 ' A' ' 318' ' ' LEU . 34.0 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.436 ' HB2' HG22 ' A' ' 252' ' ' ILE . 4.1 m-20 -56.62 151.14 32.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.04 -24.13 60.27 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.455 2.103 . . . . 0.0 111.72 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.642 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.9 tt -58.94 -32.42 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.892 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.3 mp -74.26 -35.39 63.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.942 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 326' ' ' ILE . 2.6 mm? -72.2 -20.07 61.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.779 . . . . 0.0 109.189 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -78.08 144.33 67.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 49.5 Cg_endo -69.61 139.16 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.809 2.34 . . . . 0.0 111.907 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.34 -34.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.294 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.78 -30.79 71.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.3 m-20 -76.95 -9.74 58.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.407 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.855 HD21 HD13 ' A' ' 278' ' ' ILE . 74.3 mt -57.32 144.91 34.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.92 -18.93 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.68 HD11 HG21 ' A' ' 306' ' ' VAL . 6.7 mp -64.49 169.69 4.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.5 p -75.45 164.25 26.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 109.629 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 264' ' ' VAL . 14.1 t -52.65 -27.48 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -59.82 -41.91 92.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.15 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' HD22 ' A' ' 262' ' ' LEU . 26.4 t -60.66 -50.42 73.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.56 83.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.942 . . . . 0.0 109.296 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -58.74 -40.1 82.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 73.3 m -52.08 -65.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 1.012 HD21 HD12 ' A' ' 281' ' ' LEU . 6.6 mp -65.24 -42.36 93.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.283 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.564 ' HE2' ' CE1' ' A' ' 276' ' ' HIS . 50.3 tttm -52.79 -40.11 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.26 -26.69 12.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.5 mt-10 -91.85 20.63 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 37.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 280' ' ' ASP . 77.7 mt -124.01 107.88 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.564 ' CE1' ' HE2' ' A' ' 271' ' ' LYS . 61.5 m-70 -107.37 -4.85 18.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.1 m-85 -112.94 133.55 54.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.42 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.855 HD13 HD21 ' A' ' 260' ' ' LEU . 50.7 mt -62.1 -30.99 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.191 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.974 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -48.62 -45.82 30.3 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.627 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.0 m-20 -53.61 -36.54 62.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -1.114 . . . . 0.0 109.153 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 312' ' ' LEU . 4.3 tt -53.15 -49.12 67.24 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.948 . . . . 0.0 108.953 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.4 m -67.46 -22.97 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.114 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -65.82 -33.33 75.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.002 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -105.29 143.51 33.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.044 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 m -59.99 138.04 57.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.412 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 85.2 tt0 -55.64 -29.53 59.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.32 -50.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -51.72 -37.54 51.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.695 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.4 mm? -69.72 -37.66 76.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.702 ' CD1' HD22 ' A' ' 300' ' ' LEU . 37.3 tp -64.4 -26.27 68.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.307 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.458 ' O ' ' HE2' ' B' ' 483' ' ' MET . 35.8 mttm -93.01 25.9 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -114.21 134.84 22.16 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.163 -0.96 . . . . 0.0 109.487 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.989 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.3 Cg_endo -71.92 -24.33 21.08 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.839 2.36 . . . . 0.0 112.018 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.415 ' OD1' HD12 ' B' ' 464' ' ' ILE . 75.7 m-80 -57.79 -28.69 64.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.831 ' N ' HD12 ' A' ' 295' ' ' LEU . 5.0 mp -94.54 125.4 39.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.9 171.5 32.96 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HE3' ' OE2' ' B' ' 461' ' ' GLU . 24.8 mttm -51.89 -36.71 49.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -75.01 -38.57 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.592 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.4 m -57.61 -49.06 77.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 290' ' ' LEU . 23.9 tp -52.81 -42.87 65.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 56.9 m -52.45 -53.51 44.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.8 mt-10 -54.07 -39.69 66.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -0.944 . . . . 0.0 109.069 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 295' ' ' LEU . 76.5 mt -58.47 -43.22 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.117 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -60.73 -41.51 95.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.264 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -58.28 -47.13 84.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.935 . . . . 0.0 109.225 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.68 HG21 HD11 ' A' ' 262' ' ' LEU . 2.2 t -73.28 -37.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.565 HD11 ' OG ' ' A' ' 313' ' ' SER . 0.1 OUTLIER -60.95 -26.41 67.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 310' ' ' ARG . . . -58.22 -32.06 67.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -60.55 -13.99 17.28 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 109.843 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.783 ' C ' HD21 ' A' ' 314' ' ' LEU . 75.0 mtm-85 63.67 9.83 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.892 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -113.08 -7.65 21.09 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.079 HD11 HD22 ' A' ' 281' ' ' LEU . 7.9 tp -127.04 130.68 50.43 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.188 -1.183 . . . . 0.0 109.335 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.738 ' H ' HG12 ' A' ' 282' ' ' VAL . 12.8 t 68.84 56.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.764 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.783 HD21 ' C ' ' A' ' 310' ' ' ARG . 11.2 mt -105.66 21.57 17.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.149 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.97 39.82 94.65 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.564 ' CE ' HD21 ' A' ' 253' ' ' LEU . 3.1 mtm -86.79 170.08 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 318' ' ' LEU . 40.6 mtt85 -143.28 126.24 16.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.92 HD21 ' CE2' ' A' ' 249' ' ' PHE . 4.0 mp -124.3 134.0 53.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 109.708 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.9 -39.89 95.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.912 . . . . 0.0 108.988 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 78.4 m-20 -119.1 -75.3 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.682 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 1.1 t-105 168.73 -58.3 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.496 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.0 Cg_endo -68.49 107.49 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.654 2.236 . . . . 0.0 112.001 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 1.036 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.0 Cg_endo -71.26 165.08 33.56 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.609 2.206 . . . . 0.0 111.592 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.07 -23.35 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.0 t -77.09 -38.36 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 1.036 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.0 tt -58.67 -21.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -70.48 -28.4 64.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.544 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -54.56 -36.33 64.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.488 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -54.15 -36.22 63.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -1.131 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 85.1 m-20 58.05 44.69 19.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.06 128.91 50.05 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 109.554 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.54 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.1 Cg_endo -70.71 136.53 30.69 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.593 2.195 . . . . 0.0 111.728 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -64.15 153.05 38.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -55.09 -36.91 66.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.69 -44.91 92.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.352 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.83 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -69.97 -37.12 75.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.979 ' O ' HD13 ' B' ' 435' ' ' LEU . 1.3 tm? -70.21 -33.17 71.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.588 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -90.17 8.3 33.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.646 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.822 HD22 ' CD1' ' B' ' 456' ' ' LEU . 25.5 tp -73.6 136.25 43.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -77.2 145.05 37.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.89 -6.06 73.02 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.566 HG22 ' CD2' ' B' ' 481' ' ' LEU . 61.7 t -121.78 135.68 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -1.214 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.614 ' H ' HD12 ' B' ' 444' ' ' LEU . 73.1 m-20 -91.04 152.84 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.595 ' HG2' HD11 ' B' ' 435' ' ' LEU . 96.5 mtt180 -49.85 -38.66 36.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.63 -40.68 80.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.863 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.614 HD12 ' H ' ' B' ' 441' ' ' ASP . 20.1 mt -64.61 -34.65 78.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.394 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.88 76.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.54 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.1 m-85 -62.91 -44.05 97.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.639 ' HD2' HD21 ' B' ' 473' ' ' LEU . 7.1 ttmm -55.03 -37.84 67.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 459' ' ' LEU . 85.2 mt -69.16 -39.92 78.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -59.24 -33.05 70.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.58 -35.75 6.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' B' ' 470' ' ' ILE . 9.5 mtp85 -90.12 21.47 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.502 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.72 7.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 1.047 HG21 ' HG3' ' B' ' 462' ' ' GLN . 4.9 t -81.8 112.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.915 -1.344 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 430' ' ' PRO . 3.8 p -128.04 -42.17 1.57 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -74.22 144.83 44.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.483 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.888 HD21 HD12 ' B' ' 488' ' ' ILE . 36.8 tp -48.87 -45.44 41.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.87 -45.87 78.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.216 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.756 ' HB3' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -56.55 -40.3 74.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.275 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 448' ' ' LEU . 20.5 tp -60.1 -43.59 95.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.46 -33.1 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.282 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 461' ' ' GLU . . . . . 0.454 ' OE2' ' HE3' ' A' ' 297' ' ' LYS . 72.5 mm-40 -68.09 -31.05 70.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.43 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 1.047 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.3 mm-40 -78.0 136.86 38.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.51 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -98.13 160.1 20.71 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.989 HD11 ' HG2' ' A' ' 293' ' ' PRO . 65.0 mt -44.04 -39.67 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.432 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.98 -36.53 81.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.446 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 85.7 m-20 -70.51 -28.59 65.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.302 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -82.0 -28.27 32.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.65 65.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -56.99 -31.02 64.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.696 HD11 ' CG ' ' B' ' 451' ' ' ARG . 59.6 mt -103.22 118.28 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.72 -31.01 57.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.54 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -53.83 -32.4 48.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.814 ' N ' HD22 ' B' ' 473' ' ' LEU . 2.8 mm? -107.58 138.03 44.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.495 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.04 165.08 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.495 ' N ' HG22 ' B' ' 474' ' ' THR . 91.5 m-20 -59.09 -38.46 79.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -75.79 -46.12 32.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.572 ' O ' HD13 ' B' ' 481' ' ' LEU . 20.8 tttt -63.2 -48.01 80.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -60.22 -36.44 77.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.76 -44.13 97.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.26 86.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.734 ' HB3' HD21 ' B' ' 459' ' ' LEU . 7.2 mp -69.17 -34.11 74.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 62.4 mt -69.49 -56.48 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.529 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 40.9 mmm -54.53 -38.79 66.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -62.14 -54.16 45.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -63.82 -42.41 97.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -57.53 -44.09 84.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -64.44 -36.62 84.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.466 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.888 HD12 HD21 ' B' ' 456' ' ' LEU . 65.9 mt -66.72 -37.15 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 4.8 m -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -66.61 -33.33 75.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -98.19 10.53 40.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -61.31 -25.64 65.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -54.78 -36.55 65.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -1.128 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 494' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' B' ' 495' ' ' ALA . 75.8 mm-40 -90.66 147.76 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 495' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 318' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' A' ' 252' ' ' ILE . 44.7 m-20 -67.29 133.58 93.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.55 -26.18 54.57 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.782 2.321 . . . . 0.0 111.467 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 1.035 HD13 HD22 ' A' ' 312' ' ' LEU . 14.5 tt -66.65 -25.57 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.225 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 312' ' ' LEU . 44.7 mt -74.23 -45.41 48.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 109.573 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.915 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 1.2 mm? -66.85 -26.84 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.547 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.16 143.66 96.14 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.147 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 259' ' ' ASP . 48.4 Cg_endo -69.07 132.77 25.16 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.63 2.22 . . . . 0.0 111.757 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -43.68 -32.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.31 -31.07 71.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.354 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' PRO . 33.0 m-20 -70.52 -14.46 62.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 257' ' ' VAL . 53.3 mt -48.16 138.0 10.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.33 -15.06 59.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 262' ' ' LEU . 6.9 mp -69.8 173.15 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.8 p -66.86 162.15 22.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.638 HG12 ' ND2' ' A' ' 268' ' ' ASN . 21.2 t -60.79 -23.92 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.01 -44.28 97.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.274 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -48.78 80.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.55 86.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.638 ' ND2' HG12 ' A' ' 264' ' ' VAL . 91.7 m-20 -56.8 -37.22 70.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 25.2 m -53.33 -64.77 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.784 HD21 HD11 ' A' ' 289' ' ' LEU . 78.8 mt -60.37 -45.13 94.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 64.9 tttm -52.86 -35.76 58.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.06 -20.42 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.4 mt-10 -94.8 23.84 5.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.468 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.56 37.32 1.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.728 HG23 ' HB2' ' A' ' 280' ' ' ASP . 82.6 mt -115.54 128.19 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.609 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -116.34 -27.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.609 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.4 m-85 -110.55 137.07 48.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 252' ' ' ILE . 90.8 mt -55.47 -29.78 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.89 -46.7 14.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.728 ' HB2' HG23 ' A' ' 275' ' ' ILE . 78.0 m-20 -53.58 -31.3 46.2 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.041 -1.27 . . . . 0.0 108.688 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.714 HD13 HD13 ' A' ' 270' ' ' LEU . 43.4 tp -57.07 -50.75 71.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.498 -0.751 . . . . 0.0 109.13 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.9 m -64.7 -29.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 108.912 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.45 -35.86 74.85 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.316 -0.865 . . . . 0.0 108.723 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -98.95 150.03 22.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.46 -0.775 . . . . 0.0 109.084 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.5 m -79.5 142.42 35.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.464 ' CD ' ' CD1' ' A' ' 307' ' ' LEU . 82.8 tt0 -55.63 -27.6 50.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.499 ' H ' HG22 ' A' ' 285' ' ' THR . 47.8 t -52.74 -55.5 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.12 -30.69 70.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.158 -0.964 . . . . 0.0 108.645 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 270' ' ' LEU . 20.1 tp -61.95 -37.33 84.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.509 -0.744 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.01 -23.33 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.552 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 48.5 mttm -81.62 -17.11 49.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.518 ' HB ' HD13 ' A' ' 295' ' ' LEU . 2.1 m -73.46 117.29 59.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.549 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.946 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.9 Cg_endo -71.07 -20.5 28.65 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.68 2.253 . . . . 0.0 111.865 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.9 m120 -52.89 -20.43 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.869 ' HB2' HD21 ' A' ' 300' ' ' LEU . 2.4 mp -101.98 132.59 47.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -76.68 157.64 47.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' B' ' 461' ' ' GLU . 23.6 mttm -49.66 -39.33 35.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -1.169 . . . . 0.0 109.396 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -71.46 -38.61 71.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.2 m -61.88 -47.4 85.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 295' ' ' LEU . 77.7 mt -53.01 -42.82 66.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.255 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 44.4 m -52.99 -51.73 60.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 306' ' ' VAL . 94.0 mt-10 -55.78 -39.76 71.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.317 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.475 HG21 HD21 ' A' ' 289' ' ' LEU . 33.5 mm -58.03 -48.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.901 . . . . 0.0 109.236 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -56.69 -41.45 77.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -58.58 -45.88 88.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.275 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.719 HG12 ' CD1' ' A' ' 312' ' ' LEU . 2.2 t -62.0 -38.28 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.103 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.5 mt -54.63 -25.44 26.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.416 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.41 -39.18 75.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.416 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -20.71 2.83 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.404 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 310' ' ' ARG . 21.0 tpt180 64.9 10.23 6.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.637 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -106.8 -0.92 36.61 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 252' ' ' ILE . 0.5 OUTLIER -138.45 148.55 44.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -1.169 . . . . 0.0 109.565 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.808 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 51.21 64.5 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.589 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.45 9.24 43.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.97 31.0 64.84 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.486 ' HE1' HD11 ' A' ' 253' ' ' LEU . 12.7 ptt? -114.08 150.22 34.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.583 ' C ' HD12 ' A' ' 318' ' ' LEU . 72.0 mtt85 -124.63 143.17 50.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.847 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.4 mp -118.83 140.57 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.75 -40.23 79.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 108.939 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 38.7 t-20 -122.08 -71.46 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.915 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.4 t-105 167.59 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.617 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.2 Cg_endo -67.8 107.89 1.57 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 112.069 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.996 ' O ' HG22 ' A' ' 326' ' ' ILE . 54.3 Cg_endo -73.49 164.86 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.721 2.281 . . . . 0.0 111.684 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.09 66.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 44.6 m -76.46 -38.58 55.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.877 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.996 HG22 ' O ' ' A' ' 323' ' ' PRO . 19.2 tt -58.49 -20.66 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.14 145.92 55.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.465 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 329' ' ' GLU . 91.2 m-20 -57.9 -38.84 76.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.471 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 328' ' ' ASP . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 426' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.85 -35.97 73.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -1.14 . . . . 0.0 109.474 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.515 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 28.4 m120 -87.31 8.93 22.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.414 ' HB2' ' N ' ' B' ' 426' ' ' GLY . 0.7 OUTLIER -55.75 132.38 72.42 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.969 . . . . 0.0 109.376 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.86 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.01 141.05 43.21 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.62 2.214 . . . . 0.0 111.715 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.3 156.38 35.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 432' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.2 m-20 -47.24 -38.56 12.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 433' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 456' ' ' LEU . 51.3 m-20 -60.49 -48.47 81.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.86 HD23 ' HB3' ' B' ' 430' ' ' PRO . 25.5 tp -68.18 -37.89 81.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 0.0 109.556 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.884 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.6 OUTLIER -76.85 -28.86 55.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.428 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 436' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' B' ' 432' ' ' ASP . 36.8 t-20 -90.32 10.27 25.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.835 HD23 HG21 ' B' ' 440' ' ' VAL . 41.9 tp -78.31 129.88 35.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.19 146.1 35.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.33 7.97 72.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.835 HG21 HD23 ' B' ' 437' ' ' LEU . 77.7 t -124.6 129.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 109.458 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -83.34 147.25 28.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -50.01 -40.81 45.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.464 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.9 m-20 -72.44 -40.55 66.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.706 HD11 HD13 ' B' ' 473' ' ' LEU . 23.1 tp -59.72 -42.28 92.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.72 80.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.38 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 11.7 m-30 -65.35 -41.58 93.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.46 -51.21 69.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.798 HD13 HD11 ' B' ' 459' ' ' LEU . 3.9 tt -62.23 -43.14 99.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -58.24 -31.31 67.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.75 -17.17 33.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.363 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -89.32 33.26 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 0.0 109.423 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.54 -18.97 7.66 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' B' ' 458' ' ' ASP . 61.4 t -64.17 135.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.281 . . . . 0.0 109.34 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' B' ' 431' ' ' ALA . 0.8 OUTLIER -131.82 -33.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.624 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.6 OUTLIER -115.1 142.14 47.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.0 109.733 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.806 HD11 ' HA ' ' B' ' 485' ' ' ALA . 2.0 tm? -45.42 -39.47 7.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 108.867 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.0 -48.2 76.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.205 -0.934 . . . . 0.0 108.653 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.574 ' HB3' HG13 ' B' ' 453' ' ' VAL . 28.9 t0 -54.26 -42.77 70.33 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.334 -0.853 . . . . 0.0 108.72 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.798 HD11 HD13 ' B' ' 448' ' ' LEU . 5.1 tt -53.7 -48.91 69.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 109.018 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.897 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -56.03 -35.62 67.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 461' ' ' GLU . . . . . 0.515 ' HA ' ' CE ' ' A' ' 297' ' ' LYS . 96.7 mt-10 -67.21 -28.34 68.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -63.78 164.87 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.26 154.07 16.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.946 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.9 mt -52.33 -34.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.15 -34.28 74.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.52 -31.92 63.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.011 HD12 ' HB1' ' B' ' 478' ' ' ALA . 34.6 mt -74.94 -34.86 62.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.333 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.92 -21.52 11.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.545 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -50.19 -36.97 32.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.2 125.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -62.24 -35.61 79.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.446 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -33.14 22.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.976 HD23 ' HB3' ' B' ' 467' ' ' LEU . 10.9 tp -99.17 141.7 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.554 HG22 ' N ' ' B' ' 475' ' ' ASP . 89.0 m -104.15 164.79 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.554 ' N ' HG22 ' B' ' 474' ' ' THR . 92.3 m-20 -56.5 -40.11 74.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -75.4 -46.25 34.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.469 ' HE3' HD22 ' B' ' 444' ' ' LEU . 37.7 tttp -60.41 -38.28 83.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 109.275 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.011 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -68.75 -50.66 48.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.448 ' HA2' HG12 ' B' ' 464' ' ' ILE . . . -62.58 -48.59 80.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.97 61.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -1.121 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.534 HD22 ' CG2' ' B' ' 440' ' ' VAL . 64.1 mt -62.41 -40.92 98.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.265 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.0 mt -55.01 -55.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.23 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 31.8 mtp -53.14 -45.3 68.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.26 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.9 -45.09 90.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.164 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.806 ' HA ' HD11 ' B' ' 456' ' ' LEU . . . -63.13 -52.27 63.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.255 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.897 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 89.2 mtt180 -59.46 -39.57 84.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 93.6 m-20 -57.31 -41.59 80.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' B' ' 437' ' ' LEU . 83.3 mt -59.65 -36.61 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.43 -51.62 9.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.772 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -63.84 -45.92 87.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.0 m-85 -76.08 -29.5 57.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -61.53 -27.89 68.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.64 -36.38 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -1.115 . . . . 0.0 109.497 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.27 -32.29 69.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.511 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.457 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.574 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 44.4 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.4 124.93 57.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.305 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.07 -22.68 61.76 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.623 2.215 . . . . 0.0 111.665 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 278' ' ' ILE . 12.7 tt -71.8 -31.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 108.833 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 311' ' ' GLY . 31.8 mt -74.85 -45.03 45.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 109.345 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 1.007 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.7 OUTLIER -65.48 -35.54 81.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 278' ' ' ILE . 6.4 mtt85 -55.82 141.52 65.95 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.004 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 48.1 Cg_endo -68.93 132.16 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.623 2.216 . . . . 0.0 111.935 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.84 -28.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 95.5 m-20 -65.54 -30.68 71.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 256' ' ' PRO . 72.4 m-20 -74.96 -8.58 56.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 257' ' ' VAL . 0.7 OUTLIER -42.85 129.48 4.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -15.47 50.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' A' ' 302' ' ' GLU . 40.3 mt -70.18 -162.13 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 7.1 p -81.01 155.9 26.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.565 HG12 ' ND2' ' A' ' 268' ' ' ASN . 22.8 t -57.67 -24.07 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' B' ' 465' ' ' ASP . 55.6 ttt85 -57.81 -43.36 85.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.7 m -58.82 -46.83 86.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.371 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -68.96 -39.5 79.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.565 ' ND2' HG12 ' A' ' 264' ' ' VAL . 86.7 m-20 -60.28 -32.17 70.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.4 m -66.9 -64.9 0.76 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.0 mt -54.84 -47.82 73.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.507 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 20.5 ttpt -52.94 -39.52 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.449 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.4 -23.68 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 95.3 mt-10 -94.11 23.07 5.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.42 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.5 33.26 4.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -0.929 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.714 HG23 ' HB2' ' A' ' 280' ' ' ASP . 75.8 mt -120.26 108.2 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.507 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 91.2 m-70 -104.59 -11.09 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.824 . . . . 0.0 109.581 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.98 133.37 54.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 252' ' ' ILE . 49.8 mt -62.03 -30.9 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.944 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -52.27 -41.25 54.11 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.714 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.1 m-20 -53.45 -36.36 61.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -1.181 . . . . 0.0 109.119 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.515 ' CD2' HD12 ' A' ' 312' ' ' LEU . 3.1 tp -59.19 -46.49 88.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.297 -0.877 . . . . 0.0 109.229 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 279' ' ' GLY . 15.4 m -68.37 -23.29 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -68.26 -33.09 73.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.826 . . . . 0.0 108.813 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -105.74 143.4 33.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.02 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.8 m -60.0 137.6 58.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.092 -1.005 . . . . 0.0 109.394 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.98 -30.5 71.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.551 ' H ' HG22 ' A' ' 285' ' ' THR . 50.0 t -53.1 -50.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.331 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -51.8 -39.39 58.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -72.8 -39.65 66.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.291 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.996 HD13 ' O ' ' A' ' 290' ' ' LEU . 1.8 tm? -57.61 -33.21 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.228 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' B' ' 483' ' ' MET . 32.5 mttm -88.45 17.64 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 289' ' ' LEU . 2.9 m -103.75 135.99 19.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 1.016 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -70.81 -24.82 24.45 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.671 2.247 . . . . 0.0 111.802 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.46 ' OD1' HD12 ' B' ' 464' ' ' ILE . 77.4 m-20 -57.1 -21.01 28.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.57 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 13.3 mt -81.8 149.89 28.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -112.93 147.6 18.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.08 -44.88 71.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.409 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 302' ' ' GLU . 40.1 mttp -66.52 -41.58 88.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.4 m -64.39 -32.77 74.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 303' ' ' ILE . 32.5 tp -53.36 -42.2 66.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.426 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.8 m -54.8 -43.41 72.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.835 ' HB3' HD13 ' A' ' 262' ' ' LEU . 39.5 mp0 -67.15 -37.86 84.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 300' ' ' LEU . 77.2 mt -58.24 -47.16 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.448 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.44 -36.54 84.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.47 -45.2 89.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 312' ' ' LEU . 20.6 t -68.71 -43.33 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.832 HD13 ' OG ' ' A' ' 313' ' ' SER . 16.6 tp -54.73 -29.68 54.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.606 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.62 73.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 83.0 p -79.22 -1.11 34.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.467 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 1.01 ' HA ' HD21 ' A' ' 314' ' ' LEU . 65.8 mtm180 56.88 16.99 3.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.012 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.669 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.55 -38.94 57.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 306' ' ' VAL . 1.3 pp -149.5 160.99 43.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -1.219 . . . . 0.0 109.978 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.832 ' OG ' HD13 ' A' ' 307' ' ' LEU . 0.5 OUTLIER 76.72 29.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.795 . . . . 0.0 109.538 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 1.01 HD21 ' HA ' ' A' ' 310' ' ' ARG . 72.9 mt -85.8 14.91 5.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 54.69 41.69 75.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.68 ' HE3' ' HB ' ' A' ' 282' ' ' VAL . 5.0 mtm -86.2 176.95 7.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -1.094 . . . . 0.0 109.49 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.73 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.8 mtt180 -140.98 125.77 18.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.821 ' N ' HD12 ' A' ' 318' ' ' LEU . 4.0 mp -126.55 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.85 -38.49 88.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.239 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.9 m-20 -125.31 -69.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 1.007 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 166.08 -66.41 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.451 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.87 107.75 1.76 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.652 2.235 . . . . 0.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 51.5 Cg_endo -71.71 162.45 42.04 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.625 2.217 . . . . 0.0 111.505 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.55 -17.26 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 36.4 m -66.12 -42.62 88.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.48 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.963 HD11 HD21 ' A' ' 254' ' ' LEU . 18.1 mt -58.23 -31.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.89 75.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.968 . . . . 0.0 109.393 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -55.45 -37.36 67.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.372 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.418 ' HG2' ' OXT' ' A' ' 329' ' ' GLU . 84.3 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 427' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 88.8 m-20 -54.28 -36.98 64.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' B' ' 427' ' ' ASP . 83.8 m-20 59.71 51.24 6.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.434 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -86.46 124.56 69.55 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.523 ' HB3' ' HB1' ' B' ' 445' ' ' ALA . 49.8 Cg_endo -70.56 140.93 40.76 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.664 2.242 . . . . 0.0 111.686 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -80.88 160.15 24.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 432' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.3 m-20 -53.46 -37.47 62.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.305 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 433' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 18.3 m-20 -61.39 -49.99 74.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.387 -0.82 . . . . 0.0 109.512 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.725 HD11 ' CD1' ' B' ' 448' ' ' LEU . 17.8 tp -63.45 -35.79 81.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.577 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' B' ' 442' ' ' ARG . 22.2 tp -83.51 -23.08 32.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 436' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' B' ' 432' ' ' ASP . 35.3 t-20 -88.24 7.34 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.765 HD23 HG21 ' B' ' 440' ' ' VAL . 28.6 tp -78.43 129.93 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.501 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.82 137.28 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.06 9.32 70.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.975 HG13 HD23 ' B' ' 444' ' ' LEU . 41.8 t -123.67 131.12 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.137 . . . . 0.0 109.475 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -102.46 161.82 13.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.755 ' HG2' HD11 ' B' ' 435' ' ' LEU . 61.7 mtt180 -50.19 -45.59 53.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.481 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 93.4 m-20 -61.08 -47.44 86.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.435 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.056 HD11 HD21 ' B' ' 473' ' ' LEU . 27.9 tp -55.67 -43.11 76.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.334 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' B' ' 430' ' ' PRO . . . -59.02 -43.07 91.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.23 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 17.3 m-85 -57.68 -44.75 86.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.26 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -58.24 -45.06 88.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' B' ' 434' ' ' LEU . 79.1 mt -61.34 -44.03 97.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.16 -36.19 77.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.42 33.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.533 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 16.0 mtp-105 -90.32 23.57 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.68 6.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.903 HG21 ' CG ' ' B' ' 462' ' ' GLN . 21.3 t -80.53 109.75 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.34 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 31.1 m -124.91 -34.45 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -82.09 140.89 33.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.628 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.0 tm? -48.56 -40.78 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.72 -38.77 91.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -0.922 . . . . 0.0 108.899 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.562 ' C ' HG13 ' B' ' 453' ' ' VAL . 92.5 m-20 -61.58 -40.12 93.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.85 HD13 ' O ' ' B' ' 459' ' ' LEU . 3.4 tm? -63.29 -39.03 93.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' B' ' 486' ' ' ARG . . . -63.48 -32.63 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.295 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -72.61 -30.33 64.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.903 ' CG ' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -61.65 156.91 18.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.25 155.97 15.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 1.016 HD11 ' HG2' ' A' ' 293' ' ' PRO . 52.2 mt -49.68 -38.33 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -1.131 . . . . 0.0 109.501 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 465' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 265' ' ' ARG . 89.2 m-20 -65.22 -37.51 87.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.44 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 89.6 m-20 -71.11 -31.07 67.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.088 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.0 mt -76.81 -29.85 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.61 63.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -52.67 -32.35 41.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.9 mt -104.73 128.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -63.77 -33.94 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.422 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -51.12 -28.63 18.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.056 HD21 HD11 ' B' ' 444' ' ' LEU . 55.1 mt -105.86 137.6 43.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.456 HG22 ' N ' ' B' ' 475' ' ' ASP . 29.8 m -103.97 162.0 13.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.395 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.456 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.3 -37.51 75.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -76.97 -45.94 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 70.7 tttt -65.83 -46.4 78.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.088 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -60.02 -44.64 94.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 109.535 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -62.27 -52.34 50.21 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -50.98 -33.74 26.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -1.169 . . . . 0.0 109.617 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.63 HD11 HD21 ' B' ' 444' ' ' LEU . 24.7 mt -75.33 -37.36 60.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.522 HD11 ' N ' ' B' ' 464' ' ' ILE . 92.8 mt -60.54 -55.63 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.522 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 41.2 mmm -59.68 -47.64 84.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.46 -53.15 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.45 ' CB ' HD12 ' B' ' 459' ' ' LEU . . . -60.83 -48.62 80.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.475 ' HA ' ' HB1' ' B' ' 460' ' ' ALA . 44.9 ttp85 -56.98 -43.75 82.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.7 m-20 -57.92 -39.06 77.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.616 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' B' ' 437' ' ' LEU . 76.9 mt -63.68 -36.9 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.51 -52.07 59.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.56 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -61.17 -38.75 87.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 17.2 m-85 -64.03 -31.33 72.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.492 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.86 -30.06 72.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -53.15 -37.86 62.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -1.138 . . . . 0.0 109.466 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.27 -33.05 72.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.531 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.525 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.873 ' CE2' HD21 ' A' ' 318' ' ' LEU . 79.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.482 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.2 OUTLIER -50.78 155.22 2.04 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.273 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.512 ' HA ' HD23 ' A' ' 254' ' ' LEU . 41.0 Cg_endo -64.5 -26.31 62.47 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.47 2.114 . . . . 0.0 111.425 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.788 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -53.38 -34.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 252' ' ' ILE . 5.3 mp -74.45 -39.21 62.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.463 -0.773 . . . . 0.0 109.01 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.702 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -71.32 -23.14 61.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.459 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 278' ' ' ILE . 0.2 OUTLIER -73.0 141.19 81.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.466 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 259' ' ' ASP . 51.5 Cg_endo -70.66 136.37 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.728 2.285 . . . . 0.0 111.736 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.16 -26.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.368 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.443 ' OD1' ' HE2' ' A' ' 271' ' ' LYS . 88.3 m-20 -67.61 -30.77 70.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 256' ' ' PRO . 49.9 m-20 -74.71 -9.8 58.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 49.5 mt -58.44 135.75 57.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 0.0 109.359 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.44 -21.22 66.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.571 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 262' ' ' LEU . 6.4 mp -62.59 168.35 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.2 p -70.5 166.74 19.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.679 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.0 t -63.89 -23.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -55.4 -45.09 76.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.9 p -69.16 -45.89 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -63.82 -42.4 97.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.679 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.2 m-20 -54.13 -38.36 65.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.3 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 295' ' ' LEU . 61.0 m -51.29 -62.14 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.631 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.8 mt -56.47 -46.28 80.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 16.3 mttt -53.25 -33.23 52.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.73 -33.7 49.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.1 mt-10 -92.01 25.84 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.23 45.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 1.025 HG23 ' HB2' ' A' ' 280' ' ' ASP . 91.2 mt -115.61 124.91 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.743 ' O ' HG22 ' A' ' 257' ' ' VAL . 6.5 p80 -114.09 -39.93 3.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.571 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -103.14 134.73 46.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.905 HG21 HD23 ' A' ' 312' ' ' LEU . 78.1 mt -46.66 -30.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.067 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.89 -49.41 17.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 1.025 ' HB2' HG23 ' A' ' 275' ' ' ILE . 87.5 m-20 -53.43 -32.19 48.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 108.988 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 312' ' ' LEU . 53.9 tp -53.99 -51.29 64.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.332 -0.855 . . . . 0.0 109.07 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.7 m -68.17 -33.46 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.18 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -53.06 -32.43 46.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.294 -0.879 . . . . 0.0 108.819 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -107.74 150.61 26.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 72.2 p -81.6 157.07 24.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.945 . . . . 0.0 109.616 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.529 ' OE2' HD23 ' A' ' 307' ' ' LEU . 7.2 mt-10 -63.52 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.918 . . . . 0.0 109.442 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.5 t -52.79 -50.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -55.14 -37.57 67.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.415 HD23 ' OE2' ' A' ' 273' ' ' GLU . 65.8 mt -72.62 -40.75 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.242 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 1.011 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.9 tm? -57.31 -32.69 66.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.865 . . . . 0.0 109.21 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 66.9 mttm -82.26 -13.27 57.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.82 . . . . 0.0 109.474 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.1 m -86.94 112.6 48.5 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 1.043 ' HB2' HD12 ' B' ' 482' ' ' ILE . 51.3 Cg_endo -70.86 -13.16 31.71 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.767 2.311 . . . . 0.0 111.845 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HA ' HD12 ' B' ' 464' ' ' ILE . 30.6 m120 -48.93 -41.08 32.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 269' ' ' CYS . 0.4 OUTLIER -83.74 143.17 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -80.34 165.2 48.27 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -64.48 -41.51 96.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.568 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -63.94 -39.0 93.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 303' ' ' ILE . 19.6 m -59.73 -41.67 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 304' ' ' LYS . 24.2 tp -53.06 -37.93 62.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.9 m -60.85 -45.83 92.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.14 -46.09 88.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.83 HG22 HD22 ' A' ' 307' ' ' LEU . 30.6 mm -58.76 -51.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.434 ' CE ' ' HG ' ' A' ' 300' ' ' LEU . 22.5 mttm -53.13 -39.06 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.15 -48.3 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.461 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.892 HG12 HD11 ' A' ' 312' ' ' LEU . 12.0 t -73.71 -40.84 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.83 HD22 HG22 ' A' ' 303' ' ' ILE . 8.4 mp -66.02 -26.71 67.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -29.57 66.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 8.2 t -75.2 -0.16 18.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.539 ' O ' HD21 ' A' ' 314' ' ' LEU . 40.5 mtm-85 70.31 3.89 4.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -69.32 -27.82 73.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.905 HD23 HG21 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -140.81 152.89 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 109.261 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.525 ' OG ' HD21 ' A' ' 307' ' ' LEU . 16.5 m 63.67 66.85 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.46 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.799 HD13 ' HE2' ' A' ' 316' ' ' MET . 4.7 mp -103.06 9.99 38.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.61 73.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.799 ' HE2' HD13 ' A' ' 314' ' ' LEU . 15.4 ptt? -113.04 147.38 37.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.534 ' C ' HD12 ' A' ' 318' ' ' LEU . 76.3 mtm180 -126.53 141.66 51.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.292 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.873 HD21 ' CE2' ' A' ' 249' ' ' PHE . 3.7 mp -116.9 141.78 47.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.02 -34.4 77.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.983 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 85.6 m-20 -117.41 -81.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 165.89 -62.23 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.545 ' CB ' HD11 ' A' ' 326' ' ' ILE . 48.8 Cg_endo -68.33 108.09 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.66 2.24 . . . . 0.0 111.989 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 249' ' ' PHE . 53.9 Cg_endo -76.34 161.91 34.29 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.421 2.08 . . . . 0.0 111.414 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.64 -13.92 17.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.1 p -70.35 -35.52 73.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.764 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.605 HG21 ' HG ' ' A' ' 254' ' ' LEU . 21.2 pt -94.0 -3.75 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.8 74.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.16 -38.14 76.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.489 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -57.5 -36.35 71.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -1.134 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 56.2 40.04 30.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 130.17 92.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 144.01 48.72 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.792 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.65 146.34 40.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -47.99 -32.9 7.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 109.455 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.53 -48.01 68.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.861 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.5 tm? -67.91 -36.96 81.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.93 ' O ' HD13 ' B' ' 435' ' ' LEU . 1.0 OUTLIER -72.89 -31.95 65.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.86 11.32 20.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 1.06 HD13 HD11 ' B' ' 456' ' ' LEU . 50.2 tp -74.05 133.64 42.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -76.6 145.47 38.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.74 75.1 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.732 HG13 HD23 ' B' ' 444' ' ' LEU . 95.3 t -123.54 135.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -1.214 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 442' ' ' ARG . 58.2 t0 -85.27 146.38 27.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.502 ' HG2' HD11 ' B' ' 435' ' ' LEU . 95.8 mtt180 -49.92 -43.79 49.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -68.65 -37.74 79.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.293 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.07 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.2 tp -63.66 -35.57 80.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -63.81 -41.37 97.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.953 . . . . 0.0 109.419 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 71.8 m-85 -65.88 -48.46 71.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.533 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 31.4 ttmt -57.94 -42.86 85.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.829 HD11 ' CD2' ' B' ' 459' ' ' LEU . 10.0 tt -69.73 -37.3 76.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.27 -27.6 67.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.496 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.06 -16.9 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.425 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 12.1 mtp85 -90.46 28.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.81 6.8 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 19.2 t -65.33 133.24 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.303 . . . . 0.0 109.427 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 60.4 m -135.08 -35.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.3 OUTLIER -106.57 152.1 24.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.003 . . . . 0.0 109.847 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 1.06 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -51.78 -42.77 62.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.332 -0.855 . . . . 0.0 109.363 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.83 -42.2 75.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.137 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 84.3 m-20 -61.4 -41.2 96.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.342 -0.849 . . . . 0.0 109.217 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.829 ' CD2' HD11 ' B' ' 448' ' ' LEU . 3.4 tm? -60.97 -38.92 87.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.16 -35.72 81.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.82 -35.34 80.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 3.5 mm100 -65.53 144.88 56.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.47 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -102.92 159.72 17.26 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.889 HD11 ' HG2' ' A' ' 293' ' ' PRO . 80.3 mt -46.07 -35.14 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.238 . . . . 0.0 109.204 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -63.47 -37.45 87.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.919 . . . . 0.0 109.021 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.4 m-20 -68.51 -31.55 70.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.16 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.733 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -80.84 -32.86 34.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.396 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.48 -33.07 67.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 109.392 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -46.83 -28.67 1.64 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.401 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.533 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 62.1 mt -105.79 121.53 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -55.93 -32.65 63.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.454 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.94 -28.82 49.57 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.07 ' CD2' HD11 ' B' ' 444' ' ' LEU . 65.0 mt -103.5 135.77 44.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -1.132 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.95 161.91 13.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.354 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.433 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 82.5 m-20 -58.29 -37.39 74.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.13 -46.03 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.651 ' O ' HD13 ' B' ' 481' ' ' LEU . 25.2 tttp -62.86 -44.22 96.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.733 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.85 -44.34 93.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.23 -35.85 91.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.16 76.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -1.144 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.651 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -69.51 -36.56 76.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 109.642 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.9 mt -68.84 -56.35 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.518 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 61.2 mtp -52.62 -39.08 61.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.35 -49.23 44.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' B' ' 456' ' ' LEU . . . -63.98 -46.41 84.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.422 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 45.9 ttm-85 -57.6 -45.05 85.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.34 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.0 m-20 -57.9 -40.0 79.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.643 HD12 HD11 ' B' ' 456' ' ' LEU . 84.8 mt -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.73 -49.23 49.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 490' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 58.4 m95 -65.99 -32.22 73.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.882 ' HB2' ' HB2' ' B' ' 495' ' ' ALA . 13.8 m-85 -79.22 -34.27 42.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.568 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 54.87 -135.37 46.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -51.0 -40.45 58.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -1.167 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.34 -36.63 66.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 495' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' B' ' 491' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.558 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.53 ' CD2' ' O ' ' A' ' 249' ' ' PHE . 10.4 p90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.767 ' O ' HD22 ' A' ' 254' ' ' LEU . 0.9 OUTLIER -57.86 136.95 83.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 109.272 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.687 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.05 -30.93 56.03 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.597 2.198 . . . . 0.0 111.55 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.848 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -63.11 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 312' ' ' LEU . 31.4 mt -74.31 -42.57 59.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.195 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.767 HD22 ' O ' ' A' ' 250' ' ' ASP . 0.5 OUTLIER -59.94 -34.99 73.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.813 . . . . 0.0 109.14 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -66.12 146.47 99.02 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.3 Cg_endo -70.22 140.01 39.94 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.714 2.276 . . . . 0.0 111.89 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.556 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.12 -36.92 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.362 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -58.13 -30.98 66.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 256' ' ' PRO . 21.9 m-20 -72.38 -11.41 60.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.556 HD11 HG12 ' A' ' 257' ' ' VAL . 36.8 mt -55.35 150.64 11.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -23.23 67.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.437 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 262' ' ' LEU . 5.6 mp -62.85 166.74 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -75.53 162.66 28.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.657 HG12 ' ND2' ' A' ' 268' ' ' ASN . 11.8 t -48.85 -39.67 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -51.18 -50.22 59.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.666 ' OG ' HD22 ' A' ' 262' ' ' LEU . 17.7 t -58.71 -51.02 71.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.96 -37.06 85.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 264' ' ' VAL . 94.7 m-20 -58.54 -36.47 73.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.322 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -53.64 54.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.304 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.723 HD21 HD13 ' A' ' 281' ' ' LEU . 6.6 mp -61.28 -47.87 83.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' A' ' 268' ' ' ASN . 54.8 mtmt -52.8 -38.14 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.23 20.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.3 mt-10 -92.95 25.29 3.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.453 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.05 45.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.994 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.2 mt -120.85 119.58 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.469 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 7.7 p80 -110.17 -40.05 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.557 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.457 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.6 m-30 -105.47 136.13 45.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 252' ' ' ILE . 93.5 mt -46.7 -29.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.988 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.98 -45.13 14.29 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.994 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.3 m-20 -53.52 -33.83 55.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.293 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 289' ' ' LEU . 38.7 tp -57.35 -49.48 76.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.988 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.2 m -63.44 -23.34 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 108.73 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.1 tt0 -67.45 -34.95 78.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -98.73 158.57 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 154.26 23.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.074 -1.016 . . . . 0.0 109.773 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.666 ' CD ' HD13 ' A' ' 307' ' ' LEU . 9.0 mt-10 -61.68 -36.33 80.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.539 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 42.1 t -52.64 -49.36 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -51.95 -32.55 33.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.083 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 281' ' ' LEU . 36.8 mt -69.25 -41.18 77.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.147 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.673 ' N ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm? -66.39 -25.31 66.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.342 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.546 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 54.8 mttt -86.32 -12.87 48.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.484 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.529 HG22 HD12 ' A' ' 295' ' ' LEU . 53.0 m -81.85 112.3 33.69 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.522 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 1.014 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.6 Cg_endo -71.06 -14.25 31.88 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.821 2.347 . . . . 0.0 111.916 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.67 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.9 m120 -61.98 -25.47 67.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.806 HD23 HD11 ' A' ' 303' ' ' ILE . 4.7 mp -88.02 142.35 27.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 296' ' ' GLY . . . . . 0.465 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -91.39 169.28 32.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.55 -41.07 80.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.145 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -70.14 -43.07 71.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.6 m -59.2 -49.45 77.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.39 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.752 HD21 ' HB2' ' A' ' 295' ' ' LEU . 83.5 mt -55.37 -42.37 73.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.3 m -55.41 -52.62 62.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.873 . . . . 0.0 109.451 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 306' ' ' VAL . 89.2 mt-10 -54.82 -39.4 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.806 HD11 HD23 ' A' ' 295' ' ' LEU . 78.6 mt -58.15 -51.54 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.33 -42.51 73.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.36 -44.08 79.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.986 HG12 HD21 ' A' ' 312' ' ' LEU . 1.9 t -65.93 -39.58 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.178 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.1 mt -54.63 -26.16 31.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.37 68.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.7 t -66.06 -15.53 63.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.784 ' C ' HD21 ' A' ' 314' ' ' LEU . 92.8 mtt180 59.32 14.17 3.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.442 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -105.27 1.99 40.33 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.986 HD21 HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.94 142.58 24.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -1.19 . . . . 0.0 109.641 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.784 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 67.22 38.87 3.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.577 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.784 HD21 ' C ' ' A' ' 310' ' ' ARG . 28.1 mt -88.97 18.2 5.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.31 36.29 91.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.704 ' HE2' HG11 ' A' ' 282' ' ' VAL . 6.4 mtm -87.21 167.33 14.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.571 ' C ' HD12 ' A' ' 318' ' ' LEU . 36.1 mtp180 -143.15 131.29 21.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.6 mp -130.0 139.26 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.927 . . . . 0.0 109.621 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.32 -43.97 88.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 108.88 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 69.1 m-20 -122.06 -69.42 0.83 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.041 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.567 ' HE3' HD22 ' A' ' 318' ' ' LEU . 2.6 t-105 168.42 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.354 -0.841 . . . . 0.0 109.405 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.3 Cg_endo -68.52 107.79 1.69 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.545 2.163 . . . . 0.0 111.898 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 1.016 ' O ' HG22 ' A' ' 326' ' ' ILE . 51.4 Cg_endo -71.47 152.91 60.69 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.611 2.207 . . . . 0.0 111.711 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.76 6.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 42.9 m -68.18 -32.64 73.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 1.016 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.7 tt -61.11 -25.29 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.315 -0.865 . . . . 0.0 109.564 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -59.24 144.05 47.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -60.05 -37.57 80.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 426' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.04 -35.0 72.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -1.15 . . . . 0.0 109.449 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.641 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 22.4 m120 -85.54 5.65 30.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.492 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 2.0 tttt -54.07 129.87 58.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.53 ' HG3' ' CD1' ' B' ' 446' ' ' PHE . 48.6 Cg_endo -69.98 140.85 42.85 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.677 2.251 . . . . 0.0 111.774 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.04 152.57 42.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.888 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -50.1 -39.42 42.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.4 -44.48 92.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.766 ' C ' HD13 ' B' ' 434' ' ' LEU . 2.9 tm? -64.18 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.25 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 442' ' ' ARG . 24.7 tp -79.88 -30.29 40.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -78.43 -0.77 30.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.693 HD23 HG21 ' B' ' 440' ' ' VAL . 28.8 tp -72.34 134.58 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.513 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -73.6 141.26 46.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.93 8.55 66.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.693 HG21 HD23 ' B' ' 437' ' ' LEU . 47.4 t -129.52 126.42 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.452 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.26 161.46 13.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.877 ' HG2' HD11 ' B' ' 435' ' ' LEU . 87.9 mtt-85 -55.01 -46.63 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.17 -45.6 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.519 ' CD2' ' HE2' ' B' ' 477' ' ' LYS . 12.9 tp -60.85 -41.83 96.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.635 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.15 -40.66 86.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.53 ' CD1' ' HG3' ' B' ' 430' ' ' PRO . 17.3 m-85 -63.83 -46.65 84.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.513 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 5.9 ttmm -57.66 -46.36 84.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.609 HD23 ' O ' ' B' ' 448' ' ' LEU . 8.7 tt -68.24 -36.51 79.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.586 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -60.81 -26.79 67.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -49.14 -22.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.695 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -88.66 25.01 1.83 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.63 7.15 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.71 HG21 ' HG3' ' B' ' 462' ' ' GLN . 44.7 t -62.87 132.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.942 -1.328 . . . . 0.0 109.326 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 87.5 m -135.11 -38.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 109.666 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 150.56 21.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.738 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 1.037 HD21 HD12 ' B' ' 488' ' ' ILE . 27.1 tp -48.41 -42.15 31.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.255 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -55.94 -48.36 75.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.102 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.6 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.6 m-20 -54.89 -40.99 70.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.065 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' B' ' 481' ' ' LEU . 4.6 tt -57.21 -47.05 82.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.65 70.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.08 -34.87 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.71 ' HG3' HG21 ' B' ' 453' ' ' VAL . 6.2 mm100 -67.44 156.01 37.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.57 155.08 16.32 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.965 HD11 ' HG2' ' A' ' 293' ' ' PRO . 30.0 mt -47.6 -42.63 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -1.176 . . . . 0.0 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -58.34 -42.43 86.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.14 -30.04 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.059 HD12 ' HB1' ' B' ' 478' ' ' ALA . 24.0 mt -77.98 -26.48 48.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.26 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.32 69.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.873 . . . . 0.0 109.301 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -53.74 -32.28 51.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.546 HG22 ' H ' ' B' ' 472' ' ' GLY . 61.0 mt -100.43 122.84 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.88 -26.84 67.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.546 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -59.7 -26.5 62.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.485 ' CD2' HD11 ' B' ' 444' ' ' LEU . 38.7 mt -109.73 134.66 51.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -1.163 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.02 161.93 13.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.403 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.426 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 79.9 m-20 -57.68 -38.05 74.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -76.79 -46.08 26.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.662 ' O ' HD13 ' B' ' 481' ' ' LEU . 43.7 tttt -64.93 -42.06 95.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.85 -42.15 97.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.1 -42.92 99.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.07 85.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -66.88 -39.89 87.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 293' ' ' PRO . 28.9 mt -64.69 -56.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.546 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 48.3 mtp -52.67 -40.35 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.447 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.83 -56.45 15.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -62.05 -44.42 96.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.714 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 290' ' ' LEU . 50.2 ttt180 -60.28 -45.97 91.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 84.5 m-20 -59.2 -41.13 87.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 1.037 HD12 HD21 ' B' ' 456' ' ' LEU . 71.0 mt -64.54 -37.14 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.07 -50.56 32.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.55 -39.69 77.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.5 m-85 -96.77 16.32 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -59.43 -33.76 77.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.17 -36.85 76.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -1.141 . . . . 0.0 109.388 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 494' ' ' GLU . . . . . 0.577 ' O ' ' HB3' ' B' ' 495' ' ' ALA . 98.0 mt-10 -62.17 -32.37 72.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.449 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 495' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.492 ' HB3' ' CB ' ' A' ' 325' ' ' SER . 43.5 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.347 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -65.93 135.51 95.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.68 -25.44 54.16 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.763 2.309 . . . . 0.0 111.79 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.555 ' O ' HD12 ' A' ' 278' ' ' ILE . 19.7 tt -79.54 -21.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.77 HD21 ' HE1' ' A' ' 321' ' ' TRP . 5.6 tp -74.08 -37.91 64.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.295 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 326' ' ' ILE . 3.8 mm? -82.99 -27.74 30.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.534 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 0.0 OUTLIER -63.75 144.19 97.95 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.542 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 51.1 Cg_endo -71.0 149.55 59.18 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.728 2.285 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.404 HG12 HD11 ' A' ' 260' ' ' LEU . 0.4 OUTLIER -53.53 -39.22 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.803 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 259' ' ' ASP . 9.3 p-10 -58.52 -31.0 67.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.6 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.534 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 68.6 m-20 -74.1 -13.45 60.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 257' ' ' VAL . 46.1 mt -51.17 144.13 9.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -68.71 -16.26 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.762 HD13 ' HB3' ' A' ' 302' ' ' GLU . 28.6 mt -59.72 -174.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' THR . . . . . 0.47 HG23 ' OE2' ' A' ' 302' ' ' GLU . 22.2 p -87.27 159.09 18.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.725 HG12 ' ND2' ' A' ' 268' ' ' ASN . 13.5 t -56.35 -30.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -56.05 -46.43 78.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.401 ' HB3' ' OE1' ' A' ' 302' ' ' GLU . 87.4 p -66.39 -45.27 80.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.4 90.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.725 ' ND2' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -58.11 -33.21 68.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.378 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 92.8 m -59.25 -64.3 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.938 . . . . 0.0 109.41 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.572 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.6 mt -60.79 -48.2 82.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.329 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 73.1 tttt -54.47 -38.71 66.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -55.45 -24.63 31.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.652 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.5 mt-10 -92.22 21.12 5.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 34.34 1.44 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 109.604 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 280' ' ' ASP . 85.3 mt -120.73 107.63 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.12 -0.988 . . . . 0.0 109.458 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 58.6 m-70 -108.05 -3.99 18.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.618 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.6 m-85 -113.98 131.05 56.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 252' ' ' ILE . 73.8 mt -59.47 -30.43 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.929 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.32 -47.06 16.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 275' ' ' ILE . 80.4 m-20 -53.5 -33.66 55.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.249 . . . . 0.0 108.997 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.572 HD13 ' CD1' ' A' ' 270' ' ' LEU . 35.0 tp -56.29 -49.28 74.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.134 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.929 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.3 m -66.39 -24.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 108.884 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -65.05 -35.68 81.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 108.969 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -98.36 141.22 31.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.331 -0.856 . . . . 0.0 109.191 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 8.1 m -71.38 140.77 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.531 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.63 ' CD ' HD12 ' A' ' 289' ' ' LEU . 48.4 tp10 -49.98 -29.75 9.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.59 -51.3 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.163 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.36 -34.06 56.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 109.117 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.63 HD12 ' CD ' ' A' ' 286' ' ' GLU . 39.9 mt -63.88 -41.91 97.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.331 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.68 -31.4 72.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 78.0 mttt -85.22 -10.64 56.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.527 ' HB ' HD13 ' A' ' 295' ' ' LEU . 28.8 m -83.87 113.03 44.92 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.963 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.1 Cg_endo -70.66 -18.79 32.5 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.753 2.302 . . . . 0.0 111.851 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' B' ' 464' ' ' ILE . 71.2 m-80 -56.95 -27.16 60.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 295' ' ' LEU . 4.1 mp -92.7 136.48 33.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.23 179.46 40.75 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -62.26 -38.98 91.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -1.125 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.89 -43.49 88.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 25.0 m -59.42 -49.86 76.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 290' ' ' LEU . 23.4 tp -52.88 -44.52 66.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 48.1 m -56.1 -44.42 79.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.414 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 262' ' ' LEU . 95.5 mt-10 -60.5 -43.29 97.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 295' ' ' LEU . 83.9 mt -57.95 -46.97 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -58.77 -39.99 82.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.63 -50.64 73.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.8 t -67.18 -40.17 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.848 HD13 ' HB3' ' A' ' 313' ' ' SER . 18.5 tp -55.26 -27.46 46.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.94 69.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.135 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.7 t -74.02 -14.64 61.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.868 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.505 ' O ' HD21 ' A' ' 314' ' ' LEU . 66.5 mtt-85 63.59 11.5 5.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.45 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.35 -29.57 52.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.762 ' H ' HD23 ' A' ' 312' ' ' LEU . 1.6 pt? -139.74 153.55 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -1.215 . . . . 0.0 109.61 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.848 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.7 OUTLIER 72.21 43.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.7 HD22 ' N ' ' A' ' 314' ' ' LEU . 3.4 mm? -86.73 14.52 6.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.54 36.75 68.5 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.576 ' HE2' HG11 ' A' ' 282' ' ' VAL . 3.4 mtm -90.6 167.81 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.12 . . . . 0.0 109.517 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.636 ' C ' HD12 ' A' ' 318' ' ' LEU . 95.0 mtt180 -142.7 126.02 16.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.85 . . . . 0.0 109.295 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.7 mp -138.99 131.91 29.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.68 -52.81 63.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 321' ' ' TRP . 13.5 t-20 -130.32 36.95 3.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.77 ' HE1' HD21 ' A' ' 253' ' ' LEU . 16.9 t90 44.28 57.13 13.84 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 321' ' ' TRP . 54.7 Cg_endo -99.9 71.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.333 2.688 . . . . 0.0 112.242 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.853 ' CG ' HD12 ' A' ' 326' ' ' ILE . 48.6 Cg_endo -70.18 132.81 23.41 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.288 1.992 . . . . 0.0 111.727 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.0 69.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 249' ' ' PHE . 19.1 m -62.69 -46.1 89.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 323' ' ' PRO . 63.0 mt -63.09 -28.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.69 147.98 51.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.95 -39.24 74.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.512 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 427' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 84.2 m-20 -52.2 -38.8 58.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 73.7 m-20 59.08 50.7 7.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.414 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -82.62 127.03 71.99 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 109.531 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.7 Cg_endo -70.69 136.28 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.662 2.241 . . . . 0.0 111.716 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.82 158.58 21.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.95 -31.56 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.551 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.38 -44.18 79.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.862 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -70.0 -38.91 76.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -66.6 -33.92 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.296 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.84 11.76 23.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.88 HD13 HD11 ' B' ' 456' ' ' LEU . 47.0 tp -77.93 133.02 38.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.63 145.26 50.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.45 -7.31 82.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 1.084 HG13 HD12 ' B' ' 444' ' ' LEU . 73.2 t -111.68 122.47 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -80.59 158.61 25.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -52.18 -54.34 32.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.348 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -66.67 -35.2 79.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 108.937 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.084 HD12 HG13 ' B' ' 440' ' ' VAL . 3.4 tm? -58.95 -42.93 91.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.429 -0.795 . . . . 0.0 109.1 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.63 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -58.87 -48.19 82.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 109.025 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -53.38 -41.35 65.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.438 ' HB3' HD13 ' B' ' 470' ' ' ILE . 19.2 mttt -60.05 -38.04 81.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.849 . . . . 0.0 109.211 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 459' ' ' LEU . 65.1 mt -64.99 -37.87 89.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.11 -36.79 6.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.534 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.2 mtp-105 -91.14 23.25 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.585 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 452' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.69 -18.88 6.67 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.888 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.7 t -78.14 111.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.895 -1.356 . . . . 0.0 109.325 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' B' ' 430' ' ' PRO . 12.0 m -126.84 -40.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.712 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.722 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -77.93 140.86 39.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.734 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.92 HD11 HD12 ' B' ' 488' ' ' ILE . 0.2 OUTLIER -46.79 -43.78 18.61 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 108.963 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.43 -40.5 82.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.591 ' HB3' HG13 ' B' ' 453' ' ' VAL . 92.1 m-20 -59.03 -40.79 86.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 448' ' ' LEU . 16.9 tp -64.4 -37.84 88.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 109.446 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.14 77.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.07 -28.0 61.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.888 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -68.64 148.4 50.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -104.43 154.92 17.51 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.963 HD11 ' HG2' ' A' ' 293' ' ' PRO . 22.2 mt -45.3 -36.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.242 . . . . 0.0 109.406 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.28 -39.03 93.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.484 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.409 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 79.6 m-20 -67.32 -28.47 68.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.745 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.3 mp -79.6 -25.18 41.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.96 -22.55 66.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.367 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -53.37 -32.47 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' B' ' 447' ' ' LYS . 76.9 mt -101.1 124.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -54.52 -42.88 71.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.1 -27.45 30.85 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.837 HD21 HD21 ' B' ' 444' ' ' LEU . 32.9 mt -95.87 125.94 40.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 164.1 11.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.13 -38.45 76.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -75.21 -45.9 37.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.742 ' O ' HD13 ' B' ' 481' ' ' LEU . 45.2 tttt -60.77 -44.89 96.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.379 -0.825 . . . . 0.0 109.426 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.38 -41.19 98.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -62.08 -46.91 93.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.55 74.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -1.124 . . . . 0.0 109.618 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.877 ' HB3' HD21 ' B' ' 459' ' ' LEU . 6.8 mp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.657 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.962 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.9 mt -58.07 -56.24 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.66 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 52.3 mtp -52.93 -38.54 62.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 109.536 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.16 -47.75 64.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -64.81 -44.14 90.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.462 ' NH2' ' CZ2' ' B' ' 490' ' ' TRP . 51.5 ttt85 -58.86 -46.06 88.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 88.4 m-20 -59.62 -41.18 89.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.92 HD12 HD11 ' B' ' 456' ' ' LEU . 79.5 mt -63.84 -37.01 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.84 -49.78 17.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.693 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 490' ' ' TRP . . . . . 0.462 ' CZ2' ' NH2' ' B' ' 486' ' ' ARG . 77.7 m95 -68.63 -40.89 80.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 97.9 m-85 -95.88 4.01 53.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 492' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . -63.02 -27.08 69.83 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -55.21 -36.66 66.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -1.14 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.96 143.33 38.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.489 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.773 ' CE2' HD12 ' A' ' 253' ' ' LEU . 41.2 t80 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.461 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.5 OUTLIER -53.93 116.58 10.51 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.236 -0.915 . . . . 0.0 109.242 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.727 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.7 Cg_endo -65.03 -24.47 59.94 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.669 2.246 . . . . 0.0 111.671 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 312' ' ' LEU . 15.2 tt -68.02 -30.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 108.928 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.881 HD21 ' O ' ' A' ' 311' ' ' GLY . 34.5 mt -74.73 -45.35 44.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.6 mt -62.75 -25.52 68.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 251' ' ' PRO . 0.6 OUTLIER -58.0 140.7 82.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 108.889 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.4 Cg_endo -69.06 129.72 18.87 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.587 2.191 . . . . 0.0 111.977 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.688 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.76 -29.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.351 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.437 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 96.8 m-20 -64.44 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.249 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 256' ' ' PRO . 56.4 t0 -70.0 -17.4 63.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -43.78 129.14 5.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.417 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.34 -22.4 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.481 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 262' ' ' LEU . 5.5 mp -61.01 172.82 0.9 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.0 p -66.05 168.15 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.673 HG12 ' ND2' ' A' ' 268' ' ' ASN . 30.4 t -61.99 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.603 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -41.09 97.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.213 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.2 m -59.97 -49.7 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -67.55 -40.55 84.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.673 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.0 m-20 -57.17 -36.94 71.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 294' ' ' ASN . 74.3 m -54.17 -65.04 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 289' ' ' LEU . 64.5 mt -64.4 -45.13 88.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.406 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.515 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 34.3 tttt -53.03 -37.75 61.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.53 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.55 19.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 93.8 mt-10 -91.41 21.61 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.82 34.3 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.7 mt -120.42 107.87 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.515 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 76.5 m-70 -105.14 -12.19 16.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.65 135.35 50.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 1.034 HG21 HD23 ' A' ' 312' ' ' LEU . 34.1 mt -62.9 -29.85 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.911 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.84 -43.1 11.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 77.0 m-20 -53.9 -36.41 62.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.261 . . . . 0.0 108.818 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 289' ' ' LEU . 33.1 tp -55.79 -47.94 76.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.82 . . . . 0.0 109.096 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 279' ' ' GLY . 20.4 m -69.47 -25.53 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.49 -31.52 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 108.899 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -113.12 151.21 31.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.46 -0.775 . . . . 0.0 109.152 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 287' ' ' VAL . 26.7 m -63.78 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 289' ' ' LEU . 86.4 tt0 -56.06 -33.11 64.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.737 ' HA ' HD12 ' A' ' 290' ' ' LEU . 47.5 t -52.78 -50.68 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.905 . . . . 0.0 109.356 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -51.8 -32.7 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.046 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.694 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.4 mm? -73.97 -46.48 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.803 . . . . 0.0 109.173 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 287' ' ' VAL . 7.8 mt -55.69 -20.07 13.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.271 -0.893 . . . . 0.0 109.067 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.576 ' O ' ' HE2' ' B' ' 483' ' ' MET . 54.4 mttm -81.71 -29.85 32.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.177 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 294' ' ' ASN . 40.3 m -59.87 125.66 81.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.67 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.4 Cg_endo -71.09 -19.84 29.41 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.676 2.251 . . . . 0.0 111.807 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' B' ' 464' ' ' ILE . 77.2 m-20 -64.45 -26.87 68.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 5.8 mt -67.21 144.82 55.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -101.25 146.92 17.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -54.03 -40.39 67.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -76.51 -29.96 56.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 71.2 p -64.36 -45.39 87.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 290' ' ' LEU . 53.6 tp -52.91 -45.19 67.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.1 m -51.66 -54.48 27.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 262' ' ' LEU . 94.0 mt-10 -54.74 -46.25 74.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.27 -41.78 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.157 -0.964 . . . . 0.0 109.169 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -57.36 -40.18 77.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.159 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.11 -46.49 87.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.227 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -73.05 -35.15 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.205 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.958 HD21 ' OG ' ' A' ' 313' ' ' SER . 3.3 tt -62.37 -26.5 68.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.507 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.36 -35.31 71.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.389 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 1.7 t -61.94 -14.38 34.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 309' ' ' SER . 31.6 mtt180 72.91 1.42 4.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.881 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -71.49 -22.14 78.64 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.034 HD23 HG21 ' A' ' 278' ' ' ILE . 0.8 OUTLIER -132.09 156.44 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 109.487 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.958 ' OG ' HD21 ' A' ' 307' ' ' LEU . 2.3 p 84.56 -141.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.732 -0.605 . . . . 0.0 109.793 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.778 HD22 ' OG ' ' A' ' 313' ' ' SER . 3.9 mm? 67.66 14.48 9.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 314' ' ' LEU . . . 42.22 45.04 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.728 ' HE2' HG11 ' A' ' 282' ' ' VAL . 29.5 mtm -61.67 169.01 2.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.327 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.775 ' C ' HD12 ' A' ' 318' ' ' LEU . 79.9 mtt180 -136.88 130.99 32.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.576 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.775 HD12 ' C ' ' A' ' 317' ' ' ARG . 5.1 mp -136.29 127.69 28.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 318' ' ' LEU . 96.1 mt-10 -43.91 -46.66 8.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.88 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 34.1 t30 -131.3 -56.35 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.241 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.635 ' HE3' HD22 ' A' ' 318' ' ' LEU . 1.6 t-105 164.8 -61.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 47.5 Cg_endo -67.51 107.75 1.48 Allowed 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.71 2.273 . . . . 0.0 111.98 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.0 Cg_endo -74.19 163.91 35.45 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.492 2.128 . . . . 0.0 111.579 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.78 -16.53 11.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 0.0 109.615 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.2 t -65.14 -46.71 79.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.506 HD11 HD21 ' A' ' 254' ' ' LEU . 28.5 mt -56.39 -38.29 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.7 78.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.18 -37.56 69.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.467 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.94 -32.62 73.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -1.145 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 16.1 m120 -89.47 19.0 4.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 2.3 tttm -83.66 136.57 42.07 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.285 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.478 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.2 Cg_endo -69.7 131.73 21.94 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 111.84 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.7 148.13 52.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.55 -33.78 15.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.69 -46.61 75.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' B' ' 448' ' ' LEU . 22.4 tp -69.86 -38.38 76.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.984 ' O ' HD13 ' B' ' 435' ' ' LEU . 1.4 tm? -72.78 -30.3 64.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -91.22 8.68 34.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 1.004 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.4 tp -72.94 138.75 46.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.69 138.01 36.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.29 5.37 63.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.893 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -122.92 132.66 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -1.16 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -86.85 150.32 24.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -49.83 -45.45 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.586 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.4 m-20 -64.75 -46.07 83.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 109.231 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.1 tp -53.9 -43.32 69.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.58 90.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.7 m-30 -56.84 -44.4 82.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 109.103 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.902 ' HB3' HG21 ' B' ' 470' ' ' ILE . 20.3 mttm -60.83 -40.39 92.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.49 ' CD1' HD11 ' B' ' 434' ' ' LEU . 89.0 mt -60.25 -47.02 87.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.376 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -60.94 -34.51 74.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.481 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -48.13 -35.4 11.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.652 ' HG3' HD11 ' B' ' 470' ' ' ILE . 47.2 mtp180 -91.11 22.93 3.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 452' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.79 -18.74 7.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.73 HG13 ' HB3' ' B' ' 458' ' ' ASP . 21.4 t -78.12 108.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.899 -1.354 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.482 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 95.3 m -119.84 -42.56 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.758 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.619 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -74.91 140.8 44.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 1.004 ' CD1' HD22 ' B' ' 437' ' ' LEU . 27.0 tp -49.97 -41.61 47.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.293 -0.88 . . . . 0.0 109.036 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 457' ' ' GLU . . . . . 0.402 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 31.7 mm-40 -57.32 -46.22 83.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 108.953 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.73 ' HB3' HG13 ' B' ' 453' ' ' VAL . 70.6 m-20 -58.24 -38.73 77.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.101 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.761 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -62.35 -42.85 99.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.18 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -60.42 -35.79 76.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.47 -30.81 71.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.493 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -67.38 156.29 36.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.12 161.46 13.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 294' ' ' ASN . 68.1 mt -52.75 -35.65 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -1.184 . . . . 0.0 109.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.12 -33.81 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.17 -31.47 65.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.033 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.1 mt -77.15 -33.89 56.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.81 55.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.98 -39.09 93.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.902 HG21 ' HB3' ' B' ' 447' ' ' LYS . 88.1 mt -82.54 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.47 152.65 29.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.576 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.52 -33.49 4.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' B' ' 444' ' ' LEU . 66.9 mt -85.99 126.6 34.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 475' ' ' ASP . 35.4 m -103.64 161.98 13.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.493 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 87.8 m-20 -59.55 -36.03 75.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -76.03 -46.04 31.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.448 ' CE ' HD22 ' B' ' 444' ' ' LEU . 34.4 tttp -65.1 -47.58 76.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.033 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -57.83 -44.51 86.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -59.31 -47.67 89.7 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.29 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.48 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.555 HD22 ' CG2' ' B' ' 440' ' ' VAL . 28.0 mt -61.64 -36.47 80.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.9 mt -62.52 -53.64 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.576 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 33.9 mtp -54.24 -48.92 70.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -52.67 -56.16 17.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -60.19 -49.35 77.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 109.572 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.565 ' CG ' ' HB1' ' B' ' 460' ' ' ALA . 90.3 mtt180 -59.63 -42.05 91.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.492 ' O ' ' CD1' ' B' ' 491' ' ' PHE . 99.5 m-20 -58.36 -42.75 87.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.962 HD12 ' CD2' ' B' ' 456' ' ' LEU . 38.3 mt -64.34 -38.32 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 489' ' ' CYS . . . . . 0.402 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.0 OUTLIER -75.96 -51.92 11.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -63.22 -28.01 69.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 109.42 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' B' ' 487' ' ' ASN . 3.6 m-30 -72.23 -34.36 68.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -53.82 -34.58 51.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -56.29 -40.05 73.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -1.157 . . . . 0.0 109.569 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.37 -32.51 72.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.549 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.6 ' N ' ' HG ' ' A' ' 325' ' ' SER . 14.3 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.47 126.74 56.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.382 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.776 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -65.25 -27.49 56.03 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.674 2.25 . . . . 0.0 111.601 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 312' ' ' LEU . 8.3 tt -69.07 -28.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.638 HD13 HG21 ' A' ' 282' ' ' VAL . 26.2 mt -74.54 -43.42 55.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.421 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.776 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.7 mt -64.18 -32.31 73.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 278' ' ' ILE . 5.7 ttp180 -55.82 135.89 72.46 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.6 Cg_endo -68.58 129.79 19.57 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.641 2.227 . . . . 0.0 111.842 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.818 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -44.69 -25.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.35 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 256' ' ' PRO . 97.8 m-20 -67.18 -30.88 70.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 256' ' ' PRO . 37.0 m-20 -75.36 -9.72 58.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 257' ' ' VAL . 4.5 mp -43.77 127.18 4.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 262' ' ' LEU . 97.0 mt-10 -62.63 -27.84 69.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.758 HD13 ' HG2' ' A' ' 302' ' ' GLU . 18.8 mt -54.41 -170.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.457 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -80.41 159.72 25.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.59 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.5 t -53.43 -30.58 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -52.37 -45.53 65.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.4 m -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.87 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.92 87.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.59 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.4 m-20 -59.79 -34.29 72.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -58.29 -64.0 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.45 -45.4 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -52.9 -40.38 63.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.11 -25.05 66.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.4 mm-40 -88.51 17.42 5.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.63 33.32 2.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.769 HG23 ' HB2' ' A' ' 280' ' ' ASP . 79.0 mt -108.59 127.05 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.5 p80 -112.23 -35.02 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.57 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.503 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.1 m-30 -110.07 128.8 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.687 HD11 HD11 ' A' ' 260' ' ' LEU . 76.6 mt -46.45 -29.92 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.836 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.82 -47.15 13.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.769 ' HB2' HG23 ' A' ' 275' ' ' ILE . 54.0 m-20 -53.36 -30.87 41.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.235 . . . . 0.0 108.798 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 289' ' ' LEU . 41.8 tp -59.74 -49.71 76.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.468 -0.77 . . . . 0.0 109.273 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 279' ' ' GLY . 27.3 m -65.71 -29.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.152 -0.967 . . . . 0.0 108.866 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -60.9 -33.99 73.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.371 -0.831 . . . . 0.0 108.961 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 56.1 mtt180 -100.12 143.33 30.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.299 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.3 m -69.03 143.53 54.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -54.29 -28.3 41.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.333 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 43.1 t -52.83 -50.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.304 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.2 mt-10 -52.19 -33.29 40.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 281' ' ' LEU . 60.8 mt -70.88 -30.61 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.64 -31.69 67.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.8 -14.3 56.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.02 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 77.0 m -81.76 115.88 59.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 1.007 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.5 Cg_endo -70.62 -16.91 33.96 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.698 2.265 . . . . 0.0 111.773 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.772 ' ND2' HD12 ' B' ' 464' ' ' ILE . 27.0 m120 -47.21 -33.13 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.507 ' H ' HD23 ' A' ' 295' ' ' LEU . 0.4 OUTLIER -107.26 137.12 45.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.441 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -81.58 172.06 53.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -57.75 -41.97 83.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.408 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -63.46 -35.97 82.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.932 . . . . 0.0 109.298 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 28.2 m -58.3 -37.42 75.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 28.7 tp -53.97 -33.54 57.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 109.292 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.3 m -60.93 -57.46 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.758 ' HG2' HD13 ' A' ' 262' ' ' LEU . 42.8 tt0 -53.57 -46.12 70.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 108.996 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 56.2 mt -57.74 -50.73 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -56.11 -38.73 71.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 108.761 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 302' ' ' GLU . 64.4 m-20 -53.85 -45.66 71.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 1.037 HG12 ' CD2' ' A' ' 312' ' ' LEU . 4.5 t -66.86 -40.81 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 108.865 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 313' ' ' SER . 21.3 mt -53.83 -25.65 20.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.441 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.9 63.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 108.983 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 p -71.4 -9.09 57.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.203 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.685 ' HA ' HD11 ' A' ' 314' ' ' LEU . 55.6 mtm180 53.01 19.35 1.34 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -107.96 0.22 33.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.037 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -147.23 145.87 29.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -1.231 . . . . 0.0 109.644 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.5 OUTLIER 58.13 46.69 15.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.398 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.685 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -90.46 23.95 2.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.2 39.3 95.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.748 ' HE2' HG11 ' A' ' 282' ' ' VAL . 1.3 mtm -93.63 170.95 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.108 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.453 ' C ' HD23 ' A' ' 318' ' ' LEU . 67.4 mtm-85 -136.15 117.05 14.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 317' ' ' ARG . 4.5 mt -112.47 139.81 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.354 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.88 -35.37 79.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.256 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.8 m-20 -140.46 -47.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 109.157 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.604 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.52 -62.83 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -67.87 107.04 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.549 2.166 . . . . 0.0 111.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.6 Cg_endo -69.65 165.18 31.71 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.665 2.243 . . . . 0.0 111.85 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.93 -15.72 56.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 97.0 p -85.82 -26.27 25.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.211 -0.93 . . . . 0.0 109.454 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 323' ' ' PRO . 16.3 tt -57.22 -23.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.37 140.61 55.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -59.79 -37.98 80.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.437 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -57.08 -39.95 75.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.718 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 25.6 m120 -83.95 8.04 16.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 4.5 tttm -53.98 131.94 58.61 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.459 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.6 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.9 Cg_endo -70.3 144.42 51.09 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.627 2.218 . . . . 0.0 111.833 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -79.45 161.06 26.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.453 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 432' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' B' ' 436' ' ' ASN . 85.9 m-20 -52.09 -37.55 54.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 433' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' B' ' 456' ' ' LEU . 16.7 m-20 -61.08 -50.12 74.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' B' ' 430' ' ' PRO . 23.2 tp -68.91 -38.07 79.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.703 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.971 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.1 tm? -77.04 -29.6 55.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.563 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 436' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 432' ' ' ASP . 78.9 m-20 -93.77 10.87 31.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.487 HD23 HG21 ' B' ' 440' ' ' VAL . 29.1 tp -75.53 133.22 41.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.57 143.29 48.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.6 -4.76 82.35 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.714 ' CG2' HD22 ' B' ' 481' ' ' LEU . 49.6 t -126.56 135.77 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -1.182 . . . . 0.0 109.419 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' HD12 ' B' ' 444' ' ' LEU . 49.6 p30 -103.41 175.08 5.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.534 ' HG2' HD21 ' B' ' 435' ' ' LEU . 64.4 mtm180 -61.61 -38.19 86.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.18 -41.06 99.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.513 HD13 ' HZ1' ' B' ' 477' ' ' LYS . 21.9 mt -72.23 -39.74 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.21 -35.82 78.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.873 . . . . 0.0 109.439 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 15.2 m-30 -73.08 -46.07 53.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.505 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.521 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 17.5 ttmt -61.65 -44.14 97.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.867 HD11 HG21 ' B' ' 453' ' ' VAL . 2.9 tm? -65.62 -45.45 83.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.93 -31.36 62.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.564 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.39 -20.55 4.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.593 ' CG ' HD11 ' B' ' 470' ' ' ILE . 11.4 mtp-105 -89.62 32.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.88 -18.72 7.17 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.867 HG21 HD11 ' B' ' 448' ' ' LEU . 48.0 t -61.71 137.1 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.815 -1.403 . . . . 0.0 109.318 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' B' ' 431' ' ' ALA . 1.0 OUTLIER -133.17 -34.63 1.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.783 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.572 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.4 OUTLIER -116.93 144.0 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 109.972 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.816 HD11 ' HA ' ' B' ' 485' ' ' ALA . 1.4 tm? -45.47 -39.43 7.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 108.889 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 457' ' ' GLU . . . . . 0.422 ' N ' HD13 ' B' ' 456' ' ' LEU . 44.8 mm-40 -55.68 -49.43 72.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.882 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -55.13 -41.66 72.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.855 . . . . 0.0 108.946 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.597 HD13 ' CD1' ' B' ' 434' ' ' LEU . 4.0 tt -55.86 -48.46 75.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.317 -0.864 . . . . 0.0 109.278 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.871 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -57.38 -33.09 67.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.313 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.365 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.75 160.94 28.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -116.94 152.87 17.67 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.938 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.8 mt -44.93 -42.49 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -1.172 . . . . 0.0 109.343 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.05 -39.78 83.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.343 -0.848 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.79 -29.06 66.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.026 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.8 mt -78.4 -28.25 46.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.6 -25.57 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.05 -31.28 18.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.593 HD11 ' CG ' ' B' ' 451' ' ' ARG . 60.0 mt -103.79 121.83 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.569 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.37 -32.55 72.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.78 -26.48 25.59 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.451 ' CD1' HD23 ' B' ' 448' ' ' LEU . 64.0 mt -108.82 139.26 43.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -1.122 . . . . 0.0 109.523 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.493 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.7 m -103.7 164.66 11.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.493 ' N ' HG22 ' B' ' 474' ' ' THR . 81.6 m-20 -60.49 -37.15 80.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.415 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -75.47 -46.02 35.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.513 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 64.4 tttm -63.92 -40.5 96.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.445 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.026 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.91 -39.83 94.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -63.16 -42.36 99.46 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.09 85.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.573 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.714 HD22 ' CG2' ' B' ' 440' ' ' VAL . 29.2 mt -67.16 -38.63 85.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 293' ' ' PRO . 26.3 mt -65.4 -56.02 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.4 mtp -52.36 -36.77 54.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.386 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.66 -44.53 64.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.871 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -62.86 -52.02 64.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.08 -41.74 84.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.387 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.2 m-20 -57.46 -35.88 70.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.227 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.449 HG13 ' O ' ' B' ' 484' ' ' ALA . 88.1 mt -70.88 -36.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.254 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 11.3 t -74.63 -51.69 13.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.755 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -61.73 -30.7 70.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 19.5 m-30 -82.95 -34.27 26.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.072 -1.017 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 55.58 -124.45 33.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -45.38 -47.67 13.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.253 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 494' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' B' ' 491' ' ' PHE . 81.3 tt0 -66.63 141.44 57.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 109.395 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.396 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 253' ' ' LEU . 23.4 t80 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.553 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.427 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -55.17 142.81 56.89 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.601 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.506 ' HB2' ' NH2' ' A' ' 255' ' ' ARG . 43.5 Cg_endo -65.46 -22.97 58.54 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.807 2.338 . . . . 0.0 111.654 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.533 HG21 ' CA ' ' A' ' 311' ' ' GLY . 10.3 tt -70.01 -28.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.88 . . . . 0.0 108.927 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -69.23 -38.5 78.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 253' ' ' LEU . 3.8 mm? -86.04 -24.0 26.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.365 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 4.8 ttm-85 -64.03 145.02 98.15 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.454 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 48.8 Cg_endo -70.01 136.72 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.728 2.285 . . . . 0.0 111.837 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.9 HG11 HD12 ' A' ' 270' ' ' LEU . 0.1 OUTLIER -45.74 -33.38 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.0 109.522 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.473 ' OD1' ' HB1' ' A' ' 267' ' ' ALA . 95.1 m-20 -62.51 -30.83 71.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.524 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 25.5 m-20 -68.24 -9.61 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 278' ' ' ILE . 51.2 mt -66.18 139.38 58.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 262' ' ' LEU . 74.8 mm-40 -69.38 -20.23 63.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.497 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.816 HD22 ' CG ' ' A' ' 302' ' ' GLU . 26.2 mt -52.46 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 p -80.69 160.15 25.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.558 HG12 ' OD1' ' A' ' 268' ' ' ASN . 21.2 t -55.21 -27.64 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -51.97 -48.0 64.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.0 m -58.97 -50.97 72.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.339 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.473 ' HB1' ' OD1' ' A' ' 258' ' ' ASP . . . -65.32 -33.27 75.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.558 ' OD1' HG12 ' A' ' 264' ' ' VAL . 95.5 m-20 -61.38 -37.73 84.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.38 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.8 m -53.24 -64.55 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.9 HD12 HG11 ' A' ' 257' ' ' VAL . 57.7 mt -66.51 -45.24 80.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 21.4 tptm -53.19 -40.06 64.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.12 -21.42 65.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.6 mt-10 -94.14 23.36 5.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.61 17.62 7.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 56.2 mt -104.81 122.98 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.468 ' ND1' ' HD2' ' A' ' 271' ' ' LYS . 92.2 m-70 -113.09 -12.87 13.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 254' ' ' LEU . 4.5 m-85 -112.84 141.4 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 312' ' ' LEU . 74.3 mt -65.1 -28.97 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.444 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.26 -47.5 10.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 67.8 m-20 -53.35 -32.96 51.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.99 -1.3 . . . . 0.0 108.893 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 270' ' ' LEU . 26.7 tp -55.65 -50.73 69.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.183 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 279' ' ' GLY . 28.2 m -66.77 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 108.787 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -54.92 -35.42 64.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 0.0 108.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -107.58 144.07 35.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.076 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 45.6 p -76.23 157.15 32.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 307' ' ' LEU . 10.0 mt-10 -56.16 -38.63 71.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.297 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.927 ' HA ' HD12 ' A' ' 290' ' ' LEU . 41.2 t -52.88 -52.78 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.283 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.55 -32.3 58.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 292' ' ' THR . 7.6 mp -80.42 -33.08 37.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 287' ' ' VAL . 4.9 mt -69.66 -17.12 63.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.958 . . . . 0.0 109.353 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' B' ' 483' ' ' MET . 33.8 mmtt -86.48 10.95 13.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 0.0 109.482 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.87 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.3 t -125.82 142.72 43.0 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.918 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.9 Cg_endo -71.35 -20.71 27.43 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.796 2.33 . . . . 0.0 111.941 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' B' ' 464' ' ' ILE . 87.1 m-20 -43.3 -44.14 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.634 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 292' ' ' THR . 0.2 OUTLIER -107.64 137.07 46.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.499 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -91.73 -179.16 42.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.35 -44.19 95.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -1.204 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -60.85 -42.57 98.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.4 m -54.9 -46.32 74.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.31 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.827 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.3 tm? -52.68 -45.11 66.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.241 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 23.9 m -50.84 -51.54 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.091 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.816 ' CG ' HD22 ' A' ' 262' ' ' LEU . 38.6 tp10 -54.19 -42.33 69.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 23.7 mm -57.95 -41.15 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -0.867 . . . . 0.0 108.892 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LYS . . . . . 0.769 ' HE3' HD12 ' A' ' 300' ' ' LEU . 82.9 mttt -59.43 -40.53 87.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.327 -0.858 . . . . 0.0 108.872 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.18 -46.97 87.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.662 ' CG1' HD11 ' A' ' 312' ' ' LEU . 6.0 t -70.14 -37.4 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.109 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 286' ' ' GLU . 19.9 tp -61.38 -27.3 68.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.34 76.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -79.21 -0.22 31.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.792 ' HA ' HD11 ' A' ' 314' ' ' LEU . 64.4 mtt180 63.24 11.04 5.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.182 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.533 ' CA ' HG21 ' A' ' 252' ' ' ILE . . . -64.75 -51.1 54.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 278' ' ' ILE . 0.5 OUTLIER -144.41 168.53 19.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -1.156 . . . . 0.0 109.566 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.576 ' O ' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 72.4 32.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.3 mm? -75.85 -4.9 43.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.51 41.24 96.34 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -111.54 157.96 19.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -1.139 . . . . 0.0 109.638 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -115.19 133.45 56.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 109.223 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.18 140.76 40.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -58.28 -38.51 77.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 40.7 t-20 -132.96 -73.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.404 -0.81 . . . . 0.0 109.001 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.553 ' N ' ' CD ' ' A' ' 322' ' ' PRO . 1.5 t90 175.78 -45.07 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.583 ' HA ' HD12 ' A' ' 326' ' ' ILE . 52.9 Cg_endo -97.73 74.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 123.473 2.782 . . . . 0.0 112.601 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.21 165.15 29.56 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.499 2.132 . . . . 0.0 111.615 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -44.82 -26.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.5 m -67.97 -61.01 2.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.651 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.842 HD11 HD21 ' A' ' 253' ' ' LEU . 9.5 mt -52.35 -30.27 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -74.39 145.26 43.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.591 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.68 -37.8 88.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLU . . . . . 0.413 ' HG2' ' OXT' ' A' ' 329' ' ' GLU . 84.7 tt0 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 427' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 86.4 m-20 -53.05 -37.77 61.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.171 . . . . 0.0 109.479 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 76.9 m-20 60.41 46.43 9.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.362 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 136.08 59.37 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 51.5 Cg_endo -70.58 133.24 23.63 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.674 2.25 . . . . 0.0 111.772 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.08 153.83 41.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.17 -35.34 59.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.53 -47.75 74.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.87 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.676 ' CD1' HD23 ' B' ' 448' ' ' LEU . 21.4 tp -66.35 -38.31 87.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 109.45 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.774 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -70.57 -32.46 69.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.403 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -88.65 7.31 34.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 440' ' ' VAL . 40.3 tp -72.3 134.83 45.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -80.74 141.77 34.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.51 68.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.865 HG21 HD23 ' B' ' 437' ' ' LEU . 87.6 t -122.84 126.98 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 109.399 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.52 154.3 23.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.432 ' NH1' HD11 ' B' ' 435' ' ' LEU . 68.6 mtp85 -50.26 -48.87 54.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.2 m-20 -61.91 -44.48 96.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.06 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.3 tp -55.65 -44.45 77.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.395 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.75 87.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 13.0 m-30 -58.98 -43.06 91.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.357 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.67 -40.71 93.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.676 HD23 ' CD1' ' B' ' 434' ' ' LEU . 19.7 tp -60.99 -47.28 87.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.93 -31.5 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.97 -33.81 57.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.605 ' HG3' HD11 ' B' ' 470' ' ' ILE . 33.5 mtm105 -90.32 22.06 3.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.432 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.87 6.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' B' ' 458' ' ' ASP . 3.0 t -76.87 111.49 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.915 -1.344 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 29.5 m -121.51 -35.44 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.433 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -87.5 142.63 27.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.996 HD21 HD12 ' B' ' 488' ' ' ILE . 35.3 tp -48.71 -42.06 33.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.173 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.94 -45.79 78.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.142 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.804 ' HB3' HG13 ' B' ' 453' ' ' VAL . 93.6 m-20 -57.77 -41.69 82.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.887 . . . . 0.0 109.078 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.748 HD13 ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -59.23 -41.4 88.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 109.278 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -62.09 -37.15 83.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.83 -25.86 67.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.725 ' HG3' HG21 ' B' ' 453' ' ' VAL . 88.1 mm-40 -78.36 138.92 38.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -97.85 165.38 22.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 293' ' ' PRO . 68.1 mt -48.04 -36.29 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.425 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -65.55 -38.65 90.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.256 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.73 -31.69 72.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.94 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -78.14 -26.84 48.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.6 66.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -52.85 -33.12 48.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.605 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.8 mt -104.67 128.58 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.08 -33.47 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.495 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.35 -27.33 46.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.06 ' CD2' HD11 ' B' ' 444' ' ' LEU . 35.1 mt -102.62 134.32 46.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.9 m -104.2 161.93 13.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.95 -36.35 76.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -76.94 -46.02 25.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.47 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 38.9 tttp -66.33 -40.2 89.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.3 -42.47 93.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.0 -45.11 96.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.14 90.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -1.186 . . . . 0.0 109.659 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -65.83 -39.93 91.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 88.7 mt -61.88 -56.14 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.516 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 67.1 mmm -54.06 -43.23 70.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.44 62.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.2 90.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.377 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.578 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 63.1 mtp180 -59.48 -43.82 93.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 94.2 m-20 -58.28 -43.44 87.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.996 HD12 HD21 ' B' ' 456' ' ' LEU . 68.7 mt -60.25 -37.47 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.0 m -78.8 -51.98 8.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -59.71 -45.95 90.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 51.6 m-85 -76.2 -39.68 54.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.606 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 492' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 495' ' ' ALA . . . 72.41 36.1 59.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -56.56 -35.09 67.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -1.168 . . . . 0.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.35 -33.58 73.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 495' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' B' ' 492' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.497 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.572 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 91.8 m-85 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.12 154.84 76.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.43 -24.72 56.63 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.672 2.248 . . . . 0.0 111.698 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -64.9 -30.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.934 . . . . 0.0 108.525 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.524 ' CD1' HG11 ' A' ' 282' ' ' VAL . 2.0 tp -72.8 -27.27 61.88 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.899 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.9 mt -90.93 -24.57 20.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.4 mtt85 -55.95 149.54 33.35 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 257' ' ' VAL . 50.1 Cg_endo -70.18 130.34 18.66 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.604 2.203 . . . . 0.0 111.665 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.66 -26.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.479 ' HA ' ' HZ1' ' A' ' 271' ' ' LYS . 55.2 t0 -63.21 -31.0 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.427 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' PRO . 83.1 m-20 -72.76 -12.47 61.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.674 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -46.22 137.44 6.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.52 -16.08 63.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 262' ' ' LEU . 4.6 mp -64.16 170.45 3.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.7 p -71.58 164.07 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 268' ' ' ASN . 11.5 t -51.31 -31.12 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -57.32 -45.05 84.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.038 . . . . 0.0 109.299 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.581 ' OG ' HD22 ' A' ' 262' ' ' LEU . 18.7 t -59.94 -50.06 75.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.592 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.72 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -64.59 -44.25 91.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.364 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.669 HD21 HG12 ' A' ' 264' ' ' VAL . 86.6 m-20 -53.54 -32.63 51.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.74 ' SG ' HD23 ' A' ' 295' ' ' LEU . 28.5 t -63.49 -57.22 10.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.672 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.6 mm? -66.4 -48.15 70.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.72 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 42.7 mttt -55.61 -37.53 68.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.93 -28.79 53.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 67.8 mm-40 -88.92 23.52 2.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.36 40.47 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.92 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.5 mt -116.34 125.63 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.596 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.1 p80 -115.89 -29.72 6.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.596 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.5 m-85 -111.36 131.68 54.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.531 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 252' ' ' ILE . 78.5 mt -46.97 -32.15 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.268 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.884 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.08 -47.88 14.93 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.92 ' HB2' HG23 ' A' ' 275' ' ' ILE . 90.1 m-20 -53.49 -34.29 57.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.901 -1.352 . . . . 0.0 108.878 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 289' ' ' LEU . 40.0 tp -52.97 -50.86 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.417 -0.802 . . . . 0.0 109.022 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.5 m -65.98 -30.05 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 108.772 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 49.6 tt0 -54.32 -37.6 65.02 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.402 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 58.6 mtt-85 -105.8 141.38 37.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.476 -0.765 . . . . 0.0 109.066 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -65.22 141.69 58.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -53.99 -23.93 14.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.781 ' HA ' HD12 ' A' ' 290' ' ' LEU . 50.2 t -52.73 -51.02 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 109.103 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.5 mt-10 -51.9 -37.28 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.133 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 281' ' ' LEU . 61.5 mt -61.66 -45.11 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.117 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 287' ' ' VAL . 6.1 mt -60.65 -29.11 69.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.524 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 62.8 mttm -82.02 -20.93 37.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 116.33 60.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.374 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.983 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.5 Cg_endo -70.6 -9.16 25.23 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.715 2.277 . . . . 0.0 111.821 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.523 ' OD1' HD12 ' B' ' 464' ' ' ILE . 80.0 m-20 -60.77 -37.38 81.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.74 HD23 ' SG ' ' A' ' 269' ' ' CYS . 1.3 pp -100.18 137.5 38.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -0.955 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -86.71 168.71 39.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -64.7 -36.74 85.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.7 -42.16 83.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 303' ' ' ILE . 85.1 p -63.07 -34.09 76.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.2 tp -56.76 -33.41 66.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.1 m -61.49 -52.12 65.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.424 ' CD ' ' HG ' ' A' ' 262' ' ' LEU . 80.9 tt0 -62.91 -46.3 88.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.335 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.492 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 62.7 mt -57.74 -46.99 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 108.844 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.51 -40.54 65.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.07 -44.66 87.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.822 . . . . 0.0 108.811 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.821 ' CG1' HD22 ' A' ' 312' ' ' LEU . 6.3 t -63.91 -34.98 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.287 -0.883 . . . . 0.0 108.925 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 303' ' ' ILE . 8.4 mp -60.17 -25.99 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 109.238 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.65 68.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -60.97 -14.62 24.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.67 ' HA ' HD11 ' A' ' 314' ' ' LEU . 24.2 ttm180 70.03 4.81 4.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.716 ' C ' HD12 ' A' ' 312' ' ' LEU . . . -108.11 16.25 35.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.821 HD22 ' CG1' ' A' ' 306' ' ' VAL . 5.3 mp -146.58 138.63 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.629 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.6 OUTLIER 47.13 59.41 4.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.537 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.679 HD21 ' N ' ' A' ' 312' ' ' LEU . 3.7 mm? -91.12 9.88 29.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.04 87.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.519 ' CE ' HG11 ' A' ' 282' ' ' VAL . 7.1 ptt? -114.58 153.51 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -1.2 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -125.08 125.95 44.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.5 mp -103.26 138.66 39.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.83 -35.23 76.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.158 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 39.8 t30 -125.82 -69.29 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.899 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 1.2 t-105 165.63 -62.89 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.1 Cg_endo -67.99 108.26 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.546 2.164 . . . . 0.0 112.021 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.572 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 53.5 Cg_endo -75.16 164.39 33.15 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.608 2.205 . . . . 0.0 111.506 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.9 -10.86 31.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 48.2 m -73.32 -43.78 60.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.673 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 254' ' ' LEU . 25.1 pt -90.91 -6.83 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.65 139.78 58.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -59.25 -37.23 77.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.505 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 426' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -62.22 -31.46 72.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.136 . . . . 0.0 109.463 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.594 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 26.5 m120 -90.13 3.67 52.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.605 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -53.34 128.62 50.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 109.409 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 49.9 Cg_endo -69.88 141.55 45.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.676 2.251 . . . . 0.0 111.902 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -73.51 148.06 43.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.481 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 432' ' ' ASP . . . . . 0.519 ' OD1' ' ND2' ' B' ' 436' ' ' ASN . 52.2 t0 -46.9 -37.28 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.5 -42.82 93.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.857 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.3 tm? -67.24 -30.93 70.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 442' ' ' ARG . 21.7 tp -81.33 -29.63 34.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 109.566 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 436' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' B' ' 432' ' ' ASP . 9.1 m120 -74.87 -3.8 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.634 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.793 HD23 HG21 ' B' ' 440' ' ' VAL . 37.2 tp -68.26 134.53 50.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.73 142.19 42.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.77 8.39 67.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.793 HG21 HD23 ' B' ' 437' ' ' LEU . 43.8 t -127.52 128.49 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.39 158.66 15.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.619 ' HG2' HD11 ' B' ' 435' ' ' LEU . 90.6 mtt-85 -50.22 -48.55 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.33 -51.08 69.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.01 HD11 ' CD1' ' B' ' 473' ' ' LEU . 20.7 tp -55.08 -40.6 70.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.14 -42.73 91.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -60.69 -48.16 83.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.3 -45.84 83.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.851 ' O ' HD13 ' B' ' 448' ' ' LEU . 0.7 OUTLIER -65.21 -42.85 93.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -63.35 -27.91 69.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.16 -20.04 3.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -92.23 30.07 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.64 7.5 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.581 HG13 ' CB ' ' B' ' 458' ' ' ASP . 3.4 t -60.76 135.99 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 0.0 109.386 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 31.1 p -135.24 -35.89 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 109.881 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.6 159.79 17.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 109.877 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.957 HD11 HD12 ' B' ' 488' ' ' ILE . 0.3 OUTLIER -52.25 -43.71 64.5 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.277 -0.89 . . . . 0.0 109.238 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.74 -44.03 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 108.951 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.581 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.0 m-20 -56.81 -43.34 80.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.288 -0.883 . . . . 0.0 108.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' B' ' 448' ' ' LEU . 24.6 tp -56.89 -45.18 82.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.23 72.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.384 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -65.94 -32.28 73.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.564 ' OE1' HG22 ' B' ' 453' ' ' VAL . 2.3 mp0 -62.15 157.6 18.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.28 153.91 17.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.3 mt -50.85 -38.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 109.296 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -70.17 -32.22 70.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.041 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.6 mt -77.19 -29.2 54.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.08 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.59 -33.68 66.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.587 HG22 ' H ' ' B' ' 472' ' ' GLY . 76.3 mt -103.03 129.2 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -62.1 -29.92 70.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.587 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.04 -32.75 50.02 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.01 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.9 mm? -106.13 133.22 51.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.426 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.454 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.3 m -103.62 161.87 13.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.454 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.71 -36.95 75.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -76.31 -45.53 31.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.568 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.715 ' CE ' HD22 ' B' ' 444' ' ' LEU . 25.3 tttp -67.35 -41.24 85.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.041 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.7 -45.18 91.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 109.587 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.65 -42.09 99.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.95 91.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.615 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -65.3 -47.15 77.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.934 HD12 ' HB2' ' A' ' 293' ' ' PRO . 35.7 mt -55.19 -56.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 55.8 mtp -52.91 -41.93 64.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.437 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.34 -43.89 96.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.697 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' B' ' 459' ' ' LEU . . . -65.5 -49.69 68.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 293' ' ' PRO . 95.3 mtt180 -57.79 -46.1 85.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 87.6 m-20 -57.91 -38.45 75.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.554 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.957 HD12 HD11 ' B' ' 456' ' ' LEU . 76.4 mt -70.94 -36.79 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 489' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 495' ' ' ALA . 13.5 t -77.71 -51.51 10.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.787 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -63.54 -45.72 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 99.6 m-85 -93.94 13.9 21.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.61 131.43 10.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -46.93 -40.45 14.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -1.102 . . . . 0.0 109.444 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.08 -35.04 70.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.524 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 495' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' B' ' 489' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 254' ' ' LEU . 14.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.842 ' HB2' HD13 ' A' ' 253' ' ' LEU . 25.0 m-20 -54.07 124.58 45.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.105 -0.997 . . . . 0.0 109.31 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -64.75 -25.61 60.93 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.664 2.242 . . . . 0.0 111.624 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.701 ' CG2' HD12 ' A' ' 253' ' ' LEU . 14.5 tt -63.5 -33.72 63.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 108.622 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.85 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.5 mp -74.86 -41.37 59.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.407 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.823 HD21 HD11 ' A' ' 326' ' ' ILE . 1.7 mt -72.08 -30.48 65.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.776 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 259' ' ' ASP . 4.8 ttp-105 -56.43 138.35 75.46 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 108.849 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 259' ' ' ASP . 46.3 Cg_endo -68.23 130.57 21.58 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.64 2.227 . . . . 0.0 111.757 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.735 HG23 ' HE3' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -44.55 -26.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 t0 -68.46 -30.77 69.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.255 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 256' ' ' PRO . 35.2 m-20 -69.87 -16.57 63.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 278' ' ' ILE . 37.7 mt -56.07 138.26 49.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.2 tt0 -66.02 -16.22 63.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 302' ' ' GLU . 33.4 mt -53.5 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.0 p -88.27 157.56 18.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.474 HG12 ' OD1' ' A' ' 268' ' ' ASN . 7.0 t -50.68 -37.1 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 265' ' ' ARG . 17.7 tpt85 -57.17 -46.5 82.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.1 m -57.97 -47.55 82.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.33 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -68.93 -39.71 79.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.375 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.474 ' OD1' HG12 ' A' ' 264' ' ' VAL . 12.3 m120 -56.66 -34.9 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 69.0 m -57.11 -64.37 0.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 281' ' ' LEU . 57.4 mt -56.64 -48.09 78.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HE3' HG23 ' A' ' 257' ' ' VAL . 32.3 mttt -54.75 -37.63 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.04 27.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.4 mt-10 -89.95 25.83 2.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.397 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 67.17 42.7 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 1.0 HG23 ' HB2' ' A' ' 280' ' ' ASP . 88.8 mt -115.72 124.6 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.45 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.478 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.3 p80 -110.99 -41.53 4.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.484 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.478 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 8.4 m-30 -105.22 135.02 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.19 -0.944 . . . . 0.0 109.427 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 252' ' ' ILE . 86.7 mt -46.95 -30.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 1.003 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.98 -46.34 19.83 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 1.0 ' HB2' HG23 ' A' ' 275' ' ' ILE . 83.1 m-20 -53.45 -34.54 58.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -1.167 . . . . 0.0 108.884 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 270' ' ' LEU . 35.1 tp -54.96 -49.88 70.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 108.987 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 279' ' ' GLY . 14.3 m -65.26 -23.13 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 0.0 108.84 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.9 tt0 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.02 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -96.39 159.9 14.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.345 -0.847 . . . . 0.0 109.227 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 287' ' ' VAL . 36.0 m -81.39 139.09 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 289' ' ' LEU . 77.9 tt0 -58.56 -32.21 68.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 285' ' ' THR . 45.7 t -52.72 -50.37 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.878 . . . . 0.0 109.359 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 292' ' ' THR . 97.5 mt-10 -55.2 -33.34 62.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.344 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.624 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.8 mm? -64.93 -43.44 92.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm? -66.07 -23.97 66.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 37.7 mttt -90.45 -8.54 50.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' ' CD1' ' A' ' 295' ' ' LEU . 2.1 m -86.99 113.73 54.92 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.6 Cg_endo -70.48 -22.25 29.04 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.661 2.24 . . . . 0.0 111.923 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.802 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.1 m120 -50.47 -22.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.116 -0.99 . . . . 0.0 109.345 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.91 HD23 HD11 ' A' ' 303' ' ' ILE . 4.9 mp -90.79 138.75 31.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.408 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 296' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -87.98 167.78 36.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -55.02 -45.83 75.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -69.39 -37.84 77.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.9 m -58.58 -51.48 69.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 295' ' ' LEU . 78.3 mt -53.83 -46.41 71.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.475 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 32.2 m -51.77 -51.09 58.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.978 . . . . 0.0 109.29 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.638 ' HB3' HD13 ' A' ' 262' ' ' LEU . 80.4 mt-10 -53.89 -38.47 64.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.967 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.91 HD11 HD23 ' A' ' 295' ' ' LEU . 74.1 mt -59.34 -48.04 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.104 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -56.57 -36.54 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.28 -47.82 82.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.125 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 312' ' ' LEU . 2.0 t -66.23 -38.06 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.032 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.55 HD12 HD12 ' A' ' 312' ' ' LEU . 4.7 mp -54.4 -26.71 32.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.221 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.17 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.444 -0.785 . . . . 0.0 109.503 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 2.0 t -61.63 -31.85 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.467 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 309' ' ' SER . 29.5 mtm180 82.74 -24.72 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.536 -0.727 . . . . 0.0 110.38 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.85 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -60.04 -21.18 55.59 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 306' ' ' VAL . 0.4 OUTLIER -125.36 159.95 30.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.46 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.639 ' H ' HG12 ' A' ' 282' ' ' VAL . 4.6 t 77.0 -144.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.612 ' N ' HD22 ' A' ' 314' ' ' LEU . 4.0 mm? 63.59 13.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 45.73 51.58 10.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.724 ' HE2' HG11 ' A' ' 282' ' ' VAL . 26.2 mtm -68.1 173.42 4.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -1.174 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.511 ' O ' HD23 ' A' ' 318' ' ' LEU . 50.4 mtt-85 -132.54 120.59 22.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.516 HD11 ' CG2' ' A' ' 282' ' ' VAL . 5.2 mt -122.43 141.71 51.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.29 -37.57 87.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 80.4 m-20 -143.28 -47.92 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.371 -0.831 . . . . 0.0 108.926 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.567 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.05 -68.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.481 -0.762 . . . . 0.0 109.236 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.5 Cg_endo -69.77 110.93 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.58 2.187 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 50.5 Cg_endo -70.72 155.07 63.5 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.665 2.244 . . . . 0.0 111.654 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.97 -22.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.4 m -62.06 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.823 HD11 HD21 ' A' ' 254' ' ' LEU . 19.5 mt -54.47 -42.15 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.74 70.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -52.12 -39.23 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.49 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -55.06 -38.45 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -1.177 . . . . 0.0 109.513 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 58.06 45.27 18.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' B' ' 454' ' ' CYS . 8.3 tttt -94.27 137.82 22.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.518 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.8 Cg_endo -70.49 132.57 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.703 2.268 . . . . 0.0 111.69 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.77 151.22 42.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.38 -37.71 57.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.46 -44.77 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.767 ' C ' HD13 ' B' ' 434' ' ' LEU . 3.3 tm? -69.96 -36.24 75.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.818 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.4 OUTLIER -69.54 -31.97 70.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -89.32 9.26 26.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.946 HD22 ' CD1' ' B' ' 456' ' ' LEU . 35.0 tp -80.13 132.28 35.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.497 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -77.23 144.74 38.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.67 4.63 65.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.463 HG21 HD23 ' B' ' 437' ' ' LEU . 97.9 t -126.24 126.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.395 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -84.54 151.87 24.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -50.06 -47.07 53.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.508 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 91.7 m-20 -64.99 -45.47 85.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.026 HD11 ' CD2' ' B' ' 473' ' ' LEU . 14.2 tp -57.27 -44.35 83.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.01 -41.72 88.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.91 . . . . 0.0 109.23 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 16.3 m-30 -58.62 -44.6 90.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' B' ' 470' ' ' ILE . 24.5 mttt -58.76 -40.78 84.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.867 . . . . 0.0 109.307 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.8 HD13 HD12 ' B' ' 459' ' ' LEU . 93.3 mt -61.84 -38.94 90.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -64.6 -32.7 74.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.9 -37.56 14.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.987 . . . . 0.0 109.408 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.475 ' CZ ' ' CB ' ' B' ' 469' ' ' ASP . 84.0 mtt-85 -89.66 23.0 2.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.576 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.79 6.74 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.899 HG21 ' CG ' ' B' ' 462' ' ' GLN . 46.7 t -76.79 108.52 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.305 . . . . 0.0 109.407 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 19.9 m -127.03 -38.85 1.98 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.686 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.76 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -78.39 144.32 36.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.529 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.946 ' CD1' HD22 ' B' ' 437' ' ' LEU . 25.8 tp -47.04 -42.72 18.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -55.95 -45.98 78.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.096 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.74 ' HB3' HG13 ' B' ' 453' ' ' VAL . 91.5 m-20 -56.66 -43.48 80.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.076 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.8 HD12 HD13 ' B' ' 448' ' ' LEU . 4.1 tt -55.52 -45.56 77.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.98 77.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 109.392 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.94 -28.09 68.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.899 ' CG ' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -75.45 140.01 42.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -98.45 166.06 21.71 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.962 HD11 ' HG2' ' A' ' 293' ' ' PRO . 20.5 mt -49.83 -34.02 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -1.125 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.18 -40.5 82.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.456 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 90.5 m-20 -63.29 -31.86 73.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.615 ' HB2' ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.59 -27.79 31.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.65 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -66.4 -21.1 66.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.541 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 469' ' ' ASP . . . . . 0.475 ' CB ' ' CZ ' ' B' ' 451' ' ' ARG . 82.1 m-20 -52.08 -31.91 32.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' B' ' 447' ' ' LYS . 64.1 mt -100.38 129.41 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.04 -36.06 72.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.447 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.8 -30.81 57.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.026 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.8 mt -98.91 131.37 45.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.481 HG22 ' N ' ' B' ' 475' ' ' ASP . 45.7 m -104.13 162.01 13.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.481 ' N ' HG22 ' B' ' 474' ' ' THR . 82.3 m-20 -57.12 -38.4 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -74.4 -45.97 43.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.464 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.67 ' O ' HD13 ' B' ' 481' ' ' LEU . 34.4 tttp -61.58 -46.35 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' B' ' 467' ' ' LEU . . . -60.28 -45.05 94.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -57.55 -47.72 86.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.67 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.1 mp -67.18 -44.51 79.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 293' ' ' PRO . 36.3 mt -60.99 -55.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.577 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.7 mtp -52.38 -36.53 54.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.332 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.29 -51.74 34.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.52 65.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.569 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 49.2 ttm-85 -50.56 -46.87 57.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 97.5 m-20 -58.01 -43.25 86.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 456' ' ' LEU . 81.3 mt -61.56 -37.32 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.84 -50.29 12.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 490' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 20.7 m95 -60.13 -43.23 95.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 56.6 m-85 -83.38 -27.21 29.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 64.13 -126.12 33.28 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -106.21 92.55 4.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -1.095 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.14 143.37 10.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.505 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.549 ' CD2' ' O ' ' A' ' 249' ' ' PHE . 41.0 p90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 252' ' ' ILE . 0.6 OUTLIER -65.33 134.42 95.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.14 -29.32 56.14 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.752 2.301 . . . . 0.0 111.661 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.6 tt -61.34 -29.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 108.929 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 282' ' ' VAL . 19.0 mt -74.33 -43.02 58.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.524 ' N ' HD22 ' A' ' 254' ' ' LEU . 4.3 mm? -61.55 -28.55 69.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 278' ' ' ILE . 1.8 mtt180 -75.13 140.86 73.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.525 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.88 141.6 41.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.717 2.278 . . . . 0.0 111.921 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.515 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.63 -37.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.1 -30.89 69.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.956 . . . . 0.0 109.366 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' PRO . 34.2 m-20 -75.33 -11.53 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 262' ' ' LEU . 74.1 mt -53.82 152.84 5.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -64.37 -23.98 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 302' ' ' GLU . 3.7 mp -57.46 167.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 4.0 p -81.33 165.01 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.575 HG12 ' ND2' ' A' ' 268' ' ' ASN . 42.3 t -49.14 -41.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.485 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -49.82 -45.01 49.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.367 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 14.9 m -70.41 -46.56 63.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.73 -46.88 88.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.575 ' ND2' HG12 ' A' ' 264' ' ' VAL . 85.6 m-20 -56.33 -34.74 66.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.367 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 266' ' ' SER . 87.9 m -50.52 -65.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.656 HD12 ' H ' ' A' ' 270' ' ' LEU . 6.6 mp -62.94 -44.93 94.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.241 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.51 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 17.0 ttpp -52.95 -40.93 64.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.89 -21.95 3.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 70.1 tt0 -94.82 20.75 8.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.895 . . . . 0.0 109.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.11 35.33 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.779 HG23 ' HB2' ' A' ' 280' ' ' ASP . 89.0 mt -123.08 107.53 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.51 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 81.5 m-70 -107.29 -11.66 15.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.445 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 4.8 m-85 -111.54 134.23 53.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 252' ' ' ILE . 61.5 mt -60.14 -30.73 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.266 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.888 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -51.05 -42.5 48.28 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.779 ' HB2' HG23 ' A' ' 275' ' ' ILE . 93.0 m-20 -53.54 -35.18 60.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -1.174 . . . . 0.0 109.047 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 270' ' ' LEU . 28.3 tp -58.05 -47.84 81.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 279' ' ' GLY . 21.1 m -70.05 -24.26 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.163 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -65.81 -32.65 74.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.196 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.64 145.02 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -62.17 138.36 58.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.433 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 80.6 tt0 -62.85 -27.4 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.2 t -52.92 -51.76 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.4 -34.88 67.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 281' ' ' LEU . 51.3 mt -74.97 -38.18 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 290' ' ' LEU . 32.9 tp -60.94 -30.25 70.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.493 ' C ' ' CE ' ' B' ' 483' ' ' MET . 10.0 mmtt -87.78 17.6 4.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.35 -0.844 . . . . 0.0 109.52 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 293' ' ' PRO . 0.7 OUTLIER -109.81 136.72 20.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.789 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.0 Cg_endo -70.12 -23.25 29.37 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.819 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -56.2 -24.68 43.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.398 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 14.6 mt -81.45 138.02 35.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -95.21 145.37 17.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' B' ' 461' ' ' GLU . 24.3 mttm -55.29 -42.62 73.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -1.106 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -67.49 -39.42 85.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 303' ' ' ILE . 22.0 m -64.04 -36.71 84.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.757 ' C ' HD13 ' A' ' 300' ' ' LEU . 3.4 tm? -53.1 -42.59 66.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.0 m -60.64 -51.91 67.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.768 ' HB3' HD23 ' A' ' 262' ' ' LEU . 39.7 tp10 -57.91 -45.69 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 82.9 mt -57.79 -47.29 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.065 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.02 -39.34 63.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 108.916 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.65 -42.98 99.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.74 HG12 ' CD2' ' A' ' 312' ' ' LEU . 32.0 t -69.22 -34.8 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.845 . . . . 0.0 108.995 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 313' ' ' SER . 25.2 mt -63.62 -26.68 68.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.397 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.44 -36.26 73.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 109.151 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 16.3 t -67.68 -16.87 64.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.875 ' O ' HD11 ' A' ' 314' ' ' LEU . 56.5 mtt180 64.46 10.81 6.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.184 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.77 -24.25 62.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.757 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.7 pt? -137.36 147.03 45.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 307' ' ' LEU . 1.7 t 77.21 39.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.875 HD11 ' O ' ' A' ' 310' ' ' ARG . 12.3 mt -89.9 15.26 10.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.916 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.25 97.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.628 ' HE2' HG11 ' A' ' 282' ' ' VAL . 4.5 mtm -90.33 163.19 14.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.9 mtt180 -143.14 123.09 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 318' ' ' LEU . 1.4 mp -131.31 140.73 49.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -45.74 -36.49 5.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 108.482 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 43.6 t30 -129.42 -72.2 0.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.615 ' CE2' ' HA3' ' A' ' 279' ' ' GLY . 16.2 t90 160.77 -57.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.589 -0.695 . . . . 0.0 109.547 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 326' ' ' ILE . 47.3 Cg_endo -66.97 107.81 1.38 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.132 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -73.44 165.2 33.1 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.686 2.258 . . . . 0.0 111.657 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -43.84 -26.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.582 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.532 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 22.8 m -61.71 -58.4 8.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.579 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 322' ' ' PRO . 35.1 mt -53.85 -38.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.02 144.55 49.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -56.65 -37.85 71.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.464 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 427' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 89.1 m-20 -55.3 -35.98 65.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' B' ' 427' ' ' ASP . 26.5 m120 60.41 43.84 12.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -87.68 123.62 68.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 429' ' ' LYS . 50.4 Cg_endo -70.46 134.68 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.671 2.247 . . . . 0.0 111.845 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -70.88 166.6 20.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.498 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.19 -38.54 73.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.306 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 433' ' ' ASP . . . . . 0.562 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 75.1 m-20 -61.74 -49.91 74.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.185 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.809 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.5 tm? -64.98 -38.67 91.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.807 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.3 OUTLIER -73.36 -33.94 65.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -85.67 8.54 19.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.525 HD23 HG21 ' B' ' 440' ' ' VAL . 36.1 tp -72.39 131.07 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.98 143.04 49.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 6.58 70.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.877 HG22 HD21 ' B' ' 481' ' ' LEU . 54.4 t -138.36 128.97 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -1.169 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' B' ' 444' ' ' LEU . 32.5 p30 -98.84 -177.21 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.647 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 97.6 mtt180 -62.14 -43.74 98.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.78 -55.92 19.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.003 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.9 tp -56.55 -40.84 75.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.88 -36.77 77.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.387 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 15.1 m-30 -66.72 -43.36 84.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.637 ' HB3' HG21 ' B' ' 470' ' ' ILE . 43.5 mttt -61.7 -42.0 98.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.822 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.7 tm? -62.85 -44.49 95.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -62.03 -26.82 68.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.633 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.11 -17.18 9.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 7.1 mtp85 -92.25 27.97 2.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.68 7.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' B' ' 458' ' ' ASP . 47.8 t -63.73 140.3 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.927 -1.337 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' B' ' 431' ' ' ALA . 27.1 m -135.09 -36.21 0.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -105.51 151.48 24.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.715 HD11 HD12 ' B' ' 488' ' ' ILE . 2.1 tm? -52.03 -38.32 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.2 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 457' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' B' ' 457' ' ' GLU . 43.8 mm-40 -58.12 -47.65 82.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 108.839 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.656 ' HB3' HG13 ' B' ' 453' ' ' VAL . 58.2 m-20 -55.93 -44.66 78.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.857 . . . . 0.0 109.054 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.767 ' C ' HD13 ' B' ' 459' ' ' LEU . 2.8 tm? -55.5 -42.72 74.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.074 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.431 ' O ' ' HE3' ' A' ' 297' ' ' LYS . . . -60.01 -36.06 76.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.202 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 461' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 461' ' ' GLU . 77.1 tt0 -68.78 -13.13 62.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.438 ' HG3' HG21 ' B' ' 453' ' ' VAL . 28.7 mm100 -74.65 147.6 41.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -106.17 158.21 15.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.789 HD11 ' HG2' ' A' ' 293' ' ' PRO . 24.0 mt -52.29 -34.12 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.143 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.95 -37.08 78.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.09 -32.09 69.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.9 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -74.86 -30.01 61.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.57 63.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -52.77 -31.44 38.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' B' ' 447' ' ' LYS . 64.4 mt -102.24 128.93 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -64.44 -35.67 81.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.47 -28.52 36.68 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.003 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.4 mt -102.41 134.48 45.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.491 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.4 m -103.85 162.08 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 474' ' ' THR . 84.8 m-20 -56.69 -38.63 72.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.94 -46.0 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.619 ' CE ' HD22 ' B' ' 444' ' ' LEU . 43.4 tttp -66.66 -46.74 74.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.273 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.9 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.08 -45.18 87.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -59.58 -45.54 95.45 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.37 68.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.877 HD21 HG22 ' B' ' 440' ' ' VAL . 7.7 mp -70.05 -30.58 67.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.559 HD11 ' N ' ' B' ' 464' ' ' ILE . 46.0 mt -69.83 -54.95 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 44.0 mmm -57.6 -44.31 85.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.344 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.448 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -61.38 -56.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.358 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -61.18 -46.74 89.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.504 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 77.1 ttt180 -55.18 -47.46 75.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.6 m-20 -57.76 -41.37 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.715 HD12 HD11 ' B' ' 456' ' ' LEU . 75.7 mt -56.02 -37.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.74 -51.91 8.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 490' ' ' TRP . . . . . 0.504 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 63.1 m95 -62.53 -47.15 85.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.7 m-85 -74.74 -33.03 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.13 77.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -1.163 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.61 143.91 28.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.459 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . 1.1 m-20 -65.95 141.52 97.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.61 -22.78 57.7 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 7.3 tt -67.57 -26.52 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.297 -0.877 . . . . 0.0 109.169 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 282' ' ' VAL . 2.2 mt -73.96 -45.36 50.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 326' ' ' ILE . 3.1 mm? -68.73 -30.74 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.48 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.24 139.44 91.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.49 134.85 27.36 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.695 2.264 . . . . 0.0 111.782 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.4 -32.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.95 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.229 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.1 m-20 -75.71 -12.99 60.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.842 . . . . 0.0 109.411 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.7 HD21 ' CD1' ' A' ' 278' ' ' ILE . 85.2 mt -55.71 136.86 50.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.456 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.1 tt0 -63.96 -16.84 62.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 302' ' ' GLU . 6.4 mp -62.56 165.85 5.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.3 p -71.97 169.11 16.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.438 HG12 ' OD1' ' A' ' 268' ' ' ASN . 3.5 t -51.42 -31.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -50.64 -46.91 58.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 20.7 t -60.26 -50.62 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.9 m-20 -62.41 -42.99 99.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.3 m -52.45 -58.38 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.1 mm? -73.74 -39.41 64.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 12.7 tptm -57.77 -42.14 83.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.36 -21.45 65.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 63.6 tt0 -89.35 21.67 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.43 17.29 8.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 280' ' ' ASP . 72.9 mt -107.31 125.41 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' ' 257' ' ' VAL . 95.3 m-70 -113.43 -25.67 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 109.352 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 96.0 m-85 -105.19 141.43 36.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.7 ' CD1' HD21 ' A' ' 260' ' ' LEU . 76.0 mt -63.58 -31.39 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.273 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.992 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -50.72 -45.68 48.24 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.751 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.3 m-20 -53.78 -37.38 63.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -1.207 . . . . 0.0 109.215 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD13 HD11 ' A' ' 270' ' ' LEU . 34.9 tp -52.53 -48.57 65.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.271 -0.893 . . . . 0.0 108.866 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.992 HG22 ' O ' ' A' ' 279' ' ' GLY . 3.8 m -66.77 -23.89 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 108.821 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.45 -35.92 80.8 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 72.3 mtt180 -105.97 141.92 36.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.2 m -63.68 137.89 58.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.963 . . . . 0.0 109.543 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.606 ' HA ' HD23 ' A' ' 289' ' ' LEU . 47.0 tp10 -53.7 -29.22 38.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 37.1 t -52.79 -48.25 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 108.999 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 96.3 mt-10 -51.93 -35.66 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.905 . . . . 0.0 109.008 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.8 mm? -65.48 -44.16 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 108.907 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -63.56 -17.59 62.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 108.958 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.536 ' O ' ' HE1' ' B' ' 483' ' ' MET . 21.6 mttt -93.3 26.51 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.748 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 294' ' ' ASN . 86.7 m -138.02 122.28 11.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 1.037 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -71.17 -20.24 28.63 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.686 2.257 . . . . 0.0 111.893 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.769 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.5 m120 -50.26 -22.32 1.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 295' ' ' LEU . 3.8 mp -95.54 122.03 37.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -82.87 156.51 34.56 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -48.86 -39.51 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.563 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 19.4 m -64.52 -52.02 59.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 303' ' ' ILE . 34.7 tp -53.18 -39.13 63.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.7 m -58.8 -49.73 76.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.533 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.622 ' HB3' HD23 ' A' ' 262' ' ' LEU . 74.2 mt-10 -59.75 -40.67 88.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 300' ' ' LEU . 83.9 mt -57.83 -52.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.284 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -54.54 -38.99 67.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.158 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.83 -42.08 83.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -72.39 -42.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.778 HD22 ' CB ' ' A' ' 313' ' ' SER . 24.4 mt -54.54 -26.91 34.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.92 74.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.4 p -68.47 -20.31 64.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.0 109.408 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.513 ' O ' HD11 ' A' ' 314' ' ' LEU . 32.4 ttm180 67.59 7.39 5.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -78.31 -22.47 67.75 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.796 ' H ' HD23 ' A' ' 312' ' ' LEU . 1.7 pt? -137.08 155.94 49.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.604 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.778 ' CB ' HD22 ' A' ' 307' ' ' LEU . 1.3 t 75.47 51.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.815 HD22 ' N ' ' A' ' 314' ' ' LEU . 3.0 mm? -93.14 21.25 6.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 47.04 46.16 20.15 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 282' ' ' VAL . 11.0 ptt? -121.91 139.83 53.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -1.185 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.683 ' O ' HD13 ' A' ' 318' ' ' LEU . 55.9 mtt180 -100.14 137.43 38.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 318' ' ' LEU . 2.4 mm? -122.28 111.37 16.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.901 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -77.07 -30.49 55.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.945 . . . . 0.0 108.753 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 321' ' ' TRP . 21.2 t-20 -165.29 26.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.053 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.818 ' CH2' HD22 ' A' ' 254' ' ' LEU . 0.4 OUTLIER -43.37 104.25 0.36 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.5 71.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.727 2.951 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 1.012 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.05 155.83 64.04 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.54 2.16 . . . . 0.0 111.816 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.76 -27.97 67.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.291 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.2 m -59.1 -40.08 84.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.5 tt -63.6 -22.78 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -70.24 143.72 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -54.81 -37.15 65.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.525 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.488 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 426' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 427' ' ' ASP . . . . . 0.425 ' O ' ' SG ' ' B' ' 454' ' ' CYS . 94.9 m-20 -61.28 -34.23 74.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 109.443 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.672 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 86.8 m-20 -59.15 -25.25 63.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' B' ' 426' ' ' GLY . 0.4 OUTLIER -50.98 131.84 30.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.886 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.3 136.37 31.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.907 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.84 160.55 25.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -53.15 -33.87 54.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -65.04 -49.61 69.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.624 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' B' ' 430' ' ' PRO . 17.2 tp -65.05 -38.44 90.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.5 OUTLIER -73.61 -33.22 64.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -86.87 9.84 17.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.752 HD13 HD13 ' B' ' 456' ' ' LEU . 44.8 tp -77.24 133.29 38.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -77.45 142.26 39.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.1 2.8 65.99 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' B' ' 481' ' ' LEU . 93.8 t -131.06 129.56 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.13 -1.218 . . . . 0.0 109.497 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.607 ' H ' HD12 ' B' ' 444' ' ' LEU . 75.5 m-20 -90.86 155.22 18.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.598 ' HG2' HD11 ' B' ' 435' ' ' LEU . 58.8 mtm180 -50.04 -40.62 45.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -66.9 -45.45 77.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.748 HD22 HD21 ' B' ' 473' ' ' LEU . 45.5 mt -60.39 -42.09 95.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.97 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.355 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 11.2 m-30 -58.51 -43.41 89.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.699 ' HB3' HG21 ' B' ' 470' ' ' ILE . 45.6 mttp -60.59 -52.5 64.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 7.1 tt -65.55 -42.03 92.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.672 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.99 -27.0 50.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.977 . . . . 0.0 109.487 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.36 -24.0 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.417 ' NH1' ' CG1' ' B' ' 470' ' ' ILE . 41.9 mtt-85 -88.8 26.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.63 6.93 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' B' ' 458' ' ' ASP . 73.2 t -60.71 130.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.33 . . . . 0.0 109.472 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' B' ' 431' ' ' ALA . 57.0 m -135.06 -36.59 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.743 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -97.12 153.08 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.783 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.942 HD21 HD12 ' B' ' 488' ' ' ILE . 42.5 tp -49.48 -40.42 37.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.325 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.71 -49.93 71.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 108.994 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.741 ' CB ' HG13 ' B' ' 453' ' ' VAL . 81.0 m-20 -55.52 -40.55 71.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 108.971 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.77 HD13 ' C ' ' B' ' 459' ' ' LEU . 3.4 tm? -55.62 -42.98 75.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.73 -25.69 66.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.262 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.13 -21.19 63.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.61 ' CG ' HG21 ' B' ' 453' ' ' VAL . 98.4 mm-40 -79.98 153.81 28.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -117.3 152.35 17.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 293' ' ' PRO . 33.6 mt -44.46 -36.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -63.95 -35.59 81.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.473 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 87.2 m-20 -77.35 -31.55 54.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.01 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.1 mt -73.48 -35.52 65.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.91 69.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.51 -33.2 72.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' B' ' 447' ' ' LYS . 80.5 mt -85.24 131.39 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.436 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.95 150.4 46.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.19 -29.39 12.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.748 HD21 HD22 ' B' ' 444' ' ' LEU . 64.6 mt -99.72 136.49 39.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -1.16 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.03 162.07 13.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -57.3 -38.11 73.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.65 -45.94 56.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.573 ' O ' HD13 ' B' ' 481' ' ' LEU . 14.5 tttp -62.58 -45.68 91.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.01 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.7 -42.49 88.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -61.7 -46.3 94.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.83 78.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.517 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.573 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.0 mp -66.38 -35.36 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.594 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 293' ' ' PRO . 59.6 mt -70.32 -56.33 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.579 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.536 ' HE1' ' O ' ' A' ' 291' ' ' LYS . 39.9 mtp -52.92 -37.8 61.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.34 69.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -64.81 -49.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.541 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 66.3 ttt-85 -53.85 -47.06 71.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.97 -45.84 86.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.942 HD12 HD21 ' B' ' 456' ' ' LEU . 46.2 mt -59.1 -39.51 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 91.2 m -75.3 -49.13 20.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 490' ' ' TRP . . . . . 0.541 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 15.0 m95 -59.39 -41.3 89.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 9.19 43.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.463 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -71.53 131.1 18.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.4 -39.35 75.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -1.152 . . . . 0.0 109.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -34.4 71.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.529 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.516 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.679 ' HD2' HD22 ' A' ' 253' ' ' LEU . 2.5 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -61.67 139.55 95.27 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.0 Cg_endo -64.56 -34.05 53.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.505 2.137 . . . . 0.0 111.473 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.7 tt -53.71 -34.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.679 HD22 ' HD2' ' A' ' 249' ' ' PHE . 0.6 OUTLIER -74.57 -21.67 59.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.083 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.653 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -89.58 -24.8 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.263 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -66.23 147.5 98.85 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.8 Cg_endo -70.69 140.88 40.15 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.698 2.265 . . . . 0.0 111.715 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.707 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.54 -34.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 109.365 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.84 -30.92 71.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' PRO . 30.2 m-20 -76.0 -14.96 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 257' ' ' VAL . 48.7 mt -44.75 149.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.56 -19.17 65.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 262' ' ' LEU . 6.1 mp -64.07 169.32 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 9.2 p -78.22 159.88 28.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.476 HG12 ' ND2' ' A' ' 268' ' ' ASN . 3.2 t -47.25 -37.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.486 ' NH2' ' OD2' ' B' ' 465' ' ' ASP . 52.0 ttt85 -53.37 -46.85 69.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 19.4 m -63.58 -51.05 67.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.943 . . . . 0.0 109.387 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.07 78.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.476 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.6 m-20 -59.7 -33.31 71.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.914 . . . . 0.0 109.27 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.5 m -62.29 -63.82 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.292 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 295' ' ' LEU . 60.0 mt -58.64 -47.66 83.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 19.0 tttt -52.69 -32.11 40.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.97 -17.46 51.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.328 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 58.5 tt0 -95.6 21.33 8.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.05 23.3 3.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 97.0 mt -112.34 107.66 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.507 ' C ' HG22 ' A' ' 257' ' ' VAL . 50.5 m-70 -107.1 -9.2 16.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.5 m-85 -114.55 131.96 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 252' ' ' ILE . 74.7 mt -54.16 -36.5 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 109.119 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.38 -47.53 16.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.2 m-20 -53.27 -34.41 57.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 108.704 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.498 HD13 HD13 ' A' ' 270' ' ' LEU . 31.2 tp -53.78 -50.48 65.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.146 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.8 m -67.09 -29.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 93.9 mt-30 -57.2 -34.34 68.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -96.99 159.55 14.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.416 -0.802 . . . . 0.0 109.017 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 m -83.35 140.15 32.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 88.3 tt0 -52.7 -31.18 36.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.325 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.89 -51.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.039 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 69.9 mm-40 -51.93 -37.0 51.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.087 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 281' ' ' LEU . 62.2 mt -60.75 -47.24 87.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.995 HD13 ' O ' ' A' ' 290' ' ' LEU . 1.8 tm? -59.81 -33.53 71.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.283 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.527 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 45.8 mttt -83.06 -17.84 41.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.402 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -77.08 113.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 1.026 ' HB2' HD12 ' B' ' 482' ' ' ILE . 50.8 Cg_endo -71.0 -23.29 25.31 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.766 2.311 . . . . 0.0 112.165 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.437 ' HA ' HD12 ' B' ' 464' ' ' ILE . 70.8 m-80 -50.93 -21.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.699 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 270' ' ' LEU . 3.2 mp -101.31 122.69 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -73.8 156.64 50.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -49.09 -38.63 25.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.293 -1.122 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -67.2 -42.68 83.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.355 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 59.5 p -58.43 -47.14 84.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 290' ' ' LEU . 22.9 tp -52.94 -44.19 66.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.294 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 52.2 m -52.5 -52.31 55.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.209 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.485 ' OE1' HD23 ' A' ' 262' ' ' LEU . 84.7 mt-10 -53.61 -42.24 67.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.57 -39.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.183 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -62.16 -36.11 80.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.39 -51.24 61.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 312' ' ' LEU . 3.2 t -72.29 -37.52 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.251 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 15.5 tp -60.25 -26.27 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.441 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.08 -30.7 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 109.434 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.7 OUTLIER -68.95 -7.35 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.86 . . . . 0.0 109.555 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 92.9 mtt-85 61.76 12.52 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -93.21 -2.94 65.66 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 306' ' ' VAL . 0.0 OUTLIER -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -1.197 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.676 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 46.36 67.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.486 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.6 mt -101.64 11.86 38.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.63 73.83 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.709 ' HE3' HG21 ' A' ' 282' ' ' VAL . 13.5 ptt? -107.7 150.83 26.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -1.216 . . . . 0.0 109.54 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.643 ' C ' HD12 ' A' ' 318' ' ' LEU . 61.7 mtp180 -125.57 145.85 49.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.808 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.9 mp -124.04 140.95 52.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.68 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.1 -32.2 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 85.8 m-20 -122.35 -78.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.167 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.653 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 168.76 -58.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.76 107.8 1.74 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.647 2.231 . . . . 0.0 111.889 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 1.017 ' O ' HG22 ' A' ' 326' ' ' ILE . 52.8 Cg_endo -73.16 165.12 33.55 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.554 2.169 . . . . 0.0 111.688 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.89 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.9 m -76.82 -38.68 53.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 1.017 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.5 tt -60.68 -18.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.0 147.35 45.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.85 -38.47 78.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.414 -179.971 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.46 -33.61 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -1.09 . . . . 0.0 109.478 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 20.0 m120 56.78 43.68 24.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.357 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -61.85 130.13 92.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.575 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.9 138.74 34.82 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.703 2.269 . . . . 0.0 111.728 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.71 157.52 36.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -56.89 -33.54 66.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 433' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 436' ' ' ASN . 56.0 m-20 -69.61 -37.3 76.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.32 -33.24 71.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 109.34 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' B' ' 442' ' ' ARG . 33.1 tp -86.43 -30.59 21.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 436' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 433' ' ' ASP . 24.3 p-10 -80.0 5.84 12.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.834 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.623 HD23 HG21 ' B' ' 440' ' ' VAL . 25.5 tp -77.87 133.81 38.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.9 139.22 50.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.2 63.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.623 HG21 HD23 ' B' ' 437' ' ' LEU . 48.8 t -129.5 130.88 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -1.157 . . . . 0.0 109.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -101.35 158.42 16.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' B' ' 435' ' ' LEU . 76.8 mtt-85 -50.12 -52.45 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.17 -48.38 81.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.067 HD11 ' CD2' ' B' ' 473' ' ' LEU . 12.3 tp -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.34 87.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -56.23 -44.45 79.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.738 ' HB3' HD13 ' B' ' 470' ' ' ILE . 79.2 mttt -60.1 -44.74 94.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.926 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.6 tm? -73.29 -39.35 65.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.8 -28.31 69.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.35 -16.89 10.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -92.3 30.13 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.562 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.71 -18.86 6.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.558 HG13 ' CB ' ' B' ' 458' ' ' ASP . 49.1 t -63.82 138.25 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.336 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 72.6 m -135.14 -34.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.866 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.552 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -115.97 159.31 21.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 485' ' ' ALA . 33.8 tp -50.67 -40.11 52.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.338 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 457' ' ' GLU . . . . . 0.406 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 48.0 tp10 -55.88 -48.62 75.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.185 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.558 ' CB ' HG13 ' B' ' 453' ' ' VAL . 86.7 m-20 -57.3 -40.81 78.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 481' ' ' LEU . 17.0 tp -59.49 -45.31 92.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.35 -38.99 78.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.517 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -76.26 146.52 38.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.28 154.41 16.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 293' ' ' PRO . 59.7 mt -44.03 -36.59 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 465' ' ' ASP . . . . . 0.486 ' OD2' ' NH2' ' A' ' 265' ' ' ARG . 48.0 t0 -63.2 -41.04 99.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -66.68 -25.08 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.749 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -85.52 -24.46 27.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.81 -23.9 63.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -52.06 -32.16 33.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.738 HD13 ' HB3' ' B' ' 447' ' ' LYS . 67.3 mt -97.84 124.73 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.507 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.46 -35.38 80.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.405 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.54 -31.62 52.35 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.067 ' CD2' HD11 ' B' ' 444' ' ' LEU . 60.0 mt -101.79 135.58 43.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.501 HG22 ' N ' ' B' ' 475' ' ' ASP . 39.1 m -103.73 163.87 12.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.52 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 90.7 m-20 -56.88 -39.42 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -71.86 -45.88 59.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.587 ' HD3' HD23 ' B' ' 473' ' ' LEU . 40.3 tttm -61.07 -46.74 89.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.453 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' B' ' 464' ' ' ILE . . . -58.9 -41.93 88.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.357 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.46 ' HA2' ' CG ' ' A' ' 293' ' ' PRO . . . -59.2 -45.77 94.83 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.61 -35.96 73.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' B' ' 459' ' ' LEU . 25.3 mt -68.96 -44.11 73.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.523 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.4 mt -59.5 -55.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 43.9 mtp -52.76 -44.47 66.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 0.0 109.374 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.6 -49.78 76.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -68.25 -47.75 66.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' A' ' 291' ' ' LYS . 39.5 ttm180 -55.1 -45.65 75.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 74.6 m-20 -61.02 -41.24 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.711 HD12 HD21 ' B' ' 456' ' ' LEU . 63.2 mt -67.42 -38.74 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 489' ' ' CYS . . . . . 0.406 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 47.4 m -67.44 -49.56 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -68.0 -39.51 83.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 16.9 m-30 -83.31 -13.12 55.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 492' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . -57.76 -36.1 77.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.23 -38.28 73.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 494' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' B' ' 491' ' ' PHE . 84.0 tt0 -108.02 140.62 40.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.533 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.575 ' HD2' HD11 ' A' ' 254' ' ' LEU . 16.4 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 252' ' ' ILE . 15.1 m-20 -54.64 135.67 63.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.348 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.771 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.22 -31.72 53.16 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.604 2.203 . . . . 0.0 111.672 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.672 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.2 tt -63.18 -28.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 108.756 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 312' ' ' LEU . 37.9 mt -74.6 -44.16 52.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.8 mt -65.98 -34.78 78.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.67 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 278' ' ' ILE . 4.3 ttp180 -56.04 141.11 68.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.0 109.068 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.7 Cg_endo -68.72 130.96 21.65 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.3 OUTLIER -43.51 -35.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.89 . . . . 0.0 109.396 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.98 -30.93 70.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.321 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.3 m-20 -76.81 -14.9 59.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.87 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.428 HD11 HG12 ' A' ' 257' ' ' VAL . 68.3 mt -44.79 140.88 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' LEU . 98.0 mt-10 -64.83 -26.58 68.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 306' ' ' VAL . 29.7 mt -52.84 -173.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 13.0 p -84.84 159.39 20.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.67 HG12 ' ND2' ' A' ' 268' ' ' ASN . 8.7 t -55.16 -34.66 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.357 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -53.71 -46.45 70.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.7 p -64.42 -45.04 89.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.33 85.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.67 ' ND2' HG12 ' A' ' 264' ' ' VAL . 89.3 m-20 -58.52 -32.2 68.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' CYS . . . . . 0.644 ' SG ' HD11 ' A' ' 295' ' ' LEU . 21.4 t -57.6 -64.99 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.76 -47.71 79.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -0.845 . . . . 0.0 109.454 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.504 ' HG3' ' CE1' ' A' ' 276' ' ' HIS . 36.1 ttpt -55.08 -37.17 66.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.441 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.75 -21.15 6.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.7 mt-10 -95.65 21.17 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.86 28.04 4.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.9 mt -117.09 111.48 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.504 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 96.1 m-70 -104.4 -10.13 17.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.578 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.86 143.45 33.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' A' ' 312' ' ' LEU . 92.0 mt -72.29 -31.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 1.023 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.22 -48.33 20.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.7 m-20 -53.79 -35.32 61.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -1.138 . . . . 0.0 108.757 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 0.752 HD13 ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -52.78 -47.16 67.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 1.023 HG22 ' O ' ' A' ' 279' ' ' GLY . 6.5 m -68.25 -23.81 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.23 -35.69 79.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HE ' HD11 ' A' ' 275' ' ' ILE . 64.9 mtt-85 -100.99 141.18 34.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 74.0 p -76.2 147.11 38.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 300' ' ' LEU . 85.5 tt0 -50.82 -34.1 26.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 0.0 109.339 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.76 -51.26 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.281 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.14 -37.84 62.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.653 ' N ' HD22 ' A' ' 289' ' ' LEU . 3.9 mm? -68.37 -40.77 81.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 1.088 HD13 HD22 ' A' ' 300' ' ' LEU . 34.8 tp -62.3 -25.45 67.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 109.331 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.6 ' O ' ' HE2' ' B' ' 483' ' ' MET . 22.2 mttt -88.66 17.25 5.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -116.84 136.99 23.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 0.883 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.6 Cg_endo -71.72 -30.64 14.23 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.691 2.26 . . . . 0.0 111.85 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.479 ' C ' HD12 ' A' ' 295' ' ' LEU . 76.3 m-20 -52.53 -20.8 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.804 ' N ' HD12 ' A' ' 295' ' ' LEU . 5.3 mp -104.74 124.48 49.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.605 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.79 173.86 35.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -51.37 -44.66 62.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -70.33 -36.77 74.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.9 t -54.93 -52.27 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 1.088 HD22 HD13 ' A' ' 290' ' ' LEU . 22.5 tp -52.91 -39.49 62.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.8 m -59.11 -50.17 75.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.236 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.592 ' HG2' HD13 ' A' ' 262' ' ' LEU . 54.0 tt0 -53.73 -44.92 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.089 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.64 HD11 HD23 ' A' ' 295' ' ' LEU . 63.6 mt -57.65 -40.43 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 108.783 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.66 -40.08 90.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.343 -0.848 . . . . 0.0 108.742 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.09 -46.18 85.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.367 -0.833 . . . . 0.0 108.827 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 312' ' ' LEU . 16.9 t -69.95 -35.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 108.819 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 313' ' ' SER . 17.1 tp -63.5 -26.78 68.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.371 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.77 -28.92 64.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.209 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.2 p -69.31 -12.14 61.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 314' ' ' LEU . 69.8 mtt180 57.36 15.78 2.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.37 -15.47 13.91 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 278' ' ' ILE . 9.0 tp -137.5 136.15 37.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -1.182 . . . . 0.0 109.155 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.3 OUTLIER 73.37 41.93 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -92.22 13.17 19.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.68 36.88 83.86 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.609 ' CE ' HD11 ' A' ' 253' ' ' LEU . 7.5 mtm -84.28 170.3 13.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.791 ' C ' HD12 ' A' ' 318' ' ' LEU . 45.4 mtm105 -141.0 129.56 22.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.819 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.7 mp -133.05 136.32 45.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.48 -39.89 64.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.038 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 69.5 m-20 -129.75 -65.13 0.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.0 t-105 167.31 -65.92 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.523 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.69 107.99 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.679 2.253 . . . . 0.0 112.169 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.8 Cg_endo -72.86 161.21 44.29 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.622 2.214 . . . . 0.0 111.53 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.84 -18.84 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.601 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 16.3 m -64.29 -49.26 72.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 254' ' ' LEU . 26.9 mt -51.07 -36.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -71.05 148.46 47.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.63 -38.9 82.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.481 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.5 -34.14 74.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 74.7 m-20 -89.48 19.97 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -62.02 121.83 68.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 49.5 Cg_endo -70.05 131.21 20.36 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.641 2.227 . . . . 0.0 111.741 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.37 153.86 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 432' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' B' ' 436' ' ' ASN . 92.0 m-20 -54.32 -29.57 48.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 433' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 456' ' ' LEU . 91.2 m-20 -67.05 -50.1 62.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 27.3 tp -67.78 -42.02 82.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.936 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.8 OUTLIER -71.35 -26.88 63.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.38 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 436' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 432' ' ' ASP . 40.8 t30 -96.65 7.92 45.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.628 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.72 HD13 ' N ' ' B' ' 438' ' ' GLU . 1.6 tm? -78.09 120.39 22.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 438' ' ' GLU . . . . . 0.72 ' N ' HD13 ' B' ' 437' ' ' LEU . 23.6 pt-20 -60.57 140.89 57.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 439' ' ' GLY . . . . . 0.437 ' O ' HD11 ' B' ' 481' ' ' LEU . . . 96.31 -3.64 64.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 1.042 HG22 ' CD2' ' B' ' 481' ' ' LEU . 47.0 t -120.67 129.98 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.123 -1.222 . . . . 0.0 109.487 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -87.05 154.42 20.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.529 ' HG2' HD11 ' B' ' 435' ' ' LEU . 72.8 mtt180 -49.98 -45.18 51.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.33 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 443' ' ' ASP . . . . . 0.574 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 94.3 m-20 -67.83 -46.56 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 473' ' ' LEU . 14.1 tp -53.67 -40.83 66.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.114 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.4 91.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 108.978 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 12.7 m-30 -58.55 -40.18 82.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.102 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -62.21 -42.43 99.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 459' ' ' LEU . 88.4 mt -62.02 -45.01 95.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.87 -40.33 84.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.9 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.55 -33.25 3.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 26.2 mtp85 -91.24 22.32 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.6 7.17 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.935 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.8 t -83.15 110.0 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.914 -1.344 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 14.9 m -127.51 -35.76 2.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.94 . . . . 0.0 109.587 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.52 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -79.62 140.69 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.915 ' CD2' HD12 ' B' ' 488' ' ' ILE . 23.5 tp -45.64 -43.64 12.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.191 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 457' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' B' ' 489' ' ' CYS . 13.3 mt-10 -60.1 -46.32 90.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.177 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.702 ' HB3' HG13 ' B' ' 453' ' ' VAL . 88.4 m-20 -54.94 -38.01 67.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.133 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 448' ' ' LEU . 33.3 tp -63.79 -42.9 97.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.226 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 460' ' ' ALA . . . . . 0.641 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -58.36 -37.69 75.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.46 -30.55 71.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.935 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -73.52 148.72 42.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 463' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -107.71 154.11 16.66 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 0.883 HD11 ' HG2' ' A' ' 293' ' ' PRO . 96.5 mt -44.98 -36.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.144 -1.21 . . . . 0.0 109.27 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -36.88 82.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.245 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.2 m-20 -71.41 -28.71 64.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.84 -30.68 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.963 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.39 -24.69 60.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -51.35 -33.15 28.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.892 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' B' ' 473' ' ' LEU . 64.4 mt -102.24 127.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -59.73 -31.01 69.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.531 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -59.2 -25.67 60.37 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 1.025 ' CD1' HD11 ' B' ' 444' ' ' LEU . 3.5 mm? -103.38 129.19 50.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -1.106 . . . . 0.0 109.562 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 474' ' ' THR . . . . . 0.447 HG22 ' N ' ' B' ' 475' ' ' ASP . 23.4 m -103.61 162.02 13.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.526 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 83.6 m-20 -55.88 -39.14 71.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.1 -45.85 25.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.483 ' CE ' HD22 ' B' ' 444' ' ' LEU . 32.8 tttp -62.37 -46.62 87.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.53 -45.91 81.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -63.59 -52.12 48.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.48 -42.22 61.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.215 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 1.042 ' CD2' HG22 ' B' ' 440' ' ' VAL . 6.4 mp -67.28 -42.3 84.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.36 -0.837 . . . . 0.0 109.442 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.55 HD12 HG13 ' B' ' 464' ' ' ILE . 45.3 mt -56.41 -56.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.6 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 43.4 mmm -53.29 -44.88 68.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -57.26 -60.77 3.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.193 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.509 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -55.7 -43.3 76.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.196 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.641 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 94.8 mtt180 -59.55 -41.96 91.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.831 . . . . 0.0 109.19 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 98.1 m-20 -57.84 -41.31 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.291 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.915 HD12 ' CD2' ' B' ' 456' ' ' LEU . 24.3 mt -68.55 -38.55 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.309 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 489' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' B' ' 457' ' ' GLU . 66.4 m -70.27 -51.62 29.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -61.37 -38.19 86.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 19.2 m-30 -76.29 -36.86 58.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.0 109.406 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 492' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 495' ' ' ALA . . . 53.46 -127.67 37.3 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -53.39 -42.12 66.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.352 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 494' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' B' ' 495' ' ' ALA . 95.6 mt-10 -54.94 -34.13 62.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 495' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.535 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' PHE . . . . . 0.556 ' CD2' ' O ' ' A' ' 249' ' ' PHE . 42.0 p90 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ASP . . . . . 0.784 ' O ' HD12 ' A' ' 254' ' ' LEU . 0.5 OUTLIER -69.67 137.53 88.11 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.239 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 255' ' ' ARG . 43.2 Cg_endo -65.31 -26.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.705 2.27 . . . . 0.0 111.673 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ILE . . . . . 0.606 HD13 ' HA3' ' A' ' 311' ' ' GLY . 6.0 tt -71.22 -28.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 108.709 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 253' ' ' LEU . . . . . 0.74 HD11 HG21 ' A' ' 282' ' ' VAL . 3.1 tp -74.35 -27.18 60.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 326' ' ' ILE . 4.0 mp -101.67 -20.98 14.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 251' ' ' PRO . 16.2 mtt180 -55.09 147.59 33.69 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.019 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.6 Cg_endo -69.56 132.46 23.7 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.687 2.258 . . . . 0.0 111.954 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' VAL . . . . . 0.723 HG11 HD12 ' A' ' 270' ' ' LEU . 0.2 OUTLIER -44.62 -30.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.275 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -64.25 -30.69 71.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 12.9 m-20 -69.57 -16.99 63.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 278' ' ' ILE . 46.1 mt -57.43 144.73 35.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 261' ' ' GLU . 82.2 tt0 -65.23 -14.4 60.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.504 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.696 HD21 ' CB ' ' A' ' 302' ' ' GLU . 8.0 mp -60.24 173.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.574 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.7 p -74.73 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' VAL . . . . . 0.755 HG12 HD21 ' A' ' 268' ' ' ASN . 18.5 t -62.56 -31.76 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 265' ' ' ARG . 6.8 mmt85 -60.08 -44.95 94.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.136 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' SER . . . . . 0.433 ' OG ' HD23 ' A' ' 262' ' ' LEU . 7.8 t -57.83 -51.01 71.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.214 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -66.56 -34.21 77.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.912 . . . . 0.0 109.106 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ASN . . . . . 0.755 HD21 HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -61.61 -38.88 89.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.8 m -49.86 -60.12 3.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' LEU . . . . . 0.723 HD12 HG11 ' A' ' 257' ' ' VAL . 45.3 mt -63.52 -48.33 77.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.301 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 271' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 52.5 mtmt -53.27 -39.69 64.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.81 -24.74 6.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.334 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 54.0 tt0 -93.47 24.72 3.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 66.23 29.85 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ILE . . . . . 0.621 HG23 ' OD2' ' A' ' 280' ' ' ASP . 54.7 mt -124.22 108.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 256' ' ' PRO . 89.5 m-70 -100.85 -6.83 24.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.14 140.83 37.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 260' ' ' LEU . 56.6 mt -72.61 -30.19 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.529 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' GLY . . . . . 0.975 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.5 -48.37 11.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ASP . . . . . 0.621 ' OD2' HG23 ' A' ' 275' ' ' ILE . 82.5 m-20 -53.0 -33.73 53.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.922 -1.34 . . . . 0.0 108.527 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 312' ' ' LEU . 26.9 tp -52.98 -52.7 57.42 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 282' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 279' ' ' GLY . 25.3 m -62.47 -27.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 53.0 tt0 -58.21 -37.95 75.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' ARG . . . . . 0.452 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 86.0 mtt-85 -98.07 140.92 31.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.799 . . . . 0.0 108.975 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.0 m -63.64 141.17 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 109.712 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' GLU . . . . . 0.686 ' CD ' HD12 ' A' ' 289' ' ' LEU . 49.0 tp10 -53.33 -27.27 22.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' VAL . . . . . 0.76 ' HA ' HD12 ' A' ' 290' ' ' LEU . 54.3 t -52.8 -51.81 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 93.6 mt-10 -51.87 -33.66 37.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.083 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 281' ' ' LEU . 40.5 mt -64.94 -46.76 80.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.9 mt -61.88 -29.76 70.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.446 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 23.4 mttm -84.96 -20.65 30.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 15.7 m -82.12 116.42 63.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.63 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' PRO . . . . . 1.001 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.1 Cg_endo -71.16 -24.35 23.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.626 2.217 . . . . 0.0 111.843 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.562 ' ND2' HD12 ' B' ' 464' ' ' ILE . 34.4 m120 -46.94 -23.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 300' ' ' LEU . 3.0 mp -96.02 138.87 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.84 163.29 33.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -50.79 -45.28 59.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -1.189 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -65.73 -42.12 91.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.8 t -56.1 -55.13 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 109.277 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 295' ' ' LEU . 49.9 mt -54.42 -47.02 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.4 m -50.37 -53.0 32.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.234 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 306' ' ' VAL . 60.9 mm-40 -53.75 -38.44 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 300' ' ' LEU . 93.5 mt -57.79 -46.04 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -60.38 -39.76 88.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.06 -49.92 70.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.851 . . . . 0.0 109.347 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.2 t -63.55 -41.09 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 109.203 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' LEU . . . . . 0.53 HD13 ' CB ' ' A' ' 313' ' ' SER . 24.1 tp -53.91 -26.62 26.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.86 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.313 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 20.9 t -68.98 -7.72 37.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 310' ' ' ARG . . . . . 0.748 ' CA ' HD21 ' A' ' 314' ' ' LEU . 66.2 mtt180 65.64 8.98 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.365 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 311' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.26 -31.24 63.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -148.16 173.12 13.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 109.51 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 313' ' ' SER . . . . . 0.64 ' N ' HG12 ' A' ' 282' ' ' VAL . 2.8 m 61.77 30.66 18.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.897 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' LEU . . . . . 0.748 HD21 ' CA ' ' A' ' 310' ' ' ARG . 68.4 mt -79.41 -5.46 54.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.515 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.86 38.82 65.36 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' MET . . . . . 0.684 ' HE1' HD12 ' A' ' 314' ' ' LEU . 4.2 ptt? -107.42 162.11 14.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -1.216 . . . . 0.0 109.361 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ARG . . . . . 0.57 ' C ' HD12 ' A' ' 318' ' ' LEU . 44.5 mtm180 -128.2 134.37 49.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -116.51 143.12 45.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.78 -33.71 70.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.261 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -135.02 -68.23 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' TRP . . . . . 0.571 ' CH2' ' HG ' ' A' ' 254' ' ' LEU . 0.7 OUTLIER 176.98 -64.96 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.376 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 322' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 326' ' ' ILE . 49.9 Cg_endo -68.67 107.5 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 112.041 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.7 Cg_endo -72.54 164.79 34.56 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.571 2.181 . . . . 0.0 111.579 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.92 -19.03 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.279 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 249' ' ' PHE . 61.0 m -65.77 -47.85 73.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 254' ' ' LEU . 19.4 mt -53.15 -33.98 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -59.86 147.47 38.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -0.98 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -61.58 -38.38 87.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.453 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 426' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.44 -31.46 70.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -1.119 . . . . 0.0 109.421 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 428' ' ' ASN . . . . . 0.838 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 29.5 m120 -123.94 37.97 4.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 429' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 426' ' ' GLY . 1.7 ptmt -51.19 136.25 29.72 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.587 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 430' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.6 Cg_endo -70.9 140.97 39.5 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.711 2.274 . . . . 0.0 111.652 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 431' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.92 165.56 24.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 109.662 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 432' ' ' ASP . . . . . 0.426 ' N ' ' OD1' ' B' ' 432' ' ' ASP . 25.4 p-10 -61.68 -34.12 75.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 433' ' ' ASP . . . . . 0.582 ' CB ' ' CB ' ' B' ' 456' ' ' LEU . 5.2 m-20 -63.4 -49.21 74.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.072 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 434' ' ' LEU . . . . . 0.836 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 435' ' ' LEU . . . . . 0.593 ' O ' HD13 ' B' ' 435' ' ' LEU . 0.2 OUTLIER -72.72 -35.55 67.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -88.57 4.68 46.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 437' ' ' LEU . . . . . 0.649 HD23 HG21 ' B' ' 440' ' ' VAL . 31.8 tp -71.98 132.76 44.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -76.78 141.59 40.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.2 9.39 62.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 440' ' ' VAL . . . . . 0.649 HG21 HD23 ' B' ' 437' ' ' LEU . 47.9 t -125.89 131.52 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -1.129 . . . . 0.0 109.422 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 441' ' ' ASP . . . . . 0.645 ' H ' HD12 ' B' ' 444' ' ' LEU . 86.8 m-20 -97.64 160.66 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 442' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 93.7 mtt180 -52.08 -41.35 62.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.964 . . . . 0.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.03 -42.29 85.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.449 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 444' ' ' LEU . . . . . 0.645 HD12 ' H ' ' B' ' 441' ' ' ASP . 53.6 mt -64.98 -42.56 94.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 445' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' B' ' 434' ' ' LEU . . . -59.18 -41.46 88.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 446' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 10.3 m-30 -64.14 -40.5 96.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 447' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' B' ' 470' ' ' ILE . 66.5 mttm -61.68 -41.23 97.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 448' ' ' LEU . . . . . 0.496 HD21 HD11 ' B' ' 473' ' ' LEU . 80.9 mt -64.86 -39.22 93.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 449' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.06 -37.46 84.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.97 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 451' ' ' ARG . . . . . 0.493 ' NH1' ' O ' ' B' ' 466' ' ' ASP . 35.3 mtm105 -89.7 23.34 2.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.74 6.77 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 453' ' ' VAL . . . . . 0.682 HG21 ' HG3' ' B' ' 462' ' ' GLN . 8.9 t -81.84 107.24 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.355 . . . . 0.0 109.314 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 60.4 m -123.74 -44.38 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 0.0 109.697 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 455' ' ' THR . . . . . 0.69 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -71.97 140.84 49.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 456' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' B' ' 485' ' ' ALA . 2.6 tm? -51.76 -37.91 53.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.14 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -63.07 -40.83 98.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.743 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 458' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' B' ' 453' ' ' VAL . 68.7 m-20 -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.089 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 459' ' ' LEU . . . . . 0.763 ' O ' HD13 ' B' ' 459' ' ' LEU . 3.5 tm? -59.65 -41.84 91.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.37 74.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.394 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.68 -25.76 62.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 462' ' ' GLN . . . . . 0.682 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.3 mm-40 -67.79 163.11 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.66 156.86 15.98 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 464' ' ' ILE . . . . . 1.001 HD11 ' HG2' ' A' ' 293' ' ' PRO . 58.6 mt -51.94 -34.95 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -1.182 . . . . 0.0 109.495 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -68.48 -35.95 78.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 466' ' ' ASP . . . . . 0.493 ' O ' ' NH1' ' B' ' 451' ' ' ARG . 87.3 m-20 -72.34 -31.52 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 467' ' ' LEU . . . . . 1.024 HD12 ' HB1' ' B' ' 478' ' ' ALA . 21.7 mt -74.41 -25.34 59.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -24.27 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -48.06 -33.58 8.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 470' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' B' ' 447' ' ' LYS . 61.3 mt -103.36 128.1 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.37 -31.82 72.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 472' ' ' GLY . . . . . 0.484 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -56.81 -30.92 60.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 473' ' ' LEU . . . . . 0.496 HD11 HD21 ' B' ' 448' ' ' LEU . 73.8 mt -101.53 131.03 47.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -1.185 . . . . 0.0 109.579 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.84 163.35 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 475' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 88.3 m-20 -57.87 -38.19 75.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -73.81 -46.04 47.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 477' ' ' LYS . . . . . 0.533 ' O ' HD13 ' B' ' 481' ' ' LEU . 15.7 tttp -64.78 -42.44 95.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 478' ' ' ALA . . . . . 1.024 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -61.55 -46.03 91.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 479' ' ' GLY . . . . . 0.457 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.33 -45.98 92.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.91 84.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -1.116 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 481' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.4 mp -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 482' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 293' ' ' PRO . 47.9 mt -66.89 -54.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 483' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 49.1 mtp -52.22 -37.41 55.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.395 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.49 -57.13 5.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.167 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' B' ' 456' ' ' LEU . . . -62.87 -52.09 64.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 486' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' B' ' 485' ' ' ALA . 21.6 ttm180 -46.27 -48.77 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.203 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 487' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' B' ' 483' ' ' MET . 89.2 m-20 -58.95 -41.5 87.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 488' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 492' ' ' GLY . 80.2 mt -58.93 -37.61 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 41.7 t -70.58 -49.12 51.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.606 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.41 -41.77 72.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 491' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 46.1 m-85 -79.78 -36.06 37.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 492' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' B' ' 494' ' ' GLU . . . 66.08 9.51 47.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 493' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' B' ' 488' ' ' ILE . 1.0 OUTLIER 63.96 -72.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -1.127 . . . . 0.0 109.607 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 494' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' B' ' 495' ' ' ALA . 89.2 mt-10 -91.28 150.65 21.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 109.441 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 495' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.506 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.569 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 38.4 p90 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.18 121.72 13.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.241 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.67 -26.56 60.96 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.645 2.23 . . . . 0.0 111.469 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.866 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.9 tt -69.59 -31.99 50.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.473 HD11 ' HE2' ' A' ' 316' ' ' MET . 34.2 mt -75.15 -45.16 42.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.4 -0.812 . . . . 0.0 109.39 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.913 HD21 HD11 ' A' ' 326' ' ' ILE . 0.3 OUTLIER -64.01 -37.35 87.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.453 ' CD ' ' OD2' ' A' ' 259' ' ' ASP . 5.2 ttp180 -59.6 141.86 88.1 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.241 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.2 Cg_endo -68.87 133.6 27.65 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.651 2.234 . . . . 0.0 111.691 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.582 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.0 OUTLIER -44.9 -25.36 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 256' ' ' PRO . 91.1 m-20 -69.58 -30.56 68.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.212 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 48.8 t0 -66.7 -22.55 66.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 257' ' ' VAL . 38.5 mt -43.62 131.44 5.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -55.93 -24.79 40.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.724 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.6 mp -62.35 163.59 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.3 p -62.87 161.09 13.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.796 HG12 ' OD1' ' A' ' 268' ' ' ASN . 20.4 t -54.76 -26.1 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -51.93 -44.11 63.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.436 ' CB ' ' OE1' ' A' ' 302' ' ' GLU . 8.7 t -58.79 -50.61 73.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -70.49 -33.56 71.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.796 ' OD1' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -56.42 -38.22 71.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 299' ' ' SER . 24.8 m -60.62 -64.6 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.701 HD13 HD23 ' A' ' 281' ' ' LEU . 63.7 mt -64.7 -46.64 81.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 76.9 tttt -52.98 -34.01 54.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.76 -23.59 12.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.9 mt-10 -89.05 22.59 2.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.89 36.48 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.78 HG23 ' HB3' ' A' ' 280' ' ' ASP . 70.6 mt -112.16 127.38 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.592 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.9 p80 -116.68 -30.28 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.588 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.592 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.8 m-30 -106.57 127.8 53.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.5 mt -48.26 -30.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.972 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.5 -48.64 16.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.78 ' HB3' HG23 ' A' ' 275' ' ' ILE . 40.0 t0 -53.39 -32.96 51.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.198 . . . . 0.0 108.899 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.759 ' C ' HD13 ' A' ' 281' ' ' LEU . 3.4 tm? -56.82 -46.95 81.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.386 -0.821 . . . . 0.0 109.111 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.972 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.1 m -69.01 -23.22 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 95.5 mt-30 -66.2 -36.98 84.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.948 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -104.4 143.06 33.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 288' ' ' GLU . 43.9 p -80.0 151.83 29.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.574 ' OE2' HD22 ' A' ' 307' ' ' LEU . 8.9 mt-10 -54.45 -39.46 67.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.8 t -52.98 -55.27 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 285' ' ' THR . 95.6 mt-10 -53.15 -30.58 37.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 292' ' ' THR . 8.4 mp -79.64 -42.42 24.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.7 mt -65.04 -12.75 54.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.491 ' C ' ' HE2' ' B' ' 483' ' ' MET . 45.7 mmtm -89.14 12.34 16.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.5 t -124.83 138.74 31.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.595 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.7 Cg_endo -70.82 -27.05 21.89 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.789 2.326 . . . . 0.0 111.78 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.473 ' ND2' HD12 ' B' ' 464' ' ' ILE . 26.2 m120 -48.32 -24.4 1.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 289' ' ' LEU . 20.3 mt -87.6 143.13 27.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.358 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -110.47 160.38 13.36 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.92 -42.27 72.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -1.156 . . . . 0.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -67.38 -37.84 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.364 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 269' ' ' CYS . 81.1 p -59.18 -39.4 82.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.337 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 290' ' ' LEU . 0.6 OUTLIER -57.99 -42.65 85.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.378 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 49.8 m -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.1 mt-10 -56.59 -42.8 79.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 80.7 mt -57.91 -48.26 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -54.74 -41.57 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -58.29 -51.42 69.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.6 t -68.72 -37.19 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.838 HD13 ' HB3' ' A' ' 313' ' ' SER . 20.0 tp -62.03 -26.43 68.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.315 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.23 -29.99 66.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.5 t -74.11 -13.37 60.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.2 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.774 ' HA ' HD11 ' A' ' 314' ' ' LEU . 51.2 mtt-85 61.17 13.51 4.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 109.307 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -88.98 -24.56 31.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.6 pt? -139.32 153.25 47.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -1.139 . . . . 0.0 109.562 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.838 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 71.45 32.62 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.774 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.5 mm? -89.27 14.12 11.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.268 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.5 44.88 92.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.719 ' HE2' HG11 ' A' ' 282' ' ' VAL . 8.0 mtm -94.21 168.75 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.494 ' C ' HD23 ' A' ' 318' ' ' LEU . 53.6 mtt180 -134.05 121.61 21.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 317' ' ' ARG . 5.2 mt -113.4 138.11 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.383 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.58 -32.17 67.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.159 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 72.3 m-20 -135.05 -64.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 108.988 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.837 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.2 t-105 164.73 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.371 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.565 ' HA ' HD12 ' A' ' 326' ' ' ILE . 48.2 Cg_endo -68.09 107.91 1.63 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.595 2.197 . . . . 0.0 111.967 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.51 163.07 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.667 2.245 . . . . 0.0 111.689 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.18 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.41 ' CB ' ' N ' ' A' ' 249' ' ' PHE . 3.8 t -58.73 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.913 HD11 HD21 ' A' ' 254' ' ' LEU . 30.3 mt . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.46 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.455 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 3.1 tttp -67.77 136.52 92.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.512 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.31 136.53 31.75 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.69 2.26 . . . . 0.0 111.724 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -71.13 159.51 34.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.38 -33.77 63.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.73 -48.32 77.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -38.4 75.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.891 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -73.06 -31.44 64.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -84.83 7.73 19.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.774 HD23 HG21 ' B' ' 440' ' ' VAL . 30.1 tp -72.28 133.83 45.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.86 140.83 40.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.16 2.96 68.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.774 HG21 HD23 ' B' ' 437' ' ' LEU . 58.8 t -130.82 137.15 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -1.187 . . . . 0.0 109.421 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 39.6 p30 -103.75 173.55 6.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.565 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 74.8 mtt85 -58.31 -40.52 82.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.63 -49.53 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.64 HD22 HD21 ' B' ' 473' ' ' LEU . 45.8 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.544 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.29 89.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 17.3 m-30 -66.18 -47.99 72.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 470' ' ' ILE . 61.6 mttt -58.88 -46.38 87.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.585 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.865 ' O ' HD13 ' B' ' 448' ' ' LEU . 3.1 tm? -64.12 -41.17 97.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.36 -30.68 71.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -56.79 -18.52 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.401 ' NH1' ' CB ' ' B' ' 469' ' ' ASP . 14.3 mtp85 -90.65 31.6 1.04 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.82 -18.88 6.84 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' B' ' 458' ' ' ASP . 96.3 t -63.51 139.87 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.878 -1.366 . . . . 0.0 109.382 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.511 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -135.01 -36.01 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 109.701 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -111.04 148.63 32.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 1.069 HD21 HD12 ' B' ' 488' ' ' ILE . 30.0 tp -46.17 -40.14 10.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.167 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -56.75 -49.65 74.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.848 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.759 ' HB3' HG13 ' B' ' 453' ' ' VAL . 37.4 t0 -54.8 -38.78 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.108 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.776 ' C ' HD13 ' B' ' 459' ' ' LEU . 2.9 tm? -60.04 -41.49 92.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.14 76.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 0.0 109.393 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.93 -30.77 71.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.474 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -67.53 151.85 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 109.565 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.84 165.82 12.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.884 HD11 ' HG2' ' A' ' 293' ' ' PRO . 28.9 mt -53.28 -35.75 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -1.209 . . . . 0.0 109.4 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.02 -31.27 67.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.999 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -75.44 -29.05 59.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -23.75 62.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . 0.401 ' CB ' ' NH1' ' B' ' 451' ' ' ARG . 86.3 m-20 -50.1 -33.97 20.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 447' ' ' LYS . 65.6 mt -100.89 127.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.25 -33.09 74.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.04 -31.56 40.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.64 HD21 HD22 ' B' ' 444' ' ' LEU . 50.5 mt -101.11 140.49 35.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.449 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.11 161.85 13.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.389 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.449 ' N ' HG22 ' B' ' 474' ' ' THR . 81.3 m-20 -57.91 -37.62 74.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -73.88 -46.06 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 39.2 tttp -68.74 -37.02 79.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.999 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.08 -44.68 91.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -63.87 -43.1 98.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.82 -33.97 70.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -1.125 . . . . 0.0 109.406 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 31.0 mt -74.39 -35.16 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 478' ' ' ALA . 78.6 mt -64.03 -53.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.537 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.508 ' HE1' ' O ' ' A' ' 290' ' ' LEU . 52.6 mmm -60.74 -42.48 97.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 109.426 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.44 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -58.29 -47.36 83.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -66.0 -47.68 73.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.536 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.505 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 40.2 ttm180 -60.8 -42.62 97.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.48 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 95.9 m-20 -58.85 -39.25 80.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 1.069 HD12 HD21 ' B' ' 456' ' ' LEU . 66.1 mt -62.27 -40.35 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.82 -52.06 16.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.679 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . 0.505 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 67.2 m95 -64.44 -38.48 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.9 m-85 -99.19 13.1 34.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.784 ' N ' ' HG ' ' A' ' 325' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.4 126.56 84.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.46 -32.21 50.01 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.794 2.329 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 278' ' ' ILE . 2.9 tt -66.27 -23.55 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 311' ' ' GLY . 5.3 tp -74.28 -44.12 54.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.459 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 326' ' ' ILE . 2.2 mm? -73.63 -20.36 60.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.555 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -63.87 149.87 92.41 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.0 Cg_endo -69.86 136.31 32.41 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.604 2.202 . . . . 0.0 111.934 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.542 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.79 -31.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.885 . . . . 0.0 109.424 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.35 -30.95 71.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 256' ' ' PRO . 53.8 m-20 -73.03 -14.09 61.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.631 HD21 HD13 ' A' ' 278' ' ' ILE . 59.4 mt -54.13 150.73 7.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.12 -21.52 65.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.811 HD22 ' OG ' ' A' ' 266' ' ' SER . 5.3 mp -64.64 166.08 9.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -79.88 165.27 22.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 264' ' ' VAL . 3.9 t -47.0 -32.85 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.457 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -52.78 -50.21 64.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.811 ' OG ' HD22 ' A' ' 262' ' ' LEU . 22.2 t -59.53 -51.11 71.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.34 86.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.315 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.6 m-20 -56.64 -36.89 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.339 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 60.0 m -55.41 -64.98 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.641 ' CD2' HD12 ' A' ' 289' ' ' LEU . 65.2 mt -62.41 -47.69 82.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 23.2 tttt -53.02 -36.88 61.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.79 -30.0 30.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.9 mt-10 -94.01 23.99 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.377 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.07 41.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 280' ' ' ASP . 90.3 mt -122.82 107.66 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.519 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.472 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 64.0 m-70 -109.71 -6.75 15.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.35 129.24 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.719 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.9 mt -54.72 -30.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.793 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.02 -46.78 14.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.676 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.4 m-20 -53.48 -30.9 43.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.038 -1.272 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 270' ' ' LEU . 31.4 tp -59.26 -49.9 76.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 109.136 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 279' ' ' GLY . 30.2 m -67.51 -30.55 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 108.967 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.44 -32.83 70.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 108.949 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -109.84 143.84 39.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.0 m -63.7 137.96 58.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.412 ' OE1' ' CD2' ' A' ' 307' ' ' LEU . 80.4 tt0 -50.58 -33.51 22.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.387 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 1.046 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.2 t -54.86 -54.34 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -51.15 -30.72 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.24 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.996 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -79.15 -43.67 23.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.257 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 1.046 HD12 ' HA ' ' A' ' 287' ' ' VAL . 5.4 mt -56.85 -18.73 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.645 ' O ' ' HE2' ' B' ' 483' ' ' MET . 69.5 mttt -81.44 -21.94 38.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.357 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 294' ' ' ASN . 9.8 m -59.49 128.52 86.12 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.634 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.675 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.8 Cg_endo -71.16 -14.84 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.804 2.336 . . . . 0.0 112.001 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' B' ' 464' ' ' ILE . 53.2 m-80 -78.47 3.65 15.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.996 HD11 ' O ' ' A' ' 289' ' ' LEU . 72.1 mt -81.33 149.55 28.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.517 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -108.63 140.92 15.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -52.81 -47.13 67.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -1.188 . . . . 0.0 109.455 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.99 -25.31 59.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 296' ' ' GLY . 82.5 p -73.13 -36.8 66.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 295' ' ' LEU . 29.7 mt -54.31 -39.24 66.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -54.26 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 306' ' ' VAL . 67.7 tt0 -53.82 -39.97 65.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 109.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 300' ' ' LEU . 84.5 mt -57.63 -45.85 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 108.917 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.11 -33.93 74.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 108.964 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.42 -41.58 97.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 109.248 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 1.04 HG12 ' CD2' ' A' ' 312' ' ' LEU . 1.7 t -68.25 -45.65 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.441 HD12 HD11 ' A' ' 312' ' ' LEU . 8.2 mp -56.43 -26.77 54.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.11 70.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.0 t -65.51 -17.39 64.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.897 ' O ' HD21 ' A' ' 314' ' ' LEU . 11.7 ttp180 65.93 9.07 5.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.368 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.619 ' O ' HD13 ' A' ' 253' ' ' LEU . . . -94.95 -0.3 63.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.04 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.29 163.09 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -1.215 . . . . 0.0 109.44 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.2 OUTLIER 48.47 54.96 9.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.641 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 310' ' ' ARG . 76.7 mt -91.81 9.39 32.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.36 38.22 96.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.533 ' CE ' HD12 ' A' ' 314' ' ' LEU . 5.6 ptt? -113.3 157.44 21.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.603 ' C ' HD12 ' A' ' 318' ' ' LEU . 77.6 mtt85 -130.23 137.72 50.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.8 mp -123.47 140.89 52.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 108.951 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.5 m-20 -122.45 -81.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.673 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 165.24 -65.98 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 50.7 Cg_endo -69.47 107.77 1.88 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.563 2.175 . . . . 0.0 111.95 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.587 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.1 Cg_endo -71.91 163.91 37.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.622 2.214 . . . . 0.0 111.6 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.6 25.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.969 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.784 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 62.1 p -70.54 -38.97 74.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.46 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 254' ' ' LEU . 34.3 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 -179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.827 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 24.3 m120 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.234 0.54 . . . . 0.0 109.645 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 20.0 tttm -53.03 136.89 47.48 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.489 ' HD2' ' HG3' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.09 136.76 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.641 2.227 . . . . 0.0 111.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.1 153.23 41.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.513 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -47.06 -38.6 11.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -62.29 -40.73 97.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.996 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.5 tm? -66.66 -29.87 69.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 442' ' ' ARG . 25.2 tp -85.69 -28.52 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.85 -5.81 43.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.908 HD23 HG21 ' B' ' 440' ' ' VAL . 35.4 tp -65.82 134.81 53.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -78.26 141.19 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.3 8.34 64.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.908 HG21 HD23 ' B' ' 437' ' ' LEU . 46.6 t -128.19 132.22 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.164 . . . . 0.0 109.471 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.577 ' H ' HD12 ' B' ' 444' ' ' LEU . 83.7 m-20 -97.89 166.0 11.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.405 ' HG2' HD11 ' B' ' 435' ' ' LEU . 92.7 mtt180 -54.7 -43.14 72.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.411 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.1 m-20 -66.15 -50.15 64.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.577 HD12 ' H ' ' B' ' 441' ' ' ASP . 29.7 mt -55.74 -43.43 76.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.09 -37.85 78.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.6 m-30 -64.59 -45.12 88.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 470' ' ' ILE . 81.5 mttt -62.86 -45.17 93.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 0.0 109.438 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.855 ' O ' HD13 ' B' ' 448' ' ' LEU . 1.4 tm? -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.14 -28.89 68.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.24 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -93.24 32.06 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.392 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.43 -18.61 6.65 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' B' ' 458' ' ' ASP . 84.3 t -60.9 139.48 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.9 -1.353 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 10.9 m -135.05 -35.88 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.769 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.59 159.39 20.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.896 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.771 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -48.56 -41.37 30.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.288 -0.883 . . . . 0.0 109.027 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -55.59 -42.28 74.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 0.0 108.766 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.91 ' CB ' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -59.86 -43.55 94.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 108.893 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.687 HD12 HD21 ' B' ' 434' ' ' LEU . 5.8 tt -54.31 -49.15 70.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 0.0 109.172 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.99 71.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.98 -25.71 67.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.357 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.5 mm-40 -70.48 152.23 44.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' B' ' 467' ' ' LEU . . . -116.12 162.84 12.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.675 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.2 mt -49.68 -36.67 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.5 -37.06 79.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.06 -25.12 66.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.876 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.6 mp -91.42 -27.72 18.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 0.0 109.484 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.85 -23.2 66.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.458 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.13 -32.85 68.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' B' ' 447' ' ' LYS . 73.5 mt -99.84 128.72 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.588 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.67 -32.37 74.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.462 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.38 -28.8 51.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.644 HD13 HD23 ' B' ' 467' ' ' LEU . 60.7 mt -103.68 137.19 42.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.504 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 475' ' ' ASP . 7.0 m -104.06 165.8 10.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.417 ' N ' HG22 ' B' ' 474' ' ' THR . 92.4 m-20 -58.68 -39.23 80.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.45 -45.39 31.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.463 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.51 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 48.0 tttm -60.75 -46.47 90.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.876 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -62.98 -53.22 57.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.516 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -58.38 -48.0 86.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.0 62.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -1.116 . . . . 0.0 109.388 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 96.5 mt -61.9 -43.67 98.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.5 mt -53.44 -56.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.645 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 50.1 mtp -52.93 -46.17 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.57 -52.93 63.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.477 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -61.75 -48.84 78.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 34.4 ttt180 -56.16 -45.28 79.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.83 -34.06 72.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.743 HD12 HD11 ' B' ' 456' ' ' LEU . 79.7 mt -68.31 -39.4 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.519 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.8 -50.59 16.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . 0.531 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 36.3 m95 -58.7 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.18 10.91 31.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.83 ' CZ ' HD21 ' A' ' 318' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -52.71 141.22 36.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.183 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.637 ' HA ' HD23 ' A' ' 254' ' ' LEU . 43.1 Cg_endo -65.0 -23.04 61.86 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.652 2.234 . . . . 0.0 111.903 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.923 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -64.77 -32.09 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.122 -0.986 . . . . 0.0 108.707 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.667 HD21 HG11 ' A' ' 282' ' ' VAL . 5.3 mp -74.34 -30.96 62.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.194 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 254' ' ' LEU . 3.5 mm? -69.13 -40.0 78.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.452 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -61.72 147.58 88.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 255' ' ' ARG . 48.3 Cg_endo -70.24 138.73 36.97 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.683 2.256 . . . . 0.0 111.701 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -43.5 -36.05 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.807 . . . . 0.0 109.461 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.49 -31.33 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 256' ' ' PRO . 70.6 m-20 -75.45 -11.0 59.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 257' ' ' VAL . 61.0 mt -47.47 143.54 3.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -59.94 -18.17 43.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.867 HD11 HG21 ' A' ' 306' ' ' VAL . 6.3 mp -67.86 167.1 14.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.9 p -69.53 160.23 31.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.718 HG12 HD21 ' A' ' 268' ' ' ASN . 14.0 t -50.5 -39.25 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -53.66 -48.96 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.9 m -57.78 -50.56 72.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.87 81.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.299 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.718 HD21 HG12 ' A' ' 264' ' ' VAL . 94.2 m-20 -58.51 -36.68 74.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.2 m -55.76 -65.03 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.436 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 281' ' ' LEU . 75.2 mt -58.03 -46.68 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 24.6 tttt -53.46 -37.74 62.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.37 -24.81 13.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.618 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.7 mm-40 -89.35 23.71 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.93 38.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 280' ' ' ASP . 20.0 mm -112.29 121.53 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.449 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 8.3 p80 -113.13 -33.2 6.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.436 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.2 m-85 -109.8 131.28 55.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.591 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 252' ' ' ILE . 76.6 mt -48.88 -30.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.179 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.62 -45.35 23.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.863 ' HB2' HG23 ' A' ' 275' ' ' ILE . 57.3 m-20 -53.68 -35.02 60.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 109.078 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 270' ' ' LEU . 35.5 tp -56.28 -48.3 76.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 109.258 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.6 m -71.94 -35.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.013 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -51.54 -34.9 38.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.338 -0.851 . . . . 0.0 108.89 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -112.36 143.62 43.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.391 -0.818 . . . . 0.0 109.095 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 m -59.93 138.77 57.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.617 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -61.96 -28.53 69.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.93 -53.13 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 71.1 mm-40 -51.66 -35.86 44.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.979 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -76.65 -36.27 57.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.066 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 1.008 HD13 ' O ' ' A' ' 290' ' ' LEU . 2.0 tm? -56.43 -29.17 61.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' B' ' 483' ' ' MET . 9.1 mttt -81.68 -18.84 43.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 294' ' ' ASN . 11.3 m -58.82 129.12 85.09 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.6 Cg_endo -70.46 -10.4 27.92 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.812 2.342 . . . . 0.0 111.83 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' B' ' 464' ' ' ILE . 32.6 m120 -79.66 4.09 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.979 HD11 ' O ' ' A' ' 289' ' ' LEU . 66.1 mt -84.0 146.99 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -111.66 141.6 16.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -48.74 -50.87 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.51 -33.97 71.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 303' ' ' ILE . 37.4 m -61.98 -40.79 96.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 295' ' ' LEU . 46.1 mt -52.97 -42.86 65.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.7 m -54.72 -50.83 67.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 306' ' ' VAL . 98.3 mt-10 -58.73 -39.23 80.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.798 HG22 HD13 ' A' ' 307' ' ' LEU . 23.9 mm -58.07 -47.32 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -60.56 -38.16 83.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.05 -46.4 89.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.359 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.954 ' CG1' HD21 ' A' ' 312' ' ' LEU . 2.0 t -70.19 -44.86 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.798 HD13 HG22 ' A' ' 303' ' ' ILE . 6.6 mp -62.78 -27.2 69.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.498 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.98 -33.26 70.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 66.2 p -77.49 -5.04 48.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 109.548 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.959 ' O ' HD21 ' A' ' 314' ' ' LEU . 8.9 mtt85 63.73 10.49 5.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.219 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -73.07 -22.23 79.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.954 HD21 ' CG1' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -146.64 163.1 36.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.379 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.7 OUTLIER 65.9 28.8 10.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.959 HD21 ' O ' ' A' ' 310' ' ' ARG . 93.4 mt -66.34 -14.41 62.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.24 11.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.673 ' HE3' HG21 ' A' ' 282' ' ' VAL . 4.6 ptt? -111.47 162.22 15.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.114 . . . . 0.0 109.448 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.542 ' C ' HD12 ' A' ' 318' ' ' LEU . 87.3 mtt-85 -130.76 133.49 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 249' ' ' PHE . 4.6 mp -118.3 145.29 45.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.79 -34.04 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 37.8 t-20 -125.94 -71.26 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.299 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.7 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.7 OUTLIER 167.43 -68.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.0 Cg_endo -69.7 107.88 1.94 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.504 2.136 . . . . 0.0 111.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.566 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 51.0 Cg_endo -72.1 158.12 52.86 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.529 2.153 . . . . 0.0 111.573 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.6 -15.69 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.378 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.1 m -68.55 -44.34 74.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 322' ' ' PRO . 24.5 pt . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.784 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 21.3 m120 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.43 ' CG ' ' HD2' ' B' ' 430' ' ' PRO . 9.8 tttt -51.21 139.92 24.07 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.07 142.45 46.6 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.65 2.233 . . . . 0.0 111.933 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.55 150.35 41.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.34 -36.71 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -65.26 -46.36 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.774 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -67.87 -37.82 82.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.883 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.7 OUTLIER -69.16 -31.08 69.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.515 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -89.02 9.88 23.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.877 HD22 ' CD1' ' B' ' 456' ' ' LEU . 43.0 tp -72.43 133.56 44.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.87 142.1 40.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.77 6.57 67.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.824 HG21 HD23 ' B' ' 437' ' ' LEU . 57.4 t -127.62 131.38 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -83.75 149.04 26.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.516 ' HG3' ' NH1' ' B' ' 442' ' ' ARG . 9.4 mtt85 -50.02 -45.81 52.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.09 -39.46 82.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' B' ' 473' ' ' LEU . 15.8 tp -58.88 -37.77 77.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -60.7 -42.01 96.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.8 m-85 -64.69 -44.24 90.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.529 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 13.7 ttmm -58.63 -48.55 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.825 HD13 ' O ' ' B' ' 448' ' ' LEU . 3.4 tm? -65.17 -41.24 94.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.835 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -57.25 -26.84 61.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.68 -20.53 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.948 . . . . 0.0 109.472 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -89.75 26.59 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.942 . . . . 0.0 109.564 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.88 7.13 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 57.6 t -62.32 135.82 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.306 . . . . 0.0 109.326 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 69.0 m -135.01 -36.96 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.63 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -103.72 146.56 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 1.014 ' CD2' HD12 ' B' ' 488' ' ' ILE . 36.4 tp -47.69 -42.81 25.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -55.86 -46.53 78.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.041 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.78 -41.58 74.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 108.913 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.762 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.3 tm? -57.4 -43.92 84.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.111 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -59.94 -36.37 76.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.326 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -30.13 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.2 mm-40 -75.12 140.76 43.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -100.03 163.53 19.29 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 294' ' ' ASN . 81.3 mt -47.52 -33.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.07 -36.28 79.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.424 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 86.8 m-20 -68.66 -30.61 69.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.9 mp -82.73 -30.05 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.328 -0.858 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.09 58.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.09 -30.5 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.529 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 63.9 mt -104.92 123.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.74 -31.7 71.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.37 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.456 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -52.13 -32.69 36.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.7 mm? -103.13 138.78 39.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.224 -1.162 . . . . 0.0 109.54 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.461 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.7 m -104.04 161.87 13.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.877 . . . . 0.0 109.333 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.461 ' N ' HG22 ' B' ' 474' ' ' THR . 87.5 m-20 -57.45 -38.08 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.81 -45.95 26.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.584 ' HE2' HD22 ' B' ' 444' ' ' LEU . 19.0 tttt -66.14 -47.19 74.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -59.24 -46.74 87.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.515 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.18 -49.88 68.77 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.35 54.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -1.185 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 440' ' ' VAL . 26.4 mt -56.62 -37.6 70.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 50.4 mt -63.33 -51.08 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.414 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.592 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 23.6 mtp -52.61 -48.41 66.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -55.71 -55.74 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.408 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.623 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -59.46 -47.98 83.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 75.1 mtt180 -62.8 -40.98 99.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.0 m-20 -58.24 -44.93 88.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 1.014 HD12 ' CD2' ' B' ' 456' ' ' LEU . 57.2 mt -61.6 -37.56 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -52.02 10.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -61.33 -31.59 71.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 13.1 m-30 -71.0 -33.69 70.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.592 ' HE2' HD22 ' A' ' 318' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 252' ' ' ILE . 9.9 m-20 -55.95 150.37 29.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.56 -25.28 55.16 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.749 2.299 . . . . 0.0 111.643 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.1 tt -68.6 -27.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 109.179 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 312' ' ' LEU . 26.8 mt -74.11 -45.24 50.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.916 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.5 OUTLIER -63.88 -34.65 78.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.478 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -55.91 141.74 66.23 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.156 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.0 Cg_endo -69.03 133.95 28.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.695 2.263 . . . . 0.0 111.742 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.41 -34.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 271' ' ' LYS . 55.3 t0 -59.44 -30.97 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 m-20 -73.75 -17.12 61.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 257' ' ' VAL . 51.5 mt -43.5 144.95 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -63.92 -22.06 66.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.2 mp -65.56 166.84 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.2 p -66.71 166.59 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.557 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 268' ' ' ASN . 6.6 t -57.35 -36.47 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 109.639 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.14 -48.65 70.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 262' ' ' LEU . 95.2 p -57.94 -51.04 71.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.62 -42.41 99.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.649 HD21 HG12 ' A' ' 264' ' ' VAL . 89.1 m-20 -56.58 -37.44 70.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 85.4 m -50.37 -60.48 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.32 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 281' ' ' LEU . 74.0 mt -57.51 -45.06 85.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.376 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 275' ' ' ILE . 82.3 mttt -52.92 -29.91 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.359 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.14 -34.32 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 45.1 mt-10 -90.53 26.13 2.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.21 40.91 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 22.7 mm -108.14 124.24 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.432 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.575 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -115.83 -37.27 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.37 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.575 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -106.32 133.04 51.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.831 HD12 ' O ' ' A' ' 252' ' ' ILE . 88.7 mt -46.72 -30.36 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.34 -48.64 15.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 94.0 m-20 -53.24 -31.27 42.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.004 -1.292 . . . . 0.0 108.727 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 270' ' ' LEU . 44.9 tp -55.72 -51.9 65.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.5 m -64.39 -28.26 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 108.832 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.75 -34.89 73.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.848 . . . . 0.0 108.903 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 284' ' ' ARG . 18.6 mtt-85 -107.07 144.29 33.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.256 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.8 m -68.43 143.4 55.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 0.0 109.559 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.437 ' HA ' HD23 ' A' ' 289' ' ' LEU . 50.4 tp10 -55.62 -30.25 60.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.62 -51.61 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -51.91 -33.97 39.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.388 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.2 mm? -74.68 -30.52 61.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.77 -30.91 70.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.533 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.73 -12.7 58.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.168 -0.958 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 23.8 m -79.38 117.67 68.33 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.648 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.952 ' HG2' HD11 ' B' ' 464' ' ' ILE . 48.4 Cg_endo -69.86 -20.43 34.39 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.784 2.322 . . . . 0.0 111.866 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.449 ' CG ' HD12 ' B' ' 464' ' ' ILE . 53.0 m-80 -48.85 -31.41 7.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.617 HD21 ' O ' ' A' ' 289' ' ' LEU . 0.5 OUTLIER -105.02 144.63 31.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -85.83 169.23 42.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HG2' ' NH2' ' B' ' 486' ' ' ARG . 44.7 mttt -64.92 -40.9 95.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -1.145 . . . . 0.0 109.479 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -59.78 -40.12 87.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 303' ' ' ILE . 24.6 m -57.57 -41.55 81.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.952 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.2 tm? -54.83 -37.04 65.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 27.5 m -55.75 -59.42 4.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.219 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 305' ' ' ASP . 75.2 tt0 -54.92 -44.47 74.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 67.8 mt -57.48 -52.38 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 108.856 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -53.28 -36.41 61.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.312 -0.867 . . . . 0.0 108.675 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 302' ' ' GLU . 62.5 t0 -57.46 -48.14 79.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 108.913 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.634 HG12 HD22 ' A' ' 312' ' ' LEU . 11.6 t -66.17 -34.81 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.939 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 313' ' ' SER . 21.4 mt -64.23 -26.66 68.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.42 -29.99 66.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.117 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 79.8 p -79.14 -7.94 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.658 ' O ' HD11 ' A' ' 314' ' ' LEU . 73.6 mtt85 61.76 13.15 5.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -73.03 -36.15 57.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 312' ' ' LEU . 2.1 pt? -135.05 159.37 41.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 109.688 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.712 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.2 OUTLIER 61.31 63.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.892 . . . . 0.0 109.677 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.788 ' N ' HD22 ' A' ' 314' ' ' LEU . 3.2 mm? -96.32 12.38 31.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.65 92.28 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.462 ' CE ' ' CE1' ' A' ' 249' ' ' PHE . 10.9 ptt? -114.36 150.63 34.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -109.12 133.34 53.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.592 HD22 ' HE2' ' A' ' 249' ' ' PHE . 6.1 mt -106.75 138.48 42.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.898 . . . . 0.0 109.349 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.69 -47.21 82.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.017 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 36.2 t-20 -126.64 -59.04 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 108.976 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.916 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 163.4 -65.52 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.283 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.584 ' HA ' HD11 ' A' ' 326' ' ' ILE . 48.4 Cg_endo -69.03 107.67 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.624 2.216 . . . . 0.0 111.923 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 51.0 Cg_endo -71.31 161.0 47.14 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.591 2.194 . . . . 0.0 111.45 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.2 -15.37 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.8 t -69.57 -46.42 66.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.584 HD11 ' HA ' ' A' ' 322' ' ' PRO . 22.2 pt . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 109.504 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 31.1 m120 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.322 0.582 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.457 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 33.3 tttt -64.52 136.84 96.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.7 139.69 37.52 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.607 2.205 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -66.03 156.03 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -54.77 -36.99 65.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -62.63 -48.74 78.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.77 HD13 ' C ' ' B' ' 434' ' ' LEU . 3.0 tm? -65.83 -35.52 80.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.946 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.422 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -85.34 6.29 27.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 1.042 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.9 tp -75.42 131.55 40.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.28 145.2 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.906 . . . . 0.0 109.507 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.19 7.5 67.68 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.802 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -124.43 129.5 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.414 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -85.13 147.39 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.06 -43.62 51.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.538 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 90.6 m-20 -70.3 -41.06 73.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' B' ' 473' ' ' LEU . 10.5 tp -58.49 -46.11 87.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.707 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.26 -39.34 82.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 15.9 m-30 -60.29 -43.79 95.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.01 -44.88 95.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.944 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.4 tm? -67.31 -38.08 84.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.39 -28.25 68.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -55.33 -18.92 7.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.445 ' NE ' HD11 ' B' ' 470' ' ' ILE . 33.6 mtt-85 -91.39 30.38 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.85 -18.9 6.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.628 HG13 ' CB ' ' B' ' 458' ' ' ASP . 46.4 t -61.63 136.07 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.893 -1.357 . . . . 0.0 109.326 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 9.4 m -135.17 -37.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -102.49 147.76 26.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 1.042 ' CD1' HD22 ' B' ' 437' ' ' LEU . 16.3 tp -47.2 -41.81 18.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.056 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.85 -47.27 77.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.864 . . . . 0.0 109.028 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.628 ' CB ' HG13 ' B' ' 453' ' ' VAL . 74.8 m-20 -55.14 -44.72 75.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.11 -49.91 65.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.801 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -54.54 -39.36 67.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.65 -34.69 67.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.426 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -63.65 151.77 40.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.25 154.12 16.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' A' ' 293' ' ' PRO . 60.3 mt -45.09 -40.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -1.177 . . . . 0.0 109.228 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.36 -43.06 92.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.296 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 469' ' ' ASP . 78.1 m-20 -63.41 -23.79 67.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.798 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.8 mp -93.09 -19.23 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.22 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.535 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . 0.476 ' OD1' HG13 ' B' ' 470' ' ' ILE . 18.6 p30 -79.29 3.7 17.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' B' ' 473' ' ' LEU . 36.4 mt -105.53 126.63 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.965 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.45 133.33 52.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.11 -30.16 10.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.966 ' CD2' HD11 ' B' ' 444' ' ' LEU . 64.8 mt -88.21 128.72 35.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -1.16 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.9 m -104.01 162.15 13.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.492 ' N ' HG22 ' B' ' 474' ' ' THR . 86.7 m-20 -58.97 -36.76 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -76.95 -43.32 35.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.638 ' O ' HD13 ' B' ' 481' ' ' LEU . 76.6 tttt -61.58 -47.58 84.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.798 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.66 -40.84 97.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.482 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.73 -38.08 95.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.27 77.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -1.216 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.638 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.6 mp -68.81 -27.05 65.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.474 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 293' ' ' PRO . 52.3 mt -77.08 -56.5 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 60.2 mtp -52.81 -38.3 61.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.83 14.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 109.317 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' B' ' 460' ' ' ALA . . . -61.35 -45.96 92.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.801 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 42.2 mtp180 -57.42 -45.67 84.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 91.3 m-20 -57.96 -37.13 73.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' B' ' 456' ' ' LEU . 63.6 mt -68.88 -36.99 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.52 -50.37 15.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.397 -0.814 . . . . 0.0 109.561 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.47 -43.51 90.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.917 . . . . 0.0 109.601 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 98.7 m-85 -95.46 12.41 29.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.92 ' CE2' HD21 ' A' ' 318' ' ' LEU . 34.0 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.436 ' HB2' HG22 ' A' ' 252' ' ' ILE . 4.1 m-20 -56.62 151.14 32.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.04 -24.13 60.27 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.455 2.103 . . . . 0.0 111.72 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.642 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.9 tt -58.94 -32.42 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.892 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.3 mp -74.26 -35.39 63.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.942 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 326' ' ' ILE . 2.6 mm? -72.2 -20.07 61.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.779 . . . . 0.0 109.189 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -78.08 144.33 67.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 49.5 Cg_endo -69.61 139.16 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.809 2.34 . . . . 0.0 111.907 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.34 -34.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.294 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.78 -30.79 71.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.3 m-20 -76.95 -9.74 58.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.407 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.855 HD21 HD13 ' A' ' 278' ' ' ILE . 74.3 mt -57.32 144.91 34.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.92 -18.93 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.68 HD11 HG21 ' A' ' 306' ' ' VAL . 6.7 mp -64.49 169.69 4.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.5 p -75.45 164.25 26.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 109.629 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.536 HG12 ' ND2' ' A' ' 268' ' ' ASN . 14.1 t -52.65 -27.48 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -59.82 -41.91 92.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.15 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' HD22 ' A' ' 262' ' ' LEU . 26.4 t -60.66 -50.42 73.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.56 83.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.942 . . . . 0.0 109.296 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.536 ' ND2' HG12 ' A' ' 264' ' ' VAL . 94.8 m-20 -58.74 -40.1 82.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 73.3 m -52.08 -65.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 1.012 HD21 HD12 ' A' ' 281' ' ' LEU . 6.6 mp -65.24 -42.36 93.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.283 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.564 ' HE2' ' CE1' ' A' ' 276' ' ' HIS . 50.3 tttm -52.79 -40.11 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.26 -26.69 12.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.5 mt-10 -91.85 20.63 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 37.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 280' ' ' ASP . 77.7 mt -124.01 107.88 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.564 ' CE1' ' HE2' ' A' ' 271' ' ' LYS . 61.5 m-70 -107.37 -4.85 18.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.1 m-85 -112.94 133.55 54.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.42 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.855 HD13 HD21 ' A' ' 260' ' ' LEU . 50.7 mt -62.1 -30.99 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.191 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.974 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -48.62 -45.82 30.3 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.627 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.0 m-20 -53.61 -36.54 62.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -1.114 . . . . 0.0 109.153 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 312' ' ' LEU . 4.3 tt -53.15 -49.12 67.24 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.948 . . . . 0.0 108.953 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.4 m -67.46 -22.97 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.114 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -65.82 -33.33 75.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.002 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -105.29 143.51 33.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.044 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 m -59.99 138.04 57.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.412 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 85.2 tt0 -55.64 -29.53 59.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.32 -50.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -51.72 -37.54 51.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -69.72 -37.66 76.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.702 ' CD1' HD22 ' A' ' 300' ' ' LEU . 37.3 tp -64.4 -26.27 68.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.307 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.458 ' O ' ' HE2' ' B' ' 483' ' ' MET . 35.8 mttm -93.01 25.9 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -114.21 134.84 22.16 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.163 -0.96 . . . . 0.0 109.487 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.989 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.3 Cg_endo -71.92 -24.33 21.08 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.839 2.36 . . . . 0.0 112.018 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.415 ' OD1' HD12 ' B' ' 464' ' ' ILE . 75.7 m-80 -57.79 -28.69 64.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 295' ' ' LEU . 5.0 mp -94.54 125.4 39.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.9 171.5 32.96 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HE3' ' OE2' ' B' ' 461' ' ' GLU . 24.8 mttm -51.89 -36.71 49.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -75.01 -38.57 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.592 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.4 m -57.61 -49.06 77.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 290' ' ' LEU . 23.9 tp -52.81 -42.87 65.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 56.9 m -52.45 -53.51 44.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.8 mt-10 -54.07 -39.69 66.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -0.944 . . . . 0.0 109.069 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 295' ' ' LEU . 76.5 mt -58.47 -43.22 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.117 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -60.73 -41.51 95.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.264 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -58.28 -47.13 84.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.935 . . . . 0.0 109.225 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.68 HG21 HD11 ' A' ' 262' ' ' LEU . 2.2 t -73.28 -37.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.565 HD11 ' OG ' ' A' ' 313' ' ' SER . 0.1 OUTLIER -60.95 -26.41 67.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 310' ' ' ARG . . . -58.22 -32.06 67.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -60.55 -13.99 17.28 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 109.843 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.783 ' C ' HD21 ' A' ' 314' ' ' LEU . 75.0 mtm-85 63.67 9.83 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.892 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -113.08 -7.65 21.09 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.079 HD11 HD22 ' A' ' 281' ' ' LEU . 7.9 tp -127.04 130.68 50.43 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.188 -1.183 . . . . 0.0 109.335 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.738 ' H ' HG12 ' A' ' 282' ' ' VAL . 12.8 t 68.84 56.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.764 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.783 HD21 ' C ' ' A' ' 310' ' ' ARG . 11.2 mt -105.66 21.57 17.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.149 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.97 39.82 94.65 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.564 ' CE ' HD21 ' A' ' 253' ' ' LEU . 3.1 mtm -86.79 170.08 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 318' ' ' LEU . 40.6 mtt85 -143.28 126.24 16.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.92 HD21 ' CE2' ' A' ' 249' ' ' PHE . 4.0 mp -124.3 134.0 53.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 109.708 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.9 -39.89 95.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.912 . . . . 0.0 108.988 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 78.4 m-20 -119.1 -75.3 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.682 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 1.1 t-105 168.73 -58.3 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.496 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.0 Cg_endo -68.49 107.49 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.654 2.236 . . . . 0.0 112.001 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 1.036 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.0 Cg_endo -71.26 165.08 33.56 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.609 2.206 . . . . 0.0 111.592 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.07 -23.35 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.0 t -77.09 -38.36 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 1.036 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.0 tt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.6 m120 . . . . . 0 N--CA 1.489 1.502 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.06 128.91 50.05 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 109.554 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.54 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.1 Cg_endo -70.71 136.53 30.69 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.593 2.195 . . . . 0.0 111.728 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -64.15 153.05 38.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -55.09 -36.91 66.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.69 -44.91 92.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.352 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.83 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -69.97 -37.12 75.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.979 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.3 tm? -70.21 -33.17 71.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.588 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -90.17 8.3 33.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.646 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.822 HD22 ' CD1' ' B' ' 456' ' ' LEU . 25.5 tp -73.6 136.25 43.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -77.2 145.05 37.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.89 -6.06 73.02 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.566 HG22 ' CD2' ' B' ' 481' ' ' LEU . 61.7 t -121.78 135.68 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -1.214 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.614 ' H ' HD12 ' B' ' 444' ' ' LEU . 73.1 m-20 -91.04 152.84 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.595 ' HG2' HD11 ' B' ' 435' ' ' LEU . 96.5 mtt180 -49.85 -38.66 36.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.63 -40.68 80.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.863 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.614 HD12 ' H ' ' B' ' 441' ' ' ASP . 20.1 mt -64.61 -34.65 78.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.394 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.88 76.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.54 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.1 m-85 -62.91 -44.05 97.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.639 ' HD2' HD21 ' B' ' 473' ' ' LEU . 7.1 ttmm -55.03 -37.84 67.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 459' ' ' LEU . 85.2 mt -69.16 -39.92 78.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -59.24 -33.05 70.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.58 -35.75 6.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' B' ' 470' ' ' ILE . 9.5 mtp85 -90.12 21.47 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.502 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.72 7.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 1.047 HG21 ' HG3' ' B' ' 462' ' ' GLN . 4.9 t -81.8 112.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.915 -1.344 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 430' ' ' PRO . 3.8 p -128.04 -42.17 1.57 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -74.22 144.83 44.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.483 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.888 HD21 HD12 ' B' ' 488' ' ' ILE . 36.8 tp -48.87 -45.44 41.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.87 -45.87 78.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.216 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.756 ' HB3' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -56.55 -40.3 74.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.275 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 448' ' ' LEU . 20.5 tp -60.1 -43.59 95.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.46 -33.1 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.282 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . 0.454 ' OE2' ' HE3' ' A' ' 297' ' ' LYS . 72.5 mm-40 -68.09 -31.05 70.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.43 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 1.047 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.3 mm-40 -78.0 136.86 38.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.51 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -98.13 160.1 20.71 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.989 HD11 ' HG2' ' A' ' 293' ' ' PRO . 65.0 mt -44.04 -39.67 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.432 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.98 -36.53 81.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.446 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 85.7 m-20 -70.51 -28.59 65.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.302 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -82.0 -28.27 32.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.65 65.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -56.99 -31.02 64.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.696 HD11 ' CG ' ' B' ' 451' ' ' ARG . 59.6 mt -103.22 118.28 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.72 -31.01 57.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.54 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -53.83 -32.4 48.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.814 HD22 ' N ' ' B' ' 473' ' ' LEU . 2.8 mm? -107.58 138.03 44.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.495 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.04 165.08 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.495 ' N ' HG22 ' B' ' 474' ' ' THR . 91.5 m-20 -59.09 -38.46 79.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -75.79 -46.12 32.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.572 ' O ' HD13 ' B' ' 481' ' ' LEU . 20.8 tttt -63.2 -48.01 80.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -60.22 -36.44 77.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.76 -44.13 97.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.26 86.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.734 ' HB3' HD21 ' B' ' 459' ' ' LEU . 7.2 mp -69.17 -34.11 74.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 62.4 mt -69.49 -56.48 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.529 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 40.9 mmm -54.53 -38.79 66.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -62.14 -54.16 45.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -63.82 -42.41 97.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -57.53 -44.09 84.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -64.44 -36.62 84.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.466 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.888 HD12 HD21 ' B' ' 456' ' ' LEU . 65.9 mt -66.72 -37.15 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 4.8 m -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -66.61 -33.33 75.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -98.19 10.53 40.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.983 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 318' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' A' ' 252' ' ' ILE . 44.7 m-20 -67.29 133.58 93.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.55 -26.18 54.57 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.782 2.321 . . . . 0.0 111.467 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 1.035 HD13 HD22 ' A' ' 312' ' ' LEU . 14.5 tt -66.65 -25.57 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.225 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 312' ' ' LEU . 44.7 mt -74.23 -45.41 48.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 109.573 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.915 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 1.2 mm? -66.85 -26.84 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.547 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.16 143.66 96.14 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.147 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 259' ' ' ASP . 48.4 Cg_endo -69.07 132.77 25.16 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.63 2.22 . . . . 0.0 111.757 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -43.68 -32.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.31 -31.07 71.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.354 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' PRO . 33.0 m-20 -70.52 -14.46 62.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 257' ' ' VAL . 53.3 mt -48.16 138.0 10.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.33 -15.06 59.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 262' ' ' LEU . 6.9 mp -69.8 173.15 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.8 p -66.86 162.15 22.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.638 HG12 ' ND2' ' A' ' 268' ' ' ASN . 21.2 t -60.79 -23.92 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.01 -44.28 97.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.274 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -48.78 80.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.55 86.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.638 ' ND2' HG12 ' A' ' 264' ' ' VAL . 91.7 m-20 -56.8 -37.22 70.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 25.2 m -53.33 -64.77 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.784 HD21 HD11 ' A' ' 289' ' ' LEU . 78.8 mt -60.37 -45.13 94.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 64.9 tttm -52.86 -35.76 58.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.06 -20.42 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.4 mt-10 -94.8 23.84 5.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.468 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.56 37.32 1.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.728 HG23 ' HB2' ' A' ' 280' ' ' ASP . 82.6 mt -115.54 128.19 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.609 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -116.34 -27.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.609 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.4 m-85 -110.55 137.07 48.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 252' ' ' ILE . 90.8 mt -55.47 -29.78 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.89 -46.7 14.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.728 ' HB2' HG23 ' A' ' 275' ' ' ILE . 78.0 m-20 -53.58 -31.3 46.2 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.041 -1.27 . . . . 0.0 108.688 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.714 HD13 HD13 ' A' ' 270' ' ' LEU . 43.4 tp -57.07 -50.75 71.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.498 -0.751 . . . . 0.0 109.13 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.9 m -64.7 -29.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 108.912 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.45 -35.86 74.85 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.316 -0.865 . . . . 0.0 108.723 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -98.95 150.03 22.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.46 -0.775 . . . . 0.0 109.084 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.5 m -79.5 142.42 35.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.464 ' CD ' ' CD1' ' A' ' 307' ' ' LEU . 82.8 tt0 -55.63 -27.6 50.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.499 ' H ' HG22 ' A' ' 285' ' ' THR . 47.8 t -52.74 -55.5 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.12 -30.69 70.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.158 -0.964 . . . . 0.0 108.645 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 270' ' ' LEU . 20.1 tp -61.95 -37.33 84.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.509 -0.744 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.01 -23.33 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.552 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 48.5 mttm -81.62 -17.11 49.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.518 ' HB ' HD13 ' A' ' 295' ' ' LEU . 2.1 m -73.46 117.29 59.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.549 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.946 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.9 Cg_endo -71.07 -20.5 28.65 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.68 2.253 . . . . 0.0 111.865 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.9 m120 -52.89 -20.43 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.869 ' HB2' HD21 ' A' ' 300' ' ' LEU . 2.4 mp -101.98 132.59 47.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -76.68 157.64 47.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' B' ' 461' ' ' GLU . 23.6 mttm -49.66 -39.33 35.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -1.169 . . . . 0.0 109.396 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -71.46 -38.61 71.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.2 m -61.88 -47.4 85.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 295' ' ' LEU . 77.7 mt -53.01 -42.82 66.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.255 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 44.4 m -52.99 -51.73 60.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 306' ' ' VAL . 94.0 mt-10 -55.78 -39.76 71.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.317 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.475 HG21 HD21 ' A' ' 289' ' ' LEU . 33.5 mm -58.03 -48.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.901 . . . . 0.0 109.236 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -56.69 -41.45 77.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -58.58 -45.88 88.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.275 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.719 HG12 ' CD1' ' A' ' 312' ' ' LEU . 2.2 t -62.0 -38.28 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.103 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.5 mt -54.63 -25.44 26.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.416 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.41 -39.18 75.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.416 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -20.71 2.83 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.404 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 310' ' ' ARG . 21.0 tpt180 64.9 10.23 6.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.637 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -106.8 -0.92 36.61 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 252' ' ' ILE . 0.5 OUTLIER -138.45 148.55 44.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -1.169 . . . . 0.0 109.565 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.808 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 51.21 64.5 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.589 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.45 9.24 43.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.97 31.0 64.84 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.486 ' HE1' HD11 ' A' ' 253' ' ' LEU . 12.7 ptt? -114.08 150.22 34.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.583 ' C ' HD12 ' A' ' 318' ' ' LEU . 72.0 mtt85 -124.63 143.17 50.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.847 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.4 mp -118.83 140.57 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.75 -40.23 79.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 108.939 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 38.7 t-20 -122.08 -71.46 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.915 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.4 t-105 167.59 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.617 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.2 Cg_endo -67.8 107.89 1.57 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 112.069 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.996 ' O ' HG22 ' A' ' 326' ' ' ILE . 54.3 Cg_endo -73.49 164.86 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.721 2.281 . . . . 0.0 111.684 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.09 66.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 44.6 m -76.46 -38.58 55.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.877 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.996 HG22 ' O ' ' A' ' 323' ' ' PRO . 19.2 tt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.515 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 28.4 m120 . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.269 0.557 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.401 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 0.7 OUTLIER -55.75 132.38 72.42 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.969 . . . . 0.0 109.376 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.86 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.01 141.05 43.21 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.62 2.214 . . . . 0.0 111.715 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.3 156.38 35.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.2 m-20 -47.24 -38.56 12.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 456' ' ' LEU . 51.3 m-20 -60.49 -48.47 81.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.86 HD23 ' HB3' ' B' ' 430' ' ' PRO . 25.5 tp -68.18 -37.89 81.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 0.0 109.556 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.884 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.6 OUTLIER -76.85 -28.86 55.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.428 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' B' ' 432' ' ' ASP . 36.8 t-20 -90.32 10.27 25.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.835 HD23 HG21 ' B' ' 440' ' ' VAL . 41.9 tp -78.31 129.88 35.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.19 146.1 35.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.33 7.97 72.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.835 HG21 HD23 ' B' ' 437' ' ' LEU . 77.7 t -124.6 129.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 109.458 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -83.34 147.25 28.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -50.01 -40.81 45.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.464 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.9 m-20 -72.44 -40.55 66.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.706 HD11 HD13 ' B' ' 473' ' ' LEU . 23.1 tp -59.72 -42.28 92.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.72 80.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.38 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 11.7 m-30 -65.35 -41.58 93.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.46 -51.21 69.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.798 HD13 HD11 ' B' ' 459' ' ' LEU . 3.9 tt -62.23 -43.14 99.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -58.24 -31.31 67.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.75 -17.17 33.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.363 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -89.32 33.26 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 0.0 109.423 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.54 -18.97 7.66 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' B' ' 458' ' ' ASP . 61.4 t -64.17 135.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.281 . . . . 0.0 109.34 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' B' ' 431' ' ' ALA . 0.8 OUTLIER -131.82 -33.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.624 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.6 OUTLIER -115.1 142.14 47.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.0 109.733 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.806 HD11 ' HA ' ' B' ' 485' ' ' ALA . 2.0 tm? -45.42 -39.47 7.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 108.867 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.0 -48.2 76.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.205 -0.934 . . . . 0.0 108.653 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.574 ' HB3' HG13 ' B' ' 453' ' ' VAL . 28.9 t0 -54.26 -42.77 70.33 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.334 -0.853 . . . . 0.0 108.72 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.798 HD11 HD13 ' B' ' 448' ' ' LEU . 5.1 tt -53.7 -48.91 69.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 109.018 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.897 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -56.03 -35.62 67.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . 0.515 ' HA ' ' CE ' ' A' ' 297' ' ' LYS . 96.7 mt-10 -67.21 -28.34 68.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -63.78 164.87 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.26 154.07 16.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.946 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.9 mt -52.33 -34.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.15 -34.28 74.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.52 -31.92 63.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.011 HD12 ' HB1' ' B' ' 478' ' ' ALA . 34.6 mt -74.94 -34.86 62.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.333 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.92 -21.52 11.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.545 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -50.19 -36.97 32.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.2 125.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -62.24 -35.61 79.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.446 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -33.14 22.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.976 HD23 ' HB3' ' B' ' 467' ' ' LEU . 10.9 tp -99.17 141.7 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.554 HG22 ' N ' ' B' ' 475' ' ' ASP . 89.0 m -104.15 164.79 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.554 ' N ' HG22 ' B' ' 474' ' ' THR . 92.3 m-20 -56.5 -40.11 74.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -75.4 -46.25 34.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.469 ' HE3' HD22 ' B' ' 444' ' ' LEU . 37.7 tttp -60.41 -38.28 83.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 109.275 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.011 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -68.75 -50.66 48.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.448 ' HA2' HG12 ' B' ' 464' ' ' ILE . . . -62.58 -48.59 80.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.97 61.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -1.121 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.534 HD22 ' CG2' ' B' ' 440' ' ' VAL . 64.1 mt -62.41 -40.92 98.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.265 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.0 mt -55.01 -55.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.23 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 31.8 mtp -53.14 -45.3 68.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.26 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.9 -45.09 90.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.164 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.806 ' HA ' HD11 ' B' ' 456' ' ' LEU . . . -63.13 -52.27 63.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.255 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.897 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 89.2 mtt180 -59.46 -39.57 84.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 93.6 m-20 -57.31 -41.59 80.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' B' ' 437' ' ' LEU . 83.3 mt -59.65 -36.61 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.43 -51.62 9.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.772 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -63.84 -45.92 87.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.0 m-85 -76.08 -29.5 57.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.892 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.574 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 44.4 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.4 124.93 57.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.305 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.07 -22.68 61.76 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.623 2.215 . . . . 0.0 111.665 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 278' ' ' ILE . 12.7 tt -71.8 -31.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 108.833 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 311' ' ' GLY . 31.8 mt -74.85 -45.03 45.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 109.345 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 1.007 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.7 OUTLIER -65.48 -35.54 81.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 278' ' ' ILE . 6.4 mtt85 -55.82 141.52 65.95 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.004 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 48.1 Cg_endo -68.93 132.16 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.623 2.216 . . . . 0.0 111.935 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.84 -28.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 95.5 m-20 -65.54 -30.68 71.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 256' ' ' PRO . 72.4 m-20 -74.96 -8.58 56.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 257' ' ' VAL . 0.7 OUTLIER -42.85 129.48 4.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -15.47 50.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' A' ' 302' ' ' GLU . 40.3 mt -70.18 -162.13 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 7.1 p -81.01 155.9 26.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.565 HG12 ' ND2' ' A' ' 268' ' ' ASN . 22.8 t -57.67 -24.07 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' B' ' 465' ' ' ASP . 55.6 ttt85 -57.81 -43.36 85.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.7 m -58.82 -46.83 86.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.371 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -68.96 -39.5 79.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.565 ' ND2' HG12 ' A' ' 264' ' ' VAL . 86.7 m-20 -60.28 -32.17 70.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.4 m -66.9 -64.9 0.76 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.0 mt -54.84 -47.82 73.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.507 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 20.5 ttpt -52.94 -39.52 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.449 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.4 -23.68 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 95.3 mt-10 -94.11 23.07 5.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.42 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.5 33.26 4.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -0.929 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.714 HG23 ' HB2' ' A' ' 280' ' ' ASP . 75.8 mt -120.26 108.2 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.507 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 91.2 m-70 -104.59 -11.09 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.824 . . . . 0.0 109.581 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.98 133.37 54.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 252' ' ' ILE . 49.8 mt -62.03 -30.9 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.944 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -52.27 -41.25 54.11 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.714 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.1 m-20 -53.45 -36.36 61.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -1.181 . . . . 0.0 109.119 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.515 ' CD2' HD12 ' A' ' 312' ' ' LEU . 3.1 tp -59.19 -46.49 88.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.297 -0.877 . . . . 0.0 109.229 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 279' ' ' GLY . 15.4 m -68.37 -23.29 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -68.26 -33.09 73.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.826 . . . . 0.0 108.813 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -105.74 143.4 33.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.02 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.8 m -60.0 137.6 58.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.092 -1.005 . . . . 0.0 109.394 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.98 -30.5 71.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.551 ' H ' HG22 ' A' ' 285' ' ' THR . 50.0 t -53.1 -50.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.331 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -51.8 -39.39 58.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -72.8 -39.65 66.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.291 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.996 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.8 tm? -57.61 -33.21 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.228 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' B' ' 483' ' ' MET . 32.5 mttm -88.45 17.64 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 289' ' ' LEU . 2.9 m -103.75 135.99 19.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 1.016 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -70.81 -24.82 24.45 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.671 2.247 . . . . 0.0 111.802 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.609 ' ND2' HD12 ' B' ' 464' ' ' ILE . 32.1 m120 -57.1 -21.01 28.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.57 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 13.3 mt -81.8 149.89 28.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -112.93 147.6 18.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.08 -44.88 71.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.409 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 302' ' ' GLU . 40.1 mttp -66.52 -41.58 88.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.4 m -64.39 -32.77 74.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 303' ' ' ILE . 32.5 tp -53.36 -42.2 66.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.426 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.8 m -54.8 -43.41 72.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.835 ' HB3' HD13 ' A' ' 262' ' ' LEU . 39.5 mp0 -67.15 -37.86 84.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 300' ' ' LEU . 77.2 mt -58.24 -47.16 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.448 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.44 -36.54 84.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.47 -45.2 89.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 312' ' ' LEU . 20.6 t -68.71 -43.33 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.832 HD13 ' OG ' ' A' ' 313' ' ' SER . 16.6 tp -54.73 -29.68 54.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.606 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.62 73.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 83.0 p -79.22 -1.11 34.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.467 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 1.01 ' HA ' HD21 ' A' ' 314' ' ' LEU . 65.8 mtm180 56.88 16.99 3.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.012 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.669 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.55 -38.94 57.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 306' ' ' VAL . 1.3 pp -149.5 160.99 43.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -1.219 . . . . 0.0 109.978 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.832 ' OG ' HD13 ' A' ' 307' ' ' LEU . 0.5 OUTLIER 76.72 29.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.795 . . . . 0.0 109.538 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 1.01 HD21 ' HA ' ' A' ' 310' ' ' ARG . 72.9 mt -85.8 14.91 5.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 54.69 41.69 75.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.68 ' HE3' ' HB ' ' A' ' 282' ' ' VAL . 5.0 mtm -86.2 176.95 7.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -1.094 . . . . 0.0 109.49 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.73 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.8 mtt180 -140.98 125.77 18.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.821 ' N ' HD12 ' A' ' 318' ' ' LEU . 4.0 mp -126.55 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.85 -38.49 88.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.239 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.9 m-20 -125.31 -69.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 1.007 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 166.08 -66.41 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.451 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.87 107.75 1.76 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.652 2.235 . . . . 0.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 51.5 Cg_endo -71.71 162.45 42.04 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.625 2.217 . . . . 0.0 111.505 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.55 -17.26 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 36.4 m -66.12 -42.62 88.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.48 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.963 HD11 HD21 ' A' ' 254' ' ' LEU . 18.1 mt . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.409 ' C ' ' HB1' ' B' ' 449' ' ' ALA . 27.0 m120 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -86.46 124.56 69.55 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.523 ' HB3' ' HB1' ' B' ' 445' ' ' ALA . 49.8 Cg_endo -70.56 140.93 40.76 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.664 2.242 . . . . 0.0 111.686 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -80.88 160.15 24.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.3 m-20 -53.46 -37.47 62.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.305 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 18.3 m-20 -61.39 -49.99 74.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.387 -0.82 . . . . 0.0 109.512 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.725 HD11 ' CD1' ' B' ' 448' ' ' LEU . 17.8 tp -63.45 -35.79 81.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.577 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' B' ' 442' ' ' ARG . 22.2 tp -83.51 -23.08 32.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' B' ' 432' ' ' ASP . 35.3 t-20 -88.24 7.34 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.765 HD23 HG21 ' B' ' 440' ' ' VAL . 28.6 tp -78.43 129.93 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.501 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.82 137.28 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.06 9.32 70.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.975 HG13 HD23 ' B' ' 444' ' ' LEU . 41.8 t -123.67 131.12 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.137 . . . . 0.0 109.475 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -102.46 161.82 13.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.755 ' HG2' HD11 ' B' ' 435' ' ' LEU . 61.7 mtt180 -50.19 -45.59 53.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.481 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 93.4 m-20 -61.08 -47.44 86.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.435 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.056 HD11 HD21 ' B' ' 473' ' ' LEU . 27.9 tp -55.67 -43.11 76.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.334 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' B' ' 430' ' ' PRO . . . -59.02 -43.07 91.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.23 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 17.3 m-85 -57.68 -44.75 86.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.26 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -58.24 -45.06 88.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' B' ' 434' ' ' LEU . 79.1 mt -61.34 -44.03 97.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.16 -36.19 77.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.42 33.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.533 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 16.0 mtp-105 -90.32 23.57 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.68 6.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.903 HG21 ' CG ' ' B' ' 462' ' ' GLN . 21.3 t -80.53 109.75 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.34 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 31.1 m -124.91 -34.45 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -82.09 140.89 33.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.628 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.0 tm? -48.56 -40.78 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.72 -38.77 91.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -0.922 . . . . 0.0 108.899 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.562 ' C ' HG13 ' B' ' 453' ' ' VAL . 92.5 m-20 -61.58 -40.12 93.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.85 HD13 ' O ' ' B' ' 459' ' ' LEU . 3.4 tm? -63.29 -39.03 93.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' B' ' 486' ' ' ARG . . . -63.48 -32.63 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.295 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -72.61 -30.33 64.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.903 ' CG ' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -61.65 156.91 18.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.25 155.97 15.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 1.016 HD11 ' HG2' ' A' ' 293' ' ' PRO . 52.2 mt -49.68 -38.33 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -1.131 . . . . 0.0 109.501 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 265' ' ' ARG . 89.2 m-20 -65.22 -37.51 87.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.44 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 89.6 m-20 -71.11 -31.07 67.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.088 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.0 mt -76.81 -29.85 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.61 63.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -52.67 -32.35 41.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.9 mt -104.73 128.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -63.77 -33.94 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.422 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -51.12 -28.63 18.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.056 HD21 HD11 ' B' ' 444' ' ' LEU . 55.1 mt -105.86 137.6 43.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.456 HG22 ' N ' ' B' ' 475' ' ' ASP . 29.8 m -103.97 162.0 13.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.395 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.456 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.3 -37.51 75.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -76.97 -45.94 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 70.7 tttt -65.83 -46.4 78.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.088 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -60.02 -44.64 94.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 109.535 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -62.27 -52.34 50.21 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -50.98 -33.74 26.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -1.169 . . . . 0.0 109.617 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.63 HD11 HD21 ' B' ' 444' ' ' LEU . 24.7 mt -75.33 -37.36 60.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.522 HD11 ' N ' ' B' ' 464' ' ' ILE . 92.8 mt -60.54 -55.63 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.522 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 41.2 mmm -59.68 -47.64 84.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.46 -53.15 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.45 ' CB ' HD12 ' B' ' 459' ' ' LEU . . . -60.83 -48.62 80.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.475 ' HA ' ' HB1' ' B' ' 460' ' ' ALA . 44.9 ttp85 -56.98 -43.75 82.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.7 m-20 -57.92 -39.06 77.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.616 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' B' ' 437' ' ' LEU . 76.9 mt -63.68 -36.9 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.51 -52.07 59.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.56 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -61.17 -38.75 87.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 17.2 m-85 -64.03 -31.33 72.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.492 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.282 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.992 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.873 ' CE2' HD21 ' A' ' 318' ' ' LEU . 79.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.482 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.2 OUTLIER -50.78 155.22 2.04 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.273 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.512 ' HA ' HD23 ' A' ' 254' ' ' LEU . 41.0 Cg_endo -64.5 -26.31 62.47 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.47 2.114 . . . . 0.0 111.425 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.788 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -53.38 -34.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 252' ' ' ILE . 5.3 mp -74.45 -39.21 62.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.463 -0.773 . . . . 0.0 109.01 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.702 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -71.32 -23.14 61.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.459 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 278' ' ' ILE . 0.2 OUTLIER -73.0 141.19 81.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.466 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 259' ' ' ASP . 51.5 Cg_endo -70.66 136.37 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.728 2.285 . . . . 0.0 111.736 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.16 -26.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.368 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.443 ' OD1' ' HE2' ' A' ' 271' ' ' LYS . 88.3 m-20 -67.61 -30.77 70.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 256' ' ' PRO . 49.9 m-20 -74.71 -9.8 58.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 49.5 mt -58.44 135.75 57.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 0.0 109.359 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.44 -21.22 66.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.571 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 262' ' ' LEU . 6.4 mp -62.59 168.35 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.2 p -70.5 166.74 19.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.679 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.0 t -63.89 -23.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -55.4 -45.09 76.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.9 p -69.16 -45.89 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -63.82 -42.4 97.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.679 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.2 m-20 -54.13 -38.36 65.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.3 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 295' ' ' LEU . 61.0 m -51.29 -62.14 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.631 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.8 mt -56.47 -46.28 80.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 16.3 mttt -53.25 -33.23 52.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.73 -33.7 49.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.1 mt-10 -92.01 25.84 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.23 45.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 1.025 HG23 ' HB2' ' A' ' 280' ' ' ASP . 91.2 mt -115.61 124.91 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.743 ' O ' HG22 ' A' ' 257' ' ' VAL . 6.5 p80 -114.09 -39.93 3.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.571 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -103.14 134.73 46.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.905 HG21 HD23 ' A' ' 312' ' ' LEU . 78.1 mt -46.66 -30.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.067 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.89 -49.41 17.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 1.025 ' HB2' HG23 ' A' ' 275' ' ' ILE . 87.5 m-20 -53.43 -32.19 48.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 108.988 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 312' ' ' LEU . 53.9 tp -53.99 -51.29 64.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.332 -0.855 . . . . 0.0 109.07 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.7 m -68.17 -33.46 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.18 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -53.06 -32.43 46.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.294 -0.879 . . . . 0.0 108.819 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -107.74 150.61 26.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 72.2 p -81.6 157.07 24.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.945 . . . . 0.0 109.616 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.529 ' OE2' HD23 ' A' ' 307' ' ' LEU . 7.2 mt-10 -63.52 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.918 . . . . 0.0 109.442 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.5 t -52.79 -50.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -55.14 -37.57 67.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.415 HD23 ' OE2' ' A' ' 273' ' ' GLU . 65.8 mt -72.62 -40.75 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.242 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 1.011 HD13 ' O ' ' A' ' 290' ' ' LEU . 1.9 tm? -57.31 -32.69 66.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.865 . . . . 0.0 109.21 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 66.9 mttm -82.26 -13.27 57.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.82 . . . . 0.0 109.474 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.1 m -86.94 112.6 48.5 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 1.043 ' HB2' HD12 ' B' ' 482' ' ' ILE . 51.3 Cg_endo -70.86 -13.16 31.71 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.767 2.311 . . . . 0.0 111.845 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HA ' HD12 ' B' ' 464' ' ' ILE . 30.6 m120 -48.93 -41.08 32.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 269' ' ' CYS . 0.4 OUTLIER -83.74 143.17 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -80.34 165.2 48.27 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -64.48 -41.51 96.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.568 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -63.94 -39.0 93.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 303' ' ' ILE . 19.6 m -59.73 -41.67 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 304' ' ' LYS . 24.2 tp -53.06 -37.93 62.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.9 m -60.85 -45.83 92.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.14 -46.09 88.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.83 HG22 HD22 ' A' ' 307' ' ' LEU . 30.6 mm -58.76 -51.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.434 ' CE ' ' HG ' ' A' ' 300' ' ' LEU . 22.5 mttm -53.13 -39.06 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.15 -48.3 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.461 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.892 HG12 HD11 ' A' ' 312' ' ' LEU . 12.0 t -73.71 -40.84 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.83 HD22 HG22 ' A' ' 303' ' ' ILE . 8.4 mp -66.02 -26.71 67.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -29.57 66.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 8.2 t -75.2 -0.16 18.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.539 ' O ' HD21 ' A' ' 314' ' ' LEU . 40.5 mtm-85 70.31 3.89 4.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -69.32 -27.82 73.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.905 HD23 HG21 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -140.81 152.89 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 109.261 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.525 ' OG ' HD21 ' A' ' 307' ' ' LEU . 16.5 m 63.67 66.85 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.46 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.799 HD13 ' HE2' ' A' ' 316' ' ' MET . 4.7 mp -103.06 9.99 38.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.61 73.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.799 ' HE2' HD13 ' A' ' 314' ' ' LEU . 15.4 ptt? -113.04 147.38 37.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.534 ' C ' HD12 ' A' ' 318' ' ' LEU . 76.3 mtm180 -126.53 141.66 51.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.292 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.873 HD21 ' CE2' ' A' ' 249' ' ' PHE . 3.7 mp -116.9 141.78 47.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.02 -34.4 77.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.983 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 85.6 m-20 -117.41 -81.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 165.89 -62.23 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.545 ' CB ' HD11 ' A' ' 326' ' ' ILE . 48.8 Cg_endo -68.33 108.09 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.66 2.24 . . . . 0.0 111.989 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 249' ' ' PHE . 53.9 Cg_endo -76.34 161.91 34.29 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.421 2.08 . . . . 0.0 111.414 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.64 -13.92 17.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.1 p -70.35 -35.52 73.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.764 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.605 HG21 ' HG ' ' A' ' 254' ' ' LEU . 21.2 pt . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.771 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 130.17 92.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 144.01 48.72 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.792 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.65 146.34 40.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -47.99 -32.9 7.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 109.455 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.53 -48.01 68.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.861 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.5 tm? -67.91 -36.96 81.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.93 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -72.89 -31.95 65.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.86 11.32 20.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 1.06 HD13 HD11 ' B' ' 456' ' ' LEU . 50.2 tp -74.05 133.64 42.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -76.6 145.47 38.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.74 75.1 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.732 HG13 HD23 ' B' ' 444' ' ' LEU . 95.3 t -123.54 135.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -1.214 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 442' ' ' ARG . 58.2 t0 -85.27 146.38 27.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.502 ' HG2' HD11 ' B' ' 435' ' ' LEU . 95.8 mtt180 -49.92 -43.79 49.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -68.65 -37.74 79.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.293 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.07 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.2 tp -63.66 -35.57 80.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -63.81 -41.37 97.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.953 . . . . 0.0 109.419 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 71.8 m-85 -65.88 -48.46 71.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.533 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 31.4 ttmt -57.94 -42.86 85.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.829 HD11 ' CD2' ' B' ' 459' ' ' LEU . 10.0 tt -69.73 -37.3 76.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.27 -27.6 67.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.496 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.06 -16.9 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.425 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 12.1 mtp85 -90.46 28.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.81 6.8 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 19.2 t -65.33 133.24 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.303 . . . . 0.0 109.427 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 60.4 m -135.08 -35.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.3 OUTLIER -106.57 152.1 24.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.003 . . . . 0.0 109.847 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 1.06 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -51.78 -42.77 62.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.332 -0.855 . . . . 0.0 109.363 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.83 -42.2 75.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.137 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 84.3 m-20 -61.4 -41.2 96.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.342 -0.849 . . . . 0.0 109.217 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.829 ' CD2' HD11 ' B' ' 448' ' ' LEU . 3.4 tm? -60.97 -38.92 87.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.16 -35.72 81.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.82 -35.34 80.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 3.5 mm100 -65.53 144.88 56.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.47 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -102.92 159.72 17.26 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.889 HD11 ' HG2' ' A' ' 293' ' ' PRO . 80.3 mt -46.07 -35.14 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.238 . . . . 0.0 109.204 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -63.47 -37.45 87.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.919 . . . . 0.0 109.021 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.4 m-20 -68.51 -31.55 70.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.16 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.733 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -80.84 -32.86 34.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.396 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.48 -33.07 67.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 109.392 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -46.83 -28.67 1.64 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.401 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.533 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 62.1 mt -105.79 121.53 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -55.93 -32.65 63.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.454 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.94 -28.82 49.57 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.07 ' CD2' HD11 ' B' ' 444' ' ' LEU . 65.0 mt -103.5 135.77 44.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -1.132 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.95 161.91 13.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.354 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.433 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 82.5 m-20 -58.29 -37.39 74.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.13 -46.03 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.651 ' O ' HD13 ' B' ' 481' ' ' LEU . 25.2 tttp -62.86 -44.22 96.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.733 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.85 -44.34 93.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.23 -35.85 91.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.16 76.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -1.144 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.651 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -69.51 -36.56 76.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 109.642 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.9 mt -68.84 -56.35 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.518 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 61.2 mtp -52.62 -39.08 61.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.35 -49.23 44.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' B' ' 456' ' ' LEU . . . -63.98 -46.41 84.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.422 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 45.9 ttm-85 -57.6 -45.05 85.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.34 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.0 m-20 -57.9 -40.0 79.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.643 HD12 HD11 ' B' ' 456' ' ' LEU . 84.8 mt -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.73 -49.23 49.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 58.4 m95 -65.99 -32.22 73.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.456 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 13.8 m-85 -79.22 -34.27 42.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.568 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.964 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.53 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 10.4 p90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.767 ' O ' HD22 ' A' ' 254' ' ' LEU . 0.9 OUTLIER -57.86 136.95 83.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 109.272 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.687 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.05 -30.93 56.03 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.597 2.198 . . . . 0.0 111.55 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.848 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -63.11 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 312' ' ' LEU . 31.4 mt -74.31 -42.57 59.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.195 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.767 HD22 ' O ' ' A' ' 250' ' ' ASP . 0.5 OUTLIER -59.94 -34.99 73.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.813 . . . . 0.0 109.14 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -66.12 146.47 99.02 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.3 Cg_endo -70.22 140.01 39.94 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.714 2.276 . . . . 0.0 111.89 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.556 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.12 -36.92 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.362 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -58.13 -30.98 66.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 256' ' ' PRO . 21.9 m-20 -72.38 -11.41 60.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.556 HD11 HG12 ' A' ' 257' ' ' VAL . 36.8 mt -55.35 150.64 11.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -23.23 67.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.437 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.691 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.6 mp -62.85 166.74 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -75.53 162.66 28.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.657 HG12 ' ND2' ' A' ' 268' ' ' ASN . 11.8 t -48.85 -39.67 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -51.18 -50.22 59.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.666 ' OG ' HD22 ' A' ' 262' ' ' LEU . 17.7 t -58.71 -51.02 71.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.96 -37.06 85.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 264' ' ' VAL . 94.7 m-20 -58.54 -36.47 73.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.322 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -53.64 54.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.304 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.723 HD21 HD13 ' A' ' 281' ' ' LEU . 6.6 mp -61.28 -47.87 83.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' A' ' 268' ' ' ASN . 54.8 mtmt -52.8 -38.14 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.23 20.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.3 mt-10 -92.95 25.29 3.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.453 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.05 45.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.994 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.2 mt -120.85 119.58 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.469 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 7.7 p80 -110.17 -40.05 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.557 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.457 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.6 m-30 -105.47 136.13 45.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 252' ' ' ILE . 93.5 mt -46.7 -29.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.988 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.98 -45.13 14.29 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.994 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.3 m-20 -53.52 -33.83 55.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.293 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 289' ' ' LEU . 38.7 tp -57.35 -49.48 76.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.988 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.2 m -63.44 -23.34 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 108.73 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.1 tt0 -67.45 -34.95 78.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -98.73 158.57 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 154.26 23.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.074 -1.016 . . . . 0.0 109.773 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.666 ' CD ' HD13 ' A' ' 307' ' ' LEU . 9.0 mt-10 -61.68 -36.33 80.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.539 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 42.1 t -52.64 -49.36 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -51.95 -32.55 33.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.083 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 281' ' ' LEU . 36.8 mt -69.25 -41.18 77.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.147 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.39 -25.31 66.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.342 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.546 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 54.8 mttt -86.32 -12.87 48.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.484 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.529 HG22 HD12 ' A' ' 295' ' ' LEU . 53.0 m -81.85 112.3 33.69 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.522 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 1.014 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.6 Cg_endo -71.06 -14.25 31.88 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.821 2.347 . . . . 0.0 111.916 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.67 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.9 m120 -61.98 -25.47 67.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.806 HD23 HD11 ' A' ' 303' ' ' ILE . 4.7 mp -88.02 142.35 27.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . 0.465 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -91.39 169.28 32.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.55 -41.07 80.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.145 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -70.14 -43.07 71.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.6 m -59.2 -49.45 77.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.39 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.752 HD21 ' HB2' ' A' ' 295' ' ' LEU . 83.5 mt -55.37 -42.37 73.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.3 m -55.41 -52.62 62.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.873 . . . . 0.0 109.451 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 306' ' ' VAL . 89.2 mt-10 -54.82 -39.4 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.806 HD11 HD23 ' A' ' 295' ' ' LEU . 78.6 mt -58.15 -51.54 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.33 -42.51 73.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.36 -44.08 79.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.986 HG12 HD21 ' A' ' 312' ' ' LEU . 1.9 t -65.93 -39.58 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.178 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.1 mt -54.63 -26.16 31.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.37 68.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.7 t -66.06 -15.53 63.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.784 ' C ' HD21 ' A' ' 314' ' ' LEU . 92.8 mtt180 59.32 14.17 3.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.442 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -105.27 1.99 40.33 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.986 HD21 HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.94 142.58 24.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -1.19 . . . . 0.0 109.641 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.784 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 67.22 38.87 3.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.577 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.784 HD21 ' C ' ' A' ' 310' ' ' ARG . 28.1 mt -88.97 18.2 5.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.31 36.29 91.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.704 ' HE2' HG11 ' A' ' 282' ' ' VAL . 6.4 mtm -87.21 167.33 14.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.571 ' C ' HD12 ' A' ' 318' ' ' LEU . 36.1 mtp180 -143.15 131.29 21.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.761 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.6 mp -130.0 139.26 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.927 . . . . 0.0 109.621 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.32 -43.97 88.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 108.88 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 69.1 m-20 -122.06 -69.42 0.83 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.041 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.567 ' HE3' HD22 ' A' ' 318' ' ' LEU . 2.6 t-105 168.42 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.354 -0.841 . . . . 0.0 109.405 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.3 Cg_endo -68.52 107.79 1.69 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.545 2.163 . . . . 0.0 111.898 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 1.016 ' O ' HG22 ' A' ' 326' ' ' ILE . 51.4 Cg_endo -71.47 152.91 60.69 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.611 2.207 . . . . 0.0 111.711 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.76 6.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 42.9 m -68.18 -32.64 73.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 1.016 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.7 tt . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.315 -0.865 . . . . 0.0 109.564 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.641 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 22.4 m120 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.602 -0.518 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.492 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 2.0 tttt -54.07 129.87 58.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.53 ' HG3' ' CD1' ' B' ' 446' ' ' PHE . 48.6 Cg_endo -69.98 140.85 42.85 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.677 2.251 . . . . 0.0 111.774 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.04 152.57 42.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.888 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -50.1 -39.42 42.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.4 -44.48 92.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.766 HD13 ' C ' ' B' ' 434' ' ' LEU . 2.9 tm? -64.18 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.25 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 442' ' ' ARG . 24.7 tp -79.88 -30.29 40.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -78.43 -0.77 30.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.693 HD23 HG21 ' B' ' 440' ' ' VAL . 28.8 tp -72.34 134.58 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.513 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -73.6 141.26 46.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.93 8.55 66.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.693 HG21 HD23 ' B' ' 437' ' ' LEU . 47.4 t -129.52 126.42 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.452 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.26 161.46 13.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.877 ' HG2' HD11 ' B' ' 435' ' ' LEU . 87.9 mtt-85 -55.01 -46.63 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.17 -45.6 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.519 ' CD2' ' HE2' ' B' ' 477' ' ' LYS . 12.9 tp -60.85 -41.83 96.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.635 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.15 -40.66 86.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.53 ' CD1' ' HG3' ' B' ' 430' ' ' PRO . 17.3 m-85 -63.83 -46.65 84.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.513 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 5.9 ttmm -57.66 -46.36 84.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.609 HD23 ' O ' ' B' ' 448' ' ' LEU . 8.7 tt -68.24 -36.51 79.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.586 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -60.81 -26.79 67.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -49.14 -22.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.695 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -88.66 25.01 1.83 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.63 7.15 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.71 HG21 ' HG3' ' B' ' 462' ' ' GLN . 44.7 t -62.87 132.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.942 -1.328 . . . . 0.0 109.326 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 87.5 m -135.11 -38.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 109.666 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 150.56 21.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.738 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 1.037 HD21 HD12 ' B' ' 488' ' ' ILE . 27.1 tp -48.41 -42.15 31.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.255 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -55.94 -48.36 75.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.102 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.6 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.6 m-20 -54.89 -40.99 70.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.065 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' B' ' 481' ' ' LEU . 4.6 tt -57.21 -47.05 82.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.65 70.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.08 -34.87 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.71 ' HG3' HG21 ' B' ' 453' ' ' VAL . 6.2 mm100 -67.44 156.01 37.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.57 155.08 16.32 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.965 HD11 ' HG2' ' A' ' 293' ' ' PRO . 30.0 mt -47.6 -42.63 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -1.176 . . . . 0.0 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -58.34 -42.43 86.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.14 -30.04 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.059 HD12 ' HB1' ' B' ' 478' ' ' ALA . 24.0 mt -77.98 -26.48 48.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.26 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.32 69.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.873 . . . . 0.0 109.301 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -53.74 -32.28 51.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.546 HG22 ' H ' ' B' ' 472' ' ' GLY . 61.0 mt -100.43 122.84 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.88 -26.84 67.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.546 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -59.7 -26.5 62.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.485 ' CD2' HD11 ' B' ' 444' ' ' LEU . 38.7 mt -109.73 134.66 51.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -1.163 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.02 161.93 13.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.403 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.426 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 79.9 m-20 -57.68 -38.05 74.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -76.79 -46.08 26.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.662 ' O ' HD13 ' B' ' 481' ' ' LEU . 43.7 tttt -64.93 -42.06 95.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.85 -42.15 97.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.1 -42.92 99.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.07 85.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -66.88 -39.89 87.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 293' ' ' PRO . 28.9 mt -64.69 -56.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.546 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 48.3 mtp -52.67 -40.35 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.447 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.83 -56.45 15.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -62.05 -44.42 96.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.714 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 290' ' ' LEU . 50.2 ttt180 -60.28 -45.97 91.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 84.5 m-20 -59.2 -41.13 87.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 1.037 HD12 HD21 ' B' ' 456' ' ' LEU . 71.0 mt -64.54 -37.14 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.07 -50.56 32.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.55 -39.69 77.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.5 m-85 -96.77 16.32 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.229 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.492 ' HB3' ' CB ' ' A' ' 325' ' ' SER . 43.5 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.347 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -65.93 135.51 95.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.68 -25.44 54.16 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.763 2.309 . . . . 0.0 111.79 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.555 ' O ' HD12 ' A' ' 278' ' ' ILE . 19.7 tt -79.54 -21.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.77 HD21 ' HE1' ' A' ' 321' ' ' TRP . 5.6 tp -74.08 -37.91 64.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.295 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 326' ' ' ILE . 3.8 mm? -82.99 -27.74 30.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.534 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 0.0 OUTLIER -63.75 144.19 97.95 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.542 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 51.1 Cg_endo -71.0 149.55 59.18 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.728 2.285 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.404 HG12 HD11 ' A' ' 260' ' ' LEU . 0.4 OUTLIER -53.53 -39.22 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.803 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 259' ' ' ASP . 9.3 p-10 -58.52 -31.0 67.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.6 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.534 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 68.6 m-20 -74.1 -13.45 60.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 257' ' ' VAL . 46.1 mt -51.17 144.13 9.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -68.71 -16.26 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.762 HD13 ' HB3' ' A' ' 302' ' ' GLU . 28.6 mt -59.72 -174.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . 0.47 HG23 ' OE2' ' A' ' 302' ' ' GLU . 22.2 p -87.27 159.09 18.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.725 HG12 ' ND2' ' A' ' 268' ' ' ASN . 13.5 t -56.35 -30.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -56.05 -46.43 78.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.401 ' HB3' ' OE1' ' A' ' 302' ' ' GLU . 87.4 p -66.39 -45.27 80.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.4 90.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.725 ' ND2' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -58.11 -33.21 68.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.378 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 92.8 m -59.25 -64.3 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.938 . . . . 0.0 109.41 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.572 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.6 mt -60.79 -48.2 82.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.329 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 73.1 tttt -54.47 -38.71 66.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -55.45 -24.63 31.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.652 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.5 mt-10 -92.22 21.12 5.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 34.34 1.44 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 109.604 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 280' ' ' ASP . 85.3 mt -120.73 107.63 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.12 -0.988 . . . . 0.0 109.458 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 58.6 m-70 -108.05 -3.99 18.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.618 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.6 m-85 -113.98 131.05 56.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 252' ' ' ILE . 73.8 mt -59.47 -30.43 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.929 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.32 -47.06 16.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 275' ' ' ILE . 80.4 m-20 -53.5 -33.66 55.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.249 . . . . 0.0 108.997 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.572 HD13 ' CD1' ' A' ' 270' ' ' LEU . 35.0 tp -56.29 -49.28 74.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.134 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.929 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.3 m -66.39 -24.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 108.884 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -65.05 -35.68 81.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 108.969 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -98.36 141.22 31.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.331 -0.856 . . . . 0.0 109.191 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 8.1 m -71.38 140.77 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.531 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.63 ' CD ' HD12 ' A' ' 289' ' ' LEU . 48.4 tp10 -49.98 -29.75 9.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.59 -51.3 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.163 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.36 -34.06 56.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 109.117 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.63 HD12 ' CD ' ' A' ' 286' ' ' GLU . 39.9 mt -63.88 -41.91 97.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.331 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.68 -31.4 72.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 78.0 mttt -85.22 -10.64 56.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.527 ' HB ' HD13 ' A' ' 295' ' ' LEU . 28.8 m -83.87 113.03 44.92 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.963 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.1 Cg_endo -70.66 -18.79 32.5 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.753 2.302 . . . . 0.0 111.851 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' B' ' 464' ' ' ILE . 71.2 m-80 -56.95 -27.16 60.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 295' ' ' LEU . 4.1 mp -92.7 136.48 33.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.23 179.46 40.75 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -62.26 -38.98 91.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -1.125 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.89 -43.49 88.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 25.0 m -59.42 -49.86 76.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 290' ' ' LEU . 23.4 tp -52.88 -44.52 66.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 48.1 m -56.1 -44.42 79.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.414 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 262' ' ' LEU . 95.5 mt-10 -60.5 -43.29 97.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 295' ' ' LEU . 83.9 mt -57.95 -46.97 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -58.77 -39.99 82.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.63 -50.64 73.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.8 t -67.18 -40.17 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.848 HD13 ' HB3' ' A' ' 313' ' ' SER . 18.5 tp -55.26 -27.46 46.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.94 69.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.135 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.7 t -74.02 -14.64 61.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.868 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.505 ' O ' HD21 ' A' ' 314' ' ' LEU . 66.5 mtt-85 63.59 11.5 5.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.45 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.35 -29.57 52.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.762 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.6 pt? -139.74 153.55 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -1.215 . . . . 0.0 109.61 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.848 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.7 OUTLIER 72.21 43.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.7 ' N ' HD22 ' A' ' 314' ' ' LEU . 3.4 mm? -86.73 14.52 6.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.54 36.75 68.5 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.576 ' HE2' HG11 ' A' ' 282' ' ' VAL . 3.4 mtm -90.6 167.81 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.12 . . . . 0.0 109.517 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.636 ' C ' HD12 ' A' ' 318' ' ' LEU . 95.0 mtt180 -142.7 126.02 16.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.85 . . . . 0.0 109.295 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.7 mp -138.99 131.91 29.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.68 -52.81 63.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 321' ' ' TRP . 13.5 t-20 -130.32 36.95 3.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.77 ' HE1' HD21 ' A' ' 253' ' ' LEU . 16.9 t90 44.28 57.13 13.84 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 321' ' ' TRP . 54.7 Cg_endo -99.9 71.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.333 2.688 . . . . 0.0 112.242 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.853 ' CG ' HD12 ' A' ' 326' ' ' ILE . 48.6 Cg_endo -70.18 132.81 23.41 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.288 1.992 . . . . 0.0 111.727 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.0 69.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 249' ' ' PHE . 19.1 m -62.69 -46.1 89.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 323' ' ' PRO . 63.0 mt . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 17.9 m120 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.414 -0.587 . . . . 0.0 109.414 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -82.62 127.03 71.99 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 109.531 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.7 Cg_endo -70.69 136.28 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.662 2.241 . . . . 0.0 111.716 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.82 158.58 21.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.95 -31.56 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.551 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.38 -44.18 79.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.862 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -70.0 -38.91 76.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -66.6 -33.92 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.296 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.84 11.76 23.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.88 HD13 HD11 ' B' ' 456' ' ' LEU . 47.0 tp -77.93 133.02 38.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.63 145.26 50.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.45 -7.31 82.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 1.084 HG13 HD12 ' B' ' 444' ' ' LEU . 73.2 t -111.68 122.47 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -80.59 158.61 25.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -52.18 -54.34 32.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.348 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -66.67 -35.2 79.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 108.937 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.084 HD12 HG13 ' B' ' 440' ' ' VAL . 3.4 tm? -58.95 -42.93 91.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.429 -0.795 . . . . 0.0 109.1 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.63 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -58.87 -48.19 82.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 109.025 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -53.38 -41.35 65.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.438 ' HB3' HD13 ' B' ' 470' ' ' ILE . 19.2 mttt -60.05 -38.04 81.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.849 . . . . 0.0 109.211 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 459' ' ' LEU . 65.1 mt -64.99 -37.87 89.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.11 -36.79 6.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.534 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.2 mtp-105 -91.14 23.25 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.585 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.69 -18.88 6.67 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.888 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.7 t -78.14 111.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.895 -1.356 . . . . 0.0 109.325 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' B' ' 430' ' ' PRO . 12.0 m -126.84 -40.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.712 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.722 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -77.93 140.86 39.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.734 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.92 HD11 HD12 ' B' ' 488' ' ' ILE . 0.2 OUTLIER -46.79 -43.78 18.61 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 108.963 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.43 -40.5 82.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.591 ' HB3' HG13 ' B' ' 453' ' ' VAL . 92.1 m-20 -59.03 -40.79 86.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 448' ' ' LEU . 16.9 tp -64.4 -37.84 88.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 109.446 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.14 77.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.07 -28.0 61.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.888 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -68.64 148.4 50.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -104.43 154.92 17.51 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.963 HD11 ' HG2' ' A' ' 293' ' ' PRO . 22.2 mt -45.3 -36.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.242 . . . . 0.0 109.406 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.28 -39.03 93.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.484 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.409 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 79.6 m-20 -67.32 -28.47 68.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.745 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.3 mp -79.6 -25.18 41.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.96 -22.55 66.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.367 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -53.37 -32.47 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' B' ' 447' ' ' LYS . 76.9 mt -101.1 124.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -54.52 -42.88 71.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.1 -27.45 30.85 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.837 HD21 HD21 ' B' ' 444' ' ' LEU . 32.9 mt -95.87 125.94 40.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 164.1 11.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.13 -38.45 76.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -75.21 -45.9 37.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.742 ' O ' HD13 ' B' ' 481' ' ' LEU . 45.2 tttt -60.77 -44.89 96.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.379 -0.825 . . . . 0.0 109.426 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.38 -41.19 98.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -62.08 -46.91 93.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.55 74.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -1.124 . . . . 0.0 109.618 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.877 ' HB3' HD21 ' B' ' 459' ' ' LEU . 6.8 mp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.657 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.962 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.9 mt -58.07 -56.24 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.66 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 52.3 mtp -52.93 -38.54 62.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 109.536 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.16 -47.75 64.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -64.81 -44.14 90.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.462 ' NH2' ' CZ2' ' B' ' 490' ' ' TRP . 51.5 ttt85 -58.86 -46.06 88.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 88.4 m-20 -59.62 -41.18 89.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.92 HD12 HD11 ' B' ' 456' ' ' LEU . 79.5 mt -63.84 -37.01 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.84 -49.78 17.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.693 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . 0.462 ' CZ2' ' NH2' ' B' ' 486' ' ' ARG . 77.7 m95 -68.63 -40.89 80.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 97.9 m-85 -95.88 4.01 53.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.489 2.198 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.773 ' CE2' HD12 ' A' ' 253' ' ' LEU . 41.2 t80 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.461 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.5 OUTLIER -53.93 116.58 10.51 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.236 -0.915 . . . . 0.0 109.242 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.727 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.7 Cg_endo -65.03 -24.47 59.94 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.669 2.246 . . . . 0.0 111.671 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 312' ' ' LEU . 15.2 tt -68.02 -30.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 108.928 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.881 HD21 ' O ' ' A' ' 311' ' ' GLY . 34.5 mt -74.73 -45.35 44.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.6 mt -62.75 -25.52 68.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 251' ' ' PRO . 0.6 OUTLIER -58.0 140.7 82.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 108.889 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.4 Cg_endo -69.06 129.72 18.87 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.587 2.191 . . . . 0.0 111.977 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.688 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.76 -29.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.351 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.437 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 96.8 m-20 -64.44 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.249 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 256' ' ' PRO . 56.4 t0 -70.0 -17.4 63.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -43.78 129.14 5.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.417 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.34 -22.4 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.481 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 262' ' ' LEU . 5.5 mp -61.01 172.82 0.9 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.0 p -66.05 168.15 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.673 HG12 ' ND2' ' A' ' 268' ' ' ASN . 30.4 t -61.99 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.603 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -41.09 97.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.213 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.2 m -59.97 -49.7 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -67.55 -40.55 84.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.673 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.0 m-20 -57.17 -36.94 71.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 294' ' ' ASN . 74.3 m -54.17 -65.04 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 289' ' ' LEU . 64.5 mt -64.4 -45.13 88.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.406 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.515 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 34.3 tttt -53.03 -37.75 61.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.53 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.55 19.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 93.8 mt-10 -91.41 21.61 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.82 34.3 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.7 mt -120.42 107.87 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.515 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 76.5 m-70 -105.14 -12.19 16.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.65 135.35 50.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 1.034 HG21 HD23 ' A' ' 312' ' ' LEU . 34.1 mt -62.9 -29.85 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.911 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.84 -43.1 11.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 77.0 m-20 -53.9 -36.41 62.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.261 . . . . 0.0 108.818 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 289' ' ' LEU . 33.1 tp -55.79 -47.94 76.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.82 . . . . 0.0 109.096 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 279' ' ' GLY . 20.4 m -69.47 -25.53 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.49 -31.52 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 108.899 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -113.12 151.21 31.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.46 -0.775 . . . . 0.0 109.152 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 287' ' ' VAL . 26.7 m -63.78 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 289' ' ' LEU . 86.4 tt0 -56.06 -33.11 64.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.737 ' HA ' HD12 ' A' ' 290' ' ' LEU . 47.5 t -52.78 -50.68 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.905 . . . . 0.0 109.356 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -51.8 -32.7 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.046 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.694 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -73.97 -46.48 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.803 . . . . 0.0 109.173 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 287' ' ' VAL . 7.8 mt -55.69 -20.07 13.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.271 -0.893 . . . . 0.0 109.067 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.576 ' O ' ' HE2' ' B' ' 483' ' ' MET . 54.4 mttm -81.71 -29.85 32.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.177 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 294' ' ' ASN . 40.3 m -59.87 125.66 81.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.67 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.4 Cg_endo -71.09 -19.84 29.41 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.676 2.251 . . . . 0.0 111.807 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' B' ' 464' ' ' ILE . 77.2 m-20 -64.45 -26.87 68.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 5.8 mt -67.21 144.82 55.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -101.25 146.92 17.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -54.03 -40.39 67.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -76.51 -29.96 56.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 71.2 p -64.36 -45.39 87.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 290' ' ' LEU . 53.6 tp -52.91 -45.19 67.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.1 m -51.66 -54.48 27.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 262' ' ' LEU . 94.0 mt-10 -54.74 -46.25 74.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.27 -41.78 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.157 -0.964 . . . . 0.0 109.169 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -57.36 -40.18 77.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.159 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.11 -46.49 87.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.227 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -73.05 -35.15 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.205 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.958 HD21 ' OG ' ' A' ' 313' ' ' SER . 3.3 tt -62.37 -26.5 68.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.507 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.36 -35.31 71.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.389 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 1.7 t -61.94 -14.38 34.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 309' ' ' SER . 31.6 mtt180 72.91 1.42 4.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.881 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -71.49 -22.14 78.64 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.034 HD23 HG21 ' A' ' 278' ' ' ILE . 0.8 OUTLIER -132.09 156.44 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 109.487 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.958 ' OG ' HD21 ' A' ' 307' ' ' LEU . 2.3 p 84.56 -141.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.732 -0.605 . . . . 0.0 109.793 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.778 HD22 ' OG ' ' A' ' 313' ' ' SER . 3.9 mm? 67.66 14.48 9.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 314' ' ' LEU . . . 42.22 45.04 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.728 ' HE2' HG11 ' A' ' 282' ' ' VAL . 29.5 mtm -61.67 169.01 2.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.327 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.775 ' C ' HD12 ' A' ' 318' ' ' LEU . 79.9 mtt180 -136.88 130.99 32.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.576 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.775 HD12 ' C ' ' A' ' 317' ' ' ARG . 5.1 mp -136.29 127.69 28.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 318' ' ' LEU . 96.1 mt-10 -43.91 -46.66 8.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.88 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 34.1 t30 -131.3 -56.35 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.241 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.635 ' HE3' HD22 ' A' ' 318' ' ' LEU . 1.6 t-105 164.8 -61.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 47.5 Cg_endo -67.51 107.75 1.48 Allowed 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.71 2.273 . . . . 0.0 111.98 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.0 Cg_endo -74.19 163.91 35.45 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.492 2.128 . . . . 0.0 111.579 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.78 -16.53 11.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 0.0 109.615 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.2 t -65.14 -46.71 79.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.506 HD11 HD21 ' A' ' 254' ' ' LEU . 28.5 mt . . . . . 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 16.1 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 2.3 tttm -83.66 136.57 42.07 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.285 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.478 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.2 Cg_endo -69.7 131.73 21.94 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 111.84 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.7 148.13 52.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.55 -33.78 15.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.69 -46.61 75.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' B' ' 448' ' ' LEU . 22.4 tp -69.86 -38.38 76.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.984 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.4 tm? -72.78 -30.3 64.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -91.22 8.68 34.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 1.004 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.4 tp -72.94 138.75 46.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.69 138.01 36.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.29 5.37 63.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.893 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -122.92 132.66 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -1.16 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -86.85 150.32 24.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -49.83 -45.45 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.586 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.4 m-20 -64.75 -46.07 83.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 109.231 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.1 tp -53.9 -43.32 69.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.58 90.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.7 m-30 -56.84 -44.4 82.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 109.103 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.902 ' HB3' HG21 ' B' ' 470' ' ' ILE . 20.3 mttm -60.83 -40.39 92.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.49 ' CD1' HD11 ' B' ' 434' ' ' LEU . 89.0 mt -60.25 -47.02 87.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.376 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -60.94 -34.51 74.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.481 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -48.13 -35.4 11.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.652 ' HG3' HD11 ' B' ' 470' ' ' ILE . 47.2 mtp180 -91.11 22.93 3.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.79 -18.74 7.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.73 HG13 ' HB3' ' B' ' 458' ' ' ASP . 21.4 t -78.12 108.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.899 -1.354 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.482 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 95.3 m -119.84 -42.56 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.758 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.619 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -74.91 140.8 44.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 1.004 ' CD1' HD22 ' B' ' 437' ' ' LEU . 27.0 tp -49.97 -41.61 47.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.293 -0.88 . . . . 0.0 109.036 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . 0.402 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 31.7 mm-40 -57.32 -46.22 83.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 108.953 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.73 ' HB3' HG13 ' B' ' 453' ' ' VAL . 70.6 m-20 -58.24 -38.73 77.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.101 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.761 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -62.35 -42.85 99.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.18 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -60.42 -35.79 76.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.47 -30.81 71.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.493 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -67.38 156.29 36.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.12 161.46 13.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 294' ' ' ASN . 68.1 mt -52.75 -35.65 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -1.184 . . . . 0.0 109.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.12 -33.81 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.17 -31.47 65.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.033 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.1 mt -77.15 -33.89 56.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.81 55.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.98 -39.09 93.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.902 HG21 ' HB3' ' B' ' 447' ' ' LYS . 88.1 mt -82.54 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.47 152.65 29.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.576 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.52 -33.49 4.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' B' ' 444' ' ' LEU . 66.9 mt -85.99 126.6 34.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 475' ' ' ASP . 35.4 m -103.64 161.98 13.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.493 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 87.8 m-20 -59.55 -36.03 75.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -76.03 -46.04 31.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.448 ' CE ' HD22 ' B' ' 444' ' ' LEU . 34.4 tttp -65.1 -47.58 76.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.033 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -57.83 -44.51 86.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -59.31 -47.67 89.7 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.29 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.48 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.555 HD22 ' CG2' ' B' ' 440' ' ' VAL . 28.0 mt -61.64 -36.47 80.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.9 mt -62.52 -53.64 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.576 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 33.9 mtp -54.24 -48.92 70.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -52.67 -56.16 17.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -60.19 -49.35 77.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 109.572 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.565 ' CG ' ' HB1' ' B' ' 460' ' ' ALA . 90.3 mtt180 -59.63 -42.05 91.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.492 ' O ' ' CD1' ' B' ' 491' ' ' PHE . 99.5 m-20 -58.36 -42.75 87.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.962 HD12 ' CD2' ' B' ' 456' ' ' LEU . 38.3 mt -64.34 -38.32 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . 0.402 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.0 OUTLIER -75.96 -51.92 11.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -63.22 -28.01 69.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 109.42 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' B' ' 487' ' ' ASN . 3.6 m-30 -72.23 -34.36 68.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.946 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.6 ' N ' ' HG ' ' A' ' 325' ' ' SER . 14.3 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.47 126.74 56.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.382 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.776 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -65.25 -27.49 56.03 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.674 2.25 . . . . 0.0 111.601 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 312' ' ' LEU . 8.3 tt -69.07 -28.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.638 HD13 HG21 ' A' ' 282' ' ' VAL . 26.2 mt -74.54 -43.42 55.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.421 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.776 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.7 mt -64.18 -32.31 73.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 278' ' ' ILE . 5.7 ttp180 -55.82 135.89 72.46 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.6 Cg_endo -68.58 129.79 19.57 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.641 2.227 . . . . 0.0 111.842 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.818 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -44.69 -25.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.35 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 256' ' ' PRO . 97.8 m-20 -67.18 -30.88 70.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 256' ' ' PRO . 37.0 m-20 -75.36 -9.72 58.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 257' ' ' VAL . 4.5 mp -43.77 127.18 4.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 262' ' ' LEU . 97.0 mt-10 -62.63 -27.84 69.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.758 HD13 ' HG2' ' A' ' 302' ' ' GLU . 18.8 mt -54.41 -170.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.457 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -80.41 159.72 25.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.59 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.5 t -53.43 -30.58 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -52.37 -45.53 65.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.4 m -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.87 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.92 87.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.59 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.4 m-20 -59.79 -34.29 72.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -58.29 -64.0 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.45 -45.4 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -52.9 -40.38 63.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.11 -25.05 66.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.4 mm-40 -88.51 17.42 5.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.63 33.32 2.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.769 HG23 ' HB2' ' A' ' 280' ' ' ASP . 79.0 mt -108.59 127.05 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.5 p80 -112.23 -35.02 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.57 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.503 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.1 m-30 -110.07 128.8 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.687 HD11 HD11 ' A' ' 260' ' ' LEU . 76.6 mt -46.45 -29.92 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.836 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.82 -47.15 13.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.769 ' HB2' HG23 ' A' ' 275' ' ' ILE . 54.0 m-20 -53.36 -30.87 41.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.235 . . . . 0.0 108.798 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 289' ' ' LEU . 41.8 tp -59.74 -49.71 76.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.468 -0.77 . . . . 0.0 109.273 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 279' ' ' GLY . 27.3 m -65.71 -29.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.152 -0.967 . . . . 0.0 108.866 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -60.9 -33.99 73.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.371 -0.831 . . . . 0.0 108.961 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 56.1 mtt180 -100.12 143.33 30.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.299 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.3 m -69.03 143.53 54.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -54.29 -28.3 41.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.333 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 43.1 t -52.83 -50.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.304 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.2 mt-10 -52.19 -33.29 40.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 281' ' ' LEU . 60.8 mt -70.88 -30.61 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.64 -31.69 67.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.8 -14.3 56.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.02 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 77.0 m -81.76 115.88 59.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 1.007 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.5 Cg_endo -70.62 -16.91 33.96 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.698 2.265 . . . . 0.0 111.773 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.772 ' ND2' HD12 ' B' ' 464' ' ' ILE . 27.0 m120 -47.21 -33.13 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 295' ' ' LEU . 0.4 OUTLIER -107.26 137.12 45.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.441 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -81.58 172.06 53.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -57.75 -41.97 83.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.408 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -63.46 -35.97 82.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.932 . . . . 0.0 109.298 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 28.2 m -58.3 -37.42 75.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 28.7 tp -53.97 -33.54 57.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 109.292 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.3 m -60.93 -57.46 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.758 ' HG2' HD13 ' A' ' 262' ' ' LEU . 42.8 tt0 -53.57 -46.12 70.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 108.996 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 56.2 mt -57.74 -50.73 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -56.11 -38.73 71.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 108.761 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 302' ' ' GLU . 64.4 m-20 -53.85 -45.66 71.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 1.037 HG12 ' CD2' ' A' ' 312' ' ' LEU . 4.5 t -66.86 -40.81 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 108.865 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 313' ' ' SER . 21.3 mt -53.83 -25.65 20.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.441 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.9 63.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 108.983 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 p -71.4 -9.09 57.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.203 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.685 ' HA ' HD11 ' A' ' 314' ' ' LEU . 55.6 mtm180 53.01 19.35 1.34 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -107.96 0.22 33.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.037 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -147.23 145.87 29.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -1.231 . . . . 0.0 109.644 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.5 OUTLIER 58.13 46.69 15.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.398 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.685 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -90.46 23.95 2.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.2 39.3 95.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.748 ' HE2' HG11 ' A' ' 282' ' ' VAL . 1.3 mtm -93.63 170.95 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.108 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.453 ' C ' HD23 ' A' ' 318' ' ' LEU . 67.4 mtm-85 -136.15 117.05 14.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 317' ' ' ARG . 4.5 mt -112.47 139.81 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.354 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.88 -35.37 79.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.256 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 24.7 m120 -140.46 -47.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 109.157 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.604 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.52 -62.83 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -67.87 107.04 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.549 2.166 . . . . 0.0 111.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.6 Cg_endo -69.65 165.18 31.71 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.665 2.243 . . . . 0.0 111.85 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.93 -15.72 56.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 97.0 p -85.82 -26.27 25.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.211 -0.93 . . . . 0.0 109.454 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 323' ' ' PRO . 16.3 tt . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.718 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 25.6 m120 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 4.5 tttm -53.98 131.94 58.61 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.459 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.6 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.9 Cg_endo -70.3 144.42 51.09 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.627 2.218 . . . . 0.0 111.833 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -79.45 161.06 26.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.453 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' B' ' 436' ' ' ASN . 85.9 m-20 -52.09 -37.55 54.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' B' ' 456' ' ' LEU . 16.7 m-20 -61.08 -50.12 74.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' B' ' 430' ' ' PRO . 23.2 tp -68.91 -38.07 79.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.703 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.971 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.1 tm? -77.04 -29.6 55.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.563 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 432' ' ' ASP . 78.9 m-20 -93.77 10.87 31.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.487 HD23 HG21 ' B' ' 440' ' ' VAL . 29.1 tp -75.53 133.22 41.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.57 143.29 48.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.6 -4.76 82.35 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.714 ' CG2' HD22 ' B' ' 481' ' ' LEU . 49.6 t -126.56 135.77 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -1.182 . . . . 0.0 109.419 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' HD12 ' B' ' 444' ' ' LEU . 49.6 p30 -103.41 175.08 5.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.534 ' HG2' HD21 ' B' ' 435' ' ' LEU . 64.4 mtm180 -61.61 -38.19 86.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.18 -41.06 99.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.513 HD13 ' HZ1' ' B' ' 477' ' ' LYS . 21.9 mt -72.23 -39.74 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.21 -35.82 78.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.873 . . . . 0.0 109.439 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 15.2 m-30 -73.08 -46.07 53.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.505 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.521 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 17.5 ttmt -61.65 -44.14 97.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.867 HD11 HG21 ' B' ' 453' ' ' VAL . 2.9 tm? -65.62 -45.45 83.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.93 -31.36 62.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.564 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.39 -20.55 4.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.593 ' CG ' HD11 ' B' ' 470' ' ' ILE . 11.4 mtp-105 -89.62 32.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.88 -18.72 7.17 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.867 HG21 HD11 ' B' ' 448' ' ' LEU . 48.0 t -61.71 137.1 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.815 -1.403 . . . . 0.0 109.318 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' B' ' 431' ' ' ALA . 1.0 OUTLIER -133.17 -34.63 1.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.783 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.572 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.4 OUTLIER -116.93 144.0 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 109.972 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.816 HD11 ' HA ' ' B' ' 485' ' ' ALA . 1.4 tm? -45.47 -39.43 7.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 108.889 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . 0.422 ' N ' HD13 ' B' ' 456' ' ' LEU . 44.8 mm-40 -55.68 -49.43 72.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.882 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -55.13 -41.66 72.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.855 . . . . 0.0 108.946 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.597 HD13 ' CD1' ' B' ' 434' ' ' LEU . 4.0 tt -55.86 -48.46 75.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.317 -0.864 . . . . 0.0 109.278 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.871 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -57.38 -33.09 67.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.313 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.365 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.75 160.94 28.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -116.94 152.87 17.67 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.938 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.8 mt -44.93 -42.49 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -1.172 . . . . 0.0 109.343 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.05 -39.78 83.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.343 -0.848 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.79 -29.06 66.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.026 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.8 mt -78.4 -28.25 46.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.6 -25.57 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.05 -31.28 18.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.593 HD11 ' CG ' ' B' ' 451' ' ' ARG . 60.0 mt -103.79 121.83 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.569 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.37 -32.55 72.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.78 -26.48 25.59 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.451 ' CD1' HD23 ' B' ' 448' ' ' LEU . 64.0 mt -108.82 139.26 43.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -1.122 . . . . 0.0 109.523 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.493 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.7 m -103.7 164.66 11.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.493 ' N ' HG22 ' B' ' 474' ' ' THR . 81.6 m-20 -60.49 -37.15 80.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.415 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -75.47 -46.02 35.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.513 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 64.4 tttm -63.92 -40.5 96.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.445 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.026 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.91 -39.83 94.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -63.16 -42.36 99.46 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.09 85.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.573 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.714 HD22 ' CG2' ' B' ' 440' ' ' VAL . 29.2 mt -67.16 -38.63 85.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 293' ' ' PRO . 26.3 mt -65.4 -56.02 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.4 mtp -52.36 -36.77 54.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.386 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.66 -44.53 64.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.871 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -62.86 -52.02 64.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.08 -41.74 84.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.387 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.2 m-20 -57.46 -35.88 70.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.227 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.449 HG13 ' O ' ' B' ' 484' ' ' ALA . 88.1 mt -70.88 -36.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.254 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 11.3 t -74.63 -51.69 13.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.755 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -61.73 -30.7 70.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 19.5 m-30 -82.95 -34.27 26.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.072 -1.017 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.96 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 253' ' ' LEU . 23.4 t80 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.553 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.427 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -55.17 142.81 56.89 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.601 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.506 ' HB2' ' NH2' ' A' ' 255' ' ' ARG . 43.5 Cg_endo -65.46 -22.97 58.54 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.807 2.338 . . . . 0.0 111.654 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.533 HG21 ' CA ' ' A' ' 311' ' ' GLY . 10.3 tt -70.01 -28.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.88 . . . . 0.0 108.927 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -69.23 -38.5 78.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 253' ' ' LEU . 3.8 mm? -86.04 -24.0 26.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.365 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 4.8 ttm-85 -64.03 145.02 98.15 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.454 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 48.8 Cg_endo -70.01 136.72 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.728 2.285 . . . . 0.0 111.837 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.9 HG11 HD12 ' A' ' 270' ' ' LEU . 0.1 OUTLIER -45.74 -33.38 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.0 109.522 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.473 ' OD1' ' HB1' ' A' ' 267' ' ' ALA . 95.1 m-20 -62.51 -30.83 71.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.524 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 25.5 m-20 -68.24 -9.61 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 278' ' ' ILE . 51.2 mt -66.18 139.38 58.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 262' ' ' LEU . 74.8 mm-40 -69.38 -20.23 63.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.497 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.816 HD22 ' CG ' ' A' ' 302' ' ' GLU . 26.2 mt -52.46 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 p -80.69 160.15 25.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.558 HG12 ' OD1' ' A' ' 268' ' ' ASN . 21.2 t -55.21 -27.64 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -51.97 -48.0 64.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.0 m -58.97 -50.97 72.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.339 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.473 ' HB1' ' OD1' ' A' ' 258' ' ' ASP . . . -65.32 -33.27 75.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.558 ' OD1' HG12 ' A' ' 264' ' ' VAL . 95.5 m-20 -61.38 -37.73 84.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.38 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.8 m -53.24 -64.55 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.9 HD12 HG11 ' A' ' 257' ' ' VAL . 57.7 mt -66.51 -45.24 80.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 21.4 tptm -53.19 -40.06 64.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.12 -21.42 65.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.6 mt-10 -94.14 23.36 5.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.61 17.62 7.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 56.2 mt -104.81 122.98 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.468 ' ND1' ' HD2' ' A' ' 271' ' ' LYS . 92.2 m-70 -113.09 -12.87 13.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 254' ' ' LEU . 4.5 m-85 -112.84 141.4 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 312' ' ' LEU . 74.3 mt -65.1 -28.97 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.444 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.26 -47.5 10.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 67.8 m-20 -53.35 -32.96 51.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.99 -1.3 . . . . 0.0 108.893 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 270' ' ' LEU . 26.7 tp -55.65 -50.73 69.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.183 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 279' ' ' GLY . 28.2 m -66.77 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 108.787 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -54.92 -35.42 64.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 0.0 108.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -107.58 144.07 35.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.076 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 45.6 p -76.23 157.15 32.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 307' ' ' LEU . 10.0 mt-10 -56.16 -38.63 71.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.297 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.927 ' HA ' HD12 ' A' ' 290' ' ' LEU . 41.2 t -52.88 -52.78 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.283 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.55 -32.3 58.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 292' ' ' THR . 7.6 mp -80.42 -33.08 37.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 287' ' ' VAL . 4.9 mt -69.66 -17.12 63.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.958 . . . . 0.0 109.353 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' B' ' 483' ' ' MET . 33.8 mmtt -86.48 10.95 13.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 0.0 109.482 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.87 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.3 t -125.82 142.72 43.0 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.918 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.9 Cg_endo -71.35 -20.71 27.43 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.796 2.33 . . . . 0.0 111.941 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' B' ' 464' ' ' ILE . 21.8 m120 -43.3 -44.14 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.634 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 292' ' ' THR . 0.2 OUTLIER -107.64 137.07 46.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.499 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -91.73 -179.16 42.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.35 -44.19 95.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -1.204 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -60.85 -42.57 98.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.4 m -54.9 -46.32 74.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.31 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.827 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.3 tm? -52.68 -45.11 66.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.241 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 23.9 m -50.84 -51.54 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.091 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.816 ' CG ' HD22 ' A' ' 262' ' ' LEU . 38.6 tp10 -54.19 -42.33 69.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 23.7 mm -57.95 -41.15 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -0.867 . . . . 0.0 108.892 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . 0.769 ' HE3' HD12 ' A' ' 300' ' ' LEU . 82.9 mttt -59.43 -40.53 87.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.327 -0.858 . . . . 0.0 108.872 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.18 -46.97 87.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.662 ' CG1' HD11 ' A' ' 312' ' ' LEU . 6.0 t -70.14 -37.4 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.109 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 286' ' ' GLU . 19.9 tp -61.38 -27.3 68.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.34 76.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -79.21 -0.22 31.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.792 ' HA ' HD11 ' A' ' 314' ' ' LEU . 64.4 mtt180 63.24 11.04 5.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.182 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.533 ' CA ' HG21 ' A' ' 252' ' ' ILE . . . -64.75 -51.1 54.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 278' ' ' ILE . 0.5 OUTLIER -144.41 168.53 19.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -1.156 . . . . 0.0 109.566 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.576 ' O ' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 72.4 32.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.3 mm? -75.85 -4.9 43.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.51 41.24 96.34 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -111.54 157.96 19.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -1.139 . . . . 0.0 109.638 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -115.19 133.45 56.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 109.223 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.18 140.76 40.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -58.28 -38.51 77.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 40.7 t-20 -132.96 -73.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.404 -0.81 . . . . 0.0 109.001 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.553 ' N ' ' CD ' ' A' ' 322' ' ' PRO . 1.5 t90 175.78 -45.07 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.583 ' HA ' HD12 ' A' ' 326' ' ' ILE . 52.9 Cg_endo -97.73 74.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 123.473 2.782 . . . . 0.0 112.601 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.21 165.15 29.56 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.499 2.132 . . . . 0.0 111.615 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -44.82 -26.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.5 m -67.97 -61.01 2.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.651 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.842 HD11 HD21 ' A' ' 253' ' ' LEU . 9.5 mt . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 18.4 m120 . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 136.08 59.37 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 51.5 Cg_endo -70.58 133.24 23.63 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.674 2.25 . . . . 0.0 111.772 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.08 153.83 41.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.17 -35.34 59.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.53 -47.75 74.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.87 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.676 ' CD1' HD23 ' B' ' 448' ' ' LEU . 21.4 tp -66.35 -38.31 87.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 109.45 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.774 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -70.57 -32.46 69.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.403 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -88.65 7.31 34.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 440' ' ' VAL . 40.3 tp -72.3 134.83 45.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -80.74 141.77 34.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.51 68.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.865 HG21 HD23 ' B' ' 437' ' ' LEU . 87.6 t -122.84 126.98 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 109.399 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.52 154.3 23.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.432 ' NH1' HD11 ' B' ' 435' ' ' LEU . 68.6 mtp85 -50.26 -48.87 54.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.2 m-20 -61.91 -44.48 96.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.06 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.3 tp -55.65 -44.45 77.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.395 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.75 87.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 13.0 m-30 -58.98 -43.06 91.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.357 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.67 -40.71 93.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.676 HD23 ' CD1' ' B' ' 434' ' ' LEU . 19.7 tp -60.99 -47.28 87.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.93 -31.5 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.97 -33.81 57.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.605 ' HG3' HD11 ' B' ' 470' ' ' ILE . 33.5 mtm105 -90.32 22.06 3.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.432 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.87 6.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' B' ' 458' ' ' ASP . 3.0 t -76.87 111.49 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.915 -1.344 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 29.5 m -121.51 -35.44 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.433 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -87.5 142.63 27.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.996 HD21 HD12 ' B' ' 488' ' ' ILE . 35.3 tp -48.71 -42.06 33.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.173 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.94 -45.79 78.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.142 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.804 ' HB3' HG13 ' B' ' 453' ' ' VAL . 93.6 m-20 -57.77 -41.69 82.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.887 . . . . 0.0 109.078 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.748 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -59.23 -41.4 88.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 109.278 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -62.09 -37.15 83.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.83 -25.86 67.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.725 ' HG3' HG21 ' B' ' 453' ' ' VAL . 88.1 mm-40 -78.36 138.92 38.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -97.85 165.38 22.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 293' ' ' PRO . 68.1 mt -48.04 -36.29 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.425 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -65.55 -38.65 90.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.256 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.73 -31.69 72.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.94 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -78.14 -26.84 48.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.6 66.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -52.85 -33.12 48.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.605 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.8 mt -104.67 128.58 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.08 -33.47 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.495 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.35 -27.33 46.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.06 ' CD2' HD11 ' B' ' 444' ' ' LEU . 35.1 mt -102.62 134.32 46.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.9 m -104.2 161.93 13.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.95 -36.35 76.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -76.94 -46.02 25.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.47 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 38.9 tttp -66.33 -40.2 89.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.3 -42.47 93.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.0 -45.11 96.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.14 90.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -1.186 . . . . 0.0 109.659 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -65.83 -39.93 91.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 88.7 mt -61.88 -56.14 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.516 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 67.1 mmm -54.06 -43.23 70.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.44 62.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.2 90.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.377 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.578 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 63.1 mtp180 -59.48 -43.82 93.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 94.2 m-20 -58.28 -43.44 87.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.996 HD12 HD21 ' B' ' 456' ' ' LEU . 68.7 mt -60.25 -37.47 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.0 m -78.8 -51.98 8.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -59.71 -45.95 90.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 51.6 m-85 -76.2 -39.68 54.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.606 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.981 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.572 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 91.8 m-85 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.12 154.84 76.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.43 -24.72 56.63 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.672 2.248 . . . . 0.0 111.698 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -64.9 -30.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.934 . . . . 0.0 108.525 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.524 ' CD1' HG11 ' A' ' 282' ' ' VAL . 2.0 tp -72.8 -27.27 61.88 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.899 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.9 mt -90.93 -24.57 20.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.4 mtt85 -55.95 149.54 33.35 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 257' ' ' VAL . 50.1 Cg_endo -70.18 130.34 18.66 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.604 2.203 . . . . 0.0 111.665 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.66 -26.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.479 ' HA ' ' HZ1' ' A' ' 271' ' ' LYS . 55.2 t0 -63.21 -31.0 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.427 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' PRO . 83.1 m-20 -72.76 -12.47 61.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.674 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -46.22 137.44 6.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.52 -16.08 63.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 262' ' ' LEU . 4.6 mp -64.16 170.45 3.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.7 p -71.58 164.07 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 268' ' ' ASN . 11.5 t -51.31 -31.12 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -57.32 -45.05 84.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.038 . . . . 0.0 109.299 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.581 ' OG ' HD22 ' A' ' 262' ' ' LEU . 18.7 t -59.94 -50.06 75.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.592 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.72 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -64.59 -44.25 91.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.364 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.669 HD21 HG12 ' A' ' 264' ' ' VAL . 86.6 m-20 -53.54 -32.63 51.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.74 ' SG ' HD23 ' A' ' 295' ' ' LEU . 28.5 t -63.49 -57.22 10.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.672 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.6 mm? -66.4 -48.15 70.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.72 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 42.7 mttt -55.61 -37.53 68.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.93 -28.79 53.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 67.8 mm-40 -88.92 23.52 2.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.36 40.47 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.92 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.5 mt -116.34 125.63 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.596 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.1 p80 -115.89 -29.72 6.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.596 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.5 m-85 -111.36 131.68 54.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.531 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 252' ' ' ILE . 78.5 mt -46.97 -32.15 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.268 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.884 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.08 -47.88 14.93 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.92 ' HB2' HG23 ' A' ' 275' ' ' ILE . 90.1 m-20 -53.49 -34.29 57.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.901 -1.352 . . . . 0.0 108.878 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 289' ' ' LEU . 40.0 tp -52.97 -50.86 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.417 -0.802 . . . . 0.0 109.022 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.5 m -65.98 -30.05 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 108.772 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 49.6 tt0 -54.32 -37.6 65.02 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.402 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 58.6 mtt-85 -105.8 141.38 37.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.476 -0.765 . . . . 0.0 109.066 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -65.22 141.69 58.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -53.99 -23.93 14.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.781 ' HA ' HD12 ' A' ' 290' ' ' LEU . 50.2 t -52.73 -51.02 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 109.103 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.5 mt-10 -51.9 -37.28 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.133 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 281' ' ' LEU . 61.5 mt -61.66 -45.11 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.117 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 287' ' ' VAL . 6.1 mt -60.65 -29.11 69.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.524 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 62.8 mttm -82.02 -20.93 37.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 116.33 60.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.374 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.983 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.5 Cg_endo -70.6 -9.16 25.23 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.715 2.277 . . . . 0.0 111.821 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.673 ' ND2' HD12 ' B' ' 464' ' ' ILE . 30.5 m120 -60.77 -37.38 81.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.74 HD23 ' SG ' ' A' ' 269' ' ' CYS . 1.3 pp -100.18 137.5 38.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -0.955 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -86.71 168.71 39.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -64.7 -36.74 85.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.7 -42.16 83.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 303' ' ' ILE . 85.1 p -63.07 -34.09 76.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.2 tp -56.76 -33.41 66.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.1 m -61.49 -52.12 65.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.424 ' CD ' ' HG ' ' A' ' 262' ' ' LEU . 80.9 tt0 -62.91 -46.3 88.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.335 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.492 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 62.7 mt -57.74 -46.99 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 108.844 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.51 -40.54 65.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.07 -44.66 87.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.822 . . . . 0.0 108.811 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.821 ' CG1' HD22 ' A' ' 312' ' ' LEU . 6.3 t -63.91 -34.98 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.287 -0.883 . . . . 0.0 108.925 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 303' ' ' ILE . 8.4 mp -60.17 -25.99 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 109.238 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.65 68.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -60.97 -14.62 24.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.67 ' HA ' HD11 ' A' ' 314' ' ' LEU . 24.2 ttm180 70.03 4.81 4.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.716 ' C ' HD12 ' A' ' 312' ' ' LEU . . . -108.11 16.25 35.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.821 HD22 ' CG1' ' A' ' 306' ' ' VAL . 5.3 mp -146.58 138.63 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.629 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.6 OUTLIER 47.13 59.41 4.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.537 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.679 HD21 ' N ' ' A' ' 312' ' ' LEU . 3.7 mm? -91.12 9.88 29.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.04 87.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.519 ' CE ' HG11 ' A' ' 282' ' ' VAL . 7.1 ptt? -114.58 153.51 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -1.2 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -125.08 125.95 44.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.5 mp -103.26 138.66 39.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.83 -35.23 76.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.158 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 39.8 t30 -125.82 -69.29 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.899 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 1.2 t-105 165.63 -62.89 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.1 Cg_endo -67.99 108.26 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.546 2.164 . . . . 0.0 112.021 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.572 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 53.5 Cg_endo -75.16 164.39 33.15 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.608 2.205 . . . . 0.0 111.506 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.9 -10.86 31.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 48.2 m -73.32 -43.78 60.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.673 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 254' ' ' LEU . 25.1 pt . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.62 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.594 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 26.5 m120 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -53.34 128.62 50.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 109.409 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 49.9 Cg_endo -69.88 141.55 45.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.676 2.251 . . . . 0.0 111.902 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -73.51 148.06 43.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.481 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -46.9 -37.28 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.5 -42.82 93.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.857 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.3 tm? -67.24 -30.93 70.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 442' ' ' ARG . 21.7 tp -81.33 -29.63 34.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 109.566 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -74.87 -3.8 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.634 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.793 HD23 HG21 ' B' ' 440' ' ' VAL . 37.2 tp -68.26 134.53 50.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.73 142.19 42.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.77 8.39 67.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.793 HG21 HD23 ' B' ' 437' ' ' LEU . 43.8 t -127.52 128.49 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.39 158.66 15.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.619 ' HG2' HD11 ' B' ' 435' ' ' LEU . 90.6 mtt-85 -50.22 -48.55 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.33 -51.08 69.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.01 HD11 ' CD1' ' B' ' 473' ' ' LEU . 20.7 tp -55.08 -40.6 70.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.14 -42.73 91.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -60.69 -48.16 83.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.3 -45.84 83.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.851 ' O ' HD13 ' B' ' 448' ' ' LEU . 0.7 OUTLIER -65.21 -42.85 93.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -63.35 -27.91 69.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.16 -20.04 3.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -92.23 30.07 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.64 7.5 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.581 HG13 ' CB ' ' B' ' 458' ' ' ASP . 3.4 t -60.76 135.99 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 0.0 109.386 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 31.1 p -135.24 -35.89 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 109.881 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.6 159.79 17.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 109.877 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.957 HD11 HD12 ' B' ' 488' ' ' ILE . 0.3 OUTLIER -52.25 -43.71 64.5 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.277 -0.89 . . . . 0.0 109.238 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.74 -44.03 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 108.951 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.581 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.0 m-20 -56.81 -43.34 80.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.288 -0.883 . . . . 0.0 108.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' B' ' 448' ' ' LEU . 24.6 tp -56.89 -45.18 82.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.23 72.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.384 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -65.94 -32.28 73.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.564 ' OE1' HG22 ' B' ' 453' ' ' VAL . 2.3 mp0 -62.15 157.6 18.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.28 153.91 17.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.3 mt -50.85 -38.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 109.296 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -70.17 -32.22 70.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.041 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.6 mt -77.19 -29.2 54.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.08 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.59 -33.68 66.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.587 HG22 ' H ' ' B' ' 472' ' ' GLY . 76.3 mt -103.03 129.2 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -62.1 -29.92 70.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.587 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.04 -32.75 50.02 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.01 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.9 mm? -106.13 133.22 51.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.426 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.454 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.3 m -103.62 161.87 13.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.454 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.71 -36.95 75.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -76.31 -45.53 31.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.568 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.715 ' CE ' HD22 ' B' ' 444' ' ' LEU . 25.3 tttp -67.35 -41.24 85.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.041 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.7 -45.18 91.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 109.587 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.65 -42.09 99.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.95 91.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.615 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -65.3 -47.15 77.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.934 HD12 ' HB2' ' A' ' 293' ' ' PRO . 35.7 mt -55.19 -56.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 55.8 mtp -52.91 -41.93 64.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.437 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.34 -43.89 96.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.697 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' B' ' 459' ' ' LEU . . . -65.5 -49.69 68.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 293' ' ' PRO . 95.3 mtt180 -57.79 -46.1 85.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 87.6 m-20 -57.91 -38.45 75.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.554 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.957 HD12 HD11 ' B' ' 456' ' ' LEU . 76.4 mt -70.94 -36.79 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 13.5 t -77.71 -51.51 10.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.787 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -63.54 -45.72 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 99.6 m-85 -93.94 13.9 21.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.921 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 254' ' ' LEU . 14.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.842 ' HB2' HD13 ' A' ' 253' ' ' LEU . 25.0 m-20 -54.07 124.58 45.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.105 -0.997 . . . . 0.0 109.31 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -64.75 -25.61 60.93 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.664 2.242 . . . . 0.0 111.624 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.701 ' CG2' HD12 ' A' ' 253' ' ' LEU . 14.5 tt -63.5 -33.72 63.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 108.622 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.85 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.5 mp -74.86 -41.37 59.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.407 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.823 HD21 HD11 ' A' ' 326' ' ' ILE . 1.7 mt -72.08 -30.48 65.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.776 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 259' ' ' ASP . 4.8 ttp-105 -56.43 138.35 75.46 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 108.849 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 259' ' ' ASP . 46.3 Cg_endo -68.23 130.57 21.58 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.64 2.227 . . . . 0.0 111.757 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.735 HG23 ' HE3' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -44.55 -26.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 t0 -68.46 -30.77 69.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.255 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 256' ' ' PRO . 35.2 m-20 -69.87 -16.57 63.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 278' ' ' ILE . 37.7 mt -56.07 138.26 49.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.2 tt0 -66.02 -16.22 63.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 302' ' ' GLU . 33.4 mt -53.5 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.0 p -88.27 157.56 18.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.72 HG12 HD21 ' A' ' 268' ' ' ASN . 7.0 t -50.68 -37.1 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 265' ' ' ARG . 17.7 tpt85 -57.17 -46.5 82.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.1 m -57.97 -47.55 82.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.33 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -68.93 -39.71 79.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.375 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.72 HD21 HG12 ' A' ' 264' ' ' VAL . 86.6 m-20 -56.66 -34.9 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 69.0 m -57.11 -64.37 0.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 281' ' ' LEU . 57.4 mt -56.64 -48.09 78.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HE3' HG23 ' A' ' 257' ' ' VAL . 32.3 mttt -54.75 -37.63 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.04 27.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.4 mt-10 -89.95 25.83 2.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.397 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 67.17 42.7 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 1.0 HG23 ' HB2' ' A' ' 280' ' ' ASP . 88.8 mt -115.72 124.6 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.45 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.478 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.3 p80 -110.99 -41.53 4.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.484 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.478 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 8.4 m-30 -105.22 135.02 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.19 -0.944 . . . . 0.0 109.427 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 252' ' ' ILE . 86.7 mt -46.95 -30.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 1.003 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.98 -46.34 19.83 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 1.0 ' HB2' HG23 ' A' ' 275' ' ' ILE . 83.1 m-20 -53.45 -34.54 58.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -1.167 . . . . 0.0 108.884 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 270' ' ' LEU . 35.1 tp -54.96 -49.88 70.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 108.987 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 279' ' ' GLY . 14.3 m -65.26 -23.13 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 0.0 108.84 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.9 tt0 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.02 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -96.39 159.9 14.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.345 -0.847 . . . . 0.0 109.227 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 287' ' ' VAL . 36.0 m -81.39 139.09 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 289' ' ' LEU . 77.9 tt0 -58.56 -32.21 68.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 285' ' ' THR . 45.7 t -52.72 -50.37 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.878 . . . . 0.0 109.359 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 292' ' ' THR . 97.5 mt-10 -55.2 -33.34 62.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.344 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.8 mm? -64.93 -43.44 92.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm? -66.07 -23.97 66.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 37.7 mttt -90.45 -8.54 50.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' ' CD1' ' A' ' 295' ' ' LEU . 2.1 m -86.99 113.73 54.92 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.6 Cg_endo -70.48 -22.25 29.04 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.661 2.24 . . . . 0.0 111.923 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.802 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.1 m120 -50.47 -22.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.116 -0.99 . . . . 0.0 109.345 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.91 HD23 HD11 ' A' ' 303' ' ' ILE . 4.9 mp -90.79 138.75 31.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.408 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -87.98 167.78 36.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -55.02 -45.83 75.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -69.39 -37.84 77.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.9 m -58.58 -51.48 69.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 295' ' ' LEU . 78.3 mt -53.83 -46.41 71.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.475 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 32.2 m -51.77 -51.09 58.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.978 . . . . 0.0 109.29 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.638 ' HB3' HD13 ' A' ' 262' ' ' LEU . 80.4 mt-10 -53.89 -38.47 64.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.967 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.91 HD11 HD23 ' A' ' 295' ' ' LEU . 74.1 mt -59.34 -48.04 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.104 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -56.57 -36.54 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.28 -47.82 82.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.125 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 312' ' ' LEU . 2.0 t -66.23 -38.06 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.032 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.55 HD12 HD12 ' A' ' 312' ' ' LEU . 4.7 mp -54.4 -26.71 32.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.221 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.17 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.444 -0.785 . . . . 0.0 109.503 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 2.0 t -61.63 -31.85 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.467 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 309' ' ' SER . 29.5 mtm180 82.74 -24.72 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.536 -0.727 . . . . 0.0 110.38 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.85 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -60.04 -21.18 55.59 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 306' ' ' VAL . 0.4 OUTLIER -125.36 159.95 30.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.46 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.639 ' H ' HG12 ' A' ' 282' ' ' VAL . 4.6 t 77.0 -144.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 314' ' ' LEU . 4.0 mm? 63.59 13.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 45.73 51.58 10.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.724 ' HE2' HG11 ' A' ' 282' ' ' VAL . 26.2 mtm -68.1 173.42 4.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -1.174 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.511 ' O ' HD23 ' A' ' 318' ' ' LEU . 50.4 mtt-85 -132.54 120.59 22.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.516 HD11 ' CG2' ' A' ' 282' ' ' VAL . 5.2 mt -122.43 141.71 51.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.29 -37.57 87.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 80.4 m-20 -143.28 -47.92 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.371 -0.831 . . . . 0.0 108.926 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.567 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.05 -68.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.481 -0.762 . . . . 0.0 109.236 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.5 Cg_endo -69.77 110.93 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.58 2.187 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 50.5 Cg_endo -70.72 155.07 63.5 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.665 2.244 . . . . 0.0 111.654 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.97 -22.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.4 m -62.06 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.823 HD11 HD21 ' A' ' 254' ' ' LEU . 19.5 mt . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 21.8 m120 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' B' ' 454' ' ' CYS . 8.3 tttt -94.27 137.82 22.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.518 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.8 Cg_endo -70.49 132.57 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.703 2.268 . . . . 0.0 111.69 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.77 151.22 42.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.38 -37.71 57.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.46 -44.77 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.767 HD13 ' C ' ' B' ' 434' ' ' LEU . 3.3 tm? -69.96 -36.24 75.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.818 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.4 OUTLIER -69.54 -31.97 70.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -89.32 9.26 26.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.946 HD22 ' CD1' ' B' ' 456' ' ' LEU . 35.0 tp -80.13 132.28 35.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.497 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -77.23 144.74 38.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.67 4.63 65.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.463 HG21 HD23 ' B' ' 437' ' ' LEU . 97.9 t -126.24 126.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.395 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -84.54 151.87 24.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -50.06 -47.07 53.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.508 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 91.7 m-20 -64.99 -45.47 85.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.026 HD11 ' CD2' ' B' ' 473' ' ' LEU . 14.2 tp -57.27 -44.35 83.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.01 -41.72 88.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.91 . . . . 0.0 109.23 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 16.3 m-30 -58.62 -44.6 90.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' B' ' 470' ' ' ILE . 24.5 mttt -58.76 -40.78 84.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.867 . . . . 0.0 109.307 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.8 HD13 HD12 ' B' ' 459' ' ' LEU . 93.3 mt -61.84 -38.94 90.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -64.6 -32.7 74.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.9 -37.56 14.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.987 . . . . 0.0 109.408 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.475 ' CZ ' ' CB ' ' B' ' 469' ' ' ASP . 84.0 mtt-85 -89.66 23.0 2.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.576 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.79 6.74 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.899 HG21 ' CG ' ' B' ' 462' ' ' GLN . 46.7 t -76.79 108.52 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.305 . . . . 0.0 109.407 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 19.9 m -127.03 -38.85 1.98 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.686 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.76 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -78.39 144.32 36.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.529 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.946 ' CD1' HD22 ' B' ' 437' ' ' LEU . 25.8 tp -47.04 -42.72 18.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -55.95 -45.98 78.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.096 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.74 ' HB3' HG13 ' B' ' 453' ' ' VAL . 91.5 m-20 -56.66 -43.48 80.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.076 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.8 HD12 HD13 ' B' ' 448' ' ' LEU . 4.1 tt -55.52 -45.56 77.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.98 77.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 109.392 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.94 -28.09 68.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.899 ' CG ' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -75.45 140.01 42.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -98.45 166.06 21.71 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.962 HD11 ' HG2' ' A' ' 293' ' ' PRO . 20.5 mt -49.83 -34.02 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -1.125 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.18 -40.5 82.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.456 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 90.5 m-20 -63.29 -31.86 73.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.615 ' HB2' ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.59 -27.79 31.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.65 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -66.4 -21.1 66.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.541 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . 0.475 ' CB ' ' CZ ' ' B' ' 451' ' ' ARG . 82.1 m-20 -52.08 -31.91 32.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' B' ' 447' ' ' LYS . 64.1 mt -100.38 129.41 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.04 -36.06 72.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.447 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.8 -30.81 57.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.026 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.8 mt -98.91 131.37 45.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.481 HG22 ' N ' ' B' ' 475' ' ' ASP . 45.7 m -104.13 162.01 13.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.481 ' N ' HG22 ' B' ' 474' ' ' THR . 82.3 m-20 -57.12 -38.4 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -74.4 -45.97 43.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.464 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.67 ' O ' HD13 ' B' ' 481' ' ' LEU . 34.4 tttp -61.58 -46.35 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' B' ' 467' ' ' LEU . . . -60.28 -45.05 94.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -57.55 -47.72 86.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.67 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.1 mp -67.18 -44.51 79.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 293' ' ' PRO . 36.3 mt -60.99 -55.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.577 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.7 mtp -52.38 -36.53 54.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.332 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.29 -51.74 34.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.52 65.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.569 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 49.2 ttm-85 -50.56 -46.87 57.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 97.5 m-20 -58.01 -43.25 86.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 456' ' ' LEU . 81.3 mt -61.56 -37.32 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.84 -50.29 12.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 20.7 m95 -60.13 -43.23 95.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 56.6 m-85 -83.38 -27.21 29.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.954 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.549 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 41.0 p90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 252' ' ' ILE . 0.6 OUTLIER -65.33 134.42 95.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.14 -29.32 56.14 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.752 2.301 . . . . 0.0 111.661 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.6 tt -61.34 -29.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 108.929 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 282' ' ' VAL . 19.0 mt -74.33 -43.02 58.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 254' ' ' LEU . 4.3 mm? -61.55 -28.55 69.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 278' ' ' ILE . 1.8 mtt180 -75.13 140.86 73.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.525 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.88 141.6 41.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.717 2.278 . . . . 0.0 111.921 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.515 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.63 -37.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.1 -30.89 69.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.956 . . . . 0.0 109.366 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' PRO . 34.2 m-20 -75.33 -11.53 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 262' ' ' LEU . 74.1 mt -53.82 152.84 5.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -64.37 -23.98 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 302' ' ' GLU . 3.7 mp -57.46 167.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 4.0 p -81.33 165.01 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.575 HG12 ' ND2' ' A' ' 268' ' ' ASN . 42.3 t -49.14 -41.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.485 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -49.82 -45.01 49.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.367 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 14.9 m -70.41 -46.56 63.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.73 -46.88 88.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.575 ' ND2' HG12 ' A' ' 264' ' ' VAL . 85.6 m-20 -56.33 -34.74 66.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.367 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 266' ' ' SER . 87.9 m -50.52 -65.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 270' ' ' LEU . 6.6 mp -62.94 -44.93 94.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.241 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.51 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 17.0 ttpp -52.95 -40.93 64.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.89 -21.95 3.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 70.1 tt0 -94.82 20.75 8.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.895 . . . . 0.0 109.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.11 35.33 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.779 HG23 ' HB2' ' A' ' 280' ' ' ASP . 89.0 mt -123.08 107.53 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.51 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 81.5 m-70 -107.29 -11.66 15.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.445 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 4.8 m-85 -111.54 134.23 53.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 252' ' ' ILE . 61.5 mt -60.14 -30.73 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.266 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.888 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -51.05 -42.5 48.28 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.779 ' HB2' HG23 ' A' ' 275' ' ' ILE . 93.0 m-20 -53.54 -35.18 60.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -1.174 . . . . 0.0 109.047 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 270' ' ' LEU . 28.3 tp -58.05 -47.84 81.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 279' ' ' GLY . 21.1 m -70.05 -24.26 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.163 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -65.81 -32.65 74.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.196 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.64 145.02 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -62.17 138.36 58.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.433 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 80.6 tt0 -62.85 -27.4 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.2 t -52.92 -51.76 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.4 -34.88 67.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 281' ' ' LEU . 51.3 mt -74.97 -38.18 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 290' ' ' LEU . 32.9 tp -60.94 -30.25 70.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.493 ' C ' ' CE ' ' B' ' 483' ' ' MET . 10.0 mmtt -87.78 17.6 4.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.35 -0.844 . . . . 0.0 109.52 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 293' ' ' PRO . 0.7 OUTLIER -109.81 136.72 20.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.789 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.0 Cg_endo -70.12 -23.25 29.37 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.819 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.536 HD22 HD12 ' B' ' 464' ' ' ILE . 22.3 m120 -56.2 -24.68 43.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 14.6 mt -81.45 138.02 35.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -95.21 145.37 17.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' B' ' 461' ' ' GLU . 24.3 mttm -55.29 -42.62 73.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -1.106 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -67.49 -39.42 85.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 303' ' ' ILE . 22.0 m -64.04 -36.71 84.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.757 HD13 ' C ' ' A' ' 300' ' ' LEU . 3.4 tm? -53.1 -42.59 66.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.0 m -60.64 -51.91 67.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.768 ' HB3' HD23 ' A' ' 262' ' ' LEU . 39.7 tp10 -57.91 -45.69 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 82.9 mt -57.79 -47.29 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.065 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.02 -39.34 63.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 108.916 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.65 -42.98 99.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.74 HG12 ' CD2' ' A' ' 312' ' ' LEU . 32.0 t -69.22 -34.8 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.845 . . . . 0.0 108.995 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 313' ' ' SER . 25.2 mt -63.62 -26.68 68.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.397 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.44 -36.26 73.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 109.151 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 16.3 t -67.68 -16.87 64.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.875 ' O ' HD11 ' A' ' 314' ' ' LEU . 56.5 mtt180 64.46 10.81 6.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.184 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.77 -24.25 62.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.757 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.7 pt? -137.36 147.03 45.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 307' ' ' LEU . 1.7 t 77.21 39.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.875 HD11 ' O ' ' A' ' 310' ' ' ARG . 12.3 mt -89.9 15.26 10.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.916 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.25 97.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.628 ' HE2' HG11 ' A' ' 282' ' ' VAL . 4.5 mtm -90.33 163.19 14.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.9 mtt180 -143.14 123.09 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 318' ' ' LEU . 1.4 mp -131.31 140.73 49.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -45.74 -36.49 5.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 108.482 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 43.6 t30 -129.42 -72.2 0.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.615 ' CE2' ' HA3' ' A' ' 279' ' ' GLY . 16.2 t90 160.77 -57.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.589 -0.695 . . . . 0.0 109.547 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 326' ' ' ILE . 47.3 Cg_endo -66.97 107.81 1.38 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.132 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -73.44 165.2 33.1 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.686 2.258 . . . . 0.0 111.657 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -43.84 -26.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.582 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.532 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 22.8 m -61.71 -58.4 8.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.579 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 322' ' ' PRO . 35.1 mt . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.5 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -87.68 123.62 68.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 429' ' ' LYS . 50.4 Cg_endo -70.46 134.68 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.671 2.247 . . . . 0.0 111.845 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -70.88 166.6 20.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.498 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.19 -38.54 73.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.306 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . 0.562 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 75.1 m-20 -61.74 -49.91 74.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.185 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.809 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.5 tm? -64.98 -38.67 91.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.807 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -73.36 -33.94 65.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -85.67 8.54 19.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.525 HD23 HG21 ' B' ' 440' ' ' VAL . 36.1 tp -72.39 131.07 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.98 143.04 49.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 6.58 70.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.877 HG22 HD21 ' B' ' 481' ' ' LEU . 54.4 t -138.36 128.97 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -1.169 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' B' ' 444' ' ' LEU . 32.5 p30 -98.84 -177.21 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.647 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 97.6 mtt180 -62.14 -43.74 98.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.78 -55.92 19.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.003 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.9 tp -56.55 -40.84 75.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.88 -36.77 77.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.387 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 15.1 m-30 -66.72 -43.36 84.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.637 ' HB3' HG21 ' B' ' 470' ' ' ILE . 43.5 mttt -61.7 -42.0 98.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.822 HD13 ' O ' ' B' ' 448' ' ' LEU . 2.7 tm? -62.85 -44.49 95.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -62.03 -26.82 68.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.633 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.11 -17.18 9.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 7.1 mtp85 -92.25 27.97 2.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.68 7.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' B' ' 458' ' ' ASP . 47.8 t -63.73 140.3 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.927 -1.337 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' B' ' 431' ' ' ALA . 27.1 m -135.09 -36.21 0.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -105.51 151.48 24.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.715 HD11 HD12 ' B' ' 488' ' ' ILE . 2.1 tm? -52.03 -38.32 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.2 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' B' ' 457' ' ' GLU . 43.8 mm-40 -58.12 -47.65 82.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 108.839 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.656 ' HB3' HG13 ' B' ' 453' ' ' VAL . 58.2 m-20 -55.93 -44.66 78.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.857 . . . . 0.0 109.054 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.767 ' C ' HD13 ' B' ' 459' ' ' LEU . 2.8 tm? -55.5 -42.72 74.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.074 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.431 ' O ' ' HE3' ' A' ' 297' ' ' LYS . . . -60.01 -36.06 76.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.202 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 461' ' ' GLU . 77.1 tt0 -68.78 -13.13 62.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.438 ' HG3' HG21 ' B' ' 453' ' ' VAL . 96.3 mm-40 -74.65 147.6 41.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -106.17 158.21 15.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.789 HD11 ' HG2' ' A' ' 293' ' ' PRO . 24.0 mt -52.29 -34.12 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.143 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.95 -37.08 78.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.09 -32.09 69.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.9 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -74.86 -30.01 61.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.57 63.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -52.77 -31.44 38.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' B' ' 447' ' ' LYS . 64.4 mt -102.24 128.93 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -64.44 -35.67 81.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.47 -28.52 36.68 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.003 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.4 mt -102.41 134.48 45.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.491 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.4 m -103.85 162.08 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 474' ' ' THR . 84.8 m-20 -56.69 -38.63 72.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.94 -46.0 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.619 ' CE ' HD22 ' B' ' 444' ' ' LEU . 43.4 tttp -66.66 -46.74 74.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.273 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.9 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.08 -45.18 87.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -59.58 -45.54 95.45 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.37 68.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.877 HD21 HG22 ' B' ' 440' ' ' VAL . 7.7 mp -70.05 -30.58 67.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.559 HD11 ' N ' ' B' ' 464' ' ' ILE . 46.0 mt -69.83 -54.95 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 44.0 mmm -57.6 -44.31 85.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.344 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.448 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -61.38 -56.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.358 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -61.18 -46.74 89.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.504 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 77.1 ttt180 -55.18 -47.46 75.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.6 m-20 -57.76 -41.37 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.715 HD12 HD11 ' B' ' 456' ' ' LEU . 75.7 mt -56.02 -37.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.74 -51.91 8.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . 0.504 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 63.1 m95 -62.53 -47.15 85.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.7 m-85 -74.74 -33.03 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.352 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.977 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . 1.1 m-20 -65.95 141.52 97.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.61 -22.78 57.7 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 7.3 tt -67.57 -26.52 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.297 -0.877 . . . . 0.0 109.169 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 282' ' ' VAL . 2.2 mt -73.96 -45.36 50.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 326' ' ' ILE . 3.1 mm? -68.73 -30.74 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.48 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.24 139.44 91.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.49 134.85 27.36 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.695 2.264 . . . . 0.0 111.782 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.4 -32.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.95 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.229 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.1 m-20 -75.71 -12.99 60.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.842 . . . . 0.0 109.411 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.7 HD21 ' CD1' ' A' ' 278' ' ' ILE . 85.2 mt -55.71 136.86 50.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 261' ' ' GLU . 79.1 tt0 -63.96 -16.84 62.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 302' ' ' GLU . 6.4 mp -62.56 165.85 5.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.3 p -71.97 169.11 16.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.438 HG12 ' OD1' ' A' ' 268' ' ' ASN . 3.5 t -51.42 -31.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -50.64 -46.91 58.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 20.7 t -60.26 -50.62 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.9 m-20 -62.41 -42.99 99.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.3 m -52.45 -58.38 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.1 mm? -73.74 -39.41 64.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 12.7 tptm -57.77 -42.14 83.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.36 -21.45 65.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 63.6 tt0 -89.35 21.67 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.43 17.29 8.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 280' ' ' ASP . 72.9 mt -107.31 125.41 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' ' 257' ' ' VAL . 95.3 m-70 -113.43 -25.67 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 109.352 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 96.0 m-85 -105.19 141.43 36.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.7 ' CD1' HD21 ' A' ' 260' ' ' LEU . 76.0 mt -63.58 -31.39 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.273 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.992 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -50.72 -45.68 48.24 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.751 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.3 m-20 -53.78 -37.38 63.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -1.207 . . . . 0.0 109.215 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.529 HD13 HD11 ' A' ' 270' ' ' LEU . 34.9 tp -52.53 -48.57 65.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.271 -0.893 . . . . 0.0 108.866 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.992 HG22 ' O ' ' A' ' 279' ' ' GLY . 3.8 m -66.77 -23.89 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 108.821 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.45 -35.92 80.8 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 72.3 mtt180 -105.97 141.92 36.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.2 m -63.68 137.89 58.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.963 . . . . 0.0 109.543 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.606 ' HA ' HD23 ' A' ' 289' ' ' LEU . 47.0 tp10 -53.7 -29.22 38.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 37.1 t -52.79 -48.25 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 108.999 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 96.3 mt-10 -51.93 -35.66 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.905 . . . . 0.0 109.008 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.8 mm? -65.48 -44.16 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 108.907 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -63.56 -17.59 62.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 108.958 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.536 ' O ' ' HE1' ' B' ' 483' ' ' MET . 21.6 mttt -93.3 26.51 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.748 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 294' ' ' ASN . 86.7 m -138.02 122.28 11.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 1.037 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -71.17 -20.24 28.63 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.686 2.257 . . . . 0.0 111.893 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.769 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.5 m120 -50.26 -22.32 1.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 295' ' ' LEU . 3.8 mp -95.54 122.03 37.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -82.87 156.51 34.56 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -48.86 -39.51 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.563 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 19.4 m -64.52 -52.02 59.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 303' ' ' ILE . 34.7 tp -53.18 -39.13 63.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.7 m -58.8 -49.73 76.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.533 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.622 ' HB3' HD23 ' A' ' 262' ' ' LEU . 74.2 mt-10 -59.75 -40.67 88.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 300' ' ' LEU . 83.9 mt -57.83 -52.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.284 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -54.54 -38.99 67.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.158 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.83 -42.08 83.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -72.39 -42.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.778 HD22 ' CB ' ' A' ' 313' ' ' SER . 24.4 mt -54.54 -26.91 34.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.92 74.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.4 p -68.47 -20.31 64.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.0 109.408 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.513 ' O ' HD11 ' A' ' 314' ' ' LEU . 32.4 ttm180 67.59 7.39 5.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -78.31 -22.47 67.75 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.796 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.7 pt? -137.08 155.94 49.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.604 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.778 ' CB ' HD22 ' A' ' 307' ' ' LEU . 1.3 t 75.47 51.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.815 ' N ' HD22 ' A' ' 314' ' ' LEU . 3.0 mm? -93.14 21.25 6.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 47.04 46.16 20.15 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 282' ' ' VAL . 11.0 ptt? -121.91 139.83 53.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -1.185 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.683 ' O ' HD13 ' A' ' 318' ' ' LEU . 55.9 mtt180 -100.14 137.43 38.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 318' ' ' LEU . 2.4 mm? -122.28 111.37 16.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.901 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -77.07 -30.49 55.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.945 . . . . 0.0 108.753 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 321' ' ' TRP . 21.2 t-20 -165.29 26.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.053 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.818 ' CH2' HD22 ' A' ' 254' ' ' LEU . 0.4 OUTLIER -43.37 104.25 0.36 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.5 71.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.727 2.951 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 1.012 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.05 155.83 64.04 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.54 2.16 . . . . 0.0 111.816 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.76 -27.97 67.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.291 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.2 m -59.1 -40.08 84.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.5 tt . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.672 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 23.7 m120 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -50.98 131.84 30.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.886 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.3 136.37 31.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.907 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.84 160.55 25.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -53.15 -33.87 54.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -65.04 -49.61 69.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.624 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' B' ' 430' ' ' PRO . 17.2 tp -65.05 -38.44 90.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.5 OUTLIER -73.61 -33.22 64.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -86.87 9.84 17.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.752 HD13 HD13 ' B' ' 456' ' ' LEU . 44.8 tp -77.24 133.29 38.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -77.45 142.26 39.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.1 2.8 65.99 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' B' ' 481' ' ' LEU . 93.8 t -131.06 129.56 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.13 -1.218 . . . . 0.0 109.497 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.607 ' H ' HD12 ' B' ' 444' ' ' LEU . 75.5 m-20 -90.86 155.22 18.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.598 ' HG2' HD11 ' B' ' 435' ' ' LEU . 58.8 mtm180 -50.04 -40.62 45.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -66.9 -45.45 77.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.748 HD22 HD21 ' B' ' 473' ' ' LEU . 45.5 mt -60.39 -42.09 95.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.97 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.355 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 11.2 m-30 -58.51 -43.41 89.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.699 ' HB3' HG21 ' B' ' 470' ' ' ILE . 45.6 mttp -60.59 -52.5 64.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 7.1 tt -65.55 -42.03 92.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.672 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.99 -27.0 50.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.977 . . . . 0.0 109.487 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.36 -24.0 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.417 ' NH1' ' CG1' ' B' ' 470' ' ' ILE . 41.9 mtt-85 -88.8 26.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.63 6.93 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' B' ' 458' ' ' ASP . 73.2 t -60.71 130.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.33 . . . . 0.0 109.472 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' B' ' 431' ' ' ALA . 57.0 m -135.06 -36.59 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.743 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -97.12 153.08 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.783 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.942 HD21 HD12 ' B' ' 488' ' ' ILE . 42.5 tp -49.48 -40.42 37.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.325 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.71 -49.93 71.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 108.994 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.741 ' CB ' HG13 ' B' ' 453' ' ' VAL . 81.0 m-20 -55.52 -40.55 71.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 108.971 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.77 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -55.62 -42.98 75.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.73 -25.69 66.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.262 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.13 -21.19 63.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.61 ' CG ' HG21 ' B' ' 453' ' ' VAL . 98.4 mm-40 -79.98 153.81 28.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -117.3 152.35 17.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 293' ' ' PRO . 33.6 mt -44.46 -36.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -63.95 -35.59 81.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.473 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 87.2 m-20 -77.35 -31.55 54.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.01 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.1 mt -73.48 -35.52 65.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.91 69.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.51 -33.2 72.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' B' ' 447' ' ' LYS . 80.5 mt -85.24 131.39 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.436 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.95 150.4 46.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.19 -29.39 12.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.748 HD21 HD22 ' B' ' 444' ' ' LEU . 64.6 mt -99.72 136.49 39.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -1.16 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.03 162.07 13.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -57.3 -38.11 73.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.65 -45.94 56.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.573 ' O ' HD13 ' B' ' 481' ' ' LEU . 14.5 tttp -62.58 -45.68 91.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.01 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.7 -42.49 88.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -61.7 -46.3 94.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.83 78.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.517 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.573 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.0 mp -66.38 -35.36 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.594 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 293' ' ' PRO . 59.6 mt -70.32 -56.33 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.579 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.536 ' HE1' ' O ' ' A' ' 291' ' ' LYS . 39.9 mtp -52.92 -37.8 61.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.34 69.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -64.81 -49.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.541 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 66.3 ttt-85 -53.85 -47.06 71.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.97 -45.84 86.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.942 HD12 HD21 ' B' ' 456' ' ' LEU . 46.2 mt -59.1 -39.51 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 91.2 m -75.3 -49.13 20.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . 0.541 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 15.0 m95 -59.39 -41.3 89.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 9.19 43.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.463 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.995 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.679 ' HD2' HD22 ' A' ' 253' ' ' LEU . 2.5 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -61.67 139.55 95.27 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.0 Cg_endo -64.56 -34.05 53.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.505 2.137 . . . . 0.0 111.473 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.7 tt -53.71 -34.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.679 HD22 ' HD2' ' A' ' 249' ' ' PHE . 0.6 OUTLIER -74.57 -21.67 59.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.653 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -89.58 -24.8 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.263 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -66.23 147.5 98.85 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.8 Cg_endo -70.69 140.88 40.15 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.698 2.265 . . . . 0.0 111.715 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.707 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.54 -34.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 109.365 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.84 -30.92 71.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' PRO . 30.2 m-20 -76.0 -14.96 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 257' ' ' VAL . 48.7 mt -44.75 149.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.56 -19.17 65.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 262' ' ' LEU . 6.1 mp -64.07 169.32 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 9.2 p -78.22 159.88 28.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.476 HG12 ' ND2' ' A' ' 268' ' ' ASN . 3.2 t -47.25 -37.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.486 ' NH2' ' OD2' ' B' ' 465' ' ' ASP . 52.0 ttt85 -53.37 -46.85 69.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 19.4 m -63.58 -51.05 67.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.943 . . . . 0.0 109.387 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.07 78.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.476 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.6 m-20 -59.7 -33.31 71.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.914 . . . . 0.0 109.27 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.5 m -62.29 -63.82 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.292 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 295' ' ' LEU . 60.0 mt -58.64 -47.66 83.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 19.0 tttt -52.69 -32.11 40.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.97 -17.46 51.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.328 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 58.5 tt0 -95.6 21.33 8.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.05 23.3 3.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 97.0 mt -112.34 107.66 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.507 ' C ' HG22 ' A' ' 257' ' ' VAL . 50.5 m-70 -107.1 -9.2 16.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.5 m-85 -114.55 131.96 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 252' ' ' ILE . 74.7 mt -54.16 -36.5 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 109.119 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.38 -47.53 16.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.2 m-20 -53.27 -34.41 57.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 108.704 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.498 HD13 HD13 ' A' ' 270' ' ' LEU . 31.2 tp -53.78 -50.48 65.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.146 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.8 m -67.09 -29.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 93.9 mt-30 -57.2 -34.34 68.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -96.99 159.55 14.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.416 -0.802 . . . . 0.0 109.017 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 m -83.35 140.15 32.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 88.3 tt0 -52.7 -31.18 36.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.325 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.89 -51.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.039 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 69.9 mm-40 -51.93 -37.0 51.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.087 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 281' ' ' LEU . 62.2 mt -60.75 -47.24 87.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.995 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.8 tm? -59.81 -33.53 71.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.283 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.527 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 45.8 mttt -83.06 -17.84 41.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.402 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -77.08 113.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 1.026 ' HB2' HD12 ' B' ' 482' ' ' ILE . 50.8 Cg_endo -71.0 -23.29 25.31 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.766 2.311 . . . . 0.0 112.165 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.437 ' HA ' HD12 ' B' ' 464' ' ' ILE . 70.8 m-80 -50.93 -21.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.699 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 270' ' ' LEU . 3.2 mp -101.31 122.69 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -73.8 156.64 50.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -49.09 -38.63 25.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.293 -1.122 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -67.2 -42.68 83.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.355 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 59.5 p -58.43 -47.14 84.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 290' ' ' LEU . 22.9 tp -52.94 -44.19 66.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.294 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 52.2 m -52.5 -52.31 55.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.209 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.485 ' OE1' HD23 ' A' ' 262' ' ' LEU . 84.7 mt-10 -53.61 -42.24 67.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.57 -39.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.183 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -62.16 -36.11 80.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.39 -51.24 61.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 312' ' ' LEU . 3.2 t -72.29 -37.52 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.251 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 15.5 tp -60.25 -26.27 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.441 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.08 -30.7 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 109.434 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.7 OUTLIER -68.95 -7.35 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.86 . . . . 0.0 109.555 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 92.9 mtt-85 61.76 12.52 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -93.21 -2.94 65.66 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 306' ' ' VAL . 0.0 OUTLIER -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -1.197 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.676 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 46.36 67.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.486 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.6 mt -101.64 11.86 38.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.63 73.83 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.709 ' HE3' HG21 ' A' ' 282' ' ' VAL . 13.5 ptt? -107.7 150.83 26.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -1.216 . . . . 0.0 109.54 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.643 ' C ' HD12 ' A' ' 318' ' ' LEU . 61.7 mtp180 -125.57 145.85 49.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.808 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.9 mp -124.04 140.95 52.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.68 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.1 -32.2 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 85.8 m-20 -122.35 -78.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.167 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.653 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 168.76 -58.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.76 107.8 1.74 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.647 2.231 . . . . 0.0 111.889 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 1.017 ' O ' HG22 ' A' ' 326' ' ' ILE . 52.8 Cg_endo -73.16 165.12 33.55 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.554 2.169 . . . . 0.0 111.688 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.89 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.9 m -76.82 -38.68 53.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 1.017 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.5 tt . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 20.0 m120 . . . . . 0 N--CA 1.489 1.523 0 N-CA-C 109.357 -0.608 . . . . 0.0 109.357 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -61.85 130.13 92.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.575 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.9 138.74 34.82 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.703 2.269 . . . . 0.0 111.728 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.71 157.52 36.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -56.89 -33.54 66.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 436' ' ' ASN . 56.0 m-20 -69.61 -37.3 76.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.32 -33.24 71.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 109.34 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' B' ' 442' ' ' ARG . 33.1 tp -86.43 -30.59 21.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 433' ' ' ASP . 24.3 p-10 -80.0 5.84 12.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.834 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.623 HD23 HG21 ' B' ' 440' ' ' VAL . 25.5 tp -77.87 133.81 38.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.9 139.22 50.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.2 63.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.623 HG21 HD23 ' B' ' 437' ' ' LEU . 48.8 t -129.5 130.88 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -1.157 . . . . 0.0 109.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -101.35 158.42 16.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' B' ' 435' ' ' LEU . 76.8 mtt-85 -50.12 -52.45 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.17 -48.38 81.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.067 HD11 ' CD2' ' B' ' 473' ' ' LEU . 12.3 tp -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.34 87.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -56.23 -44.45 79.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.738 ' HB3' HD13 ' B' ' 470' ' ' ILE . 79.2 mttt -60.1 -44.74 94.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.926 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.6 tm? -73.29 -39.35 65.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.8 -28.31 69.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.35 -16.89 10.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -92.3 30.13 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.562 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.71 -18.86 6.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.558 HG13 ' CB ' ' B' ' 458' ' ' ASP . 49.1 t -63.82 138.25 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.336 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 72.6 m -135.14 -34.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.866 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.552 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -115.97 159.31 21.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 485' ' ' ALA . 33.8 tp -50.67 -40.11 52.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.338 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . 0.406 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 48.0 tp10 -55.88 -48.62 75.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.185 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.558 ' CB ' HG13 ' B' ' 453' ' ' VAL . 86.7 m-20 -57.3 -40.81 78.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 481' ' ' LEU . 17.0 tp -59.49 -45.31 92.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.35 -38.99 78.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.517 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -76.26 146.52 38.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.28 154.41 16.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 293' ' ' PRO . 59.7 mt -44.03 -36.59 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . 0.486 ' OD2' ' NH2' ' A' ' 265' ' ' ARG . 48.0 t0 -63.2 -41.04 99.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -66.68 -25.08 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.749 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -85.52 -24.46 27.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.81 -23.9 63.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -52.06 -32.16 33.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.738 HD13 ' HB3' ' B' ' 447' ' ' LYS . 67.3 mt -97.84 124.73 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.507 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.46 -35.38 80.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.405 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.54 -31.62 52.35 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.067 ' CD2' HD11 ' B' ' 444' ' ' LEU . 60.0 mt -101.79 135.58 43.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.501 HG22 ' N ' ' B' ' 475' ' ' ASP . 39.1 m -103.73 163.87 12.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.52 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 90.7 m-20 -56.88 -39.42 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -71.86 -45.88 59.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.587 ' HD3' HD23 ' B' ' 473' ' ' LEU . 40.3 tttm -61.07 -46.74 89.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.453 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' B' ' 464' ' ' ILE . . . -58.9 -41.93 88.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.357 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.46 ' HA2' ' CG ' ' A' ' 293' ' ' PRO . . . -59.2 -45.77 94.83 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.61 -35.96 73.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' B' ' 459' ' ' LEU . 25.3 mt -68.96 -44.11 73.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.523 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.4 mt -59.5 -55.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 43.9 mtp -52.76 -44.47 66.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 0.0 109.374 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.6 -49.78 76.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -68.25 -47.75 66.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' A' ' 291' ' ' LYS . 39.5 ttm180 -55.1 -45.65 75.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 74.6 m-20 -61.02 -41.24 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.711 HD12 HD21 ' B' ' 456' ' ' LEU . 63.2 mt -67.42 -38.74 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . 0.406 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 47.4 m -67.44 -49.56 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -68.0 -39.51 83.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 16.9 m-30 -83.31 -13.12 55.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.575 ' HD2' HD11 ' A' ' 254' ' ' LEU . 16.4 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 252' ' ' ILE . 15.1 m-20 -54.64 135.67 63.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.348 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.771 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.22 -31.72 53.16 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.604 2.203 . . . . 0.0 111.672 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.672 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.2 tt -63.18 -28.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 108.756 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 312' ' ' LEU . 37.9 mt -74.6 -44.16 52.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.8 mt -65.98 -34.78 78.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.67 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 278' ' ' ILE . 4.3 ttp180 -56.04 141.11 68.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.0 109.068 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.7 Cg_endo -68.72 130.96 21.65 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.3 OUTLIER -43.51 -35.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.89 . . . . 0.0 109.396 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.98 -30.93 70.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.321 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.3 m-20 -76.81 -14.9 59.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.87 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.428 HD11 HG12 ' A' ' 257' ' ' VAL . 68.3 mt -44.79 140.88 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' LEU . 98.0 mt-10 -64.83 -26.58 68.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 306' ' ' VAL . 29.7 mt -52.84 -173.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 13.0 p -84.84 159.39 20.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.67 HG12 ' ND2' ' A' ' 268' ' ' ASN . 8.7 t -55.16 -34.66 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.357 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -53.71 -46.45 70.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.7 p -64.42 -45.04 89.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.33 85.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.67 ' ND2' HG12 ' A' ' 264' ' ' VAL . 89.3 m-20 -58.52 -32.2 68.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . 0.644 ' SG ' HD11 ' A' ' 295' ' ' LEU . 21.4 t -57.6 -64.99 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.76 -47.71 79.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -0.845 . . . . 0.0 109.454 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.504 ' HG3' ' CE1' ' A' ' 276' ' ' HIS . 36.1 ttpt -55.08 -37.17 66.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.441 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.75 -21.15 6.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.7 mt-10 -95.65 21.17 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.86 28.04 4.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.9 mt -117.09 111.48 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.504 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 96.1 m-70 -104.4 -10.13 17.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.578 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.86 143.45 33.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' A' ' 312' ' ' LEU . 92.0 mt -72.29 -31.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 1.023 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.22 -48.33 20.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.7 m-20 -53.79 -35.32 61.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -1.138 . . . . 0.0 108.757 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 0.752 HD13 ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -52.78 -47.16 67.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 1.023 HG22 ' O ' ' A' ' 279' ' ' GLY . 6.5 m -68.25 -23.81 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.23 -35.69 79.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HE ' HD11 ' A' ' 275' ' ' ILE . 64.9 mtt-85 -100.99 141.18 34.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 74.0 p -76.2 147.11 38.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 300' ' ' LEU . 85.5 tt0 -50.82 -34.1 26.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 0.0 109.339 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.76 -51.26 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.281 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.14 -37.84 62.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.653 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.9 mm? -68.37 -40.77 81.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 1.088 HD13 HD22 ' A' ' 300' ' ' LEU . 34.8 tp -62.3 -25.45 67.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 109.331 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.6 ' O ' ' HE2' ' B' ' 483' ' ' MET . 22.2 mttt -88.66 17.25 5.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -116.84 136.99 23.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 0.883 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.6 Cg_endo -71.72 -30.64 14.23 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.691 2.26 . . . . 0.0 111.85 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.479 ' C ' HD12 ' A' ' 295' ' ' LEU . 33.4 m120 -52.53 -20.8 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 295' ' ' LEU . 5.3 mp -104.74 124.48 49.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.605 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.79 173.86 35.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -51.37 -44.66 62.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -70.33 -36.77 74.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.9 t -54.93 -52.27 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 1.088 HD22 HD13 ' A' ' 290' ' ' LEU . 22.5 tp -52.91 -39.49 62.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.8 m -59.11 -50.17 75.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.236 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.592 ' HG2' HD13 ' A' ' 262' ' ' LEU . 54.0 tt0 -53.73 -44.92 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.089 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.64 HD11 HD23 ' A' ' 295' ' ' LEU . 63.6 mt -57.65 -40.43 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 108.783 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.66 -40.08 90.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.343 -0.848 . . . . 0.0 108.742 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.09 -46.18 85.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.367 -0.833 . . . . 0.0 108.827 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 312' ' ' LEU . 16.9 t -69.95 -35.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 108.819 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 313' ' ' SER . 17.1 tp -63.5 -26.78 68.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.371 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.77 -28.92 64.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.209 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.2 p -69.31 -12.14 61.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 314' ' ' LEU . 69.8 mtt180 57.36 15.78 2.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.37 -15.47 13.91 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 278' ' ' ILE . 9.0 tp -137.5 136.15 37.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -1.182 . . . . 0.0 109.155 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.3 OUTLIER 73.37 41.93 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -92.22 13.17 19.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.68 36.88 83.86 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.609 ' CE ' HD11 ' A' ' 253' ' ' LEU . 7.5 mtm -84.28 170.3 13.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.791 ' C ' HD12 ' A' ' 318' ' ' LEU . 45.4 mtm105 -141.0 129.56 22.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.819 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.7 mp -133.05 136.32 45.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.48 -39.89 64.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.038 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 69.5 m-20 -129.75 -65.13 0.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.0 t-105 167.31 -65.92 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.523 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.69 107.99 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.679 2.253 . . . . 0.0 112.169 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.8 Cg_endo -72.86 161.21 44.29 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.622 2.214 . . . . 0.0 111.53 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.84 -18.84 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.601 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 16.3 m -64.29 -49.26 72.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 254' ' ' LEU . 26.9 mt . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.9 m120 . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.384 -0.599 . . . . 0.0 109.384 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -62.02 121.83 68.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 49.5 Cg_endo -70.05 131.21 20.36 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.641 2.227 . . . . 0.0 111.741 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.37 153.86 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' B' ' 436' ' ' ASN . 92.0 m-20 -54.32 -29.57 48.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 456' ' ' LEU . 91.2 m-20 -67.05 -50.1 62.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 27.3 tp -67.78 -42.02 82.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.936 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -71.35 -26.88 63.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.38 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 432' ' ' ASP . 40.8 t30 -96.65 7.92 45.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.628 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.72 HD13 ' N ' ' B' ' 438' ' ' GLU . 1.6 tm? -78.09 120.39 22.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . 0.72 ' N ' HD13 ' B' ' 437' ' ' LEU . 23.6 pt-20 -60.57 140.89 57.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . 0.437 ' O ' HD11 ' B' ' 481' ' ' LEU . . . 96.31 -3.64 64.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 1.042 HG22 ' CD2' ' B' ' 481' ' ' LEU . 47.0 t -120.67 129.98 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.123 -1.222 . . . . 0.0 109.487 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -87.05 154.42 20.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.529 ' HG2' HD11 ' B' ' 435' ' ' LEU . 72.8 mtt180 -49.98 -45.18 51.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.33 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . 0.574 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 94.3 m-20 -67.83 -46.56 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 473' ' ' LEU . 14.1 tp -53.67 -40.83 66.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.114 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.4 91.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 108.978 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 12.7 m-30 -58.55 -40.18 82.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.102 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -62.21 -42.43 99.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 459' ' ' LEU . 88.4 mt -62.02 -45.01 95.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.87 -40.33 84.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.9 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.55 -33.25 3.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 26.2 mtp85 -91.24 22.32 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.6 7.17 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.935 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.8 t -83.15 110.0 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.914 -1.344 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 14.9 m -127.51 -35.76 2.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.94 . . . . 0.0 109.587 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.52 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -79.62 140.69 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.915 ' CD2' HD12 ' B' ' 488' ' ' ILE . 23.5 tp -45.64 -43.64 12.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.191 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' B' ' 489' ' ' CYS . 13.3 mt-10 -60.1 -46.32 90.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.177 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.702 ' HB3' HG13 ' B' ' 453' ' ' VAL . 88.4 m-20 -54.94 -38.01 67.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.133 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 448' ' ' LEU . 33.3 tp -63.79 -42.9 97.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.226 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . 0.641 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -58.36 -37.69 75.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.46 -30.55 71.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.935 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -73.52 148.72 42.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -107.71 154.11 16.66 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 0.883 HD11 ' HG2' ' A' ' 293' ' ' PRO . 96.5 mt -44.98 -36.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.144 -1.21 . . . . 0.0 109.27 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -36.88 82.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.245 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.2 m-20 -71.41 -28.71 64.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.84 -30.68 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.963 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.39 -24.69 60.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -51.35 -33.15 28.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.892 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' B' ' 473' ' ' LEU . 64.4 mt -102.24 127.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -59.73 -31.01 69.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.531 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -59.2 -25.67 60.37 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 1.025 ' CD1' HD11 ' B' ' 444' ' ' LEU . 3.5 mm? -103.38 129.19 50.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -1.106 . . . . 0.0 109.562 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . 0.447 HG22 ' N ' ' B' ' 475' ' ' ASP . 23.4 m -103.61 162.02 13.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.526 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 83.6 m-20 -55.88 -39.14 71.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.1 -45.85 25.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.483 ' CE ' HD22 ' B' ' 444' ' ' LEU . 32.8 tttp -62.37 -46.62 87.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.53 -45.91 81.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -63.59 -52.12 48.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.48 -42.22 61.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.215 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 1.042 ' CD2' HG22 ' B' ' 440' ' ' VAL . 6.4 mp -67.28 -42.3 84.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.36 -0.837 . . . . 0.0 109.442 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.55 HD12 HG13 ' B' ' 464' ' ' ILE . 45.3 mt -56.41 -56.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.6 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 43.4 mmm -53.29 -44.88 68.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -57.26 -60.77 3.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.193 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.509 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -55.7 -43.3 76.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.196 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.641 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 94.8 mtt180 -59.55 -41.96 91.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.831 . . . . 0.0 109.19 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 98.1 m-20 -57.84 -41.31 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.291 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.915 HD12 ' CD2' ' B' ' 456' ' ' LEU . 24.3 mt -68.55 -38.55 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.309 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' B' ' 457' ' ' GLU . 66.4 m -70.27 -51.62 29.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -61.37 -38.19 86.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 19.2 m-30 -76.29 -36.86 58.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.0 109.406 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.239 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' PHE . . . . . 0.556 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 42.0 p90 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ASP . . . . . 0.784 ' O ' HD12 ' A' ' 254' ' ' LEU . 0.5 OUTLIER -69.67 137.53 88.11 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.239 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 255' ' ' ARG . 43.2 Cg_endo -65.31 -26.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.705 2.27 . . . . 0.0 111.673 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ILE . . . . . 0.606 HD13 ' HA3' ' A' ' 311' ' ' GLY . 6.0 tt -71.22 -28.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 108.709 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' LEU . . . . . 0.74 HD11 HG21 ' A' ' 282' ' ' VAL . 3.1 tp -74.35 -27.18 60.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 326' ' ' ILE . 4.0 mp -101.67 -20.98 14.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 251' ' ' PRO . 16.2 mtt180 -55.09 147.59 33.69 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.019 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.6 Cg_endo -69.56 132.46 23.7 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.687 2.258 . . . . 0.0 111.954 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' VAL . . . . . 0.723 HG11 HD12 ' A' ' 270' ' ' LEU . 0.2 OUTLIER -44.62 -30.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.275 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -64.25 -30.69 71.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 12.9 m-20 -69.57 -16.99 63.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 278' ' ' ILE . 46.1 mt -57.43 144.73 35.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 82.2 tt0 -65.23 -14.4 60.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.504 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.696 HD21 ' CB ' ' A' ' 302' ' ' GLU . 8.0 mp -60.24 173.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.574 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.7 p -74.73 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' VAL . . . . . 0.755 HG12 HD21 ' A' ' 268' ' ' ASN . 18.5 t -62.56 -31.76 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 265' ' ' ARG . 6.8 mmt85 -60.08 -44.95 94.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.136 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' SER . . . . . 0.433 ' OG ' HD23 ' A' ' 262' ' ' LEU . 7.8 t -57.83 -51.01 71.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.214 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -66.56 -34.21 77.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.912 . . . . 0.0 109.106 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ASN . . . . . 0.755 HD21 HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -61.61 -38.88 89.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.8 m -49.86 -60.12 3.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' LEU . . . . . 0.723 HD12 HG11 ' A' ' 257' ' ' VAL . 45.3 mt -63.52 -48.33 77.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.301 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 52.5 mtmt -53.27 -39.69 64.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.81 -24.74 6.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.334 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 54.0 tt0 -93.47 24.72 3.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 66.23 29.85 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' ILE . . . . . 0.621 HG23 ' OD2' ' A' ' 280' ' ' ASP . 54.7 mt -124.22 108.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 256' ' ' PRO . 89.5 m-70 -100.85 -6.83 24.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.14 140.83 37.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 260' ' ' LEU . 56.6 mt -72.61 -30.19 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.529 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' GLY . . . . . 0.975 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.5 -48.37 11.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ASP . . . . . 0.621 ' OD2' HG23 ' A' ' 275' ' ' ILE . 82.5 m-20 -53.0 -33.73 53.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.922 -1.34 . . . . 0.0 108.527 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 312' ' ' LEU . 26.9 tp -52.98 -52.7 57.42 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 279' ' ' GLY . 25.3 m -62.47 -27.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 53.0 tt0 -58.21 -37.95 75.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' ARG . . . . . 0.452 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 86.0 mtt-85 -98.07 140.92 31.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.799 . . . . 0.0 108.975 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.0 m -63.64 141.17 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 109.712 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' GLU . . . . . 0.686 ' CD ' HD12 ' A' ' 289' ' ' LEU . 49.0 tp10 -53.33 -27.27 22.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' VAL . . . . . 0.76 ' HA ' HD12 ' A' ' 290' ' ' LEU . 54.3 t -52.8 -51.81 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 93.6 mt-10 -51.87 -33.66 37.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.083 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 281' ' ' LEU . 40.5 mt -64.94 -46.76 80.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.9 mt -61.88 -29.76 70.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.446 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 23.4 mttm -84.96 -20.65 30.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 15.7 m -82.12 116.42 63.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.63 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' PRO . . . . . 1.001 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.1 Cg_endo -71.16 -24.35 23.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.626 2.217 . . . . 0.0 111.843 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.562 ' ND2' HD12 ' B' ' 464' ' ' ILE . 34.4 m120 -46.94 -23.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 300' ' ' LEU . 3.0 mp -96.02 138.87 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.84 163.29 33.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -50.79 -45.28 59.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -1.189 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -65.73 -42.12 91.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.8 t -56.1 -55.13 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 109.277 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 295' ' ' LEU . 49.9 mt -54.42 -47.02 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.4 m -50.37 -53.0 32.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.234 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 306' ' ' VAL . 60.9 mm-40 -53.75 -38.44 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 300' ' ' LEU . 93.5 mt -57.79 -46.04 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -60.38 -39.76 88.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.06 -49.92 70.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.851 . . . . 0.0 109.347 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.2 t -63.55 -41.09 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 109.203 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' LEU . . . . . 0.53 HD13 ' CB ' ' A' ' 313' ' ' SER . 24.1 tp -53.91 -26.62 26.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.86 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.313 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 20.9 t -68.98 -7.72 37.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' ARG . . . . . 0.748 ' CA ' HD21 ' A' ' 314' ' ' LEU . 66.2 mtt180 65.64 8.98 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.365 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.26 -31.24 63.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -148.16 173.12 13.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 109.51 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . 0.64 ' N ' HG12 ' A' ' 282' ' ' VAL . 2.8 m 61.77 30.66 18.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.897 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' LEU . . . . . 0.748 HD21 ' CA ' ' A' ' 310' ' ' ARG . 68.4 mt -79.41 -5.46 54.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.515 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.86 38.82 65.36 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' MET . . . . . 0.684 ' HE1' HD12 ' A' ' 314' ' ' LEU . 4.2 ptt? -107.42 162.11 14.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -1.216 . . . . 0.0 109.361 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ARG . . . . . 0.57 ' C ' HD12 ' A' ' 318' ' ' LEU . 44.5 mtm180 -128.2 134.37 49.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -116.51 143.12 45.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.78 -33.71 70.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.261 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -135.02 -68.23 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' TRP . . . . . 0.571 ' CH2' ' HG ' ' A' ' 254' ' ' LEU . 0.7 OUTLIER 176.98 -64.96 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.376 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 326' ' ' ILE . 49.9 Cg_endo -68.67 107.5 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 112.041 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.7 Cg_endo -72.54 164.79 34.56 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.571 2.181 . . . . 0.0 111.579 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.92 -19.03 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.279 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 249' ' ' PHE . 61.0 m -65.77 -47.85 73.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 254' ' ' LEU . 19.4 mt . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 428' ' ' ASN . . . . . 0.838 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 29.5 m120 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 1.7 ptmt -51.19 136.25 29.72 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.587 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 430' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.6 Cg_endo -70.9 140.97 39.5 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.711 2.274 . . . . 0.0 111.652 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 431' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.92 165.56 24.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 109.662 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 432' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' B' ' 432' ' ' ASP . 25.4 p-10 -61.68 -34.12 75.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 433' ' ' ASP . . . . . 0.582 ' CB ' ' CB ' ' B' ' 456' ' ' LEU . 5.2 m-20 -63.4 -49.21 74.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.072 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 434' ' ' LEU . . . . . 0.836 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 435' ' ' LEU . . . . . 0.593 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -72.72 -35.55 67.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -88.57 4.68 46.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 437' ' ' LEU . . . . . 0.649 HD23 HG21 ' B' ' 440' ' ' VAL . 31.8 tp -71.98 132.76 44.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -76.78 141.59 40.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.2 9.39 62.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 440' ' ' VAL . . . . . 0.649 HG21 HD23 ' B' ' 437' ' ' LEU . 47.9 t -125.89 131.52 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -1.129 . . . . 0.0 109.422 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 441' ' ' ASP . . . . . 0.645 ' H ' HD12 ' B' ' 444' ' ' LEU . 86.8 m-20 -97.64 160.66 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 442' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 93.7 mtt180 -52.08 -41.35 62.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.964 . . . . 0.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.03 -42.29 85.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.449 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 444' ' ' LEU . . . . . 0.645 HD12 ' H ' ' B' ' 441' ' ' ASP . 53.6 mt -64.98 -42.56 94.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 445' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' B' ' 434' ' ' LEU . . . -59.18 -41.46 88.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 446' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 10.3 m-30 -64.14 -40.5 96.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 447' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' B' ' 470' ' ' ILE . 66.5 mttm -61.68 -41.23 97.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 448' ' ' LEU . . . . . 0.496 HD21 HD11 ' B' ' 473' ' ' LEU . 80.9 mt -64.86 -39.22 93.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 449' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.06 -37.46 84.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.97 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 451' ' ' ARG . . . . . 0.493 ' NH1' ' O ' ' B' ' 466' ' ' ASP . 35.3 mtm105 -89.7 23.34 2.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.74 6.77 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 453' ' ' VAL . . . . . 0.682 HG21 ' HG3' ' B' ' 462' ' ' GLN . 8.9 t -81.84 107.24 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.355 . . . . 0.0 109.314 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 60.4 m -123.74 -44.38 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 0.0 109.697 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 455' ' ' THR . . . . . 0.69 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -71.97 140.84 49.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 456' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' B' ' 485' ' ' ALA . 2.6 tm? -51.76 -37.91 53.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.14 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -63.07 -40.83 98.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.743 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 458' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' B' ' 453' ' ' VAL . 68.7 m-20 -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.089 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 459' ' ' LEU . . . . . 0.763 HD13 ' O ' ' B' ' 459' ' ' LEU . 3.5 tm? -59.65 -41.84 91.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.37 74.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.394 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.68 -25.76 62.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 462' ' ' GLN . . . . . 0.682 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.3 mm-40 -67.79 163.11 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.66 156.86 15.98 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 464' ' ' ILE . . . . . 1.001 HD11 ' HG2' ' A' ' 293' ' ' PRO . 58.6 mt -51.94 -34.95 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -1.182 . . . . 0.0 109.495 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -68.48 -35.95 78.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 466' ' ' ASP . . . . . 0.493 ' O ' ' NH1' ' B' ' 451' ' ' ARG . 87.3 m-20 -72.34 -31.52 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 467' ' ' LEU . . . . . 1.024 HD12 ' HB1' ' B' ' 478' ' ' ALA . 21.7 mt -74.41 -25.34 59.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -24.27 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -48.06 -33.58 8.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 470' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' B' ' 447' ' ' LYS . 61.3 mt -103.36 128.1 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.37 -31.82 72.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 472' ' ' GLY . . . . . 0.484 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -56.81 -30.92 60.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 473' ' ' LEU . . . . . 0.496 HD11 HD21 ' B' ' 448' ' ' LEU . 73.8 mt -101.53 131.03 47.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -1.185 . . . . 0.0 109.579 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.84 163.35 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 475' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 88.3 m-20 -57.87 -38.19 75.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -73.81 -46.04 47.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 477' ' ' LYS . . . . . 0.533 ' O ' HD13 ' B' ' 481' ' ' LEU . 15.7 tttp -64.78 -42.44 95.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 478' ' ' ALA . . . . . 1.024 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -61.55 -46.03 91.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 479' ' ' GLY . . . . . 0.457 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.33 -45.98 92.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.91 84.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -1.116 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 481' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.4 mp -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 482' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 293' ' ' PRO . 47.9 mt -66.89 -54.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 483' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 49.1 mtp -52.22 -37.41 55.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.395 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.49 -57.13 5.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.167 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' B' ' 456' ' ' LEU . . . -62.87 -52.09 64.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 486' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' B' ' 485' ' ' ALA . 21.6 ttm180 -46.27 -48.77 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.203 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 487' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' B' ' 483' ' ' MET . 89.2 m-20 -58.95 -41.5 87.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 488' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 492' ' ' GLY . 80.2 mt -58.93 -37.61 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 41.7 t -70.58 -49.12 51.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.606 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.41 -41.77 72.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 491' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 46.1 m-85 -79.78 -36.06 37.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 492' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.569 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 38.4 p90 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.508 -0.553 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -50.18 121.72 13.83 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 0.0 109.241 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -64.67 -26.56 60.96 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.645 2.23 . . . . 0.0 111.469 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.866 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.9 tt -69.59 -31.99 50.95 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.473 HD11 ' HE2' ' A' ' 316' ' ' MET . 34.2 mt -75.15 -45.16 42.7 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.4 -0.812 . . . . 0.0 109.39 179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.913 HD21 HD11 ' A' ' 326' ' ' ILE . 0.3 OUTLIER -64.01 -37.35 87.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.5 179.98 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.453 ' CD ' ' OD2' ' A' ' 259' ' ' ASP . 5.2 ttp180 -59.6 141.86 88.1 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.221 -0.925 . . . . 0.0 109.241 179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.2 Cg_endo -68.87 133.6 27.65 Favored 'Trans proline' 0 C--O 1.215 -0.659 0 C-N-CA 122.651 2.234 . . . . 0.0 111.691 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.582 ' O ' HD12 ' A' ' 260' ' ' LEU . 1.0 OUTLIER -44.9 -25.36 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.271 -0.893 . . . . 0.0 109.334 179.96 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.403 ' N ' ' O ' ' A' ' 256' ' ' PRO . 91.1 m-20 -69.58 -30.56 68.36 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.217 -0.927 . . . . 0.0 109.212 179.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 48.8 t0 -66.7 -22.55 66.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.288 -0.883 . . . . 0.0 109.423 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.582 HD12 ' O ' ' A' ' 257' ' ' VAL . 38.5 mt -43.62 131.44 5.18 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.509 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -55.93 -24.79 40.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.574 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.724 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.6 mp -62.35 163.59 8.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.479 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.3 p -62.87 161.09 13.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.917 . . . . 0.0 109.464 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.796 HG12 ' OD1' ' A' ' 268' ' ' ASN . 20.4 t -54.76 -26.1 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.249 -0.907 . . . . 0.0 109.504 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.0 ttm-85 -51.93 -44.11 63.72 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -0.889 . . . . 0.0 109.501 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.436 ' CB ' ' OE1' ' A' ' 302' ' ' GLU . 8.7 t -58.79 -50.61 73.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.31 -0.869 . . . . 0.0 109.504 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.436 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -70.49 -33.56 71.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.526 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.796 ' OD1' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -56.42 -38.22 71.27 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 109.568 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.509 ' SG ' ' CB ' ' A' ' 299' ' ' SER . 24.8 m -60.62 -64.6 0.9 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.212 -0.93 . . . . 0.0 109.54 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.701 HD13 HD23 ' A' ' 281' ' ' LEU . 63.7 mt -64.7 -46.64 81.51 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.21 -0.931 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 76.9 tttt -52.98 -34.01 54.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.225 -0.922 . . . . 0.0 109.402 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.76 -23.59 12.42 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.444 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.64 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.9 mt-10 -89.05 22.59 2.7 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.229 -0.92 . . . . 0.0 109.486 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.64 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.89 36.48 1.18 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.329 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.78 HG23 ' HB3' ' A' ' 280' ' ' ASP . 70.6 mt -112.16 127.38 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.312 -0.868 . . . . 0.0 109.499 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.592 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.9 p80 -116.68 -30.28 5.85 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.205 -0.935 . . . . 0.0 109.588 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.592 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.8 m-30 -106.57 127.8 53.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -0.9 . . . . 0.0 109.43 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.866 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.5 mt -48.26 -30.2 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 109.355 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.972 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.5 -48.64 16.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.78 ' HB3' HG23 ' A' ' 275' ' ' ILE . 40.0 t0 -53.39 -32.96 51.89 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.164 -1.198 . . . . 0.0 108.899 179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.759 ' C ' HD13 ' A' ' 281' ' ' LEU . 3.4 tm? -56.82 -46.95 81.32 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.386 -0.821 . . . . 0.0 109.111 179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.972 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.1 m -69.01 -23.22 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.453 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 95.5 mt-30 -66.2 -36.98 84.47 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.351 -0.843 . . . . 0.0 108.948 179.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -104.4 143.06 33.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.204 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.414 ' OG1' ' HG3' ' A' ' 288' ' ' GLU . 43.9 p -80.0 151.83 29.79 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.175 -0.953 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.574 ' OE2' HD22 ' A' ' 307' ' ' LEU . 8.9 mt-10 -54.45 -39.46 67.45 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.647 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.8 t -52.98 -55.27 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.27 -0.894 . . . . 0.0 109.315 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.414 ' HG3' ' OG1' ' A' ' 285' ' ' THR . 95.6 mt-10 -53.15 -30.58 37.88 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.269 -0.894 . . . . 0.0 109.186 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.901 ' O ' HG22 ' A' ' 292' ' ' THR . 8.4 mp -79.64 -42.42 24.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.297 -0.877 . . . . 0.0 109.462 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.647 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.7 mt -65.04 -12.75 54.03 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.478 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.491 ' C ' ' HE2' ' B' ' 483' ' ' MET . 45.7 mmtm -89.14 12.34 16.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.424 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.5 t -124.83 138.74 31.95 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.595 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.884 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.7 Cg_endo -70.82 -27.05 21.89 Favored 'Trans proline' 0 C--O 1.215 -0.626 0 C-N-CA 122.789 2.326 . . . . 0.0 111.78 -179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.473 ' ND2' HD12 ' B' ' 464' ' ' ILE . 26.2 m120 -48.32 -24.4 1.2 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.289 -0.882 . . . . 0.0 109.518 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 289' ' ' LEU . 20.3 mt -87.6 143.13 27.35 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.241 -0.912 . . . . 0.0 109.358 179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -110.47 160.38 13.36 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -54.92 -42.27 72.02 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.235 -1.156 . . . . 0.0 109.362 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.9 tptp -67.38 -37.84 83.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.251 -0.905 . . . . 0.0 109.364 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.509 ' CB ' ' SG ' ' A' ' 269' ' ' CYS . 81.1 p -59.18 -39.4 82.41 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.337 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.515 ' CD1' HD21 ' A' ' 290' ' ' LEU . 0.6 OUTLIER -57.99 -42.65 85.62 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.311 -0.868 . . . . 0.0 109.378 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 49.8 m -58.02 -48.28 80.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.204 -0.935 . . . . 0.0 109.431 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.1 mt-10 -56.59 -42.8 79.31 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.316 -0.865 . . . . 0.0 109.504 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 80.7 mt -57.91 -48.26 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.197 -0.939 . . . . 0.0 109.117 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 28.7 tttm -54.74 -41.57 70.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.372 -0.83 . . . . 0.0 109.319 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -58.29 -51.42 69.87 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.3 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.6 t -68.72 -37.19 77.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.221 -0.924 . . . . 0.0 109.024 179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.838 HD13 ' HB3' ' A' ' 313' ' ' SER . 20.0 tp -62.03 -26.43 68.24 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.315 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.23 -29.99 66.16 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.184 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 5.5 t -74.11 -13.37 60.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.317 -0.864 . . . . 0.0 109.2 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.774 ' HA ' HD11 ' A' ' 314' ' ' LEU . 51.2 mtt-85 61.17 13.51 4.82 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.336 -0.853 . . . . 0.0 109.307 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -88.98 -24.56 31.84 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.785 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.6 pt? -139.32 153.25 47.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.263 -1.139 . . . . 0.0 109.562 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.838 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 71.45 32.62 2.05 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 0.0 109.586 179.702 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.774 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.5 mm? -89.27 14.12 11.81 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.271 -0.893 . . . . 0.0 109.268 179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.5 44.88 92.24 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.719 ' HE2' HG11 ' A' ' 282' ' ' VAL . 8.0 mtm -94.21 168.75 10.72 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.236 -1.155 . . . . 0.0 109.366 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.494 ' C ' HD23 ' A' ' 318' ' ' LEU . 53.6 mtt180 -134.05 121.61 21.79 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.242 -0.911 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.494 HD23 ' C ' ' A' ' 317' ' ' ARG . 5.2 mt -113.4 138.11 50.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.228 -0.92 . . . . 0.0 109.383 179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -71.58 -32.17 67.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.237 -0.915 . . . . 0.0 109.159 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.492 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 72.3 m-20 -135.05 -64.29 0.66 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.31 -0.869 . . . . 0.0 108.988 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.837 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.2 t-105 164.73 -59.36 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.399 -0.813 . . . . 0.0 109.371 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.565 ' HA ' HD12 ' A' ' 326' ' ' ILE . 48.2 Cg_endo -68.09 107.91 1.63 Allowed 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.595 2.197 . . . . 0.0 111.967 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' HD12 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.51 163.07 40.17 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.667 2.245 . . . . 0.0 111.689 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.18 4.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.41 ' CB ' ' N ' ' A' ' 249' ' ' PHE . 3.8 t -58.73 -56.5 21.36 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -0.922 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.913 HD11 HD21 ' A' ' 254' ' ' LEU . 30.3 mt -56.36 -36.48 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.224 -0.922 . . . . 0.0 109.46 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . 0.443 ' O ' ' O ' ' A' ' 326' ' ' ILE . . . 44.47 -166.73 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.236 -0.915 . . . . 0.0 109.338 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -55.47 -38.45 69.1 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 109.444 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 75.1 mm-40 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.494 179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -56.92 -34.73 68.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.228 -1.16 . . . . 0.0 109.538 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 57.99 44.4 19.67 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.233 -0.917 . . . . 0.0 109.395 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.455 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 3.1 tttp -67.77 136.52 92.5 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.339 -0.85 . . . . 0.0 109.512 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.455 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.31 136.53 31.75 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.69 2.26 . . . . 0.0 111.724 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -71.13 159.51 34.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.0 109.492 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -55.38 -33.77 63.74 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.487 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.73 -48.32 77.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.25 -0.906 . . . . 0.0 109.479 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 16.3 tp -70.1 -38.4 75.62 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.267 -0.896 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.891 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -73.06 -31.44 64.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.455 -179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 41.9 t-20 -84.83 7.73 19.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.254 -0.904 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.774 HD23 HG21 ' B' ' 440' ' ' VAL . 30.1 tp -72.28 133.83 45.24 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 0.0 109.492 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -76.86 140.83 40.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.283 -0.886 . . . . 0.0 109.477 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.16 2.96 68.03 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.774 HG21 HD23 ' B' ' 437' ' ' LEU . 58.8 t -130.82 137.15 56.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.182 -1.187 . . . . 0.0 109.421 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' ' CG ' ' B' ' 444' ' ' LEU . 39.6 p30 -103.75 173.55 6.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.492 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.565 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 74.8 mtt85 -58.31 -40.52 82.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -61.63 -49.53 76.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -0.907 . . . . 0.0 109.439 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.64 HD22 HD21 ' B' ' 473' ' ' LEU . 45.8 mt -64.36 -39.9 94.79 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 109.544 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -62.58 -38.29 89.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.498 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 17.3 m-30 -66.18 -47.99 72.15 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.295 -0.878 . . . . 0.0 109.483 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.569 ' HB3' HD13 ' B' ' 470' ' ' ILE . 61.6 mttt -58.88 -46.38 87.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.291 -0.88 . . . . 0.0 109.585 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.865 ' O ' HD13 ' B' ' 448' ' ' LEU . 3.1 tm? -64.12 -41.17 97.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.0 109.436 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.36 -30.68 71.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 0.0 109.502 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -56.79 -18.52 13.06 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.401 ' NH1' ' CB ' ' B' ' 469' ' ' ASP . 14.3 mtp85 -90.65 31.6 1.04 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.228 -0.92 . . . . 0.0 109.507 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.82 -18.88 6.84 Favored Glycine 0 N--CA 1.493 2.447 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.759 HG13 ' HB3' ' B' ' 458' ' ' ASP . 96.3 t -63.51 139.87 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.878 -1.366 . . . . 0.0 109.382 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.511 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -135.01 -36.01 0.83 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.214 -0.928 . . . . 0.0 109.701 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -111.04 148.63 32.18 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.152 -0.967 . . . . 0.0 109.693 -179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 1.069 HD21 HD12 ' B' ' 488' ' ' ILE . 30.0 tp -46.17 -40.14 10.72 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.29 -0.881 . . . . 0.0 109.167 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.0 tp10 -56.75 -49.65 74.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.344 -0.848 . . . . 0.0 109.067 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.759 ' HB3' HG13 ' B' ' 453' ' ' VAL . 37.4 t0 -54.8 -38.78 67.75 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.294 -0.879 . . . . 0.0 109.108 179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.776 ' C ' HD13 ' B' ' 459' ' ' LEU . 2.9 tm? -60.04 -41.49 92.39 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.305 -0.872 . . . . 0.0 109.208 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.15 -34.14 76.98 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.28 -0.888 . . . . 0.0 109.393 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.93 -30.77 71.12 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.238 -0.914 . . . . 0.0 109.474 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.2 mm-40 -67.53 151.85 46.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.262 -0.898 . . . . 0.0 109.565 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.84 165.82 12.64 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.374 -1.49 . . . . 0.0 109.374 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.884 HD11 ' HG2' ' A' ' 293' ' ' PRO . 28.9 mt -53.28 -35.75 24.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.145 -1.209 . . . . 0.0 109.4 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -69.45 -34.29 74.19 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.273 -0.892 . . . . 0.0 109.356 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -71.02 -31.27 67.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.334 -0.854 . . . . 0.0 109.339 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.999 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -75.44 -29.05 59.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.0 109.441 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.04 -23.75 62.25 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.284 -0.885 . . . . 0.0 109.581 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . 0.401 ' CB ' ' NH1' ' B' ' 451' ' ' ARG . 86.3 m-20 -50.1 -33.97 20.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.175 -0.953 . . . . 0.0 109.46 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.569 HD13 ' HB3' ' B' ' 447' ' ' LYS . 65.6 mt -100.89 127.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.3 -0.875 . . . . 0.0 109.512 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -67.25 -33.09 74.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.461 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.04 -31.56 40.59 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.64 HD21 HD22 ' B' ' 444' ' ' LEU . 50.5 mt -101.11 140.49 35.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -1.148 . . . . 0.0 109.603 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.449 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.11 161.85 13.67 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.246 -0.909 . . . . 0.0 109.389 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.449 ' N ' HG22 ' B' ' 474' ' ' THR . 81.3 m-20 -57.91 -37.62 74.37 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.908 . . . . 0.0 109.4 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -73.88 -46.06 46.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.307 -0.871 . . . . 0.0 109.445 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.464 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 39.2 tttp -68.74 -37.02 79.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.466 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.999 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.08 -44.68 91.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.879 . . . . 0.0 109.539 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.545 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -63.87 -43.1 98.07 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.82 -33.97 70.99 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.288 -1.125 . . . . 0.0 109.406 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 31.0 mt -74.39 -35.16 63.47 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.234 -0.916 . . . . 0.0 109.517 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.458 HG13 ' O ' ' B' ' 478' ' ' ALA . 78.6 mt -64.03 -53.91 38.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.903 . . . . 0.0 109.537 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.508 ' HE1' ' O ' ' A' ' 290' ' ' LEU . 52.6 mmm -60.74 -42.48 97.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.23 -0.919 . . . . 0.0 109.426 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.44 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -58.29 -47.36 83.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.531 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.417 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -66.0 -47.68 73.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.257 -0.902 . . . . 0.0 109.536 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.505 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 40.2 ttm180 -60.8 -42.62 97.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.893 . . . . 0.0 109.48 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 95.9 m-20 -58.85 -39.25 80.74 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.221 -0.924 . . . . 0.0 109.493 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 1.069 HD12 HD21 ' B' ' 456' ' ' LEU . 66.1 mt -62.27 -40.35 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.309 -0.87 . . . . 0.0 109.558 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 44.8 t -72.82 -52.06 16.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.91 . . . . 0.0 109.679 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . 0.505 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 67.2 m95 -64.44 -38.48 91.16 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.44 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.9 m-85 -99.19 13.1 34.16 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.226 -0.921 . . . . 0.0 109.47 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -63.8 -29.76 75.72 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -57.41 -36.18 71.0 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -1.133 . . . . 0.0 109.428 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -93.31 138.71 31.41 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.269 -0.894 . . . . 0.0 109.508 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.442 -179.946 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.784 ' N ' ' HG ' ' A' ' 325' ' ' SER . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.4 126.56 84.77 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 109.429 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -65.46 -32.21 50.01 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.794 2.329 . . . . 0.0 111.754 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.719 ' O ' HD12 ' A' ' 278' ' ' ILE . 2.9 tt -66.27 -23.55 31.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.28 -0.887 . . . . 0.0 109.174 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.619 HD13 ' O ' ' A' ' 311' ' ' GLY . 5.3 tp -74.28 -44.12 54.09 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.296 -0.877 . . . . 0.0 109.459 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.962 HD21 HD11 ' A' ' 326' ' ' ILE . 2.2 mm? -73.63 -20.36 60.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.313 -0.867 . . . . 0.0 109.555 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.451 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -63.87 149.87 92.41 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.124 -0.985 . . . . 0.0 109.209 179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.477 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.0 Cg_endo -69.86 136.31 32.41 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.604 2.202 . . . . 0.0 111.934 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.542 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.79 -31.84 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.285 -0.885 . . . . 0.0 109.424 179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -62.35 -30.95 71.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.273 -0.892 . . . . 0.0 109.37 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 256' ' ' PRO . 53.8 m-20 -73.03 -14.09 61.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.191 -0.943 . . . . 0.0 109.404 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.631 HD21 HD13 ' A' ' 278' ' ' ILE . 59.4 mt -54.13 150.73 7.87 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.392 -0.818 . . . . 0.0 109.487 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -62.12 -21.52 65.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -0.88 . . . . 0.0 109.493 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.811 HD22 ' OG ' ' A' ' 266' ' ' SER . 5.3 mp -64.64 166.08 9.24 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.358 -0.839 . . . . 0.0 109.486 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -79.88 165.27 22.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.198 -0.939 . . . . 0.0 109.418 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.448 ' H ' HG23 ' A' ' 264' ' ' VAL . 3.9 t -47.0 -32.85 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.174 -0.954 . . . . 0.0 109.457 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 40.8 ttm180 -52.78 -50.21 64.03 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.401 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.811 ' OG ' HD22 ' A' ' 262' ' ' LEU . 22.2 t -59.53 -51.11 71.27 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.278 -0.889 . . . . 0.0 109.374 179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.67 -37.34 86.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.315 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.44 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.6 m-20 -56.64 -36.89 70.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.223 -0.923 . . . . 0.0 109.339 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 60.0 m -55.41 -64.98 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.218 -0.926 . . . . 0.0 109.344 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.641 ' CD2' HD12 ' A' ' 289' ' ' LEU . 65.2 mt -62.41 -47.69 82.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.253 -0.904 . . . . 0.0 109.248 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 23.2 tttt -53.02 -36.88 61.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.304 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.79 -30.0 30.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.268 -0.895 . . . . 0.0 109.425 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.9 mt-10 -94.01 23.99 4.57 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 109.377 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.07 41.59 0.64 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.288 -0.882 . . . . 0.0 109.534 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.676 HG23 ' HB2' ' A' ' 280' ' ' ASP . 90.3 mt -122.82 107.66 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.153 -0.967 . . . . 0.0 109.519 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.472 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 64.0 m-70 -109.71 -6.75 15.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.194 -0.941 . . . . 0.0 109.53 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -115.35 129.24 56.54 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.448 -179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.719 HD12 ' O ' ' A' ' 252' ' ' ILE . 80.9 mt -54.72 -30.63 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.375 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.793 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.02 -46.78 14.94 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.227 -1.549 . . . . 0.0 109.227 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.676 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.4 m-20 -53.48 -30.9 43.34 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.038 -1.272 . . . . 0.0 108.873 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.586 HD13 HD11 ' A' ' 270' ' ' LEU . 31.4 tp -59.26 -49.9 76.09 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.409 -0.807 . . . . 0.0 109.136 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 279' ' ' GLY . 30.2 m -67.51 -30.55 49.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.289 -0.882 . . . . 0.0 108.967 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -59.44 -32.83 70.57 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.35 -0.844 . . . . 0.0 108.949 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 90.0 mtt180 -109.84 143.84 39.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.0 m -63.7 137.96 58.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.161 -0.962 . . . . 0.0 109.49 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.412 ' OE1' ' CD2' ' A' ' 307' ' ' LEU . 80.4 tt0 -50.58 -33.51 22.24 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.17 -0.956 . . . . 0.0 109.387 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 1.046 ' HA ' HD12 ' A' ' 290' ' ' LEU . 55.2 t -54.86 -54.34 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.272 -0.893 . . . . 0.0 109.51 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -51.15 -30.72 17.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.254 -0.904 . . . . 0.0 109.24 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.996 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -79.15 -43.67 23.5 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 0.0 109.257 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 1.046 HD12 ' HA ' ' A' ' 287' ' ' VAL . 5.4 mt -56.85 -18.73 14.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.246 -0.909 . . . . 0.0 109.362 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.645 ' O ' ' HE2' ' B' ' 483' ' ' MET . 69.5 mttt -81.44 -21.94 38.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.192 -0.942 . . . . 0.0 109.357 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.512 HG22 ' H ' ' A' ' 294' ' ' ASN . 9.8 m -59.49 128.52 86.12 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.192 -0.942 . . . . 0.0 109.634 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.675 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.8 Cg_endo -71.16 -14.84 31.92 Favored 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.804 2.336 . . . . 0.0 112.001 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.602 ' HA ' HD12 ' B' ' 464' ' ' ILE . 53.2 m-80 -78.47 3.65 15.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.217 -0.927 . . . . 0.0 109.74 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.996 HD11 ' O ' ' A' ' 289' ' ' LEU . 72.1 mt -81.33 149.55 28.87 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.201 -0.937 . . . . 0.0 109.517 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -108.63 140.92 15.74 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -52.81 -47.13 67.85 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.181 -1.188 . . . . 0.0 109.455 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 16.4 mttp -73.99 -25.31 59.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.283 -0.886 . . . . 0.0 109.325 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 296' ' ' GLY . 82.5 p -73.13 -36.8 66.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.34 -0.85 . . . . 0.0 109.413 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.606 HD21 ' HB3' ' A' ' 295' ' ' LEU . 29.7 mt -54.31 -39.24 66.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.873 . . . . 0.0 109.494 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 63.0 m -60.18 -54.26 47.99 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.195 -0.941 . . . . 0.0 109.538 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.478 ' O ' HG23 ' A' ' 306' ' ' VAL . 67.7 tt0 -53.82 -39.97 65.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.144 -0.973 . . . . 0.0 109.337 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.592 HD12 ' HA ' ' A' ' 300' ' ' LEU . 84.5 mt -57.63 -45.85 86.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.276 -0.89 . . . . 0.0 108.917 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -61.11 -33.93 74.15 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.251 -0.906 . . . . 0.0 108.964 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -61.42 -41.58 97.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.321 -0.862 . . . . 0.0 109.248 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 1.04 HG12 ' CD2' ' A' ' 312' ' ' LEU . 1.7 t -68.25 -45.65 82.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.247 -0.908 . . . . 0.0 109.208 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.441 HD12 HD11 ' A' ' 312' ' ' LEU . 8.2 mp -56.43 -26.77 54.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.283 -0.885 . . . . 0.0 109.532 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.57 -34.11 70.7 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.0 t -65.51 -17.39 64.53 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.265 -0.897 . . . . 0.0 109.471 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.897 ' O ' HD21 ' A' ' 314' ' ' LEU . 11.7 ttp180 65.93 9.07 5.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.328 -0.857 . . . . 0.0 109.368 -179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.619 ' O ' HD13 ' A' ' 253' ' ' LEU . . . -94.95 -0.3 63.94 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.04 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.29 163.09 38.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.134 -1.215 . . . . 0.0 109.44 179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.466 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.2 OUTLIER 48.47 54.96 9.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.22 -0.925 . . . . 0.0 109.641 179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.897 HD21 ' O ' ' A' ' 310' ' ' ARG . 76.7 mt -91.81 9.39 32.91 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.463 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 63.36 38.22 96.07 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.533 ' CE ' HD12 ' A' ' 314' ' ' LEU . 5.6 ptt? -113.3 157.44 21.8 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.235 -1.156 . . . . 0.0 109.502 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.603 ' C ' HD12 ' A' ' 318' ' ' LEU . 77.6 mtt85 -130.23 137.72 50.18 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.24 -0.912 . . . . 0.0 109.465 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.85 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.8 mp -123.47 140.89 52.54 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.211 -0.93 . . . . 0.0 109.512 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.29 -31.06 65.25 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.189 -0.944 . . . . 0.0 108.951 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 82.5 m-20 -122.45 -81.22 0.64 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.46 -0.775 . . . . 0.0 109.163 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.673 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 165.24 -65.98 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.291 -0.881 . . . . 0.0 109.389 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.531 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 50.7 Cg_endo -69.47 107.77 1.88 Allowed 'Trans proline' 0 C--O 1.215 -0.669 0 C-N-CA 122.563 2.175 . . . . 0.0 111.95 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.587 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.1 Cg_endo -71.91 163.91 37.33 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.622 2.214 . . . . 0.0 111.6 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.81 -13.6 25.47 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.149 -0.969 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.784 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 62.1 p -70.54 -38.97 74.27 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -0.883 . . . . 0.0 109.46 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.962 HD11 HD21 ' A' ' 254' ' ' LEU . 34.3 mt -53.32 -33.0 20.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.14 -34.52 75.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.246 -0.909 . . . . 0.0 109.457 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -57.05 -36.23 70.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.195 -0.941 . . . . 0.0 109.475 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.476 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.247 0 N-CA-C 109.474 -1.451 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -56.02 -38.0 69.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.217 -1.167 . . . . 0.0 109.549 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.827 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 24.3 m120 -85.53 -3.01 58.74 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.0 109.645 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.489 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 20.0 tttm -53.03 136.89 47.48 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.489 ' HD2' ' HG3' ' B' ' 429' ' ' LYS . 50.1 Cg_endo -70.09 136.76 32.9 Favored 'Trans proline' 0 C--O 1.215 -0.652 0 C-N-CA 122.641 2.227 . . . . 0.0 111.899 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.1 153.23 41.81 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.513 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -47.06 -38.6 11.4 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.254 -0.904 . . . . 0.0 109.459 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -62.29 -40.73 97.25 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.264 -0.898 . . . . 0.0 109.278 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.996 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.5 tm? -66.66 -29.87 69.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.322 -0.861 . . . . 0.0 109.374 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.405 HD11 ' HG2' ' B' ' 442' ' ' ARG . 25.2 tp -85.69 -28.52 24.63 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.497 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 -73.85 -5.81 43.26 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.266 -0.896 . . . . 0.0 109.543 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.908 HD23 HG21 ' B' ' 440' ' ' VAL . 35.4 tp -65.82 134.81 53.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.543 179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -78.26 141.19 38.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.273 -0.892 . . . . 0.0 109.498 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.3 8.34 64.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.908 HG21 HD23 ' B' ' 437' ' ' LEU . 46.6 t -128.19 132.22 68.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -1.164 . . . . 0.0 109.471 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.577 ' H ' HD12 ' B' ' 444' ' ' LEU . 83.7 m-20 -97.89 166.0 11.67 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.317 -0.864 . . . . 0.0 109.437 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.405 ' HG2' HD11 ' B' ' 435' ' ' LEU . 92.7 mtt180 -54.7 -43.14 72.26 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.899 . . . . 0.0 109.559 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.411 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.1 m-20 -66.15 -50.15 64.98 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.252 -0.905 . . . . 0.0 109.464 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.577 HD12 ' H ' ' B' ' 441' ' ' ASP . 29.7 mt -55.74 -43.43 76.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -0.904 . . . . 0.0 109.442 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.629 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.09 -37.85 78.1 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.206 -0.934 . . . . 0.0 109.482 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.411 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.6 m-30 -64.59 -45.12 88.36 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.241 -0.912 . . . . 0.0 109.397 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.469 ' HB3' HD13 ' B' ' 470' ' ' ILE . 81.5 mttt -62.86 -45.17 93.81 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.328 -0.857 . . . . 0.0 109.438 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.855 ' O ' HD13 ' B' ' 448' ' ' LEU . 1.4 tm? -63.85 -40.58 96.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.208 -0.932 . . . . 0.0 109.435 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.827 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.14 -28.89 68.5 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.458 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -54.32 -19.24 5.05 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.32 -0.863 . . . . 0.0 109.473 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 43.2 mtp85 -93.24 32.06 1.38 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 109.392 179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.43 -18.61 6.65 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.417 -1.073 . . . . 0.0 110.417 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.91 HG13 ' CB ' ' B' ' 458' ' ' ASP . 84.3 t -60.9 139.48 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 120.9 -1.353 . . . . 0.0 109.5 -179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 10.9 m -135.05 -35.88 0.83 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.098 -1.001 . . . . 0.0 109.769 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.59 159.39 20.49 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.145 -0.972 . . . . 0.0 109.896 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.771 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -48.56 -41.37 30.31 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.288 -0.883 . . . . 0.0 109.027 179.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 32.8 tp10 -55.59 -42.28 74.58 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.268 -0.895 . . . . 0.0 108.766 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.91 ' CB ' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -59.86 -43.55 94.63 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.326 -0.859 . . . . 0.0 108.893 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.687 HD12 HD21 ' B' ' 434' ' ' LEU . 5.8 tt -54.31 -49.15 70.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 0.0 109.172 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -56.49 -37.99 71.12 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.293 -0.879 . . . . 0.0 109.378 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -61.98 -25.71 67.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.224 -0.923 . . . . 0.0 109.357 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.513 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.5 mm-40 -70.48 152.23 44.25 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.299 -0.876 . . . . 0.0 109.523 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.459 ' O ' ' CD1' ' B' ' 467' ' ' LEU . . . -116.12 162.84 12.48 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.675 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.2 mt -49.68 -36.67 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.385 -1.068 . . . . 0.0 109.569 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -68.5 -37.06 79.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.231 -0.918 . . . . 0.0 109.586 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -66.06 -25.12 66.89 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.239 -0.913 . . . . 0.0 109.503 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.876 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.6 mp -91.42 -27.72 18.13 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.315 -0.865 . . . . 0.0 109.484 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.85 -23.2 66.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.327 -0.858 . . . . 0.0 109.458 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -58.13 -32.85 68.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 0.0 109.56 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.469 HD13 ' HB3' ' B' ' 447' ' ' LYS . 73.5 mt -99.84 128.72 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.265 -0.897 . . . . 0.0 109.588 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -64.67 -32.37 74.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.462 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.38 -28.8 51.59 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.644 HD13 HD23 ' B' ' 467' ' ' LEU . 60.7 mt -103.68 137.19 42.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -1.148 . . . . 0.0 109.504 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.417 HG22 ' N ' ' B' ' 475' ' ' ASP . 7.0 m -104.06 165.8 10.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.185 -0.947 . . . . 0.0 109.55 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.417 ' N ' HG22 ' B' ' 474' ' ' THR . 92.4 m-20 -58.68 -39.23 80.08 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.497 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 10.3 mt-10 -76.45 -45.39 31.51 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.291 -0.88 . . . . 0.0 109.463 -179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.51 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 48.0 tttm -60.75 -46.47 90.34 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.876 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -62.98 -53.22 57.35 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.205 -0.934 . . . . 0.0 109.427 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.516 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -58.38 -48.0 86.4 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.383 -1.487 . . . . 0.0 109.383 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.35 -48.0 62.58 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.302 -1.116 . . . . 0.0 109.388 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 96.5 mt -61.9 -43.67 98.36 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.194 -0.941 . . . . 0.0 109.4 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.508 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.5 mt -53.44 -56.19 9.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 0.0 109.508 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.645 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 50.1 mtp -52.93 -46.17 67.99 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.153 -0.967 . . . . 0.0 109.486 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.452 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.57 -52.93 63.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.316 -0.865 . . . . 0.0 109.52 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.477 ' CB ' HD21 ' B' ' 456' ' ' LEU . . . -61.75 -48.84 78.89 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.202 -0.936 . . . . 0.0 109.472 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.531 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 34.4 ttt180 -56.16 -45.28 79.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.597 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -59.83 -34.06 72.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.3 -0.875 . . . . 0.0 109.547 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.743 HD12 HD11 ' B' ' 456' ' ' LEU . 79.7 mt -68.31 -39.4 80.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.0 109.519 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 57.1 m -74.8 -50.59 16.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . 0.531 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 36.3 m95 -58.7 -43.56 90.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.228 -0.92 . . . . 0.0 109.463 179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -94.18 10.91 31.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.391 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -67.25 -31.83 78.31 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.461 -1.455 . . . . 0.0 109.461 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -62.6 -37.27 85.58 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.288 -1.125 . . . . 0.0 109.491 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -55.36 143.61 28.01 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.471 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.469 -179.957 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.83 ' CZ ' HD21 ' A' ' 318' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.49 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.3 OUTLIER -52.71 141.22 36.61 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.231 -0.918 . . . . 0.0 109.183 179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.637 ' HA ' HD23 ' A' ' 254' ' ' LEU . 43.1 Cg_endo -65.0 -23.04 61.86 Favored 'Trans proline' 0 C--O 1.216 -0.594 0 C-N-CA 122.652 2.234 . . . . 0.0 111.903 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.923 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -64.77 -32.09 56.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.122 -0.986 . . . . 0.0 108.707 179.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.667 HD21 HG11 ' A' ' 282' ' ' VAL . 5.3 mp -74.34 -30.96 62.25 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.385 -0.822 . . . . 0.0 109.194 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.701 HD22 ' N ' ' A' ' 254' ' ' LEU . 3.5 mm? -69.13 -40.0 78.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.417 -0.802 . . . . 0.0 109.452 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.47 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -61.72 147.58 88.72 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.196 -0.94 . . . . 0.0 109.459 179.98 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.47 ' HD2' ' HG2' ' A' ' 255' ' ' ARG . 48.3 Cg_endo -70.24 138.73 36.97 Favored 'Trans proline' 0 C--O 1.213 -0.728 0 C-N-CA 122.683 2.256 . . . . 0.0 111.701 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.56 HG12 HD11 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -43.5 -36.05 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.408 -0.807 . . . . 0.0 109.461 179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -58.49 -31.33 67.75 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.246 -0.909 . . . . 0.0 109.381 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 256' ' ' PRO . 70.6 m-20 -75.45 -11.0 59.94 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.225 -0.922 . . . . 0.0 109.458 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.56 HD11 HG12 ' A' ' 257' ' ' VAL . 61.0 mt -47.47 143.54 3.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.308 -0.87 . . . . 0.0 109.524 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -59.94 -18.17 43.25 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.502 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.867 HD11 HG21 ' A' ' 306' ' ' VAL . 6.3 mp -67.86 167.1 14.21 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.267 -0.896 . . . . 0.0 109.515 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.9 p -69.53 160.23 31.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.245 -0.91 . . . . 0.0 109.413 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.718 HG12 HD21 ' A' ' 268' ' ' ASN . 14.0 t -50.5 -39.25 17.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.25 -0.906 . . . . 0.0 109.42 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 46.6 ttm105 -53.66 -48.96 68.94 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.471 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.544 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 18.9 m -57.78 -50.56 72.84 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.229 -0.919 . . . . 0.0 109.413 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.77 -35.87 81.95 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.19 -0.944 . . . . 0.0 109.299 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.718 HD21 HG12 ' A' ' 264' ' ' VAL . 94.2 m-20 -58.51 -36.68 74.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.257 -0.902 . . . . 0.0 109.401 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 79.2 m -55.76 -65.03 0.66 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.317 -0.864 . . . . 0.0 109.436 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 281' ' ' LEU . 75.2 mt -58.03 -46.68 84.92 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.238 -0.914 . . . . 0.0 109.435 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.438 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 24.6 tttt -53.46 -37.74 62.92 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.241 -0.912 . . . . 0.0 109.387 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.37 -24.81 13.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.288 -0.882 . . . . 0.0 109.399 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.618 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.7 mm-40 -89.35 23.71 2.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.191 -0.943 . . . . 0.0 109.483 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 71.93 38.14 0.96 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.312 -0.868 . . . . 0.0 109.536 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.863 HG23 ' HB2' ' A' ' 280' ' ' ASP . 20.0 mm -112.29 121.53 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.129 -0.982 . . . . 0.0 109.449 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.45 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 8.3 p80 -113.13 -33.2 6.08 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.226 -0.921 . . . . 0.0 109.554 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.436 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.2 m-85 -109.8 131.28 55.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.591 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.923 HD12 ' O ' ' A' ' 252' ' ' ILE . 76.6 mt -48.88 -30.84 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.143 -0.973 . . . . 0.0 109.179 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.7 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.62 -45.35 23.69 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.863 ' HB2' HG23 ' A' ' 275' ' ' ILE . 57.3 m-20 -53.68 -35.02 60.63 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.206 -1.173 . . . . 0.0 109.078 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.772 HD13 HD13 ' A' ' 270' ' ' LEU . 35.5 tp -56.28 -48.3 76.88 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.335 -0.853 . . . . 0.0 109.258 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.7 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.6 m -71.94 -35.35 54.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.174 -0.954 . . . . 0.0 109.013 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.8 tt0 -51.54 -34.9 38.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.338 -0.851 . . . . 0.0 108.89 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 63.8 mtt180 -112.36 143.62 43.15 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.391 -0.818 . . . . 0.0 109.095 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.0 m -59.93 138.77 57.75 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.232 -0.918 . . . . 0.0 109.617 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -61.96 -28.53 69.61 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.3 t -52.93 -53.13 23.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.299 -0.876 . . . . 0.0 109.494 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 71.1 mm-40 -51.66 -35.86 44.03 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.244 -0.91 . . . . 0.0 109.149 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.979 ' O ' HD11 ' A' ' 295' ' ' LEU . 3.3 mm? -76.65 -36.27 57.48 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.24 -0.912 . . . . 0.0 109.066 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 1.008 HD13 ' O ' ' A' ' 290' ' ' LEU . 2.0 tm? -56.43 -29.17 61.27 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.3 -0.875 . . . . 0.0 108.936 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.592 ' O ' ' HE2' ' B' ' 483' ' ' MET . 9.1 mttt -81.68 -18.84 43.08 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.338 -0.851 . . . . 0.0 109.117 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.552 HG22 ' H ' ' A' ' 294' ' ' ASN . 11.3 m -58.82 129.12 85.09 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.158 -0.964 . . . . 0.0 109.412 -179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.624 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.6 Cg_endo -70.46 -10.4 27.92 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.812 2.342 . . . . 0.0 111.83 -179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.669 ' HA ' HD12 ' B' ' 464' ' ' ILE . 32.6 m120 -79.66 4.09 17.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.273 -0.892 . . . . 0.0 109.599 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.979 HD11 ' O ' ' A' ' 289' ' ' LEU . 66.1 mt -84.0 146.99 27.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -111.66 141.6 16.68 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 47.8 tttm -48.74 -50.87 31.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.271 -1.135 . . . . 0.0 109.414 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -70.51 -33.97 71.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.258 -0.901 . . . . 0.0 109.379 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.464 ' O ' HG12 ' A' ' 303' ' ' ILE . 37.4 m -61.98 -40.79 96.81 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.398 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.611 HD21 ' HB3' ' A' ' 295' ' ' LEU . 46.1 mt -52.97 -42.86 65.93 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.303 -0.873 . . . . 0.0 109.31 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 30.7 m -54.72 -50.83 67.37 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.37 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.656 ' O ' HG23 ' A' ' 306' ' ' VAL . 98.3 mt-10 -58.73 -39.23 80.28 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.301 -0.875 . . . . 0.0 109.339 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.798 HG22 HD13 ' A' ' 307' ' ' LEU . 23.9 mm -58.07 -47.32 87.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.325 -0.859 . . . . 0.0 109.376 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 42.3 tttp -60.56 -38.16 83.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.215 -0.928 . . . . 0.0 109.373 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -60.05 -46.4 89.66 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.271 -0.893 . . . . 0.0 109.359 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.954 ' CG1' HD21 ' A' ' 312' ' ' LEU . 2.0 t -70.19 -44.86 77.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.2 -0.937 . . . . 0.0 109.416 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.798 HD13 HG22 ' A' ' 303' ' ' ILE . 6.6 mp -62.78 -27.2 69.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.321 -0.862 . . . . 0.0 109.498 -179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.98 -33.26 70.47 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.91 . . . . 0.0 109.393 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 66.2 p -77.49 -5.04 48.58 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.36 -0.838 . . . . 0.0 109.548 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.959 ' O ' HD21 ' A' ' 314' ' ' LEU . 8.9 mtt85 63.73 10.49 5.14 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.219 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -73.07 -22.23 79.21 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.954 HD21 ' CG1' ' A' ' 306' ' ' VAL . 0.3 OUTLIER -146.64 163.1 36.95 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.231 -1.158 . . . . 0.0 109.379 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.541 ' CB ' ' CD2' ' A' ' 307' ' ' LEU . 0.7 OUTLIER 65.9 28.8 10.6 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 179.813 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.959 HD21 ' O ' ' A' ' 310' ' ' ARG . 93.4 mt -66.34 -14.41 62.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -0.936 . . . . 0.0 109.456 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 82.86 38.24 11.93 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.673 ' HE3' HG21 ' A' ' 282' ' ' VAL . 4.6 ptt? -111.47 162.22 15.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -1.114 . . . . 0.0 109.448 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.542 ' C ' HD12 ' A' ' 318' ' ' LEU . 87.3 mtt-85 -130.76 133.49 46.06 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.92 . . . . 0.0 109.533 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.83 HD21 ' CZ ' ' A' ' 249' ' ' PHE . 4.6 mp -118.3 145.29 45.2 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.214 -0.929 . . . . 0.0 109.46 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -64.79 -34.04 77.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.264 -0.897 . . . . 0.0 109.219 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.485 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 37.8 t-20 -125.94 -71.26 0.7 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.385 -0.822 . . . . 0.0 109.299 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.7 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.7 OUTLIER 167.43 -68.47 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.302 -0.874 . . . . 0.0 109.281 179.714 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.548 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.0 Cg_endo -69.7 107.88 1.94 Allowed 'Trans proline' 0 C--O 1.214 -0.675 0 C-N-CA 122.504 2.136 . . . . 0.0 111.946 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.566 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 51.0 Cg_endo -72.1 158.12 52.86 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.529 2.153 . . . . 0.0 111.573 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -58.6 -15.69 12.61 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.235 -0.916 . . . . 0.0 109.378 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.1 m -68.55 -44.34 74.73 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.232 -0.917 . . . . 0.0 109.494 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.529 HD11 ' HA ' ' A' ' 322' ' ' PRO . 24.5 pt -86.01 -5.97 10.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.523 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.12 -31.56 72.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.23 -0.919 . . . . 0.0 109.435 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 329' ' ' GLU . 58.6 t0 -56.24 -35.86 67.87 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.226 -0.921 . . . . 0.0 109.463 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.45 ' HB3' ' O ' ' A' ' 328' ' ' ASP . 83.8 tt0 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.018 -0.991 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -59.44 -35.44 74.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.231 -1.158 . . . . 0.0 109.491 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.784 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 21.3 m120 -80.25 1.3 29.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.268 -0.895 . . . . 0.0 109.608 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.43 ' CG ' ' HD2' ' B' ' 430' ' ' PRO . 9.8 tttt -51.21 139.92 24.07 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.19 -0.944 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.472 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.07 142.45 46.6 Favored 'Trans proline' 0 C--O 1.216 -0.592 0 C-N-CA 122.65 2.233 . . . . 0.0 111.933 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.535 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.55 150.35 41.55 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -50.34 -36.71 33.31 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 109.493 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -65.26 -46.36 80.82 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.567 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.774 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -67.87 -37.82 82.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.223 -0.923 . . . . 0.0 109.456 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.883 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.7 OUTLIER -69.16 -31.08 69.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.311 -0.868 . . . . 0.0 109.515 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -89.02 9.88 23.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.877 HD22 ' CD1' ' B' ' 456' ' ' LEU . 43.0 tp -72.43 133.56 44.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.267 -0.896 . . . . 0.0 109.428 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -76.87 142.1 40.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.301 -0.875 . . . . 0.0 109.488 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.77 6.57 67.38 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.824 HG21 HD23 ' B' ' 437' ' ' LEU . 57.4 t -127.62 131.38 70.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -83.75 149.04 26.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.213 -0.929 . . . . 0.0 109.502 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.516 ' HG3' ' NH1' ' B' ' 442' ' ' ARG . 9.4 mtt85 -50.02 -45.81 52.27 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.285 -0.884 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -68.09 -39.46 82.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.248 -0.907 . . . . 0.0 109.461 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.04 HD11 ' CD1' ' B' ' 473' ' ' LEU . 15.8 tp -58.88 -37.77 77.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.269 -0.894 . . . . 0.0 109.458 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.526 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -60.7 -42.01 96.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.902 . . . . 0.0 109.456 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.472 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.8 m-85 -64.69 -44.24 90.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.247 -0.908 . . . . 0.0 109.424 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.529 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 13.7 ttmm -58.63 -48.55 80.64 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.298 -0.876 . . . . 0.0 109.42 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.825 HD13 ' O ' ' B' ' 448' ' ' LEU . 3.4 tm? -65.17 -41.24 94.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.835 . . . . 0.0 109.446 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.784 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -57.25 -26.84 61.43 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.68 -20.53 3.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.182 -0.948 . . . . 0.0 109.472 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -89.75 26.59 1.73 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.194 -0.942 . . . . 0.0 109.564 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.88 7.13 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 57.6 t -62.32 135.82 26.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.981 -1.306 . . . . 0.0 109.326 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 69.0 m -135.01 -36.96 0.81 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.175 -0.953 . . . . 0.0 109.63 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.535 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -103.72 146.56 28.42 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.701 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 1.014 ' CD2' HD12 ' B' ' 488' ' ' ILE . 36.4 tp -47.69 -42.81 25.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.385 -0.822 . . . . 0.0 109.234 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 26.2 mm-40 -55.86 -46.53 78.22 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.0 109.041 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -55.78 -41.58 74.29 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.249 -0.907 . . . . 0.0 108.913 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.762 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.3 tm? -57.4 -43.92 84.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.296 -0.877 . . . . 0.0 109.111 179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -59.94 -36.37 76.91 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.222 -0.924 . . . . 0.0 109.326 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.5 tt0 -60.08 -30.13 69.02 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.26 -0.9 . . . . 0.0 109.381 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.424 ' OE1' ' HB3' ' B' ' 466' ' ' ASP . 99.2 mm-40 -75.12 140.76 43.63 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.899 . . . . 0.0 109.442 179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -100.03 163.53 19.29 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.669 HD12 ' HA ' ' A' ' 294' ' ' ASN . 81.3 mt -47.52 -33.96 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.253 -1.145 . . . . 0.0 109.469 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -68.07 -36.28 79.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.287 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.424 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 86.8 m-20 -68.66 -30.61 69.33 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.407 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.982 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.9 mp -82.73 -30.05 29.35 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.328 -0.858 . . . . 0.0 109.445 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.25 -24.09 58.16 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.2 -0.938 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -56.09 -30.5 62.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -0.892 . . . . 0.0 109.532 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.529 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 63.9 mt -104.92 123.99 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 109.484 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -61.74 -31.7 71.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.131 -0.981 . . . . 0.0 109.37 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.456 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -52.13 -32.69 36.23 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.04 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.7 mm? -103.13 138.78 39.51 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.224 -1.162 . . . . 0.0 109.54 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.461 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.7 m -104.04 161.87 13.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.877 . . . . 0.0 109.333 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.461 ' N ' HG22 ' B' ' 474' ' ' THR . 87.5 m-20 -57.45 -38.08 73.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.925 . . . . 0.0 109.385 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -76.81 -45.95 26.77 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -0.936 . . . . 0.0 109.527 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.584 ' HE2' HD22 ' B' ' 444' ' ' LEU . 19.0 tttt -66.14 -47.19 74.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.25 -0.906 . . . . 0.0 109.438 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.982 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -59.24 -46.74 87.69 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.191 -0.943 . . . . 0.0 109.473 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.515 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.18 -49.88 68.77 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.18 -51.35 54.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.186 -1.185 . . . . 0.0 109.481 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.603 HD22 ' CG2' ' B' ' 440' ' ' VAL . 26.4 mt -56.62 -37.6 70.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.188 -0.945 . . . . 0.0 109.392 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.518 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 50.4 mt -63.33 -51.08 75.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.414 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.592 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 23.6 mtp -52.61 -48.41 66.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.12 -0.987 . . . . 0.0 109.442 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -55.71 -55.74 28.72 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.916 . . . . 0.0 109.408 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.623 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -59.46 -47.98 83.41 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.262 -0.899 . . . . 0.0 109.448 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.423 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 75.1 mtt180 -62.8 -40.98 99.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.209 -0.932 . . . . 0.0 109.444 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.565 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.0 m-20 -58.24 -44.93 88.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.291 -0.881 . . . . 0.0 109.598 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 1.014 HD12 ' CD2' ' B' ' 456' ' ' LEU . 57.2 mt -61.6 -37.56 78.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.254 -0.903 . . . . 0.0 109.373 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -76.12 -52.02 10.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.426 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -61.33 -31.59 71.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.882 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.565 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 13.1 m-30 -71.0 -33.69 70.65 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.247 -0.908 . . . . 0.0 109.52 -179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -57.92 -35.93 78.07 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 87.0 m-20 -57.45 -37.42 72.82 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -1.151 . . . . 0.0 109.536 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -102.8 136.64 42.25 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.266 -0.896 . . . . 0.0 109.518 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.509 179.953 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.592 ' HE2' HD22 ' A' ' 318' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.464 ' HB3' HG22 ' A' ' 252' ' ' ILE . 9.9 m-20 -55.95 150.37 29.3 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.276 -0.89 . . . . 0.0 109.575 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -65.56 -25.28 55.16 Favored 'Trans proline' 0 C--O 1.215 -0.641 0 C-N-CA 122.749 2.299 . . . . 0.0 111.643 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.831 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.1 tt -68.6 -27.7 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 O-C-N 121.289 -0.882 . . . . 0.0 109.179 179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.595 HD21 ' HA ' ' A' ' 312' ' ' LEU . 26.8 mt -74.11 -45.24 50.27 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.364 -0.835 . . . . 0.0 109.431 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.916 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.5 OUTLIER -63.88 -34.65 78.43 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.246 -0.909 . . . . 0.0 109.569 -179.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.478 ' HG2' ' HD2' ' A' ' 256' ' ' PRO . 0.2 OUTLIER -55.91 141.74 66.23 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.23 -0.919 . . . . 0.0 109.156 179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.481 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.0 Cg_endo -69.03 133.95 28.24 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.695 2.263 . . . . 0.0 111.742 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.682 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.41 -34.77 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.315 -0.866 . . . . 0.0 109.449 179.907 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.465 ' HB2' ' NZ ' ' A' ' 271' ' ' LYS . 55.3 t0 -59.44 -30.97 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.346 -0.846 . . . . 0.0 109.301 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 m-20 -73.75 -17.12 61.15 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -0.872 . . . . 0.0 109.417 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.682 HD11 HG12 ' A' ' 257' ' ' VAL . 51.5 mt -43.5 144.95 0.67 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.486 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 76.0 mm-40 -63.92 -22.06 66.75 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.233 -0.917 . . . . 0.0 109.533 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 262' ' ' LEU . 5.2 mp -65.56 166.84 9.84 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.406 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.2 p -66.71 166.59 12.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.111 -0.993 . . . . 0.0 109.557 -179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.649 HG12 HD21 ' A' ' 268' ' ' ASN . 6.6 t -57.35 -36.47 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 109.639 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -54.14 -48.65 70.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.196 -0.94 . . . . 0.0 109.324 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 262' ' ' LEU . 95.2 p -57.94 -51.04 71.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.243 -0.911 . . . . 0.0 109.336 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.454 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.62 -42.41 99.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.917 . . . . 0.0 109.422 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.649 HD21 HG12 ' A' ' 264' ' ' VAL . 89.1 m-20 -56.58 -37.44 70.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 0.0 109.322 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 85.4 m -50.37 -60.48 2.95 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.252 -0.905 . . . . 0.0 109.32 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 281' ' ' LEU . 74.0 mt -57.51 -45.06 85.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.248 -0.908 . . . . 0.0 109.376 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 275' ' ' ILE . 82.3 mttt -52.92 -29.91 31.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.316 -0.865 . . . . 0.0 109.359 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.14 -34.32 44.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.23 -0.919 . . . . 0.0 109.51 -179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 45.1 mt-10 -90.53 26.13 2.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.146 -0.971 . . . . 0.0 109.447 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.21 40.91 1.45 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.179 -0.951 . . . . 0.0 109.34 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 22.7 mm -108.14 124.24 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.291 -0.881 . . . . 0.0 109.432 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.575 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -115.83 -37.27 3.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.932 . . . . 0.0 109.37 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.575 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -106.32 133.04 51.64 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.251 -0.906 . . . . 0.0 109.376 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.831 HD12 ' O ' ' A' ' 252' ' ' ILE . 88.7 mt -46.72 -30.36 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.324 -0.86 . . . . 0.0 109.407 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.894 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.34 -48.64 15.85 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.09 -1.604 . . . . 0.0 109.09 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 94.0 m-20 -53.24 -31.27 42.58 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.004 -1.292 . . . . 0.0 108.727 179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.731 HD13 HD13 ' A' ' 270' ' ' LEU . 44.9 tp -55.72 -51.9 65.75 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.33 -0.856 . . . . 0.0 108.887 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.894 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.5 m -64.39 -28.26 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 0.0 108.832 179.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 -59.75 -34.89 73.56 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.344 -0.848 . . . . 0.0 108.903 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.453 ' NH1' ' HG2' ' A' ' 284' ' ' ARG . 18.6 mtt-85 -107.07 144.29 33.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.332 -0.855 . . . . 0.0 109.256 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 11.8 m -68.43 143.4 55.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -0.912 . . . . 0.0 109.559 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.437 ' HA ' HD23 ' A' ' 289' ' ' LEU . 50.4 tp10 -55.62 -30.25 60.6 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.229 -0.919 . . . . 0.0 109.472 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 51.8 t -53.62 -51.61 41.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.231 -0.918 . . . . 0.0 109.492 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -51.91 -33.97 39.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.266 -0.896 . . . . 0.0 109.388 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.2 mm? -74.68 -30.52 61.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -0.871 . . . . 0.0 109.331 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 29.0 tp -67.77 -30.91 70.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.292 -0.88 . . . . 0.0 109.502 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.533 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.73 -12.7 58.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.168 -0.958 . . . . 0.0 109.146 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 23.8 m -79.38 117.67 68.33 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.226 -0.921 . . . . 0.0 109.648 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.952 ' HG2' HD11 ' B' ' 464' ' ' ILE . 48.4 Cg_endo -69.86 -20.43 34.39 Favored 'Trans proline' 0 C--O 1.214 -0.679 0 C-N-CA 122.784 2.322 . . . . 0.0 111.866 179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.449 ' CG ' HD12 ' B' ' 464' ' ' ILE . 53.0 m-80 -48.85 -31.41 7.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.505 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.617 HD21 ' O ' ' A' ' 289' ' ' LEU . 0.5 OUTLIER -105.02 144.63 31.56 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.403 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -85.83 169.23 42.32 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HG2' ' NH2' ' B' ' 486' ' ' ARG . 44.7 mttt -64.92 -40.9 95.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.254 -1.145 . . . . 0.0 109.479 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -59.78 -40.12 87.2 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.281 -0.887 . . . . 0.0 109.4 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.428 ' O ' HG13 ' A' ' 303' ' ' ILE . 24.6 m -57.57 -41.55 81.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.293 -0.88 . . . . 0.0 109.357 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.952 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.2 tm? -54.83 -37.04 65.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.888 . . . . 0.0 109.361 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 27.5 m -55.75 -59.42 4.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.217 -0.927 . . . . 0.0 109.219 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 305' ' ' ASP . 75.2 tt0 -54.92 -44.47 74.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.918 . . . . 0.0 109.161 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.469 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 67.8 mt -57.48 -52.38 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.287 -0.883 . . . . 0.0 108.856 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -53.28 -36.41 61.13 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.312 -0.867 . . . . 0.0 108.675 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.436 ' HB3' ' O ' ' A' ' 302' ' ' GLU . 62.5 t0 -57.46 -48.14 79.98 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.411 -0.806 . . . . 0.0 108.913 179.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.634 HG12 HD22 ' A' ' 312' ' ' LEU . 11.6 t -66.17 -34.81 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.255 -0.903 . . . . 0.0 108.939 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 313' ' ' SER . 21.4 mt -64.23 -26.66 68.6 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.326 -0.859 . . . . 0.0 109.407 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.42 -29.99 66.53 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.233 -0.917 . . . . 0.0 109.117 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.423 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 79.8 p -79.14 -7.94 58.58 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.372 -0.83 . . . . 0.0 109.345 179.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.658 ' O ' HD11 ' A' ' 314' ' ' LEU . 73.6 mtt85 61.76 13.15 5.16 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.278 -0.889 . . . . 0.0 109.076 -179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.508 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -73.03 -36.15 57.17 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.82 HD23 ' H ' ' A' ' 312' ' ' LEU . 2.1 pt? -135.05 159.37 41.72 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.162 -1.199 . . . . 0.0 109.688 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.712 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.2 OUTLIER 61.31 63.23 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.892 . . . . 0.0 109.677 179.832 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.788 ' N ' HD22 ' A' ' 314' ' ' LEU . 3.2 mm? -96.32 12.38 31.31 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.255 -0.903 . . . . 0.0 109.29 179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 62.85 35.65 92.28 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.462 ' CE ' ' CE1' ' A' ' 249' ' ' PHE . 10.9 ptt? -114.36 150.63 34.28 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -1.181 . . . . 0.0 109.549 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 39.3 ttt-85 -109.12 133.34 53.14 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.336 -0.852 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.592 HD22 ' HE2' ' A' ' 249' ' ' PHE . 6.1 mt -106.75 138.48 42.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.898 . . . . 0.0 109.349 179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.69 -47.21 82.98 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.226 -0.921 . . . . 0.0 109.017 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 36.2 t-20 -126.64 -59.04 1.3 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.318 -0.864 . . . . 0.0 108.976 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.916 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.5 t-105 163.4 -65.52 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.355 -0.84 . . . . 0.0 109.283 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.584 ' HA ' HD11 ' A' ' 326' ' ' ILE . 48.4 Cg_endo -69.03 107.67 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.624 2.216 . . . . 0.0 111.923 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.511 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 51.0 Cg_endo -71.31 161.0 47.14 Favored 'Trans proline' 0 C--O 1.215 -0.63 0 C-N-CA 122.591 2.194 . . . . 0.0 111.45 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.2 -15.37 14.6 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.11 -0.994 . . . . 0.0 109.397 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 18.8 t -69.57 -46.42 66.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.246 -0.909 . . . . 0.0 109.593 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.584 HD11 ' HA ' ' A' ' 322' ' ' PRO . 22.2 pt -92.4 4.45 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 109.504 -179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.77 147.48 52.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.28 -0.887 . . . . 0.0 109.559 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 53.4 p30 -82.64 0.27 43.9 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.302 -0.873 . . . . 0.0 109.649 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.492 179.949 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -57.19 -35.69 69.92 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.295 -1.121 . . . . 0.0 109.523 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 31.1 m120 57.38 44.68 21.22 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.232 -0.917 . . . . 0.0 109.463 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.457 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 33.3 tttt -64.52 136.84 96.93 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.0 109.462 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.464 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 50.3 Cg_endo -70.7 139.69 37.52 Favored 'Trans proline' 0 C--O 1.215 -0.668 0 C-N-CA 122.607 2.205 . . . . 0.0 111.694 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 454' ' ' CYS . . . -66.03 156.03 34.95 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 0.0 109.457 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -54.77 -36.99 65.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.241 -0.912 . . . . 0.0 109.417 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -62.63 -48.74 78.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 109.397 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.77 HD13 ' C ' ' B' ' 434' ' ' LEU . 3.0 tm? -65.83 -35.52 80.9 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.371 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.946 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -74.52 -29.99 61.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.266 -0.897 . . . . 0.0 109.422 179.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.9 m-20 -85.34 6.29 27.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.283 -0.886 . . . . 0.0 109.561 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 1.042 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.9 tp -75.42 131.55 40.26 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 0.0 109.444 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -78.28 145.2 35.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.25 -0.906 . . . . 0.0 109.507 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.19 7.5 67.68 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.802 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -124.43 129.5 73.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.262 -1.14 . . . . 0.0 109.414 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -85.13 147.39 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.431 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -50.06 -43.62 51.26 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.225 -0.922 . . . . 0.0 109.516 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.538 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 90.6 m-20 -70.3 -41.06 73.84 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.251 -0.906 . . . . 0.0 109.35 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.966 HD11 ' CD2' ' B' ' 473' ' ' LEU . 10.5 tp -58.49 -46.11 87.37 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.312 -0.867 . . . . 0.0 109.491 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.707 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.26 -39.34 82.57 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -0.879 . . . . 0.0 109.409 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.538 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 15.9 m-30 -60.29 -43.79 95.96 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 0.0 109.475 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 38.6 mttt -62.01 -44.88 95.78 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.222 -0.924 . . . . 0.0 109.437 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.944 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.4 tm? -67.31 -38.08 84.39 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.172 -0.955 . . . . 0.0 109.388 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -66.39 -28.25 68.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.302 -0.874 . . . . 0.0 109.511 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -55.33 -18.92 7.35 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.318 -0.864 . . . . 0.0 109.445 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.445 ' NE ' HD11 ' B' ' 470' ' ' ILE . 33.6 mtt-85 -91.39 30.38 1.3 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.36 -0.837 . . . . 0.0 109.425 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.85 -18.9 6.85 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.628 HG13 ' CB ' ' B' ' 458' ' ' ASP . 46.4 t -61.63 136.07 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.893 -1.357 . . . . 0.0 109.326 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.52 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 9.4 m -135.17 -37.17 0.79 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 0.0 109.614 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.454 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -102.49 147.76 26.36 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 109.795 -179.742 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 1.042 ' CD1' HD22 ' B' ' 437' ' ' LEU . 16.3 tp -47.2 -41.81 18.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.056 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -55.85 -47.27 77.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.317 -0.864 . . . . 0.0 109.028 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.628 ' CB ' HG13 ' B' ' 453' ' ' VAL . 74.8 m-20 -55.14 -44.72 75.35 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.225 -0.922 . . . . 0.0 108.945 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . . . . . . . . . 6.9 tt -53.11 -49.91 65.52 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.31 -0.869 . . . . 0.0 109.231 179.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.801 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -54.54 -39.36 67.61 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.317 -0.864 . . . . 0.0 109.337 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.65 -34.69 67.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.305 -0.872 . . . . 0.0 109.334 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.426 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -63.65 151.77 40.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.298 -0.876 . . . . 0.0 109.389 179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.401 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.25 154.12 16.92 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.952 HD11 ' HG2' ' A' ' 293' ' ' PRO . 60.3 mt -45.09 -40.62 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.199 -1.177 . . . . 0.0 109.228 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.36 -43.06 92.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.287 -0.883 . . . . 0.0 109.296 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' B' ' 469' ' ' ASP . 78.1 m-20 -63.41 -23.79 67.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.0 109.369 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.798 HD22 ' HB1' ' B' ' 478' ' ' ALA . 6.8 mp -93.09 -19.23 21.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.264 -0.898 . . . . 0.0 109.61 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.22 63.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.227 -0.92 . . . . 0.0 109.535 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . 0.476 ' OD1' HG13 ' B' ' 470' ' ' ILE . 18.6 p30 -79.29 3.7 17.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.3 -0.875 . . . . 0.0 109.546 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.698 ' HB ' HD12 ' B' ' 473' ' ' LEU . 36.4 mt -105.53 126.63 60.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.155 -0.965 . . . . 0.0 109.488 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.45 133.33 52.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.182 -0.949 . . . . 0.0 109.48 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.11 -30.16 10.69 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.966 ' CD2' HD11 ' B' ' 444' ' ' LEU . 64.8 mt -88.21 128.72 35.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -1.16 . . . . 0.0 109.575 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.492 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.9 m -104.01 162.15 13.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.215 -0.928 . . . . 0.0 109.488 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.492 ' N ' HG22 ' B' ' 474' ' ' THR . 86.7 m-20 -58.97 -36.76 75.38 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.491 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -76.95 -43.32 35.71 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.164 -0.96 . . . . 0.0 109.567 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.638 ' O ' HD13 ' B' ' 481' ' ' LEU . 76.6 tttt -61.58 -47.58 84.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.252 -0.905 . . . . 0.0 109.54 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.798 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.66 -40.84 97.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.508 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.482 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.73 -38.08 95.34 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.53 -37.27 77.03 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.133 -1.216 . . . . 0.0 109.402 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.638 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.6 mp -68.81 -27.05 65.51 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.241 -0.912 . . . . 0.0 109.474 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.857 HD12 ' HB2' ' A' ' 293' ' ' PRO . 52.3 mt -77.08 -56.5 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.951 . . . . 0.0 109.463 179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.533 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 60.2 mtp -52.81 -38.3 61.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.306 -0.871 . . . . 0.0 109.338 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -65.95 -55.83 14.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.243 -0.911 . . . . 0.0 109.317 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.401 ' HB3' ' HB2' ' B' ' 460' ' ' ALA . . . -61.35 -45.96 92.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.252 -0.905 . . . . 0.0 109.314 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.801 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 42.2 mtp180 -57.42 -45.67 84.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.251 -0.906 . . . . 0.0 109.48 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 91.3 m-20 -57.96 -37.13 73.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.282 -0.886 . . . . 0.0 109.382 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.903 HD12 ' CD2' ' B' ' 456' ' ' LEU . 63.6 mt -68.88 -36.99 76.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.217 -0.927 . . . . 0.0 109.36 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 18.0 t -75.52 -50.37 15.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.397 -0.814 . . . . 0.0 109.561 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.4 m95 -65.47 -43.51 90.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.917 . . . . 0.0 109.601 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.452 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 98.7 m-85 -95.46 12.41 29.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.414 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . -71.56 135.41 23.51 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -51.54 -38.97 56.74 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.177 -1.19 . . . . 0.0 109.436 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.78 -34.21 72.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.251 -0.906 . . . . 0.0 109.511 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.528 179.937 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.92 ' CE2' HD21 ' A' ' 318' ' ' LEU . 34.0 m-85 . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.436 ' HB2' HG22 ' A' ' 252' ' ' ILE . 4.1 m-20 -56.62 151.14 32.02 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.23 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.634 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.04 -24.13 60.27 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.455 2.103 . . . . 0.0 111.72 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.642 ' O ' HD12 ' A' ' 278' ' ' ILE . 15.9 tt -58.94 -32.42 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.892 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.3 mp -74.26 -35.39 63.8 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.342 -0.849 . . . . 0.0 108.942 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.709 HD11 HD12 ' A' ' 326' ' ' ILE . 2.6 mm? -72.2 -20.07 61.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.453 -0.779 . . . . 0.0 109.189 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -78.08 144.33 67.28 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 49.5 Cg_endo -69.61 139.16 40.05 Favored 'Trans proline' 0 C--O 1.215 -0.666 0 C-N-CA 122.809 2.34 . . . . 0.0 111.907 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.503 ' HA ' ' CD1' ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.34 -34.78 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.258 -0.901 . . . . 0.0 109.294 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -61.78 -30.79 71.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.35 -0.844 . . . . 0.0 109.387 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.434 ' N ' ' O ' ' A' ' 256' ' ' PRO . 55.3 m-20 -76.95 -9.74 58.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.265 -0.897 . . . . 0.0 109.407 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.855 HD21 HD13 ' A' ' 278' ' ' ILE . 74.3 mt -57.32 144.91 34.02 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.295 -0.878 . . . . 0.0 109.5 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 82.3 tt0 -60.92 -18.93 59.58 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.336 -0.852 . . . . 0.0 109.565 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.68 HD11 HG21 ' A' ' 306' ' ' VAL . 6.7 mp -64.49 169.69 4.59 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.435 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.5 p -75.45 164.25 26.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.243 -0.911 . . . . 0.0 109.629 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.536 HG12 ' ND2' ' A' ' 268' ' ' ASN . 14.1 t -52.65 -27.48 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.343 -0.848 . . . . 0.0 109.645 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.0 mtt180 -59.82 -41.91 92.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.055 -1.028 . . . . 0.0 109.15 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.529 ' OG ' HD22 ' A' ' 262' ' ' LEU . 26.4 t -60.66 -50.42 73.59 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.424 179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -66.11 -36.56 83.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.942 . . . . 0.0 109.296 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.536 ' ND2' HG12 ' A' ' 264' ' ' VAL . 94.8 m-20 -58.74 -40.1 82.85 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.424 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 73.3 m -52.08 -65.12 0.61 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.207 -0.933 . . . . 0.0 109.347 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 1.012 HD21 HD12 ' A' ' 281' ' ' LEU . 6.6 mp -65.24 -42.36 93.42 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.19 -0.944 . . . . 0.0 109.283 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.564 ' HE2' ' CE1' ' A' ' 276' ' ' HIS . 50.3 tttm -52.79 -40.11 62.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.329 -0.857 . . . . 0.0 109.514 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.26 -26.69 12.5 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.248 -0.907 . . . . 0.0 109.506 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.633 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.5 mt-10 -91.85 20.63 5.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.633 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 37.42 0.99 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.263 -0.898 . . . . 0.0 109.542 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.627 HG23 ' HB2' ' A' ' 280' ' ' ASP . 77.7 mt -124.01 107.88 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.533 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.564 ' CE1' ' HE2' ' A' ' 271' ' ' LYS . 61.5 m-70 -107.37 -4.85 18.16 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.1 m-85 -112.94 133.55 54.86 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.176 -0.953 . . . . 0.0 109.42 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.855 HD13 HD21 ' A' ' 260' ' ' LEU . 50.7 mt -62.1 -30.99 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.295 -0.878 . . . . 0.0 109.191 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.974 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -48.62 -45.82 30.3 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.627 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.0 m-20 -53.61 -36.54 62.09 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.306 -1.114 . . . . 0.0 109.153 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 1.079 HD22 HD11 ' A' ' 312' ' ' LEU . 4.3 tt -53.15 -49.12 67.24 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.182 -0.948 . . . . 0.0 108.953 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.974 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.4 m -67.46 -22.97 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.285 -0.884 . . . . 0.0 109.114 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.5 tt0 -65.82 -33.33 75.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.366 -0.834 . . . . 0.0 109.002 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 48.5 mtt-85 -105.29 143.51 33.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.434 -0.791 . . . . 0.0 109.044 179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 9.9 m -59.99 138.04 57.94 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.405 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.412 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 85.2 tt0 -55.64 -29.53 59.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.216 -0.928 . . . . 0.0 109.37 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -53.32 -50.51 47.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.33 -0.856 . . . . 0.0 109.441 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -51.72 -37.54 51.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.236 -0.915 . . . . 0.0 109.259 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.695 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -69.72 -37.66 76.61 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.25 -0.906 . . . . 0.0 109.22 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.702 ' CD1' HD22 ' A' ' 300' ' ' LEU . 37.3 tp -64.4 -26.27 68.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.368 -0.832 . . . . 0.0 109.307 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.458 ' O ' ' HE2' ' B' ' 483' ' ' MET . 35.8 mttm -93.01 25.9 3.03 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.261 -0.899 . . . . 0.0 109.604 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.541 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -114.21 134.84 22.16 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.163 -0.96 . . . . 0.0 109.487 179.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.989 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.3 Cg_endo -71.92 -24.33 21.08 Favored 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.839 2.36 . . . . 0.0 112.018 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.415 ' OD1' HD12 ' B' ' 464' ' ' ILE . 75.7 m-80 -57.79 -28.69 64.22 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.193 -0.942 . . . . 0.0 109.638 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.831 HD12 ' N ' ' A' ' 295' ' ' LEU . 5.0 mp -94.54 125.4 39.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.132 -0.98 . . . . 0.0 109.659 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.9 171.5 32.96 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.454 ' HE3' ' OE2' ' B' ' 461' ' ' GLU . 24.8 mttm -51.89 -36.71 49.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.277 -1.131 . . . . 0.0 109.562 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -75.01 -38.57 61.53 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.228 -0.92 . . . . 0.0 109.592 -179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 38.4 m -57.61 -49.06 77.66 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.974 . . . . 0.0 109.413 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.702 HD22 ' CD1' ' A' ' 290' ' ' LEU . 23.9 tp -52.81 -42.87 65.49 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.182 -0.949 . . . . 0.0 109.264 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 56.9 m -52.45 -53.51 44.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.267 -0.895 . . . . 0.0 109.263 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.558 ' O ' HG23 ' A' ' 306' ' ' VAL . 96.8 mt-10 -54.07 -39.69 66.5 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.189 -0.944 . . . . 0.0 109.069 179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.781 HD11 HD23 ' A' ' 295' ' ' LEU . 76.5 mt -58.47 -43.22 86.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.322 -0.861 . . . . 0.0 109.117 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 20.4 tttt -60.73 -41.51 95.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.264 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -58.28 -47.13 84.6 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.205 -0.935 . . . . 0.0 109.225 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.68 HG21 HD11 ' A' ' 262' ' ' LEU . 2.2 t -73.28 -37.27 51.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.269 -0.894 . . . . 0.0 109.293 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.565 HD11 ' OG ' ' A' ' 313' ' ' SER . 0.1 OUTLIER -60.95 -26.41 67.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.244 -0.91 . . . . 0.0 109.429 179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . 0.489 ' O ' ' HG3' ' A' ' 310' ' ' ARG . . . -58.22 -32.06 67.94 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.346 -0.846 . . . . 0.0 109.574 -179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -60.55 -13.99 17.28 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.365 -0.835 . . . . 0.0 109.843 -179.503 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.783 ' C ' HD21 ' A' ' 314' ' ' LEU . 75.0 mtm-85 63.67 9.83 4.62 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.277 -0.889 . . . . 0.0 109.732 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.892 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -113.08 -7.65 21.09 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.079 HD11 HD22 ' A' ' 281' ' ' LEU . 7.9 tp -127.04 130.68 50.43 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.188 -1.183 . . . . 0.0 109.335 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.738 ' H ' HG12 ' A' ' 282' ' ' VAL . 12.8 t 68.84 56.55 0.42 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.346 -0.846 . . . . 0.0 109.764 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.783 HD21 ' C ' ' A' ' 310' ' ' ARG . 11.2 mt -105.66 21.57 17.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.916 . . . . 0.0 109.149 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 58.97 39.82 94.65 Favored Glycine 0 N--CA 1.489 2.188 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.564 ' CE ' HD21 ' A' ' 253' ' ' LEU . 3.1 mtm -86.79 170.08 12.03 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -1.147 . . . . 0.0 109.566 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.715 ' C ' HD12 ' A' ' 318' ' ' LEU . 40.6 mtt85 -143.28 126.24 16.27 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.92 HD21 ' CE2' ' A' ' 249' ' ' PHE . 4.0 mp -124.3 134.0 53.31 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.156 -0.965 . . . . 0.0 109.708 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -62.9 -39.89 95.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.912 . . . . 0.0 108.988 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.464 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 78.4 m-20 -119.1 -75.3 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.385 -0.822 . . . . 0.0 109.127 179.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.682 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 1.1 t-105 168.73 -58.3 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.885 . . . . 0.0 109.496 179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.0 Cg_endo -68.49 107.49 1.63 Allowed 'Trans proline' 0 C--O 1.215 -0.649 0 C-N-CA 122.654 2.236 . . . . 0.0 112.001 -179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 1.036 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.0 Cg_endo -71.26 165.08 33.56 Favored 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.609 2.206 . . . . 0.0 111.592 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.07 -23.35 67.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.235 -0.915 . . . . 0.0 109.486 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 27.0 t -77.09 -38.36 52.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.274 -0.891 . . . . 0.0 109.584 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 1.036 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.0 tt -58.67 -21.14 18.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.268 -0.895 . . . . 0.0 109.534 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -70.48 -28.4 64.96 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.944 . . . . 0.0 109.544 -179.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -54.56 -36.33 64.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.267 -0.895 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 117.925 -1.036 . . . . 0.0 109.488 179.988 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -54.15 -36.22 63.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.278 -1.131 . . . . 0.0 109.51 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.407 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.6 m120 58.05 44.69 19.01 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.208 -0.932 . . . . 0.0 109.44 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.06 128.91 50.05 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.888 . . . . 0.0 109.554 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.54 ' HD3' ' CD1' ' B' ' 446' ' ' PHE . 50.1 Cg_endo -70.71 136.53 30.69 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.593 2.195 . . . . 0.0 111.728 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.561 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -64.15 153.05 38.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -0.917 . . . . 0.0 109.475 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -55.09 -36.91 66.15 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -63.69 -44.91 92.31 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 0.0 109.352 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.83 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -69.97 -37.12 75.68 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.29 -0.881 . . . . 0.0 109.385 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.979 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.3 tm? -70.21 -33.17 71.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.264 -0.898 . . . . 0.0 109.588 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -90.17 8.3 33.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.268 -0.895 . . . . 0.0 109.646 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.822 HD22 ' CD1' ' B' ' 456' ' ' LEU . 25.5 tp -73.6 136.25 43.93 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.219 -0.925 . . . . 0.0 109.52 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 -77.2 145.05 37.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.282 -0.886 . . . . 0.0 109.517 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.89 -6.06 73.02 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.566 HG22 ' CD2' ' B' ' 481' ' ' LEU . 61.7 t -121.78 135.68 61.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.137 -1.214 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.614 ' H ' HD12 ' B' ' 444' ' ' LEU . 73.1 m-20 -91.04 152.84 20.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.26 -0.9 . . . . 0.0 109.349 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.595 ' HG2' HD11 ' B' ' 435' ' ' LEU . 96.5 mtt180 -49.85 -38.66 36.16 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.252 -0.905 . . . . 0.0 109.353 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -68.63 -40.68 80.21 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.318 -0.863 . . . . 0.0 109.439 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.614 HD12 ' H ' ' B' ' 441' ' ' ASP . 20.1 mt -64.61 -34.65 78.76 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.272 -0.893 . . . . 0.0 109.394 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.99 -49.88 76.2 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.23 -0.919 . . . . 0.0 109.283 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.54 ' CD1' ' HD3' ' B' ' 430' ' ' PRO . 77.1 m-85 -62.91 -44.05 97.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.87 . . . . 0.0 109.168 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.639 ' HD2' HD21 ' B' ' 473' ' ' LEU . 7.1 ttmm -55.03 -37.84 67.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.835 . . . . 0.0 109.354 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 459' ' ' LEU . 85.2 mt -69.16 -39.92 78.47 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.444 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.504 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -59.24 -33.05 70.55 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -0.891 . . . . 0.0 109.411 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.58 -35.75 6.17 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.219 -0.926 . . . . 0.0 109.421 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.696 ' CG ' HD11 ' B' ' 470' ' ' ILE . 9.5 mtp85 -90.12 21.47 3.72 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.303 -0.873 . . . . 0.0 109.502 179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.72 7.0 Favored Glycine 0 N--CA 1.493 2.441 0 N-CA-C 110.36 -1.096 . . . . 0.0 110.36 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 1.047 HG21 ' HG3' ' B' ' 462' ' ' GLN . 4.9 t -81.8 112.15 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 120.915 -1.344 . . . . 0.0 109.488 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.514 ' HB2' ' HA ' ' B' ' 430' ' ' PRO . 3.8 p -128.04 -42.17 1.57 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.206 -0.934 . . . . 0.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.1 OUTLIER -74.22 144.83 44.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.261 -0.899 . . . . 0.0 109.483 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.888 HD21 HD12 ' B' ' 488' ' ' ILE . 36.8 tp -48.87 -45.44 41.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.22 -0.925 . . . . 0.0 109.402 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.87 -45.87 78.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.224 -0.923 . . . . 0.0 109.216 179.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.756 ' HB3' HG13 ' B' ' 453' ' ' VAL . 89.5 m-20 -56.55 -40.3 74.91 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.333 -0.855 . . . . 0.0 109.275 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.744 HD13 HD13 ' B' ' 448' ' ' LEU . 20.5 tp -60.1 -43.59 95.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.262 -0.899 . . . . 0.0 109.287 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.46 -33.1 72.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.239 -0.913 . . . . 0.0 109.282 179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . 0.454 ' OE2' ' HE3' ' A' ' 297' ' ' LYS . 72.5 mm-40 -68.09 -31.05 70.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.315 -0.866 . . . . 0.0 109.43 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 1.047 ' HG3' HG21 ' B' ' 453' ' ' VAL . 99.3 mm-40 -78.0 136.86 38.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 109.51 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -98.13 160.1 20.71 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.989 HD11 ' HG2' ' A' ' 293' ' ' PRO . 65.0 mt -44.04 -39.67 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.284 -1.127 . . . . 0.0 109.432 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.98 -36.53 81.76 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.249 -0.907 . . . . 0.0 109.279 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.446 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 85.7 m-20 -70.51 -28.59 65.08 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.273 -0.892 . . . . 0.0 109.302 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.986 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -82.0 -28.27 32.69 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.902 . . . . 0.0 109.462 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.37 -22.65 65.15 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.359 -0.838 . . . . 0.0 109.331 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -56.99 -31.02 64.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.426 -0.796 . . . . 0.0 109.363 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.696 HD11 ' CG ' ' B' ' 451' ' ' ARG . 59.6 mt -103.22 118.28 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.206 -0.934 . . . . 0.0 109.436 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -54.72 -31.01 57.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.427 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.54 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -53.83 -32.4 48.03 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.814 HD22 ' N ' ' B' ' 473' ' ' LEU . 2.8 mm? -107.58 138.03 44.54 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.26 -1.141 . . . . 0.0 109.561 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.495 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.4 m -104.04 165.08 11.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.281 -0.887 . . . . 0.0 109.385 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.495 ' N ' HG22 ' B' ' 474' ' ' THR . 91.5 m-20 -59.09 -38.46 79.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.304 -0.872 . . . . 0.0 109.487 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -75.79 -46.12 32.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.223 -0.923 . . . . 0.0 109.531 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.572 ' O ' HD13 ' B' ' 481' ' ' LEU . 20.8 tttt -63.2 -48.01 80.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.417 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.986 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -60.22 -36.44 77.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.265 -0.897 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.52 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.76 -44.13 97.94 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.533 -1.427 . . . . 0.0 109.533 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.26 86.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.247 -1.149 . . . . 0.0 109.541 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.734 ' HB3' HD21 ' B' ' 459' ' ' LEU . 7.2 mp -69.17 -34.11 74.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.226 -0.921 . . . . 0.0 109.797 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.487 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 62.4 mt -69.49 -56.48 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.657 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.529 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 40.9 mmm -54.53 -38.79 66.99 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.002 -1.061 . . . . 0.0 109.465 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.462 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -62.14 -54.16 45.12 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.213 -0.929 . . . . 0.0 109.412 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -63.82 -42.41 97.66 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.251 -0.906 . . . . 0.0 109.431 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -57.53 -44.09 84.87 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.235 -0.915 . . . . 0.0 109.484 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -64.44 -36.62 84.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.211 -0.93 . . . . 0.0 109.466 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.888 HD12 HD21 ' B' ' 456' ' ' LEU . 65.9 mt -66.72 -37.15 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.183 -0.948 . . . . 0.0 109.474 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 4.8 m -73.22 -51.22 18.53 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.197 -0.939 . . . . 0.0 109.481 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -66.61 -33.33 75.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.273 -0.892 . . . . 0.0 109.508 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 14.9 m-30 -98.19 10.53 40.35 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.291 -0.88 . . . . 0.0 109.504 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -61.31 -25.64 65.08 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -54.78 -36.55 65.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.283 -1.128 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . 0.563 ' O ' ' HB3' ' B' ' 495' ' ' ALA . 75.8 mm-40 -90.66 147.76 23.07 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 0.0 109.447 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . 0.563 ' HB3' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.473 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.77 ' CE2' HD21 ' A' ' 318' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.411 ' HB3' HG22 ' A' ' 252' ' ' ILE . 44.7 m-20 -67.29 133.58 93.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.433 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -65.55 -26.18 54.57 Favored 'Trans proline' 0 C--O 1.215 -0.634 0 C-N-CA 122.782 2.321 . . . . 0.0 111.467 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 1.035 HD13 HD22 ' A' ' 312' ' ' LEU . 14.5 tt -66.65 -25.57 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 109.225 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.82 HD21 ' HA ' ' A' ' 312' ' ' LEU . 44.7 mt -74.23 -45.41 48.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.253 -0.904 . . . . 0.0 109.573 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.915 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 1.2 mm? -66.85 -26.84 67.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.547 -179.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -68.16 143.66 96.14 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.167 -0.958 . . . . 0.0 109.147 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.457 ' O ' ' N ' ' A' ' 259' ' ' ASP . 48.4 Cg_endo -69.07 132.77 25.16 Favored 'Trans proline' 0 C--O 1.216 -0.623 0 C-N-CA 122.63 2.22 . . . . 0.0 111.757 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.423 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.1 OUTLIER -43.68 -32.61 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.276 -0.89 . . . . 0.0 109.357 -179.881 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.31 -31.07 71.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 0.0 109.354 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.457 ' N ' ' O ' ' A' ' 256' ' ' PRO . 33.0 m-20 -70.52 -14.46 62.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 257' ' ' VAL . 53.3 mt -48.16 138.0 10.02 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.321 -0.862 . . . . 0.0 109.436 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -64.33 -15.06 59.61 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.462 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 262' ' ' LEU . 6.9 mp -69.8 173.15 6.58 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.28 -0.887 . . . . 0.0 109.493 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.8 p -66.86 162.15 22.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.276 -0.89 . . . . 0.0 109.515 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.638 HG12 ' ND2' ' A' ' 268' ' ' ASN . 21.2 t -60.79 -23.92 30.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.317 -0.864 . . . . 0.0 109.591 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 9.5 mtt180 -62.01 -44.28 97.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.186 -0.947 . . . . 0.0 109.274 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.0 m -59.32 -48.78 80.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.292 -0.88 . . . . 0.0 109.316 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.23 -39.55 86.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.284 -0.885 . . . . 0.0 109.293 179.834 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.638 ' ND2' HG12 ' A' ' 264' ' ' VAL . 91.7 m-20 -56.8 -37.22 70.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.238 -0.914 . . . . 0.0 109.272 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 25.2 m -53.33 -64.77 0.72 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.315 -0.866 . . . . 0.0 109.386 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.784 HD21 HD11 ' A' ' 289' ' ' LEU . 78.8 mt -60.37 -45.13 94.59 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.22 -0.925 . . . . 0.0 109.323 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.471 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 64.9 tttm -52.86 -35.76 58.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.276 -0.89 . . . . 0.0 109.442 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.06 -20.42 6.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.307 -0.871 . . . . 0.0 109.35 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.4 mt-10 -94.8 23.84 5.17 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.31 -0.869 . . . . 0.0 109.468 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.56 37.32 1.97 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.256 -0.903 . . . . 0.0 109.431 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.728 HG23 ' HB2' ' A' ' 280' ' ' ASP . 82.6 mt -115.54 128.19 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.246 -0.909 . . . . 0.0 109.492 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.609 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 6.8 p80 -116.34 -27.43 6.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.609 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.4 m-85 -110.55 137.07 48.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.897 HD12 ' O ' ' A' ' 252' ' ' ILE . 90.8 mt -55.47 -29.78 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.523 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.88 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.89 -46.7 14.27 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.057 -1.617 . . . . 0.0 109.057 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.728 ' HB2' HG23 ' A' ' 275' ' ' ILE . 78.0 m-20 -53.58 -31.3 46.2 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.041 -1.27 . . . . 0.0 108.688 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.714 HD13 HD13 ' A' ' 270' ' ' LEU . 43.4 tp -57.07 -50.75 71.79 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.498 -0.751 . . . . 0.0 109.13 179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.88 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.9 m -64.7 -29.33 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 108.912 179.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -59.45 -35.86 74.85 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.316 -0.865 . . . . 0.0 108.723 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 86.2 mtt-85 -98.95 150.03 22.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.46 -0.775 . . . . 0.0 109.084 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.499 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.5 m -79.5 142.42 35.83 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.464 ' CD ' ' CD1' ' A' ' 307' ' ' LEU . 82.8 tt0 -55.63 -27.6 50.66 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.306 -0.871 . . . . 0.0 109.656 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.499 ' H ' HG22 ' A' ' 285' ' ' THR . 47.8 t -52.74 -55.5 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.075 -1.016 . . . . 0.0 109.266 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -61.12 -30.69 70.52 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.158 -0.964 . . . . 0.0 108.645 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.784 HD11 HD21 ' A' ' 270' ' ' LEU . 20.1 tp -61.95 -37.33 84.34 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.509 -0.744 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 4.9 mt -78.01 -23.33 48.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.33 -0.856 . . . . 0.0 109.217 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.552 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 48.5 mttm -81.62 -17.11 49.33 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.338 -0.851 . . . . 0.0 109.349 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.518 ' HB ' HD13 ' A' ' 295' ' ' LEU . 2.1 m -73.46 117.29 59.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.196 -0.94 . . . . 0.0 109.549 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.946 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.9 Cg_endo -71.07 -20.5 28.65 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.68 2.253 . . . . 0.0 111.865 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.635 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.9 m120 -52.89 -20.43 3.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.227 -0.921 . . . . 0.0 109.535 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.869 ' HB2' HD21 ' A' ' 300' ' ' LEU . 2.4 mp -101.98 132.59 47.72 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.2 -0.937 . . . . 0.0 109.582 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -76.68 157.64 47.73 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.515 ' CE ' ' HA ' ' B' ' 461' ' ' GLU . 23.6 mttm -49.66 -39.33 35.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.213 -1.169 . . . . 0.0 109.396 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 13.6 mtpt -71.46 -38.61 71.28 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.189 -0.944 . . . . 0.0 109.339 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 30.2 m -61.88 -47.4 85.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.243 -0.911 . . . . 0.0 109.378 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.869 HD21 ' HB2' ' A' ' 295' ' ' LEU . 77.7 mt -53.01 -42.82 66.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.195 -0.94 . . . . 0.0 109.255 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 44.4 m -52.99 -51.73 60.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -0.909 . . . . 0.0 109.327 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.707 ' O ' HG23 ' A' ' 306' ' ' VAL . 94.0 mt-10 -55.78 -39.76 71.7 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.308 -0.87 . . . . 0.0 109.317 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.475 HG21 HD21 ' A' ' 289' ' ' LEU . 33.5 mm -58.03 -48.94 82.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.259 -0.901 . . . . 0.0 109.236 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.1 tttt -56.69 -41.45 77.38 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 109.321 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -58.58 -45.88 88.11 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.275 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.719 HG12 ' CD1' ' A' ' 312' ' ' LEU . 2.2 t -62.0 -38.28 80.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.19 -0.944 . . . . 0.0 109.103 179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.808 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.5 mt -54.63 -25.44 26.77 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.362 -0.836 . . . . 0.0 109.416 179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.41 -39.18 75.62 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.297 -0.877 . . . . 0.0 109.416 -179.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.25 -20.71 2.83 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.309 -0.869 . . . . 0.0 109.404 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.417 ' O ' ' HG3' ' A' ' 310' ' ' ARG . 21.0 tpt180 64.9 10.23 6.0 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.268 -0.895 . . . . 0.0 109.473 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.637 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -106.8 -0.92 36.61 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.035 HD22 HD13 ' A' ' 252' ' ' ILE . 0.5 OUTLIER -138.45 148.55 44.52 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.212 -1.169 . . . . 0.0 109.565 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.808 ' HB3' HD22 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 51.21 64.5 1.82 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.287 -0.883 . . . . 0.0 109.589 179.861 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.45 9.24 43.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.309 -0.869 . . . . 0.0 109.357 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 71.97 31.0 64.84 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.486 ' HE1' HD11 ' A' ' 253' ' ' LEU . 12.7 ptt? -114.08 150.22 34.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.178 -1.19 . . . . 0.0 109.45 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.583 ' C ' HD12 ' A' ' 318' ' ' LEU . 72.0 mtt85 -124.63 143.17 50.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.32 -0.863 . . . . 0.0 109.494 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.847 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.4 mp -118.83 140.57 49.74 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.23 -0.919 . . . . 0.0 109.629 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -57.75 -40.23 79.23 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.202 -0.936 . . . . 0.0 108.939 179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.471 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 38.7 t-20 -122.08 -71.46 0.73 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.082 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.915 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 1.4 t-105 167.59 -57.57 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.0 109.617 179.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 47.2 Cg_endo -67.8 107.89 1.57 Allowed 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.633 2.222 . . . . 0.0 112.069 -179.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.996 ' O ' HG22 ' A' ' 326' ' ' ILE . 54.3 Cg_endo -73.49 164.86 33.92 Favored 'Trans proline' 0 C--O 1.214 -0.686 0 C-N-CA 122.721 2.281 . . . . 0.0 111.684 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.24 -22.09 66.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.338 -0.851 . . . . 0.0 109.445 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 44.6 m -76.46 -38.58 55.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.877 . . . . 0.0 109.495 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.996 HG22 ' O ' ' A' ' 323' ' ' PRO . 19.2 tt -58.49 -20.66 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -64.14 145.92 55.13 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.31 -0.869 . . . . 0.0 109.465 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 329' ' ' GLU . 91.2 m-20 -57.9 -38.84 76.56 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -0.847 . . . . 0.0 109.471 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 328' ' ' ASP . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.493 179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . 0.414 ' N ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -58.85 -35.97 73.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.262 -1.14 . . . . 0.0 109.474 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.515 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 28.4 m120 -87.31 8.93 22.12 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.637 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.414 ' HB2' ' N ' ' B' ' 426' ' ' GLY . 0.7 OUTLIER -55.75 132.38 72.42 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.149 -0.969 . . . . 0.0 109.376 179.911 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.86 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.01 141.05 43.21 Favored 'Trans proline' 0 C--O 1.215 -0.639 0 C-N-CA 122.62 2.214 . . . . 0.0 111.715 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.624 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.3 156.38 35.65 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.921 . . . . 0.0 109.566 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . 0.424 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.2 m-20 -47.24 -38.56 12.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.301 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . 0.469 ' HB3' ' HB3' ' B' ' 456' ' ' LEU . 51.3 m-20 -60.49 -48.47 81.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 109.179 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.86 HD23 ' HB3' ' B' ' 430' ' ' PRO . 25.5 tp -68.18 -37.89 81.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.333 -0.854 . . . . 0.0 109.556 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.884 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.6 OUTLIER -76.85 -28.86 55.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.199 -0.938 . . . . 0.0 109.428 -179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' B' ' 432' ' ' ASP . 36.8 t-20 -90.32 10.27 25.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.442 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.835 HD23 HG21 ' B' ' 440' ' ' VAL . 41.9 tp -78.31 129.88 35.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -78.19 146.1 35.19 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.215 -0.928 . . . . 0.0 109.455 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.33 7.97 72.03 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.835 HG21 HD23 ' B' ' 437' ' ' LEU . 77.7 t -124.6 129.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.172 -1.193 . . . . 0.0 109.458 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -83.34 147.25 28.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 86.2 mtt180 -50.01 -40.81 45.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.932 . . . . 0.0 109.397 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.464 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.9 m-20 -72.44 -40.55 66.98 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.25 -0.906 . . . . 0.0 109.416 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.706 HD11 HD13 ' B' ' 473' ' ' LEU . 23.1 tp -59.72 -42.28 92.74 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.263 -0.898 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -60.13 -37.72 80.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.357 -0.839 . . . . 0.0 109.38 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.464 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 11.7 m-30 -65.35 -41.58 93.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.256 -0.902 . . . . 0.0 109.481 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 63.9 mttp -61.46 -51.21 69.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.223 -0.923 . . . . 0.0 109.449 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.798 HD13 HD11 ' B' ' 459' ' ' LEU . 3.9 tt -62.23 -43.14 99.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.417 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.515 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -58.24 -31.31 67.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.238 -0.913 . . . . 0.0 109.378 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -59.75 -17.17 33.01 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 109.363 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 9.5 mtp85 -89.32 33.26 0.82 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.31 -0.868 . . . . 0.0 109.423 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.54 -18.97 7.66 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 110.154 -1.178 . . . . 0.0 110.154 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.574 HG13 ' HB3' ' B' ' 458' ' ' ASP . 61.4 t -64.17 135.5 27.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.022 -1.281 . . . . 0.0 109.34 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.479 ' O ' ' N ' ' B' ' 431' ' ' ALA . 0.8 OUTLIER -131.82 -33.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.804 -179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.624 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.6 OUTLIER -115.1 142.14 47.05 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.163 -0.961 . . . . 0.0 109.733 -179.842 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.806 HD11 ' HA ' ' B' ' 485' ' ' ALA . 2.0 tm? -45.42 -39.47 7.06 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.367 -0.833 . . . . 0.0 108.867 179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -56.0 -48.2 76.34 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.205 -0.934 . . . . 0.0 108.653 179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.574 ' HB3' HG13 ' B' ' 453' ' ' VAL . 28.9 t0 -54.26 -42.77 70.33 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.334 -0.853 . . . . 0.0 108.72 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.798 HD11 HD13 ' B' ' 448' ' ' LEU . 5.1 tt -53.7 -48.91 69.1 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.385 -0.822 . . . . 0.0 109.018 179.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.897 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -56.03 -35.62 67.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.423 -0.798 . . . . 0.0 109.167 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . 0.515 ' HA ' ' CE ' ' A' ' 297' ' ' LYS . 96.7 mt-10 -67.21 -28.34 68.0 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.316 -0.865 . . . . 0.0 109.357 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 93.9 mm-40 -63.78 164.87 9.3 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.299 -0.876 . . . . 0.0 109.614 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -119.26 154.07 16.61 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.946 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.9 mt -52.33 -34.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.203 -1.174 . . . . 0.0 109.519 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 51.6 t0 -69.15 -34.28 74.74 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.252 -0.905 . . . . 0.0 109.482 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -73.52 -31.92 63.96 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.221 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.011 HD12 ' HB1' ' B' ' 478' ' ' ALA . 34.6 mt -74.94 -34.86 62.15 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.29 -0.881 . . . . 0.0 109.333 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -54.92 -21.52 11.89 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.354 -0.841 . . . . 0.0 109.545 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -50.19 -36.97 32.82 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.522 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . . . . . . . . . 62.9 mt -97.2 125.25 50.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.266 -0.896 . . . . 0.0 109.542 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -62.24 -35.61 79.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.256 -0.903 . . . . 0.0 109.446 179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -50.25 -33.14 22.75 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.976 HD23 ' HB3' ' B' ' 467' ' ' LEU . 10.9 tp -99.17 141.7 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.558 -179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.554 HG22 ' N ' ' B' ' 475' ' ' ASP . 89.0 m -104.15 164.79 11.48 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.285 -0.884 . . . . 0.0 109.446 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.554 ' N ' HG22 ' B' ' 474' ' ' THR . 92.3 m-20 -56.5 -40.11 74.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.283 -0.886 . . . . 0.0 109.564 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 8.3 mt-10 -75.4 -46.25 34.04 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -0.902 . . . . 0.0 109.609 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.469 ' HE3' HD22 ' B' ' 444' ' ' LEU . 37.7 tttp -60.41 -38.28 83.54 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.14 -0.975 . . . . 0.0 109.275 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.011 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -68.75 -50.66 48.76 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.319 -0.863 . . . . 0.0 109.509 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.448 ' HA2' HG12 ' B' ' 464' ' ' ILE . . . -62.58 -48.59 80.6 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.24 -44.97 61.84 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -1.121 . . . . 0.0 109.258 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.534 HD22 ' CG2' ' B' ' 440' ' ' VAL . 64.1 mt -62.41 -40.92 98.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.265 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.821 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.0 mt -55.01 -55.73 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 0.0 109.23 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.552 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 31.8 mtp -53.14 -45.3 68.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.867 . . . . 0.0 109.26 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.9 -45.09 90.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.192 -0.943 . . . . 0.0 109.164 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.806 ' HA ' HD11 ' B' ' 456' ' ' LEU . . . -63.13 -52.27 63.19 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.313 -0.867 . . . . 0.0 109.255 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.897 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 89.2 mtt180 -59.46 -39.57 84.06 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.363 -0.836 . . . . 0.0 109.377 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 93.6 m-20 -57.31 -41.59 80.17 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.247 -0.908 . . . . 0.0 109.164 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.778 HD11 ' CD1' ' B' ' 437' ' ' LEU . 83.3 mt -59.65 -36.61 66.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.7 t -79.43 -51.62 9.13 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.377 -0.827 . . . . 0.0 109.772 -179.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 95.4 m95 -63.84 -45.92 87.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.247 -0.908 . . . . 0.0 109.991 -179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.462 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.0 m-85 -76.08 -29.5 57.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.054 -1.029 . . . . 0.0 109.479 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -61.53 -27.89 68.75 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.64 -36.38 69.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.305 -1.115 . . . . 0.0 109.497 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -59.27 -32.29 69.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.295 -0.878 . . . . 0.0 109.511 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.98 -1.01 . . . . 0.0 109.457 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.574 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 44.4 p90 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 30.8 m-20 -55.4 124.93 57.41 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.305 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.07 -22.68 61.76 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.623 2.215 . . . . 0.0 111.665 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.761 ' O ' HD12 ' A' ' 278' ' ' ILE . 12.7 tt -71.8 -31.51 41.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.271 -0.893 . . . . 0.0 108.833 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.533 HD21 ' O ' ' A' ' 311' ' ' GLY . 31.8 mt -74.85 -45.03 45.87 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.29 -0.881 . . . . 0.0 109.345 179.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 1.007 HD22 ' CZ2' ' A' ' 321' ' ' TRP . 0.7 OUTLIER -65.48 -35.54 81.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 109.508 179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.411 ' O ' HG13 ' A' ' 278' ' ' ILE . 6.4 mtt85 -55.82 141.52 65.95 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.161 -0.962 . . . . 0.0 109.004 179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 276' ' ' HIS . 48.1 Cg_endo -68.93 132.16 24.05 Favored 'Trans proline' 0 C--O 1.215 -0.637 0 C-N-CA 122.623 2.216 . . . . 0.0 111.935 -179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.733 ' HA ' HD23 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.84 -28.37 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.2 -0.938 . . . . 0.0 109.5 -179.906 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.492 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 95.5 m-20 -65.54 -30.68 71.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.254 -0.904 . . . . 0.0 109.348 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 256' ' ' PRO . 72.4 m-20 -74.96 -8.58 56.91 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.317 -0.864 . . . . 0.0 110.01 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.733 HD23 ' HA ' ' A' ' 257' ' ' VAL . 0.7 OUTLIER -42.85 129.48 4.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.19 -0.944 . . . . 0.0 109.554 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.53 -15.47 50.82 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.3 -0.875 . . . . 0.0 109.518 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.835 HD13 ' HB3' ' A' ' 302' ' ' GLU . 40.3 mt -70.18 -162.13 0.05 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.302 -0.874 . . . . 0.0 109.542 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 7.1 p -81.01 155.9 26.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.296 -0.877 . . . . 0.0 109.507 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.565 HG12 ' ND2' ' A' ' 268' ' ' ASN . 22.8 t -57.67 -24.07 21.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.292 -0.88 . . . . 0.0 109.444 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.402 ' NH1' ' OD2' ' B' ' 465' ' ' ASP . 55.6 ttt85 -57.81 -43.36 85.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.31 -0.869 . . . . 0.0 109.387 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 25.7 m -58.82 -46.83 86.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.264 -0.898 . . . . 0.0 109.371 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.534 ' HB2' ' O ' ' A' ' 257' ' ' VAL . . . -68.96 -39.5 79.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.424 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.565 ' ND2' HG12 ' A' ' 264' ' ' VAL . 86.7 m-20 -60.28 -32.17 70.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.9 . . . . 0.0 109.442 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.4 m -66.9 -64.9 0.76 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.173 -0.954 . . . . 0.0 109.453 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 69.0 mt -54.84 -47.82 73.66 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.243 -0.91 . . . . 0.0 109.452 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.507 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 20.5 ttpt -52.94 -39.52 62.94 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.449 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.4 -23.68 6.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.412 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.587 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 95.3 mt-10 -94.11 23.07 5.25 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.299 -0.876 . . . . 0.0 109.42 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.587 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.5 33.26 4.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.213 -0.929 . . . . 0.0 109.445 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.714 HG23 ' HB2' ' A' ' 280' ' ' ASP . 75.8 mt -120.26 108.2 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.507 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 91.2 m-70 -104.59 -11.09 17.14 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.381 -0.824 . . . . 0.0 109.581 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -111.98 133.37 54.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.927 . . . . 0.0 109.401 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.761 HD12 ' O ' ' A' ' 252' ' ' ILE . 49.8 mt -62.03 -30.9 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.194 -0.941 . . . . 0.0 109.287 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.944 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -52.27 -41.25 54.11 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.714 ' HB2' HG23 ' A' ' 275' ' ' ILE . 92.1 m-20 -53.45 -36.36 61.5 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.192 -1.181 . . . . 0.0 109.119 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.515 ' CD2' HD12 ' A' ' 312' ' ' LEU . 3.1 tp -59.19 -46.49 88.28 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.297 -0.877 . . . . 0.0 109.229 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.944 HG22 ' O ' ' A' ' 279' ' ' GLY . 15.4 m -68.37 -23.29 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 108.911 179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -68.26 -33.09 73.74 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.379 -0.826 . . . . 0.0 108.813 179.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 18.4 mtt-85 -105.74 143.4 33.94 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.391 -0.818 . . . . 0.0 109.02 179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.551 HG22 ' H ' ' A' ' 287' ' ' VAL . 25.8 m -60.0 137.6 58.05 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.092 -1.005 . . . . 0.0 109.394 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 47.4 tp10 -62.98 -30.5 71.64 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.285 -0.885 . . . . 0.0 109.397 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.551 ' H ' HG22 ' A' ' 285' ' ' THR . 50.0 t -53.1 -50.99 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.331 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -51.8 -39.39 58.63 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.282 -0.886 . . . . 0.0 109.332 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.718 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -72.8 -39.65 66.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.291 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.996 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.8 tm? -57.61 -33.21 68.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.23 -0.918 . . . . 0.0 109.228 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.522 ' O ' ' HE2' ' B' ' 483' ' ' MET . 32.5 mttm -88.45 17.64 5.16 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.252 -0.905 . . . . 0.0 109.334 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.442 ' OG1' ' HA ' ' A' ' 289' ' ' LEU . 2.9 m -103.75 135.99 19.28 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 1.016 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -70.81 -24.82 24.45 Favored 'Trans proline' 0 C--O 1.215 -0.667 0 C-N-CA 122.671 2.247 . . . . 0.0 111.802 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.609 ' ND2' HD12 ' B' ' 464' ' ' ILE . 32.1 m120 -57.1 -21.01 28.83 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.269 -0.895 . . . . 0.0 109.57 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.458 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 13.3 mt -81.8 149.89 28.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 0.0 109.452 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -112.93 147.6 18.48 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -54.08 -44.88 71.56 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -1.176 . . . . 0.0 109.409 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . 0.429 ' O ' ' OE1' ' A' ' 302' ' ' GLU . 40.1 mttp -66.52 -41.58 88.57 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.4 m -64.39 -32.77 74.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.294 -0.879 . . . . 0.0 109.472 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.527 ' HA ' HD12 ' A' ' 303' ' ' ILE . 32.5 tp -53.36 -42.2 66.59 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.24 -0.912 . . . . 0.0 109.426 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 37.8 m -54.8 -43.41 72.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 109.446 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.835 ' HB3' HD13 ' A' ' 262' ' ' LEU . 39.5 mp0 -67.15 -37.86 84.51 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.172 -0.955 . . . . 0.0 109.391 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.527 HD12 ' HA ' ' A' ' 300' ' ' LEU . 77.2 mt -58.24 -47.16 88.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.448 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -65.44 -36.54 84.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.257 -0.902 . . . . 0.0 109.53 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -58.47 -45.2 89.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.178 -0.951 . . . . 0.0 109.4 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 1.046 HG11 HD21 ' A' ' 312' ' ' LEU . 20.6 t -68.71 -43.33 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.192 -0.942 . . . . 0.0 109.487 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.832 HD13 ' OG ' ' A' ' 313' ' ' SER . 16.6 tp -54.73 -29.68 54.19 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.248 -0.907 . . . . 0.0 109.606 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.3 -36.62 73.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.223 -0.923 . . . . 0.0 109.054 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 83.0 p -79.22 -1.11 34.86 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.335 -0.853 . . . . 0.0 109.467 179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 1.01 ' HA ' HD21 ' A' ' 314' ' ' LEU . 65.8 mtm180 56.88 16.99 3.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.218 -0.926 . . . . 0.0 109.012 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.669 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.55 -38.94 57.3 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.904 -1.278 . . . . 0.0 109.904 -179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.046 HD21 HG11 ' A' ' 306' ' ' VAL . 1.3 pp -149.5 160.99 43.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -1.219 . . . . 0.0 109.978 -179.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.832 ' OG ' HD13 ' A' ' 307' ' ' LEU . 0.5 OUTLIER 76.72 29.88 0.63 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.429 -0.795 . . . . 0.0 109.538 179.704 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 1.01 HD21 ' HA ' ' A' ' 310' ' ' ARG . 72.9 mt -85.8 14.91 5.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -0.898 . . . . 0.0 109.553 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 54.69 41.69 75.34 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.68 ' HE3' ' HB ' ' A' ' 282' ' ' VAL . 5.0 mtm -86.2 176.95 7.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.34 -1.094 . . . . 0.0 109.49 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.73 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.8 mtt180 -140.98 125.77 18.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.208 -0.933 . . . . 0.0 109.405 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.821 ' N ' HD12 ' A' ' 318' ' ' LEU . 4.0 mp -126.55 136.38 52.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.195 -0.941 . . . . 0.0 109.476 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -61.85 -38.49 88.44 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.171 -0.956 . . . . 0.0 109.239 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.502 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 72.9 m-20 -125.31 -69.19 0.8 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.348 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 1.007 ' CZ2' HD22 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 166.08 -66.41 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.451 179.823 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.532 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.87 107.75 1.76 Allowed 'Trans proline' 0 C--O 1.216 -0.593 0 C-N-CA 122.652 2.235 . . . . 0.0 112.016 -179.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 51.5 Cg_endo -71.71 162.45 42.04 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.625 2.217 . . . . 0.0 111.505 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.55 -17.26 7.86 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.159 -0.963 . . . . 0.0 109.402 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 36.4 m -66.12 -42.62 88.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.48 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.963 HD11 HD21 ' A' ' 254' ' ' LEU . 18.1 mt -58.23 -31.08 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.229 -0.919 . . . . 0.0 109.351 -179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -62.46 -33.89 75.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.15 -0.968 . . . . 0.0 109.393 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -55.45 -37.36 67.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.236 -0.915 . . . . 0.0 109.372 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.418 ' HG2' ' OXT' ' A' ' 329' ' ' GLU . 84.3 tt0 . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.488 179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . 0.418 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 88.8 m-20 -54.28 -36.98 64.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.203 -1.175 . . . . 0.0 109.456 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.418 ' HB2' ' O ' ' B' ' 427' ' ' ASP . 27.0 m120 59.71 51.24 6.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.174 -0.954 . . . . 0.0 109.434 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -86.46 124.56 69.55 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.246 -0.909 . . . . 0.0 109.459 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.523 ' HB3' ' HB1' ' B' ' 445' ' ' ALA . 49.8 Cg_endo -70.56 140.93 40.76 Favored 'Trans proline' 0 C--O 1.216 -0.62 0 C-N-CA 122.664 2.242 . . . . 0.0 111.686 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -80.88 160.15 24.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.123 -0.986 . . . . 0.0 109.476 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' B' ' 436' ' ' ASN . 88.3 m-20 -53.46 -37.47 62.68 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.168 -0.957 . . . . 0.0 109.305 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . 0.556 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 18.3 m-20 -61.39 -49.99 74.67 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.387 -0.82 . . . . 0.0 109.512 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.725 HD11 ' CD1' ' B' ' 448' ' ' LEU . 17.8 tp -63.45 -35.79 81.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.155 -0.965 . . . . 0.0 109.577 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.755 HD11 ' HG2' ' B' ' 442' ' ' ARG . 22.2 tp -83.51 -23.08 32.27 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . 0.51 ' N ' ' O ' ' B' ' 432' ' ' ASP . 35.3 t-20 -88.24 7.34 32.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.31 -0.869 . . . . 0.0 109.501 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.765 HD23 HG21 ' B' ' 440' ' ' VAL . 28.6 tp -78.43 129.93 35.49 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 109.501 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -65.82 137.28 57.12 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.226 -0.921 . . . . 0.0 109.538 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.06 9.32 70.8 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.975 HG13 HD23 ' B' ' 444' ' ' LEU . 41.8 t -123.67 131.12 73.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -1.137 . . . . 0.0 109.475 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 79.7 m-20 -102.46 161.82 13.41 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.319 -0.863 . . . . 0.0 109.452 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.755 ' HG2' HD11 ' B' ' 435' ' ' LEU . 61.7 mtt180 -50.19 -45.59 53.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.302 -0.874 . . . . 0.0 109.481 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.467 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 93.4 m-20 -61.08 -47.44 86.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.157 -0.964 . . . . 0.0 109.435 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.056 HD11 HD21 ' B' ' 473' ' ' LEU . 27.9 tp -55.67 -43.11 76.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.334 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' B' ' 430' ' ' PRO . . . -59.02 -43.07 91.54 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.192 -0.942 . . . . 0.0 109.23 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.467 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 17.3 m-85 -57.68 -44.75 86.02 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.248 -0.908 . . . . 0.0 109.26 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -58.24 -45.06 88.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.323 -0.861 . . . . 0.0 109.352 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.725 ' CD1' HD11 ' B' ' 434' ' ' LEU . 79.1 mt -61.34 -44.03 97.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.233 -0.917 . . . . 0.0 109.359 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.16 -36.19 77.02 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -50.94 -35.42 33.22 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.321 -0.862 . . . . 0.0 109.554 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.533 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 16.0 mtp-105 -90.32 23.57 2.88 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.219 -0.926 . . . . 0.0 109.55 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.68 6.89 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 110.315 -1.114 . . . . 0.0 110.315 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.903 HG21 ' CG ' ' B' ' 462' ' ' GLN . 21.3 t -80.53 109.75 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.922 -1.34 . . . . 0.0 109.432 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 31.1 m -124.91 -34.45 2.8 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.301 -0.874 . . . . 0.0 109.536 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.458 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -82.09 140.89 33.58 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.283 -0.885 . . . . 0.0 109.628 -179.891 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.556 ' HB2' ' CB ' ' B' ' 433' ' ' ASP . 2.0 tm? -48.56 -40.78 28.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.342 -0.849 . . . . 0.0 109.039 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -62.72 -38.77 91.78 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.225 -0.922 . . . . 0.0 108.899 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.562 ' C ' HG13 ' B' ' 453' ' ' VAL . 92.5 m-20 -61.58 -40.12 93.64 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.414 -0.804 . . . . 0.0 109.036 179.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.85 HD13 ' O ' ' B' ' 459' ' ' LEU . 3.4 tm? -63.29 -39.03 93.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.356 -0.84 . . . . 0.0 109.107 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' B' ' 486' ' ' ARG . . . -63.48 -32.63 74.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.364 -0.835 . . . . 0.0 109.295 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -72.61 -30.33 64.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.339 -0.85 . . . . 0.0 109.3 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.903 ' CG ' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -61.65 156.91 18.79 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.25 155.97 15.88 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.393 -1.483 . . . . 0.0 109.393 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 1.016 HD11 ' HG2' ' A' ' 293' ' ' PRO . 52.2 mt -49.68 -38.33 13.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -1.131 . . . . 0.0 109.501 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . 0.402 ' OD2' ' NH1' ' A' ' 265' ' ' ARG . 89.2 m-20 -65.22 -37.51 87.5 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.488 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.44 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 89.6 m-20 -71.11 -31.07 67.31 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.452 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.088 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.0 mt -76.81 -29.85 56.15 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.222 -0.923 . . . . 0.0 109.448 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.64 -23.61 63.18 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.335 -0.853 . . . . 0.0 109.525 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -52.67 -32.35 41.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.271 -0.893 . . . . 0.0 109.506 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.434 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.9 mt -104.73 128.03 58.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.161 -0.962 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 69.9 mm-40 -63.77 -33.94 76.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.202 -0.936 . . . . 0.0 109.401 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.422 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -51.12 -28.63 18.9 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.056 HD21 HD11 ' B' ' 444' ' ' LEU . 55.1 mt -105.86 137.6 43.48 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.226 -1.161 . . . . 0.0 109.418 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.456 HG22 ' N ' ' B' ' 475' ' ' ASP . 29.8 m -103.97 162.0 13.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.851 . . . . 0.0 109.395 179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.456 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.3 -37.51 75.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.336 -0.852 . . . . 0.0 109.494 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -76.97 -45.94 25.75 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.216 -0.927 . . . . 0.0 109.362 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.474 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 70.7 tttt -65.83 -46.4 78.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.303 -0.873 . . . . 0.0 109.396 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.088 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -60.02 -44.64 94.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.293 -0.879 . . . . 0.0 109.535 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -62.27 -52.34 50.21 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -50.98 -33.74 26.03 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.213 -1.169 . . . . 0.0 109.617 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.63 HD11 HD21 ' B' ' 444' ' ' LEU . 24.7 mt -75.33 -37.36 60.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.0 109.56 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.522 HD11 ' N ' ' B' ' 464' ' ' ILE . 92.8 mt -60.54 -55.63 23.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.492 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.522 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 41.2 mmm -59.68 -47.64 84.82 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.342 -0.849 . . . . 0.0 109.404 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.422 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.46 -53.15 61.44 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.261 -0.899 . . . . 0.0 109.464 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.45 ' CB ' HD12 ' B' ' 459' ' ' LEU . . . -60.83 -48.62 80.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.475 ' HA ' ' HB1' ' B' ' 460' ' ' ALA . 44.9 ttp85 -56.98 -43.75 82.01 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.222 -0.924 . . . . 0.0 109.45 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.7 m-20 -57.92 -39.06 77.06 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.263 -0.898 . . . . 0.0 109.616 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.68 HD11 ' CD1' ' B' ' 437' ' ' LEU . 76.9 mt -63.68 -36.9 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 109.454 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 45.6 t -64.51 -52.07 59.69 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.56 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.2 m95 -61.17 -38.75 87.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.0 109.424 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.514 ' CD2' ' O ' ' B' ' 487' ' ' ASN . 17.2 m-85 -64.03 -31.33 72.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.28 -0.887 . . . . 0.0 109.492 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -60.86 -30.06 72.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 53.8 t0 -53.15 -37.86 62.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -1.138 . . . . 0.0 109.466 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -61.27 -33.05 72.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.273 -0.892 . . . . 0.0 109.531 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.525 179.956 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.873 ' CE2' HD21 ' A' ' 318' ' ' LEU . 79.0 m-85 . . . . . 0 N--CA 1.49 1.549 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.482 ' HB3' HG22 ' A' ' 252' ' ' ILE . 0.2 OUTLIER -50.78 155.22 2.04 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.347 -0.846 . . . . 0.0 109.273 179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.512 ' HA ' HD23 ' A' ' 254' ' ' LEU . 41.0 Cg_endo -64.5 -26.31 62.47 Favored 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.47 2.114 . . . . 0.0 111.425 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.788 ' O ' HD12 ' A' ' 278' ' ' ILE . 13.2 tt -53.38 -34.91 23.57 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.647 HD12 ' CG2' ' A' ' 252' ' ' ILE . 5.3 mp -74.45 -39.21 62.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.463 -0.773 . . . . 0.0 109.01 179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.702 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -71.32 -23.14 61.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.397 -0.814 . . . . 0.0 109.459 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.405 ' O ' HG13 ' A' ' 278' ' ' ILE . 0.2 OUTLIER -73.0 141.19 81.32 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.169 -0.957 . . . . 0.0 109.466 -179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.501 ' O ' ' N ' ' A' ' 259' ' ' ASP . 51.5 Cg_endo -70.66 136.37 30.47 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.728 2.285 . . . . 0.0 111.736 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.743 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.16 -26.68 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.191 -0.943 . . . . 0.0 109.368 179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.443 ' OD1' ' HE2' ' A' ' 271' ' ' LYS . 88.3 m-20 -67.61 -30.77 70.44 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.905 . . . . 0.0 109.303 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.501 ' N ' ' O ' ' A' ' 256' ' ' PRO . 49.9 m-20 -74.71 -9.8 58.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.272 -0.892 . . . . 0.0 109.517 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 257' ' ' VAL . 49.5 mt -58.44 135.75 57.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.168 -0.958 . . . . 0.0 109.359 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -65.44 -21.22 66.63 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.243 -0.91 . . . . 0.0 109.571 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.64 HD12 ' H ' ' A' ' 262' ' ' LEU . 6.4 mp -62.59 168.35 3.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.299 -0.876 . . . . 0.0 109.488 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 29.2 p -70.5 166.74 19.84 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.215 -0.928 . . . . 0.0 109.457 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.679 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.0 t -63.89 -23.94 34.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -0.911 . . . . 0.0 109.462 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 11.4 tpt180 -55.4 -45.09 76.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 86.9 p -69.16 -45.89 68.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -63.82 -42.4 97.68 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.174 -0.954 . . . . 0.0 109.41 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.679 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.2 m-20 -54.13 -38.36 65.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 109.3 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 295' ' ' LEU . 61.0 m -51.29 -62.14 1.8 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.335 -0.853 . . . . 0.0 109.477 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.631 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.8 mt -56.47 -46.28 80.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.264 -0.898 . . . . 0.0 109.439 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 267' ' ' ALA . 16.3 mttt -53.25 -33.23 52.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.265 -0.897 . . . . 0.0 109.48 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.73 -33.7 49.21 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.263 -0.898 . . . . 0.0 109.498 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.571 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.1 mt-10 -92.01 25.84 2.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.462 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.23 45.31 1.26 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.237 -0.914 . . . . 0.0 109.462 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 1.025 HG23 ' HB2' ' A' ' 280' ' ' ASP . 91.2 mt -115.61 124.91 72.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.199 -0.938 . . . . 0.0 109.6 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.743 ' O ' HG22 ' A' ' 257' ' ' VAL . 6.5 p80 -114.09 -39.93 3.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.287 -0.883 . . . . 0.0 109.404 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.571 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.3 m-30 -103.14 134.73 46.07 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.279 -0.888 . . . . 0.0 109.31 179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.905 HG21 HD23 ' A' ' 312' ' ' LEU . 78.1 mt -46.66 -30.77 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.105 -0.997 . . . . 0.0 109.067 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.737 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.89 -49.41 17.36 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 1.025 ' HB2' HG23 ' A' ' 275' ' ' ILE . 87.5 m-20 -53.43 -32.19 48.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.052 -1.264 . . . . 0.0 108.988 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.837 HD23 ' HB3' ' A' ' 312' ' ' LEU . 53.9 tp -53.99 -51.29 64.38 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.332 -0.855 . . . . 0.0 109.07 179.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.737 HG22 ' O ' ' A' ' 279' ' ' GLY . 17.7 m -68.17 -33.46 60.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.257 -0.902 . . . . 0.0 109.18 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -53.06 -32.43 46.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.294 -0.879 . . . . 0.0 108.819 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 37.8 mtt-85 -107.74 150.61 26.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.425 -0.797 . . . . 0.0 109.191 179.671 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 72.2 p -81.6 157.07 24.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.189 -0.945 . . . . 0.0 109.616 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.529 ' OE2' HD23 ' A' ' 307' ' ' LEU . 7.2 mt-10 -63.52 -32.07 73.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.23 -0.918 . . . . 0.0 109.442 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 35.5 t -52.79 -50.47 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.323 -0.86 . . . . 0.0 109.263 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -55.14 -37.57 67.12 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.243 -0.911 . . . . 0.0 109.27 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.415 HD23 ' OE2' ' A' ' 273' ' ' GLU . 65.8 mt -72.62 -40.75 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.242 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 1.011 HD13 ' O ' ' A' ' 290' ' ' LEU . 1.9 tm? -57.31 -32.69 66.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.317 -0.865 . . . . 0.0 109.21 179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 66.9 mttm -82.26 -13.27 57.29 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.389 -0.82 . . . . 0.0 109.474 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 94.1 m -86.94 112.6 48.5 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.189 -0.945 . . . . 0.0 109.456 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 1.043 ' HB2' HD12 ' B' ' 482' ' ' ILE . 51.3 Cg_endo -70.86 -13.16 31.71 Favored 'Trans proline' 0 C--O 1.216 -0.614 0 C-N-CA 122.767 2.311 . . . . 0.0 111.845 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.573 ' HA ' HD12 ' B' ' 464' ' ' ILE . 30.6 m120 -48.93 -41.08 32.63 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 0.0 109.6 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.469 ' HB3' ' HB3' ' A' ' 269' ' ' CYS . 0.4 OUTLIER -83.74 143.17 30.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.507 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -80.34 165.2 48.27 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 66.6 tttt -64.48 -41.51 96.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.239 -1.154 . . . . 0.0 109.568 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 49.6 mttm -63.94 -39.0 93.14 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.261 -0.899 . . . . 0.0 109.459 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.435 ' O ' HG12 ' A' ' 303' ' ' ILE . 19.6 m -59.73 -41.67 91.43 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.93 . . . . 0.0 109.457 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.434 ' HG ' ' CE ' ' A' ' 304' ' ' LYS . 24.2 tp -53.06 -37.93 62.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.307 -0.871 . . . . 0.0 109.371 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.9 m -60.85 -45.83 92.97 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.278 -0.889 . . . . 0.0 109.433 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -63.14 -46.09 88.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.235 -0.915 . . . . 0.0 109.507 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.83 HG22 HD22 ' A' ' 307' ' ' LEU . 30.6 mm -58.76 -51.12 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.275 -0.891 . . . . 0.0 109.516 -179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.434 ' CE ' ' HG ' ' A' ' 300' ' ' LEU . 22.5 mttm -53.13 -39.06 63.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.905 . . . . 0.0 109.36 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.15 -48.3 80.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.293 -0.879 . . . . 0.0 109.461 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.892 HG12 HD11 ' A' ' 312' ' ' LEU . 12.0 t -73.71 -40.84 54.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.264 -0.898 . . . . 0.0 109.418 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.83 HD22 HG22 ' A' ' 303' ' ' ILE . 8.4 mp -66.02 -26.71 67.65 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.287 -0.883 . . . . 0.0 109.501 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -29.57 66.91 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.246 -0.909 . . . . 0.0 109.513 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 8.2 t -75.2 -0.16 18.45 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.713 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.539 ' O ' HD21 ' A' ' 314' ' ' LEU . 40.5 mtm-85 70.31 3.89 4.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.184 -0.948 . . . . 0.0 109.412 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.424 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -69.32 -27.82 73.24 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.905 HD23 HG21 ' A' ' 278' ' ' ILE . 0.0 OUTLIER -140.81 152.89 45.53 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -1.131 . . . . 0.0 109.261 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.525 ' OG ' HD21 ' A' ' 307' ' ' LEU . 16.5 m 63.67 66.85 0.66 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.217 -0.927 . . . . 0.0 109.46 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.799 HD13 ' HE2' ' A' ' 316' ' ' MET . 4.7 mp -103.06 9.99 38.25 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.275 -0.891 . . . . 0.0 109.252 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.11 28.61 73.81 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.799 ' HE2' HD13 ' A' ' 314' ' ' LEU . 15.4 ptt? -113.04 147.38 37.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.204 -1.174 . . . . 0.0 109.559 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.534 ' C ' HD12 ' A' ' 318' ' ' LEU . 76.3 mtm180 -126.53 141.66 51.8 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.404 -0.81 . . . . 0.0 109.292 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.873 HD21 ' CE2' ' A' ' 249' ' ' PHE . 3.7 mp -116.9 141.78 47.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.0 109.557 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -63.02 -34.4 77.49 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.292 -0.88 . . . . 0.0 108.983 179.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.501 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 85.6 m-20 -117.41 -81.57 0.62 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.41 -0.806 . . . . 0.0 109.191 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.702 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER 165.89 -62.23 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.281 -0.887 . . . . 0.0 109.425 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.545 ' CB ' HD11 ' A' ' 326' ' ' ILE . 48.8 Cg_endo -68.33 108.09 1.72 Allowed 'Trans proline' 0 C--O 1.216 -0.612 0 C-N-CA 122.66 2.24 . . . . 0.0 111.989 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 249' ' ' PHE . 53.9 Cg_endo -76.34 161.91 34.29 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.421 2.08 . . . . 0.0 111.414 179.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.64 -13.92 17.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.231 -0.918 . . . . 0.0 109.536 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 90.1 p -70.35 -35.52 73.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.195 -0.941 . . . . 0.0 109.764 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.605 HG21 ' HG ' ' A' ' 254' ' ' LEU . 21.2 pt -94.0 -3.75 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.14 -0.975 . . . . 0.0 109.771 -179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.8 74.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.158 -0.963 . . . . 0.0 109.392 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -58.16 -38.14 76.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 109.508 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.489 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -57.5 -36.35 71.41 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -1.134 . . . . 0.0 109.442 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 26.8 m120 56.2 40.04 30.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.134 -0.979 . . . . 0.0 109.435 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.65 130.17 92.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.293 -0.879 . . . . 0.0 109.481 179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -70.53 144.01 48.72 Favored 'Trans proline' 0 C--O 1.215 -0.644 0 C-N-CA 122.728 2.285 . . . . 0.0 111.792 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.477 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -75.65 146.34 40.33 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 86.4 m-20 -47.99 -32.9 7.08 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.146 -0.971 . . . . 0.0 109.455 -179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -67.53 -48.01 68.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.252 -0.905 . . . . 0.0 109.535 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.861 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.5 tm? -67.91 -36.96 81.1 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.259 -0.9 . . . . 0.0 109.502 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.93 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.0 OUTLIER -72.89 -31.95 65.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 109.491 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -89.86 11.32 20.62 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 1.06 HD13 HD11 ' B' ' 456' ' ' LEU . 50.2 tp -74.05 133.64 42.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.491 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -76.6 145.47 38.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.241 -0.912 . . . . 0.0 109.489 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.42 -0.74 75.1 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.732 HG13 HD23 ' B' ' 444' ' ' LEU . 95.3 t -123.54 135.73 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.137 -1.214 . . . . 0.0 109.489 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' B' ' 442' ' ' ARG . 58.2 t0 -85.27 146.38 27.08 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.243 -0.91 . . . . 0.0 109.337 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.502 ' HG2' HD11 ' B' ' 435' ' ' LEU . 95.8 mtt180 -49.92 -43.79 49.88 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.259 -0.901 . . . . 0.0 109.393 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -68.65 -37.74 79.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.264 -0.898 . . . . 0.0 109.293 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.07 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.2 tp -63.66 -35.57 80.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.284 -0.885 . . . . 0.0 109.421 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.455 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -63.81 -41.37 97.91 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.176 -0.953 . . . . 0.0 109.419 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 71.8 m-85 -65.88 -48.46 71.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.225 -0.922 . . . . 0.0 109.369 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.533 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 31.4 ttmt -57.94 -42.86 85.78 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.293 -0.879 . . . . 0.0 109.494 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.829 HD11 ' CD2' ' B' ' 459' ' ' LEU . 10.0 tt -69.73 -37.3 76.46 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.253 -0.904 . . . . 0.0 109.446 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -60.27 -27.6 67.39 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.283 -0.885 . . . . 0.0 109.496 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.06 -16.9 8.29 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.191 -0.943 . . . . 0.0 109.511 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.425 ' HD2' ' CD1' ' B' ' 470' ' ' ILE . 12.1 mtp85 -90.46 28.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.515 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.81 6.8 Favored Glycine 0 N--CA 1.493 2.499 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' B' ' 449' ' ' ALA . 19.2 t -65.33 133.24 30.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.985 -1.303 . . . . 0.0 109.427 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.463 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 60.4 m -135.08 -35.15 0.85 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.159 -0.963 . . . . 0.0 109.794 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.477 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.3 OUTLIER -106.57 152.1 24.15 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.095 -1.003 . . . . 0.0 109.847 -179.789 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 1.06 HD11 HD13 ' B' ' 437' ' ' LEU . 0.3 OUTLIER -51.78 -42.77 62.68 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.332 -0.855 . . . . 0.0 109.363 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.7 tt0 -55.83 -42.2 75.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.257 -0.902 . . . . 0.0 109.137 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' B' ' 462' ' ' GLN . 84.3 m-20 -61.4 -41.2 96.76 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.342 -0.849 . . . . 0.0 109.217 179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.829 ' CD2' HD11 ' B' ' 448' ' ' LEU . 3.4 tm? -60.97 -38.92 87.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.375 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.16 -35.72 81.21 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.265 -0.897 . . . . 0.0 109.468 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.82 -35.34 80.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.244 -0.91 . . . . 0.0 109.485 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.468 ' HG2' ' O ' ' B' ' 458' ' ' ASP . 3.5 mm100 -65.53 144.88 56.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.178 -0.951 . . . . 0.0 109.47 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.42 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -102.92 159.72 17.26 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.359 -1.496 . . . . 0.0 109.359 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.889 HD11 ' HG2' ' A' ' 293' ' ' PRO . 80.3 mt -46.07 -35.14 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.095 -1.238 . . . . 0.0 109.204 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -63.47 -37.45 87.34 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.229 -0.919 . . . . 0.0 109.021 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.4 m-20 -68.51 -31.55 70.88 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.325 -0.859 . . . . 0.0 109.16 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.733 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -80.84 -32.86 34.93 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.326 -0.859 . . . . 0.0 109.396 179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -57.48 -33.07 67.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.394 -0.816 . . . . 0.0 109.392 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 50.3 t0 -46.83 -28.67 1.64 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.221 -0.925 . . . . 0.0 109.401 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.533 ' CG2' ' HD3' ' B' ' 447' ' ' LYS . 62.1 mt -105.79 121.53 58.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.23 -0.919 . . . . 0.0 109.46 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 68.9 mm-40 -55.93 -32.65 63.98 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.233 -0.917 . . . . 0.0 109.432 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.454 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.94 -28.82 49.57 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.07 ' CD2' HD11 ' B' ' 444' ' ' LEU . 65.0 mt -103.5 135.77 44.48 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -1.132 . . . . 0.0 109.502 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.95 161.91 13.57 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.191 -0.943 . . . . 0.0 109.354 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.433 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 82.5 m-20 -58.29 -37.39 74.94 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.0 109.57 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -77.13 -46.03 24.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.278 -0.889 . . . . 0.0 109.464 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.651 ' O ' HD13 ' B' ' 481' ' ' LEU . 25.2 tttp -62.86 -44.22 96.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.296 -0.877 . . . . 0.0 109.5 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.733 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.85 -44.34 93.44 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.286 -0.884 . . . . 0.0 109.5 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.477 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.23 -35.85 91.52 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -69.06 -35.16 76.25 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.254 -1.144 . . . . 0.0 109.415 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.651 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.7 mp -69.51 -36.56 76.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 0.0 109.642 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 1.043 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.9 mt -68.84 -56.35 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.21 -0.931 . . . . 0.0 109.518 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 61.2 mtp -52.62 -39.08 61.33 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.227 -0.921 . . . . 0.0 109.486 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.35 -49.23 44.43 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.201 -0.937 . . . . 0.0 109.351 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.533 ' HB1' ' CD2' ' B' ' 456' ' ' LEU . . . -63.98 -46.41 84.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.254 -0.904 . . . . 0.0 109.367 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.422 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 45.9 ttm-85 -57.6 -45.05 85.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.259 -0.901 . . . . 0.0 109.34 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.456 ' O ' ' CD2' ' B' ' 491' ' ' PHE . 89.0 m-20 -57.9 -40.0 79.28 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 109.403 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.643 HD12 HD11 ' B' ' 456' ' ' LEU . 84.8 mt -64.72 -37.03 79.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.25 -0.906 . . . . 0.0 109.348 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.9 t -70.73 -49.23 49.18 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.237 -0.914 . . . . 0.0 109.406 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . 0.422 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 58.4 m95 -65.99 -32.22 73.58 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.882 ' HB2' ' HB2' ' B' ' 495' ' ' ALA . 13.8 m-85 -79.22 -34.27 42.99 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 109.568 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 54.87 -135.37 46.62 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -51.0 -40.45 58.14 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -1.167 . . . . 0.0 109.414 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -55.34 -36.63 66.48 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.218 -0.926 . . . . 0.0 109.493 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . 0.882 ' HB2' ' HB2' ' B' ' 491' ' ' PHE . . . . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.041 -0.981 . . . . 0.0 109.558 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.53 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 10.4 p90 . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 121.293 0.568 . . . . 0.0 109.527 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.767 ' O ' HD22 ' A' ' 254' ' ' LEU . 0.9 OUTLIER -57.86 136.95 83.43 Favored Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.172 -0.955 . . . . 0.0 109.272 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.687 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.5 Cg_endo -65.05 -30.93 56.03 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.597 2.198 . . . . 0.0 111.55 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.848 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -63.11 -29.53 47.46 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.246 -0.909 . . . . 0.0 108.891 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.707 HD21 ' HA ' ' A' ' 312' ' ' LEU . 31.4 mt -74.31 -42.57 59.27 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.399 -0.813 . . . . 0.0 109.195 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.767 HD22 ' O ' ' A' ' 250' ' ' ASP . 0.5 OUTLIER -59.94 -34.99 73.98 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.398 -0.813 . . . . 0.0 109.14 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 17.2 mtt180 -66.12 146.47 99.02 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.335 -0.853 . . . . 0.0 109.408 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.462 ' O ' ' N ' ' A' ' 259' ' ' ASP . 50.3 Cg_endo -70.22 140.01 39.94 Favored 'Trans proline' 0 C--O 1.216 -0.605 0 C-N-CA 122.714 2.276 . . . . 0.0 111.89 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.556 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.12 -36.92 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.257 -0.902 . . . . 0.0 109.362 179.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -58.13 -30.98 66.74 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.274 -0.891 . . . . 0.0 109.498 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.462 ' N ' ' O ' ' A' ' 256' ' ' PRO . 21.9 m-20 -72.38 -11.41 60.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.233 -0.917 . . . . 0.0 109.542 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.556 HD11 HG12 ' A' ' 257' ' ' VAL . 36.8 mt -55.35 150.64 11.13 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.422 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -62.75 -23.23 67.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.275 -0.89 . . . . 0.0 109.437 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.691 HD12 ' H ' ' A' ' 262' ' ' LEU . 5.6 mp -62.85 166.74 5.28 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.303 -0.873 . . . . 0.0 109.411 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -75.53 162.66 28.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.232 -0.917 . . . . 0.0 109.486 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.657 HG12 ' ND2' ' A' ' 268' ' ' ASN . 11.8 t -48.85 -39.67 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -51.18 -50.22 59.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.257 -0.902 . . . . 0.0 109.482 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.666 ' OG ' HD22 ' A' ' 262' ' ' LEU . 17.7 t -58.71 -51.02 71.73 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.41 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -62.96 -37.06 85.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.31 -0.869 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.657 ' ND2' HG12 ' A' ' 264' ' ' VAL . 94.7 m-20 -58.54 -36.47 73.94 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.897 . . . . 0.0 109.322 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 64.0 m -55.82 -53.64 54.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.327 -0.858 . . . . 0.0 109.304 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.723 HD21 HD13 ' A' ' 281' ' ' LEU . 6.6 mp -61.28 -47.87 83.99 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.272 -0.892 . . . . 0.0 109.293 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.498 ' CE ' ' HA ' ' A' ' 268' ' ' ASN . 54.8 mtmt -52.8 -38.14 60.8 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.331 -0.855 . . . . 0.0 109.552 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.07 -29.23 20.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.214 -0.929 . . . . 0.0 109.473 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.581 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 86.3 mt-10 -92.95 25.29 3.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.317 -0.864 . . . . 0.0 109.453 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.581 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.05 45.39 0.91 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.197 -0.939 . . . . 0.0 109.561 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.994 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.2 mt -120.85 119.58 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.175 -0.953 . . . . 0.0 109.417 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.469 ' H ' ' CD2' ' A' ' 276' ' ' HIS . 7.7 p80 -110.17 -40.05 4.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.197 -0.94 . . . . 0.0 109.557 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.457 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.6 m-30 -105.47 136.13 45.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.258 -0.901 . . . . 0.0 109.56 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.848 HD12 ' O ' ' A' ' 252' ' ' ILE . 93.5 mt -46.7 -29.88 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.387 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.988 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.98 -45.13 14.29 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.994 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.3 m-20 -53.52 -33.83 55.92 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.002 -1.293 . . . . 0.0 108.788 179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 289' ' ' LEU . 38.7 tp -57.35 -49.48 76.01 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.365 -0.835 . . . . 0.0 108.966 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.988 HG22 ' O ' ' A' ' 279' ' ' GLY . 13.2 m -63.44 -23.34 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 108.73 179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.442 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.1 tt0 -67.45 -34.95 78.24 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 71.9 mtt-85 -98.73 158.57 15.54 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.452 -0.78 . . . . 0.0 109.105 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.7 m -83.93 154.26 23.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.074 -1.016 . . . . 0.0 109.773 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.666 ' CD ' HD13 ' A' ' 307' ' ' LEU . 9.0 mt-10 -61.68 -36.33 80.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.286 -0.884 . . . . 0.0 109.303 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.539 ' CG1' ' HE3' ' A' ' 291' ' ' LYS . 42.1 t -52.64 -49.36 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.244 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -51.95 -32.55 33.69 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.23 -0.919 . . . . 0.0 109.083 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 1.018 HD11 HD11 ' A' ' 281' ' ' LEU . 36.8 mt -69.25 -41.18 77.29 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.335 -0.853 . . . . 0.0 109.147 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.673 ' N ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm? -66.39 -25.31 66.71 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.291 -0.881 . . . . 0.0 109.342 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.546 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 54.8 mttt -86.32 -12.87 48.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.296 -0.878 . . . . 0.0 109.484 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.529 HG22 HD12 ' A' ' 295' ' ' LEU . 53.0 m -81.85 112.3 33.69 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.149 -0.969 . . . . 0.0 109.522 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 1.014 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.6 Cg_endo -71.06 -14.25 31.88 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.821 2.347 . . . . 0.0 111.916 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.67 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.9 m120 -61.98 -25.47 67.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.158 -0.964 . . . . 0.0 109.475 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.806 HD23 HD11 ' A' ' 303' ' ' ILE . 4.7 mp -88.02 142.35 27.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -0.885 . . . . 0.0 109.543 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . 0.465 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -91.39 169.28 32.89 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -57.55 -41.07 80.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.253 -1.145 . . . . 0.0 109.47 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -70.14 -43.07 71.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.241 -0.912 . . . . 0.0 109.441 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 42.6 m -59.2 -49.45 77.81 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.39 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.752 HD21 ' HB2' ' A' ' 295' ' ' LEU . 83.5 mt -55.37 -42.37 73.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 0.0 109.421 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.3 m -55.41 -52.62 62.96 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.302 -0.873 . . . . 0.0 109.451 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.696 ' O ' HG23 ' A' ' 306' ' ' VAL . 89.2 mt-10 -54.82 -39.4 68.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.294 -0.879 . . . . 0.0 109.533 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.806 HD11 HD23 ' A' ' 295' ' ' LEU . 78.6 mt -58.15 -51.54 69.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.286 -0.884 . . . . 0.0 109.398 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -55.33 -42.51 73.9 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.259 -0.901 . . . . 0.0 109.504 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.36 -44.08 79.76 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.485 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.986 HG12 HD21 ' A' ' 312' ' ' LEU . 1.9 t -65.93 -39.58 85.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.178 179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 313' ' ' SER . 20.1 mt -54.63 -26.16 31.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.321 -0.862 . . . . 0.0 109.372 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.1 -32.37 68.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.29 -0.881 . . . . 0.0 109.397 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 1.7 t -66.06 -15.53 63.14 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.308 -0.87 . . . . 0.0 109.446 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.784 ' C ' HD21 ' A' ' 314' ' ' LEU . 92.8 mtt180 59.32 14.17 3.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.442 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -105.27 1.99 40.33 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.986 HD21 HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -149.94 142.58 24.55 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.178 -1.19 . . . . 0.0 109.641 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.784 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 67.22 38.87 3.22 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.184 -0.948 . . . . 0.0 109.577 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.784 HD21 ' C ' ' A' ' 310' ' ' ARG . 28.1 mt -88.97 18.2 5.08 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.153 -0.967 . . . . 0.0 109.43 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 66.31 36.29 91.47 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.466 -1.453 . . . . 0.0 109.466 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.704 ' HE2' HG11 ' A' ' 282' ' ' VAL . 6.4 mtm -87.21 167.33 14.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.175 -1.191 . . . . 0.0 109.455 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.571 ' C ' HD12 ' A' ' 318' ' ' LEU . 36.1 mtp180 -143.15 131.29 21.88 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.273 -0.892 . . . . 0.0 109.436 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.761 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.6 mp -130.0 139.26 51.07 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.218 -0.927 . . . . 0.0 109.621 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -58.32 -43.97 88.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 108.88 179.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 69.1 m-20 -122.06 -69.42 0.83 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.372 -0.83 . . . . 0.0 109.041 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.567 ' HE3' HD22 ' A' ' 318' ' ' LEU . 2.6 t-105 168.42 -58.12 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.354 -0.841 . . . . 0.0 109.405 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 321' ' ' TRP . 49.3 Cg_endo -68.52 107.79 1.69 Allowed 'Trans proline' 0 C--O 1.216 -0.617 0 C-N-CA 122.545 2.163 . . . . 0.0 111.898 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 1.016 ' O ' HG22 ' A' ' 326' ' ' ILE . 51.4 Cg_endo -71.47 152.91 60.69 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.611 2.207 . . . . 0.0 111.711 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -50.34 -27.76 6.79 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.192 -0.942 . . . . 0.0 109.54 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.418 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 42.9 m -68.18 -32.64 73.02 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.197 -0.939 . . . . 0.0 109.548 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 1.016 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.7 tt -61.11 -25.29 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.315 -0.865 . . . . 0.0 109.564 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -59.24 144.05 47.3 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.27 -0.894 . . . . 0.0 109.543 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -60.05 -37.57 80.21 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.204 -0.935 . . . . 0.0 109.478 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.506 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.489 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -59.04 -35.0 72.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -1.15 . . . . 0.0 109.449 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.641 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 22.4 m120 -85.54 5.65 30.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.901 . . . . 0.0 109.602 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.492 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 2.0 tttt -54.07 129.87 58.51 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.206 -0.934 . . . . 0.0 109.458 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.53 ' HG3' ' CD1' ' B' ' 446' ' ' PHE . 48.6 Cg_endo -69.98 140.85 42.85 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.677 2.251 . . . . 0.0 111.774 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -72.04 152.57 42.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.278 -0.888 . . . . 0.0 109.531 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -50.1 -39.42 42.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.209 -0.932 . . . . 0.0 109.394 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 83.9 m-20 -59.4 -44.48 92.81 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.306 -0.871 . . . . 0.0 109.263 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.766 HD13 ' C ' ' B' ' 434' ' ' LEU . 2.9 tm? -64.18 -32.66 74.32 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.264 -0.897 . . . . 0.0 109.25 179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.877 HD11 ' HG2' ' B' ' 442' ' ' ARG . 24.7 tp -79.88 -30.29 40.17 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.318 -0.864 . . . . 0.0 109.334 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -78.43 -0.77 30.54 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 0.0 109.57 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.693 HD23 HG21 ' B' ' 440' ' ' VAL . 28.8 tp -72.34 134.58 45.56 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.131 -0.981 . . . . 0.0 109.513 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -73.6 141.26 46.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.93 8.55 66.99 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.693 HG21 HD23 ' B' ' 437' ' ' LEU . 47.4 t -129.52 126.42 63.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.254 -1.145 . . . . 0.0 109.452 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 80.5 m-20 -96.26 161.46 13.94 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.213 -0.929 . . . . 0.0 109.472 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.877 ' HG2' HD11 ' B' ' 435' ' ' LEU . 87.9 mtt-85 -55.01 -46.63 75.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.241 -0.912 . . . . 0.0 109.493 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -66.17 -45.6 80.31 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.267 -0.896 . . . . 0.0 109.528 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.519 ' CD2' ' HE2' ' B' ' 477' ' ' LYS . 12.9 tp -60.85 -41.83 96.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.282 -0.886 . . . . 0.0 109.475 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.635 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.15 -40.66 86.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.342 -0.849 . . . . 0.0 109.437 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.53 ' CD1' ' HG3' ' B' ' 430' ' ' PRO . 17.3 m-85 -63.83 -46.65 84.12 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.268 -0.895 . . . . 0.0 109.435 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.513 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 5.9 ttmm -57.66 -46.36 84.34 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.263 -0.898 . . . . 0.0 109.607 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.609 HD23 ' O ' ' B' ' 448' ' ' LEU . 8.7 tt -68.24 -36.51 79.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.326 -0.859 . . . . 0.0 109.586 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.641 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -60.81 -26.79 67.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.273 -0.892 . . . . 0.0 109.535 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -49.14 -22.33 0.95 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.695 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 25.9 mtp85 -88.66 25.01 1.83 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.104 -0.997 . . . . 0.0 109.681 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.63 7.15 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 110.458 -1.057 . . . . 0.0 110.458 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.71 HG21 ' HG3' ' B' ' 462' ' ' GLN . 44.7 t -62.87 132.1 28.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.942 -1.328 . . . . 0.0 109.326 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 87.5 m -135.11 -38.52 0.77 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.102 -0.999 . . . . 0.0 109.666 -179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.64 150.56 21.63 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 0.0 109.738 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 1.037 HD21 HD12 ' B' ' 488' ' ' ILE . 27.1 tp -48.41 -42.15 31.2 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.288 -0.883 . . . . 0.0 109.255 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -55.94 -48.36 75.88 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.265 -0.897 . . . . 0.0 109.102 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.6 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.6 m-20 -54.89 -40.99 70.35 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.278 -0.889 . . . . 0.0 109.065 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.603 HD21 ' HB3' ' B' ' 481' ' ' LEU . 4.6 tt -57.21 -47.05 82.28 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.391 -0.818 . . . . 0.0 109.228 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -59.26 -32.65 70.19 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.439 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -63.08 -34.87 78.51 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.313 -0.867 . . . . 0.0 109.399 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.71 ' HG3' HG21 ' B' ' 453' ' ' VAL . 6.2 mm100 -67.44 156.01 37.63 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -117.57 155.08 16.32 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.965 HD11 ' HG2' ' A' ' 293' ' ' PRO . 30.0 mt -47.6 -42.63 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.201 -1.176 . . . . 0.0 109.305 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -58.34 -42.43 86.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.26 -0.9 . . . . 0.0 109.353 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -67.14 -30.04 69.92 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.316 -0.865 . . . . 0.0 109.323 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.059 HD12 ' HB1' ' B' ' 478' ' ' ALA . 24.0 mt -77.98 -26.48 48.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.201 -0.937 . . . . 0.0 109.26 179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.58 -29.32 69.95 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.302 -0.873 . . . . 0.0 109.301 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -53.74 -32.28 51.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.263 -0.898 . . . . 0.0 109.414 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.546 HG22 ' H ' ' B' ' 472' ' ' GLY . 61.0 mt -100.43 122.84 52.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.922 . . . . 0.0 109.446 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 81.8 tt0 -60.88 -26.84 67.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.0 109.504 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.546 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -59.7 -26.5 62.64 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.485 ' CD2' HD11 ' B' ' 444' ' ' LEU . 38.7 mt -109.73 134.66 51.74 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -1.163 . . . . 0.0 109.573 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -104.02 161.93 13.57 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -0.916 . . . . 0.0 109.403 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.426 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 79.9 m-20 -57.68 -38.05 74.49 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.192 -0.942 . . . . 0.0 109.495 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -76.79 -46.08 26.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.177 -0.952 . . . . 0.0 109.524 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.662 ' O ' HD13 ' B' ' 481' ' ' LEU . 43.7 tttt -64.93 -42.06 95.01 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.297 -0.877 . . . . 0.0 109.453 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.059 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.85 -42.15 97.64 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 0.0 109.515 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.1 -42.92 99.95 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -62.72 -37.07 85.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -1.151 . . . . 0.0 109.628 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.662 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -66.88 -39.89 87.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 109.811 -179.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 1.014 HD12 ' HB2' ' A' ' 293' ' ' PRO . 28.9 mt -64.69 -56.18 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.199 -0.938 . . . . 0.0 109.643 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.546 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 48.3 mtp -52.67 -40.35 62.79 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.61 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.447 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.83 -56.45 15.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.176 -0.953 . . . . 0.0 109.624 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.472 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -62.05 -44.42 96.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.305 -0.872 . . . . 0.0 109.714 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.497 ' NH1' ' O ' ' A' ' 290' ' ' LEU . 50.2 ttt180 -60.28 -45.97 91.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.236 -0.915 . . . . 0.0 109.68 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 84.5 m-20 -59.2 -41.13 87.82 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.224 -0.923 . . . . 0.0 109.599 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 1.037 HD12 HD21 ' B' ' 456' ' ' LEU . 71.0 mt -64.54 -37.14 79.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.929 . . . . 0.0 109.663 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 46.1 t -71.07 -50.56 32.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.254 -0.904 . . . . 0.0 109.618 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 85.9 m95 -69.55 -39.69 77.29 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.902 . . . . 0.0 109.581 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 96.5 m-85 -96.77 16.32 19.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 109.507 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -59.43 -33.76 77.76 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -59.17 -36.85 76.03 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -1.141 . . . . 0.0 109.388 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . 0.577 ' O ' ' HB3' ' B' ' 495' ' ' ALA . 98.0 mt-10 -62.17 -32.37 72.99 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.207 -0.933 . . . . 0.0 109.449 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 117.978 -1.011 . . . . 0.0 109.538 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.492 ' HB3' ' CB ' ' A' ' 325' ' ' SER . 43.5 p90 . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 121.347 0.594 . . . . 0.0 109.47 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -65.93 135.51 95.33 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.161 -0.962 . . . . 0.0 109.377 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -65.68 -25.44 54.16 Favored 'Trans proline' 0 C--O 1.215 -0.657 0 C-N-CA 122.763 2.309 . . . . 0.0 111.79 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.555 ' O ' HD12 ' A' ' 278' ' ' ILE . 19.7 tt -79.54 -21.58 12.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.268 -0.895 . . . . 0.0 109.398 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.77 HD21 ' HE1' ' A' ' 321' ' ' TRP . 5.6 tp -74.08 -37.91 64.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 0.0 109.295 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.65 HD11 ' CD1' ' A' ' 326' ' ' ILE . 3.8 mm? -82.99 -27.74 30.2 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.0 109.488 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.534 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 0.0 OUTLIER -63.75 144.19 97.95 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.149 -0.969 . . . . 0.0 109.542 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 51.1 Cg_endo -71.0 149.55 59.18 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.728 2.285 . . . . 0.0 111.913 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.404 HG12 HD11 ' A' ' 260' ' ' LEU . 0.4 OUTLIER -53.53 -39.22 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.9 . . . . 0.0 109.803 -179.84 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 259' ' ' ASP . 9.3 p-10 -58.52 -31.0 67.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.142 -0.974 . . . . 0.0 109.6 -179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.534 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 68.6 m-20 -74.1 -13.45 60.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.934 . . . . 0.0 109.552 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.404 HD11 HG12 ' A' ' 257' ' ' VAL . 46.1 mt -51.17 144.13 9.81 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.95 . . . . 0.0 109.481 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -68.71 -16.26 63.76 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.296 -0.877 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.762 HD13 ' HB3' ' A' ' 302' ' ' GLU . 28.6 mt -59.72 -174.53 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . 0.47 HG23 ' OE2' ' A' ' 302' ' ' GLU . 22.2 p -87.27 159.09 18.93 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.259 -0.9 . . . . 0.0 109.513 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.725 HG12 ' ND2' ' A' ' 268' ' ' ASN . 13.5 t -56.35 -30.14 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.193 -0.942 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 64.9 ttt180 -56.05 -46.43 78.91 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.225 -0.922 . . . . 0.0 109.366 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.401 ' HB3' ' OE1' ' A' ' 302' ' ' GLU . 87.4 p -66.39 -45.27 80.56 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.231 -0.918 . . . . 0.0 109.451 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.85 -39.4 90.72 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.258 -0.901 . . . . 0.0 109.419 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.725 ' ND2' HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -58.11 -33.21 68.88 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.304 -0.873 . . . . 0.0 109.378 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 92.8 m -59.25 -64.3 0.99 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.2 -0.938 . . . . 0.0 109.41 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.572 ' CD1' HD13 ' A' ' 281' ' ' LEU . 63.6 mt -60.79 -48.2 82.86 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.931 . . . . 0.0 109.329 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.513 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 73.1 tttt -54.47 -38.71 66.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.231 -0.918 . . . . 0.0 109.469 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -55.45 -24.63 31.95 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.301 -0.874 . . . . 0.0 109.416 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.652 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.5 mt-10 -92.22 21.12 5.37 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.273 -0.892 . . . . 0.0 109.471 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.652 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.12 34.34 1.44 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.92 . . . . 0.0 109.604 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 280' ' ' ASP . 85.3 mt -120.73 107.63 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.12 -0.988 . . . . 0.0 109.458 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.513 ' CE1' ' HE3' ' A' ' 271' ' ' LYS . 58.6 m-70 -108.05 -3.99 18.19 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.182 -0.949 . . . . 0.0 109.618 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.6 m-85 -113.98 131.05 56.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.222 -0.924 . . . . 0.0 109.473 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.555 HD12 ' O ' ' A' ' 252' ' ' ILE . 73.8 mt -59.47 -30.43 44.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.192 -0.943 . . . . 0.0 109.384 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.929 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.32 -47.06 16.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.283 -1.527 . . . . 0.0 109.283 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.53 ' HB2' HG23 ' A' ' 275' ' ' ILE . 80.4 m-20 -53.5 -33.66 55.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.077 -1.249 . . . . 0.0 108.997 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.572 HD13 ' CD1' ' A' ' 270' ' ' LEU . 35.0 tp -56.29 -49.28 74.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.41 -0.806 . . . . 0.0 109.134 179.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.929 HG22 ' O ' ' A' ' 279' ' ' GLY . 22.3 m -66.39 -24.18 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.21 -0.931 . . . . 0.0 108.884 179.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -65.05 -35.68 81.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.39 -0.819 . . . . 0.0 108.969 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.6 mtt-85 -98.36 141.22 31.52 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.331 -0.856 . . . . 0.0 109.191 179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 8.1 m -71.38 140.77 50.28 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.531 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.63 ' CD ' HD12 ' A' ' 289' ' ' LEU . 48.4 tp10 -49.98 -29.75 9.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.145 -0.972 . . . . 0.0 109.34 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.0 t -52.59 -51.3 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.302 -0.874 . . . . 0.0 109.163 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -53.36 -34.06 56.08 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.28 -0.888 . . . . 0.0 109.117 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.63 HD12 ' CD ' ' A' ' 286' ' ' GLU . 39.9 mt -63.88 -41.91 97.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.281 -0.887 . . . . 0.0 109.331 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.673 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -66.68 -31.4 72.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.238 -0.914 . . . . 0.0 109.363 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 78.0 mttt -85.22 -10.64 56.35 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.196 -0.94 . . . . 0.0 109.548 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.527 ' HB ' HD13 ' A' ' 295' ' ' LEU . 28.8 m -83.87 113.03 44.92 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.191 -0.943 . . . . 0.0 109.492 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.963 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.1 Cg_endo -70.66 -18.79 32.5 Favored 'Trans proline' 0 C--O 1.216 -0.606 0 C-N-CA 122.753 2.302 . . . . 0.0 111.851 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.713 ' OD1' HD12 ' B' ' 464' ' ' ILE . 71.2 m-80 -56.95 -27.16 60.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.137 -0.977 . . . . 0.0 109.457 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.786 ' N ' HD12 ' A' ' 295' ' ' LEU . 4.1 mp -92.7 136.48 33.19 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.23 -0.919 . . . . 0.0 109.552 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.23 179.46 40.75 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? -62.26 -38.98 91.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -1.125 . . . . 0.0 109.472 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 44.6 mttm -65.89 -43.49 88.11 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.154 -0.966 . . . . 0.0 109.399 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 25.0 m -59.42 -49.86 76.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.467 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.56 HD11 HD11 ' A' ' 290' ' ' LEU . 23.4 tp -52.88 -44.52 66.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.33 -0.856 . . . . 0.0 109.468 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 48.1 m -56.1 -44.42 79.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.221 -0.924 . . . . 0.0 109.414 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.762 ' HB3' HD13 ' A' ' 262' ' ' LEU . 95.5 mt-10 -60.5 -43.29 97.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 109.395 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.506 HD11 HD23 ' A' ' 295' ' ' LEU . 83.9 mt -57.95 -46.97 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.277 -0.889 . . . . 0.0 109.305 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.5 mttm -58.77 -39.99 82.63 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.887 . . . . 0.0 109.38 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -58.63 -50.64 73.08 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.294 -0.879 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 302' ' ' GLU . 1.8 t -67.18 -40.17 84.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.496 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.848 HD13 ' HB3' ' A' ' 313' ' ' SER . 18.5 tp -55.26 -27.46 46.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.311 -0.868 . . . . 0.0 109.421 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.89 -32.94 69.97 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.238 -0.914 . . . . 0.0 109.135 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 22.7 t -74.02 -14.64 61.04 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.312 -0.868 . . . . 0.0 109.333 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.505 ' O ' HD21 ' A' ' 314' ' ' LEU . 66.5 mtt-85 63.59 11.5 5.75 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.315 -0.866 . . . . 0.0 109.197 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.45 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.35 -29.57 52.73 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.762 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.6 pt? -139.74 153.55 47.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.134 -1.215 . . . . 0.0 109.61 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.848 ' HB3' HD13 ' A' ' 307' ' ' LEU . 0.7 OUTLIER 72.21 43.96 0.47 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.231 -0.918 . . . . 0.0 109.516 179.842 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.7 ' N ' HD22 ' A' ' 314' ' ' LEU . 3.4 mm? -86.73 14.52 6.95 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.215 -0.928 . . . . 0.0 109.36 179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.54 36.75 68.5 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.576 ' HE2' HG11 ' A' ' 282' ' ' VAL . 3.4 mtm -90.6 167.81 12.27 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.297 -1.12 . . . . 0.0 109.517 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.636 ' C ' HD12 ' A' ' 318' ' ' LEU . 95.0 mtt180 -142.7 126.02 16.59 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.341 -0.85 . . . . 0.0 109.295 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.724 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.7 mp -138.99 131.91 29.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.68 -52.81 63.9 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.165 -0.959 . . . . 0.0 109.082 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.402 ' O ' ' C ' ' A' ' 321' ' ' TRP . 13.5 t-20 -130.32 36.95 3.92 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.332 -0.855 . . . . 0.0 109.235 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.77 ' HE1' HD21 ' A' ' 253' ' ' LEU . 16.9 t90 44.28 57.13 13.84 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.359 -0.838 . . . . 0.0 109.767 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 321' ' ' TRP . 54.7 Cg_endo -99.9 71.38 0.05 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 123.333 2.688 . . . . 0.0 112.242 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.853 ' CG ' HD12 ' A' ' 326' ' ' ILE . 48.6 Cg_endo -70.18 132.81 23.41 Favored 'Trans proline' 0 C--O 1.216 -0.58 0 C-N-CA 122.288 1.992 . . . . 0.0 111.727 179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.75 -28.0 69.28 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.169 -0.957 . . . . 0.0 109.409 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 249' ' ' PHE . 19.1 m -62.69 -46.1 89.73 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.329 -0.857 . . . . 0.0 109.471 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.853 HD12 ' CG ' ' A' ' 323' ' ' PRO . 63.0 mt -63.09 -28.87 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.549 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.69 147.98 51.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 109.566 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -56.95 -39.24 74.18 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.278 -0.889 . . . . 0.0 109.541 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 118.015 -0.993 . . . . 0.0 109.512 179.943 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 84.2 m-20 -52.2 -38.8 58.96 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.259 -1.142 . . . . 0.0 109.495 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.412 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 17.9 m120 59.08 50.7 7.85 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.414 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 7.7 ttpp -82.62 127.03 71.99 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.371 -0.831 . . . . 0.0 109.531 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.7 Cg_endo -70.69 136.28 30.18 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.662 2.241 . . . . 0.0 111.716 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.722 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.82 158.58 21.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.235 -0.915 . . . . 0.0 109.49 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -61.95 -31.56 71.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 109.551 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -67.38 -44.18 79.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.213 -0.929 . . . . 0.0 109.465 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.862 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.4 tm? -70.0 -38.91 76.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.274 -0.891 . . . . 0.0 109.375 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.769 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -66.6 -33.92 76.75 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.256 -0.902 . . . . 0.0 109.296 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -91.84 11.76 23.74 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.324 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.88 HD13 HD11 ' B' ' 456' ' ' LEU . 47.0 tp -77.93 133.02 38.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.257 -0.902 . . . . 0.0 109.462 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -70.63 145.26 50.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.283 -0.885 . . . . 0.0 109.473 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 88.45 -7.31 82.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 1.084 HG13 HD12 ' B' ' 444' ' ' LEU . 73.2 t -111.68 122.47 66.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.236 -1.155 . . . . 0.0 109.437 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -80.59 158.61 25.67 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.369 -0.832 . . . . 0.0 109.637 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -52.18 -54.34 32.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.193 -0.942 . . . . 0.0 109.348 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -66.67 -35.2 79.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.255 -0.903 . . . . 0.0 108.937 179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.084 HD12 HG13 ' B' ' 440' ' ' VAL . 3.4 tm? -58.95 -42.93 91.0 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.429 -0.795 . . . . 0.0 109.1 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.63 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -58.87 -48.19 82.27 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.339 -0.851 . . . . 0.0 109.025 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -53.38 -41.35 65.81 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.261 -0.899 . . . . 0.0 109.087 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.438 ' HB3' HD13 ' B' ' 470' ' ' ILE . 19.2 mttt -60.05 -38.04 81.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.342 -0.849 . . . . 0.0 109.211 179.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 459' ' ' LEU . 65.1 mt -64.99 -37.87 89.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.289 -0.882 . . . . 0.0 109.38 179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.477 ' O ' ' N ' ' B' ' 452' ' ' GLY . . . -65.46 -37.29 86.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.11 -36.79 6.16 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.307 -0.871 . . . . 0.0 109.583 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.534 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 11.2 mtp-105 -91.14 23.25 3.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.271 -0.893 . . . . 0.0 109.585 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.69 -18.88 6.67 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.888 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.7 t -78.14 111.2 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.895 -1.356 . . . . 0.0 109.325 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.491 ' HB3' ' HA ' ' B' ' 430' ' ' PRO . 12.0 m -126.84 -40.8 1.86 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.26 -0.9 . . . . 0.0 109.712 -179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.722 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -77.93 140.86 39.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.255 -0.903 . . . . 0.0 109.734 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.92 HD11 HD12 ' B' ' 488' ' ' ILE . 0.2 OUTLIER -46.79 -43.78 18.61 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.204 -0.935 . . . . 0.0 108.963 179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -58.43 -40.5 82.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.34 -0.85 . . . . 0.0 109.199 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.591 ' HB3' HG13 ' B' ' 453' ' ' VAL . 92.1 m-20 -59.03 -40.79 86.08 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 0.0 109.208 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.893 HD13 HD13 ' B' ' 448' ' ' LEU . 16.9 tp -64.4 -37.84 88.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 109.446 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -63.2 -34.14 77.0 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.288 -0.882 . . . . 0.0 109.434 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -74.07 -28.0 61.18 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.922 . . . . 0.0 109.476 179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.888 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -68.64 148.4 50.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.426 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -104.43 154.92 17.51 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.963 HD11 ' HG2' ' A' ' 293' ' ' PRO . 22.2 mt -45.3 -36.21 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.089 -1.242 . . . . 0.0 109.406 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.28 -39.03 93.1 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.317 -0.864 . . . . 0.0 109.484 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.409 ' HB3' ' NH1' ' B' ' 451' ' ' ARG . 79.6 m-20 -67.32 -28.47 68.01 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.253 -0.904 . . . . 0.0 109.396 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.745 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.3 mp -79.6 -25.18 41.57 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.274 -0.891 . . . . 0.0 109.367 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.96 -22.55 66.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.24 -0.913 . . . . 0.0 109.367 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -53.37 -32.47 49.45 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.886 . . . . 0.0 109.49 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.438 HD13 ' HB3' ' B' ' 447' ' ' LYS . 76.9 mt -101.1 124.45 54.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.272 -0.892 . . . . 0.0 109.532 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -54.52 -42.88 71.37 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.319 -0.863 . . . . 0.0 109.438 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.1 -27.45 30.85 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.837 HD21 HD21 ' B' ' 444' ' ' LEU . 32.9 mt -95.87 125.94 40.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.517 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.24 164.1 11.96 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.0 109.44 -179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 87.2 m-20 -58.13 -38.45 76.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.255 -0.903 . . . . 0.0 109.714 -179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 44.4 tp10 -75.21 -45.9 37.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.152 -0.968 . . . . 0.0 109.436 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.742 ' O ' HD13 ' B' ' 481' ' ' LEU . 45.2 tttt -60.77 -44.89 96.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.379 -0.825 . . . . 0.0 109.426 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.745 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -63.38 -41.19 98.78 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.189 -0.944 . . . . 0.0 109.598 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.456 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -62.08 -46.91 93.05 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -61.95 -33.55 74.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.288 -1.124 . . . . 0.0 109.618 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.877 ' HB3' HD21 ' B' ' 459' ' ' LEU . 6.8 mp -67.93 -48.64 65.37 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.292 -0.88 . . . . 0.0 109.657 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.962 HD12 ' HB2' ' A' ' 293' ' ' PRO . 50.9 mt -58.07 -56.24 17.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 109.66 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 52.3 mtp -52.93 -38.54 62.03 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -0.88 . . . . 0.0 109.536 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.45 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.16 -47.75 64.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.522 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.54 ' CB ' ' CD2' ' B' ' 456' ' ' LEU . . . -64.81 -44.14 90.86 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.285 -0.884 . . . . 0.0 109.592 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.462 ' NH2' ' CZ2' ' B' ' 490' ' ' TRP . 51.5 ttt85 -58.86 -46.06 88.66 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.242 -0.911 . . . . 0.0 109.608 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 88.4 m-20 -59.62 -41.18 89.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.207 -0.933 . . . . 0.0 109.573 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.92 HD12 HD11 ' B' ' 456' ' ' LEU . 79.5 mt -63.84 -37.01 78.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.225 -0.922 . . . . 0.0 109.622 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.0 t -75.84 -49.78 17.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.693 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . 0.462 ' CZ2' ' NH2' ' B' ' 486' ' ' ARG . 77.7 m95 -68.63 -40.89 80.12 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.622 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.45 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 97.9 m-85 -95.88 4.01 53.15 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.547 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . 0.486 ' CA ' ' O ' ' B' ' 488' ' ' ILE . . . -63.02 -27.08 69.83 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 60.2 t0 -55.21 -36.66 66.19 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -1.14 . . . . 0.0 109.497 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -56.96 143.33 38.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.232 -0.917 . . . . 0.0 109.489 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.487 179.985 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.773 ' CE2' HD12 ' A' ' 253' ' ' LEU . 41.2 t80 . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.461 ' HB3' ' HG ' ' A' ' 253' ' ' LEU . 0.5 OUTLIER -53.93 116.58 10.51 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.236 -0.915 . . . . 0.0 109.242 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.727 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.7 Cg_endo -65.03 -24.47 59.94 Favored 'Trans proline' 0 C--O 1.215 -0.67 0 C-N-CA 122.669 2.246 . . . . 0.0 111.671 -179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.652 HG12 HD21 ' A' ' 312' ' ' LEU . 15.2 tt -68.02 -30.94 49.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.271 -0.893 . . . . 0.0 108.928 179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.881 HD21 ' O ' ' A' ' 311' ' ' GLY . 34.5 mt -74.73 -45.35 44.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.273 -0.892 . . . . 0.0 109.548 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.727 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.6 mt -62.75 -25.52 68.25 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.334 -0.854 . . . . 0.0 109.343 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.473 ' HD3' ' O ' ' A' ' 251' ' ' PRO . 0.6 OUTLIER -58.0 140.7 82.04 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.236 -0.915 . . . . 0.0 108.889 179.295 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.491 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.4 Cg_endo -69.06 129.72 18.87 Favored 'Trans proline' 0 C--O 1.215 -0.646 0 C-N-CA 122.587 2.191 . . . . 0.0 111.977 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.688 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.76 -29.66 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.351 179.871 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.437 ' HA ' ' CB ' ' A' ' 267' ' ' ALA . 96.8 m-20 -64.44 -31.0 72.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.239 -0.913 . . . . 0.0 109.249 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 256' ' ' PRO . 56.4 t0 -70.0 -17.4 63.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.272 -0.892 . . . . 0.0 109.527 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.688 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -43.78 129.14 5.6 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.181 -0.949 . . . . 0.0 109.417 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -56.34 -22.4 30.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.313 -0.867 . . . . 0.0 109.481 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.755 HD12 ' H ' ' A' ' 262' ' ' LEU . 5.5 mp -61.01 172.82 0.9 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.244 -0.91 . . . . 0.0 109.508 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 31.0 p -66.05 168.15 8.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 109.614 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.673 HG12 ' ND2' ' A' ' 268' ' ' ASN . 30.4 t -61.99 -21.77 27.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.218 -0.926 . . . . 0.0 109.603 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.05 -41.09 97.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.175 -0.953 . . . . 0.0 109.213 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 16.2 m -59.97 -49.7 76.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.267 -0.896 . . . . 0.0 109.402 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.437 ' CB ' ' HA ' ' A' ' 258' ' ' ASP . . . -67.55 -40.55 84.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.218 -0.926 . . . . 0.0 109.277 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.673 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.0 m-20 -57.17 -36.94 71.38 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.318 -0.864 . . . . 0.0 109.37 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.441 ' SG ' ' O ' ' A' ' 294' ' ' ASN . 74.3 m -54.17 -65.04 0.64 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.211 -0.931 . . . . 0.0 109.501 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.505 HD21 HD12 ' A' ' 289' ' ' LEU . 64.5 mt -64.4 -45.13 88.97 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.304 -0.873 . . . . 0.0 109.406 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.515 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 34.3 tttt -53.03 -37.75 61.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 109.53 179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.9 -27.55 19.19 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.264 -0.897 . . . . 0.0 109.467 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.625 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 93.8 mt-10 -91.41 21.61 4.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.31 -0.869 . . . . 0.0 109.443 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.625 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.82 34.3 2.01 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 82.7 mt -120.42 107.87 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.388 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.515 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 76.5 m-70 -105.14 -12.19 16.23 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.227 -0.92 . . . . 0.0 109.516 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -108.65 135.35 50.04 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.252 -0.905 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 1.034 HG21 HD23 ' A' ' 312' ' ' LEU . 34.1 mt -62.9 -29.85 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.363 -0.835 . . . . 0.0 109.456 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.911 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.84 -43.1 11.89 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.124 -1.59 . . . . 0.0 109.124 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 77.0 m-20 -53.9 -36.41 62.68 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.056 -1.261 . . . . 0.0 108.818 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.525 ' CD1' ' HG ' ' A' ' 289' ' ' LEU . 33.1 tp -55.79 -47.94 76.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.387 -0.82 . . . . 0.0 109.096 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.911 HG22 ' O ' ' A' ' 279' ' ' GLY . 20.4 m -69.47 -25.53 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.21 -0.931 . . . . 0.0 109.109 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -63.49 -31.52 72.71 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.312 -0.867 . . . . 0.0 108.899 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 61.6 mtt-85 -113.12 151.21 31.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.46 -0.775 . . . . 0.0 109.152 179.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.501 HG22 ' H ' ' A' ' 287' ' ' VAL . 26.7 m -63.78 141.25 58.84 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 0.0 109.585 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.499 ' HA ' HD23 ' A' ' 289' ' ' LEU . 86.4 tt0 -56.06 -33.11 64.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.258 -0.901 . . . . 0.0 109.388 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.737 ' HA ' HD12 ' A' ' 290' ' ' LEU . 47.5 t -52.78 -50.68 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.253 -0.905 . . . . 0.0 109.356 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -51.8 -32.7 32.48 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.156 -0.965 . . . . 0.0 109.046 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.694 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.4 mm? -73.97 -46.48 43.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.414 -0.803 . . . . 0.0 109.173 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 287' ' ' VAL . 7.8 mt -55.69 -20.07 13.02 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.271 -0.893 . . . . 0.0 109.067 179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.576 ' O ' ' HE2' ' B' ' 483' ' ' MET . 54.4 mttm -81.71 -29.85 32.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.843 . . . . 0.0 109.177 179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.494 HG22 ' H ' ' A' ' 294' ' ' ASN . 40.3 m -59.87 125.66 81.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.67 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.4 Cg_endo -71.09 -19.84 29.41 Favored 'Trans proline' 0 C--O 1.215 -0.665 0 C-N-CA 122.676 2.251 . . . . 0.0 111.807 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.712 ' HA ' HD12 ' B' ' 464' ' ' ILE . 77.2 m-20 -64.45 -26.87 68.63 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.269 -0.894 . . . . 0.0 109.623 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 5.8 mt -67.21 144.82 55.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -101.25 146.92 17.54 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -54.03 -40.39 67.03 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.272 -1.134 . . . . 0.0 109.418 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -76.51 -29.96 56.99 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.279 -0.888 . . . . 0.0 109.413 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 71.2 p -64.36 -45.39 87.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.206 -0.934 . . . . 0.0 109.322 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.583 HD11 HD21 ' A' ' 290' ' ' LEU . 53.6 tp -52.91 -45.19 67.48 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.265 -0.897 . . . . 0.0 109.313 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 54.1 m -51.66 -54.48 27.6 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.243 -0.911 . . . . 0.0 109.519 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.475 ' HB2' HD21 ' A' ' 262' ' ' LEU . 94.0 mt-10 -54.74 -46.25 74.25 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.277 -0.889 . . . . 0.0 109.403 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 70.2 mt -58.27 -41.78 81.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.157 -0.964 . . . . 0.0 109.169 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 18.1 mttp -57.36 -40.18 77.54 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.202 -0.936 . . . . 0.0 109.159 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -63.11 -46.49 87.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.382 -0.824 . . . . 0.0 109.227 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -73.05 -35.15 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.24 -0.912 . . . . 0.0 109.205 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.958 HD21 ' OG ' ' A' ' 313' ' ' SER . 3.3 tt -62.37 -26.5 68.49 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.507 179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.36 -35.31 71.76 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.226 -0.921 . . . . 0.0 109.389 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 1.7 t -61.94 -14.38 34.04 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.281 -0.887 . . . . 0.0 109.515 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.442 ' HB2' ' O ' ' A' ' 309' ' ' SER . 31.6 mtt180 72.91 1.42 4.02 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.258 -0.901 . . . . 0.0 109.62 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.881 ' O ' HD21 ' A' ' 253' ' ' LEU . . . -71.49 -22.14 78.64 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.034 HD23 HG21 ' A' ' 278' ' ' ILE . 0.8 OUTLIER -132.09 156.44 46.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.29 -1.123 . . . . 0.0 109.487 -179.946 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.958 ' OG ' HD21 ' A' ' 307' ' ' LEU . 2.3 p 84.56 -141.78 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.732 -0.605 . . . . 0.0 109.793 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.778 HD22 ' OG ' ' A' ' 313' ' ' SER . 3.9 mm? 67.66 14.48 9.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.426 -0.796 . . . . 0.0 109.438 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . 0.427 ' C ' ' O ' ' A' ' 314' ' ' LEU . . . 42.22 45.04 5.08 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.729 -1.348 . . . . 0.0 109.729 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.728 ' HE2' HG11 ' A' ' 282' ' ' VAL . 29.5 mtm -61.67 169.01 2.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.225 -1.162 . . . . 0.0 109.327 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.775 ' C ' HD12 ' A' ' 318' ' ' LEU . 79.9 mtt180 -136.88 130.99 32.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.576 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.775 HD12 ' C ' ' A' ' 317' ' ' ARG . 5.1 mp -136.29 127.69 28.46 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.338 -0.851 . . . . 0.0 109.351 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 318' ' ' LEU . 96.1 mt-10 -43.91 -46.66 8.19 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.291 -0.88 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.494 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 34.1 t30 -131.3 -56.35 1.02 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.366 -0.834 . . . . 0.0 109.241 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.635 ' HE3' HD22 ' A' ' 318' ' ' LEU . 1.6 t-105 164.8 -61.13 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.279 -0.888 . . . . 0.0 109.4 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.509 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 47.5 Cg_endo -67.51 107.75 1.48 Allowed 'Trans proline' 0 C--O 1.215 -0.638 0 C-N-CA 122.71 2.273 . . . . 0.0 111.98 -179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.596 ' HG3' ' CG ' ' A' ' 249' ' ' PHE . 52.0 Cg_endo -74.19 163.91 35.45 Favored 'Trans proline' 0 C--O 1.216 -0.581 0 C-N-CA 122.492 2.128 . . . . 0.0 111.579 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -57.78 -16.53 11.62 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.133 -0.979 . . . . 0.0 109.615 -179.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.2 t -65.14 -46.71 79.82 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.236 -0.915 . . . . 0.0 109.588 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.506 HD11 HD21 ' A' ' 254' ' ' LEU . 28.5 mt -56.39 -38.29 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.21 -0.931 . . . . 0.0 109.573 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -63.31 -34.7 78.25 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.913 . . . . 0.0 109.598 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.18 -37.56 69.74 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.287 -0.883 . . . . 0.0 109.56 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.022 -0.989 . . . . 0.0 109.467 -179.996 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.267 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -61.94 -32.62 73.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.253 -1.145 . . . . 0.0 109.542 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.524 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 16.1 m120 -89.47 19.0 4.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.24 -0.912 . . . . 0.0 109.42 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 2.3 tttm -83.66 136.57 42.07 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.221 -0.924 . . . . 0.0 109.285 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.478 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.2 Cg_endo -69.7 131.73 21.94 Favored 'Trans proline' 0 C--O 1.215 -0.64 0 C-N-CA 122.633 2.222 . . . . 0.0 111.84 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.619 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.7 148.13 52.33 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -0.926 . . . . 0.0 109.37 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -49.55 -33.78 15.8 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.262 -0.899 . . . . 0.0 109.572 -179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -66.69 -46.61 75.05 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.215 -0.928 . . . . 0.0 109.555 -179.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.49 HD11 ' CD1' ' B' ' 448' ' ' LEU . 22.4 tp -69.86 -38.38 76.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.173 -0.954 . . . . 0.0 109.51 -179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.984 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.4 tm? -72.78 -30.3 64.0 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.206 -0.934 . . . . 0.0 109.464 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -91.22 8.68 34.62 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.563 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 1.004 HD22 ' CD1' ' B' ' 456' ' ' LEU . 37.4 tp -72.94 138.75 46.31 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.227 -0.921 . . . . 0.0 109.436 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -80.69 138.01 36.34 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.439 -179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.29 5.37 63.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.893 HG21 HD23 ' B' ' 437' ' ' LEU . 59.6 t -122.92 132.66 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.228 -1.16 . . . . 0.0 109.382 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -86.85 150.32 24.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.246 -0.909 . . . . 0.0 109.471 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 73.3 mtt180 -49.83 -45.45 50.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.0 109.378 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.586 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 92.4 m-20 -64.75 -46.07 83.74 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.227 -0.921 . . . . 0.0 109.231 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.991 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.1 tp -53.9 -43.32 69.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.304 -0.873 . . . . 0.0 109.105 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.57 -41.58 90.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.343 -0.848 . . . . 0.0 109.138 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.586 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 16.7 m-30 -56.84 -44.4 82.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.233 -0.917 . . . . 0.0 109.103 179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.902 ' HB3' HG21 ' B' ' 470' ' ' ILE . 20.3 mttm -60.83 -40.39 92.6 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.353 -0.842 . . . . 0.0 109.364 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.49 ' CD1' HD11 ' B' ' 434' ' ' LEU . 89.0 mt -60.25 -47.02 87.78 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.209 -0.932 . . . . 0.0 109.376 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -60.94 -34.51 74.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 109.481 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -48.13 -35.4 11.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.298 -0.876 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.652 ' HG3' HD11 ' B' ' 470' ' ' ILE . 47.2 mtp180 -91.11 22.93 3.48 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.28 -0.888 . . . . 0.0 109.431 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.79 -18.74 7.02 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.73 HG13 ' HB3' ' B' ' 458' ' ' ASP . 21.4 t -78.12 108.28 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.899 -1.354 . . . . 0.0 109.359 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.482 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 95.3 m -119.84 -42.56 2.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.227 -0.921 . . . . 0.0 109.758 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.619 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -74.91 140.8 44.02 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.273 -0.892 . . . . 0.0 109.595 -179.818 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 1.004 ' CD1' HD22 ' B' ' 437' ' ' LEU . 27.0 tp -49.97 -41.61 47.12 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.293 -0.88 . . . . 0.0 109.036 179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . 0.402 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 31.7 mm-40 -57.32 -46.22 83.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.345 -0.847 . . . . 0.0 108.953 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.73 ' HB3' HG13 ' B' ' 453' ' ' VAL . 70.6 m-20 -58.24 -38.73 77.46 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.303 -0.873 . . . . 0.0 109.101 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.761 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -62.35 -42.85 99.73 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.347 -0.846 . . . . 0.0 109.18 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.83 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -60.42 -35.79 76.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.213 179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -63.47 -30.81 71.88 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.278 -0.889 . . . . 0.0 109.389 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.493 ' HG3' HG21 ' B' ' 453' ' ' VAL . 95.0 mm-40 -67.38 156.29 36.88 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.273 -0.892 . . . . 0.0 109.514 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -108.12 161.46 13.43 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.442 -1.463 . . . . 0.0 109.442 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.712 HD12 ' HA ' ' A' ' 294' ' ' ASN . 68.1 mt -52.75 -35.65 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.188 -1.184 . . . . 0.0 109.518 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -70.12 -33.81 72.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -72.17 -31.47 65.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.252 -0.905 . . . . 0.0 109.264 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.033 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.1 mt -77.15 -33.89 56.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.303 -0.873 . . . . 0.0 109.38 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -60.57 -18.81 55.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.295 -0.878 . . . . 0.0 109.517 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -62.98 -39.09 93.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -0.932 . . . . 0.0 109.479 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.902 HG21 ' HB3' ' B' ' 447' ' ' LYS . 88.1 mt -82.54 129.6 37.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -0.91 . . . . 0.0 109.439 -179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -61.47 152.65 29.41 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.212 -0.93 . . . . 0.0 109.576 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 91.52 -33.49 4.76 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.991 ' CD2' HD11 ' B' ' 444' ' ' LEU . 66.9 mt -85.99 126.6 34.25 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.268 -1.136 . . . . 0.0 109.553 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 475' ' ' ASP . 35.4 m -103.64 161.98 13.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.224 -0.923 . . . . 0.0 109.467 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.493 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 87.8 m-20 -59.55 -36.03 75.37 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.188 -0.945 . . . . 0.0 109.43 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -76.03 -46.04 31.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.232 -0.917 . . . . 0.0 109.401 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.448 ' CE ' HD22 ' B' ' 444' ' ' LEU . 34.4 tttp -65.1 -47.58 76.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 0.0 109.34 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.033 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -57.83 -44.51 86.51 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.268 -0.895 . . . . 0.0 109.311 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.53 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -59.31 -47.67 89.7 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -52.63 -47.29 67.13 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.333 -1.098 . . . . 0.0 109.48 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.555 HD22 ' CG2' ' B' ' 440' ' ' VAL . 28.0 mt -61.64 -36.47 80.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.256 -0.903 . . . . 0.0 109.493 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 57.9 mt -62.52 -53.64 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.576 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 33.9 mtp -54.24 -48.92 70.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -0.901 . . . . 0.0 109.583 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -52.67 -56.16 17.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.264 -0.898 . . . . 0.0 109.54 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.83 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -60.19 -49.35 77.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 109.572 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.565 ' CG ' ' HB1' ' B' ' 460' ' ' ALA . 90.3 mtt180 -59.63 -42.05 91.84 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.158 -0.964 . . . . 0.0 109.501 -179.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.492 ' O ' ' CD1' ' B' ' 491' ' ' PHE . 99.5 m-20 -58.36 -42.75 87.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.243 -0.911 . . . . 0.0 109.475 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.962 HD12 ' CD2' ' B' ' 456' ' ' LEU . 38.3 mt -64.34 -38.32 82.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.241 -0.912 . . . . 0.0 109.45 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . 0.402 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 0.0 OUTLIER -75.96 -51.92 11.37 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.24 -0.913 . . . . 0.0 109.489 179.948 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 93.5 m95 -63.22 -28.01 69.75 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.35 -0.844 . . . . 0.0 109.42 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.492 ' CD1' ' O ' ' B' ' 487' ' ' ASN . 3.6 m-30 -72.23 -34.36 68.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.247 -0.908 . . . . 0.0 109.46 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -53.82 -34.58 51.35 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -56.29 -40.05 73.67 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.233 -1.157 . . . . 0.0 109.569 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -61.37 -32.51 72.42 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.516 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.549 -179.979 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.6 ' N ' ' HG ' ' A' ' 325' ' ' SER . 14.3 p90 . . . . . 0 N--CA 1.49 1.544 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -54.47 126.74 56.42 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.228 -0.92 . . . . 0.0 109.382 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.776 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -65.25 -27.49 56.03 Favored 'Trans proline' 0 C--O 1.217 -0.559 0 C-N-CA 122.674 2.25 . . . . 0.0 111.601 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.709 HD11 HD22 ' A' ' 312' ' ' LEU . 8.3 tt -69.07 -28.8 40.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.284 -0.885 . . . . 0.0 108.911 179.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.638 HD13 HG21 ' A' ' 282' ' ' VAL . 26.2 mt -74.54 -43.42 55.87 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.334 -0.854 . . . . 0.0 109.421 179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.776 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.7 mt -64.18 -32.31 73.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.263 -0.898 . . . . 0.0 109.56 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.451 ' O ' HG13 ' A' ' 278' ' ' ILE . 5.7 ttp180 -55.82 135.89 72.46 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.138 -0.976 . . . . 0.0 109.077 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.476 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.6 Cg_endo -68.58 129.79 19.57 Favored 'Trans proline' 0 C--O 1.214 -0.692 0 C-N-CA 122.641 2.227 . . . . 0.0 111.842 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.818 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.3 OUTLIER -44.69 -25.67 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 0.0 109.35 179.935 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.401 ' N ' ' O ' ' A' ' 256' ' ' PRO . 97.8 m-20 -67.18 -30.88 70.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.197 -0.939 . . . . 0.0 109.21 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.476 ' N ' ' O ' ' A' ' 256' ' ' PRO . 37.0 m-20 -75.36 -9.72 58.81 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.34 -0.85 . . . . 0.0 109.517 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.818 HD13 ' HA ' ' A' ' 257' ' ' VAL . 4.5 mp -43.77 127.18 4.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.264 -0.897 . . . . 0.0 109.464 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 262' ' ' LEU . 97.0 mt-10 -62.63 -27.84 69.49 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 0.0 109.58 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.758 HD13 ' HG2' ' A' ' 302' ' ' GLU . 18.8 mt -54.41 -170.08 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.973 . . . . 0.0 109.457 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 3.7 p -80.41 159.72 25.58 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.185 -0.947 . . . . 0.0 109.374 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.59 HG12 ' ND2' ' A' ' 268' ' ' ASN . 19.5 t -53.43 -30.58 17.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.252 -0.905 . . . . 0.0 109.375 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 -52.37 -45.53 65.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.464 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 19.4 m -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.309 -0.87 . . . . 0.0 109.498 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -65.84 -37.92 87.48 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.228 -0.92 . . . . 0.0 109.539 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.59 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.4 m-20 -59.79 -34.29 72.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.237 -0.914 . . . . 0.0 109.522 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.478 ' SG ' ' CB ' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -58.29 -64.0 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 109.539 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 50.9 mt -61.45 -45.4 94.46 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.186 -0.946 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -52.9 -40.38 63.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.452 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -61.11 -25.05 66.7 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.195 -0.941 . . . . 0.0 109.473 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.609 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 73.4 mm-40 -88.51 17.42 5.39 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.277 -0.889 . . . . 0.0 109.378 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.609 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 70.63 33.32 2.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 0.0 109.35 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.769 HG23 ' HB2' ' A' ' 280' ' ' ASP . 79.0 mt -108.59 127.05 65.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 109.429 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.503 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 8.5 p80 -112.23 -35.02 5.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.198 -0.939 . . . . 0.0 109.57 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.503 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 3.1 m-30 -110.07 128.8 55.64 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.207 -0.933 . . . . 0.0 109.437 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.687 HD11 HD11 ' A' ' 260' ' ' LEU . 76.6 mt -46.45 -29.92 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.335 -0.853 . . . . 0.0 109.459 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.836 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.82 -47.15 13.93 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.156 -1.578 . . . . 0.0 109.156 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.769 ' HB2' HG23 ' A' ' 275' ' ' ILE . 54.0 m-20 -53.36 -30.87 41.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.1 -1.235 . . . . 0.0 108.798 179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 289' ' ' LEU . 41.8 tp -59.74 -49.71 76.66 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.468 -0.77 . . . . 0.0 109.273 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.836 HG22 ' O ' ' A' ' 279' ' ' GLY . 27.3 m -65.71 -29.99 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.152 -0.967 . . . . 0.0 108.866 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 60.6 tt0 -60.9 -33.99 73.98 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.371 -0.831 . . . . 0.0 108.961 179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.451 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 56.1 mtt180 -100.12 143.33 30.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.27 -0.894 . . . . 0.0 109.299 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.3 m -69.03 143.53 54.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.243 -0.911 . . . . 0.0 109.632 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -54.29 -28.3 41.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.264 -0.897 . . . . 0.0 109.333 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 43.1 t -52.83 -50.28 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.227 -0.921 . . . . 0.0 109.304 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.451 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.2 mt-10 -52.19 -33.29 40.15 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.266 -0.896 . . . . 0.0 109.326 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.997 HD11 HD11 ' A' ' 281' ' ' LEU . 60.8 mt -70.88 -30.61 67.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.0 109.239 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . . . . . . . . . 25.8 tp -71.64 -31.69 67.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.298 -0.876 . . . . 0.0 109.31 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.547 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 83.3 mttt -81.8 -14.3 56.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.285 -0.884 . . . . 0.0 109.02 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 77.0 m -81.76 115.88 59.74 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.287 -0.883 . . . . 0.0 109.409 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 1.007 ' HB2' HD12 ' B' ' 482' ' ' ILE . 52.5 Cg_endo -70.62 -16.91 33.96 Favored 'Trans proline' 0 C--O 1.215 -0.635 0 C-N-CA 122.698 2.265 . . . . 0.0 111.773 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.772 ' ND2' HD12 ' B' ' 464' ' ' ILE . 27.0 m120 -47.21 -33.13 5.06 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.431 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.507 HD23 ' H ' ' A' ' 295' ' ' LEU . 0.4 OUTLIER -107.26 137.12 45.9 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.293 -0.879 . . . . 0.0 109.441 179.94 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -81.58 172.06 53.24 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 7.5 tptt -57.75 -41.97 83.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -1.126 . . . . 0.0 109.408 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 64.0 mttp -63.46 -35.97 82.2 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.21 -0.932 . . . . 0.0 109.298 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 28.2 m -58.3 -37.42 75.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.256 -0.903 . . . . 0.0 109.329 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 28.7 tp -53.97 -33.54 57.22 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.211 -0.93 . . . . 0.0 109.292 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 7.3 m -60.93 -57.46 12.55 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.206 -0.934 . . . . 0.0 109.242 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.758 ' HG2' HD13 ' A' ' 262' ' ' LEU . 42.8 tt0 -53.57 -46.12 70.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.196 -0.94 . . . . 0.0 108.996 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.474 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 56.2 mt -57.74 -50.73 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 19.4 tttm -56.11 -38.73 71.16 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.35 -0.844 . . . . 0.0 108.761 179.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 302' ' ' GLU . 64.4 m-20 -53.85 -45.66 71.01 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 1.037 HG12 ' CD2' ' A' ' 312' ' ' LEU . 4.5 t -66.86 -40.81 86.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.343 -0.848 . . . . 0.0 108.865 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.532 ' CD2' ' HB2' ' A' ' 313' ' ' SER . 21.3 mt -53.83 -25.65 20.54 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.455 -0.778 . . . . 0.0 109.441 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.18 -28.9 63.22 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.207 -0.933 . . . . 0.0 108.983 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 4.3 p -71.4 -9.09 57.6 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.416 -0.803 . . . . 0.0 109.203 179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.685 ' HA ' HD11 ' A' ' 314' ' ' LEU . 55.6 mtm180 53.01 19.35 1.34 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.319 -0.863 . . . . 0.0 109.242 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.52 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -107.96 0.22 33.78 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.037 ' CD2' HG12 ' A' ' 306' ' ' VAL . 0.6 OUTLIER -147.23 145.87 29.61 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.107 -1.231 . . . . 0.0 109.644 -179.96 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.574 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.5 OUTLIER 58.13 46.69 15.69 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.312 -0.868 . . . . 0.0 109.398 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.685 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -90.46 23.95 2.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.252 -0.905 . . . . 0.0 109.367 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.2 39.3 95.76 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.141 -1.584 . . . . 0.0 109.141 -179.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.748 ' HE2' HG11 ' A' ' 282' ' ' VAL . 1.3 mtm -93.63 170.95 9.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.317 -1.108 . . . . 0.0 109.434 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.453 ' C ' HD23 ' A' ' 318' ' ' LEU . 67.4 mtm-85 -136.15 117.05 14.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.32 -0.862 . . . . 0.0 109.478 179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.453 HD23 ' C ' ' A' ' 317' ' ' ARG . 4.5 mt -112.47 139.81 47.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.354 179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -66.88 -35.37 79.86 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.182 -0.949 . . . . 0.0 109.256 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.518 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 24.7 m120 -140.46 -47.17 0.42 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.27 -0.894 . . . . 0.0 109.157 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.604 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.52 -62.83 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 179.774 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.514 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.2 Cg_endo -67.87 107.04 1.42 Allowed 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.549 2.166 . . . . 0.0 111.891 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.987 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.6 Cg_endo -69.65 165.18 31.71 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.665 2.243 . . . . 0.0 111.85 179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.93 -15.72 56.62 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.331 -0.856 . . . . 0.0 109.499 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 249' ' ' PHE . 97.0 p -85.82 -26.27 25.81 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.211 -0.93 . . . . 0.0 109.454 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.987 HG22 ' O ' ' A' ' 323' ' ' PRO . 16.3 tt -57.22 -23.0 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.309 -0.869 . . . . 0.0 109.485 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -68.37 140.61 55.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.285 -0.884 . . . . 0.0 109.418 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -59.79 -37.98 80.62 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.202 -0.936 . . . . 0.0 109.479 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.956 -1.021 . . . . 0.0 109.437 179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.426 -1.469 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -57.08 -39.95 75.96 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.269 -1.136 . . . . 0.0 109.424 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.718 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 25.6 m120 -83.95 8.04 16.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.551 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.459 ' HG3' ' HD2' ' B' ' 430' ' ' PRO . 4.5 tttm -53.98 131.94 58.61 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.178 -0.951 . . . . 0.0 109.459 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.6 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.9 Cg_endo -70.3 144.42 51.09 Favored 'Trans proline' 0 C--O 1.215 -0.658 0 C-N-CA 122.627 2.218 . . . . 0.0 111.833 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.572 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -79.45 161.06 26.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.339 -0.851 . . . . 0.0 109.453 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . 0.445 ' O ' ' N ' ' B' ' 436' ' ' ASN . 85.9 m-20 -52.09 -37.55 54.38 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . 0.495 ' CB ' ' HB3' ' B' ' 456' ' ' LEU . 16.7 m-20 -61.08 -50.12 74.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.321 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.6 HD23 ' HB3' ' B' ' 430' ' ' PRO . 23.2 tp -68.91 -38.07 79.35 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.403 -0.811 . . . . 0.0 109.703 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.971 HD13 ' O ' ' B' ' 435' ' ' LEU . 1.1 tm? -77.04 -29.6 55.3 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 0.0 109.563 -179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' B' ' 432' ' ' ASP . 78.9 m-20 -93.77 10.87 31.25 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.279 -0.888 . . . . 0.0 109.551 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.487 HD23 HG21 ' B' ' 440' ' ' VAL . 29.1 tp -75.53 133.22 41.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.56 179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -72.57 143.29 48.32 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.278 -0.889 . . . . 0.0 109.504 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 90.6 -4.76 82.35 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.714 ' CG2' HD22 ' B' ' 481' ' ' LEU . 49.6 t -126.56 135.77 62.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.191 -1.182 . . . . 0.0 109.419 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.509 ' OD1' HD12 ' B' ' 444' ' ' LEU . 49.6 p30 -103.41 175.08 5.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.254 -0.904 . . . . 0.0 109.407 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.534 ' HG2' HD21 ' B' ' 435' ' ' LEU . 64.4 mtm180 -61.61 -38.19 86.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.221 -0.924 . . . . 0.0 109.438 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -63.18 -41.06 99.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.32 -0.863 . . . . 0.0 109.454 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.513 HD13 ' HZ1' ' B' ' 477' ' ' LYS . 21.9 mt -72.23 -39.74 68.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.289 -0.882 . . . . 0.0 109.478 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -61.21 -35.82 78.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.302 -0.873 . . . . 0.0 109.439 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.456 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 15.2 m-30 -73.08 -46.07 53.6 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.32 -0.862 . . . . 0.0 109.505 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.521 ' HD3' ' CG2' ' B' ' 470' ' ' ILE . 17.5 ttmt -61.65 -44.14 97.52 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.639 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.867 HD11 HG21 ' B' ' 453' ' ' VAL . 2.9 tm? -65.62 -45.45 83.07 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.187 -0.946 . . . . 0.0 109.485 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.718 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.93 -31.36 62.85 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.187 -0.946 . . . . 0.0 109.564 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.39 -20.55 4.68 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.469 -179.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.593 ' CG ' HD11 ' B' ' 470' ' ' ILE . 11.4 mtp-105 -89.62 32.03 0.9 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.245 -0.909 . . . . 0.0 109.529 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.88 -18.72 7.17 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.391 -1.083 . . . . 0.0 110.391 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.867 HG21 HD11 ' B' ' 448' ' ' LEU . 48.0 t -61.71 137.1 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 120.815 -1.403 . . . . 0.0 109.318 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.451 ' O ' ' N ' ' B' ' 431' ' ' ALA . 1.0 OUTLIER -133.17 -34.63 1.07 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.139 -0.976 . . . . 0.0 109.783 -179.825 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.572 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.4 OUTLIER -116.93 144.0 45.05 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.064 -1.022 . . . . 0.0 109.972 -179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.816 HD11 ' HA ' ' B' ' 485' ' ' ALA . 1.4 tm? -45.47 -39.43 7.19 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.348 -0.845 . . . . 0.0 108.889 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . 0.422 ' N ' HD13 ' B' ' 456' ' ' LEU . 44.8 mm-40 -55.68 -49.43 72.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.241 -0.912 . . . . 0.0 108.882 179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -55.13 -41.66 72.0 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.855 . . . . 0.0 108.946 179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.597 HD13 ' CD1' ' B' ' 434' ' ' LEU . 4.0 tt -55.86 -48.46 75.48 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.317 -0.864 . . . . 0.0 109.278 179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.871 ' HB2' ' CB ' ' B' ' 485' ' ' ALA . . . -57.38 -33.09 67.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.253 -0.905 . . . . 0.0 109.313 179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -66.54 -22.64 66.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.365 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . . . . . . . . . 95.9 mm-40 -76.75 160.94 28.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -116.94 152.87 17.67 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.938 HD11 ' HG2' ' A' ' 293' ' ' PRO . 57.8 mt -44.93 -42.49 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.207 -1.172 . . . . 0.0 109.343 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 85.4 m-20 -59.05 -39.78 83.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.343 -0.848 . . . . 0.0 109.407 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -69.79 -29.06 66.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 109.358 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.026 HD12 ' HB1' ' B' ' 478' ' ' ALA . 20.8 mt -78.4 -28.25 46.86 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.255 -0.903 . . . . 0.0 109.43 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.6 -25.57 62.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.269 -0.894 . . . . 0.0 109.562 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -51.05 -31.28 18.11 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.949 . . . . 0.0 109.452 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.593 HD11 ' CG ' ' B' ' 451' ' ' ARG . 60.0 mt -103.79 121.83 55.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.221 -0.924 . . . . 0.0 109.569 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -61.37 -32.55 72.46 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.286 -0.884 . . . . 0.0 109.302 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -52.78 -26.48 25.59 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.35 -1.5 . . . . 0.0 109.35 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.451 ' CD1' HD23 ' B' ' 448' ' ' LEU . 64.0 mt -108.82 139.26 43.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.292 -1.122 . . . . 0.0 109.523 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.493 HG22 ' N ' ' B' ' 475' ' ' ASP . 24.7 m -103.7 164.66 11.53 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.232 -0.918 . . . . 0.0 109.426 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.493 ' N ' HG22 ' B' ' 474' ' ' THR . 81.6 m-20 -60.49 -37.15 80.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.9 . . . . 0.0 109.415 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -75.47 -46.02 35.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.231 -0.918 . . . . 0.0 109.509 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.513 ' HZ1' HD13 ' B' ' 444' ' ' LEU . 64.4 tttm -63.92 -40.5 96.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.194 -0.941 . . . . 0.0 109.445 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.026 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -64.91 -39.83 94.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.482 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -63.16 -42.36 99.46 Favored Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -63.15 -37.09 85.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.241 -1.152 . . . . 0.0 109.573 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.714 HD22 ' CG2' ' B' ' 440' ' ' VAL . 29.2 mt -67.16 -38.63 85.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 1.007 HD12 ' HB2' ' A' ' 293' ' ' PRO . 26.3 mt -65.4 -56.02 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.173 -0.954 . . . . 0.0 109.558 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.547 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.4 mtp -52.36 -36.77 54.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.284 -0.885 . . . . 0.0 109.386 -179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.449 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -71.66 -44.53 64.12 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.3 -0.875 . . . . 0.0 109.234 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.871 ' CB ' ' HB2' ' B' ' 460' ' ' ALA . . . -62.86 -52.02 64.73 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.267 -0.896 . . . . 0.0 109.475 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . . . . . . . . . 68.2 mtt180 -58.08 -41.74 84.1 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.304 -0.873 . . . . 0.0 109.387 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.58 ' O ' ' CG ' ' B' ' 491' ' ' PHE . 97.2 m-20 -57.46 -35.88 70.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.253 -0.905 . . . . 0.0 109.227 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.449 HG13 ' O ' ' B' ' 484' ' ' ALA . 88.1 mt -70.88 -36.89 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.154 -0.966 . . . . 0.0 109.254 179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 11.3 t -74.63 -51.69 13.76 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.286 -0.884 . . . . 0.0 109.755 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -61.73 -30.7 70.94 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.206 -0.934 . . . . 0.0 109.725 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.58 ' CG ' ' O ' ' B' ' 487' ' ' ASN . 19.5 m-30 -82.95 -34.27 26.54 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.072 -1.017 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 55.58 -124.45 33.55 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.386 -1.485 . . . . 0.0 109.386 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 81.0 m-20 -45.38 -47.67 13.49 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.223 -1.163 . . . . 0.0 109.253 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . 0.423 ' O ' ' HB3' ' B' ' 491' ' ' PHE . 81.3 tt0 -66.63 141.44 57.81 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 109.395 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.023 -0.989 . . . . 0.0 109.396 -179.971 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.423 ' CD2' HD22 ' A' ' 253' ' ' LEU . 23.4 t80 . . . . . 0 N--CA 1.489 1.523 0 CA-C-O 121.26 0.553 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.427 ' CG ' ' HD2' ' A' ' 251' ' ' PRO . 0.7 OUTLIER -55.17 142.81 56.89 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.258 -0.901 . . . . 0.0 109.601 -179.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.506 ' HB2' ' NH2' ' A' ' 255' ' ' ARG . 43.5 Cg_endo -65.46 -22.97 58.54 Favored 'Trans proline' 0 C--O 1.215 -0.656 0 C-N-CA 122.807 2.338 . . . . 0.0 111.654 179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.533 HG21 ' CA ' ' A' ' 311' ' ' GLY . 10.3 tt -70.01 -28.66 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.293 -0.88 . . . . 0.0 108.927 179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.858 HD23 ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -69.23 -38.5 78.54 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.227 179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.858 ' CD2' HD23 ' A' ' 253' ' ' LEU . 3.8 mm? -86.04 -24.0 26.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.223 -0.923 . . . . 0.0 109.365 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.524 ' HG2' ' CB ' ' A' ' 259' ' ' ASP . 4.8 ttm-85 -64.03 145.02 98.15 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.302 -0.874 . . . . 0.0 109.454 -179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 255' ' ' ARG . 48.8 Cg_endo -70.01 136.72 33.03 Favored 'Trans proline' 0 C--O 1.215 -0.631 0 C-N-CA 122.728 2.285 . . . . 0.0 111.837 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.9 HG11 HD12 ' A' ' 270' ' ' LEU . 0.1 OUTLIER -45.74 -33.38 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.895 . . . . 0.0 109.522 -179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.473 ' OD1' ' HB1' ' A' ' 267' ' ' ALA . 95.1 m-20 -62.51 -30.83 71.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.187 -0.946 . . . . 0.0 109.468 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.524 ' CB ' ' HG2' ' A' ' 255' ' ' ARG . 25.5 m-20 -68.24 -9.61 48.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.242 -0.911 . . . . 0.0 109.502 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.651 HD21 HD13 ' A' ' 278' ' ' ILE . 51.2 mt -66.18 139.38 58.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 0.0 109.534 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.433 ' O ' ' O ' ' A' ' 262' ' ' LEU . 74.8 mm-40 -69.38 -20.23 63.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.301 -0.874 . . . . 0.0 109.497 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.816 HD22 ' CG ' ' A' ' 302' ' ' GLU . 26.2 mt -52.46 -176.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.283 -0.886 . . . . 0.0 109.525 -179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 6.2 p -80.69 160.15 25.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.29 -0.881 . . . . 0.0 109.42 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.558 HG12 ' OD1' ' A' ' 268' ' ' ASN . 21.2 t -55.21 -27.64 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.254 -0.904 . . . . 0.0 109.41 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -51.97 -48.0 64.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.305 -0.872 . . . . 0.0 109.411 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.0 m -58.97 -50.97 72.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 109.339 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.473 ' HB1' ' OD1' ' A' ' 258' ' ' ASP . . . -65.32 -33.27 75.57 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.263 -0.898 . . . . 0.0 109.422 179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.558 ' OD1' HG12 ' A' ' 264' ' ' VAL . 95.5 m-20 -61.38 -37.73 84.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.236 -0.915 . . . . 0.0 109.38 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.8 m -53.24 -64.55 0.79 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.9 HD12 HG11 ' A' ' 257' ' ' VAL . 57.7 mt -66.51 -45.24 80.21 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.239 -0.913 . . . . 0.0 109.408 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 21.4 tptm -53.19 -40.06 64.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.266 -0.896 . . . . 0.0 109.473 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.12 -21.42 65.85 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.378 -0.826 . . . . 0.0 109.481 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.604 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 96.6 mt-10 -94.14 23.36 5.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.937 . . . . 0.0 109.509 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.61 17.62 7.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.277 -0.889 . . . . 0.0 109.481 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.524 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 56.2 mt -104.81 122.98 58.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.225 -0.922 . . . . 0.0 109.477 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.468 ' ND1' ' HD2' ' A' ' 271' ' ' LYS . 92.2 m-70 -113.09 -12.87 13.11 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.214 -0.929 . . . . 0.0 109.72 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.57 ' CD2' ' O ' ' A' ' 254' ' ' LEU . 4.5 m-85 -112.84 141.4 46.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 109.935 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.78 HG21 HD23 ' A' ' 312' ' ' LEU . 74.3 mt -65.1 -28.97 45.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.436 -0.79 . . . . 0.0 109.444 179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.818 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.26 -47.5 10.92 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.361 -1.495 . . . . 0.0 109.361 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.524 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 67.8 m-20 -53.35 -32.96 51.66 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.99 -1.3 . . . . 0.0 108.893 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.81 HD13 HD11 ' A' ' 270' ' ' LEU . 26.7 tp -55.65 -50.73 69.43 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.435 -0.79 . . . . 0.0 109.183 179.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.818 HG22 ' O ' ' A' ' 279' ' ' GLY . 28.2 m -66.77 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 0.0 108.787 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -54.92 -35.42 64.14 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.293 -0.879 . . . . 0.0 108.668 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -107.58 144.07 35.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.384 -0.823 . . . . 0.0 109.076 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 45.6 p -76.23 157.15 32.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 0.0 109.561 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.628 ' OE2' HD22 ' A' ' 307' ' ' LEU . 10.0 mt-10 -56.16 -38.63 71.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.256 -0.903 . . . . 0.0 109.297 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.927 ' HA ' HD12 ' A' ' 290' ' ' LEU . 41.2 t -52.88 -52.78 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.318 -0.864 . . . . 0.0 109.283 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -54.55 -32.3 58.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.273 -0.892 . . . . 0.0 109.243 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.87 ' O ' HG22 ' A' ' 292' ' ' THR . 7.6 mp -80.42 -33.08 37.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.395 -0.816 . . . . 0.0 109.42 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.927 HD12 ' HA ' ' A' ' 287' ' ' VAL . 4.9 mt -69.66 -17.12 63.47 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.168 -0.958 . . . . 0.0 109.353 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' B' ' 483' ' ' MET . 33.8 mmtt -86.48 10.95 13.7 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 0.0 109.482 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.87 HG22 ' O ' ' A' ' 289' ' ' LEU . 7.3 t -125.82 142.72 43.0 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.219 -0.926 . . . . 0.0 109.607 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.918 ' HG2' HD11 ' B' ' 464' ' ' ILE . 51.9 Cg_endo -71.35 -20.71 27.43 Favored 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.796 2.33 . . . . 0.0 111.941 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' B' ' 464' ' ' ILE . 21.8 m120 -43.3 -44.14 5.31 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.301 -0.874 . . . . 0.0 109.634 -179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.513 HD21 ' CG2' ' A' ' 292' ' ' THR . 0.2 OUTLIER -107.64 137.07 46.32 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.499 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -91.73 -179.16 42.07 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.315 -1.514 . . . . 0.0 109.315 179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -63.35 -44.19 95.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.152 -1.204 . . . . 0.0 109.395 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -60.85 -42.57 98.06 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.233 -0.917 . . . . 0.0 109.425 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 24.4 m -54.9 -46.32 74.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.23 -0.918 . . . . 0.0 109.31 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.827 ' O ' HD13 ' A' ' 300' ' ' LEU . 2.3 tm? -52.68 -45.11 66.68 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.261 -0.9 . . . . 0.0 109.241 179.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 23.9 m -50.84 -51.54 50.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.111 -0.993 . . . . 0.0 109.091 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.816 ' CG ' HD22 ' A' ' 262' ' ' LEU . 38.6 tp10 -54.19 -42.33 69.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.262 -0.899 . . . . 0.0 108.961 179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 23.7 mm -57.95 -41.15 79.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.313 -0.867 . . . . 0.0 108.892 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . 0.769 ' HE3' HD12 ' A' ' 300' ' ' LEU . 82.9 mttt -59.43 -40.53 87.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.327 -0.858 . . . . 0.0 108.872 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 61.3 t0 -59.18 -46.97 87.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.333 -0.854 . . . . 0.0 108.998 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.662 ' CG1' HD11 ' A' ' 312' ' ' LEU . 6.0 t -70.14 -37.4 71.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.327 -0.858 . . . . 0.0 109.109 179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.628 HD22 ' OE2' ' A' ' 286' ' ' GLU . 19.9 tp -61.38 -27.3 68.42 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.487 -0.758 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.33 -38.34 76.93 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.241 -0.912 . . . . 0.0 109.162 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.6 OUTLIER -79.21 -0.22 31.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.302 -0.874 . . . . 0.0 109.501 179.62 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.792 ' HA ' HD11 ' A' ' 314' ' ' LEU . 64.4 mtt180 63.24 11.04 5.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.203 -0.936 . . . . 0.0 109.182 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.533 ' CA ' HG21 ' A' ' 252' ' ' ILE . . . -64.75 -51.1 54.69 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.78 HD23 HG21 ' A' ' 278' ' ' ILE . 0.5 OUTLIER -144.41 168.53 19.9 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.234 -1.156 . . . . 0.0 109.566 -179.967 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.576 ' O ' HD13 ' A' ' 307' ' ' LEU . 0.3 OUTLIER 72.4 32.33 1.65 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.34 -0.85 . . . . 0.0 109.529 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.3 mm? -75.85 -4.9 43.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.284 -0.885 . . . . 0.0 109.546 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 65.51 41.24 96.34 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . . . . . . . . . 5.7 ptt? -111.54 157.96 19.75 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.264 -1.139 . . . . 0.0 109.638 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 59.2 mtt85 -115.19 133.45 56.03 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.338 -0.852 . . . . 0.0 109.223 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.18 140.76 40.93 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.473 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 45.4 tp10 -58.28 -38.51 77.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.218 -0.926 . . . . 0.0 109.019 179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.468 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 40.7 t-20 -132.96 -73.07 0.5 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.404 -0.81 . . . . 0.0 109.001 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.553 ' N ' ' CD ' ' A' ' 322' ' ' PRO . 1.5 t90 175.78 -45.07 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 121.373 -0.829 . . . . 0.0 109.759 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.583 ' HA ' HD12 ' A' ' 326' ' ' ILE . 52.9 Cg_endo -97.73 74.32 0.08 OUTLIER 'Trans proline' 0 C--O 1.214 -0.682 0 C-N-CA 123.473 2.782 . . . . 0.0 112.601 -179.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.541 ' CD ' ' O ' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.21 165.15 29.56 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.499 2.132 . . . . 0.0 111.615 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.405 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -44.82 -26.09 0.36 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.202 -0.936 . . . . 0.0 109.439 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 23.5 m -67.97 -61.01 2.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.236 -0.915 . . . . 0.0 109.651 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.842 HD11 HD21 ' A' ' 253' ' ' LEU . 9.5 mt -52.35 -30.27 13.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.146 -0.971 . . . . 0.0 109.636 -179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -74.39 145.26 43.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.322 -0.861 . . . . 0.0 109.591 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -64.68 -37.8 88.82 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.359 -0.838 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . 0.413 ' HG2' ' OXT' ' A' ' 329' ' ' GLU . 84.7 tt0 . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.482 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . 0.451 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 86.4 m-20 -53.05 -37.77 61.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.208 -1.171 . . . . 0.0 109.479 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 18.4 m120 60.41 46.43 9.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.253 -0.904 . . . . 0.0 109.362 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.71 136.08 59.37 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.261 -0.9 . . . . 0.0 109.546 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.408 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 51.5 Cg_endo -70.58 133.24 23.63 Favored 'Trans proline' 0 C--O 1.215 -0.627 0 C-N-CA 122.674 2.25 . . . . 0.0 111.772 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.08 153.83 41.23 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.238 -0.914 . . . . 0.0 109.483 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -53.17 -35.34 59.69 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.253 -0.904 . . . . 0.0 109.439 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 93.9 m-20 -65.53 -47.75 74.86 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.87 . . . . 0.0 109.48 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.676 ' CD1' HD23 ' B' ' 448' ' ' LEU . 21.4 tp -66.35 -38.31 87.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.234 -0.917 . . . . 0.0 109.45 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.774 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -70.57 -32.46 69.87 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.232 -0.918 . . . . 0.0 109.403 -179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -88.65 7.31 34.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.254 -0.904 . . . . 0.0 109.573 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.865 HD23 HG21 ' B' ' 440' ' ' VAL . 40.3 tp -72.3 134.83 45.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.258 -0.901 . . . . 0.0 109.47 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.9 tp10 -80.74 141.77 34.49 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.246 -0.909 . . . . 0.0 109.465 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 7.51 68.96 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.865 HG21 HD23 ' B' ' 437' ' ' LEU . 87.6 t -122.84 126.98 74.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 109.399 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 69.3 m-20 -83.52 154.3 23.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.284 -0.885 . . . . 0.0 109.425 179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.432 ' NH1' HD11 ' B' ' 435' ' ' LEU . 68.6 mtp85 -50.26 -48.87 54.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.135 -0.978 . . . . 0.0 109.519 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.562 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 88.2 m-20 -61.91 -44.48 96.69 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.148 -0.97 . . . . 0.0 109.49 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.06 HD11 ' CD2' ' B' ' 473' ' ' LEU . 15.3 tp -55.65 -44.45 77.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.235 -0.916 . . . . 0.0 109.395 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.87 -41.75 87.81 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.25 -0.906 . . . . 0.0 109.383 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.562 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 13.0 m-30 -58.98 -43.06 91.32 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.317 -0.865 . . . . 0.0 109.357 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -60.67 -40.71 93.11 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.359 -0.838 . . . . 0.0 109.409 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.676 HD23 ' CD1' ' B' ' 434' ' ' LEU . 19.7 tp -60.99 -47.28 87.18 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.428 179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.479 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.93 -31.5 68.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.951 . . . . 0.0 109.439 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.97 -33.81 57.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.925 . . . . 0.0 109.486 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.605 ' HG3' HD11 ' B' ' 470' ' ' ILE . 33.5 mtm105 -90.32 22.06 3.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.267 -0.896 . . . . 0.0 109.432 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.77 -18.87 6.8 Favored Glycine 0 N--CA 1.493 2.485 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' B' ' 458' ' ' ASP . 3.0 t -76.87 111.49 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.915 -1.344 . . . . 0.0 109.341 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.429 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 29.5 m -121.51 -35.44 3.25 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.863 . . . . 0.0 109.704 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.433 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -87.5 142.63 27.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.19 -0.944 . . . . 0.0 109.669 -179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.996 HD21 HD12 ' B' ' 488' ' ' ILE . 35.3 tp -48.71 -42.06 33.83 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.276 -0.89 . . . . 0.0 109.173 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -55.94 -45.79 78.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.301 -0.874 . . . . 0.0 109.142 179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.804 ' HB3' HG13 ' B' ' 453' ' ' VAL . 93.6 m-20 -57.77 -41.69 82.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.887 . . . . 0.0 109.078 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.748 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -59.23 -41.4 88.59 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.345 -0.847 . . . . 0.0 109.278 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.578 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -62.09 -37.15 83.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.9 . . . . 0.0 109.392 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.83 -25.86 67.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.251 -0.906 . . . . 0.0 109.53 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.725 ' HG3' HG21 ' B' ' 453' ' ' VAL . 88.1 mm-40 -78.36 138.92 38.79 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.49 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -97.85 165.38 22.06 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.918 HD11 ' HG2' ' A' ' 293' ' ' PRO . 68.1 mt -48.04 -36.29 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.309 -1.112 . . . . 0.0 109.425 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -65.55 -38.65 90.21 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.27 -0.894 . . . . 0.0 109.256 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -66.73 -31.69 72.51 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.94 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.4 mp -78.14 -26.84 48.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.269 -0.894 . . . . 0.0 109.451 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -63.27 -21.6 66.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.356 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -52.85 -33.12 48.2 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.267 -0.895 . . . . 0.0 109.492 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.605 HD11 ' HG3' ' B' ' 451' ' ' ARG . 68.8 mt -104.67 128.58 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.503 -179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 88.3 mt-10 -61.08 -33.47 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -0.919 . . . . 0.0 109.446 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.495 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.35 -27.33 46.94 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.06 ' CD2' HD11 ' B' ' 444' ' ' LEU . 35.1 mt -102.62 134.32 46.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.264 -1.139 . . . . 0.0 109.585 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.9 m -104.2 161.93 13.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.236 -0.915 . . . . 0.0 109.307 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 79.0 m-20 -59.95 -36.35 76.91 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.156 -0.965 . . . . 0.0 109.439 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -76.94 -46.02 25.66 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.328 -0.857 . . . . 0.0 109.564 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.47 ' O ' ' HG ' ' B' ' 481' ' ' LEU . 38.9 tttp -66.33 -40.2 89.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.28 -0.888 . . . . 0.0 109.459 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.3 -42.47 93.04 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.224 -0.922 . . . . 0.0 109.478 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.527 ' HA2' ' CB ' ' A' ' 293' ' ' PRO . . . -62.0 -45.11 96.78 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.44 -40.14 90.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.183 -1.186 . . . . 0.0 109.659 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' B' ' 477' ' ' LYS . 24.7 mt -65.83 -39.93 91.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.279 -0.888 . . . . 0.0 109.633 -179.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.5 ' HB ' ' HB3' ' A' ' 293' ' ' PRO . 88.7 mt -61.88 -56.14 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.226 -0.921 . . . . 0.0 109.632 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.516 ' CG ' ' HD3' ' A' ' 293' ' ' PRO . 67.1 mmm -54.06 -43.23 70.07 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.245 -0.91 . . . . 0.0 109.476 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.44 62.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.256 -0.903 . . . . 0.0 109.467 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -60.37 -46.2 90.81 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.234 -0.917 . . . . 0.0 109.377 -179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.578 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 63.1 mtp180 -59.48 -43.82 93.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.882 . . . . 0.0 109.493 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 94.2 m-20 -58.28 -43.44 87.98 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.222 -0.923 . . . . 0.0 109.544 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.996 HD12 HD21 ' B' ' 456' ' ' LEU . 68.7 mt -60.25 -37.47 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.218 -0.926 . . . . 0.0 109.505 -179.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 37.0 m -78.8 -51.98 8.98 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -59.71 -45.95 90.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.233 -0.917 . . . . 0.0 109.536 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.442 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 51.6 m-85 -76.2 -39.68 54.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.169 -0.957 . . . . 0.0 109.606 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' B' ' 495' ' ' ALA . . . 72.41 36.1 59.51 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -56.56 -35.09 67.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.215 -1.168 . . . . 0.0 109.42 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.35 -33.58 73.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.243 -0.91 . . . . 0.0 109.528 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' B' ' 492' ' ' GLY . . . . . . . . 0 N--CA 1.49 1.528 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.497 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.572 ' CD1' ' HG3' ' A' ' 323' ' ' PRO . 91.8 m-85 . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -63.12 154.84 76.14 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.243 -0.911 . . . . 0.0 109.402 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.567 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.43 -24.72 56.63 Favored 'Trans proline' 0 C--O 1.214 -0.684 0 C-N-CA 122.672 2.248 . . . . 0.0 111.698 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.929 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.2 tt -64.9 -30.98 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.206 -0.934 . . . . 0.0 108.525 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.524 ' CD1' HG11 ' A' ' 282' ' ' VAL . 2.0 tp -72.8 -27.27 61.88 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.899 HD23 ' CZ2' ' A' ' 321' ' ' TRP . 1.9 mt -90.93 -24.57 20.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.345 -0.847 . . . . 0.0 109.406 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 9.4 mtt85 -55.95 149.54 33.35 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.162 179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 257' ' ' VAL . 50.1 Cg_endo -70.18 130.34 18.66 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.604 2.203 . . . . 0.0 111.665 -179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.773 ' HA ' HD13 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.66 -26.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.479 ' HA ' ' HZ1' ' A' ' 271' ' ' LYS . 55.2 t0 -63.21 -31.0 72.04 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.095 -1.003 . . . . 0.0 109.427 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.411 ' N ' ' O ' ' A' ' 256' ' ' PRO . 83.1 m-20 -72.76 -12.47 61.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.257 -0.902 . . . . 0.0 109.674 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.773 HD13 ' HA ' ' A' ' 257' ' ' VAL . 6.0 mp -46.22 137.44 6.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.172 -0.955 . . . . 0.0 109.466 -179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -69.52 -16.08 63.37 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.295 -0.878 . . . . 0.0 109.493 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.719 ' H ' HD12 ' A' ' 262' ' ' LEU . 4.6 mp -64.16 170.45 3.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.251 -0.906 . . . . 0.0 109.523 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 21.7 p -71.58 164.07 26.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.166 -0.959 . . . . 0.0 109.554 -179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.669 HG12 HD21 ' A' ' 268' ' ' ASN . 11.5 t -51.31 -31.12 11.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.23 -0.919 . . . . 0.0 109.734 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 mtm180 -57.32 -45.05 84.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.04 -1.038 . . . . 0.0 109.299 -179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.581 ' OG ' HD22 ' A' ' 262' ' ' LEU . 18.7 t -59.94 -50.06 75.23 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.251 -0.906 . . . . 0.0 109.592 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.72 ' HB1' ' HE3' ' A' ' 271' ' ' LYS . . . -64.59 -44.25 91.26 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.245 -0.909 . . . . 0.0 109.364 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.669 HD21 HG12 ' A' ' 264' ' ' VAL . 86.6 m-20 -53.54 -32.63 51.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.464 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.74 ' SG ' HD23 ' A' ' 295' ' ' LEU . 28.5 t -63.49 -57.22 10.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 0.0 109.508 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.672 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.6 mm? -66.4 -48.15 70.99 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.207 -0.933 . . . . 0.0 109.555 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.72 ' HE3' ' HB1' ' A' ' 267' ' ' ALA . 42.7 mttt -55.61 -37.53 68.25 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.178 -0.951 . . . . 0.0 109.473 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -54.93 -28.79 53.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.244 -0.91 . . . . 0.0 109.493 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.561 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 67.8 mm-40 -88.92 23.52 2.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.921 . . . . 0.0 109.602 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.561 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 68.36 40.47 2.03 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.225 -0.922 . . . . 0.0 109.502 179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.92 HG23 ' HB2' ' A' ' 280' ' ' ASP . 83.5 mt -116.34 125.63 73.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.235 -0.916 . . . . 0.0 109.422 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.596 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.1 p80 -115.89 -29.72 6.29 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.192 -0.942 . . . . 0.0 109.58 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.596 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 2.5 m-85 -111.36 131.68 54.99 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.285 -0.884 . . . . 0.0 109.531 -179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.929 HD12 ' O ' ' A' ' 252' ' ' ILE . 78.5 mt -46.97 -32.15 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.155 -0.966 . . . . 0.0 109.268 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.884 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.08 -47.88 14.93 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.92 ' HB2' HG23 ' A' ' 275' ' ' ILE . 90.1 m-20 -53.49 -34.29 57.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.901 -1.352 . . . . 0.0 108.878 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 289' ' ' LEU . 40.0 tp -52.97 -50.86 63.25 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.417 -0.802 . . . . 0.0 109.022 179.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.884 HG22 ' O ' ' A' ' 279' ' ' GLY . 35.5 m -65.98 -30.05 48.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.181 -0.95 . . . . 0.0 108.772 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.42 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 49.6 tt0 -54.32 -37.6 65.02 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.402 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 58.6 mtt-85 -105.8 141.38 37.33 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.476 -0.765 . . . . 0.0 109.066 179.298 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -65.22 141.69 58.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.205 -0.934 . . . . 0.0 109.656 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . . . . . . . . . 23.3 pt-20 -53.99 -23.93 14.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.312 179.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.781 ' HA ' HD12 ' A' ' 290' ' ' LEU . 50.2 t -52.73 -51.02 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.285 -0.885 . . . . 0.0 109.103 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.402 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 95.5 mt-10 -51.9 -37.28 51.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.295 -0.878 . . . . 0.0 109.133 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.889 HD11 HD11 ' A' ' 281' ' ' LEU . 61.5 mt -61.66 -45.11 95.44 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.328 -0.858 . . . . 0.0 109.117 179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.781 HD12 ' HA ' ' A' ' 287' ' ' VAL . 6.1 mt -60.65 -29.11 69.07 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 0.0 109.418 179.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.524 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 62.8 mttm -82.02 -20.93 37.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.314 -0.866 . . . . 0.0 109.299 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.8 116.33 60.26 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 109.374 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.983 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.5 Cg_endo -70.6 -9.16 25.23 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.715 2.277 . . . . 0.0 111.821 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.673 ' ND2' HD12 ' B' ' 464' ' ' ILE . 30.5 m120 -60.77 -37.38 81.66 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 -179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.74 HD23 ' SG ' ' A' ' 269' ' ' CYS . 1.3 pp -100.18 137.5 38.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.172 -0.955 . . . . 0.0 109.467 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -86.71 168.71 39.96 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 26.8 mttm -64.7 -36.74 85.27 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 109.555 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.7 -42.16 83.16 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.444 ' O ' HG13 ' A' ' 303' ' ' ILE . 85.1 p -63.07 -34.09 76.84 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.276 -0.89 . . . . 0.0 109.433 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . . . . . . . . . 22.2 tp -56.76 -33.41 66.57 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.492 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.1 m -61.49 -52.12 65.84 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.155 -0.966 . . . . 0.0 109.349 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.424 ' CD ' ' HG ' ' A' ' 262' ' ' LEU . 80.9 tt0 -62.91 -46.3 88.45 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.266 -0.896 . . . . 0.0 109.335 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.492 ' O ' ' CD1' ' A' ' 307' ' ' LEU . 62.7 mt -57.74 -46.99 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.173 -0.954 . . . . 0.0 108.844 179.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -53.51 -40.54 65.5 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 179.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -58.07 -44.66 87.64 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.386 -0.822 . . . . 0.0 108.811 179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.821 ' CG1' HD22 ' A' ' 312' ' ' LEU . 6.3 t -63.91 -34.98 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.287 -0.883 . . . . 0.0 108.925 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.492 ' CD1' ' O ' ' A' ' 303' ' ' ILE . 8.4 mp -60.17 -25.99 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.409 -0.807 . . . . 0.0 109.238 179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.73 -33.65 68.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.332 -0.855 . . . . 0.0 109.307 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 0.4 OUTLIER -60.97 -14.62 24.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.366 -0.834 . . . . 0.0 109.502 179.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.67 ' HA ' HD11 ' A' ' 314' ' ' LEU . 24.2 ttm180 70.03 4.81 4.98 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.319 -0.863 . . . . 0.0 109.604 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.716 ' C ' HD12 ' A' ' 312' ' ' LEU . . . -108.11 16.25 35.9 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.821 HD22 ' CG1' ' A' ' 306' ' ' VAL . 5.3 mp -146.58 138.63 24.81 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.221 -1.164 . . . . 0.0 109.629 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.541 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.6 OUTLIER 47.13 59.41 4.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.322 -0.861 . . . . 0.0 109.537 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.679 HD21 ' N ' ' A' ' 312' ' ' LEU . 3.7 mm? -91.12 9.88 29.21 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.194 -0.941 . . . . 0.0 109.319 179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 67.3 35.04 87.17 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.431 -1.467 . . . . 0.0 109.431 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.519 ' CE ' HG11 ' A' ' 282' ' ' VAL . 7.1 ptt? -114.58 153.51 29.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.159 -1.2 . . . . 0.0 109.447 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . . . . . . . . . 43.0 ttp180 -125.08 125.95 44.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.272 -0.893 . . . . 0.0 109.473 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.857 ' N ' HD12 ' A' ' 318' ' ' LEU . 2.5 mp -103.26 138.66 39.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.257 -0.902 . . . . 0.0 109.567 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -60.83 -35.23 76.0 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.932 . . . . 0.0 109.158 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.506 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 39.8 t30 -125.82 -69.29 0.79 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.311 -0.868 . . . . 0.0 109.401 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.899 ' CZ2' HD23 ' A' ' 254' ' ' LEU . 1.2 t-105 165.63 -62.89 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.197 -0.939 . . . . 0.0 109.459 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.1 Cg_endo -67.99 108.26 1.68 Allowed 'Trans proline' 0 C--O 1.215 -0.653 0 C-N-CA 122.546 2.164 . . . . 0.0 112.021 -179.755 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.572 ' HG3' ' CD1' ' A' ' 249' ' ' PHE . 53.5 Cg_endo -75.16 164.39 33.15 Favored 'Trans proline' 0 C--O 1.216 -0.604 0 C-N-CA 122.608 2.205 . . . . 0.0 111.506 179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.9 -10.86 31.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.183 -0.948 . . . . 0.0 109.396 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 48.2 m -73.32 -43.78 60.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.237 -0.914 . . . . 0.0 109.673 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.582 HD13 HD21 ' A' ' 254' ' ' LEU . 25.1 pt -90.91 -6.83 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -61.65 139.78 58.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.19 -0.944 . . . . 0.0 109.542 -179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -59.25 -37.23 77.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.268 -0.895 . . . . 0.0 109.429 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 117.964 -1.017 . . . . 0.0 109.505 179.963 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -62.22 -31.46 72.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.268 -1.136 . . . . 0.0 109.463 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.594 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 26.5 m120 -90.13 3.67 52.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 0.0 109.605 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.456 ' HG2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -53.34 128.62 50.62 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.159 -0.963 . . . . 0.0 109.409 -179.971 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.456 ' HD2' ' HG2' ' B' ' 429' ' ' LYS . 49.9 Cg_endo -69.88 141.55 45.02 Favored 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.676 2.251 . . . . 0.0 111.902 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . . . . . . . . . . . -73.51 148.06 43.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.33 -0.856 . . . . 0.0 109.481 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -46.9 -37.28 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.267 -0.896 . . . . 0.0 109.426 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 -59.5 -42.82 93.06 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.463 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.857 ' O ' HD13 ' B' ' 434' ' ' LEU . 3.3 tm? -67.24 -30.93 70.96 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.25 -0.906 . . . . 0.0 109.377 179.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.619 HD11 ' HG2' ' B' ' 442' ' ' ARG . 21.7 tp -81.33 -29.63 34.1 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.259 -0.901 . . . . 0.0 109.566 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -74.87 -3.8 34.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.634 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.793 HD23 HG21 ' B' ' 440' ' ' VAL . 37.2 tp -68.26 134.53 50.54 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.151 -0.968 . . . . 0.0 109.501 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -75.73 142.19 42.47 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.179 -0.951 . . . . 0.0 109.511 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.77 8.39 67.53 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.793 HG21 HD23 ' B' ' 437' ' ' LEU . 43.8 t -127.52 128.49 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.272 -1.134 . . . . 0.0 109.502 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -95.39 158.66 15.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.236 -0.915 . . . . 0.0 109.412 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.619 ' HG2' HD11 ' B' ' 435' ' ' LEU . 90.6 mtt-85 -50.22 -48.55 54.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.259 -0.9 . . . . 0.0 109.536 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.33 -51.08 69.09 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 0.0 109.415 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.01 HD11 ' CD1' ' B' ' 473' ' ' LEU . 20.7 tp -55.08 -40.6 70.55 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.205 -0.934 . . . . 0.0 109.326 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' B' ' 434' ' ' LEU . . . -59.14 -42.73 91.37 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 17.8 m-85 -60.69 -48.16 83.03 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -57.3 -45.84 83.77 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.266 -0.896 . . . . 0.0 109.429 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.851 ' O ' HD13 ' B' ' 448' ' ' LEU . 0.7 OUTLIER -65.21 -42.85 93.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.874 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -63.35 -27.91 69.64 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.278 -0.888 . . . . 0.0 109.495 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -53.16 -20.04 3.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.204 -0.935 . . . . 0.0 109.455 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 31.7 mtp85 -92.23 30.07 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.252 -0.905 . . . . 0.0 109.612 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 80.02 -18.64 7.5 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.581 HG13 ' CB ' ' B' ' 458' ' ' ASP . 3.4 t -60.76 135.99 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 120.958 -1.319 . . . . 0.0 109.386 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . . . . . . . . . 31.1 p -135.24 -35.89 0.82 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.197 -0.94 . . . . 0.0 109.881 -179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.6 159.79 17.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.102 -0.999 . . . . 0.0 109.877 -179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.957 HD11 HD12 ' B' ' 488' ' ' ILE . 0.3 OUTLIER -52.25 -43.71 64.5 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.277 -0.89 . . . . 0.0 109.238 179.815 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -55.74 -44.03 77.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.334 -0.854 . . . . 0.0 108.951 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.581 ' CB ' HG13 ' B' ' 453' ' ' VAL . 82.0 m-20 -56.81 -43.34 80.87 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.288 -0.883 . . . . 0.0 108.997 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.668 HD13 ' HG ' ' B' ' 448' ' ' LEU . 24.6 tp -56.89 -45.18 82.75 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.3 -0.875 . . . . 0.0 109.245 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.04 -36.23 72.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.384 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -65.94 -32.28 73.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.226 -0.921 . . . . 0.0 109.449 179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.564 ' OE1' HG22 ' B' ' 453' ' ' VAL . 2.3 mp0 -62.15 157.6 18.8 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.247 -0.908 . . . . 0.0 109.589 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -123.28 153.91 17.18 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.983 HD11 ' HG2' ' A' ' 293' ' ' PRO . 45.3 mt -50.85 -38.37 17.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.31 -1.112 . . . . 0.0 109.296 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -61.77 -39.83 93.03 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.264 -0.897 . . . . 0.0 109.385 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -70.17 -32.22 70.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.291 -0.881 . . . . 0.0 109.406 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.041 HD12 ' HB1' ' B' ' 478' ' ' ALA . 22.6 mt -77.19 -29.2 54.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.0 109.489 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.08 66.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.576 -179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -56.59 -33.68 66.45 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.302 -0.874 . . . . 0.0 109.456 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.587 HG22 ' H ' ' B' ' 472' ' ' GLY . 76.3 mt -103.03 129.2 55.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.229 -0.919 . . . . 0.0 109.518 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -62.1 -29.92 70.65 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.257 -0.902 . . . . 0.0 109.499 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.587 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -54.04 -32.75 50.02 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.01 ' CD1' HD11 ' B' ' 444' ' ' LEU . 2.9 mm? -106.13 133.22 51.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.216 -1.167 . . . . 0.0 109.426 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.454 HG22 ' N ' ' B' ' 475' ' ' ASP . 28.3 m -103.62 161.87 13.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.334 -0.854 . . . . 0.0 109.437 179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.454 ' N ' HG22 ' B' ' 474' ' ' THR . 84.0 m-20 -58.71 -36.95 75.09 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.22 -0.925 . . . . 0.0 109.573 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -76.31 -45.53 31.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.205 -0.934 . . . . 0.0 109.568 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.715 ' CE ' HD22 ' B' ' 444' ' ' LEU . 25.3 tttp -67.35 -41.24 85.48 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.242 -0.911 . . . . 0.0 109.454 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.041 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -63.7 -45.18 91.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.232 -0.918 . . . . 0.0 109.587 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 293' ' ' PRO . . . -61.65 -42.09 99.7 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.626 -1.39 . . . . 0.0 109.626 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.18 -40.95 91.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.279 -1.13 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.615 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.3 mp -65.3 -47.15 77.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.574 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.934 HD12 ' HB2' ' A' ' 293' ' ' PRO . 35.7 mt -55.19 -56.07 13.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.374 -0.829 . . . . 0.0 109.722 -179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 55.8 mtp -52.91 -41.93 64.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.697 -179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.437 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -63.34 -43.89 96.44 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.697 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.513 ' HB2' HD23 ' B' ' 459' ' ' LEU . . . -65.5 -49.69 68.06 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.244 -0.91 . . . . 0.0 109.601 -179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.482 ' NH1' ' HA ' ' A' ' 293' ' ' PRO . 95.3 mtt180 -57.79 -46.1 85.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.602 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 87.6 m-20 -57.91 -38.45 75.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.198 -0.939 . . . . 0.0 109.554 -179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.957 HD12 HD11 ' B' ' 456' ' ' LEU . 76.4 mt -70.94 -36.79 65.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -0.907 . . . . 0.0 109.533 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' B' ' 495' ' ' ALA . 13.5 t -77.71 -51.51 10.45 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.311 -0.868 . . . . 0.0 109.787 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 96.1 m95 -63.54 -45.72 89.28 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.2 -0.938 . . . . 0.0 109.806 -179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 99.6 m-85 -93.94 13.9 21.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 109.551 -179.941 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -78.61 131.43 10.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -46.93 -40.45 14.26 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -1.102 . . . . 0.0 109.444 -179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.08 -35.04 70.81 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.0 109.524 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . 0.517 ' HB2' ' O ' ' B' ' 489' ' ' CYS . . . . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 117.928 -1.034 . . . . 0.0 109.49 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.636 ' HB2' HD11 ' A' ' 254' ' ' LEU . 14.5 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.842 ' HB2' HD13 ' A' ' 253' ' ' LEU . 25.0 m-20 -54.07 124.58 45.9 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.105 -0.997 . . . . 0.0 109.31 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.444 ' HA ' HD12 ' A' ' 254' ' ' LEU . 42.4 Cg_endo -64.75 -25.61 60.93 Favored 'Trans proline' 0 C--O 1.216 -0.61 0 C-N-CA 122.664 2.242 . . . . 0.0 111.624 -179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.701 ' CG2' HD12 ' A' ' 253' ' ' LEU . 14.5 tt -63.5 -33.72 63.15 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 O-C-N 121.229 -0.919 . . . . 0.0 108.622 179.224 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.85 HD11 ' O ' ' A' ' 311' ' ' GLY . 5.5 mp -74.86 -41.37 59.96 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.363 -0.836 . . . . 0.0 109.407 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.823 HD21 HD11 ' A' ' 326' ' ' ILE . 1.7 mt -72.08 -30.48 65.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.281 -0.887 . . . . 0.0 109.776 -179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.414 ' HG2' ' HB2' ' A' ' 259' ' ' ASP . 4.8 ttp-105 -56.43 138.35 75.46 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.096 -1.002 . . . . 0.0 108.849 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.474 ' O ' ' N ' ' A' ' 259' ' ' ASP . 46.3 Cg_endo -68.23 130.57 21.58 Favored 'Trans proline' 0 C--O 1.216 -0.599 0 C-N-CA 122.64 2.227 . . . . 0.0 111.757 -179.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.735 HG23 ' HE3' ' A' ' 271' ' ' LYS . 0.1 OUTLIER -44.55 -26.16 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.896 . . . . 0.0 109.298 -179.986 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 256' ' ' PRO . 57.9 t0 -68.46 -30.77 69.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.218 -0.926 . . . . 0.0 109.255 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.474 ' N ' ' O ' ' A' ' 256' ' ' PRO . 35.2 m-20 -69.87 -16.57 63.27 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.343 -0.848 . . . . 0.0 109.468 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 278' ' ' ILE . 37.7 mt -56.07 138.26 49.77 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.256 -0.902 . . . . 0.0 109.488 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.427 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 79.2 tt0 -66.02 -16.22 63.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 109.468 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.638 HD13 ' HB3' ' A' ' 302' ' ' GLU . 33.4 mt -53.5 -175.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.285 -0.884 . . . . 0.0 109.481 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 19.0 p -88.27 157.56 18.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 109.503 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.72 HG12 HD21 ' A' ' 268' ' ' ASN . 7.0 t -50.68 -37.1 15.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.229 -0.919 . . . . 0.0 109.488 -179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 265' ' ' ARG . 17.7 tpt85 -57.17 -46.5 82.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.0 109.438 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 20.1 m -57.97 -47.55 82.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.248 -0.908 . . . . 0.0 109.33 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -68.93 -39.71 79.42 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.221 -0.925 . . . . 0.0 109.375 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.72 HD21 HG12 ' A' ' 264' ' ' VAL . 86.6 m-20 -56.66 -34.9 67.78 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.189 -0.945 . . . . 0.0 109.337 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.455 ' HB3' ' HG ' ' A' ' 295' ' ' LEU . 69.0 m -57.11 -64.37 0.9 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.261 -0.899 . . . . 0.0 109.425 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 281' ' ' LEU . 57.4 mt -56.64 -48.09 78.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.211 -0.931 . . . . 0.0 109.457 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.735 ' HE3' HG23 ' A' ' 257' ' ' VAL . 32.3 mttt -54.75 -37.63 66.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.301 -0.875 . . . . 0.0 109.388 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -52.42 -30.04 27.38 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.246 -0.909 . . . . 0.0 109.477 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.555 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 90.4 mt-10 -89.95 25.83 2.0 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.262 -0.899 . . . . 0.0 109.397 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 67.17 42.7 2.25 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.907 . . . . 0.0 109.399 -179.92 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 1.0 HG23 ' HB2' ' A' ' 280' ' ' ASP . 88.8 mt -115.72 124.6 72.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.331 -0.856 . . . . 0.0 109.45 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.478 ' ND1' ' CD1' ' A' ' 277' ' ' TYR . 7.3 p80 -110.99 -41.53 4.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.484 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.478 ' CD1' ' ND1' ' A' ' 276' ' ' HIS . 8.4 m-30 -105.22 135.02 47.34 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.19 -0.944 . . . . 0.0 109.427 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 252' ' ' ILE . 86.7 mt -46.95 -30.76 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.207 -0.933 . . . . 0.0 109.245 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 1.003 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.98 -46.34 19.83 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 1.0 ' HB2' HG23 ' A' ' 275' ' ' ILE . 83.1 m-20 -53.45 -34.54 58.28 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.216 -1.167 . . . . 0.0 108.884 179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.568 HD13 HD13 ' A' ' 270' ' ' LEU . 35.1 tp -54.96 -49.88 70.31 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.322 -0.861 . . . . 0.0 108.987 179.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 1.003 HG22 ' O ' ' A' ' 279' ' ' GLY . 14.3 m -65.26 -23.13 32.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 0.0 108.84 179.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.428 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.9 tt0 -66.8 -33.37 75.47 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.333 -0.854 . . . . 0.0 109.02 179.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 55.5 mtt-85 -96.39 159.9 14.7 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.345 -0.847 . . . . 0.0 109.227 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . 0.587 HG22 ' H ' ' A' ' 287' ' ' VAL . 36.0 m -81.39 139.09 35.5 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.186 -0.946 . . . . 0.0 109.556 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.574 ' HA ' HD23 ' A' ' 289' ' ' LEU . 77.9 tt0 -58.56 -32.21 68.7 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.254 -0.904 . . . . 0.0 109.392 179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.587 ' H ' HG22 ' A' ' 285' ' ' THR . 45.7 t -52.72 -50.37 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.296 -0.878 . . . . 0.0 109.359 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.464 ' O ' ' OG1' ' A' ' 292' ' ' THR . 97.5 mt-10 -55.2 -33.34 62.97 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.344 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.624 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.8 mm? -64.93 -43.44 92.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 179.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.661 ' N ' HD22 ' A' ' 290' ' ' LEU . 3.4 mm? -66.07 -23.97 66.63 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.106 -0.996 . . . . 0.0 109.392 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.539 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 37.7 mttt -90.45 -8.54 50.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 109.584 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' ' CD1' ' A' ' 295' ' ' LEU . 2.1 m -86.99 113.73 54.92 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.225 -0.922 . . . . 0.0 109.758 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.962 ' HG2' HD11 ' B' ' 464' ' ' ILE . 49.6 Cg_endo -70.48 -22.25 29.04 Favored 'Trans proline' 0 C--O 1.215 -0.629 0 C-N-CA 122.661 2.24 . . . . 0.0 111.923 179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.802 ' ND2' HD12 ' B' ' 464' ' ' ILE . 31.1 m120 -50.47 -22.13 1.78 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.116 -0.99 . . . . 0.0 109.345 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.91 HD23 HD11 ' A' ' 303' ' ' ILE . 4.9 mp -90.79 138.75 31.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.329 -0.857 . . . . 0.0 109.408 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 300' ' ' LEU . . . -87.98 167.78 36.68 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -55.02 -45.83 75.2 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.296 -1.12 . . . . 0.0 109.495 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -69.39 -37.84 77.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.267 -0.896 . . . . 0.0 109.482 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 50.9 m -58.58 -51.48 69.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.314 -0.866 . . . . 0.0 109.559 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' A' ' 295' ' ' LEU . 78.3 mt -53.83 -46.41 71.18 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.274 -0.892 . . . . 0.0 109.475 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 32.2 m -51.77 -51.09 58.96 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.136 -0.978 . . . . 0.0 109.29 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.638 ' HB3' HD13 ' A' ' 262' ' ' LEU . 80.4 mt-10 -53.89 -38.47 64.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.967 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.91 HD11 HD23 ' A' ' 295' ' ' LEU . 74.1 mt -59.34 -48.04 88.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.44 -0.788 . . . . 0.0 109.104 179.601 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -56.57 -36.54 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.365 -0.834 . . . . 0.0 109.167 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -62.28 -47.82 82.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.125 179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.994 HG12 HD21 ' A' ' 312' ' ' LEU . 2.0 t -66.23 -38.06 81.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.032 179.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.55 HD12 HD12 ' A' ' 312' ' ' LEU . 4.7 mp -54.4 -26.71 32.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 0.0 109.221 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.66 -36.17 73.72 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.444 -0.785 . . . . 0.0 109.503 -179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 310' ' ' ARG . 2.0 t -61.63 -31.85 71.96 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.179 -0.951 . . . . 0.0 109.467 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.528 ' CB ' ' O ' ' A' ' 309' ' ' SER . 29.5 mtm180 82.74 -24.72 0.17 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.536 -0.727 . . . . 0.0 110.38 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.85 ' O ' HD11 ' A' ' 253' ' ' LEU . . . -60.04 -21.18 55.59 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.994 HD21 HG12 ' A' ' 306' ' ' VAL . 0.4 OUTLIER -125.36 159.95 30.54 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.232 -1.158 . . . . 0.0 109.46 -179.865 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.639 ' H ' HG12 ' A' ' 282' ' ' VAL . 4.6 t 77.0 -144.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -0.907 . . . . 0.0 109.644 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.612 HD22 ' N ' ' A' ' 314' ' ' LEU . 4.0 mm? 63.59 13.17 7.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.298 -0.876 . . . . 0.0 109.6 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 45.73 51.58 10.2 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.724 ' HE2' HG11 ' A' ' 282' ' ' VAL . 26.2 mtm -68.1 173.42 4.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.205 -1.174 . . . . 0.0 109.477 179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.511 ' O ' HD23 ' A' ' 318' ' ' LEU . 50.4 mtt-85 -132.54 120.59 22.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.273 -0.892 . . . . 0.0 109.42 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.516 HD11 ' CG2' ' A' ' 282' ' ' VAL . 5.2 mt -122.43 141.71 51.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.239 -0.913 . . . . 0.0 109.562 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -65.29 -37.57 87.56 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.292 -0.88 . . . . 0.0 109.091 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.499 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 80.4 m-20 -143.28 -47.92 0.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.371 -0.831 . . . . 0.0 108.926 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.567 ' CZ3' ' HA3' ' A' ' 279' ' ' GLY . 0.6 OUTLIER 164.05 -68.64 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.481 -0.762 . . . . 0.0 109.236 179.607 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.556 ' CD ' ' CB ' ' A' ' 321' ' ' TRP . 50.5 Cg_endo -69.77 110.93 2.68 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.58 2.187 . . . . 0.0 111.942 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.51 ' HD2' ' CD1' ' A' ' 326' ' ' ILE . 50.5 Cg_endo -70.72 155.07 63.5 Favored 'Trans proline' 0 C--O 1.216 -0.609 0 C-N-CA 122.665 2.244 . . . . 0.0 111.654 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -49.97 -22.38 1.54 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.201 -0.937 . . . . 0.0 109.536 -179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 25.4 m -62.06 -43.48 98.75 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.22 -0.925 . . . . 0.0 109.459 -179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.823 HD11 HD21 ' A' ' 254' ' ' LEU . 19.5 mt -54.47 -42.15 57.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.322 -0.861 . . . . 0.0 109.445 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -67.99 -30.74 70.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.29 -0.881 . . . . 0.0 109.461 -179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 53.2 t0 -52.12 -39.23 59.58 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.288 -0.883 . . . . 0.0 109.523 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.489 1.51 0 CA-C-O 117.985 -1.007 . . . . 0.0 109.49 179.935 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.227 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -55.06 -38.45 68.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -1.177 . . . . 0.0 109.513 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 21.8 m120 58.06 45.27 18.1 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.223 -0.923 . . . . 0.0 109.447 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.423 ' O ' ' HB3' ' B' ' 454' ' ' CYS . 8.3 tttt -94.27 137.82 22.68 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.211 -0.931 . . . . 0.0 109.49 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.518 ' HG3' ' CE1' ' B' ' 446' ' ' PHE . 49.8 Cg_endo -70.49 132.57 22.43 Favored 'Trans proline' 0 C--O 1.216 -0.624 0 C-N-CA 122.703 2.268 . . . . 0.0 111.69 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.76 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -63.77 151.22 42.73 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.171 -0.956 . . . . 0.0 109.52 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 -52.38 -37.71 57.08 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 109.494 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -62.46 -44.77 95.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.476 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.767 HD13 ' C ' ' B' ' 434' ' ' LEU . 3.3 tm? -69.96 -36.24 75.09 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.852 . . . . 0.0 109.437 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.818 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.4 OUTLIER -69.54 -31.97 70.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.29 -0.881 . . . . 0.0 109.443 179.977 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -89.32 9.26 26.7 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.253 -0.904 . . . . 0.0 109.476 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.946 HD22 ' CD1' ' B' ' 456' ' ' LEU . 35.0 tp -80.13 132.28 35.9 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.911 . . . . 0.0 109.497 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -77.23 144.74 38.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.286 -0.884 . . . . 0.0 109.468 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.67 4.63 65.44 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.463 HG21 HD23 ' B' ' 437' ' ' LEU . 97.9 t -126.24 126.18 68.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.204 -1.174 . . . . 0.0 109.395 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -84.54 151.87 24.28 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.201 -0.937 . . . . 0.0 109.403 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . . . . . . . . . 77.6 mtm180 -50.06 -47.07 53.72 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.205 -0.934 . . . . 0.0 109.481 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.508 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 91.7 m-20 -64.99 -45.47 85.5 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.174 -0.954 . . . . 0.0 109.385 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.026 HD11 ' CD2' ' B' ' 473' ' ' LEU . 14.2 tp -57.27 -44.35 83.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.298 -0.876 . . . . 0.0 109.404 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.612 ' HB1' ' CD1' ' B' ' 434' ' ' LEU . . . -59.01 -41.72 88.37 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.245 -0.91 . . . . 0.0 109.23 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.518 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 16.3 m-30 -58.62 -44.6 90.04 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.789 ' HB3' HD13 ' B' ' 470' ' ' ILE . 24.5 mttt -58.76 -40.78 84.9 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.314 -0.867 . . . . 0.0 109.307 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.8 HD13 HD12 ' B' ' 459' ' ' LEU . 93.3 mt -61.84 -38.94 90.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.338 -0.851 . . . . 0.0 109.304 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -64.6 -32.7 74.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.304 -0.872 . . . . 0.0 109.441 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.9 -37.56 14.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -0.987 . . . . 0.0 109.408 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.475 ' CZ ' ' CB ' ' B' ' 469' ' ' ASP . 84.0 mtt-85 -89.66 23.0 2.8 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.219 -0.926 . . . . 0.0 109.576 179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.65 -18.79 6.74 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 110.5 -1.04 . . . . 0.0 110.5 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.899 HG21 ' CG ' ' B' ' 462' ' ' GLN . 46.7 t -76.79 108.52 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.982 -1.305 . . . . 0.0 109.407 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.502 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 19.9 m -127.03 -38.85 1.98 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.206 -0.934 . . . . 0.0 109.686 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.76 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -78.39 144.32 36.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.144 -0.973 . . . . 0.0 109.529 -179.983 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.946 ' CD1' HD22 ' B' ' 437' ' ' LEU . 25.8 tp -47.04 -42.72 18.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.192 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -55.95 -45.98 78.7 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.292 -0.88 . . . . 0.0 109.096 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.74 ' HB3' HG13 ' B' ' 453' ' ' VAL . 91.5 m-20 -56.66 -43.48 80.4 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.379 -0.825 . . . . 0.0 109.076 179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.8 HD12 HD13 ' B' ' 448' ' ' LEU . 4.1 tt -55.52 -45.56 77.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.384 -0.823 . . . . 0.0 109.305 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -60.4 -35.98 77.05 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.321 -0.862 . . . . 0.0 109.392 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -66.94 -28.09 68.01 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.212 -0.93 . . . . 0.0 109.408 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.899 ' CG ' HG21 ' B' ' 453' ' ' VAL . 99.6 mm-40 -75.45 140.01 42.63 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.216 -0.927 . . . . 0.0 109.542 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -98.45 166.06 21.71 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 179.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.962 HD11 ' HG2' ' A' ' 293' ' ' PRO . 20.5 mt -49.83 -34.02 9.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.288 -1.125 . . . . 0.0 109.495 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -68.18 -40.5 82.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.25 -0.906 . . . . 0.0 109.401 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.456 ' HB3' ' OE1' ' B' ' 462' ' ' GLN . 90.5 m-20 -63.29 -31.86 73.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.218 -0.926 . . . . 0.0 109.553 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.615 ' HB2' ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.59 -27.79 31.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.193 -0.942 . . . . 0.0 109.65 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -66.4 -21.1 66.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.139 -0.976 . . . . 0.0 109.541 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . 0.475 ' CB ' ' CZ ' ' B' ' 451' ' ' ARG . 82.1 m-20 -52.08 -31.91 32.53 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.927 . . . . 0.0 109.614 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.789 HD13 ' HB3' ' B' ' 447' ' ' LYS . 64.1 mt -100.38 129.41 51.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -0.927 . . . . 0.0 109.584 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -58.04 -36.06 72.19 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.308 -0.87 . . . . 0.0 109.432 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.447 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -55.8 -30.81 57.37 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.026 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.8 mt -98.91 131.37 45.04 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.172 -1.193 . . . . 0.0 109.511 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.481 HG22 ' N ' ' B' ' 475' ' ' ASP . 45.7 m -104.13 162.01 13.53 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.181 -0.95 . . . . 0.0 109.378 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.481 ' N ' HG22 ' B' ' 474' ' ' THR . 82.3 m-20 -57.12 -38.4 73.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.242 -0.911 . . . . 0.0 109.464 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -74.4 -45.97 43.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.875 . . . . 0.0 109.464 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.67 ' O ' HD13 ' B' ' 481' ' ' LEU . 34.4 tttp -61.58 -46.35 90.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.305 -0.872 . . . . 0.0 109.453 -179.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.615 ' HB1' ' HB2' ' B' ' 467' ' ' LEU . . . -60.28 -45.05 94.66 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.278 -0.889 . . . . 0.0 109.486 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -57.55 -47.72 86.31 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -60.71 -35.4 76.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -1.155 . . . . 0.0 109.588 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.67 HD13 ' O ' ' B' ' 477' ' ' LYS . 7.1 mp -67.18 -44.51 79.49 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.946 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.96 HD12 ' HB2' ' A' ' 293' ' ' PRO . 36.3 mt -60.99 -55.69 22.97 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.235 -0.916 . . . . 0.0 109.577 -179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.539 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 57.7 mtp -52.38 -36.53 54.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.196 -0.94 . . . . 0.0 109.332 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.456 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.29 -51.74 34.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.203 -0.936 . . . . 0.0 109.195 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . . . . . . . . . . . -65.26 -50.52 65.45 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.262 179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.569 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 49.2 ttm-85 -50.56 -46.87 57.89 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.307 -0.87 . . . . 0.0 109.198 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.408 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 97.5 m-20 -58.01 -43.25 86.56 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.301 -0.874 . . . . 0.0 109.255 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.918 HD12 HD21 ' B' ' 456' ' ' LEU . 81.3 mt -61.56 -37.32 77.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 109.27 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 62.9 m -77.84 -50.29 12.59 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.507 179.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . 0.569 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 20.7 m95 -60.13 -43.23 95.82 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.465 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 56.6 m-85 -83.38 -27.21 29.8 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.234 -0.916 . . . . 0.0 109.486 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . 64.13 -126.12 33.28 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -106.21 92.55 4.19 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.339 -1.095 . . . . 0.0 109.447 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -51.14 143.37 10.91 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.253 -0.904 . . . . 0.0 109.48 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.505 179.989 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.549 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 41.0 p90 . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.507 ' OD2' HG22 ' A' ' 252' ' ' ILE . 0.6 OUTLIER -65.33 134.42 95.7 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.263 -0.898 . . . . 0.0 109.504 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -65.14 -29.32 56.14 Favored 'Trans proline' 0 C--O 1.216 -0.625 0 C-N-CA 122.752 2.301 . . . . 0.0 111.661 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.785 ' O ' HD12 ' A' ' 278' ' ' ILE . 18.6 tt -61.34 -29.13 45.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.321 -0.862 . . . . 0.0 108.929 179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.489 HD13 HG21 ' A' ' 282' ' ' VAL . 19.0 mt -74.33 -43.02 58.41 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.353 -0.842 . . . . 0.0 109.37 179.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.524 HD22 ' N ' ' A' ' 254' ' ' LEU . 4.3 mm? -61.55 -28.55 69.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.271 -0.893 . . . . 0.0 109.405 179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.441 ' O ' HG13 ' A' ' 278' ' ' ILE . 1.8 mtt180 -75.13 140.86 73.7 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.227 -0.921 . . . . 0.0 109.525 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.493 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.88 141.6 41.07 Favored 'Trans proline' 0 C--O 1.214 -0.68 0 C-N-CA 122.717 2.278 . . . . 0.0 111.921 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.515 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -44.63 -37.87 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.22 -0.925 . . . . 0.0 109.358 179.79 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -60.1 -30.89 69.55 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.171 -0.956 . . . . 0.0 109.366 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 256' ' ' PRO . 34.2 m-20 -75.33 -11.53 60.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.267 -0.896 . . . . 0.0 109.465 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.685 ' HB3' HD12 ' A' ' 262' ' ' LEU . 74.1 mt -53.82 152.84 5.12 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.259 -0.901 . . . . 0.0 109.469 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -64.37 -23.98 67.48 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.222 -0.924 . . . . 0.0 109.488 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.768 HD23 ' HB3' ' A' ' 302' ' ' GLU . 3.7 mp -57.46 167.29 1.03 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 0.0 109.386 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 4.0 p -81.33 165.01 21.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.239 -0.913 . . . . 0.0 109.477 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.575 HG12 ' ND2' ' A' ' 268' ' ' ASN . 42.3 t -49.14 -41.63 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.485 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -49.82 -45.01 49.67 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.168 -0.957 . . . . 0.0 109.367 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.492 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 14.9 m -70.41 -46.56 63.71 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.238 -0.914 . . . . 0.0 109.373 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -60.73 -46.88 88.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.299 -0.876 . . . . 0.0 109.411 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.575 ' ND2' HG12 ' A' ' 264' ' ' VAL . 85.6 m-20 -56.33 -34.74 66.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.367 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.436 ' HB2' ' O ' ' A' ' 266' ' ' SER . 87.9 m -50.52 -65.09 0.62 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.238 -0.914 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.656 ' H ' HD12 ' A' ' 270' ' ' LEU . 6.6 mp -62.94 -44.93 94.72 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.241 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.51 ' HG3' ' ND1' ' A' ' 276' ' ' HIS . 17.0 ttpp -52.95 -40.93 64.05 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.355 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.89 -21.95 3.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.883 . . . . 0.0 109.351 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.643 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 70.1 tt0 -94.82 20.75 8.33 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.267 -0.895 . . . . 0.0 109.398 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.643 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.11 35.33 1.29 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.279 -0.888 . . . . 0.0 109.563 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.779 HG23 ' HB2' ' A' ' 280' ' ' ASP . 89.0 mt -123.08 107.53 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.178 -0.951 . . . . 0.0 109.588 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.51 ' ND1' ' HG3' ' A' ' 271' ' ' LYS . 81.5 m-70 -107.29 -11.66 15.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.23 -0.919 . . . . 0.0 109.445 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 4.8 m-85 -111.54 134.23 53.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.282 -0.886 . . . . 0.0 109.557 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.785 HD12 ' O ' ' A' ' 252' ' ' ILE . 61.5 mt -60.14 -30.73 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.252 -0.905 . . . . 0.0 109.266 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.888 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -51.05 -42.5 48.28 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.779 ' HB2' HG23 ' A' ' 275' ' ' ILE . 93.0 m-20 -53.54 -35.18 60.43 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.204 -1.174 . . . . 0.0 109.047 179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.507 HD13 ' CD2' ' A' ' 270' ' ' LEU . 28.3 tp -58.05 -47.84 81.92 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.297 -0.877 . . . . 0.0 109.044 179.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.888 HG22 ' O ' ' A' ' 279' ' ' GLY . 21.1 m -70.05 -24.26 26.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.325 -0.859 . . . . 0.0 109.163 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -65.81 -32.65 74.29 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.311 -0.868 . . . . 0.0 109.196 179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.64 145.02 43.09 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.322 -0.861 . . . . 0.0 109.367 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 3.9 m -62.17 138.36 58.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.0 109.497 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.433 ' HB2' ' OG ' ' A' ' 313' ' ' SER . 80.6 tt0 -62.85 -27.4 69.31 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.508 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 53.2 t -52.92 -51.76 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.497 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -56.4 -34.88 67.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.27 -0.894 . . . . 0.0 109.423 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.501 ' CD1' HD12 ' A' ' 281' ' ' LEU . 51.3 mt -74.97 -38.18 61.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 109.372 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 290' ' ' LEU . 32.9 tp -60.94 -30.25 70.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.344 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.493 ' C ' ' CE ' ' B' ' 483' ' ' MET . 10.0 mmtt -87.78 17.6 4.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.35 -0.844 . . . . 0.0 109.52 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.434 HG22 ' HD2' ' A' ' 293' ' ' PRO . 0.7 OUTLIER -109.81 136.72 20.34 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.276 -0.89 . . . . 0.0 109.463 179.93 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.789 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.0 Cg_endo -70.12 -23.25 29.37 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.689 2.259 . . . . 0.0 111.819 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.536 HD22 HD12 ' B' ' 464' ' ' ILE . 22.3 m120 -56.2 -24.68 43.39 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.203 -0.936 . . . . 0.0 109.398 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.454 ' CD1' ' O ' ' A' ' 289' ' ' LEU . 14.6 mt -81.45 138.02 35.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.289 -0.882 . . . . 0.0 109.523 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -95.21 145.37 17.71 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' B' ' 461' ' ' GLU . 24.3 mttm -55.29 -42.62 73.89 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.321 -1.106 . . . . 0.0 109.427 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -67.49 -39.42 85.2 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.211 -0.931 . . . . 0.0 109.37 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . 0.447 ' O ' HG13 ' A' ' 303' ' ' ILE . 22.0 m -64.04 -36.71 84.89 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.192 -0.943 . . . . 0.0 109.338 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.757 HD13 ' C ' ' A' ' 300' ' ' LEU . 3.4 tm? -53.1 -42.59 66.11 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.278 -0.889 . . . . 0.0 109.357 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 31.0 m -60.64 -51.91 67.38 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.417 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.768 ' HB3' HD23 ' A' ' 262' ' ' LEU . 39.7 tp10 -57.91 -45.69 86.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.384 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.471 ' O ' ' HG ' ' A' ' 307' ' ' LEU . 82.9 mt -57.79 -47.29 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.229 -0.92 . . . . 0.0 109.065 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -53.02 -39.34 63.1 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.262 -0.899 . . . . 0.0 108.916 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -61.65 -42.98 99.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 108.986 179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.74 HG12 ' CD2' ' A' ' 312' ' ' LEU . 32.0 t -69.22 -34.8 64.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.347 -0.845 . . . . 0.0 108.995 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.815 HD22 ' HB3' ' A' ' 313' ' ' SER . 25.2 mt -63.62 -26.68 68.79 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.388 -0.82 . . . . 0.0 109.397 179.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.44 -36.26 73.37 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.179 -0.951 . . . . 0.0 109.151 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 16.3 t -67.68 -16.87 64.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.361 -0.837 . . . . 0.0 109.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.875 ' O ' HD11 ' A' ' 314' ' ' LEU . 56.5 mtt180 64.46 10.81 6.06 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.351 -0.843 . . . . 0.0 109.184 -179.8 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.569 ' C ' HG21 ' A' ' 252' ' ' ILE . . . -78.77 -24.25 62.71 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.757 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.7 pt? -137.36 147.03 45.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.173 -1.193 . . . . 0.0 109.682 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.815 ' HB3' HD22 ' A' ' 307' ' ' LEU . 1.7 t 77.21 39.21 0.21 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.875 HD11 ' O ' ' A' ' 310' ' ' ARG . 12.3 mt -89.9 15.26 10.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.235 -0.916 . . . . 0.0 109.268 179.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 60.01 41.25 97.85 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.628 ' HE2' HG11 ' A' ' 282' ' ' VAL . 4.5 mtm -90.33 163.19 14.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.293 -1.122 . . . . 0.0 109.439 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 318' ' ' LEU . 92.9 mtt180 -143.14 123.09 13.53 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.336 -0.853 . . . . 0.0 109.504 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.81 HD12 ' N ' ' A' ' 318' ' ' LEU . 1.4 mp -131.31 140.73 49.82 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 109.383 179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -45.74 -36.49 5.08 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.162 -0.961 . . . . 0.0 108.482 179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 43.6 t30 -129.42 -72.2 0.6 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.615 ' CE2' ' HA3' ' A' ' 279' ' ' GLY . 16.2 t90 160.77 -57.05 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.589 -0.695 . . . . 0.0 109.547 179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.921 ' HA ' HD12 ' A' ' 326' ' ' ILE . 47.3 Cg_endo -66.97 107.81 1.38 Allowed 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.552 2.168 . . . . 0.0 112.132 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.486 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.9 Cg_endo -73.44 165.2 33.1 Favored 'Trans proline' 0 C--O 1.216 -0.619 0 C-N-CA 122.686 2.258 . . . . 0.0 111.657 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.414 ' C ' ' O ' ' A' ' 323' ' ' PRO . . . -43.84 -26.61 0.27 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.201 -0.937 . . . . 0.0 109.582 179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.532 ' CB ' ' CD1' ' A' ' 249' ' ' PHE . 22.8 m -61.71 -58.4 8.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.238 -0.914 . . . . 0.0 109.579 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.921 HD12 ' HA ' ' A' ' 322' ' ' PRO . 35.1 mt -53.85 -38.63 36.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.266 -0.896 . . . . 0.0 109.483 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -60.02 144.55 49.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.21 -0.931 . . . . 0.0 109.543 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -56.65 -37.85 71.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.277 -0.89 . . . . 0.0 109.47 179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 118.035 -0.983 . . . . 0.0 109.464 -179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.374 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . 0.407 ' O ' ' HB2' ' B' ' 428' ' ' ASN . 89.1 m-20 -55.3 -35.98 65.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.311 -1.111 . . . . 0.0 109.497 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' B' ' 427' ' ' ASP . 26.5 m120 60.41 43.84 12.82 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.196 -0.94 . . . . 0.0 109.389 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.47 ' HD2' ' HD2' ' B' ' 430' ' ' PRO . 0.0 OUTLIER -87.68 123.62 68.99 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.289 -0.882 . . . . 0.0 109.47 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.47 ' HD2' ' HD2' ' B' ' 429' ' ' LYS . 50.4 Cg_endo -70.46 134.68 27.03 Favored 'Trans proline' 0 C--O 1.215 -0.674 0 C-N-CA 122.671 2.247 . . . . 0.0 111.845 -179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.46 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -70.88 166.6 20.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 109.498 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.19 -38.54 73.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.188 -0.945 . . . . 0.0 109.306 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . 0.562 ' CB ' ' HB2' ' B' ' 456' ' ' LEU . 75.1 m-20 -61.74 -49.91 74.51 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.338 -0.851 . . . . 0.0 109.185 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.809 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.5 tm? -64.98 -38.67 91.72 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.414 -0.804 . . . . 0.0 109.412 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.807 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.3 OUTLIER -73.36 -33.94 65.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.315 -0.866 . . . . 0.0 109.477 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -85.67 8.54 19.24 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.238 -0.914 . . . . 0.0 109.527 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.525 HD23 HG21 ' B' ' 440' ' ' VAL . 36.1 tp -72.39 131.07 42.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -71.98 143.04 49.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 109.46 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 89.61 6.58 70.18 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.877 HG22 HD21 ' B' ' 481' ' ' LEU . 54.4 t -138.36 128.97 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.213 -1.169 . . . . 0.0 109.394 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.497 ' OD1' ' CB ' ' B' ' 444' ' ' LEU . 32.5 p30 -98.84 -177.21 3.57 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.294 -0.879 . . . . 0.0 109.647 -179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.44 ' HB3' ' CZ ' ' B' ' 446' ' ' PHE . 97.6 mtt180 -62.14 -43.74 98.16 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.295 -0.878 . . . . 0.0 109.518 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -63.78 -55.92 19.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.184 -0.947 . . . . 0.0 109.562 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.003 HD11 ' CD2' ' B' ' 473' ' ' LEU . 13.9 tp -56.55 -40.84 75.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.226 -0.921 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.88 -36.77 77.63 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.387 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.44 ' CZ ' ' HB3' ' B' ' 442' ' ' ARG . 15.1 m-30 -66.72 -43.36 84.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.841 . . . . 0.0 109.409 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.637 ' HB3' HG21 ' B' ' 470' ' ' ILE . 43.5 mttt -61.7 -42.0 98.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 109.501 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.822 HD13 ' O ' ' B' ' 448' ' ' LEU . 2.7 tm? -62.85 -44.49 95.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.308 -0.87 . . . . 0.0 109.459 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -62.03 -26.82 68.47 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.251 -0.905 . . . . 0.0 109.633 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.11 -17.18 9.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.239 -0.913 . . . . 0.0 109.525 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.429 ' CZ ' ' HB3' ' B' ' 451' ' ' ARG . 7.1 mtp85 -92.25 27.97 2.05 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.204 -0.935 . . . . 0.0 109.432 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.72 -18.68 7.0 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.3 -1.12 . . . . 0.0 110.3 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' B' ' 458' ' ' ASP . 47.8 t -63.73 140.3 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.927 -1.337 . . . . 0.0 109.397 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.438 ' O ' ' N ' ' B' ' 431' ' ' ALA . 27.1 m -135.09 -36.21 0.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -0.991 . . . . 0.0 109.743 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.46 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -105.51 151.48 24.23 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.155 -0.966 . . . . 0.0 109.77 -179.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.715 HD11 HD12 ' B' ' 488' ' ' ILE . 2.1 tm? -52.03 -38.32 56.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.363 -0.836 . . . . 0.0 109.2 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . 0.446 ' HA ' ' OE1' ' B' ' 457' ' ' GLU . 43.8 mm-40 -58.12 -47.65 82.62 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.336 -0.852 . . . . 0.0 108.839 179.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.656 ' HB3' HG13 ' B' ' 453' ' ' VAL . 58.2 m-20 -55.93 -44.66 78.55 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.328 -0.857 . . . . 0.0 109.054 179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.767 ' C ' HD13 ' B' ' 459' ' ' LEU . 2.8 tm? -55.5 -42.72 74.85 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.074 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.431 ' O ' ' HE3' ' A' ' 297' ' ' LYS . . . -60.01 -36.06 76.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.202 179.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . 0.473 ' O ' ' HG2' ' B' ' 461' ' ' GLU . 77.1 tt0 -68.78 -13.13 62.2 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.246 179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.438 ' HG3' HG21 ' B' ' 453' ' ' VAL . 96.3 mm-40 -74.65 147.6 41.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.946 . . . . 0.0 109.565 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -106.17 158.21 15.64 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.789 HD11 ' HG2' ' A' ' 293' ' ' PRO . 24.0 mt -52.29 -34.12 17.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.256 -1.143 . . . . 0.0 109.481 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 93.7 m-20 -68.95 -37.08 78.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -70.09 -32.09 69.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.254 -0.904 . . . . 0.0 109.475 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.9 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.4 mt -74.86 -30.01 61.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.193 -0.942 . . . . 0.0 109.423 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -23.57 63.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.337 -0.852 . . . . 0.0 109.543 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -52.77 -31.44 38.36 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.256 -0.902 . . . . 0.0 109.517 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.637 HG21 ' HB3' ' B' ' 447' ' ' LYS . 64.4 mt -102.24 128.93 54.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -0.907 . . . . 0.0 109.44 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -64.44 -35.67 81.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.269 -0.895 . . . . 0.0 109.386 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -53.47 -28.52 36.68 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.003 ' CD2' HD11 ' B' ' 444' ' ' LEU . 81.4 mt -102.41 134.48 45.65 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.278 -1.131 . . . . 0.0 109.56 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.491 HG22 ' N ' ' B' ' 475' ' ' ASP . 51.4 m -103.85 162.08 13.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.273 -0.892 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.491 ' N ' HG22 ' B' ' 474' ' ' THR . 84.8 m-20 -56.69 -38.63 72.54 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.261 -0.899 . . . . 0.0 109.409 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.5 tt0 -75.94 -46.0 32.11 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.45 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.619 ' CE ' HD22 ' B' ' 444' ' ' LEU . 43.4 tttp -66.66 -46.74 74.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.211 -0.931 . . . . 0.0 109.273 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.9 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.08 -45.18 87.57 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 0.0 109.404 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -59.58 -45.54 95.45 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -56.89 -35.37 68.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.289 -1.124 . . . . 0.0 109.392 179.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.877 HD21 HG22 ' B' ' 440' ' ' VAL . 7.7 mp -70.05 -30.58 67.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.283 -0.886 . . . . 0.0 109.42 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.559 HD11 ' N ' ' B' ' 464' ' ' ILE . 46.0 mt -69.83 -54.95 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.243 -0.91 . . . . 0.0 109.572 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.494 ' SD ' ' N ' ' A' ' 293' ' ' PRO . 44.0 mmm -57.6 -44.31 85.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.35 -0.844 . . . . 0.0 109.344 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.448 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -61.38 -56.81 16.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.208 -0.932 . . . . 0.0 109.358 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -61.18 -46.74 89.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.309 -0.87 . . . . 0.0 109.437 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.504 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 77.1 ttt180 -55.18 -47.46 75.17 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.182 -0.949 . . . . 0.0 109.377 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.457 ' O ' ' HB2' ' B' ' 491' ' ' PHE . 89.6 m-20 -57.76 -41.37 81.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.454 -179.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.715 HD12 HD11 ' B' ' 456' ' ' LEU . 75.7 mt -56.02 -37.0 46.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.625 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 42.3 t -80.74 -51.91 8.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.297 -0.877 . . . . 0.0 109.774 -179.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . 0.504 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 63.1 m95 -62.53 -47.15 85.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 109.719 -179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.457 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 64.7 m-85 -74.74 -33.03 62.28 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.223 -0.923 . . . . 0.0 109.461 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -62.02 -31.13 77.55 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -62.13 -37.24 84.39 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.223 -1.163 . . . . 0.0 109.474 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.61 143.91 28.4 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.459 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.601 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 253' ' ' LEU . 1.1 m-20 -65.95 141.52 97.61 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.908 . . . . 0.0 109.452 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -65.61 -22.78 57.7 Favored 'Trans proline' 0 C--O 1.215 -0.663 0 C-N-CA 122.73 2.287 . . . . 0.0 111.511 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.521 ' CG2' ' O ' ' A' ' 311' ' ' GLY . 7.3 tt -67.57 -26.52 35.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.297 -0.877 . . . . 0.0 109.169 179.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.966 ' CD2' HG11 ' A' ' 282' ' ' VAL . 2.2 mt -73.96 -45.36 50.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.244 -0.91 . . . . 0.0 109.419 179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.86 HD11 HD12 ' A' ' 326' ' ' ILE . 3.1 mm? -68.73 -30.74 69.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.325 -0.859 . . . . 0.0 109.48 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 13.7 mtt180 -60.24 139.44 91.61 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.201 -0.937 . . . . 0.0 109.494 -179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.6 Cg_endo -70.49 134.85 27.36 Favored 'Trans proline' 0 C--O 1.215 -0.664 0 C-N-CA 122.695 2.264 . . . . 0.0 111.782 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.696 HG22 ' O ' ' A' ' 276' ' ' HIS . 0.1 OUTLIER -44.4 -32.56 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 0.0 109.298 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.95 -30.76 71.81 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.905 . . . . 0.0 109.229 179.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.1 m-20 -75.71 -12.99 60.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.354 -0.842 . . . . 0.0 109.411 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.7 HD21 ' CD1' ' A' ' 278' ' ' ILE . 85.2 mt -55.71 136.86 50.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.511 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 261' ' ' GLU . 79.1 tt0 -63.96 -16.84 62.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.254 -0.904 . . . . 0.0 109.638 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.622 HD23 ' HB3' ' A' ' 302' ' ' GLU . 6.4 mp -62.56 165.85 5.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.229 -0.919 . . . . 0.0 109.492 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 27.3 p -71.97 169.11 16.59 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.267 -0.896 . . . . 0.0 109.526 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.438 HG12 ' OD1' ' A' ' 268' ' ' ASN . 3.5 t -51.42 -31.22 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.215 -0.928 . . . . 0.0 109.526 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -50.64 -46.91 58.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.186 -0.946 . . . . 0.0 109.414 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.463 ' HB2' ' HB3' ' A' ' 262' ' ' LEU . 20.7 t -60.26 -50.62 72.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.318 -0.864 . . . . 0.0 109.459 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.47 ' O ' ' CB ' ' A' ' 271' ' ' LYS . . . -66.82 -29.2 69.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.521 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.438 ' OD1' HG12 ' A' ' 264' ' ' VAL . 94.9 m-20 -62.41 -42.99 99.85 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.247 -0.908 . . . . 0.0 109.393 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 81.3 m -52.45 -58.38 6.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.243 -0.911 . . . . 0.0 109.488 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.712 HD22 ' N ' ' A' ' 270' ' ' LEU . 3.1 mm? -73.74 -39.41 64.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.927 . . . . 0.0 109.446 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 12.7 tptm -57.77 -42.14 83.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.308 -0.87 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -67.36 -21.45 65.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.231 -0.918 . . . . 0.0 109.539 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.586 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 63.6 tt0 -89.35 21.67 3.22 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.894 . . . . 0.0 109.471 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.43 17.29 8.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 0.0 109.377 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.751 HG23 ' HB2' ' A' ' 280' ' ' ASP . 72.9 mt -107.31 125.41 63.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.231 -0.918 . . . . 0.0 109.517 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.696 ' O ' HG22 ' A' ' 257' ' ' VAL . 95.3 m-70 -113.43 -25.67 8.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.291 -0.88 . . . . 0.0 109.352 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 96.0 m-85 -105.19 141.43 36.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.252 -0.905 . . . . 0.0 109.514 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.7 ' CD1' HD21 ' A' ' 260' ' ' LEU . 76.0 mt -63.58 -31.39 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.201 -0.937 . . . . 0.0 109.273 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.992 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -50.72 -45.68 48.24 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.751 ' HB2' HG23 ' A' ' 275' ' ' ILE . 79.3 m-20 -53.78 -37.38 63.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.149 -1.207 . . . . 0.0 109.215 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.529 HD13 HD11 ' A' ' 270' ' ' LEU . 34.9 tp -52.53 -48.57 65.98 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.271 -0.893 . . . . 0.0 108.866 179.634 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.992 HG22 ' O ' ' A' ' 279' ' ' GLY . 3.8 m -66.77 -23.89 31.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.257 -0.902 . . . . 0.0 108.821 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.467 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.45 -35.92 80.8 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.366 -0.975 . . . . 0.0 108.366 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.463 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 72.3 mtt180 -105.97 141.92 36.54 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 4.2 m -63.68 137.89 58.27 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.16 -0.963 . . . . 0.0 109.543 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.606 ' HA ' HD23 ' A' ' 289' ' ' LEU . 47.0 tp10 -53.7 -29.22 38.05 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.166 -0.959 . . . . 0.0 109.211 179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 37.1 t -52.79 -48.25 50.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.198 -0.939 . . . . 0.0 108.999 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.463 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 96.3 mt-10 -51.93 -35.66 46.48 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.253 -0.905 . . . . 0.0 109.008 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.619 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.8 mm? -65.48 -44.16 87.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.318 -0.864 . . . . 0.0 108.907 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.655 HD22 ' N ' ' A' ' 290' ' ' LEU . 3.4 mm? -63.56 -17.59 62.99 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.289 -0.882 . . . . 0.0 108.958 179.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.536 ' O ' ' HE1' ' B' ' 483' ' ' MET . 21.6 mttt -93.3 26.51 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.504 -0.748 . . . . 0.0 109.438 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.426 HG22 ' H ' ' A' ' 294' ' ' ASN . 86.7 m -138.02 122.28 11.84 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.224 -0.922 . . . . 0.0 109.459 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 1.037 ' HG2' HD11 ' B' ' 464' ' ' ILE . 50.3 Cg_endo -71.17 -20.24 28.63 Favored 'Trans proline' 0 C--O 1.214 -0.703 0 C-N-CA 122.686 2.257 . . . . 0.0 111.893 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.769 ' ND2' HD12 ' B' ' 464' ' ' ILE . 33.5 m120 -50.26 -22.32 1.72 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.301 -0.874 . . . . 0.0 109.342 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 295' ' ' LEU . 3.8 mp -95.54 122.03 37.86 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.304 -0.872 . . . . 0.0 109.494 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -82.87 156.51 34.56 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 82.8 mttt -48.86 -39.51 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.262 -1.14 . . . . 0.0 109.563 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 29.4 mttt -62.32 -45.94 90.98 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.265 -0.897 . . . . 0.0 109.576 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 19.4 m -64.52 -52.02 59.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.208 -0.933 . . . . 0.0 109.531 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.562 ' HA ' HD12 ' A' ' 303' ' ' ILE . 34.7 tp -53.18 -39.13 63.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.211 -0.931 . . . . 0.0 109.521 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.7 m -58.8 -49.73 76.58 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.267 -0.895 . . . . 0.0 109.533 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.622 ' HB3' HD23 ' A' ' 262' ' ' LEU . 74.2 mt-10 -59.75 -40.67 88.89 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.163 -0.961 . . . . 0.0 109.323 179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 300' ' ' LEU . 83.9 mt -57.83 -52.39 58.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.248 -0.907 . . . . 0.0 109.284 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -54.54 -38.99 67.24 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.231 -0.918 . . . . 0.0 109.158 179.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.83 -42.08 83.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.259 -0.901 . . . . 0.0 109.248 179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.3 t -72.39 -42.76 64.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.399 179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.778 HD22 ' CB ' ' A' ' 313' ' ' SER . 24.4 mt -54.54 -26.91 34.85 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.309 -0.869 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -59.07 -35.92 74.18 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.153 -0.967 . . . . 0.0 109.387 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 60.4 p -68.47 -20.31 64.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.238 -0.914 . . . . 0.0 109.408 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.513 ' O ' HD11 ' A' ' 314' ' ' LEU . 32.4 ttm180 67.59 7.39 5.6 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 109.41 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.521 ' O ' ' CG2' ' A' ' 252' ' ' ILE . . . -78.31 -22.47 67.75 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.796 HD23 ' H ' ' A' ' 312' ' ' LEU . 1.7 pt? -137.08 155.94 49.01 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -1.165 . . . . 0.0 109.604 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.778 ' CB ' HD22 ' A' ' 307' ' ' LEU . 1.3 t 75.47 51.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -0.894 . . . . 0.0 109.492 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.815 ' N ' HD22 ' A' ' 314' ' ' LEU . 3.0 mm? -93.14 21.25 6.05 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.0 109.456 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 47.04 46.16 20.15 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.432 -1.467 . . . . 0.0 109.432 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.426 ' O ' ' O ' ' A' ' 282' ' ' VAL . 11.0 ptt? -121.91 139.83 53.17 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.186 -1.185 . . . . 0.0 109.429 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.683 ' O ' HD13 ' A' ' 318' ' ' LEU . 55.9 mtt180 -100.14 137.43 38.59 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.323 -0.86 . . . . 0.0 109.396 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.726 HD22 ' N ' ' A' ' 318' ' ' LEU . 2.4 mm? -122.28 111.37 16.84 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -0.888 . . . . 0.0 109.901 -179.804 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 72.1 tt0 -77.07 -30.49 55.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.945 . . . . 0.0 108.753 179.215 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.403 ' O ' ' C ' ' A' ' 321' ' ' TRP . 21.2 t-20 -165.29 26.33 0.05 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.494 -0.754 . . . . 0.0 109.053 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.818 ' CH2' HD22 ' A' ' 254' ' ' LEU . 0.4 OUTLIER -43.37 104.25 0.36 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.417 -0.802 . . . . 0.0 110.106 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -99.5 71.15 0.06 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 123.727 2.951 . . . . 0.0 112.08 179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 1.012 ' O ' HG22 ' A' ' 326' ' ' ILE . 50.2 Cg_endo -70.05 155.83 64.04 Favored 'Trans proline' 0 C--O 1.215 -0.636 0 C-N-CA 122.54 2.16 . . . . 0.0 111.816 179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -67.76 -27.97 67.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.271 -0.893 . . . . 0.0 109.291 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 41.2 m -59.1 -40.08 84.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.223 -0.923 . . . . 0.0 109.337 179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 1.012 HG22 ' O ' ' A' ' 323' ' ' PRO . 20.5 tt -63.6 -22.78 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.242 -0.911 . . . . 0.0 109.307 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -70.24 143.72 52.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.253 -0.904 . . . . 0.0 109.384 179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -54.81 -37.15 65.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.279 -0.888 . . . . 0.0 109.525 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.966 -1.016 . . . . 0.0 109.488 179.997 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . 0.425 ' O ' ' SG ' ' B' ' 454' ' ' CYS . 94.9 m-20 -61.28 -34.23 74.85 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -1.165 . . . . 0.0 109.443 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.672 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 23.7 m120 -59.15 -25.25 63.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' B' ' 426' ' ' GLY . 0.4 OUTLIER -50.98 131.84 30.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.268 -0.895 . . . . 0.0 109.443 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.886 ' HB3' HD23 ' B' ' 434' ' ' LEU . 49.5 Cg_endo -70.3 136.37 31.42 Favored 'Trans proline' 0 C--O 1.216 -0.608 0 C-N-CA 122.68 2.253 . . . . 0.0 111.907 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.84 160.55 25.78 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.258 -0.901 . . . . 0.0 109.451 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -53.15 -33.87 54.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.247 -0.908 . . . . 0.0 109.489 -179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -65.04 -49.61 69.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.338 -0.851 . . . . 0.0 109.624 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' B' ' 430' ' ' PRO . 17.2 tp -65.05 -38.44 90.84 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.27 -0.894 . . . . 0.0 109.547 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.839 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.5 OUTLIER -73.61 -33.22 64.48 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.207 -0.933 . . . . 0.0 109.456 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 71.0 m-20 -86.87 9.84 17.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.212 -0.93 . . . . 0.0 109.456 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.752 HD13 HD13 ' B' ' 456' ' ' LEU . 44.8 tp -77.24 133.29 38.91 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.286 -0.884 . . . . 0.0 109.55 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -77.45 142.26 39.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.264 -0.898 . . . . 0.0 109.49 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 93.1 2.8 65.99 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.468 HG22 ' CD2' ' B' ' 481' ' ' LEU . 93.8 t -131.06 129.56 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.13 -1.218 . . . . 0.0 109.497 179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.607 ' H ' HD12 ' B' ' 444' ' ' LEU . 75.5 m-20 -90.86 155.22 18.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.414 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.598 ' HG2' HD11 ' B' ' 435' ' ' LEU . 58.8 mtm180 -50.04 -40.62 45.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.252 -0.905 . . . . 0.0 109.567 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -66.9 -45.45 77.94 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.595 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.748 HD22 HD21 ' B' ' 473' ' ' LEU . 45.5 mt -60.39 -42.09 95.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.226 -0.921 . . . . 0.0 109.486 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.82 -45.97 88.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.355 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.49 ' CE1' ' HG3' ' B' ' 430' ' ' PRO . 11.2 m-30 -58.51 -43.41 89.12 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.312 -0.868 . . . . 0.0 109.592 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.699 ' HB3' HG21 ' B' ' 470' ' ' ILE . 45.6 mttp -60.59 -52.5 64.92 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.215 -0.928 . . . . 0.0 109.553 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.558 ' CD1' ' CD2' ' B' ' 459' ' ' LEU . 7.1 tt -65.55 -42.03 92.33 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.236 -0.915 . . . . 0.0 109.627 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.672 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -55.99 -27.0 50.92 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.977 . . . . 0.0 109.487 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -47.36 -24.0 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.245 -0.91 . . . . 0.0 109.465 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.417 ' NH1' ' CG1' ' B' ' 470' ' ' ILE . 41.9 mtt-85 -88.8 26.29 1.56 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 109.666 -179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.63 6.93 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.741 HG13 ' CB ' ' B' ' 458' ' ' ASP . 73.2 t -60.71 130.21 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.94 -1.33 . . . . 0.0 109.472 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.442 ' O ' ' HB3' ' B' ' 431' ' ' ALA . 57.0 m -135.06 -36.59 0.81 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.162 -0.961 . . . . 0.0 109.743 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.499 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -97.12 153.08 18.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.155 -0.966 . . . . 0.0 109.783 -179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.942 HD21 HD12 ' B' ' 488' ' ' ILE . 42.5 tp -49.48 -40.42 37.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.308 -0.87 . . . . 0.0 109.325 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -55.71 -49.93 71.69 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 108.994 179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.741 ' CB ' HG13 ' B' ' 453' ' ' VAL . 81.0 m-20 -55.52 -40.55 71.97 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.266 -0.896 . . . . 0.0 108.971 179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.77 ' C ' HD13 ' B' ' 459' ' ' LEU . 3.4 tm? -55.62 -42.98 75.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.83 . . . . 0.0 109.149 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -66.73 -25.69 66.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.287 -0.883 . . . . 0.0 109.262 179.779 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.13 -21.19 63.12 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.292 -0.88 . . . . 0.0 109.438 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.61 ' CG ' HG21 ' B' ' 453' ' ' VAL . 98.4 mm-40 -79.98 153.81 28.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.252 -0.905 . . . . 0.0 109.421 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.439 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -117.3 152.35 17.79 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 1.037 HD11 ' HG2' ' A' ' 293' ' ' PRO . 33.6 mt -44.46 -36.55 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.284 -1.127 . . . . 0.0 109.352 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 13.1 p-10 -63.95 -35.59 81.17 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.358 -0.839 . . . . 0.0 109.473 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.439 ' N ' ' O ' ' B' ' 463' ' ' GLY . 87.2 m-20 -77.35 -31.55 54.52 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.01 HD12 ' HB1' ' B' ' 478' ' ' ALA . 23.1 mt -73.48 -35.52 65.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.298 -0.876 . . . . 0.0 109.282 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -61.65 -27.91 69.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -0.925 . . . . 0.0 109.427 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -60.51 -33.2 72.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 109.498 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.699 HG21 ' HB3' ' B' ' 447' ' ' LYS . 80.5 mt -85.24 131.39 34.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.189 -0.944 . . . . 0.0 109.436 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -69.95 150.4 46.75 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.243 -0.911 . . . . 0.0 109.451 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . 100.19 -29.39 12.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.748 HD21 HD22 ' B' ' 444' ' ' LEU . 64.6 mt -99.72 136.49 39.56 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -1.16 . . . . 0.0 109.609 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 7.0 m -104.03 162.07 13.46 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.44 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -57.3 -38.11 73.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.235 -0.916 . . . . 0.0 109.536 -179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -72.65 -45.94 56.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.332 -0.855 . . . . 0.0 109.471 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.573 ' O ' HD13 ' B' ' 481' ' ' LEU . 14.5 tttp -62.58 -45.68 91.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.306 -0.871 . . . . 0.0 109.36 179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.01 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -58.7 -42.49 88.73 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' B' ' 483' ' ' MET . . . -61.7 -46.3 94.5 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.83 78.98 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -1.101 . . . . 0.0 109.517 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.573 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.0 mp -66.38 -35.36 80.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.218 -0.926 . . . . 0.0 109.594 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.917 HD12 ' HB2' ' A' ' 293' ' ' PRO . 59.6 mt -70.32 -56.33 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.248 -0.908 . . . . 0.0 109.579 -179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.536 ' HE1' ' O ' ' A' ' 291' ' ' LYS . 39.9 mtp -52.92 -37.8 61.17 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.223 -0.923 . . . . 0.0 109.398 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -63.68 -50.34 69.62 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.378 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' B' ' 459' ' ' LEU . . . -64.81 -49.74 69.44 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.346 -0.846 . . . . 0.0 109.36 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.541 ' HG2' ' CD1' ' B' ' 490' ' ' TRP . 66.3 ttt-85 -53.85 -47.06 71.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.345 -0.847 . . . . 0.0 109.453 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -57.97 -45.84 86.09 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.262 -0.899 . . . . 0.0 109.435 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.942 HD12 HD21 ' B' ' 456' ' ' LEU . 46.2 mt -59.1 -39.51 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.219 -0.926 . . . . 0.0 109.449 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 91.2 m -75.3 -49.13 20.15 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.184 -0.948 . . . . 0.0 109.444 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . 0.541 ' CD1' ' HG2' ' B' ' 486' ' ' ARG . 15.0 m95 -59.39 -41.3 89.08 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.174 -0.954 . . . . 0.0 109.472 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -98.6 9.19 43.8 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.211 -0.93 . . . . 0.0 109.463 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . . . . . . . . . . . -71.53 131.1 18.91 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.4 -39.35 75.93 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.241 -1.152 . . . . 0.0 109.471 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -34.4 71.25 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.907 . . . . 0.0 109.529 179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.508 0 CA-C-O 117.991 -1.004 . . . . 0.0 109.516 179.964 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.679 ' HD2' HD22 ' A' ' 253' ' ' LEU . 2.5 m-85 . . . . . 0 N--CA 1.491 1.584 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.519 ' O ' ' CD2' ' A' ' 254' ' ' LEU . 0.8 OUTLIER -61.67 139.55 95.27 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.242 -0.911 . . . . 0.0 109.159 179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.477 ' HA ' HD23 ' A' ' 254' ' ' LEU . 42.0 Cg_endo -64.56 -34.05 53.95 Favored 'Trans proline' 0 C--O 1.216 -0.621 0 C-N-CA 122.505 2.137 . . . . 0.0 111.473 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.619 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.7 tt -53.71 -34.56 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.397 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 178.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.679 HD22 ' HD2' ' A' ' 249' ' ' PHE . 0.6 OUTLIER -74.57 -21.67 59.38 Favored 'General case' 0 N--CA 1.487 1.411 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.083 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.653 HD13 ' CZ2' ' A' ' 321' ' ' TRP . 3.0 mm? -89.58 -24.8 21.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.481 -0.762 . . . . 0.0 109.263 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -66.23 147.5 98.85 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.286 -0.884 . . . . 0.0 109.469 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 277' ' ' TYR . 50.8 Cg_endo -70.69 140.88 40.15 Favored 'Trans proline' 0 C--O 1.215 -0.662 0 C-N-CA 122.698 2.265 . . . . 0.0 111.715 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.707 HG12 HD11 ' A' ' 260' ' ' LEU . 0.1 OUTLIER -43.54 -34.5 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 109.365 179.831 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 95.5 m-20 -61.84 -30.92 71.16 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.375 179.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.461 ' N ' ' O ' ' A' ' 256' ' ' PRO . 30.2 m-20 -76.0 -14.96 60.22 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.314 -0.866 . . . . 0.0 109.568 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.707 HD11 HG12 ' A' ' 257' ' ' VAL . 48.7 mt -44.75 149.48 0.42 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.478 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -64.56 -19.17 65.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.305 -0.872 . . . . 0.0 109.513 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.648 ' H ' HD12 ' A' ' 262' ' ' LEU . 6.1 mp -64.07 169.32 4.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.485 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 9.2 p -78.22 159.88 28.27 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.25 -0.906 . . . . 0.0 109.426 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.476 HG12 ' ND2' ' A' ' 268' ' ' ASN . 3.2 t -47.25 -37.02 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.404 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.486 ' NH2' ' OD2' ' B' ' 465' ' ' ASP . 52.0 ttt85 -53.37 -46.85 69.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -0.945 . . . . 0.0 109.5 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.533 ' CB ' ' HB3' ' A' ' 262' ' ' LEU . 19.4 m -63.58 -51.05 67.02 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.19 -0.943 . . . . 0.0 109.387 179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -62.45 -35.07 78.14 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.207 -0.933 . . . . 0.0 109.365 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.476 ' ND2' HG12 ' A' ' 264' ' ' VAL . 95.6 m-20 -59.7 -33.31 71.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.237 -0.914 . . . . 0.0 109.27 179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 56.5 m -62.29 -63.82 1.12 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.291 -0.881 . . . . 0.0 109.292 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 295' ' ' LEU . 60.0 mt -58.64 -47.66 83.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 109.343 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.5 ' HE3' ' CE1' ' A' ' 276' ' ' HIS . 19.0 tttt -52.69 -32.11 40.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.406 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -60.97 -17.46 51.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.258 -0.901 . . . . 0.0 109.328 179.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.629 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 58.5 tt0 -95.6 21.33 8.44 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.215 -0.928 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.629 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 72.05 23.3 3.48 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 0.0 109.651 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.923 HG23 ' HB2' ' A' ' 280' ' ' ASP . 97.0 mt -112.34 107.66 23.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.507 ' C ' HG22 ' A' ' 257' ' ' VAL . 50.5 m-70 -107.1 -9.2 16.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.891 . . . . 0.0 109.454 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 256' ' ' PRO . 5.5 m-85 -114.55 131.96 56.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.45 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.619 HD12 ' O ' ' A' ' 252' ' ' ILE . 74.7 mt -54.16 -36.5 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.192 -0.943 . . . . 0.0 109.119 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.868 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -46.38 -47.53 16.65 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.923 ' HB2' HG23 ' A' ' 275' ' ' ILE . 89.2 m-20 -53.27 -34.41 57.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.99 -1.3 . . . . 0.0 108.704 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.498 HD13 HD13 ' A' ' 270' ' ' LEU . 31.2 tp -53.78 -50.48 65.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.408 -0.807 . . . . 0.0 109.146 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.868 HG22 ' O ' ' A' ' 279' ' ' GLY . 34.8 m -67.09 -29.55 46.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.191 -0.943 . . . . 0.0 109.033 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.441 ' HB2' ' O ' ' A' ' 280' ' ' ASP . 93.9 mt-30 -57.2 -34.34 68.43 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . . . . . . . . . 44.7 mtp180 -96.99 159.55 14.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.416 -0.802 . . . . 0.0 109.017 179.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 2.0 m -83.35 140.15 32.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.956 . . . . 0.0 109.693 -179.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 289' ' ' LEU . 88.3 tt0 -52.7 -31.18 36.25 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.295 -0.878 . . . . 0.0 109.325 179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 54.0 t -52.89 -51.9 33.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.269 -0.894 . . . . 0.0 109.039 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.456 ' HA ' ' OE1' ' A' ' 288' ' ' GLU . 69.9 mm-40 -51.93 -37.0 51.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.296 -0.877 . . . . 0.0 109.087 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.489 HD11 HD11 ' A' ' 281' ' ' LEU . 62.2 mt -60.75 -47.24 87.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.306 -0.871 . . . . 0.0 109.202 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.995 ' O ' HD13 ' A' ' 290' ' ' LEU . 1.8 tm? -59.81 -33.53 71.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 0.0 109.283 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.527 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 45.8 mttt -83.06 -17.84 41.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.17 -0.956 . . . . 0.0 109.402 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 27.3 m -77.08 113.14 27.96 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 0.0 109.483 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 1.026 ' HB2' HD12 ' B' ' 482' ' ' ILE . 50.8 Cg_endo -71.0 -23.29 25.31 Favored 'Trans proline' 0 C--O 1.215 -0.647 0 C-N-CA 122.766 2.311 . . . . 0.0 112.165 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.437 ' HA ' HD12 ' B' ' 464' ' ' ILE . 70.8 m-80 -50.93 -21.22 1.62 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.221 -0.924 . . . . 0.0 109.699 -179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.898 HD21 HD21 ' A' ' 270' ' ' LEU . 3.2 mp -101.31 122.69 44.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.172 -0.955 . . . . 0.0 109.492 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -73.8 156.64 50.86 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 56.7 tttm -49.09 -38.63 25.23 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.293 -1.122 . . . . 0.0 109.475 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 55.1 tttp -67.2 -42.68 83.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.198 -0.939 . . . . 0.0 109.355 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 59.5 p -58.43 -47.14 84.93 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.211 -0.931 . . . . 0.0 109.409 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.48 HD21 HD23 ' A' ' 290' ' ' LEU . 22.9 tp -52.94 -44.19 66.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.294 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 52.2 m -52.5 -52.31 55.16 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.276 -0.89 . . . . 0.0 109.209 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.485 ' OE1' HD23 ' A' ' 262' ' ' LEU . 84.7 mt-10 -53.61 -42.24 67.51 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.099 179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . . . . . . . . . 28.4 mm -59.57 -39.45 79.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.283 -0.885 . . . . 0.0 109.183 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -62.16 -36.11 80.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.279 -0.888 . . . . 0.0 109.194 179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 93.2 m-20 -65.39 -51.24 61.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.27 -0.894 . . . . 0.0 109.187 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.561 HG12 HD11 ' A' ' 312' ' ' LEU . 3.2 t -72.29 -37.52 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -0.92 . . . . 0.0 109.251 179.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 312' ' ' LEU . 15.5 tp -60.25 -26.27 66.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.316 -0.865 . . . . 0.0 109.441 179.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.08 -30.7 66.43 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.234 -0.917 . . . . 0.0 109.434 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.436 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 0.7 OUTLIER -68.95 -7.35 34.34 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.325 -0.86 . . . . 0.0 109.555 179.937 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.526 ' O ' ' CD2' ' A' ' 314' ' ' LEU . 92.9 mtt-85 61.76 12.52 4.73 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.225 -0.922 . . . . 0.0 109.324 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 312' ' ' LEU . . . -93.21 -2.94 65.66 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.581 -1.407 . . . . 0.0 109.581 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.561 HD11 HG12 ' A' ' 306' ' ' VAL . 0.0 OUTLIER -137.76 153.03 49.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.166 -1.197 . . . . 0.0 109.369 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.676 ' N ' HG12 ' A' ' 282' ' ' VAL . 0.1 OUTLIER 46.36 67.92 0.69 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.206 -0.933 . . . . 0.0 109.486 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 310' ' ' ARG . 11.6 mt -101.64 11.86 38.17 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.187 -0.946 . . . . 0.0 109.258 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.49 26.63 73.83 Favored Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.709 ' HE3' HG21 ' A' ' 282' ' ' VAL . 13.5 ptt? -107.7 150.83 26.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.133 -1.216 . . . . 0.0 109.54 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.643 ' C ' HD12 ' A' ' 318' ' ' LEU . 61.7 mtp180 -125.57 145.85 49.94 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.333 -0.854 . . . . 0.0 109.248 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.808 ' N ' HD12 ' A' ' 318' ' ' LEU . 3.9 mp -124.04 140.95 52.48 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.157 -0.965 . . . . 0.0 109.68 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -68.1 -32.2 72.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.089 179.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 321' ' ' TRP . 85.8 m-20 -122.35 -78.59 0.6 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.326 -0.859 . . . . 0.0 109.167 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.653 ' CZ2' HD13 ' A' ' 254' ' ' LEU . 0.8 OUTLIER 168.76 -58.18 0.0 OUTLIER Pre-proline 0 N--CA 1.489 1.489 0 O-C-N 121.281 -0.887 . . . . 0.0 109.551 179.713 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.524 ' HD3' ' HB3' ' A' ' 321' ' ' TRP . 48.7 Cg_endo -68.76 107.8 1.74 Allowed 'Trans proline' 0 C--O 1.215 -0.648 0 C-N-CA 122.647 2.231 . . . . 0.0 111.889 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 1.017 ' O ' HG22 ' A' ' 326' ' ' ILE . 52.8 Cg_endo -73.16 165.12 33.55 Favored 'Trans proline' 0 C--O 1.216 -0.622 0 C-N-CA 122.554 2.169 . . . . 0.0 111.688 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -60.29 -20.89 60.98 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.963 . . . . 0.0 109.44 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . . . . . . . . . 22.9 m -76.82 -38.68 53.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.319 -0.863 . . . . 0.0 109.434 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 1.017 HG22 ' O ' ' A' ' 323' ' ' PRO . 18.5 tt -60.68 -18.26 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.299 -0.876 . . . . 0.0 109.453 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -73.0 147.35 45.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.0 109.46 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -58.85 -38.47 78.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.0 109.442 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.043 -0.98 . . . . 0.0 109.414 -179.971 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -57.46 -33.61 68.14 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.348 -1.09 . . . . 0.0 109.478 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . . . . . . . . . 20.0 m120 56.78 43.68 24.73 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.212 -0.93 . . . . 0.0 109.357 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt -61.85 130.13 92.22 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.369 -0.832 . . . . 0.0 109.575 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -70.9 138.74 34.82 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.703 2.269 . . . . 0.0 111.728 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.71 157.52 36.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.247 -0.908 . . . . 0.0 109.511 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -56.89 -33.54 66.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.324 -0.86 . . . . 0.0 109.475 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . 0.472 ' O ' ' OD1' ' B' ' 436' ' ' ASN . 56.0 m-20 -69.61 -37.3 76.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.268 -0.895 . . . . 0.0 109.493 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.32 -33.24 71.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.09 -1.006 . . . . 0.0 109.34 179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' B' ' 442' ' ' ARG . 33.1 tp -86.43 -30.59 21.96 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.335 -0.853 . . . . 0.0 110.049 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . 0.472 ' OD1' ' O ' ' B' ' 433' ' ' ASP . 24.3 p-10 -80.0 5.84 12.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.047 -1.033 . . . . 0.0 109.834 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.623 HD23 HG21 ' B' ' 440' ' ' VAL . 25.5 tp -77.87 133.81 38.07 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.119 -0.988 . . . . 0.0 109.484 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.9 139.22 50.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.208 -0.933 . . . . 0.0 109.414 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 91.53 9.2 63.25 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.623 HG21 HD23 ' B' ' 437' ' ' LEU . 48.8 t -129.5 130.88 67.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.233 -1.157 . . . . 0.0 109.362 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 75.5 m-20 -101.35 158.42 16.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.22 -0.925 . . . . 0.0 109.489 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.694 ' HG2' HD11 ' B' ' 435' ' ' LEU . 76.8 mtt-85 -50.12 -52.45 34.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.281 -0.887 . . . . 0.0 109.472 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 90.9 m-20 -59.17 -48.38 81.83 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.214 -0.929 . . . . 0.0 109.5 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.067 HD11 ' CD2' ' B' ' 473' ' ' LEU . 12.3 tp -56.0 -42.4 76.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.297 -0.877 . . . . 0.0 109.39 179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -58.85 -46.34 87.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.268 -0.895 . . . . 0.0 109.389 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 -56.23 -44.45 79.6 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.738 ' HB3' HD13 ' B' ' 470' ' ' ILE . 79.2 mttt -60.1 -44.74 94.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.31 -0.869 . . . . 0.0 109.535 -179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.926 ' O ' HD13 ' B' ' 448' ' ' LEU . 2.6 tm? -73.29 -39.35 65.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.141 -0.974 . . . . 0.0 109.371 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' B' ' 453' ' ' VAL . . . -63.8 -28.31 69.78 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.205 -0.934 . . . . 0.0 109.415 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -57.35 -16.89 10.11 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -0.86 . . . . 0.0 109.479 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 38.4 mtp85 -92.3 30.13 1.53 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.254 -0.904 . . . . 0.0 109.562 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.71 -18.86 6.72 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 110.467 -1.053 . . . . 0.0 110.467 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.558 HG13 ' CB ' ' B' ' 458' ' ' ASP . 49.1 t -63.82 138.25 23.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.928 -1.336 . . . . 0.0 109.42 179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.514 ' O ' ' CB ' ' B' ' 431' ' ' ALA . 72.6 m -135.14 -34.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.265 -0.897 . . . . 0.0 109.866 -179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.552 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -115.97 159.31 21.78 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.086 -1.009 . . . . 0.0 109.829 -179.621 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.764 HD21 ' HA ' ' B' ' 485' ' ' ALA . 33.8 tp -50.67 -40.11 52.75 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 109.338 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . 0.406 ' OE1' ' SG ' ' B' ' 489' ' ' CYS . 48.0 tp10 -55.88 -48.62 75.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.302 -0.874 . . . . 0.0 109.185 179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.558 ' CB ' HG13 ' B' ' 453' ' ' VAL . 86.7 m-20 -57.3 -40.81 78.61 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.259 -0.901 . . . . 0.0 109.087 179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' B' ' 481' ' ' LEU . 17.0 tp -59.49 -45.31 92.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 109.35 179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -58.35 -38.99 78.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.897 . . . . 0.0 109.441 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -63.24 -26.26 68.7 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.517 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -76.26 146.52 38.93 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.212 -0.93 . . . . 0.0 109.395 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' B' ' 464' ' ' ILE . . . -106.28 154.41 16.87 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.92 HD11 ' HG2' ' A' ' 293' ' ' PRO . 59.7 mt -44.03 -36.59 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.249 -1.148 . . . . 0.0 109.367 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . 0.486 ' OD2' ' NH2' ' A' ' 265' ' ' ARG . 48.0 t0 -63.2 -41.04 99.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.256 -0.902 . . . . 0.0 109.436 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -66.68 -25.08 66.38 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.939 . . . . 0.0 109.338 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.749 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.2 mp -85.52 -24.46 27.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.308 -0.87 . . . . 0.0 109.392 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.81 -23.9 63.71 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.483 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -52.06 -32.16 33.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.323 -0.861 . . . . 0.0 109.512 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.738 HD13 ' HB3' ' B' ' 447' ' ' LYS . 67.3 mt -97.84 124.73 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.291 -0.881 . . . . 0.0 109.507 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -63.46 -35.38 80.27 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.405 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . . . . . . . . . . . -54.54 -31.62 52.35 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.067 ' CD2' HD11 ' B' ' 444' ' ' LEU . 60.0 mt -101.79 135.58 43.08 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.163 -1.198 . . . . 0.0 109.458 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.501 HG22 ' N ' ' B' ' 475' ' ' ASP . 39.1 m -103.73 163.87 12.04 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.183 -0.948 . . . . 0.0 109.486 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.52 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 90.7 m-20 -56.88 -39.42 74.34 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 109.471 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -71.86 -45.88 59.86 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.281 -0.887 . . . . 0.0 109.479 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.587 ' HD3' HD23 ' B' ' 473' ' ' LEU . 40.3 tttm -61.07 -46.74 89.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.453 179.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.754 ' HB3' HG23 ' B' ' 464' ' ' ILE . . . -58.9 -41.93 88.4 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 109.357 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.46 ' HA2' ' CG ' ' A' ' 293' ' ' PRO . . . -59.2 -45.77 94.83 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 179.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.61 -35.96 73.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -1.132 . . . . 0.0 109.482 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.631 ' HB3' HD21 ' B' ' 459' ' ' LEU . 25.3 mt -68.96 -44.11 73.64 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.207 -0.933 . . . . 0.0 109.523 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 1.026 HD12 ' HB2' ' A' ' 293' ' ' PRO . 30.4 mt -59.5 -55.9 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.279 -0.888 . . . . 0.0 109.522 -179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.527 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 43.9 mtp -52.76 -44.47 66.53 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.141 -0.974 . . . . 0.0 109.374 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.443 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -59.6 -49.78 76.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.232 -0.918 . . . . 0.0 109.366 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.764 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -68.25 -47.75 66.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.238 -0.914 . . . . 0.0 109.43 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.417 ' NH1' ' O ' ' A' ' 291' ' ' LYS . 39.5 ttm180 -55.1 -45.65 75.47 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.475 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 74.6 m-20 -61.02 -41.24 96.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.889 . . . . 0.0 109.508 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.711 HD12 HD21 ' B' ' 456' ' ' LEU . 63.2 mt -67.42 -38.74 81.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.249 -0.907 . . . . 0.0 109.474 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . 0.406 ' SG ' ' OE1' ' B' ' 457' ' ' GLU . 47.4 m -67.44 -49.56 63.17 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.193 -0.942 . . . . 0.0 109.532 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 71.4 m95 -68.0 -39.51 83.21 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.252 -0.905 . . . . 0.0 109.512 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.475 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 16.9 m-30 -83.31 -13.12 55.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.91 . . . . 0.0 109.541 -179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' B' ' 488' ' ' ILE . . . -57.76 -36.1 77.73 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -57.23 -38.28 73.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.27 -1.135 . . . . 0.0 109.521 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . 0.445 ' O ' ' O ' ' B' ' 491' ' ' PHE . 84.0 tt0 -108.02 140.62 40.91 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 109.507 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.533 179.987 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.575 ' HD2' HD11 ' A' ' 254' ' ' LEU . 16.4 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.265 0.555 . . . . 0.0 109.581 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.405 ' HB3' HG22 ' A' ' 252' ' ' ILE . 15.1 m-20 -54.64 135.67 63.72 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.302 -0.874 . . . . 0.0 109.348 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.771 ' HA ' HD12 ' A' ' 254' ' ' LEU . 43.0 Cg_endo -65.22 -31.72 53.16 Favored 'Trans proline' 0 C--O 1.214 -0.681 0 C-N-CA 122.604 2.203 . . . . 0.0 111.672 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.672 ' O ' HD12 ' A' ' 278' ' ' ILE . 8.2 tt -63.18 -28.22 44.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.309 -0.869 . . . . 0.0 108.756 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.61 HD21 ' HA ' ' A' ' 312' ' ' LEU . 37.9 mt -74.6 -44.16 52.09 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.419 -0.801 . . . . 0.0 109.451 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.771 HD12 ' HA ' ' A' ' 251' ' ' PRO . 1.8 mt -65.98 -34.78 78.88 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.313 -0.867 . . . . 0.0 109.67 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.445 ' O ' HG13 ' A' ' 278' ' ' ILE . 4.3 ttp180 -56.04 141.11 68.78 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 121.164 -0.96 . . . . 0.0 109.068 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 259' ' ' ASP . 47.7 Cg_endo -68.72 130.96 21.65 Favored 'Trans proline' 0 C--O 1.215 -0.651 0 C-N-CA 122.594 2.196 . . . . 0.0 111.512 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.434 ' C ' ' O ' ' A' ' 256' ' ' PRO . 0.3 OUTLIER -43.51 -35.52 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.277 -0.89 . . . . 0.0 109.396 -179.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -60.98 -30.93 70.56 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.275 -0.891 . . . . 0.0 109.321 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 256' ' ' PRO . 32.3 m-20 -76.81 -14.9 59.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.309 -0.87 . . . . 0.0 109.486 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.428 HD11 HG12 ' A' ' 257' ' ' VAL . 68.3 mt -44.79 140.88 2.33 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.205 -0.935 . . . . 0.0 109.363 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 262' ' ' LEU . 98.0 mt-10 -64.83 -26.58 68.4 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.62 HD11 HG21 ' A' ' 306' ' ' VAL . 29.7 mt -52.84 -173.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.242 -0.912 . . . . 0.0 109.509 -179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 13.0 p -84.84 159.39 20.4 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.264 -0.897 . . . . 0.0 109.514 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.67 HG12 ' ND2' ' A' ' 268' ' ' ASN . 8.7 t -55.16 -34.66 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.372 -0.83 . . . . 0.0 109.357 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . . . . . . . . . 18.3 ttm-85 -53.71 -46.45 70.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.205 -0.934 . . . . 0.0 109.387 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . . . . . . . . . 91.7 p -64.42 -45.04 89.28 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.297 -0.877 . . . . 0.0 109.441 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . . . . . . . . . . . -67.47 -39.33 85.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.198 -0.939 . . . . 0.0 109.532 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.67 ' ND2' HG12 ' A' ' 264' ' ' VAL . 89.3 m-20 -58.52 -32.2 68.62 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.458 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . 0.644 ' SG ' HD11 ' A' ' 295' ' ' LEU . 21.4 t -57.6 -64.99 0.71 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.261 -0.899 . . . . 0.0 109.382 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . . . . . . . . . 60.3 mt -56.76 -47.71 79.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.349 -0.845 . . . . 0.0 109.454 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.504 ' HG3' ' CE1' ' A' ' 276' ' ' HIS . 36.1 ttpt -55.08 -37.17 66.45 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.9 . . . . 0.0 109.441 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -53.75 -21.15 6.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.221 -0.924 . . . . 0.0 109.409 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.607 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 94.7 mt-10 -95.65 21.17 8.67 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.342 -0.849 . . . . 0.0 109.528 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 69.86 28.04 4.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.213 -0.929 . . . . 0.0 109.425 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.539 ' CG2' ' HB2' ' A' ' 280' ' ' ASP . 79.9 mt -117.09 111.48 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.256 -0.903 . . . . 0.0 109.437 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.504 ' CE1' ' HG3' ' A' ' 271' ' ' LYS . 96.1 m-70 -104.4 -10.13 17.96 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.24 -0.912 . . . . 0.0 109.578 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -105.86 143.45 33.99 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.234 -0.916 . . . . 0.0 109.569 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.946 ' CG2' HD13 ' A' ' 312' ' ' LEU . 92.0 mt -72.29 -31.04 37.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.233 -0.917 . . . . 0.0 109.255 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 1.023 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -47.22 -48.33 20.56 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.539 ' HB2' ' CG2' ' A' ' 275' ' ' ILE . 90.7 m-20 -53.79 -35.32 61.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.265 -1.138 . . . . 0.0 108.757 179.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 0.752 HD13 ' C ' ' A' ' 281' ' ' LEU . 3.4 tm? -52.78 -47.16 67.72 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.421 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 1.023 HG22 ' O ' ' A' ' 279' ' ' GLY . 6.5 m -68.25 -23.81 29.04 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 179.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 63.6 tt0 -62.23 -35.69 79.7 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.454 ' HE ' HD11 ' A' ' 275' ' ' ILE . 64.9 mtt-85 -100.99 141.18 34.25 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.463 -0.773 . . . . 0.0 109.03 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 74.0 p -76.2 147.11 38.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.653 -179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.569 ' OE2' HD11 ' A' ' 300' ' ' LEU . 85.5 tt0 -50.82 -34.1 26.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.342 -0.849 . . . . 0.0 109.339 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . . . . . . . . . 49.4 t -52.76 -51.26 37.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.184 -0.948 . . . . 0.0 109.281 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -53.14 -37.84 62.17 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.196 -0.94 . . . . 0.0 109.231 179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.653 HD22 ' N ' ' A' ' 289' ' ' LEU . 3.9 mm? -68.37 -40.77 81.34 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -0.88 . . . . 0.0 109.173 179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 1.088 HD13 HD22 ' A' ' 300' ' ' LEU . 34.8 tp -62.3 -25.45 67.87 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.402 -0.811 . . . . 0.0 109.331 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.6 ' O ' ' HE2' ' B' ' 483' ' ' MET . 22.2 mttt -88.66 17.25 5.65 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.313 -0.867 . . . . 0.0 109.46 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . 0.522 ' HB ' HD13 ' A' ' 295' ' ' LEU . 0.2 OUTLIER -116.84 136.99 23.38 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.28 -0.888 . . . . 0.0 109.304 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 0.883 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.6 Cg_endo -71.72 -30.64 14.23 Favored 'Trans proline' 0 C--O 1.214 -0.677 0 C-N-CA 122.691 2.26 . . . . 0.0 111.85 -179.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.479 ' C ' HD12 ' A' ' 295' ' ' LEU . 33.4 m120 -52.53 -20.8 3.2 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.303 -0.873 . . . . 0.0 109.767 -179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.804 HD12 ' N ' ' A' ' 295' ' ' LEU . 5.3 mp -104.74 124.48 49.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.13 -0.981 . . . . 0.0 109.605 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -92.79 173.86 35.45 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 34.6 tttt -51.37 -44.66 62.19 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.281 -1.129 . . . . 0.0 109.426 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -70.33 -36.77 74.45 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.236 -0.915 . . . . 0.0 109.518 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 22.9 t -54.93 -52.27 63.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.174 -0.954 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 1.088 HD22 HD13 ' A' ' 290' ' ' LEU . 22.5 tp -52.91 -39.49 62.79 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.254 -0.904 . . . . 0.0 109.432 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 28.8 m -59.11 -50.17 75.07 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 109.236 179.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.592 ' HG2' HD13 ' A' ' 262' ' ' LEU . 54.0 tt0 -53.73 -44.92 70.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.256 -0.902 . . . . 0.0 109.089 179.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.64 HD11 HD23 ' A' ' 295' ' ' LEU . 63.6 mt -57.65 -40.43 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.289 -0.882 . . . . 0.0 108.783 179.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -60.66 -40.08 90.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.343 -0.848 . . . . 0.0 108.742 179.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.09 -46.18 85.94 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.367 -0.833 . . . . 0.0 108.827 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.644 HG11 HD23 ' A' ' 312' ' ' LEU . 16.9 t -69.95 -35.47 64.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.306 -0.871 . . . . 0.0 108.819 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.667 HD13 ' HB3' ' A' ' 313' ' ' SER . 17.1 tp -63.5 -26.78 68.87 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.511 -0.743 . . . . 0.0 109.371 179.607 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -57.77 -28.92 64.4 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.446 -0.784 . . . . 0.0 109.209 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . . . . . . . . . 3.2 p -69.31 -12.14 61.41 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.452 -0.78 . . . . 0.0 109.207 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.936 ' HA ' HD11 ' A' ' 314' ' ' LEU . 69.8 mtt180 57.36 15.78 2.82 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.328 -0.857 . . . . 0.0 109.372 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . . . . . . . . . . . -108.37 -15.47 13.91 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.619 -1.392 . . . . 0.0 109.619 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 0.946 HD13 ' CG2' ' A' ' 278' ' ' ILE . 9.0 tp -137.5 136.15 37.43 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.191 -1.182 . . . . 0.0 109.155 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.765 ' H ' HG12 ' A' ' 282' ' ' VAL . 0.3 OUTLIER 73.37 41.93 0.44 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.902 . . . . 0.0 109.7 179.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.936 HD11 ' HA ' ' A' ' 310' ' ' ARG . 3.8 mm? -92.22 13.17 19.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.221 -0.924 . . . . 0.0 109.45 179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 68.68 36.88 83.86 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.609 ' CE ' HD11 ' A' ' 253' ' ' LEU . 7.5 mtm -84.28 170.3 13.83 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.27 -1.135 . . . . 0.0 109.446 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.791 ' C ' HD12 ' A' ' 318' ' ' LEU . 45.4 mtm105 -141.0 129.56 22.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.819 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.7 mp -133.05 136.32 45.88 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.236 -0.915 . . . . 0.0 109.44 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.48 -39.89 64.89 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.162 -0.961 . . . . 0.0 109.038 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . 0.452 ' O ' ' CB ' ' A' ' 321' ' ' TRP . 69.5 m-20 -129.75 -65.13 0.85 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.247 -0.908 . . . . 0.0 109.244 179.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.523 ' HB3' ' CD ' ' A' ' 322' ' ' PRO . 3.0 t-105 167.31 -65.92 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.469 0 O-C-N 121.256 -0.902 . . . . 0.0 109.493 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.523 ' CD ' ' HB3' ' A' ' 321' ' ' TRP . 48.9 Cg_endo -68.69 107.99 1.77 Allowed 'Trans proline' 0 C--O 1.215 -0.661 0 C-N-CA 122.679 2.253 . . . . 0.0 112.169 -179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.8 Cg_endo -72.86 161.21 44.29 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.622 2.214 . . . . 0.0 111.53 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.84 -18.84 5.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.155 -0.966 . . . . 0.0 109.601 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.484 ' HB3' ' CE1' ' A' ' 249' ' ' PHE . 16.3 m -64.29 -49.26 72.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.13 -0.981 . . . . 0.0 109.47 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 0.64 HD11 HD21 ' A' ' 254' ' ' LEU . 26.9 mt -51.07 -36.55 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 109.46 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -71.05 148.46 47.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.211 -0.931 . . . . 0.0 109.499 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.63 -38.9 82.6 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.227 -0.921 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.481 179.963 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -61.5 -34.14 74.99 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.261 -1.141 . . . . 0.0 109.471 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.52 ' O ' ' CB ' ' B' ' 449' ' ' ALA . 21.9 m120 -89.48 19.97 4.2 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.384 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -62.02 121.83 68.23 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.287 -0.883 . . . . 0.0 109.378 179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.486 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 49.5 Cg_endo -70.05 131.21 20.36 Favored 'Trans proline' 0 C--O 1.215 -0.65 0 C-N-CA 122.641 2.227 . . . . 0.0 111.741 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -66.37 153.86 41.61 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.269 -0.894 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . 0.438 ' O ' ' CB ' ' B' ' 436' ' ' ASN . 92.0 m-20 -54.32 -29.57 48.28 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.272 -0.892 . . . . 0.0 109.461 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . 0.503 ' HB3' ' HB2' ' B' ' 456' ' ' LEU . 91.2 m-20 -67.05 -50.1 62.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.266 -0.896 . . . . 0.0 109.513 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.518 ' CB ' ' O ' ' B' ' 454' ' ' CYS . 27.3 tp -67.78 -42.02 82.32 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.191 -0.943 . . . . 0.0 109.472 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.936 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.8 OUTLIER -71.35 -26.88 63.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.354 -0.841 . . . . 0.0 109.38 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . 0.438 ' CB ' ' O ' ' B' ' 432' ' ' ASP . 40.8 t30 -96.65 7.92 45.43 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.132 -0.98 . . . . 0.0 109.628 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.72 HD13 ' N ' ' B' ' 438' ' ' GLU . 1.6 tm? -78.09 120.39 22.85 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.26 -0.9 . . . . 0.0 109.463 -179.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . 0.72 ' N ' HD13 ' B' ' 437' ' ' LEU . 23.6 pt-20 -60.57 140.89 57.18 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -0.948 . . . . 0.0 109.428 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . 0.437 ' O ' HD11 ' B' ' 481' ' ' LEU . . . 96.31 -3.64 64.05 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 1.042 HG22 ' CD2' ' B' ' 481' ' ' LEU . 47.0 t -120.67 129.98 75.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.123 -1.222 . . . . 0.0 109.487 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -87.05 154.42 20.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.242 -0.911 . . . . 0.0 109.447 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.529 ' HG2' HD11 ' B' ' 435' ' ' LEU . 72.8 mtt180 -49.98 -45.18 51.37 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.903 . . . . 0.0 109.33 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . 0.574 ' HA ' ' CD2' ' B' ' 446' ' ' PHE . 94.3 m-20 -67.83 -46.56 71.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.356 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 1.025 HD11 ' CD1' ' B' ' 473' ' ' LEU . 14.1 tp -53.67 -40.83 66.24 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.262 -0.899 . . . . 0.0 109.114 179.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.4 91.73 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.294 -0.879 . . . . 0.0 108.978 179.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.574 ' CD2' ' HA ' ' B' ' 443' ' ' ASP . 12.7 m-30 -58.55 -40.18 82.32 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.318 -0.864 . . . . 0.0 109.102 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . . . . . . . . . 51.9 mttm -62.21 -42.43 99.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.344 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 459' ' ' LEU . 88.4 mt -62.02 -45.01 95.47 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.277 -0.889 . . . . 0.0 109.452 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' B' ' 428' ' ' ASN . . . -58.87 -40.33 84.05 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.259 -0.9 . . . . 0.0 109.383 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -46.55 -33.25 3.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.274 -0.891 . . . . 0.0 109.409 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . . . . . . . . . 26.2 mtp85 -91.24 22.32 3.9 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.251 -0.906 . . . . 0.0 109.506 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . 0.504 ' N ' ' O ' ' B' ' 449' ' ' ALA . . . 79.76 -18.6 7.17 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.935 HG21 ' HG3' ' B' ' 462' ' ' GLN . 5.8 t -83.15 110.0 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.914 -1.344 . . . . 0.0 109.369 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.518 ' O ' ' CB ' ' B' ' 434' ' ' LEU . 14.9 m -127.51 -35.76 2.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.197 -0.94 . . . . 0.0 109.587 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.52 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -79.62 140.69 37.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.288 -0.883 . . . . 0.0 109.421 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.915 ' CD2' HD12 ' B' ' 488' ' ' ILE . 23.5 tp -45.64 -43.64 12.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.269 -0.894 . . . . 0.0 109.191 179.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . 0.414 ' HA ' ' SG ' ' B' ' 489' ' ' CYS . 13.3 mt-10 -60.1 -46.32 90.02 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.261 -0.899 . . . . 0.0 109.177 179.726 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.702 ' HB3' HG13 ' B' ' 453' ' ' VAL . 88.4 m-20 -54.94 -38.01 67.15 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.272 -0.893 . . . . 0.0 109.133 179.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.821 HD13 HD13 ' B' ' 448' ' ' LEU . 33.3 tp -63.79 -42.9 97.66 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.411 -0.806 . . . . 0.0 109.226 179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . 0.641 ' HB1' ' HG2' ' B' ' 486' ' ' ARG . . . -58.36 -37.69 75.71 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.303 -0.873 . . . . 0.0 109.361 179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -64.46 -30.55 71.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.935 ' HG3' HG21 ' B' ' 453' ' ' VAL . 97.8 mm-40 -73.52 148.72 42.81 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.276 -0.89 . . . . 0.0 109.475 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . 0.423 ' O ' ' N ' ' B' ' 466' ' ' ASP . . . -107.71 154.11 16.66 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 0.883 HD11 ' HG2' ' A' ' 293' ' ' PRO . 96.5 mt -44.98 -36.32 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.144 -1.21 . . . . 0.0 109.27 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 91.3 m-20 -61.93 -36.88 82.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.211 -0.931 . . . . 0.0 109.245 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.423 ' N ' ' O ' ' B' ' 463' ' ' GLY . 84.2 m-20 -71.41 -28.71 64.19 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.0 109.35 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 0.87 HD22 ' HB1' ' B' ' 478' ' ' ALA . 7.1 mp -82.84 -30.68 28.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.16 -0.963 . . . . 0.0 109.413 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -58.39 -24.69 60.7 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.261 -0.899 . . . . 0.0 109.455 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -51.35 -33.15 28.26 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.274 -0.892 . . . . 0.0 109.468 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.578 ' HB ' HD23 ' B' ' 473' ' ' LEU . 64.4 mt -102.24 127.72 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.218 -0.926 . . . . 0.0 109.517 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -59.73 -31.01 69.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.206 -0.934 . . . . 0.0 109.496 -179.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.531 ' C ' HD22 ' B' ' 473' ' ' LEU . . . -59.2 -25.67 60.37 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.574 -1.411 . . . . 0.0 109.574 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 1.025 ' CD1' HD11 ' B' ' 444' ' ' LEU . 3.5 mm? -103.38 129.19 50.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.32 -1.106 . . . . 0.0 109.562 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . 0.447 HG22 ' N ' ' B' ' 475' ' ' ASP . 23.4 m -103.61 162.02 13.41 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.209 -0.932 . . . . 0.0 109.424 179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.526 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 83.6 m-20 -55.88 -39.14 71.1 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.304 -0.873 . . . . 0.0 109.5 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -77.1 -45.85 25.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.203 -0.935 . . . . 0.0 109.545 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.483 ' CE ' HD22 ' B' ' 444' ' ' LEU . 32.8 tttp -62.37 -46.62 87.81 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 0.0 109.444 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 0.87 ' HB1' HD22 ' B' ' 467' ' ' LEU . . . -65.53 -45.91 81.66 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.207 -0.933 . . . . 0.0 109.508 -179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.524 ' HA2' ' HB2' ' A' ' 293' ' ' PRO . . . -63.59 -52.12 48.66 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 -179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -51.48 -42.22 61.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.135 -1.215 . . . . 0.0 109.233 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 1.042 ' CD2' HG22 ' B' ' 440' ' ' VAL . 6.4 mp -67.28 -42.3 84.05 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.36 -0.837 . . . . 0.0 109.442 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.55 HD12 HG13 ' B' ' 464' ' ' ILE . 45.3 mt -56.41 -56.27 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.22 -0.925 . . . . 0.0 109.411 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.6 ' HE2' ' O ' ' A' ' 291' ' ' LYS . 43.4 mmm -53.29 -44.88 68.65 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.265 -0.897 . . . . 0.0 109.381 179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . . . . . . . . . . . -57.26 -60.77 3.12 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.282 -0.886 . . . . 0.0 109.193 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.509 ' HA ' HD21 ' B' ' 456' ' ' LEU . . . -55.7 -43.3 76.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.298 -0.876 . . . . 0.0 109.196 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.641 ' HG2' ' HB1' ' B' ' 460' ' ' ALA . 94.8 mtt180 -59.55 -41.96 91.28 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.37 -0.831 . . . . 0.0 109.19 179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.563 ' HB3' ' CE2' ' B' ' 491' ' ' PHE . 98.1 m-20 -57.84 -41.31 82.08 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.293 -0.88 . . . . 0.0 109.291 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.915 HD12 ' CD2' ' B' ' 456' ' ' LEU . 24.3 mt -68.55 -38.55 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.268 -0.895 . . . . 0.0 109.309 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . 0.414 ' SG ' ' HA ' ' B' ' 457' ' ' GLU . 66.4 m -70.27 -51.62 29.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.302 -0.874 . . . . 0.0 109.42 179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 81.1 m95 -61.37 -38.19 86.1 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.521 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.563 ' CE2' ' HB3' ' B' ' 487' ' ' ASN . 19.2 m-30 -76.29 -36.86 58.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.253 -0.905 . . . . 0.0 109.406 -179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' B' ' 495' ' ' ALA . . . 53.46 -127.67 37.3 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 -53.39 -42.12 66.62 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.259 -1.142 . . . . 0.0 109.352 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . 0.527 ' O ' ' HB2' ' B' ' 495' ' ' ALA . 95.6 mt-10 -54.94 -34.13 62.91 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.257 -0.902 . . . . 0.0 109.487 -179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . 0.527 ' HB2' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.535 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' PHE . . . . . 0.556 ' O ' ' CD2' ' A' ' 249' ' ' PHE . 42.0 p90 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ASP . . . . . 0.784 ' O ' HD12 ' A' ' 254' ' ' LEU . 0.5 OUTLIER -69.67 137.53 88.11 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.195 -0.94 . . . . 0.0 109.239 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' PRO . . . . . 0.418 ' O ' ' N ' ' A' ' 255' ' ' ARG . 43.2 Cg_endo -65.31 -26.51 56.16 Favored 'Trans proline' 0 C--O 1.215 -0.625 0 C-N-CA 122.705 2.27 . . . . 0.0 111.673 179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ILE . . . . . 0.606 HD13 ' HA3' ' A' ' 311' ' ' GLY . 6.0 tt -71.22 -28.06 31.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 108.709 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' LEU . . . . . 0.74 HD11 HG21 ' A' ' 282' ' ' VAL . 3.1 tp -74.35 -27.18 60.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.459 -0.775 . . . . 0.0 109.059 179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 1.001 HD21 HD11 ' A' ' 326' ' ' ILE . 4.0 mp -101.67 -20.98 14.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.409 -0.807 . . . . 0.0 109.421 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ARG . . . . . 0.418 ' N ' ' O ' ' A' ' 251' ' ' PRO . 16.2 mtt180 -55.09 147.59 33.69 Favored Pre-proline 0 C--N 1.3 -1.559 0 O-C-N 121.395 -0.816 . . . . 0.0 109.019 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' PRO . . . . . 0.492 ' O ' ' N ' ' A' ' 259' ' ' ASP . 49.6 Cg_endo -69.56 132.46 23.7 Favored 'Trans proline' 0 C--O 1.215 -0.672 0 C-N-CA 122.687 2.258 . . . . 0.0 111.954 -179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' VAL . . . . . 0.723 HG11 HD12 ' A' ' 270' ' ' LEU . 0.2 OUTLIER -44.62 -30.81 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.314 -0.866 . . . . 0.0 109.275 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -64.25 -30.69 71.74 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.251 -0.906 . . . . 0.0 109.184 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' ASP . . . . . 0.492 ' N ' ' O ' ' A' ' 256' ' ' PRO . 12.9 m-20 -69.57 -16.99 63.51 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.336 -0.852 . . . . 0.0 109.187 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' LEU . . . . . 0.886 HD21 HD13 ' A' ' 278' ' ' ILE . 46.1 mt -57.43 144.73 35.34 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.26 -0.9 . . . . 0.0 109.519 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 261' ' ' GLU . 82.2 tt0 -65.23 -14.4 60.58 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.93 . . . . 0.0 109.504 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.696 HD21 ' CB ' ' A' ' 302' ' ' GLU . 8.0 mp -60.24 173.66 0.63 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.184 -0.948 . . . . 0.0 109.574 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' THR . . . . . . . . . . . . . 36.7 p -74.73 170.36 16.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.252 -0.905 . . . . 0.0 109.52 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' VAL . . . . . 0.755 HG12 HD21 ' A' ' 268' ' ' ASN . 18.5 t -62.56 -31.76 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.257 -0.902 . . . . 0.0 109.455 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ARG . . . . . 0.535 ' N ' ' HD3' ' A' ' 265' ' ' ARG . 6.8 mmt85 -60.08 -44.95 94.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.25 -0.906 . . . . 0.0 109.136 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' SER . . . . . 0.433 ' OG ' HD23 ' A' ' 262' ' ' LEU . 7.8 t -57.83 -51.01 71.35 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.251 -0.906 . . . . 0.0 109.214 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ALA . . . . . 0.451 ' O ' ' HG3' ' A' ' 271' ' ' LYS . . . -66.56 -34.21 77.38 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.242 -0.912 . . . . 0.0 109.106 179.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ASN . . . . . 0.755 HD21 HG12 ' A' ' 264' ' ' VAL . 93.3 m-20 -61.61 -38.88 89.24 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -0.885 . . . . 0.0 109.211 179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' CYS . . . . . . . . . . . . . 39.8 m -49.86 -60.12 3.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' LEU . . . . . 0.723 HD12 HG11 ' A' ' 257' ' ' VAL . 45.3 mt -63.52 -48.33 77.99 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.0 109.301 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 275' ' ' ILE . 52.5 mtmt -53.27 -39.69 64.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -0.89 . . . . 0.0 109.407 179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ALA . . . . . . . . . . . . . . . -51.81 -24.74 6.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 109.334 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' GLU . . . . . 0.539 ' O ' ' HB3' ' A' ' 274' ' ' ALA . 54.0 tt0 -93.47 24.72 3.81 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 273' ' ' GLU . . . 66.23 29.85 9.46 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.183 -0.948 . . . . 0.0 109.473 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ILE . . . . . 0.621 HG23 ' OD2' ' A' ' 280' ' ' ASP . 54.7 mt -124.22 108.56 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.26 -0.9 . . . . 0.0 109.672 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' HIS . . . . . 0.456 ' O ' ' HA ' ' A' ' 256' ' ' PRO . 89.5 m-70 -100.85 -6.83 24.23 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.193 -0.942 . . . . 0.0 109.515 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -105.14 140.83 37.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.178 -0.952 . . . . 0.0 109.505 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.886 HD13 HD21 ' A' ' 260' ' ' LEU . 56.6 mt -72.61 -30.19 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.289 -0.882 . . . . 0.0 109.529 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' GLY . . . . . 0.975 ' O ' HG22 ' A' ' 282' ' ' VAL . . . -45.5 -48.37 11.92 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.264 -1.534 . . . . 0.0 109.264 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ASP . . . . . 0.621 ' OD2' HG23 ' A' ' 275' ' ' ILE . 82.5 m-20 -53.0 -33.73 53.02 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 120.922 -1.34 . . . . 0.0 108.527 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' LEU . . . . . 1.02 HD23 HD13 ' A' ' 312' ' ' LEU . 26.9 tp -52.98 -52.7 57.42 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' VAL . . . . . 0.975 HG22 ' O ' ' A' ' 279' ' ' GLY . 25.3 m -62.47 -27.56 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 280' ' ' ASP . 53.0 tt0 -58.21 -37.95 75.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' ARG . . . . . 0.452 ' HB3' ' OE1' ' A' ' 288' ' ' GLU . 86.0 mtt-85 -98.07 140.92 31.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.799 . . . . 0.0 108.975 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' THR . . . . . . . . . . . . . 7.0 m -63.64 141.17 58.87 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.181 -0.949 . . . . 0.0 109.712 -179.679 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' GLU . . . . . 0.686 ' CD ' HD12 ' A' ' 289' ' ' LEU . 49.0 tp10 -53.33 -27.27 22.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.0 109.388 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' VAL . . . . . 0.76 ' HA ' HD12 ' A' ' 290' ' ' LEU . 54.3 t -52.8 -51.81 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.245 -0.909 . . . . 0.0 109.282 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . 0.452 ' OE1' ' HB3' ' A' ' 284' ' ' ARG . 93.6 mt-10 -51.87 -33.66 37.48 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.239 -0.913 . . . . 0.0 109.083 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' LEU . . . . . 0.86 HD11 HD11 ' A' ' 281' ' ' LEU . 40.5 mt -64.94 -46.76 80.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.321 -0.862 . . . . 0.0 109.158 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.76 HD12 ' HA ' ' A' ' 287' ' ' VAL . 3.9 mt -61.88 -29.76 70.41 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.345 -0.847 . . . . 0.0 109.446 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' LYS . . . . . 0.542 ' HB3' ' CE ' ' B' ' 483' ' ' MET . 23.4 mttm -84.96 -20.65 30.28 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' THR . . . . . . . . . . . . . 15.7 m -82.12 116.42 63.36 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.23 -0.919 . . . . 0.0 109.63 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' PRO . . . . . 1.001 ' HG2' HD11 ' B' ' 464' ' ' ILE . 52.1 Cg_endo -71.16 -24.35 23.55 Favored 'Trans proline' 0 C--O 1.215 -0.628 0 C-N-CA 122.626 2.217 . . . . 0.0 111.843 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.562 ' ND2' HD12 ' B' ' 464' ' ' ILE . 34.4 m120 -46.94 -23.81 0.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.21 -0.931 . . . . 0.0 109.562 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LEU . . . . . 0.794 ' HB2' HD21 ' A' ' 300' ' ' LEU . 3.0 mp -96.02 138.87 33.02 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.231 -0.918 . . . . 0.0 109.416 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' GLY . . . . . . . . . . . . . . . -87.84 163.29 33.39 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.536 -1.426 . . . . 0.0 109.536 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -50.79 -45.28 59.15 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.179 -1.189 . . . . 0.0 109.423 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' LYS . . . . . . . . . . . . . 26.1 mttt -65.73 -42.12 91.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.22 -0.925 . . . . 0.0 109.302 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' SER . . . . . . . . . . . . . 20.8 t -56.1 -55.13 36.72 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.862 . . . . 0.0 109.277 179.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' LEU . . . . . 0.794 HD21 ' HB2' ' A' ' 295' ' ' LEU . 49.9 mt -54.42 -47.02 73.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 0.0 109.309 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' THR . . . . . . . . . . . . . 79.4 m -50.37 -53.0 32.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.236 -0.915 . . . . 0.0 109.234 179.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' GLU . . . . . 0.849 ' O ' HG23 ' A' ' 306' ' ' VAL . 60.9 mm-40 -53.75 -38.44 64.39 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.289 -0.882 . . . . 0.0 109.215 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ILE . . . . . 0.685 HD12 ' HA ' ' A' ' 300' ' ' LEU . 93.5 mt -57.79 -46.04 87.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.285 -0.884 . . . . 0.0 109.157 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LYS . . . . . . . . . . . . . 55.7 mttt -60.38 -39.76 88.41 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.23 -0.919 . . . . 0.0 109.149 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -64.06 -49.92 70.44 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.339 -0.851 . . . . 0.0 109.347 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 302' ' ' GLU . 2.2 t -63.55 -41.09 91.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.359 -0.838 . . . . 0.0 109.203 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' LEU . . . . . 0.53 HD13 ' CB ' ' A' ' 313' ' ' SER . 24.1 tp -53.91 -26.62 26.05 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.283 -0.886 . . . . 0.0 109.344 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ALA . . . . . . . . . . . . . . . -58.78 -40.86 85.2 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.313 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 310' ' ' ARG . 20.9 t -68.98 -7.72 37.99 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.347 -0.846 . . . . 0.0 109.538 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' ARG . . . . . 0.748 ' CA ' HD21 ' A' ' 314' ' ' LEU . 66.2 mtt180 65.64 8.98 5.55 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.246 -0.909 . . . . 0.0 109.365 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' GLY . . . . . 0.606 ' HA3' HD13 ' A' ' 252' ' ' ILE . . . -72.26 -31.24 63.9 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' LEU . . . . . 1.02 HD13 HD23 ' A' ' 281' ' ' LEU . 1.0 OUTLIER -148.16 173.12 13.29 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.214 -1.168 . . . . 0.0 109.51 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . 0.64 ' N ' HG12 ' A' ' 282' ' ' VAL . 2.8 m 61.77 30.66 18.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.266 -0.897 . . . . 0.0 109.646 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' LEU . . . . . 0.748 HD21 ' CA ' ' A' ' 310' ' ' ARG . 68.4 mt -79.41 -5.46 54.71 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.286 -0.884 . . . . 0.0 109.515 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' GLY . . . . . . . . . . . . . . . 70.86 38.82 65.36 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' MET . . . . . 0.684 ' HE1' HD12 ' A' ' 314' ' ' LEU . 4.2 ptt? -107.42 162.11 14.22 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.133 -1.216 . . . . 0.0 109.361 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ARG . . . . . 0.57 ' C ' HD12 ' A' ' 318' ' ' LEU . 44.5 mtm180 -128.2 134.37 49.02 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.116 -0.99 . . . . 0.0 109.697 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 318' ' ' LEU . 3.9 mp -116.51 143.12 45.98 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.283 -0.886 . . . . 0.0 109.453 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.78 -33.71 70.63 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.261 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -135.02 -68.23 0.53 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.0 109.231 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' TRP . . . . . 0.571 ' CH2' ' HG ' ' A' ' 254' ' ' LEU . 0.7 OUTLIER 176.98 -64.96 0.0 OUTLIER Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.288 -0.882 . . . . 0.0 109.376 179.822 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' PRO . . . . . 0.707 ' HA ' HD12 ' A' ' 326' ' ' ILE . 49.9 Cg_endo -68.67 107.5 1.66 Allowed 'Trans proline' 0 C--O 1.215 -0.642 0 C-N-CA 122.642 2.228 . . . . 0.0 112.041 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 321' ' ' TRP . 52.7 Cg_endo -72.54 164.79 34.56 Favored 'Trans proline' 0 C--O 1.214 -0.691 0 C-N-CA 122.571 2.181 . . . . 0.0 111.579 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -54.92 -19.03 5.75 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.169 -0.957 . . . . 0.0 109.279 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 249' ' ' PHE . 61.0 m -65.77 -47.85 73.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.278 -0.889 . . . . 0.0 109.525 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' ILE . . . . . 1.001 HD11 HD21 ' A' ' 254' ' ' LEU . 19.4 mt -53.15 -33.98 20.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.21 -0.931 . . . . 0.0 109.478 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' ALA . . . . . . . . . . . . . . . -59.86 147.47 38.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.132 -0.98 . . . . 0.0 109.489 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' ASP . . . . . . . . . . . . . 93.3 m-20 -61.58 -38.38 87.3 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.246 -0.909 . . . . 0.0 109.46 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 118.004 -0.998 . . . . 0.0 109.453 179.963 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 426' ' ' GLY . . . . . 0.468 ' O ' ' HG2' ' B' ' 429' ' ' LYS . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 427' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -60.44 -31.46 70.43 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.298 -1.119 . . . . 0.0 109.421 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 428' ' ' ASN . . . . . 0.838 ' O ' ' HB1' ' B' ' 449' ' ' ALA . 29.5 m120 -123.94 37.97 4.29 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.328 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 429' ' ' LYS . . . . . 0.468 ' HG2' ' O ' ' B' ' 426' ' ' GLY . 1.7 ptmt -51.19 136.25 29.72 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.234 -0.916 . . . . 0.0 109.587 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 430' ' ' PRO . . . . . 0.46 ' HA ' ' HB3' ' B' ' 454' ' ' CYS . 50.6 Cg_endo -70.9 140.97 39.5 Favored 'Trans proline' 0 C--O 1.216 -0.615 0 C-N-CA 122.711 2.274 . . . . 0.0 111.652 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 431' ' ' ALA . . . . . 0.69 ' HB3' ' HA ' ' B' ' 455' ' ' THR . . . -73.92 165.56 24.9 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 109.662 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 432' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' B' ' 432' ' ' ASP . 25.4 p-10 -61.68 -34.12 75.2 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.298 -0.876 . . . . 0.0 109.335 179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 433' ' ' ASP . . . . . 0.582 ' CB ' ' CB ' ' B' ' 456' ' ' LEU . 5.2 m-20 -63.4 -49.21 74.69 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.285 -0.884 . . . . 0.0 109.072 179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 434' ' ' LEU . . . . . 0.836 HD13 ' O ' ' B' ' 434' ' ' LEU . 3.4 tm? -67.1 -40.03 86.85 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.34 -0.85 . . . . 0.0 109.488 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 435' ' ' LEU . . . . . 0.593 HD13 ' O ' ' B' ' 435' ' ' LEU . 0.2 OUTLIER -72.72 -35.55 67.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.536 179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 436' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -88.57 4.68 46.03 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.215 -0.928 . . . . 0.0 109.572 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 437' ' ' LEU . . . . . 0.649 HD23 HG21 ' B' ' 440' ' ' VAL . 31.8 tp -71.98 132.76 44.76 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.171 -0.956 . . . . 0.0 109.51 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 438' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -76.78 141.59 40.71 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.306 -0.871 . . . . 0.0 109.453 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 439' ' ' GLY . . . . . . . . . . . . . . . 92.2 9.39 62.05 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 440' ' ' VAL . . . . . 0.649 HG21 HD23 ' B' ' 437' ' ' LEU . 47.9 t -125.89 131.52 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.28 -1.129 . . . . 0.0 109.422 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 441' ' ' ASP . . . . . 0.645 ' H ' HD12 ' B' ' 444' ' ' LEU . 86.8 m-20 -97.64 160.66 14.18 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.272 -0.893 . . . . 0.0 109.406 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 442' ' ' ARG . . . . . 0.422 ' O ' ' CD2' ' B' ' 446' ' ' PHE . 93.7 mtt180 -52.08 -41.35 62.31 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.157 -0.964 . . . . 0.0 109.508 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 443' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -67.03 -42.29 85.15 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.449 179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 444' ' ' LEU . . . . . 0.645 HD12 ' H ' ' B' ' 441' ' ' ASP . 53.6 mt -64.98 -42.56 94.44 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.228 -0.92 . . . . 0.0 109.427 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 445' ' ' ALA . . . . . 0.5 ' HA ' HD11 ' B' ' 434' ' ' LEU . . . -59.18 -41.46 88.51 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.25 -0.906 . . . . 0.0 109.456 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 446' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' B' ' 442' ' ' ARG . 10.3 m-30 -64.14 -40.5 96.28 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.489 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 447' ' ' LYS . . . . . 0.514 ' HB3' HD13 ' B' ' 470' ' ' ILE . 66.5 mttm -61.68 -41.23 97.29 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.371 -0.831 . . . . 0.0 109.458 -179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 448' ' ' LEU . . . . . 0.496 HD21 HD11 ' B' ' 473' ' ' LEU . 80.9 mt -64.86 -39.22 93.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.283 -0.886 . . . . 0.0 109.485 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 449' ' ' ALA . . . . . 0.838 ' HB1' ' O ' ' B' ' 428' ' ' ASN . . . -67.06 -37.46 84.08 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.303 -0.873 . . . . 0.0 109.533 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 450' ' ' ALA . . . . . . . . . . . . . . . -52.97 -32.97 49.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 0.0 109.485 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 451' ' ' ARG . . . . . 0.493 ' NH1' ' O ' ' B' ' 466' ' ' ASP . 35.3 mtm105 -89.7 23.34 2.71 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.156 -0.965 . . . . 0.0 109.53 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 452' ' ' GLY . . . . . . . . . . . . . . . 79.63 -18.74 6.77 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 453' ' ' VAL . . . . . 0.682 HG21 ' HG3' ' B' ' 462' ' ' GLN . 8.9 t -81.84 107.24 13.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.896 -1.355 . . . . 0.0 109.314 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 454' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' B' ' 434' ' ' LEU . 60.4 m -123.74 -44.38 2.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.903 . . . . 0.0 109.697 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 455' ' ' THR . . . . . 0.69 ' HA ' ' HB3' ' B' ' 431' ' ' ALA . 0.2 OUTLIER -71.97 140.84 49.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.241 -0.912 . . . . 0.0 109.591 -179.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 456' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' B' ' 485' ' ' ALA . 2.6 tm? -51.76 -37.91 53.25 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.298 -0.876 . . . . 0.0 109.14 179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 457' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -63.07 -40.83 98.82 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.147 -0.971 . . . . 0.0 108.743 179.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 458' ' ' ASP . . . . . 0.546 ' HB3' HG13 ' B' ' 453' ' ' VAL . 68.7 m-20 -60.77 -42.33 97.25 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.417 -0.802 . . . . 0.0 109.089 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 459' ' ' LEU . . . . . 0.763 HD13 ' O ' ' B' ' 459' ' ' LEU . 3.5 tm? -59.65 -41.84 91.45 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.102 179.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 460' ' ' ALA . . . . . . . . . . . . . . . -61.88 -33.37 74.08 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.288 -0.883 . . . . 0.0 109.394 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 461' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.68 -25.76 62.24 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.246 -0.909 . . . . 0.0 109.442 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 462' ' ' GLN . . . . . 0.682 ' HG3' HG21 ' B' ' 453' ' ' VAL . 98.3 mm-40 -67.79 163.11 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.883 . . . . 0.0 109.535 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 463' ' ' GLY . . . . . . . . . . . . . . . -120.66 156.86 15.98 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 464' ' ' ILE . . . . . 1.001 HD11 ' HG2' ' A' ' 293' ' ' PRO . 58.6 mt -51.94 -34.95 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -1.182 . . . . 0.0 109.495 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 465' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -68.48 -35.95 78.25 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.298 -0.876 . . . . 0.0 109.552 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 466' ' ' ASP . . . . . 0.493 ' O ' ' NH1' ' B' ' 451' ' ' ARG . 87.3 m-20 -72.34 -31.52 65.71 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.193 -0.942 . . . . 0.0 109.45 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 467' ' ' LEU . . . . . 1.024 HD12 ' HB1' ' B' ' 478' ' ' ALA . 21.7 mt -74.41 -25.34 59.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.198 -0.939 . . . . 0.0 109.433 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 468' ' ' ALA . . . . . . . . . . . . . . . -59.95 -24.27 64.24 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.311 -0.868 . . . . 0.0 109.465 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 469' ' ' ASP . . . . . . . . . . . . . 88.9 m-20 -48.06 -33.58 8.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.529 179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 470' ' ' ILE . . . . . 0.514 HD13 ' HB3' ' B' ' 447' ' ' LYS . 61.3 mt -103.36 128.1 56.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.29 -0.881 . . . . 0.0 109.573 -179.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 471' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -62.37 -31.82 72.53 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.297 -0.877 . . . . 0.0 109.42 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 472' ' ' GLY . . . . . 0.484 ' H ' HG22 ' B' ' 470' ' ' ILE . . . -56.81 -30.92 60.39 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.454 -1.459 . . . . 0.0 109.454 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 473' ' ' LEU . . . . . 0.496 HD11 HD21 ' B' ' 448' ' ' LEU . 73.8 mt -101.53 131.03 47.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -1.185 . . . . 0.0 109.579 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 474' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -103.84 163.35 12.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.318 -0.864 . . . . 0.0 109.387 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 475' ' ' ASP . . . . . 0.473 ' HA ' ' CG2' ' B' ' 464' ' ' ILE . 88.3 m-20 -57.87 -38.19 75.29 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.198 -0.939 . . . . 0.0 109.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 476' ' ' GLU . . . . . . . . . . . . . 82.2 tt0 -73.81 -46.04 47.73 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -0.942 . . . . 0.0 109.474 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 477' ' ' LYS . . . . . 0.533 ' O ' HD13 ' B' ' 481' ' ' LEU . 15.7 tttp -64.78 -42.44 95.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.21 -0.931 . . . . 0.0 109.493 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 478' ' ' ALA . . . . . 1.024 ' HB1' HD12 ' B' ' 467' ' ' LEU . . . -61.55 -46.03 91.66 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.273 -0.892 . . . . 0.0 109.506 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 479' ' ' GLY . . . . . 0.457 ' CA ' ' HG3' ' A' ' 293' ' ' PRO . . . -57.33 -45.98 92.26 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.414 -1.475 . . . . 0.0 109.414 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 480' ' ' ALA . . . . . . . . . . . . . . . -58.11 -41.91 84.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.303 -1.116 . . . . 0.0 109.535 179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 481' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 477' ' ' LYS . 8.4 mp -63.88 -36.91 85.48 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.309 -0.87 . . . . 0.0 109.483 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 482' ' ' ILE . . . . . 0.902 HD12 ' HB2' ' A' ' 293' ' ' PRO . 47.9 mt -66.89 -54.92 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.304 -0.873 . . . . 0.0 109.682 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 483' ' ' MET . . . . . 0.542 ' CE ' ' HB3' ' A' ' 291' ' ' LYS . 49.1 mtp -52.22 -37.41 55.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 109.395 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 484' ' ' ALA . . . . . 0.454 ' O ' HG13 ' B' ' 488' ' ' ILE . . . -69.49 -57.13 5.61 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.186 -0.946 . . . . 0.0 109.167 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 485' ' ' ALA . . . . . 0.678 ' HB2' HD21 ' B' ' 456' ' ' LEU . . . -62.87 -52.09 64.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.304 -0.873 . . . . 0.0 109.35 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 486' ' ' ARG . . . . . 0.4 ' C ' ' O ' ' B' ' 485' ' ' ALA . 21.6 ttm180 -46.27 -48.77 17.96 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.203 179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 487' ' ' ASN . . . . . 0.459 ' ND2' ' O ' ' B' ' 483' ' ' MET . 89.2 m-20 -58.95 -41.5 87.58 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.309 -0.869 . . . . 0.0 109.397 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 488' ' ' ILE . . . . . 0.477 ' O ' ' N ' ' B' ' 492' ' ' GLY . 80.2 mt -58.93 -37.61 68.29 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.317 -0.864 . . . . 0.0 109.445 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 489' ' ' CYS . . . . . . . . . . . . . 41.7 t -70.58 -49.12 51.22 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.292 -0.88 . . . . 0.0 109.606 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 490' ' ' TRP . . . . . . . . . . . . . 94.8 m95 -70.41 -41.77 72.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.177 -0.952 . . . . 0.0 109.537 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 491' ' ' PHE . . . . . 0.456 ' HB2' ' O ' ' B' ' 487' ' ' ASN . 46.1 m-85 -79.78 -36.06 37.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.2 -0.938 . . . . 0.0 109.676 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 492' ' ' GLY . . . . . 0.513 ' O ' ' N ' ' B' ' 494' ' ' GLU . . . 66.08 9.51 47.97 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 -179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 493' ' ' ASP . . . . . 0.427 ' OD1' HG23 ' B' ' 488' ' ' ILE . 1.0 OUTLIER 63.96 -72.68 0.05 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.283 -1.127 . . . . 0.0 109.607 179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 494' ' ' GLU . . . . . 0.67 ' O ' ' HB3' ' B' ' 495' ' ' ALA . 89.2 mt-10 -91.28 150.65 21.23 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.184 -0.947 . . . . 0.0 109.441 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 495' ' ' ALA . . . . . 0.67 ' HB3' ' O ' ' B' ' 494' ' ' GLU . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.981 -1.009 . . . . 0.0 109.506 179.878 . . . . . . . . 1 1 . 1 stop_ save_